country,term,count
DZ,LOSS OF CONSCIOUSNESS,3
DZ,OEDEMA PERIPHERAL,3
DZ,SUICIDE ATTEMPT,3
DZ,CHRONIC KIDNEY DISEASE,2
DZ,INTENTIONAL OVERDOSE,2
DZ,PRURITUS,2
DZ,RASH,2
DZ,RESPIRATORY DISTRESS,2
DZ,SKIN DISORDER,2
DZ,SOMNOLENCE,2
DZ,VERTIGO,2
DZ,VOMITING,2
DZ,ACUTE KIDNEY INJURY,1
DZ,ALTERED STATE OF CONSCIOUSNESS,1
DZ,ANAPHYLACTIC SHOCK,1
DZ,ANGIOEDEMA,1
DZ,ASTHENIA,1
DZ,ASTHENOPIA,1
DZ,BALANCE DISORDER,1
DZ,BLISTER,1
DZ,BLOOD PRESSURE DECREASED,1
DZ,CARDIAC DISORDER,1
DZ,CARDIAC FAILURE,1
DZ,CARDIOPULMONARY FAILURE,1
DZ,CELL DEATH,1
DZ,CHOKING,1
DZ,CHOLESTASIS,1
DZ,COMA,1
DZ,CONFUSIONAL STATE,1
DZ,DERMATITIS BULLOUS,1
DZ,DIARRHOEA,1
DZ,DROOLING,1
DZ,DRUG INEFFECTIVE,1
DZ,DRY SKIN,1
DZ,EPISTAXIS,1
DZ,FLUSHING,1
DZ,GAIT DISTURBANCE,1
DZ,GENERALISED TONIC-CLONIC SEIZURE,1
DZ,GENITAL HAEMORRHAGE,1
DZ,GOUT,1
DZ,HAEMORRHAGE,1
DZ,HALLUCINATION,1
DZ,HEPATOCELLULAR INJURY,1
DZ,HYPERGLYCAEMIA,1
DZ,HYPOTENSION,1
DZ,HYPOVOLAEMIC SHOCK,1
DZ,INCOHERENT,1
DZ,INSOMNIA,1
DZ,INTENTIONAL PRODUCT MISUSE,1
DZ,IRRITABILITY,1
DZ,ISCHAEMIC STROKE,1
DZ,LARYNGEAL DISCOMFORT,1
DZ,LIP OEDEMA,1
DZ,LYMPHADENOPATHY,1
DZ,MYALGIA,1
DZ,OEDEMA DUE TO HEPATIC DISEASE,1
DZ,OVERDOSE,1
DZ,PAIN OF SKIN,1
DZ,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
DZ,PALPITATIONS,1
DZ,POLYDIPSIA,1
DZ,POLYURIA,1
DZ,PRODUCT USE ISSUE,1
DZ,RASH GENERALISED,1
DZ,RASH PRURITIC,1
DZ,SPEECH DISORDER,1
DZ,STUPOR,1
DZ,SWOLLEN TONGUE,1
DZ,TOXIC SKIN ERUPTION,1
DZ,TREMOR,1
DZ,VISUAL IMPAIRMENT,1
AR,PAIN,14
AR,FALL,9
AR,MALAISE,9
AR,ARTHRALGIA,8
AR,GAIT DISTURBANCE,8
AR,DRUG INEFFECTIVE,7
AR,BACK PAIN,6
AR,COMA,6
AR,DYSPNOEA,6
AR,CATARACT,5
AR,DIZZINESS,5
AR,FATIGUE,5
AR,HYPERTENSION,5
AR,MEMORY IMPAIRMENT,5
AR,MENTAL DISORDER,5
AR,MUSCULAR WEAKNESS,5
AR,OEDEMA,5
AR,PAIN IN EXTREMITY,5
AR,ANXIETY,4
AR,BLINDNESS,4
AR,DEPRESSION,4
AR,HEADACHE,4
AR,HYPERSENSITIVITY,4
AR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,4
AR,LIVER DISORDER,4
AR,LOCAL SWELLING,4
AR,LOSS OF CONSCIOUSNESS,4
AR,MALIGNANT NEOPLASM PROGRESSION,4
AR,PNEUMONIA,4
AR,PYREXIA,4
AR,SPINAL DISORDER,4
AR,VISUAL IMPAIRMENT,4
AR,WEIGHT DECREASED,4
AR,WEIGHT INCREASED,4
AR,ANAEMIA,3
AR,BONE PAIN,3
AR,BRONCHITIS,3
AR,DEATH,3
AR,DISEASE PROGRESSION,3
AR,DYSPHONIA,3
AR,ELECTROCARDIOGRAM QT PROLONGED,3
AR,GLAUCOMA,3
AR,INTENTIONAL OVERDOSE,3
AR,MUSCULOSKELETAL PAIN,3
AR,NECK PAIN,3
AR,OCULAR HYPERAEMIA,3
AR,OSTEOARTHRITIS,3
AR,PHARYNGITIS,3
AR,SENSORY DISTURBANCE,3
AR,SKIN ULCER,3
AR,SPEECH DISORDER,3
AR,VIRAL INFECTION,3
AR,ABASIA,2
AR,ABDOMINAL PAIN,2
AR,ACNE,2
AR,ALOPECIA,2
AR,BLOOD CHOLESTEROL DECREASED,2
AR,BLOOD CREATININE INCREASED,2
AR,BLOOD PRESSURE INCREASED,2
AR,BLOOD TRIGLYCERIDES DECREASED,2
AR,C-REACTIVE PROTEIN DECREASED,2
AR,CARDIOMYOPATHY,2
AR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
AR,CONDITION AGGRAVATED,2
AR,COUGH,2
AR,DIABETES MELLITUS,2
AR,DIARRHOEA,2
AR,DRY EYE,2
AR,ECZEMA,2
AR,GAIT INABILITY,2
AR,GASTRIC DISORDER,2
AR,GENERAL PHYSICAL HEALTH DETERIORATION,2
AR,HAEMORRHAGIC STROKE,2
AR,HYPOGLYCAEMIA,2
AR,HYPONATRAEMIA,2
AR,HYPOTENSION,2
AR,INTESTINAL ISCHAEMIA,2
AR,INTESTINAL PERFORATION,2
AR,LEUKOPENIA,2
AR,LUMBAR VERTEBRAL FRACTURE,2
AR,MACULOPATHY,2
AR,MIGRAINE,2
AR,MOBILITY DECREASED,2
AR,MYOCARDIAL INFARCTION,2
AR,NERVOUSNESS,2
AR,NUCHAL RIGIDITY,2
AR,PARAESTHESIA,2
AR,PNEUMONIA PNEUMOCOCCAL,2
AR,POLYNEUROPATHY,2
AR,PROSTATE CANCER,2
AR,RASH,2
AR,RENAL FAILURE,2
AR,RESPIRATORY FAILURE,2
AR,SOMNOLENCE,2
AR,STRESS,2
AR,THYROID DISORDER,2
AR,TRIGEMINAL PALSY,2
AR,URINARY TRACT INFECTION,2
AR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,2
AR,XEROPHTHALMIA,2
AR,ABDOMINAL DISCOMFORT,1
AR,ABDOMINAL DISTENSION,1
AR,ABDOMINAL PAIN UPPER,1
AR,ABORTION SPONTANEOUS,1
AR,AGITATION,1
AR,AMNESIA,1
AR,ANAL FISSURE,1
AR,ANAL FISTULA,1
AR,ANGINA UNSTABLE,1
AR,ANKLE FRACTURE,1
AR,ANKYLOSING SPONDYLITIS,1
AR,APHASIA,1
AR,APPARENT DEATH,1
AR,ARRHYTHMIA,1
AR,ARTHRITIS,1
AR,ARTHROPATHY,1
AR,ASTHENIA,1
AR,ATRIOVENTRICULAR BLOCK,1
AR,AUTONOMIC NERVOUS SYSTEM IMBALANCE,1
AR,BACTERAEMIA,1
AR,BACTERIAL TRANSLOCATION,1
AR,BEDRIDDEN,1
AR,BLISTER,1
AR,BLOOD CHOLESTEROL INCREASED,1
AR,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
AR,BLOOD GLUCOSE INCREASED,1
AR,BLOOD PRESSURE DECREASED,1
AR,BLOOD PRESSURE DIASTOLIC DECREASED,1
AR,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
AR,BLOOD PRESSURE SYSTOLIC DECREASED,1
AR,BONE MARROW TUMOUR CELL INFILTRATION,1
AR,BONE SCAN ABNORMAL,1
AR,BRADYCARDIA,1
AR,BUNDLE BRANCH BLOCK LEFT,1
AR,BURNING SENSATION,1
AR,CARDIAC AUTONOMIC NEUROPATHY,1
AR,CARDIAC FAILURE CONGESTIVE,1
AR,CARDIAC MURMUR,1
AR,CARDIOVASCULAR DISORDER,1
AR,CAUDA EQUINA SYNDROME,1
AR,CELLULITIS,1
AR,CEREBROVASCULAR ACCIDENT,1
AR,COLITIS,1
AR,CONCOMITANT DISEASE AGGRAVATED,1
AR,CONSTIPATION,1
AR,CONVULSION,1
AR,CRITICAL ILLNESS,1
AR,CYANOSIS,1
AR,DEAFNESS,1
AR,DECREASED IMMUNE RESPONSIVENESS,1
AR,DEEP VEIN THROMBOSIS,1
AR,DEMYELINATING POLYNEUROPATHY,1
AR,DERMATITIS DIAPER,1
AR,DIABETES MELLITUS INADEQUATE CONTROL,1
AR,DIABETIC FOOT,1
AR,DISCOMFORT,1
AR,DIVERTICULITIS,1
AR,DRUG INTOLERANCE,1
AR,DRY MOUTH,1
AR,DRY SKIN,1
AR,DYSSTASIA,1
AR,DYSURIA,1
AR,EAR PAIN,1
AR,EMOTIONAL DISORDER,1
AR,EMOTIONAL DISTRESS,1
AR,ENTERAL NUTRITION,1
AR,ENTEROCOLITIS,1
AR,EPILEPSY,1
AR,ERYSIPELAS,1
AR,FEAR,1
AR,FEAR OF DEATH,1
AR,FEELING ABNORMAL,1
AR,FEELING HOT,1
AR,FEMUR FRACTURE,1
AR,FIBROMYALGIA,1
AR,FINGER DEFORMITY,1
AR,FLUID INTAKE REDUCED,1
AR,FLUID RETENTION,1
AR,FUNGAL INFECTION,1
AR,GINGIVAL BLEEDING,1
AR,GRANULOMA,1
AR,GROIN PAIN,1
AR,GUILLAIN-BARRE SYNDROME,1
AR,HAEMOCHROMATOSIS,1
AR,HAIR DISORDER,1
AR,HEART RATE DECREASED,1
AR,HEMIPLEGIA,1
AR,HEPATIC ENZYME INCREASED,1
AR,HEPATIC FUNCTION ABNORMAL,1
AR,HEPATITIS TOXIC,1
AR,HYPERGLYCAEMIA,1
AR,HYPERHIDROSIS,1
AR,HYPERSOMNIA,1
AR,HYPOKINESIA,1
AR,HYPOTONIA,1
AR,INCORRECT DOSE ADMINISTERED,1
AR,INFLUENZA LIKE ILLNESS,1
AR,INJECTION SITE ABSCESS,1
AR,INJURY,1
AR,INTERVERTEBRAL DISC PROTRUSION,1
AR,KIDNEY INFECTION,1
AR,LABORATORY TEST ABNORMAL,1
AR,LARGE INTESTINAL OBSTRUCTION,1
AR,LARGE INTESTINE BENIGN NEOPLASM,1
AR,LARYNGEAL OEDEMA,1
AR,LEUKOENCEPHALOPATHY,1
AR,LIGAMENT SPRAIN,1
AR,LOCALISED INFECTION,1
AR,LUNG NEOPLASM,1
AR,MATERNAL EXPOSURE DURING PREGNANCY,1
AR,MENISCUS OPERATION,1
AR,METASTASES TO LIVER,1
AR,METASTASES TO LUNG,1
AR,MOLLUSCUM CONTAGIOSUM,1
AR,MOVEMENT DISORDER,1
AR,MULTI-ORGAN FAILURE,1
AR,MULTIPLE SCLEROSIS RELAPSE,1
AR,MUSCLE SPASMS,1
AR,MYALGIA,1
AR,MYOPIA,1
AR,NEOPLASM MALIGNANT,1
AR,NERVE INJURY,1
AR,NERVE ROOT COMPRESSION,1
AR,NEURITIS,1
AR,NEUROENDOCRINE TUMOUR,1
AR,NEUTROPENIA,1
AR,NOCTURIA,1
AR,ONYCHOCLASIS,1
AR,ONYCHOMADESIS,1
AR,ORAL CANDIDIASIS,1
AR,ORAL FUNGAL INFECTION,1
AR,OROPHARYNGEAL PAIN,1
AR,OSTEOPOROSIS,1
AR,PALLOR,1
AR,PANIC REACTION,1
AR,PARALYSIS,1
AR,PARESIS,1
AR,PARESIS ANAL SPHINCTER,1
AR,PARKINSON^S DISEASE,1
AR,PARONYCHIA,1
AR,PARTIAL SEIZURES,1
AR,PERITONITIS,1
AR,PERITONITIS BACTERIAL,1
AR,PETECHIAE,1
AR,PITUITARY TUMOUR,1
AR,PLASMA CELL MYELOMA,1
AR,PLEURAL DISORDER,1
AR,PLEURAL EFFUSION,1
AR,POLYMYOSITIS,1
AR,POLYURIA,1
AR,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,1
AR,POSTOPERATIVE WOUND COMPLICATION,1
AR,PRESBYOPIA,1
AR,PRESYNCOPE,1
AR,PRODUCT USE ISSUE,1
AR,PRODUCTIVE COUGH,1
AR,PRURITUS,1
AR,PSORIASIS,1
AR,PSYCHIATRIC DECOMPENSATION,1
AR,PSYCHOTIC DISORDER,1
AR,PULMONARY OEDEMA,1
AR,PYELONEPHRITIS ACUTE,1
AR,QUADRIPARESIS,1
AR,RALES,1
AR,RED BLOOD CELL COUNT DECREASED,1
AR,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
AR,RENAL DISORDER,1
AR,RENAL FAILURE ACUTE,1
AR,RENAL IMPAIRMENT,1
AR,RESPIRATORY TRACT INFECTION,1
AR,RHEUMATOID ARTHRITIS,1
AR,SCIATICA,1
AR,SECRETION DISCHARGE,1
AR,SEPSIS,1
AR,SKIN DISCOLOURATION,1
AR,SNEEZING,1
AR,SPINAL COMPRESSION FRACTURE,1
AR,SPINAL CORD COMPRESSION,1
AR,SPINAL PAIN,1
AR,SPONDYLOLISTHESIS,1
AR,STATUS EPILEPTICUS,1
AR,STOMATITIS,1
AR,SWELLING FACE,1
AR,SWOLLEN TONGUE,1
AR,SYNCOPE,1
AR,TACHYCARDIA,1
AR,TENDON DISORDER,1
AR,THERAPEUTIC PROCEDURE,1
AR,THERAPEUTIC RESPONSE DECREASED,1
AR,THROMBOSIS,1
AR,TOBACCO WITHDRAWAL SYMPTOMS,1
AR,TOXIC SKIN ERUPTION,1
AR,TOXICITY TO VARIOUS AGENTS,1
AR,TRANSAMINASES INCREASED,1
AR,TRANSFERRIN INCREASED,1
AR,TRIGEMINAL NEURALGIA,1
AR,TRISMUS,1
AR,TROPONIN INCREASED,1
AR,TUBULOINTERSTITIAL NEPHRITIS,1
AR,UNDERDOSE,1
AR,UPPER EXTREMITY MASS,1
AR,UVEITIS,1
AR,VASCULAR COMPRESSION,1
AR,VISUAL ACUITY REDUCED,1
AR,VOMITING,1
AR,WEIGHT FLUCTUATION,1
AR,WHITE BLOOD CELL COUNT DECREASED,1
AR,WRIST FRACTURE,1
AU,NAUSEA,51
AU,DIZZINESS,48
AU,PAIN,47
AU,DIARRHOEA,45
AU,PYREXIA,43
AU,MALAISE,42
AU,HEADACHE,39
AU,FALL,38
AU,FATIGUE,37
AU,SUICIDAL IDEATION,37
AU,DEPRESSION,34
AU,SOMNOLENCE,34
AU,VOMITING,32
AU,CONFUSIONAL STATE,31
AU,WEIGHT INCREASED,31
AU,BACK PAIN,27
AU,DRUG INEFFECTIVE,27
AU,DYSPNOEA,27
AU,CONSTIPATION,25
AU,ARTHRALGIA,24
AU,ASTHENIA,24
AU,GAIT DISTURBANCE,24
AU,TREMOR,24
AU,MUSCLE SPASMS,23
AU,URINARY TRACT INFECTION,23
AU,ANXIETY,22
AU,HYPERTENSION,21
AU,INSOMNIA,21
AU,MUSCULAR WEAKNESS,21
AU,OVERDOSE,21
AU,PAIN IN EXTREMITY,21
AU,FEELING ABNORMAL,20
AU,TOXICITY TO VARIOUS AGENTS,20
AU,ABDOMINAL PAIN,18
AU,LOSS OF CONSCIOUSNESS,18
AU,PERICARDITIS,17
AU,SEPSIS,17
AU,DELIRIUM,16
AU,DRY MOUTH,16
AU,HYPERHIDROSIS,16
AU,OEDEMA PERIPHERAL,16
AU,PERIPHERAL SWELLING,16
AU,PNEUMONIA,16
AU,VISION BLURRED,16
AU,CEREBROVASCULAR ACCIDENT,15
AU,PARAESTHESIA,15
AU,ANAEMIA,14
AU,ATRIAL FIBRILLATION,14
AU,BALANCE DISORDER,14
AU,DRUG ABUSE,14
AU,DRUG WITHDRAWAL SYNDROME,14
AU,MYOCARDITIS,14
AU,NEUTROPENIA,14
AU,SEIZURE,14
AU,AGGRESSION,13
AU,CHEST PAIN,13
AU,DEATH,13
AU,DEPRESSED LEVEL OF CONSCIOUSNESS,13
AU,HYPOAESTHESIA,13
AU,HYPOTENSION,13
AU,MALIGNANT NEOPLASM PROGRESSION,13
AU,PRURITUS,13
AU,ABNORMAL BEHAVIOUR,12
AU,BLOOD GLUCOSE INCREASED,12
AU,CHEST DISCOMFORT,12
AU,DECREASED APPETITE,12
AU,DISEASE PROGRESSION,12
AU,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,12
AU,ACUTE KIDNEY INJURY,11
AU,CONDITION AGGRAVATED,11
AU,HALLUCINATION,11
AU,IRRITABILITY,11
AU,LETHARGY,11
AU,MEMORY IMPAIRMENT,11
AU,NEURALGIA,11
AU,SYNCOPE,11
AU,URINARY INCONTINENCE,11
AU,ABASIA,10
AU,ACTIVITIES OF DAILY LIVING IMPAIRED,10
AU,COGNITIVE DISORDER,10
AU,DEPRESSED MOOD,10
AU,DYSPEPSIA,10
AU,MIGRAINE,10
AU,MOBILITY DECREASED,10
AU,MYALGIA,10
AU,PANIC ATTACK,10
AU,WHITE BLOOD CELL COUNT DECREASED,10
AU,ALOPECIA,9
AU,BLOOD CREATINE PHOSPHOKINASE INCREASED,9
AU,DRUG DEPENDENCE,9
AU,GASTROOESOPHAGEAL REFLUX DISEASE,9
AU,LIVER FUNCTION TEST ABNORMAL,9
AU,MITRAL VALVE INCOMPETENCE,9
AU,PLATELET COUNT DECREASED,9
AU,SPEECH DISORDER,9
AU,SUICIDE ATTEMPT,9
AU,VITAMIN D DECREASED,9
AU,ABDOMINAL PAIN UPPER,8
AU,BRADYCARDIA,8
AU,CARDIAC FAILURE,8
AU,DEMENTIA,8
AU,ERYTHEMA,8
AU,HYPERKALAEMIA,8
AU,HYPOKALAEMIA,8
AU,INTERVERTEBRAL DISC PROTRUSION,8
AU,JOINT SWELLING,8
AU,MOUTH ULCERATION,8
AU,PERICARDIAL EFFUSION,8
AU,PRODUCT USE ISSUE,8
AU,PULMONARY EMBOLISM,8
AU,RASH,8
AU,RENAL FAILURE ACUTE,8
AU,RENAL IMPAIRMENT,8
AU,SWELLING FACE,8
AU,TINNITUS,8
AU,TRICUSPID VALVE INCOMPETENCE,8
AU,AMNESIA,7
AU,ANGER,7
AU,ANTIPSYCHOTIC DRUG LEVEL DECREASED,7
AU,BACK DISORDER,7
AU,BLOOD ALBUMIN DECREASED,7
AU,BLOOD BICARBONATE INCREASED,7
AU,C-REACTIVE PROTEIN DECREASED,7
AU,CARDIAC DISORDER,7
AU,CELLULITIS,7
AU,CHILLS,7
AU,COUGH,7
AU,DEHYDRATION,7
AU,FLUID RETENTION,7
AU,HAEMOGLOBIN DECREASED,7
AU,IMPAIRED DRIVING ABILITY,7
AU,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,7
AU,INFECTION,7
AU,INFLUENZA LIKE ILLNESS,7
AU,INTENTIONAL OVERDOSE,7
AU,IRON DEFICIENCY,7
AU,LOWER RESPIRATORY TRACT INFECTION,7
AU,LYMPHADENOPATHY MEDIASTINAL,7
AU,MULTIPLE SCLEROSIS RELAPSE,7
AU,MUSCULOSKELETAL PAIN,7
AU,NECK PAIN,7
AU,OROPHARYNGEAL PAIN,7
AU,PALPITATIONS,7
AU,PHARYNGITIS,7
AU,PROTEIN TOTAL DECREASED,7
AU,RHEUMATOID ARTHRITIS,7
AU,SCHIZOPHRENIA,7
AU,SPLENOMEGALY,7
AU,TACHYCARDIA,7
AU,VISUAL IMPAIRMENT,7
AU,WEIGHT DECREASED,7
AU,ALANINE AMINOTRANSFERASE INCREASED,6
AU,ANAPHYLACTIC REACTION,6
AU,ARTHROPATHY,6
AU,ASTHMA,6
AU,BLOOD CHLORIDE DECREASED,6
AU,BLOOD PHOSPHORUS INCREASED,6
AU,BLOOD UREA DECREASED,6
AU,CONVULSION,6
AU,DRUG EFFECT INCOMPLETE,6
AU,DRUG HYPERSENSITIVITY,6
AU,DRUG USE DISORDER,6
AU,DYSPHAGIA,6
AU,EYE PAIN,6
AU,FEELING DRUNK,6
AU,FEELING HOT,6
AU,HAEMATOCRIT INCREASED,6
AU,HYPOCALCAEMIA,6
AU,INFLAMMATION,6
AU,IRON DEFICIENCY ANAEMIA,6
AU,MONOCYTE COUNT DECREASED,6
AU,MUSCULOSKELETAL STIFFNESS,6
AU,NASOPHARYNGITIS,6
AU,RECTAL HAEMORRHAGE,6
AU,ROAD TRAFFIC ACCIDENT,6
AU,SEDATION,6
AU,SYSTEMIC LUPUS ERYTHEMATOSUS,6
AU,URINARY RETENTION,6
AU,URTICARIA,6
AU,ARTHRITIS,5
AU,BLOOD PRESSURE INCREASED,5
AU,BRONCHITIS,5
AU,BURNING SENSATION,5
AU,COMPLETED SUICIDE,5
AU,CRYING,5
AU,DISORIENTATION,5
AU,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,5
AU,DRUG PRESCRIBING ERROR,5
AU,DYSARTHRIA,5
AU,DYSKINESIA,5
AU,DYSSTASIA,5
AU,EMOTIONAL DISTRESS,5
AU,FLUSHING,5
AU,GAMMA-GLUTAMYLTRANSFERASE INCREASED,5
AU,GASTROINTESTINAL HAEMORRHAGE,5
AU,GENERAL PHYSICAL HEALTH DETERIORATION,5
AU,HAEMATURIA,5
AU,HEPATIC FAILURE,5
AU,HEPATIC STEATOSIS,5
AU,HYPERCALCAEMIA,5
AU,HYPERSENSITIVITY,5
AU,HYPOGLYCAEMIA,5
AU,HYPONATRAEMIA,5
AU,IMPAIRED HEALING,5
AU,INFLUENZA,5
AU,JAUNDICE,5
AU,LACRIMATION INCREASED,5
AU,MENTAL IMPAIRMENT,5
AU,MYOCARDIAL INFARCTION,5
AU,NIGHT SWEATS,5
AU,OSTEOARTHRITIS,5
AU,PLASMA CELL MYELOMA,5
AU,PNEUMONIA ASPIRATION,5
AU,PSYCHOTIC DISORDER,5
AU,RASH ERYTHEMATOUS,5
AU,RESPIRATORY DEPRESSION,5
AU,RESPIRATORY FAILURE,5
AU,RHABDOMYOLYSIS,5
AU,SCIATICA,5
AU,SECONDARY ADRENOCORTICAL INSUFFICIENCY,5
AU,SKIN ULCER,5
AU,STOMATITIS,5
AU,TARDIVE DYSKINESIA,5
AU,TREATMENT NONCOMPLIANCE,5
AU,TROPONIN INCREASED,5
AU,VIRAL INFECTION,5
AU,WITHDRAWAL SYNDROME,5
AU,ABDOMINAL DISCOMFORT,4
AU,ADRENAL INSUFFICIENCY,4
AU,AGITATION,4
AU,ANKLE FRACTURE,4
AU,APHASIA,4
AU,ASPARTATE AMINOTRANSFERASE INCREASED,4
AU,BEDRIDDEN,4
AU,BLISTER,4
AU,BLOOD BILIRUBIN INCREASED,4
AU,BLOOD CHOLESTEROL INCREASED,4
AU,BLOOD POTASSIUM DECREASED,4
AU,BLOOD PRESSURE DECREASED,4
AU,BLOOD URIC ACID DECREASED,4
AU,BODY MASS INDEX INCREASED,4
AU,BONE PAIN,4
AU,C-REACTIVE PROTEIN INCREASED,4
AU,CARDIAC ARREST,4
AU,CARDIAC FAILURE CONGESTIVE,4
AU,CHOLELITHIASIS,4
AU,COLITIS,4
AU,COMA SCALE ABNORMAL,4
AU,CONTUSION,4
AU,DEEP VEIN THROMBOSIS,4
AU,DELUSION,4
AU,DIPLOPIA,4
AU,DISEASE RECURRENCE,4
AU,DISTURBANCE IN ATTENTION,4
AU,DRUG DISPENSING ERROR,4
AU,DRUG DOSE OMISSION,4
AU,DRUG-INDUCED LIVER INJURY,4
AU,ENCEPHALOPATHY,4
AU,FEBRILE NEUTROPENIA,4
AU,GASTRIC ULCER,4
AU,GLAUCOMA,4
AU,GLOMERULAR FILTRATION RATE DECREASED,4
AU,HAEMATOCHEZIA,4
AU,HAEMORRHAGE,4
AU,HEPATIC ENZYME INCREASED,4
AU,HERPES ZOSTER,4
AU,HOT FLUSH,4
AU,LIP SWELLING,4
AU,LIVER DISORDER,4
AU,LOCAL SWELLING,4
AU,LYMPHOCYTE COUNT DECREASED,4
AU,MENTAL DISORDER,4
AU,MUSCLE SPASTICITY,4
AU,MYOCLONUS,4
AU,NERVOUS SYSTEM DISORDER,4
AU,NEUROPATHY PERIPHERAL,4
AU,ORAL HERPES,4
AU,OSTEOMYELITIS,4
AU,PAIN IN JAW,4
AU,PANCREATITIS,4
AU,PARALYSIS,4
AU,PHOTOPHOBIA,4
AU,POLYURIA,4
AU,POOR QUALITY SLEEP,4
AU,PRESYNCOPE,4
AU,PULMONARY OEDEMA,4
AU,RASH PRURITIC,4
AU,SLEEP APNOEA SYNDROME,4
AU,SLEEP DISORDER,4
AU,SPINAL PAIN,4
AU,STRESS,4
AU,TEMPERATURE INTOLERANCE,4
AU,THERAPEUTIC RESPONSE UNEXPECTED,4
AU,TOOTH INFECTION,4
AU,TREATMENT FAILURE,4
AU,UPPER RESPIRATORY TRACT INFECTION,4
AU,VERTIGO,4
AU,VITAMIN D DEFICIENCY,4
AU,WRONG DRUG ADMINISTERED,4
AU,ABDOMINAL DISTENSION,3
AU,ACUTE MYOCARDIAL INFARCTION,3
AU,ADVERSE DRUG REACTION,3
AU,BASAL CELL CARCINOMA,3
AU,BILIARY SEPSIS,3
AU,BLOOD ALKALINE PHOSPHATASE INCREASED,3
AU,BLOOD CREATININE INCREASED,3
AU,BLOOD SODIUM DECREASED,3
AU,BLOOD UREA INCREASED,3
AU,BODY TEMPERATURE INCREASED,3
AU,BREAST CANCER,3
AU,CARPAL TUNNEL SYNDROME,3
AU,CHOLANGITIS,3
AU,CHROMATURIA,3
AU,COORDINATION ABNORMAL,3
AU,CROHN^S DISEASE,3
AU,DIVERTICULITIS,3
AU,DIVERTICULUM,3
AU,DRUG ERUPTION,3
AU,DRUG INTOLERANCE,3
AU,DRUG TOLERANCE,3
AU,DRY EYE,3
AU,DRY SKIN,3
AU,DRY THROAT,3
AU,DYSGEUSIA,3
AU,DYSPHEMIA,3
AU,DYSURIA,3
AU,EPISTAXIS,3
AU,FEELING COLD,3
AU,FEMUR FRACTURE,3
AU,FIBRIN D DIMER INCREASED,3
AU,FOOT FRACTURE,3
AU,GASTROINTESTINAL DISORDER,3
AU,HALLUCINATION_ VISUAL,3
AU,HEAD INJURY,3
AU,HEART RATE INCREASED,3
AU,HIP FRACTURE,3
AU,HOMICIDAL IDEATION,3
AU,HOSPITALISATION,3
AU,HYPERCHOLESTEROLAEMIA,3
AU,HYPERGLYCAEMIA,3
AU,HYPERLIPIDAEMIA,3
AU,HYPOKINESIA,3
AU,HYPOPHAGIA,3
AU,INFUSION RELATED REACTION,3
AU,INJECTION SITE PAIN,3
AU,INTENTIONAL DRUG MISUSE,3
AU,INTENTIONAL PRODUCT MISUSE,3
AU,JOINT DISLOCATION,3
AU,LACTIC ACIDOSIS,3
AU,LIMB DISCOMFORT,3
AU,LIMB INJURY,3
AU,LIVER FUNCTION TEST INCREASED,3
AU,MAJOR DEPRESSION,3
AU,MALIGNANT BOWEL OBSTRUCTION,3
AU,MEDICATION ERROR,3
AU,MELAENA,3
AU,MOOD ALTERED,3
AU,MOVEMENT DISORDER,3
AU,MUSCULOSKELETAL CHEST PAIN,3
AU,MYELODYSPLASTIC SYNDROME,3
AU,MYOPATHY,3
AU,MYOSITIS,3
AU,NERVE INJURY,3
AU,NEUTROPHIL COUNT DECREASED,3
AU,OESOPHAGEAL DISCOMFORT,3
AU,OESOPHAGEAL PERFORATION,3
AU,OSTEOPOROTIC FRACTURE,3
AU,PARANOIA,3
AU,PARKINSON^S DISEASE,3
AU,POLLAKIURIA,3
AU,POST PROCEDURAL COMPLICATION,3
AU,PRESCRIBED OVERDOSE,3
AU,PYODERMA GANGRENOSUM,3
AU,RASH GENERALISED,3
AU,RENAL CYST,3
AU,RENAL FAILURE,3
AU,RESPIRATORY TRACT INFECTION BACTERIAL,3
AU,RHINORRHOEA,3
AU,RIB FRACTURE,3
AU,SENSORY DISTURBANCE,3
AU,SINUS RHYTHM,3
AU,SINUSITIS,3
AU,SKIN DISCOLOURATION,3
AU,SKIN INFECTION,3
AU,SPINAL COLUMN STENOSIS,3
AU,SPINAL FRACTURE,3
AU,SPINAL OSTEOARTHRITIS,3
AU,SWELLING,3
AU,TEMPORAL ARTERITIS,3
AU,THROMBOCYTOPENIA,3
AU,THROMBOSIS,3
AU,TRANSAMINASES INCREASED,3
AU,TRANSIENT ISCHAEMIC ATTACK,3
AU,TYPE 2 DIABETES MELLITUS,3
AU,UNDERDOSE,3
AU,UROSEPSIS,3
AU,VISUAL ACUITY REDUCED,3
AU,VISUAL FIELD DEFECT,3
AU,VITAMIN B12 DEFICIENCY,3
AU,WHITE BLOOD CELL COUNT INCREASED,3
AU,ABNORMAL DREAMS,2
AU,ACCIDENTAL DEATH,2
AU,ACUTE RESPIRATORY DISTRESS SYNDROME,2
AU,ADVERSE EVENT,2
AU,ANKYLOSING SPONDYLITIS,2
AU,ANTICOAGULATION DRUG LEVEL INCREASED,2
AU,APATHY,2
AU,ATAXIA,2
AU,ATELECTASIS,2
AU,ATYPICAL PNEUMONIA,2
AU,BAND SENSATION,2
AU,BILE DUCT OBSTRUCTION,2
AU,BITE,2
AU,BLADDER DISORDER,2
AU,BLINDNESS,2
AU,BLOOD GLUCOSE ABNORMAL,2
AU,BLOOD PROLACTIN INCREASED,2
AU,BLOOD URINE PRESENT,2
AU,BODY TEMPERATURE ABNORMAL,2
AU,BRAIN INJURY,2
AU,BREAKTHROUGH PAIN,2
AU,BURSITIS,2
AU,C-REACTIVE PROTEIN ABNORMAL,2
AU,CACHEXIA,2
AU,CATARACT,2
AU,CATARACT OPERATION,2
AU,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
AU,CHRONIC SINUSITIS,2
AU,CIRCULATORY COLLAPSE,2
AU,CLOSTRIDIUM DIFFICILE COLITIS,2
AU,COLD SWEAT,2
AU,COLON ADENOMA,2
AU,CONCOMITANT DISEASE AGGRAVATED,2
AU,CONJUNCTIVITIS,2
AU,CONTRAINDICATED DRUG ADMINISTERED,2
AU,CYSTITIS,2
AU,DEAFNESS UNILATERAL,2
AU,DEVICE RELATED INFECTION,2
AU,DIABETES MELLITUS,2
AU,DIABETES MELLITUS INADEQUATE CONTROL,2
AU,DISCOMFORT,2
AU,DISSOCIATION,2
AU,DRUG DIVERSION,2
AU,DRUG EFFECT DECREASED,2
AU,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,2
AU,EAR INFECTION,2
AU,EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED,2
AU,EATING DISORDER,2
AU,ELECTROLYTE IMBALANCE,2
AU,EMOTIONAL DISORDER,2
AU,ESCHERICHIA URINARY TRACT INFECTION,2
AU,EYE DISORDER,2
AU,EYE PRURITUS,2
AU,FACE OEDEMA,2
AU,FACIAL PAIN,2
AU,FAECALOMA,2
AU,FEELING JITTERY,2
AU,FIBROMYALGIA,2
AU,FOOT OPERATION,2
AU,FORMICATION,2
AU,GASTRITIS,2
AU,GASTRITIS EROSIVE,2
AU,GLYCOSYLATED HAEMOGLOBIN INCREASED,2
AU,GOUT,2
AU,GRIP STRENGTH DECREASED,2
AU,HAEMATEMESIS,2
AU,HAEMORRHAGE INTRACRANIAL,2
AU,HAEMORRHOIDS,2
AU,HEAD DISCOMFORT,2
AU,HEMIPARESIS,2
AU,HERNIA,2
AU,HYDROCEPHALUS,2
AU,HYDRONEPHROSIS,2
AU,HYPERSOMNIA,2
AU,HYPOACUSIS,2
AU,HYPOPHOSPHATAEMIA,2
AU,HYPOPITUITARISM,2
AU,HYPOTHYROIDISM,2
AU,HYPOXIA,2
AU,IMMUNOSUPPRESSION,2
AU,IMPAIRED WORK ABILITY,2
AU,INADEQUATE ANALGESIA,2
AU,INCORRECT DOSAGE ADMINISTERED,2
AU,INCORRECT ROUTE OF DRUG ADMINISTRATION,2
AU,INFLAMMATORY MARKER INCREASED,2
AU,INJECTION SITE REACTION,2
AU,INTENTIONAL SELF-INJURY,2
AU,INTENTIONAL UNDERDOSE,2
AU,INTERVERTEBRAL DISC DEGENERATION,2
AU,INTESTINAL OBSTRUCTION,2
AU,JOINT RANGE OF MOTION DECREASED,2
AU,JUDGEMENT IMPAIRED,2
AU,KERATOACANTHOMA,2
AU,KLEBSIELLA INFECTION,2
AU,LEUKOERYTHROBLASTIC ANAEMIA,2
AU,LIGAMENT SPRAIN,2
AU,LOCALISED INFECTION,2
AU,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,2
AU,LOW DENSITY LIPOPROTEIN INCREASED,2
AU,LOWER LIMB FRACTURE,2
AU,LYMPHADENOPATHY,2
AU,LYMPHOPENIA,2
AU,MULTIPLE FRACTURES,2
AU,MULTIPLE SCLEROSIS,2
AU,MUSCLE TIGHTNESS,2
AU,MUSCLE TWITCHING,2
AU,NERVE COMPRESSION,2
AU,NERVOUSNESS,2
AU,NOCARDIOSIS,2
AU,NODULE,2
AU,NYSTAGMUS,2
AU,OEDEMA,2
AU,OLIGURIA,2
AU,ORAL CANDIDIASIS,2
AU,OSTEITIS DEFORMANS,2
AU,OSTEONECROSIS OF JAW,2
AU,OSTEOPOROSIS,2
AU,OVARIAN CYST,2
AU,OXYGEN SATURATION DECREASED,2
AU,PANCREATIC CARCINOMA,2
AU,PAPILLOEDEMA,2
AU,PARKINSONISM,2
AU,PERIARTHRITIS,2
AU,PERIPHERAL SENSORY NEUROPATHY,2
AU,PERSONALITY CHANGE,2
AU,PHARYNGEAL OEDEMA,2
AU,PHOTOSENSITIVITY REACTION,2
AU,PLEURAL EFFUSION,2
AU,PNEUMOTHORAX,2
AU,POST HERPETIC NEURALGIA,2
AU,POST PROCEDURAL HAEMORRHAGE,2
AU,POSTOPERATIVE WOUND INFECTION,2
AU,PRE-EXISTING CONDITION IMPROVED,2
AU,PRESCRIPTION FORM TAMPERING,2
AU,PRODUCT QUALITY ISSUE,2
AU,PRODUCT USE IN UNAPPROVED INDICATION,2
AU,PRODUCTIVE COUGH,2
AU,PROSTATE CANCER,2
AU,PSORIASIS,2
AU,PSYCHIATRIC SYMPTOM,2
AU,PUBIS FRACTURE,2
AU,PULMONARY THROMBOSIS,2
AU,RASH MACULAR,2
AU,RASH MACULO-PAPULAR,2
AU,RESPIRATORY RATE DECREASED,2
AU,RESPIRATORY SYNCYTIAL VIRUS INFECTION,2
AU,RESPIRATORY TRACT OEDEMA,2
AU,RESTLESSNESS,2
AU,RETROGRADE AMNESIA,2
AU,ROTATOR CUFF SYNDROME,2
AU,SCOLIOSIS,2
AU,SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS,2
AU,SENSORY LOSS,2
AU,SEPTIC SHOCK,2
AU,SEROTONIN SYNDROME,2
AU,SINUS HEADACHE,2
AU,SKIN CANCER,2
AU,SKIN EXFOLIATION,2
AU,SKIN LESION,2
AU,SKIN NEOPLASM EXCISION,2
AU,SMALL INTESTINAL OBSTRUCTION,2
AU,SOCIAL AVOIDANT BEHAVIOUR,2
AU,SPINAL COMPRESSION FRACTURE,2
AU,SPINAL CORD COMPRESSION,2
AU,SQUAMOUS CELL CARCINOMA,2
AU,STAPHYLOCOCCAL INFECTION,2
AU,STAPHYLOCOCCUS TEST POSITIVE,2
AU,STATUS EPILEPTICUS,2
AU,SUPRAPUBIC PAIN,2
AU,SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT,2
AU,SWOLLEN TONGUE,2
AU,THEFT,2
AU,THROAT TIGHTNESS,2
AU,THYROID NEOPLASM,2
AU,TONGUE DISORDER,2
AU,TOOTH DISORDER,2
AU,TOOTH LOSS,2
AU,TOOTHACHE,2
AU,UPPER LIMB FRACTURE,2
AU,URETERIC OBSTRUCTION,2
AU,VAGINAL HAEMORRHAGE,2
AU,VASCULITIS,2
AU,WEIGHT FLUCTUATION,2
AU,WRONG TECHNIQUE IN DRUG USAGE PROCESS,2
AU,ABDOMINAL ABSCESS,1
AU,ABDOMINAL ADHESIONS,1
AU,ABDOMINAL TENDERNESS,1
AU,ABORTION SPONTANEOUS,1
AU,ACTINIC KERATOSIS,1
AU,ACUTE CORONARY SYNDROME,1
AU,ACUTE PRERENAL FAILURE,1
AU,ADENOCARCINOMA OF COLON,1
AU,ADENOMA BENIGN,1
AU,AFFECTIVE DISORDER,1
AU,AGE-RELATED MACULAR DEGENERATION,1
AU,AGEUSIA,1
AU,ALBUMIN URINE PRESENT,1
AU,ALCOHOL INTOLERANCE,1
AU,ALCOHOLISM,1
AU,ALLODYNIA,1
AU,ALTERED STATE OF CONSCIOUSNESS,1
AU,ALVEOLAR OSTEITIS,1
AU,ALVEOLITIS,1
AU,AMMONIA ABNORMAL,1
AU,ANAEMIA POSTOPERATIVE,1
AU,ANAESTHESIA,1
AU,ANAL ABSCESS,1
AU,ANAL INCONTINENCE,1
AU,ANGINA PECTORIS,1
AU,ANGIOPATHY,1
AU,ANIMAL BITE,1
AU,ANION GAP INCREASED,1
AU,ANOSMIA,1
AU,ANTINUCLEAR ANTIBODY INCREASED,1
AU,ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC,1
AU,ANURIA,1
AU,AORTIC DISSECTION,1
AU,AORTIC VALVE DISEASE,1
AU,AORTIC VALVE INCOMPETENCE,1
AU,APHAGIA,1
AU,APNOEA,1
AU,APPARENT DEATH,1
AU,APPENDICECTOMY,1
AU,APPLICATION SITE PRURITUS,1
AU,APPLICATION SITE REACTION,1
AU,ARTERIAL DISORDER,1
AU,ARTERIAL THROMBOSIS,1
AU,ARTHRITIS INFECTIVE,1
AU,ASPHYXIA,1
AU,ASPIRATION,1
AU,ATYPICAL FEMUR FRACTURE,1
AU,AUTOIMMUNE HEPATITIS,1
AU,B-CELL LYMPHOMA,1
AU,BACK INJURY,1
AU,BACTERIAL INFECTION,1
AU,BIOPSY LYMPH GLAND,1
AU,BIOPSY UTERUS,1
AU,BLISTER INFECTED,1
AU,BLOOD ALKALINE PHOSPHATASE ABNORMAL,1
AU,BLOOD ALKALINE PHOSPHATASE DECREASED,1
AU,BLOOD CREATINE INCREASED,1
AU,BLOOD GLUCOSE DECREASED,1
AU,BLOOD GLUCOSE FLUCTUATION,1
AU,BLOOD MAGNESIUM DECREASED,1
AU,BLOOD POTASSIUM INCREASED,1
AU,BLOOD PRESSURE FLUCTUATION,1
AU,BLOOD PRESSURE SYSTOLIC INCREASED,1
AU,BLOOD TEST ABNORMAL,1
AU,BLOOD THYROID STIMULATING HORMONE DECREASED,1
AU,BLOOD TRIGLYCERIDES INCREASED,1
AU,BONE DENSITY DECREASED,1
AU,BONE DISORDER,1
AU,BONE GRAFT,1
AU,BONE LESION,1
AU,BRADYPHRENIA,1
AU,BRAIN ABSCESS,1
AU,BRAIN MIDLINE SHIFT,1
AU,BRAIN STEM STROKE,1
AU,BREAST CANCER METASTATIC,1
AU,BREAST DISCHARGE,1
AU,BREAST PAIN,1
AU,BRONCHOPULMONARY ASPERGILLOSIS,1
AU,BURNS SECOND DEGREE,1
AU,BUTTERFLY RASH,1
AU,CALCIFICATION OF MUSCLE,1
AU,CAMPYLOBACTER INFECTION,1
AU,CANDIDA INFECTION,1
AU,CARDIAC INFECTION,1
AU,CARDIOMEGALY,1
AU,CARDIOMYOPATHY,1
AU,CAROTID ARTERIOSCLEROSIS,1
AU,CATARACT SUBCAPSULAR,1
AU,CATHETER CULTURE POSITIVE,1
AU,CATHETER MANAGEMENT,1
AU,CATHETER SITE HAEMORRHAGE,1
AU,CD4 LYMPHOCYTES DECREASED,1
AU,CENTRAL NERVOUS SYSTEM LESION,1
AU,CEREBELLAR SYNDROME,1
AU,CEREBRAL HAEMATOMA,1
AU,CERVICAL SPINAL STENOSIS,1
AU,CERVICAL VERTEBRAL FRACTURE,1
AU,CHAPPED LIPS,1
AU,CHEST INJURY,1
AU,CHOKING,1
AU,CHOLECYSTECTOMY,1
AU,CHOLECYSTITIS,1
AU,CHONDROSARCOMA METASTATIC,1
AU,CHOREA,1
AU,CLUMSINESS,1
AU,CLUSTER HEADACHE,1
AU,COLECTOMY,1
AU,COLITIS ISCHAEMIC,1
AU,COLON DYSPLASIA,1
AU,COLORECTAL CANCER,1
AU,COMPRESSION FRACTURE,1
AU,CORONARY ARTERY OCCLUSION,1
AU,CREATININE RENAL CLEARANCE DECREASED,1
AU,CREATININE URINE INCREASED,1
AU,CYANOSIS,1
AU,CYSTITIS HAEMORRHAGIC,1
AU,CYSTOID MACULAR OEDEMA,1
AU,DEAFNESS NEUROSENSORY,1
AU,DECREASED ACTIVITY,1
AU,DECREASED INTEREST,1
AU,DECUBITUS ULCER,1
AU,DEMENTIA ALZHEIMER^S TYPE,1
AU,DENTAL CARIES,1
AU,DEPERSONALISATION/DEREALISATION DISORDER,1
AU,DEPRESSION SUICIDAL,1
AU,DERMATITIS,1
AU,DERMATITIS ALLERGIC,1
AU,DEVICE DISLOCATION,1
AU,DEVICE FAILURE,1
AU,DEVICE OCCLUSION,1
AU,DIABETIC FOOT,1
AU,DIABETIC KETOACIDOSIS,1
AU,DIABETIC RETINAL OEDEMA,1
AU,DIABETIC RETINOPATHY,1
AU,DIAPHRAGMATIC SPASM,1
AU,DISINHIBITION,1
AU,DISSOCIATIVE FUGUE,1
AU,DREAMY STATE,1
AU,DROP ATTACKS,1
AU,DRUG ADMINISTRATION ERROR,1
AU,DRUG LEVEL INCREASED,1
AU,DRUG RESISTANCE,1
AU,DRUG SCREEN POSITIVE,1
AU,DRUG WITHDRAWAL CONVULSIONS,1
AU,DRUG WITHDRAWAL SYNDROME NEONATAL,1
AU,DYSGRAPHIA,1
AU,DYSPLASTIC NAEVUS,1
AU,DYSTONIA,1
AU,EAR DISCOMFORT,1
AU,ELECTROCARDIOGRAM ABNORMAL,1
AU,ELECTROCARDIOGRAM AMBULATORY ABNORMAL,1
AU,ELECTROCARDIOGRAM PR PROLONGATION,1
AU,ELEVATED MOOD,1
AU,ENCEPHALITIS,1
AU,ENDOMETRIAL HYPERPLASIA,1
AU,ENTERITIS,1
AU,EOSINOPHIL COUNT INCREASED,1
AU,EOSINOPHILIC OESOPHAGITIS,1
AU,EPISCLERITIS,1
AU,ERECTILE DYSFUNCTION,1
AU,EROSIVE DUODENITIS,1
AU,ERUCTATION,1
AU,ERYTHEMA MULTIFORME,1
AU,ERYTHRODERMIC PSORIASIS,1
AU,ESCHERICHIA INFECTION,1
AU,ESCHERICHIA SEPSIS,1
AU,EYE IRRITATION,1
AU,EYE LUXATION,1
AU,EYE SWELLING,1
AU,FACIAL PARALYSIS,1
AU,FAECES DISCOLOURED,1
AU,FEBRILE INFECTION,1
AU,FEEDING DISORDER,1
AU,FEELING OF DESPAIR,1
AU,FEMORAL NECK FRACTURE,1
AU,FIBROMATOSIS,1
AU,FIBULA FRACTURE,1
AU,FINGER DEFORMITY,1
AU,FLANK PAIN,1
AU,FLATULENCE,1
AU,FLUID OVERLOAD,1
AU,FOLATE DEFICIENCY,1
AU,FOOT DEFORMITY,1
AU,FORAMEN MAGNUM STENOSIS,1
AU,FRACTURE DISPLACEMENT,1
AU,FRACTURED COCCYX,1
AU,FUNGAL INFECTION,1
AU,FUNGAL SEPSIS,1
AU,GASTRIC PH DECREASED,1
AU,GASTROENTERITIS SALMONELLA,1
AU,GASTROINTESTINAL CANCER METASTATIC,1
AU,GASTROINTESTINAL CARCINOMA,1
AU,GASTROINTESTINAL INFECTION,1
AU,GASTROINTESTINAL SOUNDS ABNORMAL,1
AU,GASTROINTESTINAL SURGERY,1
AU,GASTROINTESTINAL TRACT ADENOMA,1
AU,GASTROINTESTINAL WALL THICKENING,1
AU,GENITAL BLISTER,1
AU,GINGIVAL ABSCESS,1
AU,GINGIVITIS,1
AU,GLOMERULONEPHRITIS ACUTE,1
AU,GLOSSODYNIA,1
AU,GOITRE,1
AU,GRAND MAL CONVULSION,1
AU,GUILLAIN-BARRE SYNDROME,1
AU,HAEMATOMA,1
AU,HAEMODILUTION,1
AU,HAEMOGLOBIN INCREASED,1
AU,HAEMOPTYSIS,1
AU,HAEMORRHAGIC STROKE,1
AU,HAIR TEXTURE ABNORMAL,1
AU,HALLUCINATION_ AUDITORY,1
AU,HALLUCINATION_ GUSTATORY,1
AU,HEARING IMPAIRED,1
AU,HEART RATE DECREASED,1
AU,HEMIPLEGIA,1
AU,HEPARIN-INDUCED THROMBOCYTOPENIA,1
AU,HEPATIC FUNCTION ABNORMAL,1
AU,HEPATIC NEOPLASM,1
AU,HEPATIC PAIN,1
AU,HEPATITIS B CORE ANTIBODY POSITIVE,1
AU,HEPATITIS B SURFACE ANTIBODY POSITIVE,1
AU,HEPATITIS C,1
AU,HEPATITIS C VIRUS TEST POSITIVE,1
AU,HEPATITIS VIRAL,1
AU,HEPATOMEGALY,1
AU,HIATUS HERNIA,1
AU,HIATUS HERNIA STRANGULATED,1
AU,HIGH FREQUENCY ABLATION,1
AU,HILAR LYMPHADENOPATHY,1
AU,HORMONE LEVEL ABNORMAL,1
AU,HOSTILITY,1
AU,HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR DECREASED,1
AU,HUMERUS FRACTURE,1
AU,HYDROURETER,1
AU,HYPERREFLEXIA,1
AU,HYPERTHYROIDISM,1
AU,HYPERTONIC BLADDER,1
AU,HYPERURICAEMIA,1
AU,HYPOAESTHESIA ORAL,1
AU,HYPOAESTHESIA TEETH,1
AU,HYPOALBUMINAEMIA,1
AU,HYPOMAGNESAEMIA,1
AU,HYPOPNOEA,1
AU,HYPOTHERMIA,1
AU,HYPOTONIA,1
AU,HYSTERECTOMY,1
AU,ILEAL STENOSIS,1
AU,IMMOBILE,1
AU,IMMUNE SYSTEM DISORDER,1
AU,IMMUNODEFICIENCY,1
AU,IMPAIRED FASTING GLUCOSE,1
AU,INCONTINENCE,1
AU,INCORRECT DOSE ADMINISTERED,1
AU,INCORRECT DRUG DOSAGE FORM ADMINISTERED,1
AU,INCORRECT PRODUCT STORAGE,1
AU,INCREASED APPETITE,1
AU,INDIFFERENCE,1
AU,INFECTED SEROMA,1
AU,INFECTION SUSCEPTIBILITY INCREASED,1
AU,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,1
AU,INFERTILITY FEMALE,1
AU,INFLAMMATORY BOWEL DISEASE,1
AU,INJECTION SITE BRUISING,1
AU,INJECTION SITE HAEMORRHAGE,1
AU,INJECTION SITE URTICARIA,1
AU,INTERNAL HAEMORRHAGE,1
AU,INTERSTITIAL LUNG DISEASE,1
AU,INTERVERTEBRAL DISC DISORDER,1
AU,INTERVERTEBRAL DISC SPACE NARROWING,1
AU,INTESTINAL DILATATION,1
AU,INTESTINAL ISCHAEMIA,1
AU,INTESTINAL ULCER,1
AU,INTRACRANIAL ANEURYSM,1
AU,INVASIVE DUCTAL BREAST CARCINOMA,1
AU,ISCHAEMIC STROKE,1
AU,JAUNDICE CHOLESTATIC,1
AU,JC VIRUS GRANULE CELL NEURONOPATHY,1
AU,JC VIRUS TEST POSITIVE,1
AU,JOINT EFFUSION,1
AU,JOINT LOCK,1
AU,KETOACIDOSIS,1
AU,KIDNEY INFECTION,1
AU,KNEE ARTHROPLASTY,1
AU,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
AU,LACERATION,1
AU,LACK OF INJECTION SITE ROTATION,1
AU,LAPAROTOMY,1
AU,LARYNGITIS,1
AU,LEFT ATRIAL DILATATION,1
AU,LEFT VENTRICULAR DYSFUNCTION,1
AU,LEFT VENTRICULAR HYPERTROPHY,1
AU,LEUKOCYTOSIS,1
AU,LIBIDO DECREASED,1
AU,LICHEN SCLEROSUS,1
AU,LIGAMENT INJURY,1
AU,LIGAMENT RUPTURE,1
AU,LIMBIC ENCEPHALITIS,1
AU,LIP BLISTER,1
AU,LIP DRY,1
AU,LIPASE INCREASED,1
AU,LIVER FUNCTION TEST DECREASED,1
AU,LOCALISED OEDEMA,1
AU,LOOSE TOOTH,1
AU,LUNG CONSOLIDATION,1
AU,LUNG INFECTION,1
AU,MACULAR DEGENERATION,1
AU,MACULAR OEDEMA,1
AU,MALNUTRITION,1
AU,MANIA,1
AU,MASKED FACIES,1
AU,MATERNAL EXPOSURE DURING PREGNANCY,1
AU,MEAN CELL HAEMOGLOBIN DECREASED,1
AU,MEDICAL DEVICE PAIN,1
AU,MEDICATION RESIDUE PRESENT,1
AU,MENINGISM,1
AU,MENORRHAGIA,1
AU,MENSTRUAL DISORDER,1
AU,METASTASES TO CENTRAL NERVOUS SYSTEM,1
AU,METASTASES TO FALLOPIAN TUBE,1
AU,METASTASES TO LIVER,1
AU,METASTASES TO LUNG,1
AU,METASTASES TO OVARY,1
AU,METASTASES TO PELVIS,1
AU,MICROALBUMINURIA,1
AU,MICROANGIOPATHY,1
AU,MINI MENTAL STATUS EXAMINATION ABNORMAL,1
AU,MITOCHONDRIAL TOXICITY,1
AU,MOOD SWINGS,1
AU,MORBID THOUGHTS,1
AU,MOTOR DYSFUNCTION,1
AU,MUCINOUS ADENOCARCINOMA OF APPENDIX,1
AU,MUCINOUS CYSTADENOCARCINOMA OVARY,1
AU,MUCOSAL INFLAMMATION,1
AU,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
AU,MUSCLE ATROPHY,1
AU,MUSCLE CONTRACTIONS INVOLUNTARY,1
AU,MUSCLE DISORDER,1
AU,MUSCLE SWELLING,1
AU,MUSCULOSKELETAL DISORDER,1
AU,MUTISM,1
AU,MYELITIS TRANSVERSE,1
AU,MYOCARDIAL ISCHAEMIA,1
AU,MYOGLOBINURIA,1
AU,MYOPIA,1
AU,NAIL GROWTH ABNORMAL,1
AU,NECROSIS,1
AU,NEGLECT OF PERSONAL APPEARANCE,1
AU,NEOPLASM MALIGNANT,1
AU,NEPHROLITHIASIS,1
AU,NEUROENDOCRINE TUMOUR,1
AU,NEUROGENIC BLADDER,1
AU,NEUTROPENIC COLITIS,1
AU,NIGHT BLINDNESS,1
AU,NIGHTMARE,1
AU,NOCARDIA TEST POSITIVE,1
AU,NOCTURIA,1
AU,NON-CARDIAC CHEST PAIN,1
AU,NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL,1
AU,OBESITY,1
AU,OBSESSIVE-COMPULSIVE DISORDER,1
AU,OCCULT BLOOD POSITIVE,1
AU,OCULAR HYPERAEMIA,1
AU,OCULAR TOXICITY,1
AU,ODYNOPHAGIA,1
AU,ONYCHOCLASIS,1
AU,ONYCHOMADESIS,1
AU,OPTIC NERVE INJURY,1
AU,OPTIC NEURITIS,1
AU,ORAL LICHEN PLANUS,1
AU,ORAL MUCOSAL BLISTERING,1
AU,ORAL PAIN,1
AU,ORTHOSTATIC HYPOTENSION,1
AU,OSTEONECROSIS,1
AU,OSTEOSARCOMA METASTATIC,1
AU,OVARIAN CALCIFICATION,1
AU,PALLOR,1
AU,PANCYTOPENIA,1
AU,PATERNAL EXPOSURE TIMING UNSPECIFIED,1
AU,PELVIC MASS,1
AU,PELVIC PAIN,1
AU,PEMPHIGOID,1
AU,PERIHEPATIC ABSCESS,1
AU,PERINEAL ULCERATION,1
AU,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
AU,PERIPHERAL COLDNESS,1
AU,PERIPHERAL ISCHAEMIA,1
AU,PERIPROSTHETIC FRACTURE,1
AU,PERITONECTOMY,1
AU,PERONEAL NERVE PALSY,1
AU,PIGMENTATION DISORDER,1
AU,PILONIDAL CYST,1
AU,PLEURISY,1
AU,PLEURITIC PAIN,1
AU,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
AU,PNEUMONIA CRYPTOCOCCAL,1
AU,PNEUMONITIS,1
AU,POLYDIPSIA,1
AU,POLYNEUROPATHY,1
AU,POLYP,1
AU,POST PROCEDURAL INFECTION,1
AU,POST-TRAUMATIC NECK SYNDROME,1
AU,POST-TRAUMATIC STRESS DISORDER,1
AU,POSTMENOPAUSAL HAEMORRHAGE,1
AU,POSTOPERATIVE WOUND COMPLICATION,1
AU,PREMATURE MENOPAUSE,1
AU,PROCEDURAL HAEMORRHAGE,1
AU,PROCTALGIA,1
AU,PRODUCT DIFFICULT TO SWALLOW,1
AU,PROSTATE CANCER METASTATIC,1
AU,PROSTATIC DISORDER,1
AU,PROSTATOMEGALY,1
AU,PROTEIN TOTAL INCREASED,1
AU,PROTEINURIA,1
AT,FALL,21
AT,WEIGHT INCREASED,21
AT,FATIGUE,19
AT,NAUSEA,17
AT,CONFUSIONAL STATE,16
AT,HEADACHE,15
AT,DELIRIUM,14
AT,DEPRESSION,14
AT,DIZZINESS,14
AT,CONDITION AGGRAVATED,13
AT,GAMMA-GLUTAMYLTRANSFERASE INCREASED,13
AT,BLOOD CHOLESTEROL INCREASED,12
AT,OEDEMA PERIPHERAL,12
AT,TOXICITY TO VARIOUS AGENTS,12
AT,DEPRESSED MOOD,11
AT,DISORIENTATION,11
AT,TREMOR,11
AT,COLITIS MICROSCOPIC,10
AT,NERVOUSNESS,10
AT,POLLAKIURIA,10
AT,SEDATION,10
AT,VOMITING,10
AT,MUSCULAR WEAKNESS,9
AT,DIARRHOEA,8
AT,DYSPNOEA,8
AT,HYPONATRAEMIA,8
AT,SEIZURE,8
AT,SLEEP DISORDER,8
AT,SOMNOLENCE,8
AT,URINARY TRACT INFECTION,8
AT,ALTERED STATE OF CONSCIOUSNESS,7
AT,ANXIETY,7
AT,ASTHENIA,7
AT,GAIT DISTURBANCE,7
AT,GENERAL PHYSICAL HEALTH DETERIORATION,7
AT,HYPERTENSION,7
AT,OVERDOSE,7
AT,PULMONARY EMBOLISM,7
AT,ALANINE AMINOTRANSFERASE INCREASED,6
AT,ASPARTATE AMINOTRANSFERASE INCREASED,6
AT,ATAXIA,6
AT,BLOOD TRIGLYCERIDES INCREASED,6
AT,BRADYPHRENIA,6
AT,COUGH,6
AT,GASTROOESOPHAGEAL REFLUX DISEASE,6
AT,INFECTION,6
AT,MITOCHONDRIAL TOXICITY,6
AT,PALPITATIONS,6
AT,RESTLESSNESS,6
AT,SYNCOPE,6
AT,ABDOMINAL PAIN UPPER,5
AT,ACUTE RESPIRATORY DISTRESS SYNDROME,5
AT,BLOOD PRESSURE FLUCTUATION,5
AT,C-REACTIVE PROTEIN INCREASED,5
AT,ERYTHEMA,5
AT,HALLUCINATIONS_ MIXED,5
AT,HYPERHIDROSIS,5
AT,INCREASED APPETITE,5
AT,INTENTION TREMOR,5
AT,NEUTROPHIL COUNT DECREASED,5
AT,PAIN,5
AT,PAIN IN EXTREMITY,5
AT,POLYNEUROPATHY,5
AT,PRESCRIBED OVERDOSE,5
AT,REFLUX LARYNGITIS,5
AT,RESTING TREMOR,5
AT,SENSORY LOSS,5
AT,URINARY RETENTION,5
AT,VERTIGO,5
AT,WITHDRAWAL SYNDROME,5
AT,AGGRESSION,4
AT,ANORGASMIA,4
AT,ARTHRALGIA,4
AT,DEPRESSIVE SYMPTOM,4
AT,DISTURBANCE IN ATTENTION,4
AT,DRUG ABUSE,4
AT,DRUG WITHDRAWAL SYNDROME,4
AT,DYSPHAGIA,4
AT,ELECTROCARDIOGRAM QT PROLONGED,4
AT,FRUSTRATION TOLERANCE DECREASED,4
AT,HEPATIC ENZYME INCREASED,4
AT,HYPERPROLACTINAEMIA,4
AT,INSOMNIA,4
AT,LETHARGY,4
AT,LEUKOPENIA,4
AT,LIVER INJURY,4
AT,MYALGIA,4
AT,PNEUMONIA,4
AT,PSYCHOMOTOR HYPERACTIVITY,4
AT,SOCIAL AVOIDANT BEHAVIOUR,4
AT,SPLENOMEGALY,4
AT,WEIGHT DECREASED,4
AT,ANAPHYLACTIC REACTION,3
AT,BLOOD PRESSURE INCREASED,3
AT,DECREASED APPETITE,3
AT,DRUG INEFFECTIVE,3
AT,DRY MOUTH,3
AT,EXTRAPYRAMIDAL DISORDER,3
AT,KIDNEY ENLARGEMENT,3
AT,NEUTROPENIA,3
AT,PNEUMONIA ASPIRATION,3
AT,PRURITUS,3
AT,PYREXIA,3
AT,RASH,3
AT,RESTLESS LEGS SYNDROME,3
AT,SALIVARY HYPERSECRETION,3
AT,SUICIDAL IDEATION,3
AT,TENSION,3
AT,ABDOMINAL PAIN,2
AT,AFFECTIVE DISORDER,2
AT,AMAUROSIS,2
AT,ANAEMIA,2
AT,BLOOD ALKALINE PHOSPHATASE INCREASED,2
AT,BLOOD GLUCOSE INCREASED,2
AT,BONE PAIN,2
AT,BRADYCARDIA,2
AT,BURSITIS,2
AT,CARDIOMYOPATHY,2
AT,CHEST PAIN,2
AT,CONSTIPATION,2
AT,CONTUSION,2
AT,CRYING,2
AT,DEATH,2
AT,DEMENTIA,2
AT,DEPENDENCE,2
AT,DRUG DEPENDENCE,2
AT,EPILEPSY,2
AT,FEBRILE NEUTROPENIA,2
AT,GASTRITIS,2
AT,HEAD INJURY,2
AT,HEPATOBILIARY DISEASE,2
AT,HERPES ZOSTER,2
AT,HYPOCALCAEMIA,2
AT,HYPOKALAEMIA,2
AT,HYPOMANIA,2
AT,HYPOTENSION,2
AT,IMPAIRED HEALING,2
AT,INFLUENZA,2
AT,JUGULAR VEIN THROMBOSIS,2
AT,MEMORY IMPAIRMENT,2
AT,METABOLIC ACIDOSIS,2
AT,MUCOSAL INFLAMMATION,2
AT,MYELOFIBROSIS,2
AT,NASOPHARYNGITIS,2
AT,NEUROPATHY PERIPHERAL,2
AT,OXYGEN SATURATION DECREASED,2
AT,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,2
AT,PARAESTHESIA,2
AT,PLEURAL EFFUSION,2
AT,POST HERPETIC NEURALGIA,2
AT,PRODUCT USE IN UNAPPROVED INDICATION,2
AT,PRURITUS GENERALISED,2
AT,PULMONARY CONGESTION,2
AT,SCAPULA FRACTURE,2
AT,SECOND PRIMARY MALIGNANCY,2
AT,SUBCLAVIAN VEIN THROMBOSIS,2
AT,SUICIDE ATTEMPT,2
AT,TACHYCARDIA,2
AT,TACHYPNOEA,2
AT,THERAPEUTIC RESPONSE UNEXPECTED,2
AT,THROMBOPHLEBITIS,2
AT,VISION BLURRED,2
AT,WHITE BLOOD CELL COUNT DECREASED,2
AT,WHITE BLOOD CELL COUNT INCREASED,2
AT,ACCOMMODATION DISORDER,1
AT,ACTION TREMOR,1
AT,ACUTE KIDNEY INJURY,1
AT,ACUTE MYOCARDIAL INFARCTION,1
AT,ADRENAL ATROPHY,1
AT,AGITATION,1
AT,ALCOHOL USE,1
AT,ALOPECIA,1
AT,ANAL FISTULA,1
AT,ANAPHYLACTIC SHOCK,1
AT,ANTIPSYCHOTIC DRUG LEVEL INCREASED,1
AT,ARRHYTHMIA,1
AT,ARTERIOSCLEROSIS,1
AT,ASCITES,1
AT,BACK PAIN,1
AT,BARRETT^S OESOPHAGUS,1
AT,BASOPHIL COUNT INCREASED,1
AT,BLINDNESS,1
AT,BLOOD CREATININE INCREASED,1
AT,BLOOD FOLATE DECREASED,1
AT,BLOOD GLUCOSE DECREASED,1
AT,BLOOD PROLACTIN INCREASED,1
AT,BLOOD TRIGLYCERIDES,1
AT,BODY MASS INDEX INCREASED,1
AT,BODY TEMPERATURE INCREASED,1
AT,BONE DENSITY DECREASED,1
AT,BONE EROSION,1
AT,BRAIN INJURY,1
AT,CARDIAC ARREST,1
AT,CARDIAC FAILURE,1
AT,CEREBELLAR SYNDROME,1
AT,CEREBRAL DISORDER,1
AT,CEREBRAL MICROANGIOPATHY,1
AT,CEREBROVASCULAR ACCIDENT,1
AT,CERVICAL SPINAL STENOSIS,1
AT,CHOKING,1
AT,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
AT,CHRONIC TIC DISORDER,1
AT,CLOSTRIDIUM DIFFICILE COLITIS,1
AT,COGNITIVE DISORDER,1
AT,COLORECTAL CANCER METASTATIC,1
AT,COMA,1
AT,COMMUNICATION DISORDER,1
AT,COMPULSIONS,1
AT,CONCOMITANT DISEASE PROGRESSION,1
AT,CYANOSIS,1
AT,CYTOMEGALOVIRUS VIRAEMIA,1
AT,DEFORMITY,1
AT,DEHYDRATION,1
AT,DEPRESSED LEVEL OF CONSCIOUSNESS,1
AT,DERMATITIS EXFOLIATIVE GENERALISED,1
AT,DEVICE CONNECTION ISSUE,1
AT,DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL,1
AT,DISCOMFORT,1
AT,DISEASE RECURRENCE,1
AT,DIVERTICULAR PERFORATION,1
AT,DIVERTICULITIS,1
AT,DOPAMINE DYSREGULATION SYNDROME,1
AT,DROP ATTACKS,1
AT,DRUG EFFECT INCOMPLETE,1
AT,DRUG INTOLERANCE,1
AT,DRUG WITHDRAWAL CONVULSIONS,1
AT,DRUG-INDUCED LIVER INJURY,1
AT,DUODENITIS,1
AT,DYSGEUSIA,1
AT,DYSKINESIA,1
AT,DYSPHONIA,1
AT,EAR PAIN,1
AT,ENCEPHALOPATHY,1
AT,EPISTAXIS,1
AT,ERUCTATION,1
AT,ERYSIPELAS,1
AT,EUPHORIC MOOD,1
AT,EXPOSURE VIA FATHER,1
AT,EYE PAIN,1
AT,FAECALOMA,1
AT,FEAR,1
AT,FEMORAL NECK FRACTURE,1
AT,FEMUR FRACTURE,1
AT,FOOD CRAVING,1
AT,GALLBLADDER DISORDER,1
AT,GASTRIC BYPASS,1
AT,GASTRIC POLYPS,1
AT,GASTROINTESTINAL TUBE INSERTION,1
AT,GENERALISED ANXIETY DISORDER,1
AT,GENERALISED ERYTHEMA,1
AT,GENERALISED OEDEMA,1
AT,GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT,1
AT,GRAFT VERSUS HOST DISEASE IN LIVER,1
AT,GRAFT VERSUS HOST DISEASE IN SKIN,1
AT,GRAND MAL CONVULSION,1
AT,HAEMATOCHEZIA,1
AT,HAEMOGLOBIN ABNORMAL,1
AT,HALLUCINATION,1
AT,HEAD TITUBATION,1
AT,HELICOBACTER GASTRITIS,1
AT,HEPATITIS,1
AT,HERPES SIMPLEX,1
AT,HIATUS HERNIA,1
AT,HOSPITALISATION,1
AT,HYPERAESTHESIA,1
AT,HYPERBILIRUBINAEMIA,1
AT,HYPERSENSITIVITY,1
AT,HYPERTHYROIDISM,1
AT,HYPOAESTHESIA,1
AT,HYPOREFLEXIA,1
AT,ILLNESS ANXIETY DISORDER,1
AT,IMPAIRED GASTRIC EMPTYING,1
AT,IMPAIRED WORK ABILITY,1
AT,INFUSION RELATED REACTION,1
AT,INTENTIONAL OVERDOSE,1
AT,INTENTIONAL PRODUCT MISUSE,1
AT,INTENTIONAL PRODUCT USE ISSUE,1
AT,INTERSTITIAL LUNG DISEASE,1
AT,INTERVERTEBRAL DISC DEGENERATION,1
AT,INTESTINAL HAEMORRHAGE,1
AT,ISCHAEMIC STROKE,1
AT,LEARNING DISORDER,1
AT,LEUKOCYTOSIS,1
AT,LEUKOENCEPHALOPATHY,1
AT,LISTLESS,1
AT,LIVER DISORDER,1
AT,LOGORRHOEA,1
AT,LUNG INFECTION,1
AT,LYMPHOCYTE COUNT INCREASED,1
AT,LYMPHOEDEMA,1
AT,MAGICAL THINKING,1
AT,MALIGNANT NEOPLASM PROGRESSION,1
AT,MANIA,1
AT,MENTAL IMPAIRMENT,1
AT,METASTASES TO MUSCLE,1
AT,METASTASIS,1
AT,MICTURITION DISORDER,1
AT,MIGRAINE,1
AT,MOTOR DYSFUNCTION,1
AT,MOUTH HAEMORRHAGE,1
AT,MUCOSAL NECROSIS,1
AT,MULTI-ORGAN FAILURE,1
AT,MULTIPLE SCLEROSIS RELAPSE,1
AT,MUSCLE SPASMS,1
AT,MYOCLONUS,1
AT,NECK PAIN,1
AT,NEGATIVE THOUGHTS,1
AT,NERVOUS SYSTEM DISORDER,1
AT,NEURALGIA,1
AT,NEUTROPHIL COUNT INCREASED,1
AT,NEUTROPHIL PERCENTAGE DECREASED,1
AT,NIGHT SWEATS,1
AT,NO THERAPEUTIC RESPONSE,1
AT,OBSESSIVE THOUGHTS,1
AT,OBSESSIVE-COMPULSIVE DISORDER,1
AT,OEDEMA,1
AT,OESOPHAGEAL STENOSIS,1
AT,ORAL HERPES,1
AT,OSTEOARTHRITIS,1
AT,OSTEONECROSIS OF JAW,1
AT,OTITIS EXTERNA,1
AT,PANIC ATTACK,1
AT,PARKINSONISM,1
AT,PELVIC CONGESTION,1
AT,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
AT,PERIPHERAL COLDNESS,1
AT,PERIPHERAL SENSORY NEUROPATHY,1
AT,PERSONALITY CHANGE,1
AT,PHARYNGEAL HAEMATOMA,1
AT,PLASMA CELL MYELOMA,1
AT,PLATELET COUNT DECREASED,1
AT,PLATELET COUNT INCREASED,1
AT,POLYCYTHAEMIA VERA,1
AT,POLYDIPSIA,1
AT,POLYDIPSIA PSYCHOGENIC,1
AT,POST PROCEDURAL HAEMORRHAGE,1
AT,PRE-EXISTING CONDITION IMPROVED,1
AT,PROCEDURAL PAIN,1
AT,PRODUCT USE ISSUE,1
AT,PULMONARY FIBROSIS,1
AT,PULMONARY OEDEMA,1
AT,RECURRENT CANCER,1
AT,REGURGITATION,1
AT,RENAL IMPAIRMENT,1
AT,RETINAL DETACHMENT,1
AT,RETINAL HAEMORRHAGE,1
AT,SEPSIS,1
AT,SINUS ARREST,1
AT,SKIN DISCOLOURATION,1
AT,SKIN DISORDER,1
AT,SLOW SPEECH,1
AT,SOMATIC SYMPTOM DISORDER,1
AT,SOMATISATION DISORDER,1
AT,SPINAL PAIN,1
AT,SPONDYLOLISTHESIS,1
AT,SQUAMOUS CELL CARCINOMA,1
AT,SQUAMOUS CELL CARCINOMA OF THE TONGUE,1
AT,STOMATITIS,1
AT,SUBSTANCE USE,1
AT,SUDDEN DEATH,1
AT,SWELLING FACE,1
AT,SWOLLEN TONGUE,1
AT,THIRST,1
AT,THROMBOSIS,1
AT,THYROID CYST,1
AT,TONGUE BITING,1
AT,TOOTH DISORDER,1
AT,TRANSAMINASES INCREASED,1
AT,TRIGEMINAL NEURALGIA,1
AT,TROPONIN T INCREASED,1
AT,URINARY INCONTINENCE,1
AT,URTICARIA,1
AT,VIOLENCE-RELATED SYMPTOM,1
AT,VITAMIN B12 DECREASED,1
AT,VITAMIN D DEFICIENCY,1
AT,WHITE BLOOD CELL COUNT,1
AT,WOUND DEHISCENCE,1
BS,BLISTER,1
BH,ACNE,1
BH,ACTIVITIES OF DAILY LIVING IMPAIRED,1
BH,BURNING SENSATION,1
BH,HAEMORRHAGIC STROKE,1
BH,IMPAIRED WORK ABILITY,1
BH,INSOMNIA,1
BH,MENTAL IMPAIRMENT,1
BH,MILIARIA,1
BH,PAIN,1
BH,PRURITUS GENERALISED,1
BH,PSORIASIS,1
BH,ROSACEA,1
BH,SKIN SENSITISATION,1
BD,FLUID OVERLOAD,1
BD,MOBILITY DECREASED,1
BD,RENAL DISORDER,1
BE,FATIGUE,10
BE,CONFUSIONAL STATE,8
BE,HEADACHE,8
BE,DYSPNOEA,7
BE,ARTHRALGIA,6
BE,EPISTAXIS,6
BE,HYPOKALAEMIA,6
BE,ANAEMIA,5
BE,ANXIETY,5
BE,PYREXIA,5
BE,RENAL FAILURE,5
BE,URINARY TRACT INFECTION,5
BE,ARTHRITIS,4
BE,ASTHENIA,4
BE,ATRIAL FIBRILLATION,4
BE,DECREASED APPETITE,4
BE,FALL,4
BE,FEBRILE NEUTROPENIA,4
BE,HYPERTENSION,4
BE,MUSCULOSKELETAL PAIN,4
BE,MYOCLONUS,4
BE,NAUSEA,4
BE,PNEUMONIA,4
BE,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,4
BE,RHABDOMYOLYSIS,4
BE,SOMNOLENCE,4
BE,SPEECH DISORDER,4
BE,TRANSAMINASES INCREASED,4
BE,TREMOR,4
BE,ACUTE KIDNEY INJURY,3
BE,AGGRESSION,3
BE,ALLERGIC OEDEMA,3
BE,ANAPHYLACTIC REACTION,3
BE,BALANCE DISORDER,3
BE,DEPRESSION,3
BE,EAR INFECTION,3
BE,ECZEMA,3
BE,EPILEPSY,3
BE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,3
BE,HOT FLUSH,3
BE,LIP SWELLING,3
BE,MALAISE,3
BE,MULTIPLE SCLEROSIS RELAPSE,3
BE,NEURALGIA,3
BE,PLATELET COUNT DECREASED,3
BE,PRURITUS,3
BE,RASH,3
BE,SUDDEN DEATH,3
BE,SUICIDAL IDEATION,3
BE,THROMBOCYTOPENIA,3
BE,URTICARIA,3
BE,WEIGHT DECREASED,3
BE,ADENOCARCINOMA,2
BE,ALANINE AMINOTRANSFERASE INCREASED,2
BE,ASPARTATE AMINOTRANSFERASE INCREASED,2
BE,BLOOD ALKALINE PHOSPHATASE INCREASED,2
BE,C-REACTIVE PROTEIN INCREASED,2
BE,CARDIAC FAILURE,2
BE,CARDIOMYOPATHY,2
BE,CHILLS,2
BE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
BE,CONCOMITANT DISEASE AGGRAVATED,2
BE,COUGH,2
BE,CYANOSIS,2
BE,DEATH,2
BE,DEEP VEIN THROMBOSIS,2
BE,DEHYDRATION,2
BE,DEVICE ISSUE,2
BE,DIARRHOEA,2
BE,DIZZINESS,2
BE,DRUG DEPENDENCE,2
BE,DYSKINESIA,2
BE,FAECALOMA,2
BE,FREEZING PHENOMENON,2
BE,GAIT DISTURBANCE,2
BE,GASTROINTESTINAL INFECTION,2
BE,GENERAL PHYSICAL HEALTH DETERIORATION,2
BE,HAEMORRHAGE,2
BE,HAEMORRHAGE INTRACRANIAL,2
BE,HALLUCINATION,2
BE,HALLUCINATION_ VISUAL,2
BE,HEPATOCELLULAR INJURY,2
BE,HIGH DENSITY LIPOPROTEIN INCREASED,2
BE,HYPERKALAEMIA,2
BE,IIIRD NERVE PARALYSIS,2
BE,INCREASED APPETITE,2
BE,INFLAMMATION,2
BE,INSOMNIA,2
BE,INTERSTITIAL LUNG DISEASE,2
BE,INVASIVE DUCTAL BREAST CARCINOMA,2
BE,LOW DENSITY LIPOPROTEIN INCREASED,2
BE,LUNG ABSCESS,2
BE,LUNG INFECTION,2
BE,MOBILITY DECREASED,2
BE,MOOD SWINGS,2
BE,MUSCLE RIGIDITY,2
BE,MUSCLE SPASMS,2
BE,MUSCULAR WEAKNESS,2
BE,OLIGURIA,2
BE,PANIC ATTACK,2
BE,PAPILLARY THYROID CANCER,2
BE,PARKINSON^S DISEASE,2
BE,PLEURAL EFFUSION,2
BE,PLEURAL INFECTION,2
BE,POLYNEUROPATHY,2
BE,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,2
BE,PULMONARY OEDEMA,2
BE,RESPIRATORY TRACT INFECTION,2
BE,SINUS TACHYCARDIA,2
BE,TACHYCARDIA,2
BE,TRANSIENT ISCHAEMIC ATTACK,2
BE,TUMOUR PAIN,2
BE,VAGINAL HAEMORRHAGE,2
BE,VENTRICULAR EXTRASYSTOLES,2
BE,VERTIGO,2
BE,VISUAL IMPAIRMENT,2
BE,VOMITING,2
BE,ABDOMINAL DISTENSION,1
BE,ABDOMINAL PAIN,1
BE,ABNORMAL DREAMS,1
BE,ABNORMAL FAECES,1
BE,ACCIDENTAL OVERDOSE,1
BE,ACUTE MYELOID LEUKAEMIA,1
BE,ACUTE PULMONARY OEDEMA,1
BE,ACUTE RESPIRATORY FAILURE,1
BE,AGITATION,1
BE,AMAUROSIS,1
BE,AMNESIA,1
BE,ANAL ABSCESS,1
BE,ANGIOEDEMA,1
BE,APATHY,1
BE,APHASIA,1
BE,ARACHNOIDITIS,1
BE,ASCITES,1
BE,ATAXIA,1
BE,ATRIAL FLUTTER,1
BE,AUTOIMMUNE DISORDER,1
BE,AUTOIMMUNE MYOCARDITIS,1
BE,AZOTAEMIA,1
BE,B PRECURSOR TYPE ACUTE LEUKAEMIA,1
BE,BACTERIAL DIARRHOEA,1
BE,BASAL CELL CARCINOMA,1
BE,BILE DUCT STONE,1
BE,BILIARY TRACT DISORDER,1
BE,BLOOD CHOLESTEROL INCREASED,1
BE,BLOOD GLUCOSE INCREASED,1
BE,BLOOD PRESSURE INCREASED,1
BE,BODY TEMPERATURE DECREASED,1
BE,BRADYCARDIA,1
BE,BRADYKINESIA,1
BE,BREAST CANCER FEMALE,1
BE,BURNS THIRD DEGREE,1
BE,CACHEXIA,1
BE,CARCINOEMBRYONIC ANTIGEN INCREASED,1
BE,CARDIAC ABLATION,1
BE,CARDIAC DISORDER,1
BE,CARDIOGENIC SHOCK,1
BE,CATATONIA,1
BE,CATHETER SITE INFLAMMATION,1
BE,CAUDA EQUINA SYNDROME,1
BE,CEREBROVASCULAR ACCIDENT,1
BE,CLUMSINESS,1
BE,COLON ADENOMA,1
BE,COMMUNICATION DISORDER,1
BE,CONSTIPATION,1
BE,CYSTITIS,1
BE,DELIRIUM,1
BE,DEMENTIA,1
BE,DIABETES MELLITUS,1
BE,DIASTOLIC DYSFUNCTION,1
BE,DIPLOPIA,1
BE,DISEASE PROGRESSION,1
BE,DISEASE RECURRENCE,1
BE,DISINHIBITION,1
BE,DISORIENTATION,1
BE,DISSEMINATED INTRAVASCULAR COAGULATION,1
BE,DISTURBANCE IN ATTENTION,1
BE,DRUG DIVERSION,1
BE,DRUG EFFECT DECREASED,1
BE,DRUG EFFECT INCOMPLETE,1
BE,DRUG INEFFECTIVE,1
BE,DRUG INTOLERANCE,1
BE,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
BE,DRUG TOLERANCE INCREASED,1
BE,DRUG-INDUCED LIVER INJURY,1
BE,DRY MOUTH,1
BE,DYSGRAPHIA,1
BE,DYSPHAGIA,1
BE,DYSPHONIA,1
BE,DYSPNOEA EXERTIONAL,1
BE,DYSTONIA,1
BE,EMOTIONAL DISTRESS,1
BE,ENCEPHALOPATHY,1
BE,ERYTHEMA,1
BE,FACE OEDEMA,1
BE,FACET JOINT SYNDROME,1
BE,FEAR,1
BE,FEELING ABNORMAL,1
BE,FEMUR FRACTURE,1
BE,FLUID OVERLOAD,1
BE,FRUSTRATION TOLERANCE DECREASED,1
BE,GASTRITIS,1
BE,GASTRODUODENAL ULCER,1
BE,HEMIPARESIS,1
BE,HEPATIC ENZYME INCREASED,1
BE,HEPATIC STEATOSIS,1
BE,HEPATITIS B REACTIVATION,1
BE,HEPATITIS B SURFACE ANTIBODY POSITIVE,1
BE,HEPATITIS CHOLESTATIC,1
BE,HEPATITIS FULMINANT,1
BE,HERPES ZOSTER,1
BE,HOSPITALISATION,1
BE,HYPERACUSIS,1
BE,HYPERCHOLESTEROLAEMIA,1
BE,HYPERHIDROSIS,1
BE,HYPERSOMNIA,1
BE,HYPERTONIC BLADDER,1
BE,HYPOAESTHESIA,1
BE,HYPOKINESIA,1
BE,HYPOMANIA,1
BE,HYPOTHERMIA,1
BE,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,1
BE,INCISION SITE CELLULITIS,1
BE,INCORRECT DOSAGE ADMINISTERED,1
BE,INCORRECT DOSE ADMINISTERED,1
BE,INFECTED SKIN ULCER,1
BE,INFLUENZA,1
BE,INJECTION SITE ERYTHEMA,1
BE,INJECTION SITE PAIN,1
BE,INJECTION SITE SWELLING,1
BE,IRON DEFICIENCY,1
BE,IRRITABILITY,1
BE,ISCHAEMIC STROKE,1
BE,KELOID SCAR,1
BE,LARGE INTESTINE POLYP,1
BE,LARYNGEAL HAEMATOMA,1
BE,LATENT TUBERCULOSIS,1
BE,LETHARGY,1
BE,LIMB DISCOMFORT,1
BE,LIPASE INCREASED,1
BE,LIVER DISORDER,1
BE,LIVER FUNCTION TEST ABNORMAL,1
BE,LIVER FUNCTION TEST INCREASED,1
BE,LOSS OF CONSCIOUSNESS,1
BE,LOWER EXTREMITY MASS,1
BE,LUNG ADENOCARCINOMA,1
BE,LUNG ADENOCARCINOMA METASTATIC,1
BE,LUNG DISORDER,1
BE,LUNG INFILTRATION,1
BE,LUNG SQUAMOUS CELL CARCINOMA STAGE III,1
BE,LYMPHADENOPATHY,1
BE,LYMPHOCYTE COUNT DECREASED,1
BE,MALIGNANT NEOPLASM PROGRESSION,1
BE,MANIA,1
BE,MEDICAL DEVICE SITE REACTION,1
BE,MEMORY IMPAIRMENT,1
BE,MENINGIOMA SURGERY,1
BE,MENTAL DISORDER,1
BE,MENTAL IMPAIRMENT,1
BE,METASTASES TO LIVER,1
BE,METASTASES TO LUNG,1
BE,METASTASIS,1
BE,MICTURITION DISORDER,1
BE,MITRAL VALVE INCOMPETENCE,1
BE,MONOPLEGIA,1
BE,MOUTH SWELLING,1
BE,MULTIPLE SCLEROSIS,1
BE,MUSCULOSKELETAL DISORDER,1
BE,MUTISM,1
BE,MYOCARDIAL INFARCTION,1
BE,NASOPHARYNGITIS,1
BE,NECK PAIN,1
BE,NEPHROPATHY TOXIC,1
BE,NERVOUSNESS,1
BE,NEUROBORRELIOSIS,1
BE,NEUTROPENIA,1
BE,NEUTROPHIL COUNT INCREASED,1
BE,NIGHT SWEATS,1
BE,ODYNOPHAGIA,1
BE,OESOPHAGITIS,1
BE,ON AND OFF PHENOMENON,1
BE,OPTIC NEURITIS,1
BE,OSTEONECROSIS OF JAW,1
BE,OXYGEN SATURATION DECREASED,1
BE,PAIN,1
BE,PAIN IN EXTREMITY,1
BE,PALPITATIONS,1
BE,PANCREATIC DISORDER,1
BE,PANCREATOLITHIASIS,1
BE,PARAESTHESIA,1
BE,PARALYSIS,1
BE,PARANEOPLASTIC SYNDROME,1
BE,PARANOIA,1
BE,PERICARDIAL EFFUSION,1
BE,PERICARDITIS INFECTIVE,1
BE,PLANTAR ERYTHEMA,1
BE,PLASMA CELL MYELOMA,1
BE,PNEUMATOSIS INTESTINALIS,1
BE,POOR QUALITY SLEEP,1
BE,POST PROCEDURAL HAEMORRHAGE,1
BE,POST PROCEDURAL SEPSIS,1
BE,PRECANCEROUS SKIN LESION,1
BE,PROCTALGIA,1
BE,PRODUCT QUALITY ISSUE,1
BE,PRODUCT USE IN UNAPPROVED INDICATION,1
BE,PRODUCT USE ISSUE,1
BE,PSYCHIATRIC DECOMPENSATION,1
BE,PULMONARY EMBOLISM,1
BE,PULMONARY HAEMORRHAGE,1
BE,PULMONARY THROMBOSIS,1
BE,RADIATION SKIN INJURY,1
BE,RALES,1
BE,RECTAL DISCHARGE,1
BE,RENAL ABSCESS,1
BE,RENAL ARTERY THROMBOSIS,1
BE,RENAL FAILURE ACUTE,1
BE,RENAL INFARCT,1
BE,RESPIRATORY DISORDER,1
BE,RESPIRATORY DISTRESS,1
BE,RHINITIS,1
BE,SECOND PRIMARY MALIGNANCY,1
BE,SEDATION,1
BE,SEIZURE,1
BE,SEIZURE CLUSTER,1
BE,SELF-MEDICATION,1
BE,SENSATION OF HEAVINESS,1
BE,SENSORY DISTURBANCE,1
BE,SEPTIC SHOCK,1
BE,SERUM FERRITIN DECREASED,1
BE,SKIN BURNING SENSATION,1
BE,SKIN EXFOLIATION,1
BE,SKIN TEXTURE ABNORMAL,1
BE,SMALL INTESTINAL OBSTRUCTION,1
BE,SPLENOMEGALY,1
BE,STAPHYLOCOCCAL SEPSIS,1
BE,STATUS EPILEPTICUS,1
BE,STOMA SITE DISCHARGE,1
BE,STOMA SITE ERYTHEMA,1
BE,STOMA SITE HYPERGRANULATION,1
BE,SUBSTANCE ABUSE,1
BE,SUBSTANCE-INDUCED PSYCHOTIC DISORDER,1
BE,SUICIDE ATTEMPT,1
BE,SUPRAVENTRICULAR EXTRASYSTOLES,1
BE,SWOLLEN TONGUE,1
BE,THERAPEUTIC RESPONSE DECREASED,1
BE,TOOTH INFECTION,1
BE,TOXIC ENCEPHALOPATHY,1
BE,TOXICITY TO VARIOUS AGENTS,1
BE,TYPE 2 DIABETES MELLITUS,1
BE,UNDERDOSE,1
BE,UNEVALUABLE EVENT,1
BE,UPPER LIMB FRACTURE,1
BE,URINARY INCONTINENCE,1
BE,URINARY RETENTION,1
BE,URINE ANALYSIS ABNORMAL,1
BE,URINE OUTPUT DECREASED,1
BE,UTERINE DISORDER,1
BE,UTERINE POLYP,1
BE,VITAMIN D DECREASED,1
BE,WALDENSTROM^S MACROGLOBULINAEMIA RECURRENT,1
BE,WEIGHT INCREASED,1
BE,WITHDRAWAL SYNDROME,1
BO,DEATH,1
BO,MYOCARDIAL INFARCTION,1
BR,PAIN,181
BR,DRUG INEFFECTIVE,141
BR,DIZZINESS,106
BR,SPINAL DISORDER,88
BR,FEELING ABNORMAL,86
BR,ARTHRALGIA,83
BR,FALL,83
BR,MALAISE,82
BR,PAIN IN EXTREMITY,82
BR,INTERVERTEBRAL DISC PROTRUSION,80
BR,GAIT DISTURBANCE,77
BR,SOMNOLENCE,70
BR,HEADACHE,69
BR,FATIGUE,62
BR,DYSPNOEA,58
BR,ASTHENIA,53
BR,NAUSEA,53
BR,WEIGHT DECREASED,53
BR,WEIGHT INCREASED,49
BR,DEPRESSION,48
BR,PNEUMONIA,48
BR,VOMITING,48
BR,SPINAL PAIN,46
BR,INSOMNIA,45
BR,SWELLING,43
BR,HYPOAESTHESIA,42
BR,MEMORY IMPAIRMENT,42
BR,URINARY TRACT INFECTION,40
BR,CONDITION AGGRAVATED,39
BR,BACK PAIN,38
BR,HYPERTENSION,38
BR,PYREXIA,36
BR,ABASIA,35
BR,ANXIETY,35
BR,DYSSTASIA,34
BR,OSTEOARTHRITIS,34
BR,DIARRHOEA,32
BR,BEDRIDDEN,31
BR,HYPERSENSITIVITY,31
BR,INFLUENZA,31
BR,ARTHROPATHY,30
BR,DIABETES MELLITUS,30
BR,TREMOR,29
BR,BLOOD PRESSURE INCREASED,28
BR,PRODUCT USE ISSUE,28
BR,CEREBROVASCULAR ACCIDENT,26
BR,SPEECH DISORDER,26
BR,CARDIAC DISORDER,25
BR,CONFUSIONAL STATE,25
BR,DEATH,24
BR,DRY MOUTH,24
BR,FIBROMYALGIA,24
BR,PERIPHERAL SWELLING,24
BR,DECREASED APPETITE,23
BR,ACTIVITIES OF DAILY LIVING IMPAIRED,22
BR,NERVOUSNESS,22
BR,SYNCOPE,22
BR,VISION BLURRED,21
BR,ABDOMINAL PAIN,20
BR,ABDOMINAL PAIN UPPER,20
BR,ARRHYTHMIA,20
BR,COUGH,20
BR,INFARCTION,20
BR,MOBILITY DECREASED,20
BR,CATARACT,19
BR,CHEST PAIN,19
BR,IMMUNODEFICIENCY,19
BR,INFECTION,19
BR,PARAESTHESIA,19
BR,ANAEMIA,18
BR,CONSTIPATION,18
BR,INJECTION SITE PAIN,18
BR,MUSCULAR WEAKNESS,18
BR,RHEUMATOID ARTHRITIS,18
BR,BALANCE DISORDER,17
BR,DISEASE PROGRESSION,17
BR,DRUG EFFECT INCOMPLETE,17
BR,JOINT SWELLING,17
BR,MUSCLE SPASMS,17
BR,PRURITUS,17
BR,THROMBOSIS,17
BR,OROPHARYNGEAL PAIN,16
BR,PRODUCT USE IN UNAPPROVED INDICATION,16
BR,ROAD TRAFFIC ACCIDENT,16
BR,VISUAL IMPAIRMENT,16
BR,FEMUR FRACTURE,15
BR,INTENTIONAL PRODUCT MISUSE,15
BR,MUSCULOSKELETAL PAIN,15
BR,MUSCULOSKELETAL STIFFNESS,15
BR,NECK PAIN,15
BR,NEOPLASM MALIGNANT,15
BR,SLUGGISHNESS,15
BR,SWELLING FACE,15
BR,TACHYCARDIA,15
BR,AMNESIA,14
BR,BURNING SENSATION,14
BR,DENGUE FEVER,14
BR,DRUG DOSE OMISSION,14
BR,FEAR,14
BR,HYPOKINESIA,14
BR,INFLAMMATION,14
BR,PALPITATIONS,14
BR,RETCHING,14
BR,SPINAL COLUMN INJURY,14
BR,ABDOMINAL DISTENSION,13
BR,BACK DISORDER,13
BR,BLISTER,13
BR,CHILLS,13
BR,CHOLELITHIASIS,13
BR,CRYING,13
BR,LIMB DISCOMFORT,13
BR,MOVEMENT DISORDER,13
BR,SKIN DISCOLOURATION,13
BR,SPINAL FRACTURE,13
BR,URINARY INCONTINENCE,13
BR,ALOPECIA,12
BR,BLOOD PRESSURE DECREASED,12
BR,BLOOD PRESSURE FLUCTUATION,12
BR,CARPAL TUNNEL SYNDROME,12
BR,EMOTIONAL DISORDER,12
BR,GASTRITIS,12
BR,IRRITABILITY,12
BR,NEURALGIA,12
BR,PLEURAL EFFUSION,12
BR,SEPSIS,12
BR,AGITATION,11
BR,APHASIA,11
BR,BONE PAIN,11
BR,BREAST CANCER,11
BR,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,11
BR,DYSGEUSIA,11
BR,ERYTHEMA,11
BR,HEAD DISCOMFORT,11
BR,HYPOTENSION,11
BR,RENAL DISORDER,11
BR,SINUSITIS,11
BR,SLEEP DISORDER,11
BR,THYROID DISORDER,11
BR,ARTHRITIS,10
BR,BLOOD GLUCOSE INCREASED,10
BR,BURSITIS,10
BR,DEMENTIA ALZHEIMER^S TYPE,10
BR,DYSPHONIA,10
BR,FEELING DRUNK,10
BR,FLUID RETENTION,10
BR,HYPERHIDROSIS,10
BR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,10
BR,INCREASED APPETITE,10
BR,LOCAL SWELLING,10
BR,MULTIPLE SCLEROSIS RELAPSE,10
BR,NODULE,10
BR,SCIATICA,10
BR,SEDATION,10
BR,STRESS,10
BR,TENDONITIS,10
BR,TINNITUS,10
BR,WRONG TECHNIQUE IN DRUG USAGE PROCESS,10
BR,ABDOMINAL DISCOMFORT,9
BR,DRUG INTOLERANCE,9
BR,DYSPHAGIA,9
BR,EATING DISORDER,9
BR,EXOSTOSIS,9
BR,EYE PAIN,9
BR,FEELING HOT,9
BR,FLATULENCE,9
BR,FORMICATION,9
BR,GASTROINTESTINAL DISORDER,9
BR,HEART RATE INCREASED,9
BR,HYPERSOMNIA,9
BR,HYPOACUSIS,9
BR,JOINT INJURY,9
BR,LIMB INJURY,9
BR,LUNG INFECTION,9
BR,MYALGIA,9
BR,NASOPHARYNGITIS,9
BR,NERVOUS SYSTEM DISORDER,9
BR,OSTEOPOROSIS,9
BR,PANIC DISORDER,9
BR,PULMONARY EMBOLISM,9
BR,SEIZURE,9
BR,THERAPEUTIC RESPONSE UNEXPECTED,9
BR,UPPER LIMB FRACTURE,9
BR,APATHY,8
BR,BLOOD CHOLESTEROL INCREASED,8
BR,BODY HEIGHT DECREASED,8
BR,DIABETIC NEUROPATHY,8
BR,DISORIENTATION,8
BR,DIVERTICULITIS,8
BR,DRUG HYPERSENSITIVITY,8
BR,DYSURIA,8
BR,FEEDING DISORDER,8
BR,GASTRIC DISORDER,8
BR,HAEMORRHAGE,8
BR,HEAD INJURY,8
BR,LOSS OF CONSCIOUSNESS,8
BR,MENTAL IMPAIRMENT,8
BR,NEUROPATHY PERIPHERAL,8
BR,OEDEMA PERIPHERAL,8
BR,PARALYSIS,8
BR,PLATELET COUNT DECREASED,8
BR,RASH,8
BR,RENAL IMPAIRMENT,8
BR,BLOOD PRESSURE ABNORMAL,7
BR,BLOOD TEST ABNORMAL,7
BR,BONE DISORDER,7
BR,BRONCHITIS,7
BR,COORDINATION ABNORMAL,7
BR,CYST,7
BR,DECREASED IMMUNE RESPONSIVENESS,7
BR,DEVICE DISLOCATION,7
BR,DYSPEPSIA,7
BR,EYE DISORDER,7
BR,EYE SWELLING,7
BR,HAEMATOMA,7
BR,HERPES ZOSTER,7
BR,HYPERGLYCAEMIA,7
BR,ILL-DEFINED DISORDER,7
BR,INJECTION SITE ERYTHEMA,7
BR,JOINT DISLOCATION,7
BR,LABYRINTHITIS,7
BR,LIVER DISORDER,7
BR,LOWER LIMB FRACTURE,7
BR,LUNG NEOPLASM MALIGNANT,7
BR,MENTAL DISORDER,7
BR,MONOPLEGIA,7
BR,MOOD ALTERED,7
BR,MUSCULOSKELETAL CHEST PAIN,7
BR,NEPHROLITHIASIS,7
BR,PSORIASIS,7
BR,RESPIRATORY FAILURE,7
BR,SPINAL CORD COMPRESSION,7
BR,SYSTEMIC LUPUS ERYTHEMATOSUS,7
BR,URINARY RETENTION,7
BR,VENOUS OCCLUSION,7
BR,WOUND,7
BR,ABNORMAL BEHAVIOUR,6
BR,ANKLE FRACTURE,6
BR,ARTHRODESIS,6
BR,ASTHMA,6
BR,BACTERIAL INFECTION,6
BR,CARDIAC ARREST,6
BR,COMA,6
BR,DEPRESSED MOOD,6
BR,DEVICE RELATED INFECTION,6
BR,DRY EYE,6
BR,EMPHYSEMA,6
BR,EYE HAEMORRHAGE,6
BR,FOOT FRACTURE,6
BR,GLAUCOMA,6
BR,HEPATIC STEATOSIS,6
BR,HUNGER,6
BR,IMPAIRED WORK ABILITY,6
BR,INTERVERTEBRAL DISC DEGENERATION,6
BR,JOINT EFFUSION,6
BR,LOCALISED INFECTION,6
BR,LUNG DISORDER,6
BR,MASS,6
BR,MIGRAINE,6
BR,NOSOCOMIAL INFECTION,6
BR,OCULAR HYPERAEMIA,6
BR,PARKINSON^S DISEASE,6
BR,PRODUCT QUALITY ISSUE,6
BR,PULMONARY OEDEMA,6
BR,RIB FRACTURE,6
BR,SENSORY LOSS,6
BR,SEPTIC SHOCK,6
BR,SUICIDE ATTEMPT,6
BR,THIRST,6
BR,TOXICITY TO VARIOUS AGENTS,6
BR,WHEELCHAIR USER,6
BR,AGGRESSION,5
BR,ANGINA PECTORIS,5
BR,APPARENT DEATH,5
BR,ARTERIAL OCCLUSIVE DISEASE,5
BR,BLOOD CHOLESTEROL ABNORMAL,5
BR,CARDIAC FAILURE,5
BR,CHONDROPATHY,5
BR,DIPLEGIA,5
BR,DIPLOPIA,5
BR,DRY SKIN,5
BR,DYSENTERY,5
BR,EPISTAXIS,5
BR,GAIT INABILITY,5
BR,GASTROOESOPHAGEAL REFLUX DISEASE,5
BR,HALLUCINATION_ VISUAL,5
BR,HYPERTENSIVE CRISIS,5
BR,HYPOAESTHESIA ORAL,5
BR,HYPOGLYCAEMIA,5
BR,INCORRECT DOSE ADMINISTERED,5
BR,INJECTION SITE MASS,5
BR,INJECTION SITE PRURITUS,5
BR,INTENTIONAL PRODUCT USE ISSUE,5
BR,INTERVERTEBRAL DISC DISORDER,5
BR,JOINT RANGE OF MOTION DECREASED,5
BR,KIDNEY INFECTION,5
BR,LOSS OF CONTROL OF LEGS,5
BR,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,5
BR,MYOCARDIAL INFARCTION,5
BR,NERVE COMPRESSION,5
BR,PALLOR,5
BR,PANCREATITIS,5
BR,PRE-EXISTING CONDITION IMPROVED,5
BR,RENAL FAILURE,5
BR,RHINITIS,5
BR,SJOGREN^S SYNDROME,5
BR,SKIN EXFOLIATION,5
BR,SPINAL OSTEOARTHRITIS,5
BR,SWOLLEN TONGUE,5
BR,TENDON RUPTURE,5
BR,THERAPEUTIC RESPONSE DECREASED,5
BR,TONGUE MOVEMENT DISTURBANCE,5
BR,URTICARIA,5
BR,VARICOSE VEIN,5
BR,VERTIGO,5
BR,VISUAL ACUITY REDUCED,5
BR,WHITE BLOOD CELL COUNT DECREASED,5
BR,ABSCESS,4
BR,ACCIDENT,4
BR,ANGIOPATHY,4
BR,BLINDNESS,4
BR,BLOOD GLUCOSE ABNORMAL,4
BR,BLOOD URINE PRESENT,4
BR,CARDIO-RESPIRATORY ARREST,4
BR,CELLULITIS,4
BR,CHOKING,4
BR,COLD SWEAT,4
BR,DEAFNESS,4
BR,DECREASED ACTIVITY,4
BR,DELIRIUM,4
BR,DISEASE RECURRENCE,4
BR,DISTURBANCE IN ATTENTION,4
BR,DRUG DEPENDENCE,4
BR,DRUG EFFECT DECREASED,4
BR,DYSARTHRIA,4
BR,EAR PAIN,4
BR,FEELING COLD,4
BR,FIBROSIS,4
BR,HAEMATURIA,4
BR,HEMIPLEGIA,4
BR,HERPES VIRUS INFECTION,4
BR,HIP FRACTURE,4
BR,HYPOTHYROIDISM,4
BR,IMMUNE SYSTEM DISORDER,4
BR,INJECTION SITE DISCOLOURATION,4
BR,INTENTIONAL DRUG MISUSE,4
BR,LACRIMATION INCREASED,4
BR,MALIGNANT NEOPLASM PROGRESSION,4
BR,MEDICATION ERROR,4
BR,METASTASIS,4
BR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,4
BR,MULTIPLE SCLEROSIS,4
BR,NERVE INJURY,4
BR,NERVE ROOT COMPRESSION,4
BR,OBESITY,4
BR,OVERWEIGHT,4
BR,PERIPHERAL COLDNESS,4
BR,PHARYNGITIS,4
BR,POLYNEUROPATHY,4
BR,POST PROCEDURAL COMPLICATION,4
BR,PRESYNCOPE,4
BR,RESPIRATORY DISORDER,4
BR,RHEUMATIC DISORDER,4
BR,ROTATOR CUFF SYNDROME,4
BR,SCAR,4
BR,SKIN INFECTION,4
BR,SPONDYLOLISTHESIS,4
BR,SUICIDAL IDEATION,4
BR,SURGERY,4
BR,THROAT IRRITATION,4
BR,THROAT TIGHTNESS,4
BR,TONGUE DISORDER,4
BR,VASCULAR INJURY,4
BR,VITAMIN D DECREASED,4
BR,ANGER,3
BR,ANKYLOSING SPONDYLITIS,3
BR,ASTHMATIC CRISIS,3
BR,BLADDER DISORDER,3
BR,BLOOD DISORDER,3
BR,BLOOD URIC ACID ABNORMAL,3
BR,BONE MARROW DISORDER,3
BR,BRONCHOSPASM,3
BR,C-REACTIVE PROTEIN INCREASED,3
BR,CHEST DISCOMFORT,3
BR,COAGULOPATHY,3
BR,CONCOMITANT DISEASE AGGRAVATED,3
BR,CONVULSION,3
BR,CORNEAL DISORDER,3
BR,CORONARY ARTERY OCCLUSION,3
BR,CROHN^S DISEASE,3
BR,DEHYDRATION,3
BR,DEPRESSED LEVEL OF CONSCIOUSNESS,3
BR,DIABETES MELLITUS INADEQUATE CONTROL,3
BR,DIABETIC RETINOPATHY,3
BR,DRUG ABUSE,3
BR,EXPIRED PRODUCT ADMINISTERED,3
BR,FACE INJURY,3
BR,FEBRILE NEUTROPENIA,3
BR,FEELING OF DESPAIR,3
BR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,3
BR,GASTRITIS EROSIVE,3
BR,GASTROINTESTINAL CARCINOMA,3
BR,GASTROINTESTINAL INFECTION,3
BR,GENERALISED OEDEMA,3
BR,GROIN PAIN,3
BR,HAEMORRHOIDS,3
BR,HAND DEFORMITY,3
BR,HAND FRACTURE,3
BR,HEART RATE DECREASED,3
BR,HELICOBACTER INFECTION,3
BR,HEPATIC NEOPLASM,3
BR,HEPATITIS,3
BR,HERNIA,3
BR,HIATUS HERNIA,3
BR,HOT FLUSH,3
BR,HYPERAESTHESIA,3
BR,HYPOTONIA,3
BR,IMMOBILE,3
BR,IMMUNOSUPPRESSION,3
BR,INFUSION RELATED REACTION,3
BR,INJECTION SITE BRUISING,3
BR,INJURY,3
BR,INTERVERTEBRAL DISC SPACE NARROWING,3
BR,INTRACRANIAL ANEURYSM,3
BR,ISCHAEMIC STROKE,3
BR,JOINT STIFFNESS,3
BR,KNEE OPERATION,3
BR,LETHARGY,3
BR,LIGAMENT SPRAIN,3
BR,LIMB ASYMMETRY,3
BR,LIMB DEFORMITY,3
BR,LYMPHOCYTE COUNT DECREASED,3
BR,MENISCUS INJURY,3
BR,MENORRHAGIA,3
BR,MOTOR DYSFUNCTION,3
BR,MUSCLE ATROPHY,3
BR,MUSCLE CONTRACTIONS INVOLUNTARY,3
BR,MUSCLE DISORDER,3
BR,MUSCLE TWITCHING,3
BR,NEOPLASM,3
BR,NEURITIS,3
BR,OEDEMA MOUTH,3
BR,ORAL DISCOMFORT,3
BR,OVARIAN CYST,3
BR,PANIC REACTION,3
BR,PERIPHERAL VASCULAR DISORDER,3
BR,PHLEBITIS,3
BR,PLASMA CELL MYELOMA,3
BR,PLATELET DISORDER,3
BR,POLLAKIURIA,3
BR,POST PROCEDURAL INFECTION,3
BR,PREMATURE MENOPAUSE,3
BR,PSYCHOTIC DISORDER,3
BR,RASH MACULAR,3
BR,SCOLIOSIS,3
BR,SENSORY DISTURBANCE,3
BR,SKIN DISORDER,3
BR,SLEEP APNOEA SYNDROME,3
BR,SPINAL COLUMN STENOSIS,3
BR,SPINAL CORD DISORDER,3
BR,SPINAL OPERATION,3
BR,TENDON INJURY,3
BR,TOOTH DISORDER,3
BR,TUBERCULOSIS,3
BR,ULCER,3
BR,UMBILICAL HERNIA,3
BR,UNEVALUABLE EVENT,3
BR,VASCULITIS,3
BR,WALKING DISABILITY,3
BR,WEIGHT FLUCTUATION,3
BR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,3
BR,ACNE,2
BR,ACUTE RESPIRATORY FAILURE,2
BR,ALANINE AMINOTRANSFERASE ABNORMAL,2
BR,ALANINE AMINOTRANSFERASE INCREASED,2
BR,ANEURYSM,2
BR,ANGIOEDEMA,2
BR,APHAGIA,2
BR,APHONIA,2
BR,ASPARTATE AMINOTRANSFERASE INCREASED,2
BR,ASPHYXIA,2
BR,ATAXIA,2
BR,ATROPHY,2
BR,AUTOIMMUNE HEPATITIS,2
BR,BLINDNESS TRANSIENT,2
BR,BLOOD GLUCOSE DECREASED,2
BR,BLOOD GLUCOSE FLUCTUATION,2
BR,BLOOD POTASSIUM DECREASED,2
BR,BLOOD THYROID STIMULATING HORMONE ABNORMAL,2
BR,BLOOD TRIGLYCERIDES INCREASED,2
BR,BONE EROSION,2
BR,BONE FISSURE,2
BR,BONE FRAGMENTATION,2
BR,BONE LESION,2
BR,BONE LOSS,2
BR,BONE MARROW FAILURE,2
BR,BRADYPHRENIA,2
BR,BRAIN NEOPLASM,2
BR,BREAST DISORDER,2
BR,BREAST ENLARGEMENT,2
BR,BREAST PAIN,2
BR,BREAST SWELLING,2
BR,BRUXISM,2
BR,CALCIUM DEFICIENCY,2
BR,CANCER PAIN,2
BR,CANDIDA INFECTION,2
BR,CAPILLARY FRAGILITY,2
BR,CARDIAC FIBRILLATION,2
BR,CARTILAGE INJURY,2
BR,CATARRH,2
BR,CAUDA EQUINA SYNDROME,2
BR,CENTRAL NERVOUS SYSTEM INFLAMMATION,2
BR,CENTRAL NERVOUS SYSTEM LESION,2
BR,CEREBROSPINAL FISTULA,2
BR,CHIKUNGUNYA VIRUS INFECTION,2
BR,CHROMATURIA,2
BR,CHRONIC KIDNEY DISEASE,2
BR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
BR,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,2
BR,COLITIS,2
BR,COLITIS ULCERATIVE,2
BR,COMPLICATION ASSOCIATED WITH DEVICE,2
BR,CONTUSION,2
BR,DEAFNESS UNILATERAL,2
BR,DEEP VEIN THROMBOSIS,2
BR,DEFAECATION URGENCY,2
BR,DEFORMITY,2
BR,DEMENTIA,2
BR,DENTAL PROSTHESIS PLACEMENT,2
BR,DEPENDENCE,2
BR,DERMATITIS ALLERGIC,2
BR,DEVICE BREAKAGE,2
BR,DEVICE FAILURE,2
BR,DISSOCIATION,2
BR,DRUG ABUSER,2
BR,DRUG ADMINISTRATION ERROR,2
BR,DRUG DISPENSING ERROR,2
BR,DRUG LEVEL INCREASED,2
BR,DRUG PRESCRIBING ERROR,2
BR,DRUG WITHDRAWAL SYNDROME,2
BR,DRUG-INDUCED LIVER INJURY,2
BR,DYSGRAPHIA,2
BR,DYSKINESIA,2
BR,EAR INFECTION,2
BR,EMOTIONAL DISTRESS,2
BR,EPICONDYLITIS,2
BR,EPILEPSY,2
BR,ERYSIPELAS,2
BR,EUPHORIC MOOD,2
BR,EXPOSURE DURING PREGNANCY,2
BR,EYE DISCHARGE,2
BR,FEELING OF RELAXATION,2
BR,FINGER DEFORMITY,2
BR,FLUID INTAKE REDUCED,2
BR,FOOT DEFORMITY,2
BR,FRACTURED COCCYX,2
BR,FREQUENT BOWEL MOVEMENTS,2
BR,FURUNCLE,2
BR,GALLBLADDER DISORDER,2
BR,GASTRIC CANCER,2
BR,GASTRIC ULCER,2
BR,GASTROINTESTINAL ULCER,2
BR,GENERAL PHYSICAL CONDITION ABNORMAL,2
BR,GENERAL PHYSICAL HEALTH DETERIORATION,2
BR,GLOSSODYNIA,2
BR,GRIP STRENGTH DECREASED,2
BR,GUILLAIN-BARRE SYNDROME,2
BR,HAEMANGIOMA OF BONE,2
BR,HAEMATEMESIS,2
BR,HAEMATOCRIT DECREASED,2
BR,HAEMOGLOBIN DECREASED,2
BR,HAEMOPTYSIS,2
BR,HANGOVER,2
BR,HEART RATE ABNORMAL,2
BR,HEPATIC CANCER,2
BR,HEPATITIS C,2
BR,HYPERTHYROIDISM,2
BR,HYPONATRAEMIA,2
BR,HYPOPHAGIA,2
BR,HYPOXIA,2
BR,IMPAIRED DRIVING ABILITY,2
BR,IMPAIRED HEALING,2
BR,IMPAIRED REASONING,2
BR,IMPLANT SITE PAIN,2
BR,INCORRECT ROUTE OF DRUG ADMINISTRATION,2
BR,INDURATION,2
BR,INFLUENZA LIKE ILLNESS,2
BR,INGUINAL HERNIA,2
BR,INJECTION SITE REACTION,2
BR,INJECTION SITE WARMTH,2
BR,INTELLECTUAL DISABILITY,2
BR,INTENTIONAL UNDERDOSE,2
BR,INTERVERTEBRAL DISCITIS,2
BR,INTRAOCULAR PRESSURE INCREASED,2
BR,ISCHAEMIA,2
BR,KYPHOSIS,2
BR,LACK OF APPLICATION SITE ROTATION,2
BR,LARYNGEAL OEDEMA,2
BR,LEUKOCYTOSIS,2
BR,LIGAMENT RUPTURE,2
BR,LISTLESS,2
BR,LIVER INJURY,2
BR,LOGORRHOEA,2
BR,LOOSE TOOTH,2
BR,LYMPHADENOPATHY,2
BR,MEDICAL DEVICE COMPLICATION,2
BR,MENSTRUAL DISORDER,2
BR,METASTASES TO BONE,2
BR,MOUTH HAEMORRHAGE,2
BR,MOUTH SWELLING,2
BR,MUCOSAL INFLAMMATION,2
BR,MUSCLE RIGIDITY,2
BR,MUSCULOSKELETAL DISCOMFORT,2
BR,MYOFASCIAL PAIN SYNDROME,2
BR,MYOSITIS,2
BR,NIGHTMARE,2
BR,NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL,2
BR,OBSTRUCTIVE AIRWAYS DISORDER,2
BR,OEDEMA,2
BR,OESOPHAGITIS,2
BR,OPTIC ISCHAEMIC NEUROPATHY,2
BR,OSTEOARTHROPATHY,2
BR,OSTEOMYELITIS,2
BR,OSTEOPENIA,2
BR,OXYGEN SATURATION DECREASED,2
BR,PAIN IN JAW,2
BR,PANCREATIC NEOPLASM,2
BR,PARAESTHESIA ORAL,2
BR,PARAPLEGIA,2
BR,PAROSMIA,2
BR,PATIENT-DEVICE INCOMPATIBILITY,2
BR,PELVIC PAIN,2
BR,PHARYNGEAL INFLAMMATION,2
BR,PHARYNGEAL OEDEMA,2
BR,PIGMENTATION DISORDER,2
BR,POLYP,2
BR,POOR PERIPHERAL CIRCULATION,2
BR,POOR QUALITY DRUG ADMINISTERED,2
BR,POSTOPERATIVE WOUND INFECTION,2
BR,PRESCRIBED UNDERDOSE,2
BR,PROCEDURAL COMPLICATION,2
BR,PROCEDURAL HAEMORRHAGE,2
BR,PRODUCT BLISTER PACKAGING ISSUE,2
BR,PRODUCTIVE COUGH,2
BR,PROSTATE CANCER,2
BR,PRURITUS GENERALISED,2
BR,PSORIATIC ARTHROPATHY,2
BR,PSYCHIATRIC SYMPTOM,2
BR,PULMONARY SEPSIS,2
BR,PYELONEPHRITIS,2
BR,QUALITY OF LIFE DECREASED,2
BR,RASH ERYTHEMATOUS,2
BR,RASH PAPULAR,2
BR,RASH PUSTULAR,2
BR,RECTAL CANCER,2
BR,RED BLOOD CELL SEDIMENTATION RATE INCREASED,2
BR,REFLEXES ABNORMAL,2
BR,REHABILITATION THERAPY,2
BR,RENAL CANCER,2
BR,RENAL INJURY,2
BR,RESPIRATORY TRACT INFECTION,2
BR,RESTLESSNESS,2
BR,RETINAL HAEMORRHAGE,2
BR,RHINITIS ALLERGIC,2
BR,RHINORRHOEA,2
BR,SALIVARY HYPERSECRETION,2
BR,SCIATIC NERVE INJURY,2
BR,SCIATIC NERVE NEUROPATHY,2
BR,SELF INJURIOUS BEHAVIOUR,2
BR,SEXUAL DYSFUNCTION,2
BR,SKIN CANCER,2
BR,SKIN IRRITATION,2
BR,SOFT TISSUE INFECTION,2
BR,SPINAL VASCULAR DISORDER,2
BR,SPONDYLITIS,2
BR,SUFFOCATION FEELING,2
BR,SYNOVIAL CYST,2
BR,SYNOVIAL DISORDER,2
BR,TENDON PAIN,2
BR,THROMBOCYTOPENIA,2
BR,THYROID NEOPLASM,2
BR,TONGUE DRY,2
BR,TREATMENT NONCOMPLIANCE,2
BR,TRIGEMINAL NERVE DISORDER,2
BR,TRIGEMINAL NEURALGIA,2
BR,TYPE 2 DIABETES MELLITUS,2
BR,UNDERDOSE,2
BR,URINE FLOW DECREASED,2
BR,UTERINE LEIOMYOMA,2
BR,VASCULAR RUPTURE,2
BR,VEIN DISORDER,2
BR,VERTEBRAL OSTEOPHYTE,2
BR,VIRAL INFECTION,2
BR,VITAMIN D DEFICIENCY,2
BR,WITHDRAWAL SYNDROME,2
BR,WRIST FRACTURE,2
BR,WRONG DRUG ADMINISTERED,2
BR,YELLOW SKIN,2
BR,ABDOMINAL ADHESIONS,1
BR,ABDOMINAL HERNIA,1
BR,ABDOMINAL RIGIDITY,1
BR,ABNORMAL FAECES,1
BR,ABNORMAL SLEEP-RELATED EVENT,1
BR,ABORTION,1
BR,ACCIDENT AT HOME,1
BR,ACCIDENTAL EXPOSURE TO PRODUCT,1
BR,ACUTE PULMONARY OEDEMA,1
BR,ADRENAL INSUFFICIENCY,1
BR,ADVERSE DRUG REACTION,1
BR,AFFECT LABILITY,1
BR,AGEUSIA,1
BR,ALCOHOL ABUSE,1
BR,ALLERGIC COUGH,1
BR,ALLERGIC OEDEMA,1
BR,ALLODYNIA,1
BR,ANAL FISSURE,1
BR,ANAL HAEMORRHAGE,1
BR,ANAL INCONTINENCE,1
BR,ANAPHYLACTIC REACTION,1
BR,ANAPHYLACTIC SHOCK,1
BR,ANGIOPLASTY,1
BR,ANKYLOGLOSSIA ACQUIRED,1
BR,AORTIC ARTERIOSCLEROSIS,1
BR,APHTHOUS STOMATITIS,1
BR,APHTHOUS ULCER,1
BR,APNOEA,1
BR,APPENDICITIS,1
BR,APPLICATION SITE ERYTHEMA,1
BR,APPLICATION SITE HYPERSENSITIVITY,1
BR,APPLICATION SITE IRRITATION,1
BR,APPLICATION SITE PAIN,1
BR,APPLICATION SITE PRURITUS,1
BR,APPLICATION SITE RASH,1
BR,APPLICATION SITE SWELLING,1
BR,ARTERIOVENOUS FISTULA OCCLUSION,1
BR,ARTERIOVENOUS FISTULA THROMBOSIS,1
BR,ASCITES,1
BR,ASPARTATE AMINOTRANSFERASE ABNORMAL,1
BR,ASPIRATION,1
BR,ASPIRATION BRONCHIAL,1
BR,ASTHENOPIA,1
BR,ATRIOVENTRICULAR BLOCK,1
BR,ATTENTION DEFICIT/HYPERACTIVITY DISORDER,1
BR,AUTOIMMUNE DISORDER,1
BR,AUTONOMIC NERVOUS SYSTEM IMBALANCE,1
BR,AZOTAEMIA,1
BR,BACTERIAL PYELONEPHRITIS,1
BR,BED REST,1
BR,BENIGN NEOPLASM,1
BR,BENIGN PANCREATIC NEOPLASM,1
BR,BIPOLAR DISORDER,1
BR,BLADDER CANCER,1
BR,BLADDER PROLAPSE,1
BR,BLINDNESS UNILATERAL,1
BR,BLOOD BILIRUBIN ABNORMAL,1
BR,BLOOD CREATININE INCREASED,1
BR,BLOOD CULTURE NEGATIVE,1
BR,BLOOD CULTURE POSITIVE,1
BR,BLOOD IMMUNOGLOBULIN G DECREASED,1
BR,BLOOD INSULIN INCREASED,1
BR,BLOOD IRON DECREASED,1
BR,BLOOD IRON INCREASED,1
BR,BLOOD KETONE BODY INCREASED,1
BR,BLOOD OESTROGEN ABNORMAL,1
BR,BLOOD PRESSURE DIASTOLIC DECREASED,1
BR,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
BR,BLOOD SODIUM DECREASED,1
BR,BLOOD TESTOSTERONE DECREASED,1
BR,BLOOD UREA INCREASED,1
BR,BLOOD URIC ACID INCREASED,1
BR,BODY TEMPERATURE DECREASED,1
BR,BONE ATROPHY,1
BR,BONE CANCER,1
BR,BONE DENSITY DECREASED,1
BR,BONE NEOPLASM,1
BR,BONE OPERATION,1
BR,BONE SWELLING,1
BR,BRAIN DEATH,1
BR,BREAST CANCER METASTATIC,1
BR,BREAST INJURY,1
BR,BREAST MASS,1
BR,BREAST OEDEMA,1
BR,BREATH SOUNDS ABNORMAL,1
BR,BRONCHIAL DISORDER,1
BR,BRONCHIECTASIS,1
BR,BRONCHIOLITIS,1
BR,CALCULUS URETHRAL,1
BR,CALCULUS URINARY,1
BR,CARDIAC ANEURYSM,1
BR,CARDIAC DISCOMFORT,1
BR,CARDIAC FAILURE CONGESTIVE,1
BR,CARDIAC INFECTION,1
BR,CARDIAC VALVE DISEASE,1
BR,CARDIOMEGALY,1
BR,CARDIOVASCULAR DISORDER,1
BR,CARDIOVASCULAR INSUFFICIENCY,1
BR,CARTILAGE ATROPHY,1
BR,CATHETER PLACEMENT,1
BR,CATHETERISATION CARDIAC,1
BR,CEREBRAL CYST,1
BR,CEREBRAL DISORDER,1
BR,CEREBRAL ISCHAEMIA,1
BR,CEREBROSPINAL FLUID LEAKAGE,1
BR,CERUMEN IMPACTION,1
BR,CERVICAL CORD COMPRESSION,1
BR,CERVICAL DYSPLASIA,1
BR,CERVICAL RADICULOPATHY,1
BR,CERVICOBRACHIAL SYNDROME,1
BR,CERVICOGENIC HEADACHE,1
BR,CHEMOTHERAPY,1
BR,CHLOASMA,1
BR,CHOLECYSTITIS,1
BR,CHOLELITHIASIS MIGRATION,1
BR,CHRONIC GASTRITIS,1
BR,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
BR,CHRONIC SINUSITIS,1
BR,CIRCULATORY COLLAPSE,1
BR,CLUMSINESS,1
BR,COCCYDYNIA,1
BR,COGNITIVE DISORDER,1
BR,COLLAGEN DISORDER,1
BR,COMMUNICATION DISORDER,1
BR,COMPLICATION OF DEVICE INSERTION,1
BR,COMPUTERISED TOMOGRAM THORAX ABNORMAL,1
BR,CONJUNCTIVAL HAEMORRHAGE,1
BR,CONVERSION DISORDER,1
BR,CRANIAL NERVE INFECTION,1
BR,CRANIOCEREBRAL INJURY,1
BR,CREATININE URINE INCREASED,1
BR,CYST RUPTURE,1
BR,CYSTITIS BACTERIAL,1
BR,CYTOTOXIC CARDIOMYOPATHY,1
BR,DECUBITUS ULCER,1
BR,DENTAL CARIES,1
BR,DEPRESSIVE SYMPTOM,1
BR,DERMATITIS,1
BR,DERMATOMYOSITIS,1
BR,DEVICE BATTERY ISSUE,1
BR,DEVICE MALFUNCTION,1
BR,DIABETIC FOOT,1
BR,DIABETIC NEPHROPATHY,1
BR,DIAPHRAGMATIC DISORDER,1
BR,DIARRHOEA HAEMORRHAGIC,1
BR,DISLOCATION OF VERTEBRA,1
BR,DISTRACTIBILITY,1
BR,DISTURBANCE IN SOCIAL BEHAVIOUR,1
BR,DIZZINESS POSTURAL,1
BR,DROOLING,1
BR,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
BR,DRUG EFFECT INCREASED,1
BR,DRUG SPECIFIC ANTIBODY PRESENT,1
BR,DRUG TOLERANCE,1
BR,DUODENAL ULCER,1
BR,DUODENITIS,1
BR,DYSLEXIA,1
BR,DYSPLASIA,1
BR,EAR HAEMORRHAGE,1
BR,ECZEMA,1
BR,EHLERS-DANLOS SYNDROME,1
BR,ELECTROENCEPHALOGRAM ABNORMAL,1
BR,ELEVATED MOOD,1
BR,ENCEPHALOPATHY,1
BR,ENDOCARDITIS,1
BR,ENDOMETRIOSIS,1
BR,ENDOTRACHEAL INTUBATION,1
BR,ENTERITIS INFECTIOUS,1
BR,EPIGASTRIC DISCOMFORT,1
BR,EPISCLERITIS,1
BR,ERUCTATION,1
BR,ERYTHROPSIA,1
BR,ESCHERICHIA INFECTION,1
BR,EXOPHTHALMOS,1
BR,EXPANDED DISABILITY STATUS SCALE SCORE INCREASED,1
BR,EXPOSURE TO TOXIC AGENT,1
BR,EXTRA DOSE ADMINISTERED,1
BR,EXTREMITY CONTRACTURE,1
BR,EYE ALLERGY,1
BR,EYE CONTUSION,1
BR,EYE INFLAMMATION,1
BR,EYE INJURY,1
BR,EYE IRRITATION,1
BR,EYE OEDEMA,1
BR,EYE OPERATION COMPLICATION,1
BR,EYELID OEDEMA,1
BR,EYELID PTOSIS,1
BR,FACE OEDEMA,1
BR,FACET JOINT SYNDROME,1
BR,FACIAL PARALYSIS,1
BR,FAECAL INCONTINENCE,1
BR,FAECES DISCOLOURED,1
BR,FAECES HARD,1
BR,FEAR OF DEATH,1
BR,FEELING JITTERY,1
BR,FINGER AMPUTATION,1
BR,FISTULA,1
BR,FLAVIVIRUS INFECTION,1
BR,FLUSHING,1
BR,FOOD CRAVING,1
BR,FOOD INTOLERANCE,1
BR,FOREIGN BODY SENSATION IN EYES,1
BR,FRACTURE,1
BR,FRACTURE MALUNION,1
BR,FRACTURED SACRUM,1
BR,FULL BLOOD COUNT ABNORMAL,1
BR,FUNCTIONAL GASTROINTESTINAL DISORDER,1
BR,FUNGAL SKIN INFECTION,1
BR,GALLBLADDER NECROSIS,1
BR,GANGRENE,1
BR,GASTRIC DILATATION,1
BR,GASTRIC HAEMORRHAGE,1
BR,GASTRIC INFECTION,1
BR,GASTROENTERITIS,1
BR,GASTROENTERITIS VIRAL,1
BR,GASTROINTESTINAL HAEMORRHAGE,1
BR,GASTROINTESTINAL HYPOMOTILITY,1
BR,GASTROINTESTINAL MOTILITY DISORDER,1
BR,GASTROINTESTINAL PAIN,1
BR,GENERAL SYMPTOM,1
BR,GENERALISED ERYTHEMA,1
BR,GENITAL INFECTION FEMALE,1
BR,GINGIVAL PAIN,1
BR,GINGIVITIS,1
BR,GLIOSIS,1
BR,GLOMERULONEPHRITIS,1
BR,HAEMATOCHEZIA,1
BR,HAEMOCHROMATOSIS,1
BR,HAEMOLYSIS,1
BR,HAEMOLYTIC ANAEMIA,1
BR,HAEMORRHAGE URINARY TRACT,1
BR,HAEMORRHAGIC STROKE,1
BR,HAIR DISORDER,1
BR,HALLUCINATION,1
BR,HALLUCINATION_ AUDITORY,1
BR,HEAD TITUBATION,1
BR,HEART RATE IRREGULAR,1
BR,HEPATIC CIRRHOSIS,1
BR,HEPATIC ENCEPHALOPATHY,1
BR,HEPATIC ENZYME INCREASED,1
BR,HEPATIC INFECTION,1
BR,HEPATIC PAIN,1
BR,HEPATIC VASCULAR THROMBOSIS,1
BR,HEPATITIS B,1
BR,HEPATOTOXICITY,1
BR,HERNIA PERFORATION,1
BR,HIGH DENSITY LIPOPROTEIN DECREASED,1
BR,HIP ARTHROPLASTY,1
BR,HIP DEFORMITY,1
BR,HIV TEST POSITIVE,1
BR,HODGKIN^S DISEASE,1
BR,HOMICIDAL IDEATION,1
BR,HORDEOLUM,1
BR,HUMERUS FRACTURE,1
BR,HYPERACUSIS,1
BR,HYPERCHLORHYDRIA,1
BR,HYPERCHOLESTEROLAEMIA,1
BR,HYPERKERATOSIS,1
BR,HYPERMETROPIA,1
BR,HYPERPHAGIA,1
BR,HYPERTRICHOSIS,1
BR,HYPOCHONDRIASIS,1
BR,HYPOGAMMAGLOBULINAEMIA,1
BR,HYPOGLOBULINAEMIA,1
BR,HYPOKALAEMIA,1
BR,HYPOTHERMIA,1
BR,HYPOVOLAEMIC SHOCK,1
BR,HYSTERECTOMY,1
BR,IMMUNOGLOBULINS ABNORMAL,1
BR,INADEQUATE DIET,1
BR,INCORRECT DRUG ADMINISTRATION DURATION,1
BR,INCREASED BRONCHIAL SECRETION,1
BR,INFECTIOUS PLEURAL EFFUSION,1
BR,INFECTIVE MYOSITIS,1
BR,INFECTIVE TENOSYNOVITIS,1
BR,INFUSION SITE PAIN,1
BR,INJECTION SITE DISCOMFORT,1
BR,INJECTION SITE HAEMATOMA,1
BR,INJECTION SITE HAEMORRHAGE,1
BR,INJECTION SITE NODULE,1
BR,INJECTION SITE RASH,1
BR,INJECTION SITE VESICLES,1
BR,INNER EAR DISORDER,1
BR,INTENTIONAL OVERDOSE,1
BR,INTENTIONAL SELF-INJURY,1
BR,INTERSTITIAL LUNG DISEASE,1
BR,INTERVERTEBRAL DISC CALCIFICATION,1
BR,INTERVERTEBRAL DISC COMPRESSION,1
BR,INTESTINAL FISTULA,1
BR,INTESTINAL INFARCTION,1
BR,INTESTINAL OBSTRUCTION,1
BR,INTESTINAL PERFORATION,1
BR,INTESTINAL STENOSIS,1
BR,INTESTINAL ULCER,1
BR,INTRANEURAL CYST,1
BR,IRRITABLE BOWEL SYNDROME,1
BR,JAW CYST,1
BR,JOINT INSTABILITY,1
BR,JOINT LOCK,1
BR,JOINT PROSTHESIS USER,1
BR,JUDGEMENT IMPAIRED,1
BG,ANAPHYLACTIC SHOCK,1
BG,ANURIA,1
BG,BONE MARROW FAILURE,1
BG,CIRCULATORY COLLAPSE,1
CM,DYSPNOEA,1
CM,FACE OEDEMA,1
CM,FATIGUE,1
CM,LOCALISED OEDEMA,1
CM,OEDEMA PERIPHERAL,1
CA,DRUG INEFFECTIVE,473
CA,PAIN,390
CA,RHEUMATOID ARTHRITIS,337
CA,FATIGUE,297
CA,ARTHRALGIA,236
CA,DYSPNOEA,218
CA,NAUSEA,213
CA,DIARRHOEA,209
CA,PAIN IN EXTREMITY,189
CA,DRUG INTOLERANCE,183
CA,MALAISE,168
CA,HEADACHE,166
CA,RASH,163
CA,PNEUMONIA,162
CA,CONDITION AGGRAVATED,160
CA,FALL,157
CA,JOINT SWELLING,152
CA,VOMITING,148
CA,BLOOD PRESSURE INCREASED,135
CA,WEIGHT DECREASED,135
CA,DIZZINESS,132
CA,MUSCLE SPASMS,131
CA,TREATMENT FAILURE,120
CA,ASTHENIA,117
CA,NASOPHARYNGITIS,114
CA,SINUSITIS,111
CA,BACK PAIN,107
CA,DRUG HYPERSENSITIVITY,106
CA,PYREXIA,106
CA,WEIGHT INCREASED,106
CA,SOMNOLENCE,105
CA,INFECTION,103
CA,ABDOMINAL PAIN,102
CA,HYPOAESTHESIA,101
CA,GAIT DISTURBANCE,98
CA,INSOMNIA,97
CA,PERIPHERAL SWELLING,96
CA,COUGH,93
CA,DEATH,91
CA,SWELLING,89
CA,DRUG EFFECT INCOMPLETE,88
CA,PRURITUS,83
CA,INFUSION RELATED REACTION,79
CA,PSORIATIC ARTHROPATHY,79
CA,URINARY TRACT INFECTION,77
CA,GASTROOESOPHAGEAL REFLUX DISEASE,76
CA,FIBROMYALGIA,74
CA,HAEMOGLOBIN DECREASED,74
CA,ARTHROPATHY,72
CA,SCIATICA,72
CA,MUSCULOSKELETAL PAIN,70
CA,MUSCULOSKELETAL STIFFNESS,68
CA,INFLUENZA,67
CA,DECREASED APPETITE,65
CA,HERPES ZOSTER,65
CA,HYPERTENSION,65
CA,ABDOMINAL PAIN UPPER,64
CA,HOT FLUSH,62
CA,BRONCHITIS,60
CA,ERYTHEMA,59
CA,HYPOTENSION,57
CA,HYPERSENSITIVITY,55
CA,LUNG DISORDER,55
CA,CONSTIPATION,53
CA,OEDEMA PERIPHERAL,53
CA,ARTHRITIS,52
CA,ANXIETY,51
CA,CHILLS,50
CA,COMA,50
CA,PNEUMONIA ASPIRATION,50
CA,FEELING ABNORMAL,49
CA,HEART RATE INCREASED,49
CA,MYALGIA,49
CA,SLEEP DISORDER,48
CA,PRODUCT USE ISSUE,47
CA,SYNOVITIS,47
CA,PARAESTHESIA,46
CA,ALOPECIA,45
CA,CHEST PAIN,45
CA,DEPRESSION,44
CA,HYPERHIDROSIS,44
CA,MUSCULAR WEAKNESS,44
CA,OROPHARYNGEAL PAIN,44
CA,BALANCE DISORDER,42
CA,LOWER RESPIRATORY TRACT INFECTION,42
CA,MOBILITY DECREASED,42
CA,OSTEOARTHRITIS,42
CA,PAIN IN JAW,42
CA,BURNING SENSATION,39
CA,CONFUSIONAL STATE,39
CA,DISEASE PROGRESSION,39
CA,OXYGEN SATURATION DECREASED,39
CA,GENERAL PHYSICAL HEALTH DETERIORATION,38
CA,LOSS OF CONSCIOUSNESS,37
CA,CATARACT,36
CA,DEHYDRATION,36
CA,MYOCARDIAL INFARCTION,36
CA,DRUG EFFECT DECREASED,34
CA,GASTROINTESTINAL DISORDER,34
CA,ASTHMA,33
CA,INFLAMMATION,33
CA,LUNG INFECTION,33
CA,MALIGNANT NEOPLASM PROGRESSION,33
CA,PRODUCTIVE COUGH,33
CA,TREMOR,33
CA,VISUAL IMPAIRMENT,33
CA,WHITE BLOOD CELL COUNT DECREASED,33
CA,ABDOMINAL DISCOMFORT,32
CA,BLOOD PRESSURE SYSTOLIC INCREASED,32
CA,PLATELET COUNT DECREASED,32
CA,RENAL DISORDER,32
CA,URTICARIA,32
CA,ANAEMIA,31
CA,MEMORY IMPAIRMENT,31
CA,NEUROPATHY PERIPHERAL,31
CA,CYSTITIS,30
CA,JOINT STIFFNESS,30
CA,RENAL IMPAIRMENT,30
CA,SWELLING FACE,30
CA,THERAPEUTIC RESPONSE DECREASED,30
CA,CARDIAC FAILURE CONGESTIVE,29
CA,INTERSTITIAL LUNG DISEASE,29
CA,OEDEMA,29
CA,THROMBOSIS,29
CA,BLOOD PRESSURE DECREASED,28
CA,CONTUSION,28
CA,LOCALISED INFECTION,28
CA,ACNE,27
CA,BLOOD PRESSURE FLUCTUATION,27
CA,BURSITIS,27
CA,CHEST DISCOMFORT,27
CA,DYSPEPSIA,27
CA,NECK PAIN,27
CA,RIB FRACTURE,27
CA,SEPSIS,27
CA,CELLULITIS,26
CA,CEREBROVASCULAR ACCIDENT,26
CA,ENCEPHALITIS,26
CA,MOVEMENT DISORDER,26
CA,NEOPLASM MALIGNANT,26
CA,NEPHROLITHIASIS,26
CA,RHINORRHOEA,26
CA,WOUND,26
CA,DEPRESSED MOOD,25
CA,DRY MOUTH,25
CA,DYSPHAGIA,25
CA,DYSPNOEA EXERTIONAL,25
CA,EPISTAXIS,25
CA,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,25
CA,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,25
CA,PALPITATIONS,25
CA,AMNESIA,24
CA,BONE PAIN,24
CA,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,24
CA,DRY EYE,24
CA,DYSARTHRIA,24
CA,EYE PAIN,24
CA,HEPATIC ENZYME INCREASED,24
CA,IMPAIRED WORK ABILITY,24
CA,MIGRAINE,24
CA,PYELONEPHRITIS,24
CA,VISION BLURRED,24
CA,ABDOMINAL DISTENSION,23
CA,BLOOD GLUCOSE INCREASED,23
CA,C-REACTIVE PROTEIN INCREASED,23
CA,DIABETES MELLITUS,23
CA,HAEMATOCHEZIA,23
CA,LOCAL SWELLING,23
CA,OCULAR HYPERAEMIA,23
CA,SEIZURE,23
CA,WHEEZING,23
CA,BLOOD CHOLESTEROL INCREASED,22
CA,HEART RATE DECREASED,22
CA,INFLUENZA LIKE ILLNESS,22
CA,INJECTION SITE PAIN,22
CA,INTERNATIONAL NORMALISED RATIO FLUCTUATION,22
CA,MULTIPLE ALLERGIES,22
CA,PNEUMONITIS,22
CA,CARPAL TUNNEL SYNDROME,21
CA,SENSITIVITY TO WEATHER CHANGE,21
CA,SLEEP APNOEA SYNDROME,21
CA,STRESS,21
CA,SUICIDAL IDEATION,21
CA,ADVERSE EVENT,20
CA,BRONCHOSPASM,20
CA,CROHN^S DISEASE,20
CA,DRUG DOSE OMISSION,20
CA,INTESTINAL OBSTRUCTION,20
CA,JOINT EFFUSION,20
CA,NEUTROPHIL COUNT DECREASED,20
CA,PALLOR,20
CA,PRERENAL FAILURE,20
CA,PSORIASIS,20
CA,RESPIRATORY TRACT INFECTION,20
CA,ACTIVITIES OF DAILY LIVING IMPAIRED,19
CA,C-REACTIVE PROTEIN ABNORMAL,19
CA,DRY SKIN,19
CA,INTERVERTEBRAL DISC PROTRUSION,19
CA,NASAL CONGESTION,19
CA,NODULE,19
CA,BLOOD TEST ABNORMAL,18
CA,DYSPHONIA,18
CA,FEELING HOT,18
CA,FLUSHING,18
CA,GLAUCOMA,18
CA,HAEMORRHAGE,18
CA,HELICOBACTER INFECTION,18
CA,HERNIA,18
CA,LIMB INJURY,18
CA,RENAL FAILURE,18
CA,STAPHYLOCOCCAL INFECTION,18
CA,SYNCOPE,18
CA,CARDIAC DISORDER,17
CA,DELIRIUM,17
CA,DERMATITIS,17
CA,FLANK PAIN,17
CA,ILL-DEFINED DISORDER,17
CA,LYMPHADENOPATHY,17
CA,LYMPHOCYTE COUNT DECREASED,17
CA,NEURALGIA,17
CA,NEUTROPENIA,17
CA,ORAL HERPES,17
CA,STOMATITIS,17
CA,SYNOVIAL CYST,17
CA,ULCER,17
CA,BLOOD URINE PRESENT,16
CA,CONJUNCTIVITIS,16
CA,RED BLOOD CELL SEDIMENTATION RATE ABNORMAL,16
CA,SCAR,16
CA,ACUTE KIDNEY INJURY,15
CA,ALANINE AMINOTRANSFERASE INCREASED,15
CA,DRUG WITHDRAWAL SYNDROME,15
CA,EYE IRRITATION,15
CA,FAECES SOFT,15
CA,FLUID RETENTION,15
CA,HEAD INJURY,15
CA,LIMB DISCOMFORT,15
CA,PHOTOPHOBIA,15
CA,POOR VENOUS ACCESS,15
CA,PRODUCT USE IN UNAPPROVED INDICATION,15
CA,PULMONARY EMBOLISM,15
CA,RED BLOOD CELL COUNT DECREASED,15
CA,SPINAL COLUMN STENOSIS,15
CA,UPPER RESPIRATORY TRACT INFECTION,15
CA,VIRAL UPPER RESPIRATORY TRACT INFECTION,15
CA,ANGINA PECTORIS,14
CA,APHONIA,14
CA,ATELECTASIS,14
CA,BLISTER,14
CA,BODY TEMPERATURE DECREASED,14
CA,CLOSTRIDIUM DIFFICILE INFECTION,14
CA,COGNITIVE DISORDER,14
CA,DIVERTICULITIS,14
CA,DYSSTASIA,14
CA,FEELING COLD,14
CA,GASTROENTERITIS,14
CA,GASTROENTERITIS VIRAL,14
CA,OSTEOPOROSIS,14
CA,PULMONARY FIBROSIS,14
CA,PULMONARY OEDEMA,14
CA,RHEUMATOID NODULE,14
CA,SKIN DISCOLOURATION,14
CA,SKIN ULCER,14
CA,SURGERY,14
CA,VAGINAL INFECTION,14
CA,ANTINUCLEAR ANTIBODY POSITIVE,13
CA,CONTRAINDICATED PRODUCT ADMINISTERED,13
CA,CRYING,13
CA,DISORIENTATION,13
CA,FAECES DISCOLOURED,13
CA,FLATULENCE,13
CA,FREQUENT BOWEL MOVEMENTS,13
CA,HAEMATEMESIS,13
CA,HYPERSOMNIA,13
CA,MIDDLE INSOMNIA,13
CA,MULTIPLE SCLEROSIS RELAPSE,13
CA,NERVOUS SYSTEM DISORDER,13
CA,POLLAKIURIA,13
CA,RED BLOOD CELL SEDIMENTATION RATE INCREASED,13
CA,SEPTIC SHOCK,13
CA,SINUS CONGESTION,13
CA,SPEECH DISORDER,13
CA,URINARY INCONTINENCE,13
CA,ABASIA,12
CA,ADVERSE DRUG REACTION,12
CA,APHASIA,12
CA,APHTHOUS ULCER,12
CA,BLOOD PRESSURE DIASTOLIC DECREASED,12
CA,BLOODY DISCHARGE,12
CA,CENTRAL NERVOUS SYSTEM LESION,12
CA,CHOLELITHIASIS,12
CA,CREPITATIONS,12
CA,DYSURIA,12
CA,EYE SWELLING,12
CA,HYPOACUSIS,12
CA,INCORRECT DOSE ADMINISTERED,12
CA,LABORATORY TEST ABNORMAL,12
CA,MASS,12
CA,PANCREATITIS,12
CA,PLEURAL EFFUSION,12
CA,PLEURITIC PAIN,12
CA,POST PROCEDURAL INFECTION,12
CA,PSYCHIATRIC SYMPTOM,12
CA,RESPIRATORY RATE INCREASED,12
CA,RESTLESS LEGS SYNDROME,12
CA,SCLERITIS,12
CA,SKIN EXFOLIATION,12
CA,SPINAL FRACTURE,12
CA,TACHYCARDIA,12
CA,TENDERNESS,12
CA,TENOSYNOVITIS STENOSANS,12
CA,WHITE BLOOD CELL COUNT INCREASED,12
CA,ANKLE FRACTURE,11
CA,ATRIAL FIBRILLATION,11
CA,CUSHINGOID,11
CA,CYTOLOGY ABNORMAL,11
CA,DEFORMITY,11
CA,DIPLOPIA,11
CA,EYE INFECTION,11
CA,FEELING JITTERY,11
CA,HAEMATOCRIT DECREASED,11
CA,HAEMOPTYSIS,11
CA,HIP FRACTURE,11
CA,IMMOBILE,11
CA,IMPAIRED HEALING,11
CA,MUSCULOSKELETAL DISORDER,11
CA,OSTEOPENIA,11
CA,OVERDOSE,11
CA,PHOTOSENSITIVITY REACTION,11
CA,POOR QUALITY SLEEP,11
CA,RESPIRATORY DISORDER,11
CA,SKIN IRRITATION,11
CA,SPUTUM DISCOLOURED,11
CA,TINNITUS,11
CA,TRANSIENT ISCHAEMIC ATTACK,11
CA,URINARY RETENTION,11
CA,URINE ODOUR ABNORMAL,11
CA,VIRAL INFECTION,11
CA,WRIST FRACTURE,11
CA,ARRHYTHMIA,10
CA,ASPARTATE AMINOTRANSFERASE INCREASED,10
CA,BLOOD COUNT ABNORMAL,10
CA,BLOOD CREATININE INCREASED,10
CA,BREAST CANCER METASTATIC,10
CA,CARDIAC FAILURE,10
CA,CARDIAC OUTPUT DECREASED,10
CA,CORONARY ARTERY OCCLUSION,10
CA,ECZEMA,10
CA,HEART RATE IRREGULAR,10
CA,HYPERCHOLESTEROLAEMIA,10
CA,HYPOTHYROIDISM,10
CA,IMMUNE SYSTEM DISORDER,10
CA,IMMUNODEFICIENCY,10
CA,INJECTION SITE BRUISING,10
CA,INJECTION SITE ERYTHEMA,10
CA,INJURY,10
CA,LYME DISEASE,10
CA,NEUTROPHIL COUNT INCREASED,10
CA,PANCYTOPENIA,10
CA,RASH GENERALISED,10
CA,RECTAL HAEMORRHAGE,10
CA,RENAL PAIN,10
CA,SYNOVIAL FLUID ANALYSIS,10
CA,TEMPERATURE INTOLERANCE,10
CA,TOXICITY TO VARIOUS AGENTS,10
CA,ATAXIA,9
CA,BACTERIAL INFECTION,9
CA,BLOOD BILIRUBIN INCREASED,9
CA,CARDIAC ARREST,9
CA,EAR INFECTION,9
CA,FEMUR FRACTURE,9
CA,FRACTURE,9
CA,FULL BLOOD COUNT DECREASED,9
CA,GASTRIC DISORDER,9
CA,GASTROINTESTINAL HAEMORRHAGE,9
CA,GLOMERULAR FILTRATION RATE DECREASED,9
CA,HIP ARTHROPLASTY,9
CA,HOSPITALISATION,9
CA,JOINT INJURY,9
CA,KIDNEY INFECTION,9
CA,KNEE ARTHROPLASTY,9
CA,LIVER FUNCTION TEST INCREASED,9
CA,MEDICATION ERROR,9
CA,MULTIPLE SCLEROSIS,9
CA,NEOPLASM,9
CA,NERVOUSNESS,9
CA,PANIC ATTACK,9
CA,PERIARTHRITIS,9
CA,PLATELET COUNT INCREASED,9
CA,PROCEDURAL PAIN,9
CA,PRODUCT SUBSTITUTION ISSUE,9
CA,RHEUMATOID FACTOR NEGATIVE,9
CA,SPINAL DISORDER,9
CA,THROAT IRRITATION,9
CA,THROAT TIGHTNESS,9
CA,AGEUSIA,8
CA,BLINDNESS,8
CA,BLOOD ALKALINE PHOSPHATASE INCREASED,8
CA,BLOOD MAGNESIUM DECREASED,8
CA,BLOOD POTASSIUM DECREASED,8
CA,BLOOD PRESSURE ABNORMAL,8
CA,COLITIS,8
CA,CONVULSION,8
CA,DYSGEUSIA,8
CA,ENCEPHALITIS BRAIN STEM,8
CA,FEAR,8
CA,FEBRILE NEUTROPENIA,8
CA,FOOT FRACTURE,8
CA,FUNGAL INFECTION,8
CA,GAMMA-GLUTAMYLTRANSFERASE INCREASED,8
CA,HALLUCINATION,8
CA,HYPERAESTHESIA,8
CA,HYPERTROPHIC CARDIOMYOPATHY,8
CA,HYPOAESTHESIA ORAL,8
CA,INTESTINAL PERFORATION,8
CA,IRON DEFICIENCY,8
CA,LIP SWELLING,8
CA,LUNG NEOPLASM MALIGNANT,8
CA,MENTAL DISORDER,8
CA,MONOPLEGIA,8
CA,MOOD ALTERED,8
CA,MOUTH ULCERATION,8
CA,NERVE COMPRESSION,8
CA,PARALYSIS,8
CA,PERICARDIAL EFFUSION,8
CA,PERIPHERAL SENSORY NEUROPATHY,8
CA,PHARYNGITIS,8
CA,PLASMA CELL MYELOMA,8
CA,PRURITUS GENERALISED,8
CA,PULMONARY FUNCTION TEST DECREASED,8
CA,PULMONARY MASS,8
CA,SKIN LESION,8
CA,SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION_ INSOMNIA TYPE,8
CA,SNEEZING,8
CA,SPINAL DEFORMITY,8
CA,SPINAL OSTEOARTHRITIS,8
CA,THROMBOCYTOPENIA,8
CA,UVEITIS,8
CA,VERTIGO,8
CA,WOUND INFECTION,8
CA,AKATHISIA,7
CA,BASAL CELL CARCINOMA,7
CA,BLOOD IRON DECREASED,7
CA,BLOOD PRESSURE SYSTOLIC DECREASED,7
CA,BRAIN INJURY,7
CA,COSTOCHONDRITIS,7
CA,DISABILITY,7
CA,DISCOMFORT,7
CA,DRUG-INDUCED LIVER INJURY,7
CA,DYSKINESIA,7
CA,EMOTIONAL DISORDER,7
CA,FOOT DEFORMITY,7
CA,HEPATITIS,7
CA,INJECTION SITE MASS,7
CA,LACERATION,7
CA,LARYNGITIS,7
CA,LIVER INJURY,7
CA,METASTASES TO LUNG,7
CA,MONOCYTE COUNT INCREASED,7
CA,MUSCULOSKELETAL DISCOMFORT,7
CA,MYOCLONIC EPILEPSY,7
CA,NERVE INJURY,7
CA,NOCTURIA,7
CA,ORAL CANDIDIASIS,7
CA,PAIN OF SKIN,7
CA,PARKINSON^S DISEASE,7
CA,PELVIC FRACTURE,7
CA,PERIPHERAL MOTOR NEUROPATHY,7
CA,POST PROCEDURAL COMPLICATION,7
CA,PROSTATE CANCER,7
CA,PULMONARY CONGESTION,7
CA,ROAD TRAFFIC ACCIDENT,7
CA,ROTATOR CUFF SYNDROME,7
CA,SCAB,7
CA,SEDATION,7
CA,SWOLLEN TONGUE,7
CA,TOOTH ABSCESS,7
CA,UPPER LIMB FRACTURE,7
CA,VARICOSE VEIN,7
CA,VISUAL ACUITY REDUCED,7
CA,ABDOMINAL PAIN LOWER,6
CA,ABSCESS,6
CA,AGITATION,6
CA,ANKYLOSING SPONDYLITIS,6
CA,ANORECTAL DISCOMFORT,6
CA,BLOOD GLUCOSE DECREASED,6
CA,BLOOD LACTATE DEHYDROGENASE INCREASED,6
CA,BONE MARROW FAILURE,6
CA,BRONCHIECTASIS,6
CA,CANDIDA INFECTION,6
CA,CARDIOVASCULAR DISORDER,6
CA,CHROMATURIA,6
CA,DEEP VEIN THROMBOSIS,6
CA,DENTAL CARIES,6
CA,DEPENDENCE,6
CA,DIABETIC KETOACIDOSIS,6
CA,DISTURBANCE IN ATTENTION,6
CA,DRY THROAT,6
CA,EAR PAIN,6
CA,EATING DISORDER,6
CA,EMOTIONAL DISTRESS,6
CA,EXERCISE TOLERANCE DECREASED,6
CA,FEELING OF BODY TEMPERATURE CHANGE,6
CA,FISTULA,6
CA,FORCED EXPIRATORY VOLUME DECREASED,6
CA,GALLBLADDER DISORDER,6
CA,GASTRITIS,6
CA,GINGIVITIS,6
CA,HAEMATOMA,6
CA,HAEMORRHOIDS,6
CA,HEPATIC CIRRHOSIS,6
CA,INTESTINAL RESECTION,6
CA,JOINT DESTRUCTION,6
CA,JOINT RANGE OF MOTION DECREASED,6
CA,LACRIMATION INCREASED,6
CA,LETHARGY,6
CA,LEUKOPENIA,6
CA,LIPOMA,6
CA,LIVER FUNCTION TEST ABNORMAL,6
CA,MENORRHAGIA,6
CA,METASTASES TO LIVER,6
CA,NASAL DISCHARGE DISCOLOURATION,6
CA,NO THERAPEUTIC RESPONSE,6
CA,ORAL PAIN,6
CA,PARAESTHESIA ORAL,6
CA,PRODUCT QUALITY ISSUE,6
CA,RECTAL FISSURE,6
CA,RED CELL DISTRIBUTION WIDTH INCREASED,6
CA,RESTLESSNESS,6
CA,SENSORY LOSS,6
CA,SKIN BURNING SENSATION,6
CA,SKIN FISSURES,6
CA,SKIN MASS,6
CA,SPINAL CORD COMPRESSION,6
CA,SPINAL PAIN,6
CA,TENDON RUPTURE,6
CA,THERAPEUTIC RESPONSE UNEXPECTED,6
CA,TONGUE DISORDER,6
CA,TOOTH INFECTION,6
CA,UNEVALUABLE EVENT,6
CA,URINE ABNORMALITY,6
CA,VAGINAL HAEMORRHAGE,6
CA,VULVOVAGINAL MYCOTIC INFECTION,6
CA,WOUND COMPLICATION,6
CA,ABDOMINAL HERNIA,5
CA,ANAPHYLACTIC REACTION,5
CA,ANAPHYLACTIC SHOCK,5
CA,APPARENT DEATH,5
CA,ASCITES,5
CA,BACK DISORDER,5
CA,BLADDER CANCER,5
CA,BLOOD CREATINE PHOSPHOKINASE INCREASED,5
CA,BLOOD PRESSURE DIASTOLIC INCREASED,5
CA,BODY TEMPERATURE INCREASED,5
CA,BONE DISORDER,5
CA,CARDIOMEGALY,5
CA,CHOKING,5
CA,CONCUSSION,5
CA,CORONARY ARTERY DISEASE,5
CA,DEMENTIA ALZHEIMER^S TYPE,5
CA,DIABETES MELLITUS INADEQUATE CONTROL,5
CA,ECCHYMOSIS,5
CA,EPIGASTRIC DISCOMFORT,5
CA,EYE INFLAMMATION,5
CA,EYE PRURITUS,5
CA,FEEDING DISORDER,5
CA,FOOT OPERATION,5
CA,GASTRIC ULCER,5
CA,GOUT,5
CA,HEMIPLEGIA,5
CA,HYPERGLYCAEMIA,5
CA,HYPERKALAEMIA,5
CA,INGROWING NAIL,5
CA,INJECTION SITE EXTRAVASATION,5
CA,INJECTION SITE PRURITUS,5
CA,INJECTION SITE REACTION,5
CA,INJECTION SITE SWELLING,5
CA,INTERNATIONAL NORMALISED RATIO INCREASED,5
CA,IRRITABILITY,5
CA,LACTIC ACIDOSIS,5
CA,LEG AMPUTATION,5
CA,LOW DENSITY LIPOPROTEIN INCREASED,5
CA,LUNG NEOPLASM,5
CA,METASTASES TO CENTRAL NERVOUS SYSTEM,5
CA,MIGRAINE WITH AURA,5
CA,MUSCLE CONTRACTIONS INVOLUNTARY,5
CA,MUSCLE TIGHTNESS,5
CA,MUSCLE TWITCHING,5
CA,MUSCULOSKELETAL CHEST PAIN,5
CA,NASAL DRYNESS,5
CA,NEEDLE ISSUE,5
CA,NEOPLASM PROGRESSION,5
CA,NIGHT SWEATS,5
CA,ORTHOSTATIC HYPOTENSION,5
CA,OSTEOMYELITIS,5
CA,PARKINSONISM,5
CA,PERIPHERAL COLDNESS,5
CA,PERIPHERAL VASCULAR DISORDER,5
CA,PRESYNCOPE,5
CA,PROCTALGIA,5
CA,PSYCHOTIC DISORDER,5
CA,PULMONARY PAIN,5
CA,PULMONARY TOXICITY,5
CA,QUALITY OF LIFE DECREASED,5
CA,RASH ERYTHEMATOUS,5
CA,RASH PRURITIC,5
CA,RENAL FAILURE ACUTE,5
CA,RESPIRATORY DISTRESS,5
CA,RESPIRATORY FAILURE,5
CA,RESPIRATORY TRACT CONGESTION,5
CA,SALIVARY HYPERSECRETION,5
CA,SCRATCH,5
CA,SEROTONIN SYNDROME,5
CA,SHOULDER OPERATION,5
CA,SKIN CANCER,5
CA,SKIN DISORDER,5
CA,SPINA BIFIDA,5
CA,TENDONITIS,5
CA,THERAPY NON-RESPONDER,5
CA,THINKING ABNORMAL,5
CA,THYROID DISORDER,5
CA,TIBIA FRACTURE,5
CA,TOOTH DISORDER,5
CA,TOOTH FRACTURE,5
CA,TOOTH LOSS,5
CA,TRANSFUSION,5
CA,UNDERDOSE,5
CA,UROSEPSIS,5
CA,VASCULAR OCCLUSION,5
CA,WALKING AID USER,5
CA,ABNORMAL BEHAVIOUR,4
CA,ABNORMAL DREAMS,4
CA,ABSCESS LIMB,4
CA,ACUTE MYOCARDIAL INFARCTION,4
CA,ADVERSE REACTION,4
CA,AGGRESSION,4
CA,ALANINE AMINOTRANSFERASE ABNORMAL,4
CA,AMYOTROPHIC LATERAL SCLEROSIS,4
CA,ANEURYSM,4
CA,ANOSMIA,4
CA,APHAGIA,4
CA,APPENDICITIS,4
CA,ARTERIAL OCCLUSIVE DISEASE,4
CA,ARTHRITIS BACTERIAL,4
CA,BACK INJURY,4
CA,BLOOD CALCIUM INCREASED,4
CA,BLOOD PRESSURE DIASTOLIC ABNORMAL,4
CA,BONE DENSITY DECREASED,4
CA,BONE MARROW TRANSPLANT,4
CA,BRADYCARDIA,4
CA,BREAST CANCER,4
CA,BREAST MASS,4
CA,BURSITIS INFECTIVE,4
CA,CARBON MONOXIDE DIFFUSING CAPACITY DECREASED,4
CA,CARDIAC MURMUR,4
CA,CARDIAC VALVE DISEASE,4
CA,CATARACT OPERATION,4
CA,CATHETER SITE INFECTION,4
CA,CEREBRAL HAEMORRHAGE,4
CA,CHOLANGITIS,4
CA,COLD SWEAT,4
CA,COLITIS ULCERATIVE,4
CA,CYST,4
CA,DACTYLITIS,4
CA,DEAFNESS,4
CA,DECREASED ACTIVITY,4
CA,DECUBITUS ULCER,4
CA,DEPRESSED LEVEL OF CONSCIOUSNESS,4
CA,DEVICE RELATED INFECTION,4
CA,DRUG ADMINISTRATION ERROR,4
CA,DRUG ERUPTION,4
CA,DRUG PRESCRIBING ERROR,4
CA,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,4
CA,DRUG RESISTANCE,4
CA,DYSLEXIA,4
CA,EAR DISCOMFORT,4
CA,EPILEPSY,4
CA,EXOSTOSIS,4
CA,EYE DISORDER,4
CA,FAECAL INCONTINENCE,4
CA,FINGER DEFORMITY,4
CA,FOETAL EXPOSURE DURING PREGNANCY,4
CA,GASTRIC CANCER,4
CA,GASTROINTESTINAL PAIN,4
CA,GENERALISED ERYTHEMA,4
CA,GLAUCOMA SURGERY,4
CA,GRAFT VERSUS HOST DISEASE,4
CA,GRANULOMATOSIS WITH POLYANGIITIS,4
CA,GRIP STRENGTH DECREASED,4
CA,HAEMATURIA,4
CA,HAEMORRHAGE URINARY TRACT,4
CA,HAIR TEXTURE ABNORMAL,4
CA,HALLUCINATION_ VISUAL,4
CA,HEMIPARESIS,4
CA,HEPATIC STEATOSIS,4
CA,HEPATOMEGALY,4
CA,HYPOGLYCAEMIA,4
CA,HYPOKINESIA,4
CA,IMMUNE THROMBOCYTOPENIC PURPURA,4
CA,INCISIONAL HERNIA,4
CA,INCONTINENCE,4
CA,INCREASED APPETITE,4
CA,INCREASED UPPER AIRWAY SECRETION,4
CA,INFUSION SITE ERYTHEMA,4
CA,INTERNAL HAEMORRHAGE,4
CA,IRRITABLE BOWEL SYNDROME,4
CA,JAUNDICE,4
CA,KNEE OPERATION,4
CA,LIGAMENT SPRAIN,4
CA,LIVER DISORDER,4
CA,LOWER LIMB FRACTURE,4
CA,LYMPHOEDEMA,4
CA,MEAN CELL HAEMOGLOBIN INCREASED,4
CA,MENIERE^S DISEASE,4
CA,MUCOSAL INFLAMMATION,4
CA,MUSCLE STRAIN,4
CA,MYOCARDITIS,4
CA,MYOCLONUS,4
CA,NECROSIS,4
CA,NEURITIS,4
CA,NEURODERMATITIS,4
CA,NYSTAGMUS,4
CA,OPHTHALMIC HERPES ZOSTER,4
CA,OSTEITIS,4
CA,OSTEONECROSIS,4
CA,OSTEONECROSIS OF JAW,4
CA,PALMAR ERYTHEMA,4
CA,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,4
CA,PERITONITIS,4
CA,PHARYNGEAL OEDEMA,4
CA,PHARYNGITIS STREPTOCOCCAL,4
CA,PNEUMONIA STAPHYLOCOCCAL,4
CA,POSTOPERATIVE WOUND INFECTION,4
CA,PRESCRIBED UNDERDOSE,4
CA,PROSTATE CANCER METASTATIC,4
CA,RECURRENT CANCER,4
CA,RENAL MASS,4
CA,RETCHING,4
CA,RETINOPATHY,4
CA,RHABDOMYOLYSIS,4
CA,RHINITIS,4
CA,SECOND PRIMARY MALIGNANCY,4
CA,SECRETION DISCHARGE,4
CA,SKIN INFECTION,4
CA,SPLENOMEGALY,4
CA,TERMINAL STATE,4
CA,TOOTHACHE,4
CA,TRANSAMINASES INCREASED,4
CA,VEIN DISORDER,4
CA,VIRAL MUTATION IDENTIFIED,4
CA,VIROLOGIC FAILURE,4
CA,VULVOVAGINAL DRYNESS,4
CA,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,4
CA,ABDOMINAL ABSCESS,3
CA,ACCIDENTAL OVERDOSE,3
CA,ACUTE MYELOID LEUKAEMIA,3
CA,ANAL INCONTINENCE,3
CA,ASPHYXIA,3
CA,ATYPICAL FRACTURE,3
CA,AUDITORY DISORDER,3
CA,AVULSION FRACTURE,3
CA,BACTERAEMIA,3
CA,BILE DUCT STENOSIS,3
CA,BILE DUCT STONE,3
CA,BLADDER PAIN,3
CA,BLADDER PROLAPSE,3
CA,BLINDNESS UNILATERAL,3
CA,BLOOD ALBUMIN DECREASED,3
CA,BLOOD CALCIUM DECREASED,3
CA,BLOOD CREATININE DECREASED,3
CA,BLOOD POTASSIUM INCREASED,3
CA,BLOOD PRESSURE SYSTOLIC ABNORMAL,3
CA,BLOOD SODIUM DECREASED,3
CA,BONE DENSITY ABNORMAL,3
CA,BOWEL MOVEMENT IRREGULARITY,3
CA,BREAST ABSCESS,3
CA,CHAPPED LIPS,3
CA,CHOLESTASIS,3
CA,CHONDROCALCINOSIS PYROPHOSPHATE,3
CA,CHRONIC KIDNEY DISEASE,3
CA,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,3
CA,CLOSTRIDIUM DIFFICILE COLITIS,3
CA,COMPLETED SUICIDE,3
CA,COMPULSIVE SHOPPING,3
CA,CYSTITIS INTERSTITIAL,3
CA,DECREASED IMMUNE RESPONSIVENESS,3
CA,DEEP BRAIN STIMULATION,3
CA,DEVICE FAILURE,3
CA,DEVICE MALFUNCTION,3
CA,DIARRHOEA HAEMORRHAGIC,3
CA,DISABILITY ASSESSMENT SCALE SCORE INCREASED,3
CA,DISEASE RECURRENCE,3
CA,DRUG DEPENDENCE,3
CA,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,3
CA,ELECTROLYTE IMBALANCE,3
CA,ENCEPHALOPATHY,3
CA,ERECTILE DYSFUNCTION,3
CA,EUPHORIC MOOD,3
CA,EYELID OEDEMA,3
CA,FACIAL PAIN,3
CA,FACIAL SPASM,3
CA,FEBRILE NONHAEMOLYTIC TRANSFUSION REACTION,3
CA,FIBULA FRACTURE,3
CA,FLAGELLATE DERMATITIS,3
CA,FRUSTRATION TOLERANCE DECREASED,3
CA,FURUNCLE,3
CA,GAIT INABILITY,3
CA,GANGRENE,3
CA,GENERAL PHYSICAL CONDITION ABNORMAL,3
CA,GINGIVAL PAIN,3
CA,GROIN PAIN,3
CA,GUILLAIN-BARRE SYNDROME,3
CA,HALLUCINATION_ AUDITORY,3
CA,HAND FRACTURE,3
CA,HEAD DISCOMFORT,3
CA,HEPATITIS B,3
CA,HEPATOTOXICITY,3
CA,HERPES ZOSTER OTICUS,3
CA,HYPERTHYROIDISM,3
CA,INDURATION,3
CA,INFECTION SUSCEPTIBILITY INCREASED,3
CA,INFLAMMATORY BOWEL DISEASE,3
CA,INFLAMMATORY MARKER INCREASED,3
CA,INFUSION SITE EXTRAVASATION,3
CA,INJECTION SITE DISCOLOURATION,3
CA,INTERVERTEBRAL DISC DEGENERATION,3
CA,INTESTINAL MASS,3
CA,INTESTINAL OPERATION,3
CA,INTESTINAL STENOSIS,3
CA,IRON DEFICIENCY ANAEMIA,3
CA,JAW DISORDER,3
CA,JOINT CREPITATION,3
CA,JOINT DISLOCATION,3
CA,LUMBAR SPINAL STENOSIS,3
CA,LUMBAR VERTEBRAL FRACTURE,3
CA,LYMPHOMA,3
CA,MENISCUS INJURY,3
CA,MENTAL IMPAIRMENT,3
CA,METASTASES TO BONE,3
CA,METASTASES TO GASTROINTESTINAL TRACT,3
CA,METASTASES TO SPINE,3
CA,MICTURITION URGENCY,3
CA,MOUTH SWELLING,3
CA,NEUTROPENIC COLITIS,3
CA,NO ADVERSE EVENT,3
CA,OBSTRUCTIVE AIRWAYS DISORDER,3
CA,OESOPHAGITIS,3
CA,OPPORTUNISTIC INFECTION,3
CA,OPTIC NEURITIS,3
CA,ORAL INFECTION,3
CA,OROPHARYNGEAL PLAQUE,3
CA,OVARIAN CYST,3
CA,PANCREATITIS ACUTE,3
CA,PARANASAL SINUS DISCOMFORT,3
CA,PERFUME SENSITIVITY,3
CA,PHLEBITIS,3
CA,PNEUMOCOCCAL INFECTION,3
CA,PNEUMOTHORAX,3
CA,POLYP,3
CA,POST PROCEDURAL HAEMORRHAGE,3
CA,PRE-EXISTING CONDITION IMPROVED,3
CA,PROSTATIC SPECIFIC ANTIGEN INCREASED,3
CA,PULMONARY HYPERTENSION,3
CA,PULMONARY THROMBOSIS,3
CA,PURULENT DISCHARGE,3
CA,PUSTULAR PSORIASIS,3
CA,RASH PAPULAR,3
CA,RECTAL ADENOCARCINOMA,3
CA,RED BLOOD CELL COUNT INCREASED,3
CA,RESPIRATORY ARREST,3
CA,ROSACEA,3
CA,SCLERODERMA,3
CA,SCOLIOSIS,3
CA,SENSORY DISTURBANCE,3
CA,SERUM FERRITIN INCREASED,3
CA,SINUS DISORDER,3
CA,SKIN ATROPHY,3
CA,SKIN HAEMORRHAGE,3
CA,SKIN REACTION,3
CA,SKULL FRACTURE,3
CA,SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION,3
CA,SPINAL OPERATION,3
CA,SPUTUM RETENTION,3
CA,STAPHYLOCOCCUS TEST POSITIVE,3
CA,STOMACH MASS,3
CA,STRESS FRACTURE,3
CA,SUICIDE ATTEMPT,3
CA,SYPHILIS,3
CA,SYSTEMIC LUPUS ERYTHEMATOSUS,3
CA,TACHYPNOEA,3
CA,TENDON DISORDER,3
CA,THERMAL BURN,3
CA,TONGUE DISCOMFORT,3
CA,TONGUE GEOGRAPHIC,3
CA,TOXIC EPIDERMAL NECROLYSIS,3
CA,TREATMENT NONCOMPLIANCE,3
CA,TRISMUS,3
CA,TYPE 2 DIABETES MELLITUS,3
CA,VASCULITIS,3
CA,VOMITING PROJECTILE,3
CA,VULVOVAGINAL BURNING SENSATION,3
CA,VULVOVAGINAL DISCOMFORT,3
CA,WEIGHT FLUCTUATION,3
CA,WEIGHT LOSS POOR,3
CA,WITHDRAWAL SYNDROME,3
CA,WRIST DEFORMITY,3
CA,ABDOMINAL ADHESIONS,2
CA,ACCIDENT,2
CA,ACCIDENTAL EXPOSURE TO PRODUCT,2
CA,ACUTE RESPIRATORY DISTRESS SYNDROME,2
CA,ACUTE RESPIRATORY FAILURE,2
CA,ADDISON^S DISEASE,2
CA,ADENOCARCINOMA OF COLON,2
CA,ADRENAL INSUFFICIENCY,2
CA,AFFECT LABILITY,2
CA,ALVEOLITIS,2
CA,AMMONIA INCREASED,2
CA,ANAL FISTULA,2
CA,ANGER,2
CA,ANGIOEDEMA,2
CA,ANGIOPATHY,2
CA,ANKLE OPERATION,2
CA,AORTIC ANEURYSM,2
CA,APHTHOUS STOMATITIS,2
CA,APPLICATION SITE BRUISE,2
CA,ARTERIAL STENOSIS,2
CA,ARTERIOSCLEROSIS CORONARY ARTERY,2
CA,ARTHRODESIS,2
CA,AUTOIMMUNE HEPATITIS,2
CA,BACTERIAL TEST,2
CA,BALANITIS CANDIDA,2
CA,BEDRIDDEN,2
CA,BILIARY DILATATION,2
CA,BILIARY TRACT DISORDER,2
CA,BLADDER DISORDER,2
CA,BLADDER TRANSITIONAL CELL CARCINOMA,2
CA,BLINDNESS TRANSIENT,2
CA,BLOOD BILIRUBIN DECREASED,2
CA,BLOOD BLISTER,2
CA,BLOOD CHLORIDE DECREASED,2
CA,BLOOD ELECTROLYTES DECREASED,2
CA,BLOOD GLUCOSE ABNORMAL,2
CA,BLOOD GLUCOSE NORMAL,2
CA,BLOOD PHOSPHORUS DECREASED,2
CA,BLOOD THYROID STIMULATING HORMONE INCREASED,2
CA,BLOOD TRIGLYCERIDES INCREASED,2
CA,BLOOD UREA INCREASED,2
CA,BONE DECALCIFICATION,2
CA,BRAIN NEOPLASM,2
CA,BRAIN OEDEMA,2
CA,BREAST CYST,2
CA,BREAST OPERATION,2
CA,CALCULUS BLADDER,2
CA,CANCER SURGERY,2
CA,CARBOHYDRATE ANTIGEN 125 INCREASED,2
CA,CARPAL TUNNEL DECOMPRESSION,2
CA,CARTILAGE INJURY,2
CA,CENTRAL OBESITY,2
CA,CENTRAL VENOUS CATHETERISATION,2
CA,CEREBRAL DISORDER,2
CA,CERVIX NEOPLASM,2
CA,CHALAZION,2
CA,CHOLECYSTITIS,2
CA,CHROMOSOME ANALYSIS ABNORMAL,2
CA,CLAUSTROPHOBIA,2
CA,CLAVICLE FRACTURE,2
CA,COLORECTAL CANCER METASTATIC,2
CA,CONCOMITANT DISEASE AGGRAVATED,2
CA,COORDINATION ABNORMAL,2
CA,CYANOSIS,2
CA,CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION,2
CA,DARK CIRCLES UNDER EYES,2
CA,DEFAECATION URGENCY,2
CA,DEMENTIA,2
CA,DENTAL DISCOMFORT,2
CA,DEVICE DIFFICULT TO USE,2
CA,DIFFUSE LARGE B-CELL LYMPHOMA,2
CA,DRUG DISPENSING ERROR,2
CA,DRUG LEVEL INCREASED,2
CA,DYSPHEMIA,2
CA,EAR DISORDER,2
CA,EAR PRURITUS,2
CA,ELECTROCARDIOGRAM ABNORMAL,2
CA,ELECTROCARDIOGRAM P WAVE ABNORMAL,2
CA,ELECTROCARDIOGRAM QT PROLONGED,2
CA,EMPHYSEMA,2
CA,ENDOCARDITIS,2
CA,ENTERITIS,2
CA,ENTEROCOCCAL INFECTION,2
CA,ENTHESOPATHY,2
CA,ESCHERICHIA INFECTION,2
CA,ESCHERICHIA URINARY TRACT INFECTION,2
CA,EXPANDED DISABILITY STATUS SCALE SCORE DECREASED,2
CA,EXPOSURE DURING PREGNANCY,2
CA,EYE DEGENERATIVE DISORDER,2
CA,EYE DISCHARGE,2
CA,EYELID MARGIN CRUSTING,2
CA,FACE OEDEMA,2
KY,ABDOMINAL DISCOMFORT,1
KY,DIZZINESS,1
KY,DRUG ABUSE,1
KY,TREATMENT NONCOMPLIANCE,1
CL,DEATH,7
CL,DIZZINESS,5
CL,ARTHRALGIA,4
CL,DIARRHOEA,4
CL,FALL,4
CL,URINARY TRACT INFECTION,4
CL,ANAEMIA,3
CL,BRONCHITIS,3
CL,GAIT DISTURBANCE,3
CL,GASTRITIS,3
CL,HEADACHE,3
CL,LUNG NEOPLASM MALIGNANT,3
CL,PAIN,3
CL,ARTHROPATHY,2
CL,BLOOD URIC ACID INCREASED,2
CL,BONE DISORDER,2
CL,CROHN^S DISEASE,2
CL,CUSHING^S SYNDROME,2
CL,DEAFNESS,2
CL,DEPRESSION,2
CL,DRUG INEFFECTIVE,2
CL,EYE DISORDER,2
CL,GLUCOSE TOLERANCE IMPAIRED,2
CL,HERPES VIRUS INFECTION,2
CL,HYPERTENSION,2
CL,INFECTION,2
CL,INTERVERTEBRAL DISC PROTRUSION,2
CL,MACULOPATHY,2
CL,MALAISE,2
CL,MUSCULAR WEAKNESS,2
CL,NAUSEA,2
CL,NEOPLASM MALIGNANT,2
CL,NEURALGIA,2
CL,OSTEOARTHRITIS,2
CL,PANCREATIC CARCINOMA,2
CL,PULMONARY HYPERTENSION,2
CL,SJOGREN^S SYNDROME,2
CL,SOMNOLENCE,2
CL,ABDOMINAL DISTENSION,1
CL,ABDOMINAL PAIN,1
CL,ABDOMINAL PAIN LOWER,1
CL,ALANINE AMINOTRANSFERASE INCREASED,1
CL,ALOPECIA,1
CL,AMNESIA,1
CL,ANAL ABSCESS,1
CL,ANAL PROLAPSE,1
CL,ANTI-THYROID ANTIBODY,1
CL,ANXIETY,1
CL,ARRHYTHMIA,1
CL,ASPARTATE AMINOTRANSFERASE INCREASED,1
CL,BACK PAIN,1
CL,BASOPHIL COUNT DECREASED,1
CL,BILE DUCT STONE,1
CL,BLINDNESS,1
CL,BLOOD ALKALINE PHOSPHATASE INCREASED,1
CL,BLOOD CHOLESTEROL INCREASED,1
CL,BLOOD GLUCOSE INCREASED,1
CL,BLOOD PRESSURE ABNORMAL,1
CL,BLOOD PROLACTIN DECREASED,1
CL,BLOOD SODIUM INCREASED,1
CL,BLOOD TRIGLYCERIDES INCREASED,1
CL,BRAIN INJURY,1
CL,BRONCHIAL OBSTRUCTION,1
CL,BURNING SENSATION,1
CL,CAMPYLOBACTER INFECTION,1
CL,CANDIDURIA,1
CL,CARDIAC DISORDER,1
CL,CATARACT,1
CL,CHOLELITHIASIS,1
CL,CHROMATURIA,1
CL,CITROBACTER TEST POSITIVE,1
CL,COLON CANCER,1
CL,CONSTIPATION,1
CL,DEHYDRATION,1
CL,DEMENTIA ALZHEIMER^S TYPE,1
CL,DENTAL CARIES,1
CL,DIABETES MELLITUS,1
CL,DISEASE PROGRESSION,1
CL,DISEASE RECURRENCE,1
CL,DRUG DEPENDENCE,1
CL,DRUG EFFECT INCOMPLETE,1
CL,DYSPNOEA,1
CL,EAR DISORDER,1
CL,ECZEMA,1
CL,EOSINOPHIL COUNT DECREASED,1
CL,ERYTHEMA,1
CL,FACET JOINT SYNDROME,1
CL,FAECAL CALPROTECTIN ABNORMAL,1
CL,FATIGUE,1
CL,FEELING ABNORMAL,1
CL,FOAMING AT MOUTH,1
CL,FOOT FRACTURE,1
CL,FRACTURE,1
CL,FRACTURED COCCYX,1
CL,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
CL,GASTRIC ULCER,1
CL,GASTROINTESTINAL INJURY,1
CL,HAEMATOCHEZIA,1
CL,HAEMORRHAGE,1
CL,HAEMORRHOIDS,1
CL,HEARING IMPAIRED,1
CL,HEART RATE DECREASED,1
CL,HEPATIC ENZYME INCREASED,1
CL,HERPES ZOSTER DISSEMINATED,1
CL,HIGH DENSITY LIPOPROTEIN DECREASED,1
CL,HIGH DENSITY LIPOPROTEIN INCREASED,1
CL,HYPERGLYCAEMIA,1
CL,HYPERHIDROSIS,1
CL,HYPERSOMNIA,1
CL,HYPOACUSIS,1
CL,HYPOPROTHROMBINAEMIA,1
CL,HYPOTHYROIDISM,1
CL,INCREASED APPETITE,1
CL,INFLAMMATION,1
CL,INGUINAL HERNIA,1
CL,INSULIN-LIKE GROWTH FACTOR INCREASED,1
CL,INTERNATIONAL NORMALISED RATIO INCREASED,1
CL,IRRITABILITY,1
CL,JOINT SWELLING,1
CL,LIGAMENT SPRAIN,1
CL,LIMB INJURY,1
CL,LIMB OPERATION,1
CL,LOSS OF CONSCIOUSNESS,1
CL,LUMBAR RADICULOPATHY,1
CL,MACULAR DEGENERATION,1
CL,MALARIA,1
CL,MEMORY IMPAIRMENT,1
CL,METASTASES TO BONE,1
CL,METASTASIS,1
CL,MITRAL VALVE DISEASE,1
CL,MOBILITY DECREASED,1
CL,MONOCYTE COUNT DECREASED,1
CL,MOTOR DYSFUNCTION,1
CL,MUSCULOSKELETAL DISORDER,1
CL,N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE,1
CL,NASOPHARYNGITIS,1
CL,NEUTROPENIC SEPSIS,1
CL,PAIN IN EXTREMITY,1
CL,PALLOR,1
CL,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
CL,PERIPHERAL SWELLING,1
CL,PNEUMONIA,1
CL,POSTOPERATIVE WOUND INFECTION,1
CL,PULMONARY FIBROSIS,1
CL,PYELONEPHRITIS ACUTE,1
CL,PYREXIA,1
CL,RASH MACULO-PAPULAR,1
CL,READING DISORDER,1
CL,RECTAL POLYP,1
CL,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
CL,RESPIRATORY DEPRESSION,1
CL,RESPIRATORY FAILURE,1
CL,RESPIRATORY TRACT INFECTION,1
CL,RESPIRATORY TRACT INFECTION VIRAL,1
CL,RETINOPATHY,1
CL,SEPSIS,1
CL,SKIN EXFOLIATION,1
CL,SLEEP APNOEA SYNDROME,1
CL,SLOW RESPONSE TO STIMULI,1
CL,SPINAL DISORDER,1
CL,STRESS,1
CL,SUICIDAL IDEATION,1
CL,SUICIDE ATTEMPT,1
CL,THYROID CYST,1
CL,THYROID NEOPLASM,1
CL,TOOTH DISORDER,1
CL,TOOTHACHE,1
CL,UNDERDOSE,1
CL,URINARY TRACT DISCOMFORT,1
CL,URINARY TRACT INFECTION ENTEROCOCCAL,1
CL,URINE ABNORMALITY,1
CL,URINE ANALYSIS ABNORMAL,1
CL,URINE ODOUR ABNORMAL,1
CL,VASCULAR GRAFT COMPLICATION,1
CL,VERTIGO,1
CL,VISION BLURRED,1
CL,VISUAL ACUITY REDUCED,1
CL,VISUAL IMPAIRMENT,1
CL,VOMITING,1
CL,WEIGHT INCREASED,1
CL,WHITE BLOOD CELLS URINE POSITIVE,1
CL,WOUND,1
CN,HEPATIC FUNCTION ABNORMAL,7
CN,HYPERAESTHESIA,7
CN,ALANINE AMINOTRANSFERASE INCREASED,4
CN,ASPARTATE AMINOTRANSFERASE INCREASED,3
CN,SOMNOLENCE,3
CN,ALTERED STATE OF CONSCIOUSNESS,2
CN,BLOOD ALKALINE PHOSPHATASE INCREASED,2
CN,DELIRIUM,2
CN,DIZZINESS,2
CN,DRUG ERUPTION,2
CN,ERYTHEMA MULTIFORME,2
CN,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
CN,MOUTH ULCERATION,2
CN,PAIN,2
CN,PRODUCT USE IN UNAPPROVED INDICATION,2
CN,PYREXIA,2
CN,RESPIRATORY FAILURE,2
CN,ABDOMINAL DISTENSION,1
CN,AGRANULOCYTOSIS,1
CN,ASTHENIA,1
CN,BEDRIDDEN,1
CN,BLINDNESS TRANSIENT,1
CN,BLISTER,1
CN,BRADYCARDIA,1
CN,CEREBRAL DISORDER,1
CN,CEREBRAL INFARCTION,1
CN,CHILLS,1
CN,COGNITIVE DISORDER,1
CN,DEATH,1
CN,DECREASED APPETITE,1
CN,DEMENTIA,1
CN,DRUG INEFFECTIVE,1
CN,DRUG LEVEL INCREASED,1
CN,DRUG WITHDRAWAL SYNDROME,1
CN,DYSPNOEA,1
CN,DYSSTASIA,1
CN,DYSURIA,1
CN,ELECTROCARDIOGRAM RR INTERVAL PROLONGED,1
CN,FALL,1
CN,FRACTURED COCCYX,1
CN,FRACTURED SACRUM,1
CN,GASTROINTESTINAL PERFORATION,1
CN,GENERALISED ERYTHEMA,1
CN,HEPATOTOXICITY,1
CN,HYPOGLYCAEMIC COMA,1
CN,INCONTINENCE,1
CN,LUMBAR VERTEBRAL FRACTURE,1
CN,LUNG INFECTION,1
CN,MENTAL IMPAIRMENT,1
CN,MOBILITY DECREASED,1
CN,MOUTH HAEMORRHAGE,1
CN,MUSCULOSKELETAL STIFFNESS,1
CN,NEURALGIA,1
CN,NEUROPSYCHIATRIC SYNDROME,1
CN,NEUTROPHIL COUNT DECREASED,1
CN,OEDEMA PERIPHERAL,1
CN,OXYGEN SATURATION DECREASED,1
CN,PAPILLOEDEMA,1
CN,PETECHIAE,1
CN,PIGMENTATION DISORDER,1
CN,PLATELET COUNT DECREASED,1
CN,PNEUMONIA,1
CN,PRODUCT USE ISSUE,1
CN,PRURITUS,1
CN,RASH,1
CN,RASH PAPULAR,1
CN,RED BLOOD CELL COUNT DECREASED,1
CN,SCAB,1
CN,SEPTIC SHOCK,1
CN,SPINAL PAIN,1
CN,STEVENS-JOHNSON SYNDROME,1
CN,SWELLING FACE,1
CN,TENDERNESS,1
CN,THERAPEUTIC RESPONSE DECREASED,1
CN,THROMBOCYTOPENIA,1
CN,TREMOR,1
CN,URINARY RETENTION,1
CN,URINARY TRACT INFECTION,1
CN,URINE ABNORMALITY,1
CN,WHITE BLOOD CELL COUNT DECREASED,1
CO,PAIN IN EXTREMITY,32
CO,ARTHRALGIA,31
CO,HEADACHE,27
CO,MALAISE,27
CO,PAIN,23
CO,DIZZINESS,21
CO,VOMITING,19
CO,DRUG INEFFECTIVE,18
CO,PYREXIA,18
CO,ASTHENIA,17
CO,DYSPNOEA,17
CO,FALL,17
CO,GENERAL PHYSICAL HEALTH DETERIORATION,17
CO,URINARY TRACT INFECTION,17
CO,DEATH,16
CO,BACK PAIN,14
CO,SOMNOLENCE,14
CO,ABDOMINAL PAIN,13
CO,COUGH,13
CO,GAIT DISTURBANCE,13
CO,INSOMNIA,13
CO,DIARRHOEA,12
CO,FATIGUE,12
CO,HYPERTENSION,12
CO,NAUSEA,12
CO,WEIGHT DECREASED,12
CO,ABDOMINAL DISCOMFORT,11
CO,CHEST PAIN,11
CO,DEPRESSION,11
CO,OSTEOARTHRITIS,11
CO,ABDOMINAL PAIN UPPER,10
CO,BLOOD GLUCOSE INCREASED,10
CO,INFLUENZA,10
CO,MALIGNANT NEOPLASM PROGRESSION,10
CO,MOBILITY DECREASED,10
CO,OEDEMA PERIPHERAL,10
CO,PNEUMONIA,10
CO,SYNCOPE,10
CO,BONE PAIN,9
CO,HAEMOGLOBIN DECREASED,9
CO,HYPOAESTHESIA,9
CO,MUSCULOSKELETAL PAIN,9
CO,PLATELET COUNT DECREASED,9
CO,ANAEMIA,8
CO,DISORIENTATION,8
CO,EATING DISORDER,8
CO,INTERVERTEBRAL DISC PROTRUSION,8
CO,JOINT SWELLING,8
CO,LOSS OF CONSCIOUSNESS,8
CO,MEMORY IMPAIRMENT,8
CO,MUSCULAR WEAKNESS,8
CO,GASTRITIS,7
CO,INFLAMMATION,7
CO,OROPHARYNGEAL PAIN,7
CO,SKIN DISCOLOURATION,7
CO,THROMBOSIS,7
CO,AMNESIA,6
CO,ASPHYXIA,6
CO,BLINDNESS,6
CO,BLOOD PRESSURE INCREASED,6
CO,BREAST CANCER,6
CO,CARDIAC FAILURE,6
CO,DECREASED APPETITE,6
CO,PRURITUS,6
CO,PRURITUS GENERALISED,6
CO,STOMATITIS,6
CO,ABDOMINAL DISTENSION,5
CO,ANXIETY,5
CO,CARDIAC ARREST,5
CO,CATARACT,5
CO,CORONARY ARTERY DISEASE,5
CO,DIABETES MELLITUS,5
CO,DRY SKIN,5
CO,DYSPHAGIA,5
CO,ERYTHEMA,5
CO,FEELING ABNORMAL,5
CO,HERPES ZOSTER,5
CO,HYPOTENSION,5
CO,MULTIPLE SCLEROSIS RELAPSE,5
CO,NEURALGIA,5
CO,SPEECH DISORDER,5
CO,TACHYCARDIA,5
CO,THROMBOCYTOPENIA,5
CO,ABASIA,4
CO,ACUTE MYOCARDIAL INFARCTION,4
CO,ARTHRITIS,4
CO,BENIGN PROSTATIC HYPERPLASIA,4
CO,BLOOD PRESSURE DECREASED,4
CO,BURNING SENSATION,4
CO,CEREBROVASCULAR ACCIDENT,4
CO,CHOKING,4
CO,CHOLELITHIASIS,4
CO,CONDITION AGGRAVATED,4
CO,CONSTIPATION,4
CO,DECREASED IMMUNE RESPONSIVENESS,4
CO,DEHYDRATION,4
CO,DIABETIC NEUROPATHY,4
CO,DISTURBANCE IN ATTENTION,4
CO,DRUG DEPENDENCE,4
CO,DRUG DOSE OMISSION,4
CO,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,4
CO,DRY MOUTH,4
CO,FIBROMYALGIA,4
CO,GASTRIC DISORDER,4
CO,GASTRIC ULCER,4
CO,GASTROINTESTINAL HAEMORRHAGE,4
CO,HIATUS HERNIA,4
CO,HYPERSENSITIVITY,4
CO,JOINT INJURY,4
CO,LUNG DISORDER,4
CO,METASTASES TO BONE,4
CO,MIGRAINE,4
CO,MOUTH HAEMORRHAGE,4
CO,MOVEMENT DISORDER,4
CO,MYALGIA,4
CO,MYOCARDIAL INFARCTION,4
CO,NEOPLASM,4
CO,ORAL DISORDER,4
CO,PERIPHERAL SWELLING,4
CO,POSTOPERATIVE WOUND INFECTION,4
CO,PRODUCTIVE COUGH,4
CO,PULMONARY OEDEMA,4
CO,RESPIRATORY ARREST,4
CO,RESPIRATORY DISTRESS,4
CO,RHINORRHOEA,4
CO,SPINAL PAIN,4
CO,SWELLING FACE,4
CO,TOOTHACHE,4
CO,URINARY INCONTINENCE,4
CO,VERTIGO,4
CO,WALKING DISABILITY,4
CO,WEIGHT INCREASED,4
CO,ALOPECIA,3
CO,ANAL HAEMORRHAGE,3
CO,ANAL INCONTINENCE,3
CO,BALANCE DISORDER,3
CO,BLISTER,3
CO,BLOOD CREATININE INCREASED,3
CO,BONE CANCER,3
CO,BRAIN NEOPLASM,3
CO,BRONCHITIS,3
CO,CARDIO-RESPIRATORY ARREST,3
CO,CARPAL TUNNEL SYNDROME,3
CO,CHRONIC GASTRITIS,3
CO,CHRONIC MYELOID LEUKAEMIA,3
CO,CONTUSION,3
CO,DECUBITUS ULCER,3
CO,DEPENDENT PERSONALITY DISORDER,3
CO,DEPRESSED MOOD,3
CO,DERMATITIS ALLERGIC,3
CO,DIABETIC COMPLICATION,3
CO,DIABETIC FOOT,3
CO,DISEASE PROGRESSION,3
CO,DYSARTHRIA,3
CO,DYSURIA,3
CO,EYE PAIN,3
CO,FACIAL PAIN,3
CO,FLATULENCE,3
CO,FLUID RETENTION,3
CO,GLUCOSE TOLERANCE IMPAIRED,3
CO,HAEMATEMESIS,3
CO,HEAD INJURY,3
CO,HYPERHIDROSIS,3
CO,HYPOACUSIS,3
CO,HYPOKINESIA,3
CO,HYPOTONIA,3
CO,INFARCTION,3
CO,INTESTINAL OBSTRUCTION,3
CO,ISCHAEMIC CARDIOMYOPATHY,3
CO,MALLORY-WEISS SYNDROME,3
CO,MUSCLE SPASMS,3
CO,MUSCULOSKELETAL CHEST PAIN,3
CO,MUSCULOSKELETAL STIFFNESS,3
CO,NEOPLASM MALIGNANT,3
CO,NERVOUS SYSTEM DISORDER,3
CO,NERVOUSNESS,3
CO,NONINFECTIVE GINGIVITIS,3
CO,OEDEMA,3
CO,ORAL MUCOSAL BLISTERING,3
CO,PAIN IN JAW,3
CO,PARAESTHESIA,3
CO,PARANEOPLASTIC SYNDROME,3
CO,PHARYNGEAL DISORDER,3
CO,RASH,3
CO,REFLUX GASTRITIS,3
CO,RENAL PAIN,3
CO,RESPIRATORY FAILURE,3
CO,RIB FRACTURE,3
CO,SEIZURE,3
CO,SKIN ULCER,3
CO,SOFT TISSUE DISORDER,3
CO,THROAT IRRITATION,3
CO,TINNITUS,3
CO,URTICARIA,3
CO,UTERINE HAEMORRHAGE,3
CO,UTERINE LEIOMYOMA,3
CO,VAGINAL HAEMORRHAGE,3
CO,VARICOSE VEIN,3
CO,VISION BLURRED,3
CO,VULVOVAGINAL INFLAMMATION,3
CO,ABDOMINAL PAIN LOWER,2
CO,ACUTE KIDNEY INJURY,2
CO,AGITATION,2
CO,ALTERED STATE OF CONSCIOUSNESS,2
CO,ANGINA UNSTABLE,2
CO,APHONIA,2
CO,APNOEA,2
CO,ARTERIAL OCCLUSIVE DISEASE,2
CO,ARTHROPATHY,2
CO,BACK INJURY,2
CO,BACTERIURIA,2
CO,BLOOD GLUCOSE DECREASED,2
CO,BLOOD SODIUM DECREASED,2
CO,BLOOD TEST ABNORMAL,2
CO,BLOOD TRIGLYCERIDES INCREASED,2
CO,BLOOD URINE PRESENT,2
CO,BRAIN DEATH,2
CO,CANCER PAIN,2
CO,CARDIAC DISORDER,2
CO,CHILLS,2
CO,COORDINATION ABNORMAL,2
CO,CORTISOL INCREASED,2
CO,DEAFNESS,2
CO,DEAFNESS UNILATERAL,2
CO,DIABETIC COMA,2
CO,DISEASE RECURRENCE,2
CO,DRUG EFFECT INCOMPLETE,2
CO,DRUG HYPERSENSITIVITY,2
CO,DRY THROAT,2
CO,DYSPEPSIA,2
CO,EAR PAIN,2
CO,EPILEPSY,2
CO,EPISTAXIS,2
CO,EYE INFLAMMATION,2
CO,EYE SWELLING,2
CO,FAECALOMA,2
CO,FEELING OF DESPAIR,2
CO,GAIT INABILITY,2
CO,GASTROINTESTINAL INFECTION,2
CO,GLAUCOMA,2
CO,GROIN PAIN,2
CO,HAEMATOCHEZIA,2
CO,HAEMATOMA,2
CO,HAEMATURIA,2
CO,HAEMORRHAGE,2
CO,HIP FRACTURE,2
CO,HYPERGLYCAEMIA,2
CO,HYPERSOMNIA,2
CO,HYPERTHYROIDISM,2
CO,HYPOTHYROIDISM,2
CO,IMMUNE THROMBOCYTOPENIC PURPURA,2
CO,IMMUNOSUPPRESSION,2
CO,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
CO,INCONTINENCE,2
CO,INFECTION,2
CO,INFUSION RELATED REACTION,2
CO,INJECTION SITE INDURATION,2
CO,INJECTION SITE PAIN,2
CO,INJECTION SITE SWELLING,2
CO,INTENTIONAL PRODUCT MISUSE,2
CO,ISCHAEMIA,2
CO,ISCHAEMIC STROKE,2
CO,JAW DISORDER,2
CO,JOINT DISLOCATION,2
CO,JOINT RANGE OF MOTION DECREASED,2
CO,LARYNGITIS,2
CO,LEUKOPENIA,2
CO,LIGAMENT SPRAIN,2
CO,LIMB INJURY,2
CO,LIVER DISORDER,2
CO,LOWER LIMB FRACTURE,2
CO,LYMPHOCYTE COUNT ABNORMAL,2
CO,LYMPHOPENIA,2
CO,MENOPAUSE,2
CO,MENTAL RETARDATION,2
CO,METASTASES TO LIVER,2
CO,METASTASES TO LUNG,2
CO,METASTASES TO SPINE,2
CO,MOOD ALTERED,2
CO,MOUTH ULCERATION,2
CO,MUSCLE RIGIDITY,2
CO,MYELOFIBROSIS,2
CO,MYOCARDIAL ISCHAEMIA,2
CO,NEPHROLITHIASIS,2
CO,OPHTHALMIC HERPES ZOSTER,2
CO,OROPHARYNGEAL DISCOMFORT,2
CO,OXYGEN SATURATION DECREASED,2
CO,PELVIC FRACTURE,2
CO,PERICARDIAL EFFUSION,2
CO,PHOTOSENSITIVITY REACTION,2
CO,PLEURAL EFFUSION,2
CO,POLLAKIURIA,2
CO,PRODUCT QUALITY ISSUE,2
CO,PSYCHIATRIC SYMPTOM,2
CO,PULMONARY HYPERTENSION,2
CO,RASH GENERALISED,2
CO,RENAL FAILURE,2
CO,RESPIRATORY DISORDER,2
CO,RHEUMATOID ARTHRITIS,2
CO,RHINITIS,2
CO,ROAD TRAFFIC ACCIDENT,2
CO,SENSORY LOSS,2
CO,SERUM FERRITIN INCREASED,2
CO,SKELETAL INJURY,2
CO,SKIN HYPERPIGMENTATION,2
CO,SKIN WARM,2
CO,SPINAL FRACTURE,2
CO,THROMBOPHLEBITIS,2
CO,THYROID DISORDER,2
CO,TONSILLAR HYPERTROPHY,2
CO,TRAUMATIC LUNG INJURY,2
CO,TREMOR,2
CO,UNDERWEIGHT,2
CO,UPPER LIMB FRACTURE,2
CO,VENOUS VALVE RUPTURED,2
CO,VOCAL CORD DISORDER,2
CO,WHITE BLOOD CELL COUNT DECREASED,2
CO,ABDOMINAL HERNIA,1
CO,ABSCESS INTESTINAL,1
CO,ACNE,1
CO,ACTIVITIES OF DAILY LIVING IMPAIRED,1
CO,ADENOSQUAMOUS CARCINOMA OF THE CERVIX,1
CO,AGGRESSION,1
CO,ALANINE AMINOTRANSFERASE ABNORMAL,1
CO,ANAL FISTULA,1
CO,ANKYLOSING SPONDYLITIS,1
CO,AORTIC VALVE DISEASE,1
CO,APHASIA,1
CO,APLASTIC ANAEMIA,1
CO,APPARENT DEATH,1
CO,APPLICATION SITE PRURITUS,1
CO,APPLICATION SITE RASH,1
CO,ARTHRITIS BACTERIAL,1
CO,ARTICULAR CALCIFICATION,1
CO,ASPARTATE AMINOTRANSFERASE ABNORMAL,1
CO,ASTHMA,1
CO,ASTHMATIC CRISIS,1
CO,BACK DISORDER,1
CO,BACTERIAL INFECTION,1
CO,BEDRIDDEN,1
CO,BILIARY CYST,1
CO,BLADDER CANCER,1
CO,BLADDER PROLAPSE,1
CO,BLASTOCYSTIS INFECTION,1
CO,BLISTER INFECTED,1
CO,BLOOD BILIRUBIN ABNORMAL,1
CO,BLOOD CHOLESTEROL INCREASED,1
CO,BLOOD CHROMOGRANIN A INCREASED,1
CO,BLOOD CREATINE PHOSPHOKINASE ABNORMAL,1
CO,BLOOD GLUCOSE ABNORMAL,1
CO,BLOOD GLUCOSE FLUCTUATION,1
CO,BLOOD GROWTH HORMONE INCREASED,1
CO,BLOOD IRON DECREASED,1
CO,BLOOD IRON INCREASED,1
CO,BLOOD LACTATE DEHYDROGENASE ABNORMAL,1
CO,BLOOD POTASSIUM DECREASED,1
CO,BLOOD POTASSIUM INCREASED,1
CO,BLOOD VISCOSITY ABNORMAL,1
CO,BODY HEIGHT DECREASED,1
CO,BONE DECALCIFICATION,1
CO,BONE DENSITY ABNORMAL,1
CO,BONE DISORDER,1
CO,BONE LOSS,1
CO,BONE MARROW DISORDER,1
CO,BONE MARROW INFILTRATION,1
CO,BRAIN HYPOXIA,1
CO,BRAIN OEDEMA,1
CO,BREAST CANCER FEMALE,1
CO,BREAST CANCER RECURRENT,1
CO,BREAST CYST,1
CO,BREAST DISCHARGE,1
CO,BREAST PAIN,1
CO,BREATH ODOUR,1
CO,BRONCHIAL SECRETION RETENTION,1
CO,BRONCHOPNEUMONIA,1
CO,C-REACTIVE PROTEIN ABNORMAL,1
CO,CARDIOMEGALY,1
CO,CARDIOPULMONARY FAILURE,1
CO,CARTILAGE INJURY,1
CO,CATARACT OPERATION,1
CO,CATHETER REMOVAL,1
CO,CD8 LYMPHOCYTES ABNORMAL,1
CO,CELLULITIS,1
CO,CENTRAL NERVOUS SYSTEM LESION,1
CO,CEREBRAL CYST,1
CO,CEREBRAL DISORDER,1
CO,CEREBRAL HAEMORRHAGE,1
CO,CEREBRAL INFARCTION,1
CO,CEREBRAL ISCHAEMIA,1
CO,CERVICAL SPINAL STENOSIS,1
CO,CHOKING SENSATION,1
CO,CHOLECYSTITIS,1
CO,COAGULOPATHY,1
CO,COCCYDYNIA,1
CO,COLITIS ULCERATIVE,1
CO,COMPLEX REGIONAL PAIN SYNDROME,1
CO,CONCOMITANT DISEASE AGGRAVATED,1
CO,CONGENITAL CYSTIC KIDNEY DISEASE,1
CO,CONGESTIVE CARDIOMYOPATHY,1
CO,CONJUNCTIVITIS,1
CO,CONVULSION,1
CO,CORONARY ARTERY STENOSIS,1
CO,CRYING,1
CO,CYANOSIS,1
CO,DEATH OF RELATIVE,1
CO,DECREASED ACTIVITY,1
CO,DEEP VEIN THROMBOSIS,1
CO,DEVICE RELATED INFECTION,1
CO,DIABETES INSIPIDUS,1
CO,DIABETES MELLITUS INADEQUATE CONTROL,1
CO,DIASTOLIC DYSFUNCTION,1
CO,DIPLOPIA,1
CO,DISCOMFORT,1
CO,DIVERTICULUM,1
CO,DRUG ADMINISTRATION ERROR,1
CO,DRUG DISPENSING ERROR,1
CO,DRUG EFFECT DECREASED,1
CO,DRUG PRESCRIBING ERROR,1
CO,DRUG-INDUCED LIVER INJURY,1
CO,DYSKINESIA,1
CO,DYSPHONIA,1
CO,DYSSTASIA,1
CO,EAR HAEMORRHAGE,1
CO,EAR INJURY,1
CO,EJACULATION DISORDER,1
CO,EJECTION FRACTION DECREASED,1
CO,ELECTROCARDIOGRAM ABNORMAL,1
CO,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,1
CO,EMBOLISM,1
CO,ENCEPHALOPATHY,1
CO,EOSINOPHIL COUNT ABNORMAL,1
CO,EPIDIDYMAL DISORDER,1
CO,ERUCTATION,1
CO,ERYTHROPENIA,1
CO,ESCHERICHIA INFECTION,1
CO,EXTRAPYRAMIDAL DISORDER,1
CO,EYE IRRITATION,1
CO,FACIAL NERVE DISORDER,1
CO,FACTOR XI DEFICIENCY,1
CO,FAECAL INCONTINENCE,1
CO,FEAR OF INJECTION,1
CO,FEBRILE NEUTROPENIA,1
CO,FEEDING DISORDER,1
CO,FEELING COLD,1
CO,FEELING HOT,1
CO,FEMUR FRACTURE,1
CO,FIBROSIS,1
CO,FISTULA,1
CO,FLANK PAIN,1
CO,FOOT FRACTURE,1
CO,FRACTURED SACRUM,1
CO,FREQUENT BOWEL MOVEMENTS,1
CO,FURUNCLE,1
CO,GALLBLADDER DISORDER,1
CO,GAMMA-GLUTAMYLTRANSFERASE ABNORMAL,1
CO,GASTRITIS EROSIVE,1
CO,GASTROINTESTINAL CARCINOMA,1
CO,GASTROINTESTINAL INFLAMMATION,1
CO,GASTROINTESTINAL OBSTRUCTION,1
CO,GINGIVAL DISORDER,1
CO,GINGIVITIS,1
CO,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
CO,HAEMANGIOMA,1
CO,HAEMATOCRIT ABNORMAL,1
CO,HAEMATOCRIT DECREASED,1
CO,HAEMODIALYSIS,1
CO,HAEMORRHAGIC DISORDER,1
CO,HAEMORRHAGIC OVARIAN CYST,1
CO,HAEMORRHOIDS,1
CO,HALLUCINATION,1
CO,HALLUCINATION_ VISUAL,1
CO,HAND DEFORMITY,1
CO,HEARING IMPAIRED,1
CO,HEART VALVE STENOSIS,1
CO,HELICOBACTER GASTRITIS,1
CO,HEMIPARESIS,1
CO,HEPATIC CANCER,1
CO,HEPATIC LESION,1
CO,HEPATIC NEOPLASM,1
CO,HEPATITIS,1
CO,HERPES ZOSTER DISSEMINATED,1
CO,HOT FLUSH,1
CO,HYDRONEPHROSIS,1
CO,HYPERCALCAEMIA,1
CO,HYPERTENSIVE NEPHROPATHY,1
CO,HYPOAESTHESIA ORAL,1
CO,HYPOCHROMIC ANAEMIA,1
CO,HYPOGLYCAEMIA,1
CO,HYPOPHAGIA,1
CO,HYPOPHYSITIS,1
CO,ILEUS,1
CO,IMMUNODEFICIENCY,1
CO,IMPAIRED SELF-CARE,1
CO,INCORRECT DOSE ADMINISTERED,1
CO,INCREASED APPETITE,1
CO,INCREASED UPPER AIRWAY SECRETION,1
CO,INGROWING NAIL,1
CO,INJECTION SITE ERYTHEMA,1
CO,INJECTION SITE PRURITUS,1
CO,INJECTION SITE URTICARIA,1
CO,INJECTION SITE WARMTH,1
CO,INTESTINAL ANGINA,1
CO,INTESTINAL DILATATION,1
CO,INTESTINAL ISCHAEMIA,1
CO,INTESTINAL PERFORATION,1
CO,IRON DEFICIENCY ANAEMIA,1
CO,IRRITABLE BOWEL SYNDROME,1
CO,JOINT INSTABILITY,1
CO,KIDNEY INFECTION,1
CO,LABORATORY TEST ABNORMAL,1
CO,LACK OF SPONTANEOUS SPEECH,1
CO,LACRIMATION DECREASED,1
CO,LACRIMATION INCREASED,1
CO,LEFT VENTRICULAR DILATATION,1
CO,LEG AMPUTATION,1
CO,LENS DISLOCATION,1
CO,LETHARGY,1
CO,LEUKAEMIA,1
CO,LIMB DISCOMFORT,1
CO,LIMB IMMOBILISATION,1
CO,LOCALISED INFECTION,1
CO,LOOSE TOOTH,1
CO,LUMBAR SPINAL STENOSIS,1
CO,LUNG NEOPLASM MALIGNANT,1
CO,LYMPHATIC OBSTRUCTION,1
CO,LYMPHOCYTE COUNT INCREASED,1
CO,MASS,1
CO,MEDICAL DEVICE DISCOMFORT,1
CO,MENISCUS INJURY,1
CO,MENTAL IMPAIRMENT,1
CO,METASTASES TO BILIARY TRACT,1
CO,METASTASIS,1
CO,METASTATIC PAIN,1
CO,MILIARIA,1
CO,MITRAL VALVE INCOMPETENCE,1
CO,MOUTH INJURY,1
CO,MUCOSAL INFLAMMATION,1
CO,MULTIPLE SCLEROSIS,1
CO,MUSCLE CONTRACTIONS INVOLUNTARY,1
CO,MYOCARDIAL OEDEMA,1
CO,NAIL DISORDER,1
CO,NASAL CAVITY MASS,1
CO,NASAL INFLAMMATION,1
CO,NASAL OBSTRUCTION,1
CO,NECK PAIN,1
CO,NEOPLASM PROGRESSION,1
CO,NERVE INJURY,1
CO,NEUROMYELITIS OPTICA SPECTRUM DISORDER,1
CO,NEUROPATHY PERIPHERAL,1
CO,NEUTROPHIL COUNT ABNORMAL,1
CO,NIGHT SWEATS,1
CO,OCULAR HYPERAEMIA,1
CO,ODYNOPHAGIA,1
CO,OESOPHAGEAL CANDIDIASIS,1
CO,ONCOLOGIC COMPLICATION,1
CO,ONYCHALGIA,1
CO,OPEN ANGLE GLAUCOMA,1
CO,ORAL INFECTION,1
CO,OSTEOMYELITIS CHRONIC,1
CO,OSTEONECROSIS,1
CO,OSTEOPOROSIS,1
CO,OTITIS MEDIA,1
CO,OVARIAN DISORDER,1
CO,PAINFUL RESPIRATION,1
CO,PANCREATIC CARCINOMA,1
CO,PANCREATIC NEUROENDOCRINE TUMOUR,1
CO,PANIC ATTACK,1
CO,PARALYSIS,1
CO,PARESIS,1
CO,PARKINSON^S DISEASE,1
CO,PENILE ULCERATION,1
CO,PERIPHERAL ARTERY THROMBOSIS,1
CO,PERONEAL NERVE PALSY,1
CO,PETECHIAE,1
CO,PHANTOM PAIN,1
CO,PHOTOPSIA,1
CO,PLASMA CELL MYELOMA,1
CO,PLATELET COUNT ABNORMAL,1
CO,PLATELET COUNT INCREASED,1
CO,PLEURISY,1
CO,POISONING,1
CO,POLYMEDICATION,1
CO,POOR PERIPHERAL CIRCULATION,1
CO,POST LAMINECTOMY SYNDROME,1
CO,POST PROCEDURAL COMPLICATION,1
CO,POST STROKE EPILEPSY,1
CO,PROCEDURAL PAIN,1
CO,PRODUCT ADHESION ISSUE,1
CO,PRODUCT SUPPLY ISSUE,1
CO,PRODUCT USE ISSUE,1
CO,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
CO,PROSTATE CANCER,1
CO,PROSTATIC DISORDER,1
CO,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
CO,PROTEINURIA,1
CO,PRURITUS GENITAL,1
CO,PUBIC PAIN,1
CO,PULMONARY CONGESTION,1
CO,PULMONARY EMBOLISM,1
CO,PULMONARY FIBROSIS,1
CO,PULMONARY MASS,1
CO,PULMONARY PAIN,1
CO,PYELONEPHRITIS,1
CO,PYODERMA GANGRENOSUM,1
CO,QUADRIPLEGIA,1
CO,RECTAL CANCER,1
CO,RECTAL HAEMORRHAGE,1
CO,RED BLOOD CELL COUNT ABNORMAL,1
CO,RED BLOOD CELL COUNT DECREASED,1
CO,REFLEXES ABNORMAL,1
CO,RENAL CANCER,1
CO,RENAL CANCER METASTATIC,1
CO,RENAL MASS,1
CO,RENAL TRANSPLANT,1
CO,RENAL TUBERCULOSIS,1
CO,ROTATOR CUFF SYNDROME,1
CO,SCIATIC NERVE INJURY,1
CO,SCLERAL DISORDER,1
CO,SCOLIOSIS,1
CO,SENILE DEMENTIA,1
CO,SENSATION OF FOREIGN BODY,1
CO,SEPSIS,1
CO,SEXUAL ABUSE,1
CO,SKIN CANCER,1
CO,SKIN DISCOMFORT,1
CO,SKIN LESION,1
CO,SLEEP DISORDER,1
CO,SPINAL COLUMN INJURY,1
CO,SPINAL COLUMN STENOSIS,1
CO,SPINAL CORD DISORDER,1
CO,SPINAL DISORDER,1
CO,SPLENOMEGALY,1
CO,SPONDYLITIS,1
CO,STRABISMUS,1
CO,STRESS,1
CO,STUPOR,1
CO,SUBARACHNOID HAEMORRHAGE,1
CO,SWELLING,1
CO,SYNOVITIS,1
CO,SYSTEMIC LUPUS ERYTHEMATOSUS,1
CO,TEMPERATURE INTOLERANCE,1
CO,TENDON RUPTURE,1
CO,TERMINAL STATE,1
CO,THERAPEUTIC RESPONSE DECREASED,1
CO,THERAPEUTIC RESPONSE UNEXPECTED,1
CO,THERMAL BURN,1
CO,THINKING ABNORMAL,1
CO,THIRST,1
CO,THORACIC VERTEBRAL FRACTURE,1
CO,THROAT LESION,1
CO,THYROID CANCER METASTATIC,1
CO,THYROID NEOPLASM,1
CO,THYROIDECTOMY,1
CO,TONGUE CANCER RECURRENT,1
CO,TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED,1
CO,TONGUE PRURITUS,1
CO,TOOTH ABSCESS,1
CO,TOOTH INJURY,1
CO,TOOTH LOSS,1
CO,TREATMENT NONCOMPLIANCE,1
CO,TRICUSPID VALVE INCOMPETENCE,1
CO,TRIGEMINAL NERVE DISORDER,1
CO,TUBERCULIN TEST POSITIVE,1
CO,TUMOUR HAEMORRHAGE,1
CO,ULCER,1
CO,UPPER GASTROINTESTINAL HAEMORRHAGE,1
CO,URINARY TRACT INFECTION BACTERIAL,1
CO,UTERINE NEOPLASM,1
CO,VARICELLA ZOSTER VIRUS INFECTION,1
CO,VEIN DISORDER,1
CO,VIITH NERVE PARALYSIS,1
CO,VISUAL ACUITY REDUCED,1
CO,VISUAL IMPAIRMENT,1
CO,VOCAL CORD INFLAMMATION,1
CO,VULVOVAGINAL DRYNESS,1
CO,VULVOVAGINAL PRURITUS,1
CO,WALLENBERG SYNDROME,1
CO,WANDERING PACEMAKER,1
CO,WHEELCHAIR USER,1
CO,WOUND INFECTION,1
CO,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
CR,DEATH,4
CR,PNEUMONIA,4
CR,DRUG INEFFECTIVE,3
CR,MALAISE,3
CR,MYOCARDIAL INFARCTION,3
CR,NAUSEA,3
CR,DEAFNESS,2
CR,HYPOACUSIS,2
CR,INSOMNIA,2
CR,PAIN,2
CR,PAIN IN EXTREMITY,2
CR,VOMITING,2
CR,ABASIA,1
CR,ABDOMINAL DISCOMFORT,1
CR,ABDOMINAL PAIN,1
CR,ANEURYSM,1
CR,APHONIA,1
CR,ASTHENIA,1
CR,BLOOD PRESSURE DECREASED,1
CR,BODY TEMPERATURE INCREASED,1
CR,BRAIN NEOPLASM,1
CR,BREAST CANCER,1
CR,BRONCHITIS,1
CR,CEREBELLAR ISCHAEMIA,1
CR,CEREBRAL DISORDER,1
CR,CHEST DISCOMFORT,1
CR,COMA,1
CR,DECREASED APPETITE,1
CR,DECREASED INTEREST,1
CR,DELIRIUM,1
CR,DEPRESSION,1
CR,DIARRHOEA,1
CR,DIZZINESS,1
CR,DYSGEUSIA,1
CR,DYSPHONIA,1
CR,EAR PAIN,1
CR,EMOTIONAL DISORDER,1
CR,FATIGUE,1
CR,FEELING ABNORMAL,1
CR,GAIT DISTURBANCE,1
CR,GENERAL PHYSICAL HEALTH DETERIORATION,1
CR,HALLUCINATION,1
CR,HEADACHE,1
CR,HYPOXIA,1
CR,INFLAMMATION,1
CR,LAZINESS,1
CR,LIMB DISCOMFORT,1
CR,LIPASE INCREASED,1
CR,LOWER RESPIRATORY TRACT INFECTION,1
CR,MOTOR DYSFUNCTION,1
CR,MOUTH INJURY,1
CR,MUSCLE SPASMS,1
CR,NASOPHARYNGITIS,1
CR,OBESITY,1
CR,OEDEMA,1
CR,PANCREATIC DUCT OBSTRUCTION,1
CR,PANCREATIC PSEUDOCYST,1
CR,PANCREATITIS,1
CR,PANIC ATTACK,1
CR,PARALYSIS,1
CR,PERIPHERAL SWELLING,1
CR,PHARYNGITIS,1
CR,POISONING,1
CR,POLLAKIURIA,1
CR,PYREXIA,1
CR,RENAL FAILURE,1
CR,RESPIRATORY DISORDER,1
CR,SENSITIVITY TO WEATHER CHANGE,1
CR,SPINAL PAIN,1
CR,STRESS,1
CR,TACHYCARDIA,1
CR,TRANSIENT GLOBAL AMNESIA,1
CR,VISION BLURRED,1
CR,VISUAL IMPAIRMENT,1
CR,WEIGHT BEARING DIFFICULTY,1
CR,WEIGHT DECREASED,1
CR,WITHDRAWAL SYNDROME,1
CI,HYPERGLYCAEMIA,1
HR,INTENTIONAL OVERDOSE,8
HR,SUICIDE ATTEMPT,8
HR,URINARY RETENTION,6
HR,SOMNOLENCE,4
HR,CONDITION AGGRAVATED,3
HR,CONFUSIONAL STATE,3
HR,DISTURBANCE IN ATTENTION,3
HR,DRUG INEFFECTIVE,3
HR,DYSPNOEA,3
HR,PARKINSON^S DISEASE,3
HR,PYREXIA,3
HR,THERAPEUTIC RESPONSE DECREASED,3
HR,ATAXIA,2
HR,CONSTIPATION,2
HR,DIPLOPIA,2
HR,DIZZINESS,2
HR,EXTRAPYRAMIDAL DISORDER,2
HR,FEELING ABNORMAL,2
HR,LOSS OF CONSCIOUSNESS,2
HR,MENTAL IMPAIRMENT,2
HR,OLIGURIA,2
HR,PIGMENTATION DISORDER,2
HR,RESTLESSNESS,2
HR,SWELLING FACE,2
HR,TOXIC NEUROPATHY,2
HR,ALOPECIA,1
HR,ALTERED STATE OF CONSCIOUSNESS,1
HR,ANXIETY,1
HR,ASPHYXIA,1
HR,ASTHENIA,1
HR,COGNITIVE DISORDER,1
HR,CONVERSION DISORDER,1
HR,DEPRESSION,1
HR,DISORIENTATION,1
HR,DRY MOUTH,1
HR,DYSARTHRIA,1
HR,ERECTILE DYSFUNCTION,1
HR,HALLUCINATION_ AUDITORY,1
HR,HALLUCINATION_ VISUAL,1
HR,HYPOAESTHESIA,1
HR,INSOMNIA,1
HR,LIP SWELLING,1
HR,LOCAL SWELLING,1
HR,MICTURITION DISORDER,1
HR,MIDDLE INSOMNIA,1
HR,NAUSEA,1
HR,NEUROSIS,1
HR,OVERDOSE,1
HR,PAIN,1
HR,PRODUCT USE ISSUE,1
HR,PRURITUS,1
HR,QUADRIPARESIS,1
HR,RASH MACULO-PAPULAR,1
HR,RHINORRHOEA,1
HR,SCHIZOPHRENIA,1
HR,SEDATION,1
HR,SYNCOPE,1
HR,TRANSIENT ISCHAEMIC ATTACK,1
HR,TREMOR,1
HR,VOMITING,1
CY,DYSPHAGIA,1
CY,FOETAL EXPOSURE DURING PREGNANCY,1
CY,GLAUCOMA,1
CY,HYDROCEPHALUS,1
CY,INFECTION,1
CY,MATERNAL EXPOSURE DURING PREGNANCY,1
CY,PANCYTOPENIA,1
CY,PRODUCT USE IN UNAPPROVED INDICATION,1
CY,SKULL MALFORMATION,1
CY,SPINA BIFIDA,1
CY,VOCAL CORD PARALYSIS,1
CY,WHITE BLOOD CELL COUNT DECREASED,1
CZ,DEATH,5
CZ,DIABETIC METABOLIC DECOMPENSATION,4
CZ,CONDITION AGGRAVATED,3
CZ,FALL,3
CZ,FATIGUE,3
CZ,ASTHENIA,2
CZ,BACK PAIN,2
CZ,CONSTIPATION,2
CZ,DISEASE PROGRESSION,2
CZ,DISORIENTATION,2
CZ,DRUG EFFECT INCOMPLETE,2
CZ,DRUG INEFFECTIVE,2
CZ,HAEMATURIA,2
CZ,HEADACHE,2
CZ,HYPOTENSION,2
CZ,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,2
CZ,MATERNAL EXPOSURE DURING PREGNANCY,2
CZ,MULTIPLE SCLEROSIS RELAPSE,2
CZ,NAUSEA,2
CZ,OEDEMA PERIPHERAL,2
CZ,PNEUMONIA,2
CZ,PRODUCT USE ISSUE,2
CZ,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,2
CZ,SOMNOLENCE,2
CZ,URTICARIA,2
CZ,VARICOSE ULCERATION,2
CZ,VOMITING,2
CZ,ABDOMINAL PAIN,1
CZ,ABDOMINAL PAIN UPPER,1
CZ,ABORTION SPONTANEOUS,1
CZ,ACCIDENTAL OVERDOSE,1
CZ,ACUTE MOTOR AXONAL NEUROPATHY,1
CZ,AGGRESSION,1
CZ,ALTERED STATE OF CONSCIOUSNESS,1
CZ,ANAEMIA,1
CZ,ASPIRATION,1
CZ,BLOOD PRESSURE INCREASED,1
CZ,BONE CANCER,1
CZ,C-REACTIVE PROTEIN INCREASED,1
CZ,CEREBRAL HAEMORRHAGE,1
CZ,COMPLETED SUICIDE,1
CZ,CONFUSIONAL STATE,1
CZ,CONGENITAL RENAL DISORDER,1
CZ,CONJUNCTIVITIS,1
CZ,CONVULSION,1
CZ,DECREASED APPETITE,1
CZ,DEEP VEIN THROMBOSIS,1
CZ,DEHYDRATION,1
CZ,DELIRIUM,1
CZ,DEPRESSED LEVEL OF CONSCIOUSNESS,1
CZ,DEPRESSION,1
CZ,DIABETIC KETOACIDOSIS,1
CZ,DIABETIC NEUROPATHY,1
CZ,DRUG EFFECT DECREASED,1
CZ,DRUG ERUPTION,1
CZ,DRUG PRESCRIBING ERROR,1
CZ,DRY SKIN,1
CZ,DYSKINESIA,1
CZ,ECZEMA,1
CZ,EPILEPSY,1
CZ,EPILEPTIC AURA,1
CZ,FOAMING AT MOUTH,1
CZ,FOETAL EXPOSURE DURING PREGNANCY,1
CZ,GAIT DISTURBANCE,1
CZ,GENERALISED TONIC-CLONIC SEIZURE,1
CZ,GLOSSODYNIA,1
CZ,HAEMATOTOXICITY,1
CZ,HALLUCINATION,1
CZ,HALLUCINATION_ VISUAL,1
CZ,HEAD INJURY,1
CZ,HEPATIC ENZYME INCREASED,1
CZ,HEPATOMEGALY,1
CZ,HERPES VIRUS INFECTION,1
CZ,HERPES ZOSTER,1
CZ,HUMERUS FRACTURE,1
CZ,HYPERAESTHESIA,1
CZ,HYPERGLYCAEMIA,1
CZ,HYPERTENSION,1
CZ,IMMUNE COMPLEX LEVEL INCREASED,1
CZ,INFLUENZA LIKE ILLNESS,1
CZ,INJECTION SITE ABSCESS,1
CZ,INTENTIONAL OVERDOSE,1
CZ,INTERNATIONAL NORMALISED RATIO INCREASED,1
CZ,INVASIVE DUCTAL BREAST CARCINOMA,1
CZ,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
CZ,LEUKOCYTOSIS,1
CZ,LOSS OF CONSCIOUSNESS,1
CZ,MALAISE,1
CZ,MASTOIDITIS,1
CZ,METASTATIC NEOPLASM,1
CZ,MOOD ALTERED,1
CZ,MOUTH HAEMORRHAGE,1
CZ,MYOCARDITIS,1
CZ,MYOCLONUS,1
CZ,NASAL DISCOMFORT,1
CZ,NEOPLASM PROGRESSION,1
CZ,NEUROPATHY PERIPHERAL,1
CZ,NEUTROPHILIA,1
CZ,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
CZ,OSTEOPOROSIS,1
CZ,PAIN,1
CZ,PARAPARESIS,1
CZ,PATIENT RESTRAINT,1
CZ,PELVIC PAIN,1
CZ,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
CZ,PERIPHERAL SWELLING,1
CZ,PETIT MAL EPILEPSY,1
CZ,PROTEINURIA,1
CZ,PSYCHOTIC DISORDER,1
CZ,PUBIS FRACTURE,1
CZ,PYREXIA,1
CZ,RASH PRURITIC,1
CZ,RENAL NEOPLASM,1
CZ,RESPIRATORY TRACT INFECTION,1
CZ,ROTATOR CUFF SYNDROME,1
CZ,SECOND PRIMARY MALIGNANCY,1
CZ,SEIZURE,1
CZ,SKIN FISSURES,1
CZ,SOMATOFORM DISORDER,1
CZ,STOMATITIS,1
CZ,SUICIDE ATTEMPT,1
CZ,SWELLING FACE,1
CZ,THROMBOPHLEBITIS SUPERFICIAL,1
CZ,UPPER LIMB FRACTURE,1
CZ,URINARY TRACT INFECTION,1
CZ,VERTIGO,1
CZ,VIRAL INFECTION,1
CZ,VISION BLURRED,1
CZ,VISUAL IMPAIRMENT,1
CZ,WEIGHT INCREASED,1
DK,FALL,19
DK,DIZZINESS,18
DK,OVERDOSE,17
DK,EOSINOPHILIC MYOCARDITIS,16
DK,DYSPNOEA,13
DK,TOXICITY TO VARIOUS AGENTS,13
DK,LOSS OF CONSCIOUSNESS,12
DK,NAUSEA,12
DK,SOMNOLENCE,12
DK,ANXIETY,11
DK,DRUG INEFFECTIVE,11
DK,PAIN,11
DK,SLEEP DISORDER,11
DK,DRUG LEVEL INCREASED,10
DK,FATIGUE,10
DK,OSTEOPOROSIS,10
DK,RESTLESSNESS,10
DK,ARRHYTHMIA,9
DK,CONFUSIONAL STATE,9
DK,HALLUCINATION_ VISUAL,9
DK,PAIN IN EXTREMITY,9
DK,SUICIDAL IDEATION,9
DK,SYNCOPE,9
DK,UPPER LIMB FRACTURE,9
DK,ASTHENIA,8
DK,DRUG ABUSE,8
DK,HALLUCINATION_ AUDITORY,8
DK,NIGHTMARE,8
DK,COMPLETED SUICIDE,7
DK,DIARRHOEA,7
DK,MYALGIA,7
DK,PARAESTHESIA,7
DK,ABDOMINAL PAIN,6
DK,ANGER,6
DK,BRONCHITIS,6
DK,DEPRESSED LEVEL OF CONSCIOUSNESS,6
DK,DEPRESSED MOOD,6
DK,DRUG WITHDRAWAL SYNDROME,6
DK,INSOMNIA,6
DK,INTENTIONAL PRODUCT MISUSE,6
DK,IRRITABLE BOWEL SYNDROME,6
DK,NASOPHARYNGITIS,6
DK,OTITIS MEDIA,6
DK,PNEUMONIA,6
DK,PRODUCT USE ISSUE,6
DK,SEIZURE,6
DK,SLEEP PARALYSIS,6
DK,VOMITING,6
DK,WEIGHT FLUCTUATION,6
DK,WEIGHT INCREASED,6
DK,ARTHRALGIA,5
DK,CHEST PAIN,5
DK,DECREASED IMMUNE RESPONSIVENESS,5
DK,DEREALISATION,5
DK,DISTURBANCE IN SEXUAL AROUSAL,5
DK,FOETAL EXPOSURE DURING PREGNANCY,5
DK,FOOT FRACTURE,5
DK,FRACTURE,5
DK,FUNGAL INFECTION,5
DK,GASTROINTESTINAL DISORDER,5
DK,HALLUCINATION,5
DK,HEADACHE,5
DK,HYPERSOMNIA,5
DK,IMPAIRED REASONING,5
DK,IMPULSIVE BEHAVIOUR,5
DK,LUNG INFECTION,5
DK,MUSCLE SPASMS,5
DK,MUSCULAR WEAKNESS,5
DK,PERSONALITY CHANGE,5
DK,PYREXIA,5
DK,RHABDOMYOLYSIS,5
DK,SPEECH DISORDER,5
DK,VIOLENCE-RELATED SYMPTOM,5
DK,ADACTYLY,4
DK,BALANCE DISORDER,4
DK,CARDIAC ARREST,4
DK,CARDIAC FAILURE,4
DK,DELUSION,4
DK,DRUG DEPENDENCE,4
DK,DYSARTHRIA,4
DK,POISONING,4
DK,POLYNEUROPATHY,4
DK,SKIN BURNING SENSATION,4
DK,SUICIDAL BEHAVIOUR,4
DK,TACHYCARDIA,4
DK,TREATMENT NONCOMPLIANCE,4
DK,TREMOR,4
DK,VISUAL IMPAIRMENT,4
DK,ANKLE FRACTURE,3
DK,ATRIAL FIBRILLATION,3
DK,BACK PAIN,3
DK,BLOOD CREATINE PHOSPHOKINASE INCREASED,3
DK,CHILLS,3
DK,CONDITION AGGRAVATED,3
DK,CONTUSION,3
DK,DEATH,3
DK,DECUBITUS ULCER,3
DK,DEMENTIA,3
DK,DISLOCATION OF VERTEBRA,3
DK,DISORIENTATION,3
DK,DISTURBANCE IN ATTENTION,3
DK,EPILEPSY,3
DK,ERECTILE DYSFUNCTION,3
DK,FEELING ABNORMAL,3
DK,FINE MOTOR DELAY,3
DK,HAEMATOMA,3
DK,HYPONATRAEMIA,3
DK,INFECTION,3
DK,MALAISE,3
DK,MYOGLOBIN BLOOD INCREASED,3
DK,RASH,3
DK,SALIVARY HYPERSECRETION,3
DK,SPINAL COMPRESSION FRACTURE,3
DK,SUICIDE ATTEMPT,3
DK,SWOLLEN TONGUE,3
DK,TENDERNESS,3
DK,TOOTH DISORDER,3
DK,TOOTH LOSS,3
DK,WITHDRAWAL SYNDROME,3
DK,WOUND,3
DK,ABDOMINAL PAIN UPPER,2
DK,ABNORMAL DREAMS,2
DK,ABULIA,2
DK,AGGRESSION,2
DK,ANGIOEDEMA,2
DK,ANTIPSYCHOTIC DRUG LEVEL INCREASED,2
DK,ANXIETY DISORDER,2
DK,ATONIC URINARY BLADDER,2
DK,BLOOD PRESSURE INCREASED,2
DK,BUNDLE BRANCH BLOCK LEFT,2
DK,CARDIAC DISORDER,2
DK,CEREBRAL FUNGAL INFECTION,2
DK,COGNITIVE DISORDER,2
DK,CONSTIPATION,2
DK,CYST,2
DK,DEPENDENCE,2
DK,DISABILITY,2
DK,DRUG WITHDRAWAL SYNDROME NEONATAL,2
DK,DRY MOUTH,2
DK,EJECTION FRACTION DECREASED,2
DK,ELECTROCARDIOGRAM QT PROLONGED,2
DK,EMOTIONAL DISORDER,2
DK,GAIT DISTURBANCE,2
DK,HALLUCINATIONS_ MIXED,2
DK,HOT FLUSH,2
DK,HYPERHIDROSIS,2
DK,HYPERKALAEMIA,2
DK,HYPERSENSITIVITY,2
DK,KETOACIDOSIS,2
DK,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,2
DK,LETHARGY,2
DK,LIP SWELLING,2
DK,LOWER LIMB FRACTURE,2
DK,LUNG NEOPLASM MALIGNANT,2
DK,MATERNAL EXPOSURE DURING PREGNANCY,2
DK,MENTAL DISORDER,2
DK,METABOLIC ACIDOSIS,2
DK,MOBILITY DECREASED,2
DK,MOUTH SWELLING,2
DK,MUSCULOSKELETAL PAIN,2
DK,MYELODYSPLASTIC SYNDROME,2
DK,OEDEMA,2
DK,OEDEMA PERIPHERAL,2
DK,PALPITATIONS,2
DK,PARANOIA,2
DK,PERIPHERAL SWELLING,2
DK,PIERRE ROBIN SYNDROME,2
DK,PRODUCT USE IN UNAPPROVED INDICATION,2
DK,PSYCHOTIC DISORDER,2
DK,ROAD TRAFFIC ACCIDENT,2
DK,SEDATION,2
DK,URINARY RETENTION,2
DK,VENTRICULAR DYSKINESIA,2
DK,WHITE BLOOD CELL COUNT INCREASED,2
DK,WOUND INFECTION,2
DK,WOUND SECRETION,2
DK,ABDOMINAL ADHESIONS,1
DK,ABORTION INDUCED,1
DK,ACUTE KIDNEY INJURY,1
DK,ACUTE MYOCARDIAL INFARCTION,1
DK,ACUTE PSYCHOSIS,1
DK,ADVERSE DRUG REACTION,1
DK,ALANINE AMINOTRANSFERASE INCREASED,1
DK,ALCOHOL USE,1
DK,ALTERED STATE OF CONSCIOUSNESS,1
DK,ANAEMIA,1
DK,ANAPHYLACTIC SHOCK,1
DK,ANGINA PECTORIS,1
DK,BLISTER,1
DK,BLOOD ALKALINE PHOSPHATASE INCREASED,1
DK,BLOOD BILIRUBIN INCREASED,1
DK,BLOOD CREATININE INCREASED,1
DK,BLOOD PARATHYROID HORMONE INCREASED,1
DK,BLOOD PRESSURE IMMEASURABLE,1
DK,BLOOD UREA INCREASED,1
DK,BRADYCARDIA,1
DK,BRAIN INJURY,1
DK,BREAST CANCER METASTATIC,1
DK,BRONCHITIS CHRONIC,1
DK,C-REACTIVE PROTEIN INCREASED,1
DK,CAPILLARY NAIL REFILL TEST ABNORMAL,1
DK,CARDIAC FAILURE ACUTE,1
DK,CARDIOMEGALY,1
DK,CARDIOMYOPATHY,1
DK,CEREBRAL DISORDER,1
DK,CEREBRAL HAEMORRHAGE,1
DK,CEREBROVASCULAR ACCIDENT,1
DK,CHEST DISCOMFORT,1
DK,COLD SWEAT,1
DK,COMMINUTED FRACTURE,1
DK,CONGENITAL HAND MALFORMATION,1
DK,CONTRAINDICATED PRODUCT ADMINISTERED,1
DK,CONVULSION,1
DK,COORDINATION ABNORMAL,1
DK,CYANOSIS,1
DK,DECREASED APPETITE,1
DK,DEHYDRATION,1
DK,DENTAL CARIES,1
DK,DISEASE PROGRESSION,1
DK,DISINHIBITION,1
DK,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
DK,DRUG EFFECT DECREASED,1
DK,DYSAESTHESIA,1
DK,DYSKINESIA,1
DK,DYSPHONIA,1
DK,EAR PAIN,1
DK,ELECTROCARDIOGRAM T WAVE INVERSION,1
DK,ELECTROLYTE IMBALANCE,1
DK,EMOTIONAL DISTRESS,1
DK,EMPHYSEMA,1
DK,EOSINOPHILIA,1
DK,EPIDERMAL GROWTH FACTOR RECEPTOR DECREASED,1
DK,ERYTHEMA,1
DK,EYE ABSCESS,1
DK,FACIAL PARESIS,1
DK,FUNGAL SKIN INFECTION,1
DK,GASTRIC ULCER,1
DK,GASTROINTESTINAL HAEMORRHAGE,1
DK,GENERAL PHYSICAL CONDITION ABNORMAL,1
DK,GENERAL PHYSICAL HEALTH DETERIORATION,1
DK,GENERALISED TONIC-CLONIC SEIZURE,1
DK,GENITAL INFECTION FUNGAL,1
DK,GLOMERULAR FILTRATION RATE DECREASED,1
DK,HAEMATURIA,1
DK,HAEMOGLOBIN DECREASED,1
DK,HEART RATE INCREASED,1
DK,HEMIPARESIS,1
DK,HEPATITIS TOXIC,1
DK,HERPES VIRUS INFECTION,1
DK,HUNGER,1
DK,HYDROCEPHALUS,1
DK,HYPOACUSIS,1
DK,HYPOGLYCAEMIA,1
DK,HYPOKALAEMIA,1
DK,HYPOTENSION,1
DK,IMMUNODEFICIENCY,1
DK,IMPAIRED WORK ABILITY,1
DK,IMPULSE-CONTROL DISORDER,1
DK,INCORRECT DOSE ADMINISTERED,1
DK,INJECTION SITE URTICARIA,1
DK,INTENTIONAL OVERDOSE,1
DK,JAUNDICE,1
DK,JAW OPERATION,1
DK,KIDNEY RUPTURE,1
DK,LIBIDO DISORDER,1
DK,LIMB DISCOMFORT,1
DK,LIMB INJURY,1
DK,LISFRANC FRACTURE,1
DK,MANTLE CELL LYMPHOMA,1
DK,MEMORY IMPAIRMENT,1
DK,METASTASES TO CENTRAL NERVOUS SYSTEM,1
DK,MUSCLE RIGIDITY,1
DK,MUSCULOSKELETAL STIFFNESS,1
DK,MYOCLONUS,1
DK,NAIL INFECTION,1
DK,NASAL CONGESTION,1
DK,OSTEONECROSIS OF JAW,1
DK,PAIN THRESHOLD DECREASED,1
DK,PALLOR,1
DK,PANCREATITIS ACUTE,1
DK,PERIODONTITIS,1
DK,PERIPHERAL ARTERY THROMBOSIS,1
DK,PERIPHERAL COLDNESS,1
DK,PERIPHERAL PULSE DECREASED,1
DK,PERONEAL NERVE PALSY,1
DK,PERSONALITY DISORDER,1
DK,PHARYNGEAL OEDEMA,1
DK,PLATELET COUNT INCREASED,1
DK,PNEUMONIA HAEMOPHILUS,1
DK,PRE-EXISTING CONDITION IMPROVED,1
DK,PREGNANCY ON ORAL CONTRACEPTIVE,1
DK,PRESCRIBED OVERDOSE,1
DK,PROSTATE CANCER,1
DK,PULMONARY EMBOLISM,1
DK,RED BLOOD CELL COUNT DECREASED,1
DK,RENAL FAILURE,1
DK,RENAL HYPERTENSION,1
DK,RENAL IMPAIRMENT,1
DK,SCOLIOSIS,1
DK,SENSORY DISTURBANCE,1
DK,SEROMA,1
DK,SERUM FERRITIN INCREASED,1
DK,SEXUAL DYSFUNCTION,1
DK,SKIN DISCOLOURATION,1
DK,SKIN WOUND,1
DK,SLEEP ATTACKS,1
DK,SLEEP TERROR,1
DK,SLOW SPEECH,1
DK,SUBCUTANEOUS ABSCESS,1
DK,SUPRAVENTRICULAR TACHYARRHYTHMIA,1
DK,SUSPECTED COUNTERFEIT PRODUCT,1
DK,SWELLING FACE,1
DK,TENDON PAIN,1
DK,TENSION,1
DK,THERAPEUTIC RESPONSE UNEXPECTED,1
DK,THROAT IRRITATION,1
DK,THROAT TIGHTNESS,1
DK,TIC,1
DK,TINNITUS,1
DK,TONGUE DISCOLOURATION,1
DK,TRANSFERRIN DECREASED,1
DK,ULTRASOUND DOPPLER ABNORMAL,1
DK,URINARY INCONTINENCE,1
DK,URTICARIA,1
DK,VAGINAL ABSCESS,1
DK,VAGINAL HAEMORRHAGE,1
DK,VENTRICULAR EXTRASYSTOLES,1
DK,VENTRICULAR FIBRILLATION,1
DK,VENTRICULAR TACHYCARDIA,1
DK,VERTIGO POSITIONAL,1
DK,VISION BLURRED,1
DK,VITAMIN B12 DECREASED,1
DK,WALKING AID USER,1
DK,WALKING DISABILITY,1
DK,WHEELCHAIR USER,1
DO,ARTHRALGIA,1
DO,ARTHRITIS,1
DO,BEDRIDDEN,1
DO,CONVULSION,1
DO,ERYTHEMA,1
DO,FALL,1
DO,NERVOUS SYSTEM DISORDER,1
DO,OEDEMA,1
DO,PERIPHERAL SWELLING,1
DO,PHARYNGITIS STREPTOCOCCAL,1
DO,UPPER LIMB FRACTURE,1
EC,DEATH,11
EC,SPINAL DISORDER,6
EC,DRUG INEFFECTIVE,4
EC,CARDIAC DISORDER,3
EC,DEPRESSION,3
EC,INTERVERTEBRAL DISC PROTRUSION,3
EC,MUSCLE SPASMS,3
EC,MYOCARDIAL INFARCTION,3
EC,PNEUMONIA,3
EC,RENAL FAILURE,3
EC,ABASIA,2
EC,CEREBROVASCULAR ACCIDENT,2
EC,GASTROINTESTINAL DISORDER,2
EC,GASTROINTESTINAL INFECTION,2
EC,HEADACHE,2
EC,INFARCTION,2
EC,LEUKAEMIA,2
EC,LUNG NEOPLASM MALIGNANT,2
EC,NECK PAIN,2
EC,NEOPLASM MALIGNANT,2
EC,PAIN IN EXTREMITY,2
EC,POISONING,2
EC,PROSTATE CANCER,2
EC,SPINAL PAIN,2
EC,URINARY TRACT INFECTION,2
EC,ABDOMINAL PAIN,1
EC,ABNORMAL SLEEP-RELATED EVENT,1
EC,ANAL FISTULA,1
EC,ARTHROPATHY,1
EC,BLOOD URIC ACID INCREASED,1
EC,BONE CANCER,1
EC,BRAIN INJURY,1
EC,BRONCHOPNEUMONIA,1
EC,CARDIAC FAILURE,1
EC,CARDIO-RESPIRATORY ARREST,1
EC,CARDIOPULMONARY FAILURE,1
EC,CERVICAL SPINAL STENOSIS,1
EC,COLON CANCER,1
EC,COMA,1
EC,CONDITION AGGRAVATED,1
EC,CONVULSION,1
EC,DEAFNESS UNILATERAL,1
EC,DIABETES MELLITUS,1
EC,DIARRHOEA,1
EC,DIZZINESS,1
EC,DRUG INTOLERANCE,1
EC,DYSPHAGIA,1
EC,ELDERLY,1
EC,EPISTAXIS,1
EC,ERYTHEMA,1
EC,FEAR,1
EC,FOOT FRACTURE,1
EC,FRACTURE,1
EC,GALLBLADDER DISORDER,1
EC,GASTRIC CANCER,1
EC,HALLUCINATION,1
EC,HEMIPLEGIA,1
EC,HEPATIC CANCER,1
EC,HEPATIC CIRRHOSIS,1
EC,HERNIA,1
EC,HERPES ZOSTER,1
EC,HUNGER,1
EC,HYPERTENSION,1
EC,HYPOAESTHESIA,1
EC,IMMOBILE,1
EC,INFECTION,1
EC,LIMB OPERATION,1
EC,LIVER DISORDER,1
EC,LYMPHADENITIS,1
EC,METASTASES TO LIVER,1
EC,METASTATIC NEOPLASM,1
EC,MONOPARESIS,1
EC,MULTIPLE SCLEROSIS,1
EC,MUSCULOSKELETAL STIFFNESS,1
EC,NEOPLASM,1
EC,NEURALGIA,1
EC,OVERDOSE,1
EC,PAIN,1
EC,PANCREATIC CARCINOMA,1
EC,PARAESTHESIA,1
EC,PLATELET COUNT DECREASED,1
EC,POLLAKIURIA,1
EC,PULMONARY THROMBOSIS,1
EC,PYELONEPHRITIS,1
EC,PYREXIA,1
EC,RENAL INJURY,1
EC,RESPIRATORY DISORDER,1
EC,RESPIRATORY FAILURE,1
EC,RETINAL DETACHMENT,1
EC,RHEUMATOID ARTHRITIS,1
EC,SPLEEN DISORDER,1
EC,SWELLING,1
EC,SYNOVIAL CYST,1
EC,TENSION,1
EC,THIRST,1
EC,UTERINE CANCER,1
EC,VASCULAR PAIN,1
EC,VISUAL IMPAIRMENT,1
EC,VOMITING,1
EC,WEIGHT INCREASED,1
EG,SOMNOLENCE,4
EG,ARRHYTHMIA,2
EG,CARDIAC ARREST,2
EG,CHEST PAIN,2
EG,COMA,2
EG,ASPARTATE AMINOTRANSFERASE INCREASED,1
EG,BACK PAIN,1
EG,CEREBROVASCULAR ACCIDENT,1
EG,CONCOMITANT DISEASE PROGRESSION,1
EG,DEPRESSED LEVEL OF CONSCIOUSNESS,1
EG,DIZZINESS,1
EG,DRUG ABUSE,1
EG,DYSPHAGIA,1
EG,EYE OEDEMA,1
EG,FATIGUE,1
EG,GASTROINTESTINAL MOTILITY DISORDER,1
EG,HYPERHIDROSIS,1
EG,HYPOKINESIA,1
EG,HYPOTENSION,1
EG,INTESTINAL OBSTRUCTION,1
EG,OVERDOSE,1
EG,PAIN IN EXTREMITY,1
EG,PARALYSIS,1
EG,PERIPHERAL SWELLING,1
EG,PRODUCT USE ISSUE,1
EG,ROAD TRAFFIC ACCIDENT,1
EG,SALIVARY HYPERSECRETION,1
EG,TACHYCARDIA,1
EG,TRANSIENT ISCHAEMIC ATTACK,1
SV,DEATH,1
SV,DELIRIUM,1
SV,DISCOMFORT,1
SV,NAUSEA,1
SV,SOMNOLENCE,1
SV,VOMITING,1
EE,ALANINE AMINOTRANSFERASE INCREASED,1
EE,ASPARTATE AMINOTRANSFERASE INCREASED,1
EE,BLOOD ALKALINE PHOSPHATASE INCREASED,1
EE,CANDIDA INFECTION,1
EE,CHOLESTASIS,1
EE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
EE,HEAD DISCOMFORT,1
EE,HEPATIC ENZYME INCREASED,1
EE,HYPOPHYSITIS,1
EE,HYPOPITUITARISM,1
EE,PALPITATIONS,1
EE,PNEUMONITIS,1
EE,PULMONARY OEDEMA,1
EE,PYREXIA,1
EE,RASH,1
EE,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
EE,VENTRICULAR EXTRASYSTOLES,1
FI,TOXICITY TO VARIOUS AGENTS,55
FI,DRUG ABUSE,23
FI,DIZZINESS,16
FI,RHABDOMYOLYSIS,16
FI,VOMITING,13
FI,CERVICAL MYELOPATHY,12
FI,COMPARTMENT SYNDROME,12
FI,PAIN,12
FI,FALL,11
FI,HYPERTHYROIDISM,11
FI,NAUSEA,11
FI,FATIGUE,9
FI,GENERAL PHYSICAL HEALTH DETERIORATION,9
FI,HEADACHE,9
FI,MEMORY IMPAIRMENT,9
FI,WEIGHT INCREASED,9
FI,HYPOAESTHESIA,8
FI,MUSCULAR WEAKNESS,8
FI,PYREXIA,8
FI,CONFUSIONAL STATE,7
FI,INTENTIONAL PRODUCT USE ISSUE,7
FI,PAIN IN EXTREMITY,7
FI,SUICIDAL IDEATION,7
FI,BALANCE DISORDER,6
FI,DEATH,6
FI,DRUG INEFFECTIVE,6
FI,GAIT DISTURBANCE,6
FI,LOSS OF CONSCIOUSNESS,6
FI,PNEUMONIA,6
FI,QUADRIPARESIS,6
FI,SUBSTANCE ABUSE,6
FI,BLOOD CREATININE INCREASED,5
FI,C-REACTIVE PROTEIN INCREASED,5
FI,CONDITION AGGRAVATED,5
FI,FEELING ABNORMAL,5
FI,INTENTIONAL PRODUCT MISUSE,5
FI,MUSCLE SPASMS,5
FI,MUSCULOSKELETAL STIFFNESS,5
FI,VISUAL IMPAIRMENT,5
FI,ARRHYTHMIA,4
FI,ARTHRALGIA,4
FI,ASTHENIA,4
FI,CARDIAC ARREST,4
FI,COMPLETED SUICIDE,4
FI,DEREALISATION,4
FI,DEVICE ISSUE,4
FI,DIARRHOEA,4
FI,DISORIENTATION,4
FI,DRUG DEPENDENCE,4
FI,DRY EYE,4
FI,DYSPHAGIA,4
FI,DYSPNOEA,4
FI,HAEMOGLOBIN DECREASED,4
FI,HYPERHIDROSIS,4
FI,ILEUS,4
FI,INSOMNIA,4
FI,IRRITABILITY,4
FI,NEURALGIA,4
FI,PARAESTHESIA,4
FI,PARALYSIS,4
FI,PERIPHERAL SWELLING,4
FI,SLEEP DISORDER,4
FI,VISION BLURRED,4
FI,ACUTE KIDNEY INJURY,3
FI,ALOPECIA,3
FI,ANAEMIA,3
FI,ANGER,3
FI,ANGINA PECTORIS,3
FI,ANXIETY,3
FI,BACK PAIN,3
FI,CARDIAC DISORDER,3
FI,CHEST DISCOMFORT,3
FI,DEPRESSED LEVEL OF CONSCIOUSNESS,3
FI,DISCOMFORT,3
FI,DYSLIPIDAEMIA,3
FI,DYSURIA,3
FI,EPILEPSY,3
FI,ERYTHEMA,3
FI,FLUID RETENTION,3
FI,GASTROINTESTINAL DISORDER,3
FI,HALLUCINATION,3
FI,HYPERTENSION,3
FI,HYPOTHYROIDISM,3
FI,IMPAIRED DRIVING ABILITY,3
FI,INFECTION,3
FI,INTENTIONAL OVERDOSE,3
FI,JOINT RANGE OF MOTION DECREASED,3
FI,MERALGIA PARAESTHETICA,3
FI,MYOCARDIAL INFARCTION,3
FI,OEDEMA PERIPHERAL,3
FI,PARKINSON^S DISEASE,3
FI,PLATELET COUNT DECREASED,3
FI,POSTERIOR TIBIAL NERVE INJURY,3
FI,PRODUCT USE ISSUE,3
FI,RASH,3
FI,RESTLESSNESS,3
FI,SELF-INJURIOUS IDEATION,3
FI,SPEECH DISORDER,3
FI,STRESS FRACTURE,3
FI,SWOLLEN TONGUE,3
FI,TINNITUS,3
FI,TREMOR,3
FI,VERTIGO,3
FI,WITHDRAWAL SYNDROME,3
FI,ACTIVITIES OF DAILY LIVING IMPAIRED,2
FI,ACUTE HEPATIC FAILURE,2
FI,AGGRESSION,2
FI,AMNESIA,2
FI,ANAL INCONTINENCE,2
FI,ANGIOEDEMA,2
FI,APHASIA,2
FI,ASTHMA,2
FI,CARDIAC FAILURE,2
FI,CATARACT,2
FI,CEREBRAL INFARCTION,2
FI,CHILLS,2
FI,COGNITIVE DISORDER,2
FI,COMMUNICATION DISORDER,2
FI,CONTUSION,2
FI,DECREASED APPETITE,2
FI,DELUSION,2
FI,DEPRESSION,2
FI,DEVICE ALARM ISSUE,2
FI,DEVICE OCCLUSION,2
FI,DIPLOPIA,2
FI,DRUG EFFECT INCOMPLETE,2
FI,DRUG LEVEL INCREASED,2
FI,DRUG WITHDRAWAL SYNDROME,2
FI,DRY MOUTH,2
FI,DRY SKIN,2
FI,DYSGEUSIA,2
FI,DYSPEPSIA,2
FI,DYSSTASIA,2
FI,EYE PAIN,2
FI,EYELID OEDEMA,2
FI,FEELING HOT,2
FI,GASTROOESOPHAGEAL REFLUX DISEASE,2
FI,HAEMORRHAGE,2
FI,HEART RATE INCREASED,2
FI,HEPATIC FAILURE,2
FI,HERPES ZOSTER,2
FI,HOT FLUSH,2
FI,HYPOKALAEMIA,2
FI,HYPONATRAEMIA,2
FI,INCORRECT DOSE ADMINISTERED,2
FI,INCORRECT ROUTE OF DRUG ADMINISTRATION,2
FI,INITIAL INSOMNIA,2
FI,INTERSTITIAL LUNG DISEASE,2
FI,INTERVERTEBRAL DISC PROTRUSION,2
FI,IRON DEFICIENCY ANAEMIA,2
FI,JOINT EFFUSION,2
FI,LIP SWELLING,2
FI,LOCAL SWELLING,2
FI,LYMPHOPENIA,2
FI,MALAISE,2
FI,MALIGNANT NEOPLASM PROGRESSION,2
FI,METASTASES TO BONE,2
FI,MOBILITY DECREASED,2
FI,MULTIPLE SCLEROSIS RELAPSE,2
FI,MUSCLE DISORDER,2
FI,MUSCULOSKELETAL DISORDER,2
FI,MYALGIA,2
FI,NECK PAIN,2
FI,NOCTURIA,2
FI,NYSTAGMUS,2
FI,OLIGURIA,2
FI,ON AND OFF PHENOMENON,2
FI,PALPITATIONS,2
FI,PERIPHERAL COLDNESS,2
FI,PLEURAL EFFUSION,2
FI,POISONING,2
FI,POLYNEUROPATHY,2
FI,PSYCHOTIC DISORDER,2
FI,RENAL FAILURE,2
FI,SKIN REACTION,2
FI,SOCIAL AVOIDANT BEHAVIOUR,2
FI,SOMNOLENCE,2
FI,SWELLING,2
FI,SWELLING FACE,2
FI,SYNCOPE,2
FI,THROMBOCYTOPENIA,2
FI,TONGUE BLISTERING,2
FI,TYPE 2 DIABETES MELLITUS,2
FI,URINARY TRACT INFECTION,2
FI,WEIGHT DECREASED,2
FI,WHITE BLOOD CELL COUNT INCREASED,2
FI,ABASIA,1
FI,ABDOMINAL DISCOMFORT,1
FI,ABDOMINAL DISTENSION,1
FI,ABDOMINAL PAIN,1
FI,ABDOMINAL PAIN UPPER,1
FI,ABNORMAL BEHAVIOUR,1
FI,ABNORMAL DREAMS,1
FI,ABNORMAL FAECES,1
FI,ACARIASIS,1
FI,ACCIDENTAL OVERDOSE,1
FI,ACCIDENTAL POISONING,1
FI,ADVERSE EVENT,1
FI,AGEUSIA,1
FI,AGITATION,1
FI,AKINESIA,1
FI,ALANINE AMINOTRANSFERASE INCREASED,1
FI,ALCOHOL INTERACTION,1
FI,ALCOHOL POISONING,1
FI,AMYOTROPHIC LATERAL SCLEROSIS,1
FI,ANAPHYLACTIC REACTION,1
FI,ANOSMIA,1
FI,ANURIA,1
FI,AORTIC VALVE PROLAPSE,1
FI,AORTIC VALVE SCLEROSIS,1
FI,APATHY,1
FI,APHAGIA,1
FI,APHONIA,1
FI,APLASIA PURE RED CELL,1
FI,ARTHRITIS INFECTIVE,1
FI,ASCITES,1
FI,ATAXIA,1
FI,ATRIAL FIBRILLATION,1
FI,BACTERIAL INFECTION,1
FI,BEZOAR,1
FI,BLEPHARITIS,1
FI,BLINDNESS UNILATERAL,1
FI,BLISTER,1
FI,BLOOD BICARBONATE DECREASED,1
FI,BLOOD BILIRUBIN DECREASED,1
FI,BLOOD GLUCOSE ABNORMAL,1
FI,BLOOD GLUCOSE INCREASED,1
FI,BLOOD PRESSURE FLUCTUATION,1
FI,BLOOD PRESSURE INCREASED,1
FI,BLOOD SODIUM DECREASED,1
FI,BLOOD THROMBOPLASTIN DECREASED,1
FI,BRADYCARDIA,1
FI,BRADYKINESIA,1
FI,BRADYPHRENIA,1
FI,BUNDLE BRANCH BLOCK RIGHT,1
FI,BURNING SENSATION,1
FI,CARBON DIOXIDE INCREASED,1
FI,CAROTID ENDARTERECTOMY,1
FI,CARPAL TUNNEL SYNDROME,1
FI,CENTRAL NERVOUS SYSTEM LESION,1
FI,CEREBELLAR INFARCTION,1
FI,CEREBRAL CONGESTION,1
FI,CEREBRAL ISCHAEMIA,1
FI,CHANGE OF BOWEL HABIT,1
FI,CHEST PAIN,1
FI,CHOLELITHIASIS,1
FI,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
FI,CIRCULATORY COLLAPSE,1
FI,COLECTOMY,1
FI,COLITIS,1
FI,COLON GANGRENE,1
FI,CONSTIPATION,1
FI,CONVULSION,1
FI,CORONARY ARTERY STENOSIS,1
FI,CRYING,1
FI,CYSTITIS,1
FI,CYTOKINE RELEASE SYNDROME,1
FI,CYTOMEGALOVIRUS INFECTION,1
FI,DECUBITUS ULCER,1
FI,DEEP BRAIN STIMULATION,1
FI,DEEP VEIN THROMBOSIS,1
FI,DEHYDRATION,1
FI,DENTAL CARIES,1
FI,DEPENDENCE,1
FI,DEPRESSED MOOD,1
FI,DERMATITIS EXFOLIATIVE,1
FI,DEVICE CONNECTION ISSUE,1
FI,DEVICE DIFFICULT TO USE,1
FI,DEVICE DISLOCATION,1
FI,DEVICE KINK,1
FI,DEVICE LEAKAGE,1
FI,DIALYSIS,1
FI,DIARRHOEA HAEMORRHAGIC,1
FI,DISEASE PROGRESSION,1
FI,DISTURBANCE IN ATTENTION,1
FI,DRUG DOSE OMISSION,1
FI,DRUG EFFECT DECREASED,1
FI,DRUG ERUPTION,1
FI,DRUG INTOLERANCE,1
FI,DRUG SPECIFIC ANTIBODY PRESENT,1
FI,DRUG-INDUCED LIVER INJURY,1
FI,DYSARTHRIA,1
FI,DYSCHEZIA,1
FI,DYSKINESIA,1
FI,DYSPHEMIA,1
FI,DYSPHONIA,1
FI,EAR CONGESTION,1
FI,EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED,1
FI,EJECTION FRACTION DECREASED,1
FI,ELECTROCARDIOGRAM ABNORMAL,1
FI,EMOTIONAL DISORDER,1
FI,EMOTIONAL DISTRESS,1
FI,ENDOMETRIAL CANCER,1
FI,ENDOMETRIOSIS,1
FI,EPIGASTRIC DISCOMFORT,1
FI,ERYSIPELAS,1
FI,ERYTHEMA NODOSUM,1
FI,EUPHORIC MOOD,1
FI,EXTRASYSTOLES,1
FI,EXTREMITY CONTRACTURE,1
FI,FACE INJURY,1
FI,FACIAL PAIN,1
FI,FACIAL PARALYSIS,1
FI,FALLOPIAN TUBE CANCER,1
FI,FEAR OF DEATH,1
FI,FEELING COLD,1
FI,FEELING DRUNK,1
FI,FEMORAL NECK FRACTURE,1
FI,FIBROMYALGIA,1
FI,FLAT AFFECT,1
FI,FLATULENCE,1
FI,FLUSHING,1
FI,FOAMING AT MOUTH,1
FI,FUNCTIONAL GASTROINTESTINAL DISORDER,1
FI,FUNGAL INFECTION,1
FI,GAIT INABILITY,1
FI,GAMMA-GLUTAMYLTRANSFERASE DECREASED,1
FI,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
FI,GASTRIC DISORDER,1
FI,GASTRIC ULCER,1
FI,GASTRIC ULCER HAEMORRHAGE,1
FI,GASTROINTESTINAL HYPOMOTILITY,1
FI,GASTROINTESTINAL STOMA COMPLICATION,1
FI,GENERAL PHYSICAL CONDITION ABNORMAL,1
FI,GESTATIONAL DIABETES,1
FI,GLOMERULAR FILTRATION RATE DECREASED,1
FI,GLOMERULONEPHRITIS MEMBRANOUS,1
FI,GLOSSODYNIA,1
FI,GOUT,1
FI,HAEMATOCRIT DECREASED,1
FI,HAEMOPTYSIS,1
FI,HALLUCINATION_ VISUAL,1
FI,HEART RATE DECREASED,1
FI,HEART VALVE INCOMPETENCE,1
FI,HEPATIC ENCEPHALOPATHY,1
FI,HEPATOTOXICITY,1
FI,HERPES SIMPLEX,1
FI,HOMICIDAL IDEATION,1
FI,HORNER^S SYNDROME,1
FI,HYDRONEPHROSIS,1
FI,HYPERGAMMAGLOBULINAEMIA BENIGN MONOCLONAL,1
FI,HYPERSENSITIVITY,1
FI,HYPERSOMNIA,1
FI,HYPOAESTHESIA ORAL,1
FI,HYPOALBUMINAEMIA,1
FI,HYPOKINESIA,1
FI,HYPOTHERMIA,1
FI,HYPOTONIA,1
FI,ILEUS PARALYTIC,1
FI,IMMOBILE,1
FI,IMMUNE SYSTEM DISORDER,1
FI,IMPAIRED HEALING,1
FI,IMPAIRED WORK ABILITY,1
FI,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
FI,INCREASED APPETITE,1
FI,INCREASED UPPER AIRWAY SECRETION,1
FI,INFLAMMATION,1
FI,INFUSION SITE EXTRAVASATION,1
FI,INJECTION SITE ABSCESS,1
FI,INJECTION SITE BRUISING,1
FI,INJECTION SITE INFECTION,1
FI,INJECTION SITE PAIN,1
FI,INTENTIONAL DRUG MISUSE,1
FI,INTERVERTEBRAL DISC SPACE NARROWING,1
FI,INTESTINAL OBSTRUCTION,1
FI,INTRACARDIAC THROMBUS,1
FI,JC VIRUS TEST POSITIVE,1
FI,JOINT INJURY,1
FI,JOINT STIFFNESS,1
FI,LACRIMAL DISORDER,1
FI,LACUNAR INFARCTION,1
FI,LARYNGEAL OEDEMA,1
FI,LEUKOCYTOSIS,1
FI,LIP DISCOLOURATION,1
FI,LIVER TRANSPLANT,1
FI,LOWER LIMB FRACTURE,1
FI,LUNG DISORDER,1
FI,LUNG INFECTION,1
FI,LUNG INFILTRATION,1
FI,LYMPHADENOPATHY,1
FI,LYMPHADENOPATHY MEDIASTINAL,1
FI,MANIA,1
FI,MEDICATION ERROR,1
FI,MENOPAUSE,1
FI,MENTAL IMPAIRMENT,1
FI,MIDDLE INSOMNIA,1
FI,MIGRAINE,1
FI,MITRAL VALVE INCOMPETENCE,1
FI,MONOCYTE COUNT INCREASED,1
FI,MONONEUROPATHY MULTIPLEX,1
FI,MONOPARESIS,1
FI,MOOD ALTERED,1
FI,MOOD SWINGS,1
FI,MOTOR DYSFUNCTION,1
FI,MOUTH HAEMORRHAGE,1
FI,MOVEMENT DISORDER,1
FI,MUCOSAL DRYNESS,1
FI,MUCOUS STOOLS,1
FI,MUSCLE TWITCHING,1
FI,MYASTHENIA GRAVIS,1
FI,MYDRIASIS,1
FI,MYOCARDIAL ISCHAEMIA,1
FI,N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED,1
FI,NASAL INJURY,1
FI,NASOPHARYNGITIS,1
FI,NEOPLASM MALIGNANT,1
FI,NERVOUSNESS,1
FI,NEUROGENIC BLADDER,1
FI,NEUROLEPTIC MALIGNANT SYNDROME,1
FI,NEUROPATHY PERIPHERAL,1
FI,NEUTROPHILIA,1
FI,NIGHTMARE,1
FI,NON-ALCOHOLIC STEATOHEPATITIS,1
FI,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
FI,NOSOCOMIAL INFECTION,1
FI,OBESITY,1
FI,OEDEMA,1
FI,OESOPHAGEAL IRRITATION,1
FI,ORAL DISORDER,1
FI,ORAL MUCOSAL BLISTERING,1
FI,ORAL PAIN,1
FI,ORGANISING PNEUMONIA,1
FI,OSTEONECROSIS,1
FI,OSTEONECROSIS OF JAW,1
FI,OVERDOSE,1
FI,OXYGEN SATURATION DECREASED,1
FI,PAIN OF SKIN,1
FI,PANCREATITIS,1
FI,PANIC ATTACK,1
FI,PARAESTHESIA ORAL,1
FI,PARANOIA,1
FI,PEMPHIGOID,1
FI,PERIPHERAL NERVE LESION,1
FI,PERSONALITY CHANGE,1
FI,PETECHIAE,1
FI,PHARYNGEAL OEDEMA,1
FI,PLASMA CELL MYELOMA,1
FI,PNEUMONIA BACTERIAL,1
FI,PNEUMONITIS,1
FI,POISONING DELIBERATE,1
FI,POOR QUALITY SLEEP,1
FI,POST PROCEDURAL COMPLICATION,1
FI,POST PROCEDURAL DIARRHOEA,1
FI,POSTERIOR CAPSULE OPACIFICATION,1
FI,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,1
FI,PRODUCT USE IN UNAPPROVED INDICATION,1
FI,PROTHROMBIN TIME SHORTENED,1
FI,PRURITUS,1
FI,PULMONARY EMBOLISM,1
FI,PULMONARY HAEMORRHAGE,1
FI,PULMONARY THROMBOSIS,1
FI,PYELONEPHRITIS,1
FI,QUADRIPLEGIA,1
FI,RADIAL NERVE INJURY,1
FI,RASH GENERALISED,1
FI,RASH VESICULAR,1
FI,READING DISORDER,1
FI,RED BLOOD CELL COUNT DECREASED,1
FI,RENAL IMPAIRMENT,1
FI,RESPIRATORY TRACT INFECTION,1
FI,RETINOSCHISIS,1
FI,RHEUMATIC DISORDER,1
FI,RHEUMATOID ARTHRITIS,1
FI,RHINORRHOEA,1
FI,RIB FRACTURE,1
FI,SARCOIDOSIS,1
FI,SENSORY LOSS,1
FI,SEPTIC SHOCK,1
FI,SERUM FERRITIN INCREASED,1
FI,SERUM SICKNESS,1
FI,SKIN ATROPHY,1
FI,SKIN DISORDER,1
FI,SKIN EXFOLIATION,1
FI,SKIN HYPERTROPHY,1
FI,SKIN LESION,1
FI,SKIN TIGHTNESS,1
FI,SKIN WARM,1
FI,SKIN WOUND,1
FI,SNORING,1
FI,SQUAMOUS CELL CARCINOMA OF SKIN,1
FI,STAPHYLOCOCCAL SEPSIS,1
FI,STOMA SITE DISCHARGE,1
FI,STOMA SITE HYPERGRANULATION,1
FI,STOMA SITE INFLAMMATION,1
FI,STOMA SITE IRRITATION,1
FI,SUFFOCATION FEELING,1
FI,SUICIDE ATTEMPT,1
FI,TACHYCARDIA PAROXYSMAL,1
FI,TEMPERATURE REGULATION DISORDER,1
FI,TENDERNESS,1
FI,TENDINOUS CONTRACTURE,1
FI,TENDON RUPTURE,1
FI,TENOSYNOVITIS,1
FI,TENSION,1
FI,TESTICULAR CYST,1
FI,THERAPEUTIC RESPONSE DECREASED,1
FI,THINKING ABNORMAL,1
FI,THIRST,1
FI,TONGUE DISORDER,1
FI,TONGUE MOVEMENT DISTURBANCE,1
FI,TOOTHACHE,1
FI,ULCERATIVE KERATITIS,1
FI,UNINTENTIONAL MEDICAL DEVICE REMOVAL,1
FI,UNRESPONSIVE TO STIMULI,1
FI,UPPER RESPIRATORY TRACT INFECTION,1
FI,URINARY INCONTINENCE,1
FI,URINARY RETENTION,1
FI,URINARY TRACT DISORDER,1
FI,URINARY TRACT INFECTION PSEUDOMONAL,1
FI,URINE OUTPUT DECREASED,1
FI,URTICARIA,1
FI,URTICARIAL VASCULITIS,1
FI,VAGINAL HAEMORRHAGE,1
FI,VASCULITIS,1
FI,VIRAL TEST POSITIVE,1
FI,VITREOUS DETACHMENT,1
FI,VULVOVAGINAL DRYNESS,1
FI,WOUND,1
FI,WRONG DEVICE USED,1
FR,CONFUSIONAL STATE,202
FR,SOMNOLENCE,182
FR,ACUTE KIDNEY INJURY,168
FR,FALL,159
FR,HEPATOCELLULAR INJURY,137
FR,PYREXIA,134
FR,OVERDOSE,119
FR,THROMBOCYTOPENIA,117
FR,ASTHENIA,111
FR,ANAEMIA,109
FR,DIARRHOEA,109
FR,CHOLESTASIS,108
FR,VOMITING,107
FR,GENERAL PHYSICAL HEALTH DETERIORATION,103
FR,COMA,102
FR,HYPOTENSION,102
FR,DYSPNOEA,92
FR,NEUTROPENIA,85
FR,NAUSEA,84
FR,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,82
FR,MALAISE,81
FR,RENAL FAILURE,81
FR,HEADACHE,71
FR,PANCYTOPENIA,71
FR,HYPONATRAEMIA,69
FR,RASH,69
FR,DISORIENTATION,67
FR,HALLUCINATION,63
FR,FATIGUE,62
FR,ABDOMINAL PAIN,61
FR,PRURITUS,61
FR,RENAL FAILURE ACUTE,61
FR,INTENTIONAL OVERDOSE,59
FR,CONDITION AGGRAVATED,58
FR,HEPATITIS,57
FR,HYPERKALAEMIA,56
FR,LUNG DISORDER,56
FR,DEHYDRATION,55
FR,EOSINOPHILIA,53
FR,TREMOR,52
FR,LOSS OF CONSCIOUSNESS,51
FR,OEDEMA PERIPHERAL,51
FR,RASH MACULO-PAPULAR,51
FR,AGRANULOCYTOSIS,50
FR,DEATH,50
FR,CARDIAC FAILURE,49
FR,DECREASED APPETITE,49
FR,BRADYCARDIA,48
FR,WEIGHT INCREASED,48
FR,CONSTIPATION,47
FR,PAIN,47
FR,TOXICITY TO VARIOUS AGENTS,47
FR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,46
FR,PULMONARY EMBOLISM,45
FR,TACHYCARDIA,45
FR,ERYTHEMA,44
FR,SEPSIS,44
FR,DRUG INEFFECTIVE,43
FR,HYPOKALAEMIA,43
FR,ABDOMINAL PAIN UPPER,42
FR,CHILLS,42
FR,MALIGNANT NEOPLASM PROGRESSION,42
FR,SEPTIC SHOCK,42
FR,DIZZINESS,41
FR,VERTIGO,41
FR,AGITATION,40
FR,DEPRESSION,40
FR,DISTURBANCE IN ATTENTION,40
FR,TOXIC SKIN ERUPTION,40
FR,PNEUMONIA,39
FR,HYPERTENSION,38
FR,URINARY RETENTION,38
FR,RESPIRATORY DISTRESS,37
FR,MYOCLONUS,36
FR,PAIN IN EXTREMITY,36
FR,PRODUCT USE ISSUE,36
FR,GAIT DISTURBANCE,35
FR,INTERSTITIAL LUNG DISEASE,35
FR,MYALGIA,35
FR,NEUROPATHY PERIPHERAL,35
FR,WEIGHT DECREASED,35
FR,DEPRESSED LEVEL OF CONSCIOUSNESS,34
FR,LEUKOPENIA,33
FR,PNEUMONIA ASPIRATION,33
FR,RHABDOMYOLYSIS,33
FR,BLOOD ALKALINE PHOSPHATASE INCREASED,32
FR,MIOSIS,32
FR,SUICIDE ATTEMPT,32
FR,TRANSAMINASES INCREASED,32
FR,EPILEPSY,31
FR,ANXIETY,30
FR,ARTHRALGIA,30
FR,ENCEPHALOPATHY,30
FR,MELAENA,30
FR,PARAESTHESIA,30
FR,COMPLETED SUICIDE,29
FR,INFLAMMATION,29
FR,CHEST PAIN,28
FR,DRUG DEPENDENCE,28
FR,HALLUCINATION_ VISUAL,28
FR,BALANCE DISORDER,27
FR,HYPERTHERMIA,27
FR,VISUAL ACUITY REDUCED,27
FR,DRUG ABUSE,26
FR,RECTAL HAEMORRHAGE,26
FR,ASPARTATE AMINOTRANSFERASE INCREASED,25
FR,INTERNATIONAL NORMALISED RATIO INCREASED,25
FR,ACUTE RESPIRATORY DISTRESS SYNDROME,24
FR,AGGRESSION,24
FR,ALANINE AMINOTRANSFERASE INCREASED,24
FR,CARDIO-RESPIRATORY ARREST,24
FR,DYSPHAGIA,24
FR,ELECTROCARDIOGRAM QT PROLONGED,24
FR,LYMPHOPENIA,24
FR,NEURALGIA,24
FR,OXYGEN SATURATION DECREASED,24
FR,PANCREATITIS ACUTE,24
FR,BACK PAIN,23
FR,BLOOD CREATININE INCREASED,23
FR,HAEMATOMA,23
FR,PURPURA,23
FR,URINARY TRACT INFECTION,23
FR,COUGH,22
FR,DYSARTHRIA,22
FR,FACE OEDEMA,22
FR,HYPERHIDROSIS,22
FR,MUSCLE SPASMS,22
FR,SEIZURE,22
FR,SPEECH DISORDER,22
FR,STEVENS-JOHNSON SYNDROME,22
FR,VISION BLURRED,22
FR,VISUAL IMPAIRMENT,22
FR,HYPOXIA,21
FR,INSOMNIA,21
FR,IRRITABILITY,21
FR,JAUNDICE,21
FR,LACTIC ACIDOSIS,21
FR,MYDRIASIS,21
FR,RESPIRATORY DEPRESSION,21
FR,CARDIAC ARREST,20
FR,DYSKINESIA,20
FR,FEBRILE BONE MARROW APLASIA,20
FR,FEBRILE NEUTROPENIA,20
FR,HYPOTHERMIA,20
FR,MEMORY IMPAIRMENT,20
FR,RASH ERYTHEMATOUS,20
FR,SUICIDAL IDEATION,20
FR,APHASIA,19
FR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,19
FR,OEDEMA,19
FR,PRODUCT USE IN UNAPPROVED INDICATION,19
FR,SKIN ULCER,19
FR,URTICARIA,19
FR,ABNORMAL BEHAVIOUR,18
FR,ANGIOEDEMA,18
FR,BONE MARROW FAILURE,18
FR,ERYSIPELAS,18
FR,LUNG INFECTION,18
FR,SHOCK,18
FR,SHOCK HAEMORRHAGIC,18
FR,WITHDRAWAL SYNDROME,18
FR,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,17
FR,ATRIAL FIBRILLATION,17
FR,C-REACTIVE PROTEIN INCREASED,17
FR,DERMATITIS EXFOLIATIVE,17
FR,GASTROINTESTINAL HAEMORRHAGE,17
FR,HYPOCALCAEMIA,17
FR,INFECTION,17
FR,ISCHAEMIC STROKE,17
FR,PLASMA CELL MYELOMA,17
FR,SCIATICA,17
FR,ALTERED STATE OF CONSCIOUSNESS,16
FR,CEREBRAL HAEMATOMA,16
FR,HAEMATEMESIS,16
FR,HEPATITIS CHOLESTATIC,16
FR,METABOLIC ACIDOSIS,16
FR,MIXED LIVER INJURY,16
FR,PRESYNCOPE,16
FR,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,16
FR,RASH PRURITIC,16
FR,ARRHYTHMIA,15
FR,DEEP VEIN THROMBOSIS,15
FR,DRY MOUTH,15
FR,ECZEMA,15
FR,HAEMOGLOBIN DECREASED,15
FR,HAEMORRHAGE,15
FR,HYPERSENSITIVITY,15
FR,INTENTIONAL PRODUCT MISUSE,15
FR,INTESTINAL OBSTRUCTION,15
FR,MUSCULAR WEAKNESS,15
FR,POLYNEUROPATHY,15
FR,BRADYPNOEA,14
FR,DELIRIUM,14
FR,DISEASE PROGRESSION,14
FR,GENERALISED OEDEMA,14
FR,HYPERSENSITIVITY VASCULITIS,14
FR,PEMPHIGOID,14
FR,POISONING DELIBERATE,14
FR,ACUTE PULMONARY OEDEMA,13
FR,AMNESIA,13
FR,CEREBROVASCULAR ACCIDENT,13
FR,HAEMATURIA,13
FR,HAEMOLYTIC ANAEMIA,13
FR,HEPATIC ENZYME INCREASED,13
FR,HYPOGLYCAEMIA,13
FR,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,13
FR,MUSCULOSKELETAL PAIN,13
FR,MYOCARDIAL INFARCTION,13
FR,ORTHOSTATIC HYPOTENSION,13
FR,PLEURAL EFFUSION,13
FR,PYELONEPHRITIS,13
FR,PYELONEPHRITIS ACUTE,13
FR,RESPIRATORY FAILURE,13
FR,SINUS TACHYCARDIA,13
FR,SKIN EXFOLIATION,13
FR,ACUTE RESPIRATORY FAILURE,12
FR,BRONCHITIS,12
FR,BURNING SENSATION,12
FR,CELL DEATH,12
FR,COGNITIVE DISORDER,12
FR,CREATININE RENAL CLEARANCE DECREASED,12
FR,EJECTION FRACTION DECREASED,12
FR,EXTRAPYRAMIDAL DISORDER,12
FR,FAECALOMA,12
FR,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,12
FR,NERVOUS SYSTEM DISORDER,12
FR,NORMOCHROMIC NORMOCYTIC ANAEMIA,12
FR,OSTEONECROSIS OF JAW,12
FR,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,12
FR,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,12
FR,SKIN NECROSIS,12
FR,STAPHYLOCOCCAL INFECTION,12
FR,TOXIC ENCEPHALOPATHY,12
FR,ACCIDENTAL OVERDOSE,11
FR,BLOOD CREATINE PHOSPHOKINASE INCREASED,11
FR,CLONUS,11
FR,DERMATITIS BULLOUS,11
FR,DIABETES MELLITUS INADEQUATE CONTROL,11
FR,DYSURIA,11
FR,FEELING ABNORMAL,11
FR,HEAD INJURY,11
FR,HYPOVOLAEMIC SHOCK,11
FR,LIVER INJURY,11
FR,MUCOSAL INFLAMMATION,11
FR,PACKED RED BLOOD CELL TRANSFUSION,11
FR,PSYCHOMOTOR SKILLS IMPAIRED,11
FR,RESPIRATORY DISORDER,11
FR,SINUS BRADYCARDIA,11
FR,STATUS EPILEPTICUS,11
FR,TUBULOINTERSTITIAL NEPHRITIS,11
FR,ACUTE CORONARY SYNDROME,10
FR,ASCITES,10
FR,BLOOD PRESSURE INCREASED,10
FR,CARDIOGENIC SHOCK,10
FR,CEREBRAL HAEMORRHAGE,10
FR,CHEST DISCOMFORT,10
FR,DIPLOPIA,10
FR,DRUG USE DISORDER,10
FR,DRUG WITHDRAWAL SYNDROME,10
FR,GASTRIC ULCER,10
FR,HEMIPARESIS,10
FR,HYPERAESTHESIA,10
FR,HYPOAESTHESIA,10
FR,INCOHERENT,10
FR,LIPASE INCREASED,10
FR,MATERNAL EXPOSURE DURING PREGNANCY,10
FR,MOVEMENT DISORDER,10
FR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,10
FR,MYELODYSPLASTIC SYNDROME,10
FR,OSTEONECROSIS,10
FR,PHLEBITIS,10
FR,PROTEINURIA,10
FR,RENAL IMPAIRMENT,10
FR,SLEEP DISORDER,10
FR,TOXIC EPIDERMAL NECROLYSIS,10
FR,ALOPECIA,9
FR,ATAXIA,9
FR,BLOOD BILIRUBIN INCREASED,9
FR,BLOOD PRESSURE DECREASED,9
FR,CHOLELITHIASIS,9
FR,COAGULOPATHY,9
FR,DEAFNESS,9
FR,DRUG-INDUCED LIVER INJURY,9
FR,GASTRITIS,9
FR,HAEMOPTYSIS,9
FR,HAEMORRHAGIC ANAEMIA,9
FR,HEPATIC FAILURE,9
FR,HEPATIC STEATOSIS,9
FR,HERPES ZOSTER,9
FR,HISTIOCYTOSIS HAEMATOPHAGIC,9
FR,HYPERCALCAEMIA,9
FR,HYPOVENTILATION,9
FR,JAUNDICE CHOLESTATIC,9
FR,MOTOR DYSFUNCTION,9
FR,MULTIPLE SCLEROSIS RELAPSE,9
FR,MUSCULOSKELETAL STIFFNESS,9
FR,NECK PAIN,9
FR,OSTEOARTHRITIS,9
FR,PERITONITIS,9
FR,PLATELET COUNT DECREASED,9
FR,RALES,9
FR,SKIN LESION,9
FR,STAPHYLOCOCCAL SEPSIS,9
FR,SYNCOPE,9
FR,TACHYPNOEA,9
FR,ANURIA,8
FR,BONE PAIN,8
FR,CARDIAC DISORDER,8
FR,COLITIS,8
FR,ESCHERICHIA URINARY TRACT INFECTION,8
FR,FEELING COLD,8
FR,HAEMORRHAGIC STROKE,8
FR,HEART RATE INCREASED,8
FR,HEPATOCELLULAR CARCINOMA,8
FR,HYPERBILIRUBINAEMIA,8
FR,HYPOTONIA,8
FR,INCORRECT DOSE ADMINISTERED,8
FR,INFLUENZA LIKE ILLNESS,8
FR,LIVER DISORDER,8
FR,PERICARDIAL EFFUSION,8
FR,PLEURISY,8
FR,PNEUMOCYSTIS JIROVECII PNEUMONIA,8
FR,PSORIASIS,8
FR,RASH MORBILLIFORM,8
FR,RESPIRATORY ACIDOSIS,8
FR,RESPIRATORY TRACT CONGESTION,8
FR,VENTRICULAR TACHYCARDIA,8
FR,ABDOMINAL DISTENSION,7
FR,AGEUSIA,7
FR,BICYTOPENIA,7
FR,BLINDNESS,7
FR,BRONCHOSPASM,7
FR,CATARACT,7
FR,CONVULSION,7
FR,CYANOSIS,7
FR,DRUG INTOLERANCE,7
FR,DRY SKIN,7
FR,DYSPEPSIA,7
FR,EPISTAXIS,7
FR,ERYTHEMA MULTIFORME,7
FR,FEELING DRUNK,7
FR,HYPERTHYROIDISM,7
FR,HYPERTRIGLYCERIDAEMIA,7
FR,MENINGIOMA,7
FR,PALPITATIONS,7
FR,PERIPHERAL SWELLING,7
FR,PRESCRIBED OVERDOSE,7
FR,PRODUCTIVE COUGH,7
FR,PULMONARY FIBROSIS,7
FR,PULMONARY OEDEMA,7
FR,RASH GENERALISED,7
FR,RASH MACULAR,7
FR,RASH PUSTULAR,7
FR,RENAL TUBULAR NECROSIS,7
FR,RETINAL VEIN OCCLUSION,7
FR,STAPHYLOCOCCAL BACTERAEMIA,7
FR,SWELLING FACE,7
FR,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,7
FR,THROMBOSIS,7
FR,ABORTION SPONTANEOUS,6
FR,ACUTE PRERENAL FAILURE,6
FR,ADRENAL INSUFFICIENCY,6
FR,ADRENOCORTICOTROPIC HORMONE DEFICIENCY,6
FR,ANAEMIA MACROCYTIC,6
FR,APLASIA,6
FR,B-CELL LYMPHOMA,6
FR,BLOOD ALBUMIN DECREASED,6
FR,BLOOD THYROID STIMULATING HORMONE DECREASED,6
FR,BONE DISORDER,6
FR,CLOSTRIDIUM DIFFICILE COLITIS,6
FR,CRYING,6
FR,CYSTITIS,6
FR,DEPENDENCE,6
FR,DRUG PRESCRIBING ERROR,6
FR,DRY EYE,6
FR,EUPHORIC MOOD,6
FR,EYE IRRITATION,6
FR,FACIAL PARALYSIS,6
FR,FEMORAL NECK FRACTURE,6
FR,FOETAL EXPOSURE DURING PREGNANCY,6
FR,GENERALISED TONIC-CLONIC SEIZURE,6
FR,HALLUCINATIONS_ MIXED,6
FR,HIP FRACTURE,6
FR,HUMERUS FRACTURE,6
FR,HYPERCAPNIA,6
FR,HYPERTENSIVE CRISIS,6
FR,HYPOPHOSPHATAEMIA,6
FR,HYPOTHYROIDISM,6
FR,IMPAIRED HEALING,6
FR,INJURY,6
FR,INTERVERTEBRAL DISC PROTRUSION,6
FR,LICHENOID KERATOSIS,6
FR,LYMPHANGITIS,6
FR,LYMPHOEDEMA,6
FR,MALNUTRITION,6
FR,MYOCARDIAL ISCHAEMIA,6
FR,MYOCARDITIS,6
FR,NEPHROLITHIASIS,6
FR,NYSTAGMUS,6
FR,OPTIC NEURITIS,6
FR,PERICARDITIS,6
FR,PERIPHERAL ISCHAEMIA,6
FR,PERIPHERAL SENSORY NEUROPATHY,6
FR,RESPIRATORY ARREST,6
FR,SKIN FISSURES,6
FR,SKIN REACTION,6
FR,SUBDURAL HAEMATOMA,6
FR,TESTICULAR PAIN,6
FR,TRANSIENT ISCHAEMIC ATTACK,6
FR,WOUND,6
FR,ACUTE MYELOID LEUKAEMIA,5
FR,AGE-RELATED MACULAR DEGENERATION,5
FR,ANAPHYLACTIC REACTION,5
FR,ANGINA PECTORIS,5
FR,APHTHOUS ULCER,5
FR,ATRIOVENTRICULAR BLOCK,5
FR,ATRIOVENTRICULAR BLOCK COMPLETE,5
FR,ATRIOVENTRICULAR BLOCK FIRST DEGREE,5
FR,ATRIOVENTRICULAR BLOCK SECOND DEGREE,5
FR,BACTERAEMIA,5
FR,BLISTER,5
FR,BLOOD TRIGLYCERIDES INCREASED,5
FR,BRONCHIAL DISORDER,5
FR,BUNDLE BRANCH BLOCK RIGHT,5
FR,CEREBELLAR SYNDROME,5
FR,CIRCULATORY COLLAPSE,5
FR,COLITIS ISCHAEMIC,5
FR,COLITIS ULCERATIVE,5
FR,COMA SCALE ABNORMAL,5
FR,COMPULSIVE SHOPPING,5
FR,CRANIOCEREBRAL INJURY,5
FR,DELUSION,5
FR,DEVICE RELATED INFECTION,5
FR,DISSEMINATED INTRAVASCULAR COAGULATION,5
FR,DIVERTICULUM,5
FR,DYSAESTHESIA,5
FR,DYSPHONIA,5
FR,DYSPNOEA EXERTIONAL,5
FR,ELECTROCARDIOGRAM ABNORMAL,5
FR,EPSTEIN-BARR VIRUS INFECTION,5
FR,EYE PAIN,5
FR,EYELID OEDEMA,5
FR,FEAR,5
FR,FLUID RETENTION,5
FR,GASTROENTERITIS,5
FR,GASTROINTESTINAL DISORDER,5
FR,GLAUCOMA,5
FR,GRANULOMATOUS LIVER DISEASE,5
FR,GYNAECOMASTIA,5
FR,HEPATIC ENCEPHALOPATHY,5
FR,HOT FLUSH,5
FR,HYPERGLYCAEMIA,5
FR,HYPERNATRAEMIA,5
FR,HYPOALBUMINAEMIA,5
FR,HYPOGAMMAGLOBULINAEMIA,5
FR,HYPOGLYCAEMIC COMA,5
FR,HYPOPITUITARISM,5
FR,INCORRECT DRUG ADMINISTRATION DURATION,5
FR,INTENTIONAL DRUG MISUSE,5
FR,IRON DEFICIENCY ANAEMIA,5
FR,JOINT SWELLING,5
FR,KLEBSIELLA INFECTION,5
FR,LEUKOCYTOSIS,5
FR,LIBIDO DECREASED,5
FR,LIVEDO RETICULARIS,5
FR,LOCALISED OEDEMA,5
FR,LYMPHANGIOSIS CARCINOMATOSA,5
FR,MOUTH ULCERATION,5
FR,NECROSIS,5
FR,NEUROLEPTIC MALIGNANT SYNDROME,5
FR,NEUTROPHIL COUNT DECREASED,5
FR,OXYGEN SATURATION ABNORMAL,5
FR,PANCREATITIS,5
FR,PANIC ATTACK,5
FR,PARALYSIS,5
FR,PARESIS,5
FR,PARTIAL SEIZURES,5
FR,PERSECUTORY DELUSION,5
FR,POLYDIPSIA,5
FR,POTENTIATING DRUG INTERACTION,5
FR,PRERENAL FAILURE,5
FR,PSYCHOMOTOR RETARDATION,5
FR,RASH PAPULAR,5
FR,RASH SCARLATINIFORM,5
FR,RENAL TUBULAR DISORDER,5
FR,RESTLESSNESS,5
FR,SEROTONIN SYNDROME,5
FR,SIALOADENITIS,5
FR,SKIN DISCOLOURATION,5
FR,SKIN HYPERPIGMENTATION,5
FR,STRESS CARDIOMYOPATHY,5
FR,TENDONITIS,5
FR,TONIC CLONIC MOVEMENTS,5
FR,TRANSFUSION,5
FR,VASCULITIS,5
FR,VIRAL INFECTION,5
FR,VISUAL FIELD DEFECT,5
FR,WHITE BLOOD CELL COUNT INCREASED,5
FR,ABASIA,4
FR,ABDOMINAL WALL HAEMATOMA,4
FR,ACIDOSIS,4
FR,ANAPHYLACTIC SHOCK,4
FR,ASPHYXIA,4
FR,ASTERIXIS,4
FR,BASAL CELL CARCINOMA,4
FR,BLADDER CANCER,4
FR,BLADDER TRANSITIONAL CELL CARCINOMA,4
FR,BLOOD GLUCOSE INCREASED,4
FR,BLOOD THYROID STIMULATING HORMONE INCREASED,4
FR,BRONCHOPULMONARY ASPERGILLOSIS,4
FR,CACHEXIA,4
FR,CARDIOMYOPATHY,4
FR,CENTRAL NERVOUS SYSTEM LESION,4
FR,CHOLECYSTITIS,4
FR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,4
FR,CONTRAINDICATED PRODUCT ADMINISTERED,4
FR,CUTANEOUS LUPUS ERYTHEMATOSUS,4
FR,CYTOMEGALOVIRUS OESOPHAGITIS,4
FR,DECREASED EYE CONTACT,4
FR,DERMATITIS,4
FR,DIABETES MELLITUS,4
FR,DIABETIC KETOACIDOSIS,4
FR,DRUG LEVEL INCREASED,4
FR,DRUG TOLERANCE,4
FR,DYSGRAPHIA,4
FR,DYSSTASIA,4
FR,ESCHERICHIA INFECTION,4
FR,FOETAL ALCOHOL SYNDROME,4
FR,FOLLICULITIS,4
FR,FORMICATION,4
FR,GENERAL PHYSICAL CONDITION ABNORMAL,4
FR,GENERALISED ERYTHEMA,4
FR,HEPATITIS ACUTE,4
FR,HEPATITIS FULMINANT,4
FR,HYPERLACTACIDAEMIA,4
FR,IMPAIRED GASTRIC EMPTYING,4
FR,INFLUENZA,4
FR,INFUSION RELATED REACTION,4
FR,INTENTIONAL PRODUCT USE ISSUE,4
FR,INTERVERTEBRAL DISCITIS,4
FR,JUGULAR VEIN THROMBOSIS,4
FR,LANGUAGE DISORDER,4
FR,LINEAR IGA DISEASE,4
FR,LOCALISED INFECTION,4
FR,LOGORRHOEA,4
FR,LUMBAR SPINAL STENOSIS,4
FR,MENINGITIS,4
FR,MENTAL DISORDER,4
FR,METABOLIC ENCEPHALOPATHY,4
FR,MONOPARESIS,4
FR,MULTI-ORGAN FAILURE,4
FR,MUSCLE CONTRACTURE,4
FR,MUSCULOSKELETAL DISORDER,4
FR,NERVOUSNESS,4
FR,NEUTROPHIL COUNT INCREASED,4
FR,ORAL CANDIDIASIS,4
FR,PANCREATIC NECROSIS,4
FR,PERIPHERAL ARTERY THROMBOSIS,4
FR,PERIPHERAL MOTOR NEUROPATHY,4
FR,PERSONALITY DISORDER,4
FR,PHARYNGEAL OEDEMA,4
FR,PNEUMONIA ESCHERICHIA,4
FR,PNEUMONIA PNEUMOCOCCAL,4
FR,PNEUMOTHORAX,4
FR,POLYURIA,4
FR,PREGNANCY,4
FR,PRURITUS GENERALISED,4
FR,PSEUDOMONAS INFECTION,4
FR,PULMONARY ARTERIAL HYPERTENSION,4
FR,PULMONARY HYPERTENSION,4
FR,RAYNAUD^S PHENOMENON,4
FR,RHEUMATOID ARTHRITIS,4
FR,RHONCHI,4
FR,SEDATION,4
FR,SLEEP APNOEA SYNDROME,4
FR,SUBARACHNOID HAEMORRHAGE,4
FR,SYSTEMIC LUPUS ERYTHEMATOSUS,4
FR,TESTICULAR NECROSIS,4
FR,THERMOPHOBIA,4
FR,THROMBOTIC MICROANGIOPATHY,4
FR,TINNITUS,4
FR,TONGUE OEDEMA,4
FR,URINARY INCONTINENCE,4
FR,VASCULAR PURPURA,4
FR,VASODILATATION,4
FR,VENOUS THROMBOSIS,4
FR,WHITE BLOOD CELL COUNT DECREASED,4
FR,ABDOMINAL HERNIA,3
FR,ABORTION INDUCED,3
FR,ABSCESS,3
FR,ACNE,3
FR,ANASTOMOTIC STENOSIS,3
FR,ANOSMIA,3
FR,APATHY,3
FR,APLASIA PURE RED CELL,3
FR,ARTERIAL DISORDER,3
FR,ARTERITIS,3
FR,ASPERGILLUS INFECTION,3
FR,ASPIRATION,3
FR,ATRIAL SEPTAL DEFECT,3
FR,AXONAL NEUROPATHY,3
FR,BILIARY DILATATION,3
FR,BILIARY TRACT DISORDER,3
FR,BILIARY TRACT INFECTION,3
FR,BLOOD LACTATE DEHYDROGENASE INCREASED,3
FR,BLOOD THYROID STIMULATING HORMONE NORMAL,3
FR,BRADYPHRENIA,3
FR,BREAST CANCER,3
FR,BRONCHIAL OBSTRUCTION,3
FR,BUNDLE BRANCH BLOCK LEFT,3
FR,CAMPTOCORMIA,3
FR,CARDIAC FAILURE CONGESTIVE,3
FR,CARDIAC TAMPONADE,3
FR,CEREBRAL ISCHAEMIA,3
FR,CHEILITIS,3
FR,CHEST X-RAY ABNORMAL,3
FR,CHOKING,3
FR,CHOLECYSTITIS ACUTE,3
FR,CHONDROCALCINOSIS,3
FR,CONGENITAL HAND MALFORMATION,3
FR,CONGESTIVE CARDIOMYOPATHY,3
FR,CONSCIOUSNESS FLUCTUATING,3
FR,COORDINATION ABNORMAL,3
FR,CROHN^S DISEASE,3
FR,CYTOMEGALOVIRUS INFECTION,3
FR,DELIRIUM TREMENS,3
FR,DEMENTIA,3
FR,DEPRESSED MOOD,3
FR,DERMATITIS PSORIASIFORM,3
FR,DEVICE RELATED SEPSIS,3
FR,DISINHIBITION,3
FR,DRUG ADMINISTRATION ERROR,3
FR,DRUG ERUPTION,3
FR,DRUG HYPERSENSITIVITY,3
FR,DRUG SCREEN POSITIVE,3
FR,DUODENAL ULCER,3
FR,ECCHYMOSIS,3
FR,EMBOLISM,3
FR,EXCORIATION,3
FR,EYE INFECTION,3
FR,FAECAL VOMITING,3
FR,FLUSHING,3
FR,FUNGAL INFECTION,3
FR,FURUNCLE,3
FR,GASTROOESOPHAGEAL REFLUX DISEASE,3
FR,GLOMERULAR FILTRATION RATE DECREASED,3
FR,GUILLAIN-BARRE SYNDROME,3
FR,HAEMARTHROSIS,3
FR,HALLUCINATION_ AUDITORY,3
FR,HEPATOTOXICITY,3
FR,HERNIA,3
FR,HERNIAL EVENTRATION,3
FR,HIATUS HERNIA,3
FR,HOSPITALISATION,3
FR,HYPERLEUKOCYTOSIS,3
FR,HYPERLIPASAEMIA,3
FR,HYPERTONIA,3
FR,HYPERTRICHOSIS,3
FR,HYPERTROPHIC CARDIOMYOPATHY,3
FR,HYPOACUSIS,3
FR,HYPOCHLORAEMIA,3
FR,HYPOMAGNESAEMIA,3
FR,ILEUS,3
FR,IMMUNE THROMBOCYTOPENIC PURPURA,3
FR,IMMUNOGLOBULINS DECREASED,3
FR,INCONTINENCE,3
FR,INCORRECT ROUTE OF DRUG ADMINISTRATION,3
FR,JOINT INJURY,3
FR,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,3
FR,LEFT VENTRICULAR DYSFUNCTION,3
FR,LIP OEDEMA,3
FR,LIVER ABSCESS,3
FR,LIVER FUNCTION TEST ABNORMAL,3
FR,LOCAL SWELLING,3
FR,LOWER GASTROINTESTINAL HAEMORRHAGE,3
FR,LUNG INFILTRATION,3
FR,LYMPHADENOPATHY,3
FR,LYMPHOCYTE COUNT DECREASED,3
FR,MAJOR DEPRESSION,3
FR,MALIGNANT MELANOMA,3
FR,MALIGNANT NEOPLASM OF UNKNOWN PRIMARY SITE,3
FR,MEDICATION ERROR,3
FR,MENTAL IMPAIRMENT,3
FR,METASTASES TO BONE,3
FR,METASTASIS,3
FR,MICROCYTIC ANAEMIA,3
FR,MIGRAINE,3
FR,MIGRAINE WITH AURA,3
FR,MOOD ALTERED,3
FR,MOOD SWINGS,3
FR,MUSCLE INJURY,3
FR,NASAL DISCOMFORT,3
FR,NEOPLASM MALIGNANT,3
FR,NEOPLASM PROGRESSION,3
FR,NEUROENDOCRINE CARCINOMA,3
FR,NIGHT SWEATS,3
FR,NIGHTMARE,3
FR,ODYNOPHAGIA,3
FR,OESOPHAGITIS,3
FR,OLIGURIA,3
FR,OPTIC NEUROPATHY,3
FR,ORGANISING PNEUMONIA,3
FR,PALLOR,3
FR,PANCREAS INFECTION,3
FR,PARONYCHIA,3
FR,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,3
FR,PERIPHERAL ARTERY STENOSIS,3
FR,PERIPHERAL COLDNESS,3
FR,PERIPHERAL SENSORIMOTOR NEUROPATHY,3
FR,PLASMA CELL MYELOMA RECURRENT,3
FR,PLASMACYTOMA,3
FR,PNEUMONIA CYTOMEGALOVIRAL,3
FR,PNEUMONIA PSEUDOMONAL,3
FR,POISONING,3
FR,POST PROCEDURAL HAEMORRHAGE,3
FR,POSTICTAL STATE,3
FR,PRESCRIPTION FORM TAMPERING,3
FR,PROSTATITIS,3
FR,PSYCHOTIC DISORDER,3
FR,PULMONARY INFARCTION,3
FR,PYRAMIDAL TRACT SYNDROME,3
FR,QUADRIPLEGIA,3
FR,RADIATION SKIN INJURY,3
FR,RED BLOOD CELL COUNT DECREASED,3
FR,RENAL DISORDER,3
FR,RENAL FAILURE CHRONIC,3
FR,RETINAL HAEMORRHAGE,3
FR,RETROPERITONEAL HAEMATOMA,3
FR,RHEUMATIC DISORDER,3
FR,RHINORRHOEA,3
FR,ROTATOR CUFF SYNDROME,3
FR,SENSORIMOTOR DISORDER,3
FR,SJOGREN^S SYNDROME,3
FR,STUPOR,3
FR,SUPERINFECTION,3
FR,SWELLING,3
FR,THIRST,3
FR,TONGUE FUNGAL INFECTION,3
FR,TOOTH ABSCESS,3
FR,TOOTHACHE,3
FR,TYPE 2 DIABETES MELLITUS,3
FR,UMBILICAL HERNIA,3
FR,UPPER RESPIRATORY TRACT INFECTION,3
FR,URINARY TRACT DISORDER,3
FR,UROSEPSIS,3
FR,VASCULITIS NECROTISING,3
FR,VULVAL OEDEMA,3
FR,WHEEZING,3
FR,WRONG DRUG ADMINISTERED,3
FR,WRONG PATIENT RECEIVED MEDICATION,3
FR,ACCOMMODATION DISORDER,2
FR,ACTIVITIES OF DAILY LIVING IMPAIRED,2
FR,ADENOCARCINOMA GASTRIC,2
FR,ADENOCARCINOMA OF COLON,2
FR,ADENOCARCINOMA PANCREAS,2
FR,ADVERSE EVENT,2
FR,AKATHISIA,2
FR,ALCOHOL POISONING,2
FR,ALKALOSIS,2
FR,ALLERGIC GRANULOMATOUS ANGIITIS,2
FR,ALVEOLITIS,2
FR,AMYLASE INCREASED,2
FR,AMYOTROPHY,2
FR,ANAPHYLACTOID REACTION,2
FR,ANAPHYLACTOID SHOCK,2
FR,ANGINA UNSTABLE,2
FR,ANKYLOSING SPONDYLITIS,2
FR,ANTINUCLEAR ANTIBODY INCREASED,2
FR,AORTIC STENOSIS,2
FR,APHTHOUS STOMATITIS,2
FR,APLASTIC ANAEMIA,2
FR,APPLICATION SITE BURN,2
FR,APPLICATION SITE ERYTHEMA,2
FR,ARTERIOSCLEROSIS,2
FR,ARTERIOSCLEROSIS CORONARY ARTERY,2
FR,ARTHRITIS BACTERIAL,2
FR,ARTHROPATHY,2
FR,ASPIRATION BONE MARROW ABNORMAL,2
FR,ATELECTASIS,2
FR,BACTERIAL PROSTATITIS,2
FR,BACTERIAL SEPSIS,2
FR,BACTERIAL TEST POSITIVE,2
FR,BILIARY COLIC,2
FR,BINGE EATING,2
FR,BLADDER DILATATION,2
FR,BLADDER DISORDER,2
FR,BLINDNESS UNILATERAL,2
FR,BLOOD ALCOHOL INCREASED,2
FR,BLOOD CHOLESTEROL INCREASED,2
FR,BLOOD CREATININE DECREASED,2
FR,BLOOD DISORDER,2
FR,BLOOD GLUCOSE ABNORMAL,2
FR,BLOOD OSMOLARITY DECREASED,2
FR,BLOOD PRESSURE ABNORMAL,2
FR,BLOOD PRESSURE FLUCTUATION,2
FR,BLOOD PRESSURE SYSTOLIC INCREASED,2
FR,BLOOD TEST ABNORMAL,2
FR,BODY TEMPERATURE INCREASED,2
FR,BOWEN^S DISEASE,2
FR,BRAIN ABSCESS,2
FR,BRAIN HERNIATION,2
FR,BRAIN NATRIURETIC PEPTIDE INCREASED,2
FR,BREAST SWELLING,2
FR,BREATH SOUNDS ABNORMAL,2
FR,BRONCHIECTASIS,2
FR,BRONCHOPNEUMONIA,2
FR,CAPILLARY LEAK SYNDROME,2
FR,CARDIAC MURMUR,2
FR,CARDIOVASCULAR DISORDER,2
FR,CAROTID ARTERY STENOSIS,2
FR,CARPAL TUNNEL SYNDROME,2
FR,CAUDA EQUINA SYNDROME,2
FR,CAVERNOUS SINUS THROMBOSIS,2
FR,CD4 LYMPHOCYTES DECREASED,2
FR,CD8 LYMPHOCYTES DECREASED,2
FR,CELLULITIS,2
FR,CEREBELLAR ATAXIA,2
FR,CEREBRAL DISORDER,2
FR,CERVICAL DYSPLASIA,2
FR,CERVIX CARCINOMA STAGE III,2
FR,CHOLANGITIS,2
FR,CHRONIC KIDNEY DISEASE,2
FR,CIRRHOSIS ALCOHOLIC,2
FR,CLUMSINESS,2
FR,COAGULATION FACTOR DECREASED,2
FR,COGWHEEL RIGIDITY,2
FR,COLITIS MICROSCOPIC,2
FR,COLON CANCER,2
FR,CONGENITAL HYDROCEPHALUS,2
FR,CONGENITAL MUSCULOSKELETAL ANOMALY,2
FR,CONJUNCTIVITIS,2
FR,CONTUSION,2
FR,CORONARY ARTERY OCCLUSION,2
FR,CREATININE URINE DECREASED,2
FR,CUTANEOUS VASCULITIS,2
FR,CYTOMEGALOVIRUS COLITIS,2
FR,CYTOMEGALOVIRUS TEST POSITIVE,2
FR,DAYDREAMING,2
FR,DEAFNESS UNILATERAL,2
FR,DELAYED RECOVERY FROM ANAESTHESIA,2
FR,DERMATITIS ACNEIFORM,2
FR,DERMATITIS CONTACT,2
FR,DERMATOMYOSITIS,2
FR,DIABETIC NEPHROPATHY,2
FR,DIASTOLIC DYSFUNCTION,2
FR,DISEASE RECURRENCE,2
FR,DIVERTICULAR PERFORATION,2
FR,DIVERTICULUM INTESTINAL,2
FR,DIZZINESS POSTURAL,2
FR,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,2
FR,DRUG DISPENSING ERROR,2
FR,DRUG EFFECT INCOMPLETE,2
FR,DRUG LEVEL ABOVE THERAPEUTIC,2
FR,DRUG RESISTANCE,2
FR,DYSGEUSIA,2
FR,DYSHIDROTIC ECZEMA,2
FR,DYSPRAXIA,2
FR,EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED,2
FR,ECHOLALIA,2
FR,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,2
FR,ELECTROCARDIOGRAM T WAVE ABNORMAL,2
FR,ELECTROCARDIOGRAM T WAVE INVERSION,2
FR,ELECTROCARDIOGRAM U-WAVE ABNORMALITY,2
FR,ELECTROENCEPHALOGRAM ABNORMAL,2
FR,EMOTIONAL DISTRESS,2
FR,EMPHYSEMA,2
FR,ENCEPHALITIS,2
FR,ENDOCARDITIS,2
FR,ENDOCARDITIS STAPHYLOCOCCAL,2
FR,ENTERITIS,2
FR,ENTEROCOLITIS,2
FR,ERECTILE DYSFUNCTION,2
FR,ERYTHROSIS,2
FR,ESCHERICHIA SEPSIS,2
FR,EXTRAOCULAR MUSCLE PARESIS,2
FR,EXTRASYSTOLES,2
FR,EXTREMITY NECROSIS,2
FR,EYE DISORDER,2
FR,EYE HAEMORRHAGE,2
FR,EYE OEDEMA,2
FR,EYELID RASH,2
FR,FEEDING DISORDER,2
FR,FEELING HOT,2
FR,FOOT FRACTURE,2
FR,FULL BLOOD COUNT ABNORMAL,2
FR,GASTRIC DISORDER,2
FR,GASTRIC ULCER HAEMORRHAGE,2
FR,GASTRODUODENAL ULCER,2
FR,GASTROENTERITIS RADIATION,2
FR,GENITAL ULCERATION,2
FR,GESTATIONAL DIABETES,2
FR,GINGIVAL DISORDER,2
FR,GINGIVAL INJURY,2
FR,GINGIVAL RECESSION,2
FR,GLYCOSYLATED HAEMOGLOBIN INCREASED,2
FR,HAEMOGLOBIN ABNORMAL,2
FR,HAEMOLYSIS,2
FR,HAEMOLYTIC URAEMIC SYNDROME,2
FR,HAEMORRHAGIC TRANSFORMATION STROKE,2
FR,HEAD DISCOMFORT,2
FR,HEART RATE DECREASED,2
FR,HEMIANOPIA,2
FR,HEMIPLEGIA,2
FR,HENOCH-SCHONLEIN PURPURA,2
FR,HEPATIC FUNCTION ABNORMAL,2
FR,HEPATIC HAEMATOMA,2
FR,HEPATOMEGALY,2
FR,HYPERACUSIS,2
FR,HYPOGONADISM,2
FR,HYPOKINESIA,2
FR,HYPOPHYSITIS,2
FR,HYPOPROTHROMBINAEMIA,2
FR,HYPOREFLEXIA,2
FR,IMMOBILISATION PROLONGED,2
FR,INCORRECT DRUG ADMINISTRATION RATE,2
FR,INCREASED APPETITE,2
FR,INFLAMMATORY MARKER INCREASED,2
FR,INJECTION SITE INFLAMMATION,2
FR,INJECTION SITE PAIN,2
FR,INTERMITTENT CLAUDICATION,2
FR,INTERTRIGO,2
FR,INTERVERTEBRAL DISC DEGENERATION,2
FR,INTESTINAL ISCHAEMIA,2
FR,INTRACARDIAC THROMBUS,2
FR,ISCHAEMIC HEPATITIS,2
FR,JAW DISORDER,2
FR,JAW FRACTURE,2
FR,KIDNEY INFECTION,2
FR,LABORATORY TEST ABNORMAL,2
FR,LACRIMATION INCREASED,2
FR,LARGE INTESTINE PERFORATION,2
FR,LEFT VENTRICULAR FAILURE,2
FR,LIMB DISCOMFORT,2
FR,LIMB INJURY,2
FR,LIMB MALFORMATION,2
FR,LOBAR PNEUMONIA,2
FR,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,2
FR,LOWER GASTROINTESTINAL PERFORATION,2
FR,LUPUS-LIKE SYNDROME,2
FR,LYMPHOCYTE COUNT INCREASED,2
FR,LYMPHOCYTE MORPHOLOGY ABNORMAL,2
FR,LYMPHOCYTIC INFILTRATION,2
FR,LYMPHOCYTOSIS,2
FR,MACROCYTOSIS,2
FR,MACROGLOSSIA,2
FR,MATERNAL DRUGS AFFECTING FOETUS,2
FR,MEDICATION RESIDUE PRESENT,2
FR,MENDELSON^S SYNDROME,2
FR,MENINGEAL DISORDER,2
FR,MENINGITIS ASEPTIC,2
FR,MENINGORRHAGIA,2
FR,METABOLIC DISORDER,2
FR,MUSCLE ATROPHY,2
FR,MUSCLE CONTRACTIONS INVOLUNTARY,2
FR,MUSCLE HAEMORRHAGE,2
FR,MUSCLE RIGIDITY,2
FR,MYOPATHY,2
FR,NAIL PSORIASIS,2
FR,NASAL CONGESTION,2
FR,NASAL DRYNESS,2
FR,NEGATIVISM,2
FR,NEPHRITIS,2
FR,NEPHROPATHY TOXIC,2
FR,NEPHROTIC SYNDROME,2
FR,NEUROENDOCRINE CARCINOMA OF THE SKIN,2
FR,NEUROGENIC SHOCK,2
FR,NEUROLOGICAL DECOMPENSATION,2
FR,NEUROTOXICITY,2
FR,NICOTINE DEPENDENCE,2
FR,OCULAR HYPERAEMIA,2
FR,OESOPHAGEAL CANDIDIASIS,2
FR,OESOPHAGEAL CARCINOMA,2
FR,OESOPHAGEAL VARICES HAEMORRHAGE,2
FR,OESOPHAGITIS ULCERATIVE,2
FR,ONYCHOCLASIS,2
FR,ONYCHOMYCOSIS,2
FR,ORAL DISCOMFORT,2
FR,ORCHITIS,2
FR,OROPHARYNGEAL PAIN,2
FR,OSMOTIC DEMYELINATION SYNDROME,2
FR,OSTEOPOROSIS,2
FR,PAIN IN JAW,2
FR,PAINFUL RESPIRATION,2
FR,PANCREATIC ENZYMES INCREASED,2
FR,PANCREATITIS CHRONIC,2
FR,PANCREATITIS RELAPSING,2
FR,PAPILLOEDEMA,2
FR,PARAESTHESIA ORAL,2
FR,PARAPLEGIA,2
FR,PARAPSORIASIS,2
FR,PARKINSON^S DISEASE,2
FR,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,2
FR,PATHOLOGICAL FRACTURE,2
FR,PATHOLOGICAL GAMBLING,2
FR,PELVIC HAEMORRHAGE,2
FR,PELVIC PAIN,2
FR,PELVIC VENOUS THROMBOSIS,2
FR,PERICARDIAL HAEMORRHAGE,2
DE,FATIGUE,102
DE,NAUSEA,101
DE,DIZZINESS,94
DE,FALL,89
DE,GENERAL PHYSICAL HEALTH DETERIORATION,86
DE,PNEUMONIA,83
DE,PAIN,82
DE,DRUG ABUSE,75
DE,DYSPNOEA,73
DE,DIARRHOEA,72
DE,VOMITING,68
DE,RESTLESSNESS,60
DE,ARTHRALGIA,59
DE,PAIN IN EXTREMITY,57
DE,GAIT DISTURBANCE,56
DE,OVERDOSE,55
DE,HEADACHE,54
DE,ANAEMIA,48
DE,PYREXIA,47
DE,SOMNOLENCE,45
DE,THROMBOCYTOPENIA,45
DE,URINARY TRACT INFECTION,43
DE,LEUKOPENIA,42
DE,TREMOR,42
DE,DEPRESSION,41
DE,SEIZURE,40
DE,ACUTE KIDNEY INJURY,38
DE,BLOOD CREATINE PHOSPHOKINASE INCREASED,38
DE,DRUG INEFFECTIVE,38
DE,SLEEP DISORDER,38
DE,BACK PAIN,37
DE,DRUG DEPENDENCE,37
DE,OEDEMA PERIPHERAL,37
DE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,36
DE,MYALGIA,36
DE,PARAESTHESIA,36
DE,CONDITION AGGRAVATED,34
DE,DEATH,34
DE,HYPERTENSION,34
DE,CONFUSIONAL STATE,33
DE,ASTHENIA,32
DE,MALIGNANT NEOPLASM PROGRESSION,32
DE,WEIGHT INCREASED,32
DE,SUICIDE ATTEMPT,31
DE,WEIGHT DECREASED,31
DE,ABDOMINAL PAIN,30
DE,DISTURBANCE IN ATTENTION,30
DE,HYPOAESTHESIA,30
DE,PLEURAL EFFUSION,30
DE,POLYNEUROPATHY,30
DE,SEPSIS,30
DE,VISUAL IMPAIRMENT,30
DE,ANXIETY,29
DE,PRURITUS,29
DE,INFECTION,28
DE,MUSCULAR WEAKNESS,28
DE,RASH,28
DE,RENAL FAILURE,28
DE,CARDIAC FAILURE,27
DE,CONSTIPATION,27
DE,DRUG WITHDRAWAL SYNDROME,27
DE,MALAISE,27
DE,MUSCLE SPASMS,27
DE,TACHYCARDIA,27
DE,AGITATION,26
DE,C-REACTIVE PROTEIN INCREASED,26
DE,DELIRIUM,26
DE,SYNCOPE,26
DE,BLOOD CREATININE INCREASED,25
DE,CHILLS,25
DE,HYPERHIDROSIS,25
DE,INSOMNIA,25
DE,RESPIRATORY FAILURE,25
DE,WITHDRAWAL SYNDROME,25
DE,DYSPHAGIA,24
DE,MEMORY IMPAIRMENT,24
DE,DEHYDRATION,23
DE,DISORIENTATION,23
DE,HYPOKALAEMIA,23
DE,HYPOTENSION,23
DE,MULTIPLE SCLEROSIS RELAPSE,23
DE,TRANSAMINASES INCREASED,23
DE,DECREASED APPETITE,22
DE,EPILEPSY,22
DE,IMPAIRED HEALING,22
DE,INTENTIONAL OVERDOSE,22
DE,AGGRESSION,21
DE,ATRIAL FIBRILLATION,21
DE,BLOOD ALKALINE PHOSPHATASE INCREASED,21
DE,ERYTHEMA,21
DE,HYPONATRAEMIA,21
DE,INTERVERTEBRAL DISC PROTRUSION,21
DE,LIPASE INCREASED,21
DE,PRODUCT USE ISSUE,21
DE,SUICIDAL IDEATION,21
DE,ALANINE AMINOTRANSFERASE INCREASED,20
DE,BALANCE DISORDER,20
DE,CHEST PAIN,20
DE,HAEMOGLOBIN DECREASED,20
DE,HEPATIC ENZYME INCREASED,20
DE,NASOPHARYNGITIS,20
DE,PULMONARY EMBOLISM,20
DE,ASPARTATE AMINOTRANSFERASE INCREASED,19
DE,HERPES ZOSTER,19
DE,MYOCARDIAL INFARCTION,19
DE,OEDEMA,19
DE,ALOPECIA,18
DE,COMPLETED SUICIDE,18
DE,COUGH,18
DE,GENERALISED TONIC-CLONIC SEIZURE,18
DE,LOSS OF CONSCIOUSNESS,18
DE,PULMONARY OEDEMA,18
DE,COMA,17
DE,HYPERSENSITIVITY,17
DE,HYPOGLYCAEMIA,17
DE,LACERATION,17
DE,RHABDOMYOLYSIS,17
DE,BRONCHITIS,16
DE,CIRCULATORY COLLAPSE,16
DE,EPISTAXIS,16
DE,FEELING ABNORMAL,16
DE,GASTRITIS,16
DE,NEUTROPENIA,16
DE,PERIPHERAL SWELLING,16
DE,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,16
DE,VERTIGO,16
DE,VISION BLURRED,16
DE,CARDIAC ARREST,15
DE,CHOLELITHIASIS,15
DE,COGNITIVE DISORDER,15
DE,CONVULSION,15
DE,DYSARTHRIA,15
DE,MOBILITY DECREASED,15
DE,PALPITATIONS,15
DE,PANIC ATTACK,15
DE,SWELLING FACE,15
DE,UPPER LIMB FRACTURE,15
DE,URINARY HESITATION,15
DE,URINARY RETENTION,15
DE,WHITE BLOOD CELL COUNT DECREASED,15
DE,BLOOD PRESSURE INCREASED,14
DE,COLITIS,14
DE,CYSTITIS,14
DE,DEMENTIA,14
DE,FOETAL EXPOSURE DURING PREGNANCY,14
DE,HAEMATOMA,14
DE,HALLUCINATION,14
DE,ILEUS,14
DE,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,14
DE,MATERNAL EXPOSURE DURING PREGNANCY,14
DE,OSTEOARTHRITIS,14
DE,ABDOMINAL DISCOMFORT,13
DE,ABDOMINAL PAIN UPPER,13
DE,AMYLASE INCREASED,13
DE,BLOOD BILIRUBIN INCREASED,13
DE,DIPLOPIA,13
DE,FEBRILE NEUTROPENIA,13
DE,HYPERTENSIVE CRISIS,13
DE,RESTLESS LEGS SYNDROME,13
DE,VISUAL ACUITY REDUCED,13
DE,ACUTE HEPATIC FAILURE,12
DE,AGITATION NEONATAL,12
DE,APATHY,12
DE,APHASIA,12
DE,ASCITES,12
DE,ASPIRATION,12
DE,CEREBROVASCULAR ACCIDENT,12
DE,DRUG INTOLERANCE,12
DE,DRY MOUTH,12
DE,ELECTROCARDIOGRAM QT PROLONGED,12
DE,FLUID RETENTION,12
DE,INFLUENZA,12
DE,INFLUENZA LIKE ILLNESS,12
DE,JAUNDICE,12
DE,MULTI-ORGAN FAILURE,12
DE,PANCYTOPENIA,12
DE,RHEUMATOID ARTHRITIS,12
DE,SEPTIC SHOCK,12
DE,TOXICITY TO VARIOUS AGENTS,12
DE,AKINESIA,11
DE,AMNESIA,11
DE,BLOOD CHOLESTEROL INCREASED,11
DE,CARDIOVASCULAR DISORDER,11
DE,ERYSIPELAS,11
DE,EXTRAPYRAMIDAL DISORDER,11
DE,GASTROINTESTINAL HAEMORRHAGE,11
DE,HYPERKINESIA,11
DE,PRODUCT USE IN UNAPPROVED INDICATION,11
DE,SPEECH DISORDER,11
DE,WHITE BLOOD CELL COUNT INCREASED,11
DE,ABDOMINAL DISTENSION,10
DE,ARRHYTHMIA,10
DE,BASAL CELL CARCINOMA,10
DE,DISEASE PROGRESSION,10
DE,DRUG-INDUCED LIVER INJURY,10
DE,DYSSTASIA,10
DE,HEPATIC CYST,10
DE,HYPERAESTHESIA,10
DE,INCREASED APPETITE,10
DE,LIVER FUNCTION TEST ABNORMAL,10
DE,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,10
DE,PLATELET COUNT DECREASED,10
DE,PLEUROTHOTONUS,10
DE,PNEUMONIA ASPIRATION,10
DE,PSYCHOTIC DISORDER,10
DE,RENAL FAILURE ACUTE,10
DE,STOMATITIS,10
DE,URINARY INCONTINENCE,10
DE,UROSEPSIS,10
DE,ABORTION SPONTANEOUS,9
DE,ACIDOSIS,9
DE,ANAEMIA OF MALIGNANT DISEASE,9
DE,ASTHMA,9
DE,CARDIAC DISORDER,9
DE,CEREBRAL HAEMORRHAGE,9
DE,CHOLECYSTITIS,9
DE,CHOLESTASIS,9
DE,DEVICE RELATED INFECTION,9
DE,DRUG EFFECT INCOMPLETE,9
DE,DRUG RESISTANCE,9
DE,DYSKINESIA,9
DE,GLOMERULAR FILTRATION RATE DECREASED,9
DE,HAEMORRHAGE,9
DE,HEPATIC FAILURE,9
DE,INTENTIONAL PRODUCT MISUSE,9
DE,MENTAL DISORDER,9
DE,MENTAL IMPAIRMENT,9
DE,MOVEMENT DISORDER,9
DE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,9
DE,MUSCLE RIGIDITY,9
DE,MUSCULOSKELETAL PAIN,9
DE,MUSCULOSKELETAL STIFFNESS,9
DE,MYOGLOBIN URINE,9
DE,NERVOUSNESS,9
DE,OSTEOPOROSIS,9
DE,PANCREATITIS,9
DE,PARKINSONISM,9
DE,PNEUMONITIS,9
DE,STAPHYLOCOCCAL INFECTION,9
DE,ABSCESS,8
DE,ANGIOEDEMA,8
DE,ARTHROPATHY,8
DE,BLOOD GLUCOSE INCREASED,8
DE,BLOOD LACTATE DEHYDROGENASE INCREASED,8
DE,BLOOD PRESSURE DECREASED,8
DE,BONE PAIN,8
DE,CATARACT,8
DE,CEREBRAL INFARCTION,8
DE,CHROMATURIA,8
DE,CONTUSION,8
DE,DEPRESSED LEVEL OF CONSCIOUSNESS,8
DE,DERMATITIS ALLERGIC,8
DE,DRUG EFFECT DECREASED,8
DE,DYSPEPSIA,8
DE,DYSPNOEA EXERTIONAL,8
DE,FAECES DISCOLOURED,8
DE,GANGRENE,8
DE,HYPERKALAEMIA,8
DE,METABOLIC ACIDOSIS,8
DE,METABOLIC MYOPATHY,8
DE,MUSCLE ATROPHY,8
DE,NEURALGIA,8
DE,PARKINSON^S DISEASE,8
DE,PELVIC FRACTURE,8
DE,PLASMA CELL MYELOMA,8
DE,ROAD TRAFFIC ACCIDENT,8
DE,SMALL FOR DATES BABY,8
DE,SPINAL COLUMN STENOSIS,8
DE,TRANSIENT ISCHAEMIC ATTACK,8
DE,ASPHYXIA,7
DE,BLISTER,7
DE,BREAST CANCER METASTATIC,7
DE,DEEP VEIN THROMBOSIS,7
DE,DIABETES MELLITUS,7
DE,DRY SKIN,7
DE,DYSPHONIA,7
DE,FEELING DRUNK,7
DE,FLATULENCE,7
DE,FRACTURED SACRUM,7
DE,GASTRIC ULCER,7
DE,GASTROENTERITIS NOROVIRUS,7
DE,GASTROOESOPHAGEAL REFLUX DISEASE,7
DE,GENERALISED OEDEMA,7
DE,GESTATIONAL DIABETES,7
DE,HEPATOTOXICITY,7
DE,HICCUPS,7
DE,HOSPITALISATION,7
DE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,7
DE,INFLAMMATION,7
DE,INTERSTITIAL LUNG DISEASE,7
DE,ISCHAEMIC STROKE,7
DE,LEFT VENTRICULAR FAILURE,7
DE,MUCOSAL INFLAMMATION,7
DE,MUSCLE SPASTICITY,7
DE,NECK PAIN,7
DE,NEONATAL RESPIRATORY DISTRESS SYNDROME,7
DE,NEUTROPHIL COUNT DECREASED,7
DE,OROPHARYNGEAL PAIN,7
DE,PERIPHERAL SENSORY NEUROPATHY,7
DE,RESPIRATORY DISTRESS,7
DE,SCIATICA,7
DE,SKIN ULCER,7
DE,SPINAL OSTEOARTHRITIS,7
DE,SPINAL PAIN,7
DE,SWOLLEN TONGUE,7
DE,URTICARIA,7
DE,ABDOMINAL ADHESIONS,6
DE,ACCESSORY SPLEEN,6
DE,ALTERED STATE OF CONSCIOUSNESS,6
DE,BONE EROSION,6
DE,BRADYCARDIA,6
DE,BRADYCARDIA NEONATAL,6
DE,CACHEXIA,6
DE,CHEST DISCOMFORT,6
DE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,6
DE,DEPRESSED MOOD,6
DE,DRUG LEVEL INCREASED,6
DE,EXPOSURE DURING PREGNANCY,6
DE,FACE OEDEMA,6
DE,FEAR,6
DE,FEEDING DISORDER NEONATAL,6
DE,FOOD INTERACTION,6
DE,GOITRE,6
DE,HEART RATE INCREASED,6
DE,HYPOSPADIAS,6
DE,HYPOTHYROIDISM,6
DE,JOINT SWELLING,6
DE,LUMBAR VERTEBRAL FRACTURE,6
DE,LYMPHOCYTE COUNT DECREASED,6
DE,MACULAR DEGENERATION,6
DE,MAJOR DEPRESSION,6
DE,MULTIPLE SCLEROSIS,6
DE,MYELODYSPLASTIC SYNDROME,6
DE,OSTEONECROSIS OF JAW,6
DE,PALLOR,6
DE,PSORIASIS,6
DE,PSYCHOMOTOR HYPERACTIVITY,6
DE,PULMONARY ARTERY STENOSIS CONGENITAL,6
DE,PYELONEPHRITIS,6
DE,RHINORRHOEA,6
DE,RIB FRACTURE,6
DE,SPINAL FRACTURE,6
DE,STATUS EPILEPTICUS,6
DE,STOMA SITE INFLAMMATION,6
DE,STRESS,6
DE,THROMBOSIS,6
DE,VASCULITIS,6
DE,WOUND,6
DE,ABDOMINAL PAIN LOWER,5
DE,ACCIDENTAL EXPOSURE TO PRODUCT,5
DE,ACUTE MYELOID LEUKAEMIA,5
DE,ACUTE MYOCARDIAL INFARCTION,5
DE,AFFECTIVE DISORDER,5
DE,ARTHRITIS,5
DE,ATAXIA,5
DE,BODY HEIGHT DECREASED,5
DE,BRAIN INJURY,5
DE,BUNDLE BRANCH BLOCK LEFT,5
DE,BURNING SENSATION,5
DE,CARPAL TUNNEL SYNDROME,5
DE,CEREBRAL ISCHAEMIA,5
DE,COLITIS ULCERATIVE,5
DE,CORONARY ARTERY DISEASE,5
DE,DELUSION,5
DE,DISEASE RECURRENCE,5
DE,DISINHIBITION,5
DE,DRUG WITHDRAWAL SYNDROME NEONATAL,5
DE,DYSGEUSIA,5
DE,DYSGRAPHIA,5
DE,EUPHORIC MOOD,5
DE,FLUSHING,5
DE,GASTROENTERITIS,5
DE,GASTROINTESTINAL DISORDER,5
DE,GRAND MAL CONVULSION,5
DE,HEAD INJURY,5
DE,HEART RATE IRREGULAR,5
DE,HEMIPARESIS,5
DE,HEPATIC FUNCTION ABNORMAL,5
DE,HEPATIC STEATOSIS,5
DE,HIATUS HERNIA,5
DE,HYPERGLYCAEMIA,5
DE,HYPOCALCAEMIA,5
DE,INCONTINENCE,5
DE,INGUINAL HERNIA,5
DE,INTENTIONAL DRUG MISUSE,5
DE,INTENTIONAL PRODUCT USE ISSUE,5
DE,JOINT DISLOCATION,5
DE,KETOACIDOSIS,5
DE,LACTIC ACIDOSIS,5
DE,LIMB INJURY,5
DE,LIVER FUNCTION TEST INCREASED,5
DE,LOCALISED INFECTION,5
DE,LUMBAR SPINAL STENOSIS,5
DE,LYMPHOPENIA,5
DE,MELAENA,5
DE,NECROSIS,5
DE,OSTEOMYELITIS,5
DE,PERIPHERAL COLDNESS,5
DE,POISONING,5
DE,PREMATURE BABY,5
DE,PRERENAL FAILURE,5
DE,PRESCRIBED OVERDOSE,5
DE,RED BLOOD CELL COUNT DECREASED,5
DE,RENAL IMPAIRMENT,5
DE,RESPIRATORY DISORDER,5
DE,SEDATION,5
DE,SENSORY DISTURBANCE,5
DE,SKIN DISCOLOURATION,5
DE,SKIN DISORDER,5
DE,SPLENOMEGALY,5
DE,TACHYPHRENIA,5
DE,THORACIC VERTEBRAL FRACTURE,5
DE,TINNITUS,5
DE,TRIGEMINAL NEURALGIA,5
DE,TYPE 2 DIABETES MELLITUS,5
DE,VENTRICULAR EXTRASYSTOLES,5
DE,ABASIA,4
DE,ACUTE CORONARY SYNDROME,4
DE,ACUTE RESPIRATORY DISTRESS SYNDROME,4
DE,ADJUSTMENT DISORDER,4
DE,AKATHISIA,4
DE,ANGINA PECTORIS,4
DE,ANXIETY DISORDER,4
DE,ATRIAL FLUTTER,4
DE,ATRIOVENTRICULAR BLOCK FIRST DEGREE,4
DE,BACTERIAL INFECTION,4
DE,BLOOD TRIGLYCERIDES INCREASED,4
DE,BOWEN^S DISEASE,4
DE,BREAST CANCER,4
DE,BRONCHOSPASM,4
DE,BUNDLE BRANCH BLOCK RIGHT,4
DE,CAESAREAN SECTION,4
DE,CENTRAL NERVOUS SYSTEM LESION,4
DE,COMPLEX REGIONAL PAIN SYNDROME,4
DE,COMPULSIONS,4
DE,CROHN^S DISEASE,4
DE,CUBITAL TUNNEL SYNDROME,4
DE,DISCOMFORT,4
DE,DRUG DOSE OMISSION,4
DE,DUODENAL ULCER,4
DE,DYSURIA,4
DE,EAR NEOPLASM MALIGNANT,4
DE,ELECTROENCEPHALOGRAM ABNORMAL,4
DE,EXTRASYSTOLES,4
DE,EYE DISORDER,4
DE,EYELID OEDEMA,4
DE,FACIAL PARESIS,4
DE,FOLATE DEFICIENCY,4
DE,FUNGAL INFECTION,4
DE,GASTRITIS EROSIVE,4
DE,GASTROINTESTINAL INFLAMMATION,4
DE,GLAUCOMA,4
DE,GLYCOSYLATED HAEMOGLOBIN INCREASED,4
DE,HAEMATOCRIT DECREASED,4
DE,HAEMATURIA,4
DE,HAEMORRHAGIC ANAEMIA,4
DE,HEAD DISCOMFORT,4
DE,HOT FLUSH,4
DE,HYPERBILIRUBINAEMIA NEONATAL,4
DE,HYPERSENSITIVITY VASCULITIS,4
DE,HYPOKINESIA,4
DE,ILLUSION,4
DE,IMPAIRED DRIVING ABILITY,4
DE,INCORRECT ROUTE OF DRUG ADMINISTRATION,4
DE,INJECTION SITE ERYTHEMA,4
DE,INJECTION SITE SWELLING,4
DE,INTERVERTEBRAL DISCITIS,4
DE,IRRITABILITY,4
DE,LARYNGITIS,4
DE,LISTLESS,4
DE,LIVER DISORDER,4
DE,LOW BIRTH WEIGHT BABY,4
DE,LUNG INFECTION,4
DE,LYMPHOEDEMA,4
DE,MATERNAL EXPOSURE TIMING UNSPECIFIED,4
DE,MENORRHAGIA,4
DE,METASTASES TO LIVER,4
DE,MOTOR DYSFUNCTION,4
DE,MUSCLE CONTRACTIONS INVOLUNTARY,4
DE,MYOCLONUS,4
DE,NEOPLASM MALIGNANT,4
DE,NIGHT SWEATS,4
DE,OPTIC NEURITIS,4
DE,ORAL PAIN,4
DE,OSTEOLYSIS,4
DE,PANIC DISORDER,4
DE,PARALYSIS,4
DE,PHARYNGITIS,4
DE,POLLAKIURIA,4
DE,POST PROCEDURAL COMPLICATION,4
DE,PRESCRIBED UNDERDOSE,4
DE,PROTHROMBIN TIME PROLONGED,4
DE,RASH GENERALISED,4
DE,RENAL DISORDER,4
DE,RENAL FUNCTION TEST ABNORMAL,4
DE,SENSITIVITY TO WEATHER CHANGE,4
DE,SINUS TACHYCARDIA,4
DE,SINUSITIS,4
DE,SKIN BURNING SENSATION,4
DE,SKIN FISSURES,4
DE,SMALL INTESTINAL PERFORATION,4
DE,SUBACUTE HEPATIC FAILURE,4
DE,SUBCUTANEOUS ABSCESS,4
DE,SUBILEUS,4
DE,SUBSTANCE ABUSE,4
DE,THINKING ABNORMAL,4
DE,TOOTH DISORDER,4
DE,UNRESPONSIVE TO STIMULI,4
DE,URINE OUTPUT DECREASED,4
DE,VENTRICULAR FIBRILLATION,4
DE,VENTRICULAR TACHYARRHYTHMIA,4
DE,VITAMIN D DEFICIENCY,4
DE,ABNORMAL BEHAVIOUR,3
DE,ABORTION MISSED,3
DE,ABSCESS LIMB,3
DE,ADRENAL INSUFFICIENCY,3
DE,AGRANULOCYTOSIS,3
DE,ANAPHYLACTIC REACTION,3
DE,ANAPHYLACTIC SHOCK,3
DE,APNOEA NEONATAL,3
DE,ARTHRITIS BACTERIAL,3
DE,ATELECTASIS,3
DE,BACK DISORDER,3
DE,BASEDOW^S DISEASE,3
DE,BICYTOPENIA,3
DE,BLADDER HYPERTROPHY,3
DE,BLOOD CALCIUM DECREASED,3
DE,BLOOD GLUCOSE DECREASED,3
DE,BLOOD PRESSURE FLUCTUATION,3
DE,BLOOD SODIUM DECREASED,3
DE,BLOOD TEST ABNORMAL,3
DE,BODY TEMPERATURE INCREASED,3
DE,BRADYPHRENIA,3
DE,BRAIN NEOPLASM,3
DE,BRAIN OEDEMA,3
DE,BRONCHIAL CARCINOMA,3
DE,CELLULITIS,3
DE,CHRONIC GASTRITIS,3
DE,CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY,3
DE,CRYING,3
DE,DENTAL CARIES,3
DE,DEPENDENCE,3
DE,DEPRESSIVE SYMPTOM,3
DE,DERMATITIS,3
DE,DEVICE DISLOCATION,3
DE,DIABETIC FOOT,3
DE,DISTRACTIBILITY,3
DE,DIVERTICULITIS,3
DE,DRUG CLEARANCE DECREASED,3
DE,DRUG HYPERSENSITIVITY,3
DE,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,3
DE,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,3
DE,DRUG TOLERANCE,3
DE,DRUG USE DISORDER,3
DE,DRY EYE,3
DE,DYSAESTHESIA,3
DE,DYSTONIA,3
DE,EAR DISCOMFORT,3
DE,EMPHYSEMA,3
DE,ENCEPHALITIS,3
DE,ENERGY INCREASED,3
DE,EROSIVE DUODENITIS,3
DE,EYE SWELLING,3
DE,EYELID PTOSIS,3
DE,FACIAL PARALYSIS,3
DE,FAECALOMA,3
DE,FEBRILE INFECTION,3
DE,FEELING HOT,3
DE,FEMORAL NECK FRACTURE,3
DE,FIBROMYALGIA,3
DE,FINE MOTOR SKILL DYSFUNCTION,3
DE,FISTULA,3
DE,FOOT DEFORMITY,3
DE,FRACTURE DELAYED UNION,3
DE,GASTROINTESTINAL INFECTION,3
DE,GASTROINTESTINAL PAIN,3
DE,GASTROINTESTINAL SOUNDS ABNORMAL,3
DE,GASTROINTESTINAL TUBE INSERTION,3
DE,HAEMATEMESIS,3
DE,HAEMATOCHEZIA,3
DE,HAEMORRHOIDS,3
DE,HAIR COLOUR CHANGES,3
DE,HUMERUS FRACTURE,3
DE,HYPERSEXUALITY,3
DE,HYPERSOMNIA,3
DE,HYPERTHYROIDISM,3
DE,HYPERTONIA NEONATAL,3
DE,HYPOACUSIS,3
DE,HYPOCHROMIC ANAEMIA,3
DE,HYPOTONIA,3
DE,ILEUS PARALYTIC,3
DE,ILL-DEFINED DISORDER,3
DE,IMMUNODEFICIENCY,3
DE,INCORRECT DOSE ADMINISTERED,3
DE,INFLAMMATORY MARKER INCREASED,3
DE,INTESTINAL ISCHAEMIA,3
DE,INTESTINAL OBSTRUCTION,3
DE,JOINT INSTABILITY,3
DE,JOINT RANGE OF MOTION DECREASED,3
DE,LANGUAGE DISORDER,3
DE,LARGE INTESTINE PERFORATION,3
DE,LEUKOCYTOSIS,3
DE,LIMB DISCOMFORT,3
DE,LONG QT SYNDROME,3
DE,LOSS OF LIBIDO,3
DE,LOWER LIMB FRACTURE,3
DE,LUNG DISORDER,3
DE,LUNG INFILTRATION,3
DE,LYMPHOCELE,3
DE,MALNUTRITION,3
DE,MEDICATION ERROR,3
DE,MELANOCYTIC NAEVUS,3
DE,MENISCUS INJURY,3
DE,METABOLIC SYNDROME,3
DE,METASTASES TO LUNG,3
DE,MONOCYTE COUNT INCREASED,3
DE,MOOD SWINGS,3
DE,MUSCLE TIGHTNESS,3
DE,MUSCLE TWITCHING,3
DE,MYELOFIBROSIS,3
DE,MYOSITIS,3
DE,NASAL CONGESTION,3
DE,NEOPLASM,3
DE,NEUROPATHY PERIPHERAL,3
DE,OESOPHAGEAL CANDIDIASIS,3
DE,OLIGURIA,3
DE,OPHTHALMIC HERPES ZOSTER,3
DE,ORAL DISORDER,3
DE,OSTEITIS,3
DE,OSTEOCHONDROSIS,3
DE,OXYGEN SATURATION DECREASED,3
DE,PANCREATITIS ACUTE,3
DE,PARAPARESIS,3
DE,PARTIAL SEIZURES,3
DE,PERIPHERAL ARTERY STENOSIS,3
DE,PHARYNGEAL OEDEMA,3
DE,PHOTOPHOBIA,3
DE,PHOTOPSIA,3
DE,PLATELET COUNT INCREASED,3
DE,POLYURIA,3
DE,POST HERPETIC NEURALGIA,3
DE,POST PROCEDURAL HAEMORRHAGE,3
DE,PRE-EXISTING CONDITION IMPROVED,3
DE,PREGNANCY,3
DE,PREMATURE LABOUR,3
DE,PRODUCTIVE COUGH,3
DE,PSEUDARTHROSIS,3
DE,PSYCHOMOTOR RETARDATION,3
DE,PULMONARY CONGESTION,3
DE,PURULENCE,3
DE,QUADRIPARESIS,3
DE,RASH MACULO-PAPULAR,3
DE,RED BLOOD CELLS URINE POSITIVE,3
DE,RESPIRATORY ARREST,3
DE,RESPIRATORY DEPRESSION,3
DE,RETINAL DETACHMENT,3
DE,RHINITIS,3
DE,SCHIZOPHRENIA,3
DE,SEROMA,3
DE,SKIN EXFOLIATION,3
DE,SKIN HAEMORRHAGE,3
DE,SPONDYLOLISTHESIS,3
DE,SQUAMOUS CELL CARCINOMA,3
DE,STEVENS-JOHNSON SYNDROME,3
DE,STOMA SITE DISCHARGE,3
DE,SUDDEN CARDIAC DEATH,3
DE,SWELLING,3
DE,TENSION HEADACHE,3
DE,THERAPEUTIC RESPONSE UNEXPECTED,3
DE,THROMBOCYTOSIS,3
DE,TOBACCO ABUSE,3
DE,TONGUE OEDEMA,3
DE,TOOTH LOSS,3
DE,TOOTHACHE,3
DE,UTERINE HAEMORRHAGE,3
DE,UTERINE LEIOMYOMA,3
DE,VIRAL INFECTION,3
DE,VULVOVAGINAL CANDIDIASIS,3
DE,WHEEZING,3
DE,WOUND DEHISCENCE,3
DE,ABNORMAL DREAMS,2
DE,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,2
DE,ACCIDENTAL OVERDOSE,2
DE,ACCOMMODATION DISORDER,2
DE,ACTIVITIES OF DAILY LIVING IMPAIRED,2
DE,ACUTE DISSEMINATED ENCEPHALOMYELITIS,2
DE,ACUTE PRERENAL FAILURE,2
DE,ADENOCARCINOMA OF COLON,2
DE,ADJUSTMENT DISORDER WITH DEPRESSED MOOD,2
DE,ADMINISTRATION SITE ABSCESS STERILE,2
DE,AFFECT LABILITY,2
DE,AMBLYOPIA,2
DE,ANAEMIA POSTOPERATIVE,2
DE,ANAL FISTULA,2
DE,ANAL HAEMORRHAGE,2
DE,ANGINA UNSTABLE,2
DE,ANKYLOSING SPONDYLITIS,2
DE,ANTIDEPRESSANT DRUG LEVEL INCREASED,2
DE,ANTIPSYCHOTIC DRUG LEVEL INCREASED,2
DE,AORTIC ANEURYSM,2
DE,AORTIC VALVE SCLEROSIS,2
DE,ARTERIOSCLEROSIS,2
DE,ARTHRITIS INFECTIVE,2
DE,ASTERIXIS,2
DE,ATRIAL SEPTAL DEFECT,2
DE,ATRIOVENTRICULAR BLOCK SECOND DEGREE,2
DE,ATYPICAL FEMUR FRACTURE,2
DE,ATYPICAL PNEUMONIA,2
DE,AUTONOMIC NERVOUS SYSTEM IMBALANCE,2
DE,AZOTAEMIA,2
DE,B-CELL LYMPHOMA,2
DE,B-CELL LYMPHOMA STAGE I,2
DE,B-CELL SMALL LYMPHOCYTIC LYMPHOMA,2
DE,BACTERAEMIA,2
DE,BLADDER DISORDER,2
DE,BLADDER SPASM,2
DE,BLINDNESS,2
DE,BLINDNESS UNILATERAL,2
DE,BLOOD CREATINE INCREASED,2
DE,BLOOD CREATINE PHOSPHOKINASE MB INCREASED,2
DE,BLOOD GLUCOSE ABNORMAL,2
DE,BLOOD IRON DECREASED,2
DE,BLOOD POTASSIUM INCREASED,2
DE,BLOOD PROLACTIN INCREASED,2
DE,BLOOD THYROID STIMULATING HORMONE INCREASED,2
DE,BLOOD UREA INCREASED,2
DE,BLOOD URIC ACID INCREASED,2
DE,BONE CONTUSION,2
DE,BOREDOM,2
DE,BORRELIA INFECTION,2
DE,BRADYARRHYTHMIA,2
DE,BRAIN MIDLINE SHIFT,2
DE,BREAST ENLARGEMENT,2
DE,BREAST MASS,2
DE,BURSITIS,2
DE,CALCIPHYLAXIS,2
DE,CAMPTOCORMIA,2
DE,CANDIDA SEPSIS,2
DE,CARDIAC VENTRICULAR DISORDER,2
DE,CARDIOGENIC SHOCK,2
DE,CATHETER SITE INFECTION,2
DE,CENTRAL VENOUS CATHETERISATION,2
DE,CEREBELLAR SYNDROME,2
DE,CERVICOBRACHIAL SYNDROME,2
DE,CHANGE IN SEIZURE PRESENTATION,2
DE,CHOLANGITIS,2
DE,CHRONIC KIDNEY DISEASE,2
DE,CHRONIC LYMPHOCYTIC LEUKAEMIA,2
DE,CHRONIC SINUSITIS,2
DE,CLOSTRIDIUM COLITIS,2
DE,COAGULOPATHY,2
DE,COLITIS ISCHAEMIC,2
DE,COLLAGEN DISORDER,2
DE,COLON CANCER METASTATIC,2
DE,CONCOMITANT DISEASE AGGRAVATED,2
DE,CONCOMITANT DISEASE PROGRESSION,2
DE,COORDINATION ABNORMAL,2
DE,CORONARY ARTERY STENOSIS,2
DE,CYANOSIS,2
DE,CYST,2
DE,CYTOMEGALOVIRUS INFECTION,2
DE,DECREASED INTEREST,2
DE,DELINQUENCY,2
DE,DEVICE FASTENER ISSUE,2
DE,DIABETIC HYPEROSMOLAR COMA,2
DE,DIABETIC NEUROPATHY,2
DE,DIAPHRAGMATIC HERNIA,2
DE,DIASTOLIC DYSFUNCTION,2
DE,DIPLEGIA,2
DE,DRUG DOSE TITRATION NOT PERFORMED,2
DE,DRY THROAT,2
DE,DUODENAL ULCER HAEMORRHAGE,2
DE,ECZEMA,2
DE,EJACULATION DISORDER,2
DE,ELECTROLYTE IMBALANCE,2
DE,ELEVATED MOOD,2
DE,EMBOLIC STROKE,2
DE,ENCEPHALOPATHY,2
DE,EOSINOPHIL COUNT INCREASED,2
DE,ERECTILE DYSFUNCTION,2
DE,ESCHERICHIA TEST POSITIVE,2
DE,ESCHERICHIA URINARY TRACT INFECTION,2
DE,EXPIRED PRODUCT ADMINISTERED,2
DE,EYE INFLAMMATION,2
DE,EYE IRRITATION,2
DE,EYE PAIN,2
DE,FACIAL BONES FRACTURE,2
DE,FAECES HARD,2
DE,FEEDING DISORDER,2
DE,FEELING COLD,2
DE,FEMUR FRACTURE,2
DE,FISTULA OF SMALL INTESTINE,2
DE,FOREIGN BODY SENSATION IN EYES,2
DE,FRACTURE,2
DE,FREQUENT BOWEL MOVEMENTS,2
DE,GALLBLADDER PAIN,2
DE,GASTRIC HAEMORRHAGE,2
DE,GASTROENTERITIS CLOSTRIDIAL,2
DE,GENE MUTATION,2
DE,GLUCOSE URINE PRESENT,2
DE,HAEMATOTOXICITY,2
DE,HAEMOGLOBIN INCREASED,2
DE,HAEMOLYSIS,2
DE,HAEMORRHAGE SUBCUTANEOUS,2
DE,HALLUCINATION_ VISUAL,2
DE,HEPATITIS,2
DE,HEPATITIS ACUTE,2
DE,HERPES OPHTHALMIC,2
DE,HIP ARTHROPLASTY,2
DE,HUNGER,2
DE,HYDRONEPHROSIS,2
DE,HYPERBILIRUBINAEMIA,2
DE,HYPERPHOSPHATAEMIA,2
DE,HYPERURICAEMIA,2
DE,HYPOAESTHESIA ORAL,2
DE,HYPOPHAGIA,2
DE,HYSTERECTOMY,2
DE,IMMUNE THROMBOCYTOPENIC PURPURA,2
DE,INCISIONAL HERNIA,2
DE,INCOHERENT,2
DE,INFECTIOUS PLEURAL EFFUSION,2
DE,INFUSION RELATED REACTION,2
DE,INITIAL INSOMNIA,2
DE,INJECTION SITE DISCHARGE,2
DE,INJECTION SITE INDURATION,2
DE,INJECTION SITE PAIN,2
DE,INJURY,2
DE,INTERMITTENT CLAUDICATION,2
DE,INTERVERTEBRAL DISC DISORDER,2
DE,INTESTINAL HAEMORRHAGE,2
DE,INTESTINAL STENOSIS,2
DE,INTRAOCULAR PRESSURE INCREASED,2
DE,INVASIVE DUCTAL BREAST CARCINOMA,2
DE,IRIS ADHESIONS,2
DE,IRITIS,2
DE,IRON DEFICIENCY,2
DE,JOINT DESTRUCTION,2
DE,JOINT EFFUSION,2
DE,JOINT INJURY,2
DE,JOINT STIFFNESS,2
DE,KERATITIS,2
DE,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,2
DE,LABORATORY TEST ABNORMAL,2
DE,LACRIMATION INCREASED,2
DE,LEUKOCYTURIA,2
DE,LIVER INJURY,2
DE,LOCAL SWELLING,2
DE,LOGORRHOEA,2
DE,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,2
DE,LOW DENSITY LIPOPROTEIN INCREASED,2
DE,LUMBAR RADICULOPATHY,2
DE,LUNG ADENOCARCINOMA,2
DE,LUNG CANCER METASTATIC,2
DE,LYMPHADENOPATHY,2
DE,MALIGNANT MELANOMA,2
DE,MASTOIDITIS,2
DE,MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED,2
DE,MENINGIOMA,2
DE,METABOLIC DISORDER,2
DE,METASTASES TO BONE,2
DE,METASTASES TO CENTRAL NERVOUS SYSTEM,2
DE,MICTURITION DISORDER,2
DE,MIGRAINE,2
DE,MITRAL VALVE DISEASE,2
DE,MONOCLONAL GAMMOPATHY,2
DE,MONOPLEGIA,2
DE,MOOD ALTERED,2
DE,MOUTH SWELLING,2
DE,MUCOSAL INFECTION,2
DE,MUCOUS MEMBRANE DISORDER,2
DE,MULTIPLE-DRUG RESISTANCE,2
DE,MUSCLE ABSCESS,2
DE,MUSCULOSKELETAL DISCOMFORT,2
DE,MUSCULOSKELETAL DISORDER,2
DE,MYELOPATHY,2
DE,MYOPATHY,2
DE,NARCOLEPSY,2
DE,NEOPLASM PROGRESSION,2
DE,NEPHROLITHIASIS,2
DE,NEPHROTIC SYNDROME,2
DE,NEUROENDOCRINE TUMOUR OF THE LUNG,2
DE,NEUROGENIC BLADDER,2
DE,NON-HODGKIN^S LYMPHOMA,2
DE,OBESITY,2
DE,OBSTRUCTIVE PANCREATITIS,2
DE,OCCULT BLOOD POSITIVE,2
DE,OCULAR DISCOMFORT,2
DE,OEDEMA MUCOSAL,2
DE,ONYCHOCLASIS,2
DE,ORAL CANDIDIASIS,2
DE,ORAL HERPES,2
DE,ORTHOPAEDIC EXAMINATION,2
DE,OSTEONECROSIS,2
DE,OVARIAN CYST,2
DE,OVERWEIGHT,2
DE,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,2
DE,PANCREATIC CARCINOMA METASTATIC,2
DE,PANIC REACTION,2
DE,PAPILLOMA VIRAL INFECTION,2
DE,PARAPLEGIA,2
DE,PARESIS,2
DE,PAROSMIA,2
DE,PATENT DUCTUS ARTERIOSUS,2
DE,PEMPHIGOID,2
DE,PENETRATING AORTIC ULCER,2
DE,PERFORMANCE STATUS DECREASED,2
DE,PERICARDIAL EFFUSION,2
DE,PERIPHERAL ARTERY OCCLUSION,2
DE,PHOTOSENSITIVITY REACTION,2
DE,PIGMENTATION DISORDER,2
DE,PLASMA CELL LEUKAEMIA,2
DE,PNEUMONIA FUNGAL,2
DE,POLYP,2
DE,POST PROCEDURAL HAEMATOMA,2
DE,POST THROMBOTIC SYNDROME,2
DE,POSTICTAL STATE,2
DE,PREMATURE DELIVERY,2
DE,PREMATURE RUPTURE OF MEMBRANES,2
DE,PROCEDURAL COMPLICATION,2
DE,PROCEDURAL PAIN,2
DE,PROSTATIC SPECIFIC ANTIGEN INCREASED,2
DE,PRURITUS GENERALISED,2
DE,PULMONARY FIBROSIS,2
DE,PULMONARY HYPERTENSION,2
DE,PULMONARY MASS,2
DE,PULSE ABSENT,2
DE,PYODERMA GANGRENOSUM,2
DE,RASH MACULAR,2
DE,RED BLOOD CELL COUNT INCREASED,2
DE,REDUCED FACIAL EXPRESSION,2
DE,RENAL ATROPHY,2
DE,RENAL CYST,2
DE,RETCHING,2
DE,RETINAL ARTERY OCCLUSION,2
DE,RETINAL HAEMORRHAGE,2
DE,RHEUMATIC DISORDER,2
DE,RIGHT VENTRICULAR FAILURE,2
DE,RIGHT VENTRICULAR SYSTOLIC PRESSURE INCREASED,2
DE,ROTATOR CUFF SYNDROME,2
DE,SALIVARY HYPERSECRETION,2
DE,SARCOIDOSIS,2
DE,SCAB,2
DE,SECOND PRIMARY MALIGNANCY,2
DE,SEPTIC ENCEPHALOPATHY,2
DE,SEROTONIN SYNDROME,2
DE,SERUM FERRITIN INCREASED,2
DE,SIALOADENITIS,2
DE,SKIN INJURY,2
DE,SKIN IRRITATION,2
DE,SKIN REACTION,2
DE,SKIN WARM,2
DE,SLEEP APNOEA SYNDROME,2
DE,SLOW RESPONSE TO STIMULI,2
DE,SOMATOFORM DISORDER,2
DE,SOPOR,2
DE,SPINAL DISORDER,2
DE,SQUAMOUS CELL CARCINOMA OF THE VULVA,2
DE,STAPHYLOCOCCUS TEST POSITIVE,2
DE,STRABISMUS,2
DE,SUNBURN,2
DE,SUPRAVENTRICULAR EXTRASYSTOLES,2
DE,TACHYPNOEA,2
DE,TENDINOUS CONTRACTURE,2
DE,TENDON PAIN,2
DE,TENDONITIS,2
DE,TENSION,2
DE,TETANY,2
DE,THIRST,2
DE,THROMBOTIC THROMBOCYTOPENIC PURPURA,2
DE,THYROID CANCER,2
DE,THYROID MASS,2
DE,TONGUE DISCOMFORT,2
DE,TONSILLITIS,2
DE,TOOTH INJURY,2
DE,TOXIC EPIDERMAL NECROLYSIS,2
DE,TRANSAMINASES ABNORMAL,2
DE,TRAUMATIC HAEMORRHAGE,2
DE,TUMOUR HAEMORRHAGE,2
DE,TUMOUR PAIN,2
DE,URINARY TRACT INFECTION BACTERIAL,2
DE,URINARY TRACT OBSTRUCTION,2
DE,UTERINE CANCER,2
DE,UTERINE DISORDER,2
DE,UTERINE PROLAPSE,2
DE,VAGINAL HAEMORRHAGE,2
DE,VASCULITIS NECROTISING,2
DE,VENOUS THROMBOSIS,2
DE,VENTRICULAR HYPOKINESIA,2
DE,VENTRICULAR TACHYCARDIA,2
DE,VERTEBRAL FORAMINAL STENOSIS,2
DE,VISUAL FIELD DEFECT,2
DE,VITAMIN B12 DEFICIENCY,2
DE,WHEELCHAIR USER,2
DE,WOUND INFECTION,2
DE,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,2
DE,ABDOMINAL INCARCERATED HERNIA,1
DE,ABDOMINAL INFECTION,1
DE,ABDOMINAL MASS,1
GH,ASTHENIA,1
GH,RASH PRURITIC,1
GH,URTICARIA,1
GR,DRUG INEFFECTIVE,14
GR,SOMNOLENCE,11
GR,ANAEMIA,10
GR,SEPTIC SHOCK,9
GR,HYPOAESTHESIA,8
GR,OEDEMA PERIPHERAL,8
GR,HYPONATRAEMIA,7
GR,FATIGUE,6
GR,SYNCOPE,6
GR,VOMITING,6
GR,ABDOMINAL PAIN,5
GR,ACUTE KIDNEY INJURY,5
GR,AGITATION,5
GR,ATRIAL FIBRILLATION,5
GR,CARDIAC DISORDER,5
GR,COUGH,5
GR,HAEMATOCRIT DECREASED,5
GR,PRURITUS,5
GR,URINARY TRACT INFECTION,5
GR,WEIGHT DECREASED,5
GR,BURNING SENSATION,4
GR,CEREBROVASCULAR ACCIDENT,4
GR,DECREASED APPETITE,4
GR,DIARRHOEA,4
GR,DIASTOLIC DYSFUNCTION,4
GR,FEBRILE NEUTROPENIA,4
GR,GAIT DISTURBANCE,4
GR,HAEMORRHOIDS,4
GR,HYPOTENSION,4
GR,MUSCULAR WEAKNESS,4
GR,RENAL IMPAIRMENT,4
GR,VISUAL IMPAIRMENT,4
GR,BLOOD GLUCOSE INCREASED,3
GR,BLOOD URIC ACID INCREASED,3
GR,CHEST PAIN,3
GR,CONDITION AGGRAVATED,3
GR,CONFUSIONAL STATE,3
GR,DIZZINESS,3
GR,DRUG ABUSE,3
GR,DYSPNOEA,3
GR,ECCHYMOSIS,3
GR,HAEMATOCHEZIA,3
GR,HEADACHE,3
GR,HYPERTENSION,3
GR,LOSS OF CONSCIOUSNESS,3
GR,NAUSEA,3
GR,NEURALGIA,3
GR,OPTIC NEURITIS,3
GR,PETECHIAE,3
GR,PLATELET COUNT DECREASED,3
GR,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,3
GR,PYREXIA,3
GR,RASH,3
GR,ABDOMINAL DISTENSION,2
GR,AGGRESSION,2
GR,ANGINA PECTORIS,2
GR,ANXIETY,2
GR,ARTHRALGIA,2
GR,ASTERIXIS,2
GR,ASTHENIA,2
GR,BACTERAEMIA,2
GR,BLINDNESS,2
GR,BLOOD PRESSURE INCREASED,2
GR,BONE LESION,2
GR,BONE PAIN,2
GR,BREAST CANCER METASTATIC,2
GR,CARDIO-RESPIRATORY ARREST,2
GR,COLOUR BLINDNESS,2
GR,CYTOMEGALOVIRUS COLITIS,2
GR,DEATH,2
GR,DEEP VEIN THROMBOSIS,2
GR,DELIRIUM,2
GR,DEMENTIA,2
GR,DEPRESSION,2
GR,DIABETES MELLITUS,2
GR,DISEASE PROGRESSION,2
GR,DYSKINESIA,2
GR,EPILEPSY,2
GR,ERYTHEMA,2
GR,EYE OEDEMA,2
GR,EYE SWELLING,2
GR,FALL,2
GR,FEMUR FRACTURE,2
GR,GASTROINTESTINAL DISORDER,2
GR,HAEMORRHAGE,2
GR,HIP FRACTURE,2
GR,HYPERSENSITIVITY,2
GR,HYPERTENSIVE CRISIS,2
GR,HYPOKALAEMIA,2
GR,HYPOVOLAEMIC SHOCK,2
GR,INSOMNIA,2
GR,LARGE INTESTINAL HAEMORRHAGE,2
GR,LARGE INTESTINE POLYP,2
GR,LOWER RESPIRATORY TRACT INFECTION,2
GR,MYOCARDIAL INFARCTION,2
GR,NEUTROPENIA,2
GR,OEDEMA,2
GR,ORAL MUCOSAL ERUPTION,2
GR,OVARIAN CYST,2
GR,PAIN,2
GR,PANCREATIC PSEUDOCYST,2
GR,PAPULE,2
GR,PEMPHIGOID,2
GR,PHOTOPSIA,2
GR,PNEUMONIA,2
GR,PULMONARY MASS,2
GR,RENAL DISORDER,2
GR,RENAL FAILURE ACUTE,2
GR,RESTLESS LEGS SYNDROME,2
GR,SEPSIS,2
GR,SKIN ULCER,2
GR,SUICIDAL IDEATION,2
GR,SUICIDE ATTEMPT,2
GR,TACHYCARDIA,2
GR,THROMBOCYTOPENIA,2
GR,THYROID DISORDER,2
GR,TUMOUR MARKER INCREASED,2
GR,TUMOUR PAIN,2
GR,VISION BLURRED,2
GR,WEIGHT INCREASED,2
GR,ABASIA,1
GR,ABDOMINAL DISCOMFORT,1
GR,ACIDOSIS,1
GR,ACUTE RESPIRATORY FAILURE,1
GR,ADENOCARCINOMA OF COLON,1
GR,ADRENAL MASS,1
GR,ALOPECIA,1
GR,ALTERED STATE OF CONSCIOUSNESS,1
GR,AMNIOTIC CAVITY DISORDER,1
GR,ANAPHYLACTIC SHOCK,1
GR,ANGLE CLOSURE GLAUCOMA,1
GR,ANKLE FRACTURE,1
GR,ANURIA,1
GR,APATHY,1
GR,APNOEA,1
GR,ARRHYTHMIA,1
GR,ARTERIOVENOUS FISTULA SITE COMPLICATION,1
GR,ATAXIA,1
GR,AUTOIMMUNE DISORDER,1
GR,AUTOIMMUNE MYOCARDITIS,1
GR,BACK PAIN,1
GR,BASOPHIL COUNT DECREASED,1
GR,BEDRIDDEN,1
GR,BLOOD ALKALINE PHOSPHATASE INCREASED,1
GR,BLOOD CREATININE INCREASED,1
GR,BLOOD GLUCOSE ABNORMAL,1
GR,BLOOD TRIGLYCERIDES INCREASED,1
GR,BLOOD URINE PRESENT,1
GR,BONE DISORDER,1
GR,BONE MARROW TUMOUR CELL INFILTRATION,1
GR,BRADYPHRENIA,1
GR,BREAST CANCER,1
GR,BREATH SOUNDS ABNORMAL,1
GR,CARDIAC ARREST,1
GR,CARDIAC PACEMAKER INSERTION,1
GR,CAROTID ARTERY OCCLUSION,1
GR,CATARACT,1
GR,CHOKING,1
GR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
GR,CLAVICLE FRACTURE,1
GR,COELIAC DISEASE,1
GR,COLONIC PSEUDO-OBSTRUCTION,1
GR,COMA,1
GR,COMMUNICATION DISORDER,1
GR,CONSTIPATION,1
GR,CORONARY ARTERY DISEASE,1
GR,CORTISOL FREE URINE INCREASED,1
GR,CYSTITIS,1
GR,DECUBITUS ULCER,1
GR,DEMENTIA ALZHEIMER^S TYPE,1
GR,DIARRHOEA HAEMORRHAGIC,1
GR,DIPLOPIA,1
GR,DISCOMFORT,1
GR,DISORIENTATION,1
GR,DRUG DOSE OMISSION,1
GR,DRUG ERUPTION,1
GR,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
GR,DRUG-INDUCED LIVER INJURY,1
GR,DYSARTHRIA,1
GR,DYSPEPSIA,1
GR,DYSTONIA,1
GR,ELECTROLYTE IMBALANCE,1
GR,ENCEPHALOPATHY,1
GR,EOSINOPHILIA,1
GR,ESCHERICHIA INFECTION,1
GR,EUPHORIC MOOD,1
GR,EYE ALLERGY,1
GR,EYE PRURITUS,1
GR,FACE OEDEMA,1
GR,FEAR,1
GR,FEELING ABNORMAL,1
GR,FOETAL EXPOSURE DURING PREGNANCY,1
GR,FOETAL MALFORMATION,1
GR,FOOD POISONING,1
GR,GENERALISED OEDEMA,1
GR,GINGIVAL BLEEDING,1
GR,GINGIVAL HYPERPLASIA,1
GR,GLAUCOMA,1
GR,GLOMERULAR FILTRATION RATE ABNORMAL,1
GR,GRAND MAL CONVULSION,1
GR,HAEMATOMA,1
GR,HAEMOGLOBIN DECREASED,1
GR,HAEMOLYSIS,1
GR,HAEMORRHAGE INTRACRANIAL,1
GR,HALLUCINATION,1
GR,HALLUCINATION_ AUDITORY,1
GR,HALLUCINATIONS_ MIXED,1
GR,HAND DEFORMITY,1
GR,HEAD INJURY,1
GR,HEMIPLEGIA,1
GR,HERPES VIRUS INFECTION,1
GR,HERPES ZOSTER,1
GR,HYPERAEMIA,1
GR,HYPERGLYCAEMIA,1
GR,HYPERHIDROSIS,1
GR,HYPERLIPIDAEMIA,1
GR,HYPERTHYROIDISM,1
GR,HYPERTRIGLYCERIDAEMIA,1
GR,HYPOAESTHESIA ORAL,1
GR,HYPOMAGNESAEMIA,1
GR,HYPOTHYROIDISM,1
GR,ILEUS,1
GR,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,1
GR,IMPAIRED HEALING,1
GR,IMPAIRED SELF-CARE,1
GR,INCORRECT DRUG ADMINISTRATION DURATION,1
GR,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
GR,INTENTIONAL OVERDOSE,1
GR,INTESTINAL PERFORATION,1
GR,ISCHAEMIC STROKE,1
GR,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
GR,LACRIMATION INCREASED,1
GR,LARGE INTESTINE PERFORATION,1
GR,LETHARGY,1
GR,LEUKOCYTOSIS,1
GR,LEUKOPENIA,1
GR,LIMB INJURY,1
GR,LUMBAR VERTEBRAL FRACTURE,1
GR,LUNG NEOPLASM MALIGNANT,1
GR,LYMPHOCYTE COUNT DECREASED,1
GR,MALIGNANT MELANOMA,1
GR,MALIGNANT NEOPLASM PROGRESSION,1
GR,MEGACOLON,1
GR,MEMORY IMPAIRMENT,1
GR,MENTAL DISORDER,1
GR,MICROANGIOPATHY,1
GR,MONOPARESIS,1
GR,MULTIPLE SCLEROSIS RELAPSE,1
GR,MUSCLE ATROPHY,1
GR,MUSCULOSKELETAL DISORDER,1
GR,MUSCULOSKELETAL PAIN,1
GR,MUSCULOSKELETAL STIFFNESS,1
GR,MYOCARDIAL ISCHAEMIA,1
GR,MYOCLONIC EPILEPSY,1
GR,NAIL DISORDER,1
GR,NASOPHARYNGITIS,1
GR,NERVOUSNESS,1
GR,NIEMANN-PICK DISEASE,1
GR,NOCTURIA,1
GR,OBSESSIVE THOUGHTS,1
GR,OBSESSIVE-COMPULSIVE DISORDER,1
GR,OCULAR HYPERAEMIA,1
GR,OESOPHAGEAL SQUAMOUS CELL CARCINOMA,1
GR,ORAL DISORDER,1
GR,OSTEONECROSIS OF JAW,1
GR,OSTEOPOROSIS,1
GR,OXYGEN SATURATION DECREASED,1
GR,PAIN IN EXTREMITY,1
GR,PALLOR,1
GR,PERIPHERAL COLDNESS,1
GR,PERIPHERAL ISCHAEMIA,1
GR,PERIPHERAL SWELLING,1
GR,PERSECUTORY DELUSION,1
GR,PLASMACYTOMA,1
GR,PLEURAL EFFUSION,1
GR,PLEURITIC PAIN,1
GR,PLEUROTHOTONUS,1
GR,POLLAKIURIA,1
GR,PRESCRIBED OVERDOSE,1
GR,PROCEDURAL COMPLICATION,1
GR,PRODUCTIVE COUGH,1
GR,PROSTATIC OPERATION,1
GR,PSEUDOMONAS INFECTION,1
GR,PSORIASIS,1
GR,PSORIATIC ARTHROPATHY,1
GR,PSYCHOTIC DISORDER,1
GR,PULMONARY OEDEMA,1
GR,QUALITY OF LIFE DECREASED,1
GR,RASH ERYTHEMATOUS,1
GR,RASH MACULO-PAPULAR,1
GR,RASH PAPULAR,1
GR,RED MAN SYNDROME,1
GR,RENAL INJURY,1
GR,RESPIRATORY FAILURE,1
GR,RESPIRATORY TRACT INFECTION,1
GR,RESTLESSNESS,1
GR,ROAD TRAFFIC ACCIDENT,1
GR,SALIVARY HYPERSECRETION,1
GR,SCHIZOPHRENIA,1
GR,SCIATICA,1
GR,SEDATION,1
GR,SELF-INJURIOUS IDEATION,1
GR,SELF-MEDICATION,1
GR,SKIN NECROSIS,1
GR,SMALL INTESTINAL OBSTRUCTION,1
GR,SOFT TISSUE INFECTION,1
GR,SPINAL DISORDER,1
GR,SPINAL PAIN,1
GR,STEATOHEPATITIS,1
GR,STOMATITIS,1
GR,STRESS,1
GR,SUFFOCATION FEELING,1
GR,TACHYPNOEA,1
GR,THERAPEUTIC RESPONSE UNEXPECTED,1
GR,THERAPY PARTIAL RESPONDER,1
GR,THROMBOCYTOSIS,1
GR,THROMBOPHLEBITIS SUPERFICIAL,1
GR,THROMBOSIS,1
GR,TONIC CONVULSION,1
GR,TOOTH DISORDER,1
GR,TOXICITY TO VARIOUS AGENTS,1
GR,TREATMENT NONCOMPLIANCE,1
GR,TREMOR,1
GR,TRIGEMINAL NERVE PARESIS,1
GR,TUMOUR HAEMORRHAGE,1
GR,URINARY RETENTION,1
GR,VASCULITIS,1
GR,WHEEZING,1
GT,MULTIPLE SCLEROSIS RELAPSE,5
GT,AGGRESSION,3
GT,DEPRESSION,3
GT,DYSPNOEA,3
GT,HEADACHE,3
GT,MALAISE,3
GT,MUSCULAR WEAKNESS,3
GT,PAIN,3
GT,PAIN IN EXTREMITY,3
GT,ABDOMINAL PAIN,2
GT,ANXIETY,2
GT,BURNING SENSATION,2
GT,DEATH,2
GT,DYSURIA,2
GT,FATIGUE,2
GT,FEELING ABNORMAL,2
GT,HEPATITIS,2
GT,HYPOAESTHESIA,2
GT,INSOMNIA,2
GT,LIVER FUNCTION TEST INCREASED,2
GT,MEMORY IMPAIRMENT,2
GT,MOBILITY DECREASED,2
GT,NEPHROLITHIASIS,2
GT,PARAESTHESIA,2
GT,SYNCOPE,2
GT,URINARY TRACT INFECTION,2
GT,ABDOMINAL ADHESIONS,1
GT,ABDOMINAL DISCOMFORT,1
GT,ABNORMAL BEHAVIOUR,1
GT,ACNE,1
GT,ALANINE AMINOTRANSFERASE INCREASED,1
GT,AMNESIA,1
GT,APHTHOUS ULCER,1
GT,ARTHRALGIA,1
GT,ASPARTATE AMINOTRANSFERASE INCREASED,1
GT,ASTHENIA,1
GT,BLOOD CREATININE INCREASED,1
GT,BLOOD GLUCOSE DECREASED,1
GT,BLOOD PRESSURE INCREASED,1
GT,BLOOD URINE PRESENT,1
GT,BONE PAIN,1
GT,CALCULUS URINARY,1
GT,CENTRAL NERVOUS SYSTEM LESION,1
GT,CHEST DISCOMFORT,1
GT,CHEST PAIN,1
GT,CHOLELITHIASIS,1
GT,COGNITIVE DISORDER,1
GT,CONDITION AGGRAVATED,1
GT,CONFUSIONAL STATE,1
GT,CONSTIPATION,1
GT,CRYING,1
GT,DECREASED APPETITE,1
GT,DEMENTIA ALZHEIMER^S TYPE,1
GT,DIPLOPIA,1
GT,DISORIENTATION,1
GT,DIZZINESS,1
GT,DYSPHAGIA,1
GT,EATING DISORDER,1
GT,EMOTIONAL DISORDER,1
GT,ERYTHEMA,1
GT,FALL,1
GT,FEELING HOT,1
GT,FOOD POISONING,1
GT,GAIT DISTURBANCE,1
GT,GASTRIC CANCER,1
GT,HAEMATOCHEZIA,1
GT,HAEMATURIA,1
GT,HALLUCINATION,1
GT,HEAD DISCOMFORT,1
GT,HEART RATE DECREASED,1
GT,HEPATIC STEATOSIS,1
GT,HYPOGLYCAEMIA,1
GT,HYPOTONIA,1
GT,INCOHERENT,1
GT,INCONTINENCE,1
GT,INFECTED SKIN ULCER,1
GT,INFECTION,1
GT,INTERVERTEBRAL DISC DISORDER,1
GT,LIVER DISORDER,1
GT,LIVER FUNCTION TEST ABNORMAL,1
GT,LYMPHOCYTE COUNT DECREASED,1
GT,MULTIPLE SCLEROSIS,1
GT,MUSCLE SPASMS,1
GT,MUSCULOSKELETAL PAIN,1
GT,NASOPHARYNGITIS,1
GT,NAUSEA,1
GT,NERVOUSNESS,1
GT,OEDEMA PERIPHERAL,1
GT,OROPHARYNGEAL DISCOMFORT,1
GT,PARAPARESIS,1
GT,PARAPLEGIA,1
GT,PELVIC PAIN,1
GT,PHARYNGEAL ULCERATION,1
GT,POLLAKIURIA,1
GT,PROSTATE CANCER,1
GT,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
GT,PYREXIA,1
GT,RENAL FAILURE,1
GT,RENAL PAIN,1
GT,SEIZURE,1
GT,SENSORY DISTURBANCE,1
GT,SKIN FISSURES,1
GT,SKIN REACTION,1
GT,SPEECH DISORDER,1
GT,THROAT TIGHTNESS,1
GT,TRANSAMINASES INCREASED,1
GT,URINARY INCONTINENCE,1
GT,VIRAL UPPER RESPIRATORY TRACT INFECTION,1
GT,VOMITING,1
GT,WEIGHT DECREASED,1
GT,WRONG DRUG ADMINISTERED,1
HN,CEREBROVASCULAR ACCIDENT,4
HN,ABASIA,1
HN,ACCIDENT,1
HN,BALANCE DISORDER,1
HN,DIZZINESS,1
HN,DRUG INEFFECTIVE,1
HN,FALL,1
HN,HAEMATOMA,1
HN,HERPES SIMPLEX HEPATITIS,1
HN,INFARCTION,1
HN,LIMB DISCOMFORT,1
HN,MUSCULAR WEAKNESS,1
HN,MYOCARDIAL INFARCTION,1
HN,PRODUCT USE IN UNAPPROVED INDICATION,1
HN,SPINAL CORD DISORDER,1
HK,DEAFNESS,1
HK,DEATH,1
HK,DRUG INEFFECTIVE,1
HK,DYSPNOEA,1
HK,HAEMORRHAGE INTRACRANIAL,1
HU,DIZZINESS,6
HU,DIARRHOEA,4
HU,GAIT DISTURBANCE,4
HU,MALAISE,4
HU,MUSCLE SPASMS,4
HU,PNEUMONIA,4
HU,BLOOD PRESSURE INCREASED,3
HU,DEATH,3
HU,DRUG INEFFECTIVE,3
HU,DYSPNOEA,3
HU,FALL,3
HU,HYPERHIDROSIS,3
HU,PAIN,3
HU,PERIPHERAL ISCHAEMIA,3
HU,WEIGHT DECREASED,3
HU,ABDOMINAL PAIN,2
HU,ASTHENIA,2
HU,ATRIOVENTRICULAR BLOCK,2
HU,BLOOD GLUCOSE INCREASED,2
HU,CEREBRAL INFARCTION,2
HU,CHILLS,2
HU,CHOKING,2
HU,HEADACHE,2
HU,HYPOAESTHESIA,2
HU,MENTAL IMPAIRMENT,2
HU,OEDEMA PERIPHERAL,2
HU,PAIN IN EXTREMITY,2
HU,PARKINSON^S DISEASE,2
HU,PLATELET COUNT DECREASED,2
HU,PYREXIA,2
HU,RESTLESSNESS,2
HU,SOMNOLENCE,2
HU,SWOLLEN TONGUE,2
HU,TREMOR,2
HU,VISUAL IMPAIRMENT,2
HU,ABDOMINAL DISTENSION,1
HU,ABDOMINAL PAIN UPPER,1
HU,ABNORMAL DREAMS,1
HU,ACNE,1
HU,ACTIVITIES OF DAILY LIVING IMPAIRED,1
HU,ACUTE MYELOID LEUKAEMIA,1
HU,ACUTE RESPIRATORY DISTRESS SYNDROME,1
HU,AGGRESSION,1
HU,AMNESIA,1
HU,AMYLASE INCREASED,1
HU,ANGER,1
HU,ANGINA PECTORIS,1
HU,ANGIOPATHY,1
HU,ANXIETY,1
HU,AORTIC STENOSIS,1
HU,APHASIA,1
HU,ARRHYTHMIA,1
HU,ARTERIOGRAM CORONARY,1
HU,ARTHRALGIA,1
HU,ARTHROPATHY,1
HU,AUTOIMMUNE DISORDER,1
HU,BACK PAIN,1
HU,BLOOD ALKALINE PHOSPHATASE INCREASED,1
HU,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
HU,BLOOD CREATININE INCREASED,1
HU,BLOOD GLUCOSE DECREASED,1
HU,BLOOD POTASSIUM INCREASED,1
HU,BLOOD TEST ABNORMAL,1
HU,BRAIN INJURY,1
HU,BRAIN NEOPLASM,1
HU,CARDIAC ARREST,1
HU,CEREBROVASCULAR ACCIDENT,1
HU,COMA,1
HU,CONDITION AGGRAVATED,1
HU,CONFUSIONAL STATE,1
HU,CONTRAINDICATED PRODUCT ADMINISTERED,1
HU,CONTUSION,1
HU,COUGH,1
HU,CYST,1
HU,DECREASED APPETITE,1
HU,DEEP VEIN THROMBOSIS,1
HU,DEPRESSION,1
HU,DEVICE BREAKAGE,1
HU,DIABETES MELLITUS,1
HU,DISCOMFORT,1
HU,DRUG ADMINISTRATION ERROR,1
HU,DRUG EFFECT DECREASED,1
HU,DRY EYE,1
HU,DRY MOUTH,1
HU,DYSBACTERIOSIS,1
HU,DYSPEPSIA,1
HU,DYSPHAGIA,1
HU,DYSURIA,1
HU,ENERGY INCREASED,1
HU,EPILEPTIC AURA,1
HU,EYE HAEMORRHAGE,1
HU,EYE INFLAMMATION,1
HU,EYE SWELLING,1
HU,FEELING ABNORMAL,1
HU,FEMORAL NECK FRACTURE,1
HU,FLUID RETENTION,1
HU,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
HU,GANGRENE,1
HU,GASTRIC CANCER,1
HU,GENERAL PHYSICAL CONDITION ABNORMAL,1
HU,GLOMERULAR FILTRATION RATE DECREASED,1
HU,HAEMATOCRIT DECREASED,1
HU,HAEMATOMA,1
HU,HAEMOGLOBIN DECREASED,1
HU,HAEMOPHILUS INFECTION,1
HU,HAEMORRHAGE,1
HU,HALLUCINATION,1
HU,HEAD INJURY,1
HU,HEARING IMPAIRED,1
HU,HEPATIC ENZYME ABNORMAL,1
HU,HEPATOMEGALY,1
HU,HUNGER,1
HU,HYPERACUSIS,1
HU,HYPERSENSITIVITY,1
HU,HYPERTENSION,1
HU,ILLUSION,1
HU,INFLAMMATION,1
HU,INSOMNIA,1
HU,IRRITABILITY,1
HU,ISCHAEMIC STROKE,1
HU,JOINT SWELLING,1
HU,LACRIMATION INCREASED,1
HU,LIPASE INCREASED,1
HU,LOSS OF CONSCIOUSNESS,1
HU,LOWER LIMB FRACTURE,1
HU,LYMPHOCYTE COUNT DECREASED,1
HU,MICTURITION DISORDER,1
HU,MONOPARESIS,1
HU,MONOPLEGIA,1
HU,MUSCULAR WEAKNESS,1
HU,MYOCARDIAL INFARCTION,1
HU,NASAL CONGESTION,1
HU,NASAL DRYNESS,1
HU,NAUSEA,1
HU,NECK PAIN,1
HU,NERVOUSNESS,1
HU,NIGHTMARE,1
HU,NODULE,1
HU,OXYGEN SATURATION DECREASED,1
HU,PANCREATIC CARCINOMA,1
HU,PANIC ATTACK,1
HU,PARAESTHESIA,1
HU,PERIPHERAL COLDNESS,1
HU,PERIPHERAL SWELLING,1
HU,PHOTOPSIA,1
HU,POST PROCEDURAL HAEMORRHAGE,1
HU,PRE-EXISTING CONDITION IMPROVED,1
HU,PRODUCT USE IN UNAPPROVED INDICATION,1
HU,PRODUCT USE ISSUE,1
HU,PROTHROMBIN TIME PROLONGED,1
HU,PRURITUS,1
HU,PRURITUS GENERALISED,1
HU,PULMONARY FUNCTION TEST DECREASED,1
HU,RASH,1
HU,RED CELL DISTRIBUTION WIDTH INCREASED,1
HU,RENAL DISORDER,1
HU,RESPIRATORY FAILURE,1
HU,ROAD TRAFFIC ACCIDENT,1
HU,SEIZURE,1
HU,SENSATION OF HEAVINESS,1
HU,SHOCK,1
HU,SLEEP DISORDER,1
HU,SPEECH DISORDER,1
HU,STATUS EPILEPTICUS,1
HU,SUBACUTE HEPATIC FAILURE,1
HU,SUICIDAL IDEATION,1
HU,SWELLING,1
HU,TENSION,1
HU,THERAPEUTIC RESPONSE UNEXPECTED,1
HU,THIRST,1
HU,TINNITUS,1
HU,VENOUS OCCLUSION,1
HU,VOMITING,1
HU,WEIGHT INCREASED,1
HU,WHITE BLOOD CELL COUNT DECREASED,1
HU,WOUND,1
HU,YELLOW SKIN,1
IS,GENERALISED TONIC-CLONIC SEIZURE,2
IS,OVERDOSE,2
IS,DRUG ABUSE,1
IS,DYSARTHRIA,1
IS,FACIAL PARALYSIS,1
IS,FEELING ABNORMAL,1
IS,HEMIPARESIS,1
IN,DEATH,4
IN,DRUG DEPENDENCE,4
IN,GAIT DISTURBANCE,4
IN,DEMENTIA,3
IN,DRUG ABUSE,3
IN,ANXIETY,2
IN,CONDITION AGGRAVATED,2
IN,DEPRESSION,2
IN,LETHARGY,2
IN,NORMAL PRESSURE HYDROCEPHALUS,2
IN,PAIN,2
IN,SELF INJURIOUS BEHAVIOUR,2
IN,SEROTONIN SYNDROME,2
IN,STATUS EPILEPTICUS,2
IN,TACHYCARDIA,2
IN,ABASIA,1
IN,ABNORMAL BEHAVIOUR,1
IN,ACUTE CORONARY SYNDROME,1
IN,ALOPECIA,1
IN,AMYLASE INCREASED,1
IN,ANGIOEDEMA,1
IN,APATHY,1
IN,APHASIA,1
IN,ASTHENIA,1
IN,AUTOIMMUNE THYROIDITIS,1
IN,BLOOD CREATININE INCREASED,1
IN,BRADYCARDIA,1
IN,BRADYKINESIA,1
IN,C-REACTIVE PROTEIN INCREASED,1
IN,CANDIDA INFECTION,1
IN,CARDIAC FAILURE CONGESTIVE,1
IN,CATHETER SITE DISCHARGE,1
IN,DERMATITIS EXFOLIATIVE,1
IN,DIZZINESS,1
IN,DRUG HYPERSENSITIVITY,1
IN,DRUG INTOLERANCE,1
IN,DRUG TOLERANCE,1
IN,DRUG WITHDRAWAL SYNDROME,1
IN,DYSPEPSIA,1
IN,DYSPHORIA,1
IN,ELECTROCARDIOGRAM T WAVE INVERSION,1
IN,ENERGY INCREASED,1
IN,EOSINOPHILIA,1
IN,EUPHORIC MOOD,1
IN,FALL,1
IN,FEELINGS OF WORTHLESSNESS,1
IN,FEMUR FRACTURE,1
IN,GOUT,1
IN,HAEMORRHAGE,1
IN,HEPATITIS C,1
IN,HYPERHIDROSIS,1
IN,HYPERSENSITIVITY,1
IN,HYPERTENSION,1
IN,HYPERURICAEMIA,1
IN,HYPOTENSION,1
IN,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
IN,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
IN,INJURY,1
IN,INTENTIONAL PRODUCT MISUSE,1
IN,INTENTIONAL SELF-INJURY,1
IN,INTESTINAL ULCER,1
IN,IRRITABILITY,1
IN,LACK OF SPONTANEOUS SPEECH,1
IN,LEFT VENTRICULAR DYSFUNCTION,1
IN,LIPASE INCREASED,1
IN,MACULAR OEDEMA,1
IN,MEMORY IMPAIRMENT,1
IN,MOBILITY DECREASED,1
IN,MOVEMENT DISORDER,1
IN,MUSCULAR WEAKNESS,1
IN,MYDRIASIS,1
IN,NEPHROPATHY,1
IN,NEURALGIA,1
IN,NEUROTOXICITY,1
IN,OBSTRUCTION,1
IN,OVERDOSE,1
IN,PALPITATIONS,1
IN,PERFORATED ULCER,1
IN,PERIPHERAL SENSORIMOTOR NEUROPATHY,1
IN,POLYMEDICATION,1
IN,POLYNEUROPATHY,1
IN,POST PROCEDURAL DISCHARGE,1
IN,PURPURA,1
IN,PYREXIA,1
IN,RASH PRURITIC,1
IN,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
IN,RESTLESSNESS,1
IN,RETINAL VEIN OCCLUSION,1
IN,RHABDOMYOLYSIS,1
IN,SEDATION,1
IN,SUICIDAL IDEATION,1
IN,SUICIDE ATTEMPT,1
IN,THERAPEUTIC RESPONSE DECREASED,1
IN,TOXIC ENCEPHALOPATHY,1
IN,TRANSAMINASES INCREASED,1
IN,URINARY INCONTINENCE,1
IN,URINARY TRACT INFECTION,1
IN,VISION BLURRED,1
IN,VISUAL ACUITY REDUCED,1
IN,VOMITING,1
IN,WEIGHT DECREASED,1
IN,WHITE BLOOD CELL COUNT DECREASED,1
ID,DEATH,1
ID,HEPATIC ENZYME INCREASED,1
ID,INTERNATIONAL NORMALISED RATIO INCREASED,1
ID,RENAL IMPAIRMENT,1
IR,CENTRAL OBESITY,1
IE,DEATH,52
IE,DRUG ABUSE,19
IE,FALL,19
IE,DIARRHOEA,17
IE,LOWER RESPIRATORY TRACT INFECTION,17
IE,HEADACHE,16
IE,MALAISE,16
IE,PAIN IN EXTREMITY,15
IE,FATIGUE,13
IE,PRODUCT USE ISSUE,13
IE,ARTHRALGIA,12
IE,DYSPNOEA,12
IE,NAUSEA,12
IE,OVERDOSE,12
IE,BACK PAIN,11
IE,COUGH,11
IE,TOXICITY TO VARIOUS AGENTS,11
IE,CONFUSIONAL STATE,9
IE,DRUG INEFFECTIVE,9
IE,PAIN,9
IE,CONSTIPATION,8
IE,DIZZINESS,8
IE,HYPOTENSION,8
IE,MUSCLE SPASMS,8
IE,PULMONARY EMBOLISM,8
IE,PYREXIA,8
IE,RESPIRATORY TRACT INFECTION,8
IE,VOMITING,8
IE,CHOREOATHETOSIS,7
IE,DEHYDRATION,7
IE,DEPRESSION,7
IE,HOSPITALISATION,7
IE,HYPERHIDROSIS,7
IE,HYPOGLYCAEMIA,7
IE,INFECTION,7
IE,MUSCULAR WEAKNESS,7
IE,PNEUMONIA,7
IE,TREMOR,7
IE,WEIGHT INCREASED,7
IE,DIABETES MELLITUS INADEQUATE CONTROL,6
IE,DRUG DEPENDENCE,6
IE,EXPOSURE DURING PREGNANCY,6
IE,HYPOAESTHESIA,6
IE,MOBILITY DECREASED,6
IE,NEUROPATHY PERIPHERAL,6
IE,POSTPARTUM HAEMORRHAGE,6
IE,URINARY TRACT INFECTION,6
IE,ACUTE HEPATIC FAILURE,5
IE,ASTHENIA,5
IE,CARDIAC FAILURE,5
IE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,5
IE,DECREASED APPETITE,5
IE,DRUG WITHDRAWAL SYNDROME,5
IE,ERYTHEMA,5
IE,EYE PAIN,5
IE,HAEMOGLOBIN DECREASED,5
IE,HYPERSENSITIVITY,5
IE,MULTI-ORGAN DISORDER,5
IE,MUSCULOSKELETAL PAIN,5
IE,PULMONARY OEDEMA,5
IE,RASH GENERALISED,5
IE,RENAL FAILURE,5
IE,UNRESPONSIVE TO STIMULI,5
IE,WEIGHT DECREASED,5
IE,ABDOMINAL PAIN,4
IE,ACUTE MYOCARDIAL INFARCTION,4
IE,AGITATION,4
IE,AMNESIA,4
IE,BLOOD PRESSURE DECREASED,4
IE,BODY TEMPERATURE INCREASED,4
IE,CAESAREAN SECTION,4
IE,DRUG EFFECT INCOMPLETE,4
IE,DYSKINESIA,4
IE,DYSPHAGIA,4
IE,EPILEPSY,4
IE,FEELING ABNORMAL,4
IE,HALLUCINATION,4
IE,INSOMNIA,4
IE,LETHARGY,4
IE,LIVER INJURY,4
IE,LOSS OF CONSCIOUSNESS,4
IE,MALIGNANT NEOPLASM PROGRESSION,4
IE,NECK PAIN,4
IE,OEDEMA PERIPHERAL,4
IE,PARAESTHESIA,4
IE,PARANOIA,4
IE,PARKINSON^S DISEASE,4
IE,PLASMA CELL MYELOMA,4
IE,PREMATURE BABY,4
IE,PULMONARY SEPSIS,4
IE,SEIZURE,4
IE,SKIN ULCER,4
IE,SOMNOLENCE,4
IE,SWELLING FACE,4
IE,SWOLLEN TONGUE,4
IE,SYNCOPE,4
IE,VISION BLURRED,4
IE,VISUAL IMPAIRMENT,4
IE,WHEEZING,4
IE,ABNORMAL DREAMS,3
IE,ACUTE KIDNEY INJURY,3
IE,ANAEMIA,3
IE,ANAPHYLACTIC REACTION,3
IE,ANXIETY,3
IE,AURA,3
IE,BLOOD GLUCOSE INCREASED,3
IE,CHOKING,3
IE,CONVULSION,3
IE,CYANOSIS,3
IE,DEPENDENCE,3
IE,DIALYSIS,3
IE,DISEASE PROGRESSION,3
IE,DYSARTHRIA,3
IE,EMOTIONAL DISTRESS,3
IE,FOETAL EXPOSURE DURING PREGNANCY,3
IE,GAIT DISTURBANCE,3
IE,GENERALISED TONIC-CLONIC SEIZURE,3
IE,HAEMATEMESIS,3
IE,HEART RATE INCREASED,3
IE,HERPES ZOSTER,3
IE,HYPERPARATHYROIDISM,3
IE,HYPERSOMNIA,3
IE,HYPOCALCAEMIA,3
IE,INFECTED SKIN ULCER,3
IE,JOINT SWELLING,3
IE,LIMB INJURY,3
IE,MEMORY IMPAIRMENT,3
IE,MUSCLE STRAIN,3
IE,MUSCULOSKELETAL CHEST PAIN,3
IE,MYALGIA,3
IE,PALPITATIONS,3
IE,PLACENTAL TRANSFUSION SYNDROME,3
IE,PLATELET COUNT INCREASED,3
IE,PLEURAL EFFUSION,3
IE,RASH,3
IE,RENAL IMPAIRMENT,3
IE,RESPIRATORY FAILURE,3
IE,RHABDOMYOLYSIS,3
IE,SPEECH DISORDER,3
IE,SUICIDAL IDEATION,3
IE,SWELLING,3
IE,URINARY INCONTINENCE,3
IE,VISUAL FIELD DEFECT,3
IE,ABDOMINAL NEOPLASM,2
IE,ACCIDENT,2
IE,ANGER,2
IE,ANGIOEDEMA,2
IE,BALANCE DISORDER,2
IE,BLOOD PRESSURE INCREASED,2
IE,BLOOD SODIUM DECREASED,2
IE,BLOOD URINE PRESENT,2
IE,BRADYCARDIA,2
IE,BRAIN CONTUSION,2
IE,BRAIN OEDEMA,2
IE,C-REACTIVE PROTEIN INCREASED,2
IE,CARDIO-RESPIRATORY ARREST,2
IE,CARPAL TUNNEL SYNDROME,2
IE,CEREBROVASCULAR ACCIDENT,2
IE,CHEST PAIN,2
IE,CHILLS,2
IE,CHRONIC LYMPHOCYTIC LEUKAEMIA,2
IE,COMA,2
IE,COMPLETED SUICIDE,2
IE,DECUBITUS ULCER,2
IE,DEEP VEIN THROMBOSIS,2
IE,DEPRESSED MOOD,2
IE,DEVICE DISLOCATION,2
IE,DEVICE KINK,2
IE,DIABETES MELLITUS,2
IE,DIET NONCOMPLIANCE,2
IE,DISCOMFORT,2
IE,DISORIENTATION,2
IE,DRUG DOSE OMISSION,2
IE,DRUG HYPERSENSITIVITY,2
IE,DRUG PRESCRIBING ERROR,2
IE,EUPHORIC MOOD,2
IE,EXPOSURE DURING BREAST FEEDING,2
IE,EYE SWELLING,2
IE,FEAR OF INJECTION,2
IE,FEELING COLD,2
IE,FLUID OVERLOAD,2
IE,FUNGAL INFECTION,2
IE,GASTRIC HAEMORRHAGE,2
IE,GASTRITIS,2
IE,GASTROINTESTINAL INFECTION,2
IE,GENERAL PHYSICAL HEALTH DETERIORATION,2
IE,GROIN PAIN,2
IE,HAEMORRHOIDS,2
IE,HEAD INJURY,2
IE,HEPATITIS,2
IE,HIATUS HERNIA,2
IE,HYPERTENSION,2
IE,INCORRECT ROUTE OF DRUG ADMINISTRATION,2
IE,INFLUENZA LIKE ILLNESS,2
IE,INJECTION SITE ERYTHEMA,2
IE,INTENTIONAL OVERDOSE,2
IE,JOINT DISLOCATION,2
IE,LIVER FUNCTION TEST ABNORMAL,2
IE,LIVER FUNCTION TEST INCREASED,2
IE,LUNG NEOPLASM MALIGNANT,2
IE,MACULAR DEGENERATION,2
IE,MATERNAL EXPOSURE DURING PREGNANCY,2
IE,MEDICATION ERROR,2
IE,METASTASES TO SPINE,2
IE,MUCOSAL INFLAMMATION,2
IE,MULTI-ORGAN FAILURE,2
IE,MUSCULOSKELETAL STIFFNESS,2
IE,MYOCARDITIS,2
IE,MYOCLONUS,2
IE,MYOSITIS,2
IE,NASAL CONGESTION,2
IE,NASOPHARYNGITIS,2
IE,NEURALGIA,2
IE,OESOPHAGEAL FOOD IMPACTION,2
IE,OSTEONECROSIS OF JAW,2
IE,PALLOR,2
IE,PANCREATITIS ACUTE,2
IE,PERIPHERAL NERVE SHEATH TUMOUR MALIGNANT,2
IE,PLATELET COUNT DECREASED,2
IE,PNEUMOCEPHALUS,2
IE,POISONING,2
IE,PRODUCT USE IN UNAPPROVED INDICATION,2
IE,PRODUCTIVE COUGH,2
IE,PULMONARY PAIN,2
IE,RENAL FAILURE ACUTE,2
IE,RESTLESSNESS,2
IE,SLEEP DISORDER,2
IE,STOMA SITE DISCHARGE,2
IE,STOMA SITE PAIN,2
IE,STOMATITIS,2
IE,SUBDURAL HAEMATOMA,2
IE,TACHYCARDIA,2
IE,TRANSIENT ISCHAEMIC ATTACK,2
IE,WHITE BLOOD CELL COUNT INCREASED,2
IE,WITHDRAWAL SYNDROME,2
IE,WRONG TECHNIQUE IN DRUG USAGE PROCESS,2
IE,ABASIA,1
IE,ABDOMINAL ADHESIONS,1
IE,ABDOMINAL DISCOMFORT,1
IE,ABDOMINAL DISTENSION,1
IE,ABDOMINAL PAIN LOWER,1
IE,ABDOMINAL PAIN UPPER,1
IE,ABDOMINAL WALL HAEMATOMA,1
IE,ABNORMAL BEHAVIOUR,1
IE,ACID BASE BALANCE ABNORMAL,1
IE,ADVERSE DRUG REACTION,1
IE,AFFECT LABILITY,1
IE,AGEUSIA,1
IE,AGGRESSION,1
IE,ALOPECIA,1
IE,ANKLE FRACTURE,1
IE,ANORECTAL INFECTION,1
IE,APHASIA,1
IE,ARRHYTHMIA,1
IE,ASCITES,1
IE,ASTHENOPIA,1
IE,ATRIAL FIBRILLATION,1
IE,ATYPICAL FEMUR FRACTURE,1
IE,AXILLARY PAIN,1
IE,BACK INJURY,1
IE,BALANOPOSTHITIS,1
IE,BASILAR ARTERY ANEURYSM,1
IE,BLADDER CANCER,1
IE,BLADDER PAIN,1
IE,BLEPHAROSPASM,1
IE,BLISTER,1
IE,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
IE,BLOOD CREATININE INCREASED,1
IE,BLOOD GLUCOSE DECREASED,1
IE,BLOOD IRON DECREASED,1
IE,BLOOD LACTATE DEHYDROGENASE INCREASED,1
IE,BLOOD PRESSURE SYSTOLIC INCREASED,1
IE,BLOOD PROLACTIN INCREASED,1
IE,BLOOD SODIUM INCREASED,1
IE,BODY SURFACE AREA INCREASED,1
IE,BONE PAIN,1
IE,BRAIN LOBECTOMY,1
IE,BRONCHITIS,1
IE,BRONCHOSPASM,1
IE,CAMPYLOBACTER GASTROENTERITIS,1
IE,CANDIDA INFECTION,1
IE,CARDIAC ARREST,1
IE,CARDIAC FAILURE CHRONIC,1
IE,CARDIOGENIC SHOCK,1
IE,CELLULITIS,1
IE,CENTRAL NERVOUS SYSTEM LESION,1
IE,CEREBELLAR HAEMORRHAGE,1
IE,CEREBRAL INFARCTION,1
IE,CERVICAL VERTEBRAL FRACTURE,1
IE,CHEST DISCOMFORT,1
IE,CLAVICLE FRACTURE,1
IE,CLOSTRIDIUM DIFFICILE COLITIS,1
IE,CLOSTRIDIUM DIFFICILE INFECTION,1
IE,CLUMSINESS,1
IE,COGNITIVE DISORDER,1
IE,COLD SWEAT,1
IE,COLITIS,1
IE,COLON ADENOMA,1
IE,COMPRESSION FRACTURE,1
IE,CONCOMITANT DISEASE PROGRESSION,1
IE,CONDITION AGGRAVATED,1
IE,CONTUSION,1
IE,CREPITATIONS,1
IE,CYANOSIS CENTRAL,1
IE,DELUSIONAL PERCEPTION,1
IE,DEPRESSED LEVEL OF CONSCIOUSNESS,1
IE,DERMATITIS,1
IE,DERMATITIS ACNEIFORM,1
IE,DEVICE CONNECTION ISSUE,1
IE,DEVICE DIFFICULT TO USE,1
IE,DEVICE ISSUE,1
IE,DEVICE OCCLUSION,1
IE,DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL,1
IE,DIPLOPIA,1
IE,DISSEMINATED INTRAVASCULAR COAGULATION,1
IE,DISTURBANCE IN ATTENTION,1
IE,DRUG ABUSER,1
IE,DRUG EFFECT DECREASED,1
IE,DRUG INTOLERANCE,1
IE,DRUG TOLERANCE,1
IE,DRUG USE DISORDER,1
IE,DRUG-DISEASE INTERACTION,1
IE,DRY EYE,1
IE,DRY SKIN,1
IE,DRY THROAT,1
IE,DUODENITIS,1
IE,EAR PAIN,1
IE,ECCHYMOSIS,1
IE,ELECTROCARDIOGRAM QT PROLONGED,1
IE,ENDOMETRIAL CANCER,1
IE,ENTEROCOCCAL INFECTION,1
IE,EOSINOPHIL COUNT INCREASED,1
IE,EOSINOPHILIA,1
IE,ERECTILE DYSFUNCTION,1
IE,ERYTHEMA MULTIFORME,1
IE,ESCHERICHIA URINARY TRACT INFECTION,1
IE,EXTRAGONADAL PRIMARY EMBRYONAL CARCINOMA,1
IE,EXTRASYSTOLES,1
IE,EYE ABSCESS,1
IE,EYE DISORDER,1
IE,EYE INFECTION,1
IE,FACE OEDEMA,1
IE,FACET JOINT SYNDROME,1
IE,FAECALOMA,1
IE,FAECES DISCOLOURED,1
IE,FEAR,1
IE,FEMUR FRACTURE,1
IE,FLANK PAIN,1
IE,FLUSHING,1
IE,FOETAL DEATH,1
IE,FOOT DEFORMITY,1
IE,FORMICATION,1
IE,FRACTURE DISPLACEMENT,1
IE,FURUNCLE,1
IE,GALACTORRHOEA,1
IE,GANGRENE,1
IE,GASTROINTESTINAL CARCINOMA,1
IE,GASTROINTESTINAL DISORDER,1
IE,GASTROINTESTINAL EROSION,1
IE,GASTROINTESTINAL HAEMORRHAGE,1
IE,GASTROINTESTINAL INFLAMMATION,1
IE,GASTROINTESTINAL SCAN,1
IE,GASTROINTESTINAL TUBE INSERTION,1
IE,GENERALISED ERYTHEMA,1
IE,GINGIVAL SWELLING,1
IE,GLOMERULAR FILTRATION RATE DECREASED,1
IE,HAEMATOCHEZIA,1
IE,HAEMORRHAGE INTRACRANIAL,1
IE,HALLUCINATION_ VISUAL,1
IE,HAND FRACTURE,1
IE,HEARING IMPAIRED,1
IE,HEART RATE DECREASED,1
IE,HEMIPARESIS,1
IE,HEPATIC FUNCTION ABNORMAL,1
IE,HEPATIC STEATOSIS,1
IE,HEPATOSPLENOMEGALY,1
IE,HERNIA,1
IE,HIP ARTHROPLASTY,1
IE,HORDEOLUM,1
IE,HYPERGLYCAEMIA,1
IE,HYPOAESTHESIA ORAL,1
IE,HYPOKINESIA,1
IE,HYPONATRAEMIA,1
IE,HYPOXIA,1
IE,IDIOPATHIC PULMONARY FIBROSIS,1
IE,IMMOBILISATION PROLONGED,1
IE,IMPAIRED DRIVING ABILITY,1
IE,IMPAIRED HEALING,1
IE,IMPAIRED WORK ABILITY,1
IE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
IE,INCORRECT DOSE ADMINISTERED,1
IE,INCREASED APPETITE,1
IE,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,1
IE,INFUSION RELATED REACTION,1
IE,INJECTION SITE HAEMORRHAGE,1
IE,INJECTION SITE REACTION,1
IE,INTENTIONAL DRUG MISUSE,1
IE,INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT,1
IE,INTENTIONAL PRODUCT MISUSE,1
IE,INTERNAL HAEMORRHAGE,1
IE,INTERSTITIAL LUNG DISEASE,1
IE,INTERVERTEBRAL DISC DEGENERATION,1
IE,INTERVERTEBRAL DISC DISPLACEMENT,1
IE,INTESTINAL MASS,1
IE,INTESTINAL POLYP,1
IE,INTRAOCULAR PRESSURE INCREASED,1
IE,INTRAVENTRICULAR HAEMORRHAGE,1
IE,IRRITABILITY,1
IE,JAUNDICE,1
IE,JOINT CREPITATION,1
IE,LACERATION,1
IE,LACRIMATION INCREASED,1
IE,LARGE INTESTINE PERFORATION,1
IE,LARGE INTESTINE POLYP,1
IE,LEUKAEMOID REACTION,1
IE,LEUKOENCEPHALOPATHY,1
IE,LIBIDO DECREASED,1
IE,LIBIDO INCREASED,1
IE,LICHENOID KERATOSIS,1
IE,LIMB DISCOMFORT,1
IE,LIP SWELLING,1
IE,LIVER DISORDER,1
IE,LOCALISED INFECTION,1
IE,LOOSE TOOTH,1
IE,LOWER GASTROINTESTINAL HAEMORRHAGE,1
IE,LUNG CONSOLIDATION,1
IE,LUNG INFECTION,1
IE,LYMPHADENOPATHY,1
IE,LYMPHOCYTOSIS,1
IE,LYMPHOMATOID PAPULOSIS,1
IE,MADAROSIS,1
IE,MASKED FACIES,1
IE,MASTOID DISORDER,1
IE,MEDICAL DEVICE CHANGE,1
IE,MELAENA,1
IE,MENTAL DISORDER,1
IE,METASTASES TO BREAST,1
IE,METASTASES TO CENTRAL NERVOUS SYSTEM,1
IE,METASTASES TO LIVER,1
IE,METASTASES TO LUNG,1
IE,METASTASES TO STOMACH,1
IE,METASTASIS,1
IE,MICTURITION URGENCY,1
IE,MIGRAINE,1
IE,MIGRAINE WITH AURA,1
IE,MITRAL VALVE INCOMPETENCE,1
IE,MONARTHRITIS,1
IE,MOTOR DYSFUNCTION,1
IE,MOUTH ULCERATION,1
IE,MOVEMENT DISORDER,1
IE,MULTIPLE SCLEROSIS,1
IE,MULTIPLE SCLEROSIS RELAPSE,1
IE,MYOCARDIAL INFARCTION,1
IE,MYOCARDIAL ISCHAEMIA,1
IE,MYOCARDIAL NECROSIS MARKER INCREASED,1
IE,MYOPATHY,1
IE,NAIL DISCOLOURATION,1
IE,NASAL DRYNESS,1
IE,NECROTISING FASCIITIS,1
IE,NEOPLASM MALIGNANT,1
IE,NERVOUS SYSTEM DISORDER,1
IE,NEUROLEPTIC MALIGNANT SYNDROME,1
IE,NEUROLOGICAL DECOMPENSATION,1
IE,NEUTROPENIA,1
IE,NEUTROPHIL COUNT DECREASED,1
IE,NODULE,1
IE,NON-SMALL CELL LUNG CANCER STAGE IV,1
IE,OCULAR DISCOMFORT,1
IE,OESOPHAGITIS,1
IE,ON AND OFF PHENOMENON,1
IE,ORAL HERPES,1
IE,ORAL MUCOSAL BLISTERING,1
IE,ORAL PAIN,1
IE,OROPHARYNGEAL PAIN,1
IE,ORTHOSTATIC HYPOTENSION,1
IE,OSTEITIS,1
IE,OSTEOARTHRITIS,1
IE,OTITIS EXTERNA,1
IE,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
IE,PARALYSIS,1
IE,PELVIC FRACTURE,1
IE,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
IE,PERIPHERAL ARTERY OCCLUSION,1
IE,PERIPHERAL CIRCULATORY FAILURE,1
IE,PERIPHERAL ISCHAEMIA,1
IE,PERIPHERAL SWELLING,1
IE,PHARYNGEAL OEDEMA,1
IE,PHOTOPHOBIA,1
IE,PLEURISY,1
IE,PLEURITIC PAIN,1
IE,PNEUMONIA ASPIRATION,1
IE,PNEUMONITIS,1
IE,POOR QUALITY SLEEP,1
IE,POST HERPETIC NEURALGIA,1
IE,POST-TRAUMATIC AMNESTIC DISORDER,1
IE,POTENTIATING DRUG INTERACTION,1
IE,PRE-EXISTING CONDITION IMPROVED,1
IE,PREMATURE DELIVERY,1
IE,PRESCRIPTION FORM TAMPERING,1
IE,PROCTITIS,1
IE,PRODUCT SUBSTITUTION ISSUE,1
IE,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
IE,PSORIASIS,1
IE,PSORIATIC ARTHROPATHY,1
IE,PSYCHIATRIC SYMPTOM,1
IE,PSYCHOTIC DISORDER,1
IE,PULMONARY MASS,1
IE,PYELONEPHRITIS ACUTE,1
IE,RASH PRURITIC,1
IE,RECTAL HAEMORRHAGE,1
IE,REHABILITATION THERAPY,1
IE,RENAL CELL CARCINOMA,1
IE,RENAL DISORDER,1
IE,RESPIRATORY ARREST,1
IE,RESPIRATORY DISTRESS,1
IE,RESPIRATORY RATE DECREASED,1
IE,RESPIRATORY SYMPTOM,1
IE,RESPIRATORY TRACT CONGESTION,1
IE,RESPIRATORY TRACT IRRITATION,1
IE,RIB FRACTURE,1
IE,SCIATICA,1
IE,SCROTAL ERYTHEMA,1
IE,SECRETION DISCHARGE,1
IE,SELF-INJURIOUS IDEATION,1
IE,SEROTONIN SYNDROME,1
IE,SEX HORMONE BINDING GLOBULIN INCREASED,1
IE,SEXUAL ACTIVITY INCREASED,1
IE,SINOATRIAL BLOCK,1
IE,SINUS DISORDER,1
IE,SINUSITIS,1
IE,SKIN DISCOLOURATION,1
IE,SKIN IRRITATION,1
IE,SKIN LESION,1
IE,SKIN PAPILLOMA,1
IE,SKULL FRACTURE,1
IE,SKULL FRACTURED BASE,1
IE,SMALL INTESTINAL OBSTRUCTION,1
IE,SOCIAL AVOIDANT BEHAVIOUR,1
IE,SPLENOMEGALY,1
IE,SPUTUM INCREASED,1
IE,SQUAMOUS CELL CARCINOMA OF HEAD AND NECK,1
IE,STOMA SITE ERYTHEMA,1
IE,STOMA SITE HYPERGRANULATION,1
IE,STOMA SITE INFECTION,1
IE,STRESS,1
IE,SUDDEN CARDIAC DEATH,1
IE,SUDDEN DEATH,1
IE,SUICIDE ATTEMPT,1
IE,SUPRAVENTRICULAR TACHYCARDIA,1
IE,SYNOVIAL CYST,1
IE,SYNOVIAL SARCOMA METASTATIC,1
IE,TACHYARRHYTHMIA,1
IE,TEARFULNESS,1
IE,TERMINAL STATE,1
IE,THERAPEUTIC RESPONSE UNEXPECTED,1
IE,THROAT IRRITATION,1
IE,THROMBOCYTOPENIA,1
IE,THYROID HORMONES INCREASED,1
IE,TINNITUS,1
IE,TOOTH DISCOLOURATION,1
IE,TOOTH LOSS,1
IE,TOOTHACHE,1
IE,TRANSFUSION,1
IE,TRANSFUSION REACTION,1
IE,TRAUMATIC INTRACRANIAL HAEMORRHAGE,1
IE,TREATMENT NONCOMPLIANCE,1
IE,TRICUSPID VALVE INCOMPETENCE,1
IE,TROPONIN INCREASED,1
IE,TUMOUR PAIN,1
IE,ULCER,1
IE,UMBILICAL HERNIA,1
IE,UNINTENTIONAL MEDICAL DEVICE REMOVAL,1
IE,URINARY RETENTION,1
IE,URINARY TRACT INFECTION STAPHYLOCOCCAL,1
IE,URTICARIA,1
IE,VAGINAL HAEMORRHAGE,1
IE,VERTIGO,1
IE,VIOLENCE-RELATED SYMPTOM,1
IE,VIRAL INFECTION,1
IE,VISUAL ACUITY REDUCED,1
IE,VITREOUS DISORDER,1
IE,WHITE BLOOD CELL COUNT DECREASED,1
IE,WHITE BLOOD CELLS URINE,1
IE,WOUND,1
IL,DRUG INEFFECTIVE,8
IL,NAUSEA,7
IL,ASTHENIA,6
IL,NEUTROPENIA,5
IL,PNEUMONIA,5
IL,PYREXIA,5
IL,SEPSIS,5
IL,ANAEMIA,4
IL,FEELING ABNORMAL,4
IL,MALIGNANT NEOPLASM PROGRESSION,4
IL,ABDOMINAL PAIN,3
IL,DYSPNOEA,3
IL,FATIGUE,3
IL,GENERAL PHYSICAL HEALTH DETERIORATION,3
IL,HAEMOGLOBIN DECREASED,3
IL,HAEMORRHAGE,3
IL,MALAISE,3
IL,OEDEMA PERIPHERAL,3
IL,PLASMA CELL MYELOMA,3
IL,SYNCOPE,3
IL,URINARY TRACT INFECTION,3
IL,ABORTION SPONTANEOUS,2
IL,ANGINA UNSTABLE,2
IL,BLOOD LACTATE DEHYDROGENASE INCREASED,2
IL,CEREBROVASCULAR ACCIDENT,2
IL,CONDITION AGGRAVATED,2
IL,CONSTIPATION,2
IL,DEATH,2
IL,DIARRHOEA,2
IL,FALL,2
IL,FEBRILE NEUTROPENIA,2
IL,GRIP STRENGTH DECREASED,2
IL,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,2
IL,INJECTION SITE PAIN,2
IL,INTERNATIONAL NORMALISED RATIO INCREASED,2
IL,MULTI-ORGAN FAILURE,2
IL,PAIN,2
IL,RENAL FAILURE ACUTE,2
IL,RENAL IMPAIRMENT,2
IL,SEPTIC SHOCK,2
IL,SUBSTANCE USE,2
IL,TACHYCARDIA,2
IL,TRIGEMINAL NEURALGIA,2
IL,VOMITING,2
IL,ABDOMINAL ABSCESS,1
IL,ABDOMINAL HERNIA,1
IL,ABDOMINAL OPERATION,1
IL,ABDOMINAL PAIN LOWER,1
IL,ABDOMINAL PAIN UPPER,1
IL,ACTIVITIES OF DAILY LIVING IMPAIRED,1
IL,ACUTE KIDNEY INJURY,1
IL,ADRENAL INSUFFICIENCY,1
IL,AMYLOIDOSIS,1
IL,ANGIOPATHY,1
IL,ANKYLOSING SPONDYLITIS,1
IL,APATHY,1
IL,APPLICATION SITE ERYTHEMA,1
IL,APPLICATION SITE PRURITUS,1
IL,ARRHYTHMIA,1
IL,ARTERIAL HAEMORRHAGE,1
IL,ARTHRALGIA,1
IL,ARTHRITIS,1
IL,ASPHYXIA,1
IL,ATRIAL FIBRILLATION,1
IL,BACK INJURY,1
IL,BACTERAEMIA,1
IL,BLOOD CREATININE ABNORMAL,1
IL,BLOOD CREATININE INCREASED,1
IL,BLOOD FIBRINOGEN DECREASED,1
IL,BLOOD GLUCOSE INCREASED,1
IL,BLOOD PRESSURE INCREASED,1
IL,BLOOD TEST ABNORMAL,1
IL,BLOOD URIC ACID INCREASED,1
IL,BREAST PAIN,1
IL,BURNING SENSATION,1
IL,CARDIOVASCULAR EVALUATION,1
IL,CHEST PAIN,1
IL,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
IL,COMA,1
IL,COMMUNICATION DISORDER,1
IL,CONFUSIONAL STATE,1
IL,CONTUSION,1
IL,COUGH,1
IL,CYTOKINE RELEASE SYNDROME,1
IL,DEPRESSED LEVEL OF CONSCIOUSNESS,1
IL,DEPRESSED MOOD,1
IL,DIABETIC KETOACIDOSIS,1
IL,DIAPHRAGMATIC DISORDER,1
IL,DISSEMINATED INTRAVASCULAR COAGULATION,1
IL,DRUG EFFECT INCOMPLETE,1
IL,DRUG HYPERSENSITIVITY,1
IL,DRY SKIN,1
IL,DYSKINESIA,1
IL,DYSPHEMIA,1
IL,DYSURIA,1
IL,EAR PRURITUS,1
IL,EPISTAXIS,1
IL,ESSENTIAL HYPERTENSION,1
IL,EUPHORIC MOOD,1
IL,EYE PRURITUS,1
IL,FLUSHING,1
IL,FREQUENT BOWEL MOVEMENTS,1
IL,FRUSTRATION,1
IL,GAIT DISTURBANCE,1
IL,GASTROINTESTINAL NECROSIS,1
IL,GENERALISED OEDEMA,1
IL,GLOMERULONEPHRITIS MEMBRANOUS,1
IL,GLOMERULONEPHRITIS MINIMAL LESION,1
IL,HAEMARTHROSIS,1
IL,HAEMATOCHEZIA,1
IL,HAEMOGLOBIN ABNORMAL,1
IL,HALLUCINATION,1
IL,HALLUCINATION_ AUDITORY,1
IL,HEADACHE,1
IL,HEART INJURY,1
IL,HEPATOCELLULAR INJURY,1
IL,HOT FLUSH,1
IL,HYDRONEPHROSIS,1
IL,HYPERCOAGULATION,1
IL,HYPERGLYCAEMIA,1
IL,HYPERKALAEMIA,1
IL,HYPERVIGILANCE,1
IL,HYPOAESTHESIA,1
IL,HYPOGLYCAEMIA,1
IL,HYPOKALAEMIA,1
IL,HYPONATRAEMIA,1
IL,HYPOTENSION,1
IL,HYPOTHYROIDISM,1
IL,INCORRECT DOSE ADMINISTERED,1
IL,INFLAMMATION,1
IL,INFLAMMATORY MARKER INCREASED,1
IL,INJECTION SITE ERYTHEMA,1
IL,INSOMNIA,1
IL,INTENTIONAL OVERDOSE,1
IL,INTENTIONAL PRODUCT USE ISSUE,1
IL,INTERVERTEBRAL DISC PROTRUSION,1
IL,INTESTINAL OBSTRUCTION,1
IL,INVESTIGATION,1
IL,IRRITABILITY,1
IL,LEUKAEMOID REACTION,1
IL,LEUKOCYTOSIS,1
IL,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,1
IL,LYMPHADENOPATHY,1
IL,LYMPHOMA,1
IL,MALIGNANT MELANOMA,1
IL,MECHANICAL VENTILATION,1
IL,METASTASES TO LUNG,1
IL,METASTASES TO LYMPH NODES,1
IL,METASTATIC MALIGNANT MELANOMA,1
IL,MUSCULOSKELETAL DISORDER,1
IL,NEOPLASM MALIGNANT,1
IL,NEUTROPHIL COUNT ABNORMAL,1
IL,ONYCHOMYCOSIS,1
IL,OPTIC NEURITIS,1
IL,PAIN IN EXTREMITY,1
IL,PAINFUL RESPIRATION,1
IL,PANCREATITIS,1
IL,PARALYSIS,1
IL,PERIPHERAL SENSORIMOTOR NEUROPATHY,1
IL,PHARYNGEAL OEDEMA,1
IL,PLATELET COUNT ABNORMAL,1
IL,PNEUMONIA BACTERIAL,1
IL,PROSTATE CANCER,1
IL,PROSTATIC DISORDER,1
IL,PROTHROMBIN TIME PROLONGED,1
IL,PRURITUS,1
IL,PSORIASIS,1
IL,PSORIATIC ARTHROPATHY,1
IL,PULMONARY CONGESTION,1
IL,PULMONARY EMBOLISM,1
IL,RASH,1
IL,RASH GENERALISED,1
IL,RENAL FAILURE,1
IL,RESPIRATORY FAILURE,1
IL,RESTLESSNESS,1
IL,RETINAL VEIN OCCLUSION,1
IL,RHEUMATOID ARTHRITIS,1
IL,RHINORRHOEA,1
IL,SARCOIDOSIS,1
IL,SECOND PRIMARY MALIGNANCY,1
IL,SENSORY DISTURBANCE,1
IL,SEXUAL DYSFUNCTION,1
IL,SKIN DISCOLOURATION,1
IL,SKIN FISSURES,1
IL,SLEEP TALKING,1
IL,SPINAL COLUMN INJURY,1
IL,SPONDYLOLISTHESIS,1
IL,STAPHYLOCOCCAL INFECTION,1
IL,SUBDURAL HAEMATOMA,1
IL,SUICIDE ATTEMPT,1
IL,SWELLING FACE,1
IL,TACHYPNOEA,1
IL,THERAPEUTIC RESPONSE UNEXPECTED,1
IL,THERAPY CHANGE,1
IL,THROMBOCYTOPENIA,1
IL,THROMBOSIS MESENTERIC VESSEL,1
IL,TINNITUS,1
IL,TOXIC ENCEPHALOPATHY,1
IL,TRANSIENT ISCHAEMIC ATTACK,1
IL,TREMOR,1
IL,TUMOUR ASSOCIATED FEVER,1
IL,URINARY INCONTINENCE,1
IL,URINARY RETENTION,1
IL,URINARY TRACT DISORDER,1
IL,UROSEPSIS,1
IL,VAGINAL HAEMORRHAGE,1
IL,VAGINAL POLYP,1
IL,VENTRICULAR TACHYCARDIA,1
IL,VIITH NERVE PARALYSIS,1
IL,VISION BLURRED,1
IL,VISUAL FIELD DEFECT,1
IL,WEIGHT INCREASED,1
IL,WHITE BLOOD CELL COUNT ABNORMAL,1
IL,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
IT,SOPOR,198
IT,DRUG ABUSE,171
IT,ASTHENIA,74
IT,CONFUSIONAL STATE,71
IT,INTENTIONAL SELF-INJURY,61
IT,TOXICITY TO VARIOUS AGENTS,60
IT,OVERDOSE,59
IT,HYPOTENSION,56
IT,HYPOGLYCAEMIA,55
IT,SOMNOLENCE,48
IT,DYSPNOEA,42
IT,NAUSEA,39
IT,PYREXIA,39
IT,SUICIDE ATTEMPT,37
IT,MALAISE,36
IT,SYNCOPE,34
IT,AGITATION,32
IT,BRADYPHRENIA,32
IT,VOMITING,32
IT,HEADACHE,31
IT,COMA,30
IT,INTENTIONAL OVERDOSE,30
IT,VERTIGO,29
IT,BRADYKINESIA,28
IT,DIZZINESS,28
IT,PRESYNCOPE,28
IT,ANAEMIA,26
IT,FALL,25
IT,HYPONATRAEMIA,24
IT,BRADYCARDIA,23
IT,LOSS OF CONSCIOUSNESS,23
IT,RESPIRATORY FAILURE,23
IT,DYSARTHRIA,22
IT,PARAESTHESIA,22
IT,DIARRHOEA,21
IT,TACHYCARDIA,21
IT,HYPERSENSITIVITY VASCULITIS,20
IT,ABDOMINAL PAIN UPPER,19
IT,PNEUMONIA,19
IT,ABDOMINAL PAIN,18
IT,DRUG INEFFECTIVE,18
IT,THROMBOCYTOPENIA,18
IT,ELECTROCARDIOGRAM QT PROLONGED,17
IT,LIVER INJURY,17
IT,TREMOR,17
IT,BALANCE DISORDER,16
IT,COMPLETED SUICIDE,16
IT,CHOLESTASIS,15
IT,DECREASED APPETITE,15
IT,DISORIENTATION,15
IT,HYPOKALAEMIA,15
IT,MIOSIS,15
IT,NEUTROPENIA,15
IT,OEDEMA PERIPHERAL,15
IT,DYSKINESIA,14
IT,ERYTHEMA,14
IT,HYPERKALAEMIA,14
IT,HEAD INJURY,13
IT,HYPOGLYCAEMIC COMA,13
IT,MELAENA,13
IT,PAIN,13
IT,WEIGHT DECREASED,13
IT,CHEST PAIN,12
IT,CONSTIPATION,12
IT,MEDICATION ERROR,12
IT,PRODUCT USE ISSUE,12
IT,PRURITUS,12
IT,SEPSIS,12
IT,ABORTION SPONTANEOUS,11
IT,DIPLOPIA,11
IT,DYSPHAGIA,11
IT,FEBRILE NEUTROPENIA,11
IT,GAIT DISTURBANCE,11
IT,HALLUCINATION,11
IT,HYPERGLYCAEMIA,11
IT,HYPERHIDROSIS,11
IT,INTENTIONAL PRODUCT MISUSE,11
IT,PAIN IN EXTREMITY,11
IT,SPEECH DISORDER,11
IT,ACUTE RESPIRATORY FAILURE,10
IT,DEHYDRATION,10
IT,HAEMATEMESIS,10
IT,OSTEONECROSIS OF JAW,10
IT,PRURITUS GENERALISED,10
IT,PSYCHOMOTOR HYPERACTIVITY,10
IT,PSYCHOTIC DISORDER,10
IT,PULMONARY EMBOLISM,10
IT,STEVENS-JOHNSON SYNDROME,10
IT,ACUTE KIDNEY INJURY,9
IT,BLOOD CREATININE INCREASED,9
IT,CARDIAC ARREST,9
IT,COGNITIVE DISORDER,9
IT,CONDITION AGGRAVATED,9
IT,ELECTROCARDIOGRAM ABNORMAL,9
IT,HALLUCINATION_ VISUAL,9
IT,HEPATOTOXICITY,9
IT,HYPOCOAGULABLE STATE,9
IT,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,9
IT,MALIGNANT NEOPLASM PROGRESSION,9
IT,PRODUCT USE IN UNAPPROVED INDICATION,9
IT,RENAL FAILURE,9
IT,URTICARIA,9
IT,ACUTE MYOCARDIAL INFARCTION,8
IT,ALLODYNIA,8
IT,ANXIETY,8
IT,ATRIAL FIBRILLATION,8
IT,CHILLS,8
IT,DEATH,8
IT,DYSAESTHESIA,8
IT,ENTERITIS,8
IT,HYPERPYREXIA,8
IT,HYPERTENSION,8
IT,LEUKOPENIA,8
IT,MUSCLE SPASMS,8
IT,NYSTAGMUS,8
IT,PSYCHOMOTOR RETARDATION,8
IT,SELF INJURIOUS BEHAVIOUR,8
IT,SUICIDAL IDEATION,8
IT,VISION BLURRED,8
IT,ACCIDENTAL OVERDOSE,7
IT,AGGRESSION,7
IT,ANURIA,7
IT,CARDIAC FAILURE,7
IT,CARDIOGENIC SHOCK,7
IT,CEREBRAL HAEMORRHAGE,7
IT,DRUG USE DISORDER,7
IT,EPILEPSY,7
IT,EPISTAXIS,7
IT,FATIGUE,7
IT,HEPATIC FAILURE,7
IT,HYPERBILIRUBINAEMIA,7
IT,HYPERSENSITIVITY,7
IT,HYPERTENSIVE CRISIS,7
IT,INTERNATIONAL NORMALISED RATIO INCREASED,7
IT,INTERSTITIAL LUNG DISEASE,7
IT,MYDRIASIS,7
IT,OESOPHAGEAL VARICES HAEMORRHAGE,7
IT,PALLOR,7
IT,RASH,7
IT,SLUGGISHNESS,7
IT,ACUTE CORONARY SYNDROME,6
IT,ANGIOEDEMA,6
IT,ANORGASMIA,6
IT,CARDIO-RESPIRATORY ARREST,6
IT,EXPOSURE DURING PREGNANCY,6
IT,EYELID SKIN DRYNESS,6
IT,GASTRIC HAEMORRHAGE,6
IT,GENERAL PHYSICAL HEALTH DETERIORATION,6
IT,HEMIPARESIS,6
IT,HEPATIC ENCEPHALOPATHY,6
IT,HYPOVOLAEMIC SHOCK,6
IT,INCORRECT DOSE ADMINISTERED,6
IT,INFUSION RELATED REACTION,6
IT,INSOMNIA,6
IT,LACTIC ACIDOSIS,6
IT,METAMORPHOPSIA,6
IT,MOTOR DYSFUNCTION,6
IT,MUSCLE RIGIDITY,6
IT,NEURALGIA,6
IT,NEUROPATHY PERIPHERAL,6
IT,PANCYTOPENIA,6
IT,PARKINSONISM,6
IT,PHARYNGEAL ERYTHEMA,6
IT,PLEURAL EFFUSION,6
IT,PSYCHOMOTOR SKILLS IMPAIRED,6
IT,SEPTIC SHOCK,6
IT,SHOCK,6
IT,ARTHRALGIA,5
IT,ATAXIA,5
IT,BLOOD PRESSURE INCREASED,5
IT,BURNING SENSATION,5
IT,COUGH,5
IT,DEEP VEIN THROMBOSIS,5
IT,DISEASE PROGRESSION,5
IT,DRUG DEPENDENCE,5
IT,DRUG LEVEL INCREASED,5
IT,DYSPEPSIA,5
IT,DYSSTASIA,5
IT,ECZEMA,5
IT,HEART RATE INCREASED,5
IT,HYPOAESTHESIA,5
IT,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,5
IT,IRRITABILITY,5
IT,LETHARGY,5
IT,MAJOR DEPRESSION,5
IT,MYOCLONUS,5
IT,NEUROLOGICAL SYMPTOM,5
IT,PETIT MAL EPILEPSY,5
IT,POISONING,5
IT,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,5
IT,SEDATION,5
IT,STOMATITIS,5
IT,SUBARACHNOID HAEMORRHAGE,5
IT,SUBDURAL HAEMATOMA,5
IT,TREATMENT NONCOMPLIANCE,5
IT,VERTIGO CNS ORIGIN,5
IT,ABDOMINAL DISTENSION,4
IT,ABNORMAL BEHAVIOUR,4
IT,ANAPHYLACTIC SHOCK,4
IT,ASTHENOPIA,4
IT,BASAL CELL CARCINOMA,4
IT,BONE PAIN,4
IT,BUNDLE BRANCH BLOCK RIGHT,4
IT,DELIRIUM,4
IT,DEPRESSED LEVEL OF CONSCIOUSNESS,4
IT,DRUG ADMINISTRATION ERROR,4
IT,ELECTROLYTE IMBALANCE,4
IT,EXPOSED BONE IN JAW,4
IT,EYE DISORDER,4
IT,FAECALOMA,4
IT,FEELING ABNORMAL,4
IT,FEELING HOT,4
IT,GASTROENTERITIS CLOSTRIDIAL,4
IT,HALLUCINATION_ AUDITORY,4
IT,HYPOGLYCAEMIC UNCONSCIOUSNESS,4
IT,INTESTINAL OBSTRUCTION,4
IT,LARYNGOSPASM,4
IT,LUNG INFECTION,4
IT,MYOCARDIAL INFARCTION,4
IT,OXYGEN SATURATION DECREASED,4
IT,PALPITATIONS,4
IT,PARAESTHESIA ORAL,4
IT,PERIPHERAL SENSORY NEUROPATHY,4
IT,PERIPHERAL SWELLING,4
IT,PLASMA CELL MYELOMA,4
IT,RECTAL HAEMORRHAGE,4
IT,RESTLESSNESS,4
IT,RHYTHM IDIOVENTRICULAR,4
IT,SCIATIC NERVE INJURY,4
IT,SLEEP DISORDER,4
IT,STREPTOCOCCAL SEPSIS,4
IT,TOXIC EPIDERMAL NECROLYSIS,4
IT,TOXIC SHOCK SYNDROME,4
IT,TRANSAMINASES INCREASED,4
IT,UNRESPONSIVE TO STIMULI,4
IT,URINARY RETENTION,4
IT,URINARY TRACT INFECTION,4
IT,VISUAL IMPAIRMENT,4
IT,WEIGHT INCREASED,4
IT,ACIDOSIS,3
IT,ANAL SPHINCTER ATONY,3
IT,BLADDER SPHINCTER ATONY,3
IT,BLINDNESS,3
IT,BLOOD BILIRUBIN INCREASED,3
IT,BLOOD BILIRUBIN UNCONJUGATED INCREASED,3
IT,BLOOD CREATINE PHOSPHOKINASE INCREASED,3
IT,BLOOD PRESSURE DECREASED,3
IT,BRONCHOSPASM,3
IT,CHEST DISCOMFORT,3
IT,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
IT,COLD SWEAT,3
IT,CONTUSION,3
IT,DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT,3
IT,DROP ATTACKS,3
IT,DRUG EFFECT INCOMPLETE,3
IT,DRY EYE,3
IT,DRY MOUTH,3
IT,DUODENAL ULCER,3
IT,EPIDIDYMITIS,3
IT,ERYTHRODERMIC PSORIASIS,3
IT,GASTRITIS EROSIVE,3
IT,GASTROINTESTINAL HYPOMOTILITY,3
IT,GENERALISED OEDEMA,3
IT,GLUCOSE TOLERANCE IMPAIRED,3
IT,GRAVITATIONAL OEDEMA,3
IT,HAEMATURIA,3
IT,HAEMORRHAGE SUBCUTANEOUS,3
IT,HEAD DISCOMFORT,3
IT,HEMIANOPIA,3
IT,HEPATITIS FULMINANT,3
IT,HYPERCHLORHYDRIA,3
IT,HYPORESPONSIVE TO STIMULI,3
IT,HYPOXIA,3
IT,INVASIVE DUCTAL BREAST CARCINOMA,3
IT,IRON DEFICIENCY ANAEMIA,3
IT,ISCHAEMIC STROKE,3
IT,JAUNDICE,3
IT,LEUKOCYTOSIS,3
IT,LONG QT SYNDROME,3
IT,MANIA,3
IT,MATERNAL EXPOSURE DURING PREGNANCY,3
IT,METAPNEUMOVIRUS INFECTION,3
IT,MUCOSAL INFLAMMATION,3
IT,MULTIPLE INJURIES,3
IT,MYALGIA,3
IT,MYOGLOBIN BLOOD INCREASED,3
IT,NODAL ARRHYTHMIA,3
IT,OSTEONECROSIS,3
IT,PAIN IN JAW,3
IT,PALATAL OEDEMA,3
IT,PETECHIAE,3
IT,PHOTOPSIA,3
IT,PNEUMONITIS,3
IT,POLYNEUROPATHY,3
IT,PRESCRIBED UNDERDOSE,3
IT,PULMONARY OEDEMA,3
IT,RENAL IMPAIRMENT,3
IT,RESPIRATORY ACIDOSIS,3
IT,RESPIRATORY DISTRESS,3
IT,SHOCK HAEMORRHAGIC,3
IT,SKIN ULCER,3
IT,SKIN ULCER HAEMORRHAGE,3
IT,SLOW RESPONSE TO STIMULI,3
IT,SLOW SPEECH,3
IT,SOMATISATION DISORDER,3
IT,STAPHYLOCOCCAL SEPSIS,3
IT,SUBCUTANEOUS HAEMATOMA,3
IT,SWELLING FACE,3
IT,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,3
IT,TOXIC SKIN ERUPTION,3
IT,VISUAL FIELD DEFECT,3
IT,ABDOMINAL DISCOMFORT,2
IT,ACUTE MYELOID LEUKAEMIA,2
IT,ALANINE AMINOTRANSFERASE INCREASED,2
IT,ALTERED STATE OF CONSCIOUSNESS,2
IT,ANAL STENOSIS,2
IT,APHASIA,2
IT,APRAXIA,2
IT,ARTERIAL THROMBOSIS,2
IT,BACK PAIN,2
IT,BARTTER^S SYNDROME,2
IT,BIPOLAR DISORDER,2
IT,BLOOD ALKALINE PHOSPHATASE INCREASED,2
IT,BLOOD FIBRINOGEN INCREASED,2
IT,BLOOD GLUCOSE INCREASED,2
IT,BLOOD POTASSIUM INCREASED,2
IT,BLOOD TEST ABNORMAL,2
IT,BLOOD UREA INCREASED,2
IT,BONE CYST,2
IT,BREATH SOUNDS ABNORMAL,2
IT,BRONCHIAL OBSTRUCTION,2
IT,BRONCHOPNEUMONIA,2
IT,BRUGADA SYNDROME,2
IT,BURSITIS INFECTIVE,2
IT,CEREBRAL ISCHAEMIA,2
IT,CERVICOBRACHIAL SYNDROME,2
IT,CIRCULATORY COLLAPSE,2
IT,CLONUS,2
IT,CONJUNCTIVAL HAEMORRHAGE,2
IT,CORONARY ARTERY DISEASE,2
IT,CYANOSIS,2
IT,CYSTITIS HAEMORRHAGIC,2
IT,CYTOMEGALOVIRUS INFECTION,2
IT,CYTOMEGALOVIRUS TEST POSITIVE,2
IT,DEMYELINATION,2
IT,DEPENDENCE,2
IT,DEPRESSION,2
IT,DRUG DOSE OMISSION,2
IT,DRUG INTOLERANCE,2
IT,DRUG PRESCRIBING ERROR,2
IT,DRUG SCREEN POSITIVE,2
IT,DRUG WITHDRAWAL SYNDROME,2
IT,DYSPHONIA,2
IT,EJACULATION DELAYED,2
IT,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,2
IT,ELECTROCARDIOGRAM T WAVE ABNORMAL,2
IT,ELECTROENCEPHALOGRAM ABNORMAL,2
IT,ENANTHEMA,2
IT,ENDOCARDITIS BACTERIAL,2
IT,EPIGLOTTIC OEDEMA,2
IT,ERECTILE DYSFUNCTION,2
IT,EXCORIATION,2
IT,EYE SWELLING,2
IT,FACIAL PARALYSIS,2
IT,FASTING,2
IT,FEMUR FRACTURE,2
IT,FISTULA,2
IT,FLUSHING,2
IT,FRACTURE,2
IT,GAIT INABILITY,2
IT,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
IT,GASTRIC DISORDER,2
IT,GASTRODUODENITIS,2
IT,GASTROENTERITIS,2
IT,GASTROOESOPHAGEAL REFLUX DISEASE,2
IT,GAZE PALSY,2
IT,GENERALISED ERYTHEMA,2
IT,GINGIVITIS,2
IT,HAEMATOMA,2
IT,HAEMOGLOBIN DECREASED,2
IT,HAEMOPTYSIS,2
IT,HAEMORRHAGE,2
IT,HALLUCINATIONS_ MIXED,2
IT,HEPATITIS NON-A NON-B,2
IT,HEPATORENAL FAILURE,2
IT,HERPES ZOSTER,2
IT,HYPERAEMIA,2
IT,HYPERTRANSAMINASAEMIA,2
IT,HYPOACUSIS,2
IT,HYPOCALCAEMIA,2
IT,HYPOKINESIA,2
IT,INFECTION,2
IT,INFLUENZA,2
IT,INTESTINAL PERFORATION,2
IT,ISCHAEMIA,2
IT,KAPOSI^S SARCOMA,2
IT,LABORATORY TEST ABNORMAL,2
IT,LARYNGEAL OEDEMA,2
IT,LEFT VENTRICULAR FAILURE,2
IT,LIMB INJURY,2
IT,LIVER DISORDER,2
IT,LOCALISED OEDEMA,2
IT,LUNG NEOPLASM,2
IT,LYMPHOCYTE COUNT DECREASED,2
IT,MELANOCYTIC NAEVUS,2
IT,MEMORY IMPAIRMENT,2
IT,METABOLIC ACIDOSIS,2
IT,METABOLIC ALKALOSIS,2
IT,METABOLIC ENCEPHALOPATHY,2
IT,METASTASES TO LIVER,2
IT,METRORRHAGIA,2
IT,MICROCYTIC ANAEMIA,2
IT,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
IT,MUSCULOSKELETAL PAIN,2
IT,MYELODYSPLASTIC SYNDROME,2
IT,NERVOUS SYSTEM DISORDER,2
IT,NEUTROPHILIA,2
IT,NO THERAPEUTIC RESPONSE,2
IT,OBESITY,2
IT,PAROSMIA,2
IT,PARTIAL SEIZURES,2
IT,PATHOLOGICAL GAMBLING,2
IT,PERFORMANCE STATUS DECREASED,2
IT,PERICARDIAL EFFUSION,2
IT,PERITONITIS,2
IT,PLATELET COUNT DECREASED,2
IT,PRERENAL FAILURE,2
IT,PRODUCTIVE COUGH,2
IT,PROTEINURIA,2
IT,PSORIASIS,2
IT,RENAL FAILURE ACUTE,2
IT,RESPIRATORY DEPRESSION,2
IT,RETCHING,2
IT,ROAD TRAFFIC ACCIDENT,2
IT,SEIZURE,2
IT,SINUS BRADYCARDIA,2
IT,SINUS TACHYCARDIA,2
IT,SKIN ABRASION,2
IT,SKIN DISCOLOURATION,2
IT,SPINAL PAIN,2
IT,STATUS EPILEPTICUS,2
IT,SUBSTANCE ABUSE,2
IT,SUDDEN DEATH,2
IT,SWOLLEN TONGUE,2
IT,THROAT TIGHTNESS,2
IT,THROMBOPHLEBITIS SUPERFICIAL,2
IT,TONIC CLONIC MOVEMENTS,2
IT,TRANSFUSION,2
IT,URINARY INCONTINENCE,2
IT,VASCULITIS,2
IT,WHEEZING,2
IT,ABDOMINAL PAIN LOWER,1
IT,ABNORMAL LOSS OF WEIGHT,1
IT,ACIDOSIS HYPERCHLORAEMIC,1
IT,ACUTE ABDOMEN,1
IT,ACUTE HEPATIC FAILURE,1
IT,ACUTE PULMONARY OEDEMA,1
IT,ADENOCARCINOMA,1
IT,ADENOCARCINOMA OF COLON,1
IT,ADENOMA BENIGN,1
IT,ADVERSE DRUG REACTION,1
IT,AFFECTIVE DISORDER,1
IT,AIRWAY COMPLICATION OF ANAESTHESIA,1
IT,AKATHISIA,1
IT,ALCOHOL POISONING,1
IT,AMNESIA,1
IT,ANTIPSYCHOTIC DRUG LEVEL INCREASED,1
IT,AORTIC DISORDER,1
IT,APPENDICITIS,1
IT,ARRHYTHMIA,1
IT,ARTERIAL DISORDER,1
IT,ARTERIOSCLEROSIS,1
IT,ARTHRITIS,1
IT,ASPARTATE AMINOTRANSFERASE INCREASED,1
IT,ASTRINGENT THERAPY,1
IT,ATONIC SEIZURES,1
IT,ATRIOVENTRICULAR BLOCK,1
IT,ATRIOVENTRICULAR BLOCK COMPLETE,1
IT,ATRIOVENTRICULAR BLOCK FIRST DEGREE,1
IT,ATRIOVENTRICULAR BLOCK SECOND DEGREE,1
IT,AUTOIMMUNE HEPATITIS,1
IT,AUTOIMMUNE THYROIDITIS,1
IT,AUTONOMIC NERVOUS SYSTEM IMBALANCE,1
IT,AUTONOMIC NEUROPATHY,1
IT,AZOTAEMIA,1
IT,BILIARY DRAINAGE,1
IT,BILIARY TRACT DISORDER,1
IT,BILIRUBIN CONJUGATED INCREASED,1
IT,BLADDER TRANSITIONAL CELL CARCINOMA,1
IT,BLINDNESS UNILATERAL,1
IT,BLOOD COUNT ABNORMAL,1
IT,BLOOD LACTATE DEHYDROGENASE INCREASED,1
IT,BLOOD PH DECREASED,1
IT,BLOOD POTASSIUM DECREASED,1
IT,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
IT,BLOOD THYROID STIMULATING HORMONE INCREASED,1
IT,BLOOD URIC ACID INCREASED,1
IT,BODY TEMPERATURE DECREASED,1
IT,BODY TEMPERATURE INCREASED,1
IT,BREAST MASS,1
IT,BREAST SWELLING,1
IT,BRONCHIOLITIS,1
IT,BUNDLE BRANCH BLOCK LEFT,1
IT,C-REACTIVE PROTEIN INCREASED,1
IT,CARDIAC AMYLOIDOSIS,1
IT,CARDIAC DEATH,1
IT,CARDIAC DISORDER,1
IT,CARDIAC FAILURE CONGESTIVE,1
IT,CARDIAC VENTRICULAR THROMBOSIS,1
IT,CAROTID ARTERIOSCLEROSIS,1
IT,CAROTID ARTERY THROMBOSIS,1
IT,CENTRAL NERVOUS SYSTEM LESION,1
IT,CEREBRAL ATROPHY,1
IT,CEREBROVASCULAR ACCIDENT,1
IT,CHOKING,1
IT,CHOKING SENSATION,1
IT,CHOLECYSTITIS ACUTE,1
IT,CHOREA,1
IT,CHRONIC KIDNEY DISEASE,1
IT,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
IT,COLITIS,1
IT,COLORECTAL CANCER,1
IT,COMPENSATORY SWEATING,1
IT,CONDUCT DISORDER,1
IT,CONFABULATION,1
IT,CONGENITAL ANOMALY,1
IT,CONJUNCTIVITIS,1
IT,CONSTRICTED AFFECT,1
IT,CONVULSION,1
IT,CRANIOCEREBRAL INJURY,1
IT,CREATININE URINE INCREASED,1
IT,DEAFNESS BILATERAL,1
IT,DECREASED VIBRATORY SENSE,1
IT,DERMATITIS BULLOUS,1
IT,DERMATITIS EXFOLIATIVE,1
IT,DEVICE CONNECTION ISSUE,1
IT,DEVICE ISSUE,1
IT,DEVICE OCCLUSION,1
IT,DEVICE RELATED SEPSIS,1
IT,DIABETES MELLITUS,1
IT,DISEASE RECURRENCE,1
IT,DISSOCIATION,1
IT,DIVERTICULITIS,1
IT,DIVERTICULUM,1
IT,DRUG CLEARANCE DECREASED,1
IT,DRUG HYPERSENSITIVITY,1
IT,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
IT,DRUG LEVEL ABOVE THERAPEUTIC,1
IT,DRUG RESISTANCE,1
IT,DRY GANGRENE,1
IT,DRY SKIN,1
IT,DYSGRAPHIA,1
IT,DYSLALIA,1
IT,DYSLIPIDAEMIA,1
IT,DYSMETRIA,1
IT,DYSPHEMIA,1
IT,DYSPNOEA AT REST,1
IT,DYSPNOEA EXERTIONAL,1
IT,DYSTONIA,1
IT,EAR HAEMORRHAGE,1
IT,EAR INFECTION,1
IT,EAR PAIN,1
IT,ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY,1
IT,ELECTROCARDIOGRAM ST-T CHANGE,1
IT,EMBOLIC STROKE,1
IT,EMOTIONAL DISORDER,1
IT,ENCAPSULATING PERITONEAL SCLEROSIS,1
IT,ENDOCARDITIS,1
IT,EPICONDYLITIS,1
IT,ERUCTATION,1
IT,ERYSIPELAS,1
IT,ERYTHROLEUKAEMIA,1
IT,ESCHERICHIA INFECTION,1
IT,ESCHERICHIA URINARY TRACT INFECTION,1
IT,EUPHORIC MOOD,1
IT,EXPANDED DISABILITY STATUS SCALE SCORE INCREASED,1
IT,EXPOSURE VIA PARTNER,1
IT,EXTRASKELETAL OSSIFICATION,1
IT,EXTRASYSTOLES,1
IT,EXTRAVASATION,1
IT,EYE HAEMORRHAGE,1
IT,EYE IRRITATION,1
IT,EYE MOVEMENT DISORDER,1
IT,EYELID OEDEMA,1
IT,FACE OEDEMA,1
IT,FAECES DISCOLOURED,1
IT,FAECES PALE,1
IT,FAECES SOFT,1
IT,FEELING COLD,1
IT,FEELING OF RELAXATION,1
IT,FEMALE SEXUAL AROUSAL DISORDER,1
IT,FIBRIN D DIMER INCREASED,1
IT,FLATULENCE,1
IT,FLUID RETENTION,1
IT,FOLATE DEFICIENCY,1
IT,FOLLICULITIS,1
IT,FOOT FRACTURE,1
IT,FORMICATION,1
IT,FREEZING PHENOMENON,1
IT,FUNGAL PERITONITIS,1
IT,GALLBLADDER DISORDER,1
IT,GAMBLING DISORDER,1
IT,GASTRIC POLYPS,1
IT,GASTRIC ULCER,1
IT,GASTROINTESTINAL AMYLOIDOSIS,1
IT,GASTROINTESTINAL ANGIODYSPLASIA,1
IT,GASTROINTESTINAL HAEMORRHAGE,1
IT,GASTROINTESTINAL NECROSIS,1
IT,GENERALISED TONIC-CLONIC SEIZURE,1
IT,GLIOBLASTOMA,1
IT,GLOSSODYNIA,1
IT,GROIN PAIN,1
IT,GUILLAIN-BARRE SYNDROME,1
IT,HAEMATOCHEZIA,1
IT,HAEMODIALYSIS,1
IT,HAEMOLYTIC URAEMIC SYNDROME,1
IT,HAEMORRHAGIC ANAEMIA,1
IT,HAEMORRHOIDS,1
IT,HALLUCINATION_ TACTILE,1
IT,HEART RATE DECREASED,1
IT,HEMIPLEGIA,1
IT,HEPATECTOMY,1
IT,HEPATIC ENZYME INCREASED,1
IT,HEPATIC FUNCTION ABNORMAL,1
IT,HEPATITIS ACUTE,1
IT,HERNIA,1
IT,HERPES VIRUS INFECTION,1
IT,HIP FRACTURE,1
IT,HOT FLUSH,1
IT,HYDRONEPHROSIS,1
IT,HYPERCREATININAEMIA,1
IT,HYPERINSULINAEMIC HYPOGLYCAEMIA,1
IT,HYPERPROLACTINAEMIA,1
IT,HYPERREFLEXIA,1
IT,HYPERSOMNIA,1
IT,HYPERTROPHIC SCAR,1
IT,HYPOAESTHESIA ORAL,1
IT,HYPOALBUMINAEMIA,1
IT,HYPOCHLORAEMIA,1
IT,HYPONATRAEMIC SYNDROME,1
IT,HYPOPHONESIS,1
IT,HYPOVOLAEMIA,1
IT,ILLNESS ANXIETY DISORDER,1
IT,INCORRECT DOSE ADMINISTERED BY DEVICE,1
IT,INCORRECT DRUG ADMINISTRATION DURATION,1
IT,INFARCTION,1
IT,INFLUENZA A VIRUS TEST POSITIVE,1
IT,INFLUENZA LIKE ILLNESS,1
IT,INGUINAL HERNIA,1
IT,INJECTION SITE INFLAMMATION,1
IT,INJECTION SITE PAIN,1
IT,INJURY,1
IT,INTENTIONAL DRUG MISUSE,1
IT,INTENTIONAL PRODUCT USE ISSUE,1
IT,INTERNATIONAL NORMALISED RATIO FLUCTUATION,1
IT,INTESTINAL HAEMORRHAGE,1
IT,INTESTINAL TRANSIT TIME INCREASED,1
IT,JAUNDICE CHOLESTATIC,1
IT,JOINT INJURY,1
IT,JOINT LOCK,1
IT,JOINT RANGE OF MOTION DECREASED,1
IT,JOINT SWELLING,1
IT,KERATITIS,1
IT,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
IT,LACRIMATION INCREASED,1
IT,LANGUAGE DISORDER,1
IT,LIP OEDEMA,1
IT,LIVER FUNCTION TEST INCREASED,1
IT,LOCAL SWELLING,1
IT,LOGORRHOEA,1
IT,LUMBAR SPINAL STENOSIS,1
IT,LUNG ADENOCARCINOMA,1
IT,LUNG DISORDER,1
IT,LYMPHADENOPATHY,1
IT,LYMPHANGIOSIS CARCINOMATOSA,1
IT,LYMPHANGITIS,1
IT,LYMPHOPENIA,1
IT,MALIGNANT MEDIASTINAL NEOPLASM,1
IT,MALOCCLUSION,1
IT,MASTITIS,1
IT,MASTOIDITIS,1
IT,MEGACOLON,1
IT,MENSTRUATION IRREGULAR,1
IT,MENTAL IMPAIRMENT,1
IT,MENTAL STATUS CHANGES,1
IT,METASTASES TO LYMPH NODES,1
IT,MIGRAINE,1
IT,MITRAL VALVE DISEASE,1
IT,MITRAL VALVE INCOMPETENCE,1
IT,MUCOSAL DRYNESS,1
IT,MUCOUS MEMBRANE DISORDER,1
IT,MULTIPLE SCLEROSIS,1
IT,MUSCULOSKELETAL CHEST PAIN,1
IT,MYOCARDIAL DEPRESSION,1
IT,MYOCARDIAL NECROSIS MARKER INCREASED,1
IT,MYOSITIS,1
IT,NASAL DRYNESS,1
IT,NASAL ODOUR,1
IT,NASOPHARYNGITIS,1
IT,NECK PAIN,1
IT,NECROTISING FASCIITIS,1
IT,NEGATIVISM,1
IT,NEOPLASM,1
IT,NEOPLASM PROGRESSION,1
IT,NEPHROLITHIASIS,1
IT,NEPHROTIC SYNDROME,1
IT,NERVOUSNESS,1
IT,NEUROLEPTIC MALIGNANT SYNDROME,1
IT,NEUROTOXICITY,1
IT,NO ADVERSE EVENT,1
IT,NODAL RHYTHM,1
IT,NON-24-HOUR SLEEP-WAKE DISORDER,1
IT,NONINFECTIOUS PERITONITIS,1
IT,OBSESSIVE THOUGHTS,1
IT,OCULAR DISCOMFORT,1
IT,OCULAR VASCULAR DISORDER,1
IT,OEDEMA,1
IT,OESOPHAGEAL CANDIDIASIS,1
IT,OESOPHAGEAL DISORDER,1
IT,OESOPHAGITIS,1
IT,OLIGURIA,1
IT,ON AND OFF PHENOMENON,1
IT,OPPOSITIONAL DEFIANT DISORDER,1
IT,ORAL CANDIDIASIS,1
IT,OROPHARYNGEAL CANCER,1
IT,OROPHARYNGEAL PAIN,1
IT,ORTHOPNOEA,1
IT,ORTHOSTATIC HYPOTENSION,1
IT,OSTEITIS,1
IT,OSTEOLYSIS,1
IT,OSTEOMYELITIS,1
IT,OSTEOPOROSIS,1
IT,OSTEOSCLEROSIS,1
IT,OTOTOXICITY,1
IT,OVERWEIGHT,1
IT,OXYGEN SATURATION,1
IT,PACKED RED BLOOD CELL TRANSFUSION,1
IT,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
IT,PANCREATITIS ACUTE,1
IT,PANIC ATTACK,1
IT,PAPULE,1
IT,PARANEOPLASTIC SYNDROME,1
IT,PARANOIA,1
IT,PARAPARESIS,1
IT,PENILE HAEMORRHAGE,1
IT,PERICARDITIS,1
IT,PERIODONTITIS,1
IT,PERIPHERAL ARTERY ANEURYSM,1
IT,PERIPHERAL ARTERY THROMBOSIS,1
IT,PERIPHERAL COLDNESS,1
IT,PERIPHERAL ISCHAEMIA,1
IT,PERITONITIS BACTERIAL,1
IT,PERSECUTORY DELUSION,1
IT,PERSONALITY DISORDER,1
IT,PHARYNGEAL OEDEMA,1
IT,PHLEBITIS,1
IT,PHOTOPHOBIA,1
IT,PLASMA CELL LEUKAEMIA,1
IT,PLATELET TRANSFUSION,1
IT,PNEUMOCOCCAL SEPSIS,1
IT,PNEUMONIA ASPIRATION,1
IT,POISONING DELIBERATE,1
IT,POLYDIPSIA,1
IT,POLYURIA,1
IT,POOR VENOUS ACCESS,1
IT,PORTAL HYPERTENSION,1
IT,PORTAL VEIN THROMBOSIS,1
IT,POSTMORTEM BLOOD DRUG LEVEL INCREASED,1
IT,POSTURAL TREMOR,1
IT,POSTURE ABNORMAL,1
IT,POTENTIATING DRUG INTERACTION,1
IT,PREGNANCY,1
IT,PRETERM PREMATURE RUPTURE OF MEMBRANES,1
IT,PRODUCT DROPPER ISSUE,1
IT,PRODUCT MEASURED POTENCY ISSUE,1
IT,PROSTATIC ADENOMA,1
IT,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
IT,PSEUDOMONAL SEPSIS,1
IT,PULMONARY CONGESTION,1
IT,PULMONARY FIBROSIS,1
IT,PULMONARY FUNCTION TEST ABNORMAL,1
IT,PULMONARY HYPERTENSION,1
IT,PULMONARY INFARCTION,1
IT,RASH MORBILLIFORM,1
IT,RASH PAPULAR,1
IT,RASH PRURITIC,1
IT,RECTAL ULCER HAEMORRHAGE,1
IT,REFLEXES ABNORMAL,1
IT,RENAL CANCER,1
IT,RENAL FAILURE CHRONIC,1
IT,RENAL PAIN,1
IT,RESPIRATORY ARREST,1
IT,RESPIRATORY FATIGUE,1
IT,RESTING TREMOR,1
IT,RETINAL ISCHAEMIA,1
IT,RETINOIC ACID SYNDROME,1
IT,RHABDOMYOLYSIS,1
IT,RHINITIS,1
IT,RHINORRHOEA,1
IT,RIB FRACTURE,1
IT,ROSACEA,1
IT,SACROILIITIS,1
IT,SALIVARY HYPERSECRETION,1
IT,SCHIZOPHRENIFORM DISORDER,1
IT,SCIATICA,1
IT,SCLERODERMA-LIKE REACTION,1
IT,SCRATCH,1
IT,SELF-MEDICATION,1
IT,SENSITIVITY OF TEETH,1
IT,SEROTONIN SYNDROME,1
IT,SHIFT TO THE RIGHT,1
IT,SINUS NODE DYSFUNCTION,1
IT,SKIN EXFOLIATION,1
IT,SKIN LESION,1
IT,SKIN PAPILLOMA,1
IT,SKIN REACTION,1
IT,SKIN TOXICITY,1
IT,SKIN WARM,1
IT,SNORING,1
IT,SPINAL CORD COMPRESSION,1
IT,SQUAMOUS CELL CARCINOMA,1
IT,STARING,1
IT,STOMA SITE INFLAMMATION,1
IT,STRANGURY,1
IT,STRESS,1
IT,STRIDOR,1
IT,STUPOR,1
IT,SUBCLAVIAN ARTERY THROMBOSIS,1
IT,SUBILEUS,1
IT,SUBSTANCE-INDUCED PSYCHOTIC DISORDER,1
IT,SUDDEN ONSET OF SLEEP,1
IT,SUPRAPUBIC PAIN,1
IT,SUPRAVENTRICULAR TACHYCARDIA,1
IT,SWELLING,1
IT,SYSTEMIC LUPUS ERYTHEMATOSUS,1
IT,TENDON PAIN,1
IT,TENOSYNOVITIS,1
IT,TENSION,1
IT,TETANY,1
IT,THERAPEUTIC RESPONSE DECREASED,1
IT,THERMAL BURN,1
IT,THOUGHT BLOCKING,1
IT,THROAT IRRITATION,1
IT,THROMBOSIS,1
IT,THROMBOTIC THROMBOCYTOPENIC PURPURA,1
IT,THYROID CANCER,1
IT,THYROID NEOPLASM,1
IT,TONGUE FUNGAL INFECTION,1
IT,TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED,1
IT,TONGUE OEDEMA,1
IT,TONSIL CANCER,1
IT,TOOTH ABSCESS,1
IT,TORSADE DE POINTES,1
IT,TRANSIENT ISCHAEMIC ATTACK,1
IT,TRIGEMINAL NEURALGIA,1
IT,TROPONIN INCREASED,1
IT,TUBULOINTERSTITIAL NEPHRITIS,1
IT,UPPER GASTROINTESTINAL HAEMORRHAGE,1
IT,UPPER RESPIRATORY TRACT INFECTION,1
IT,URINARY TRACT OBSTRUCTION,1
IT,VAGINAL HAEMORRHAGE,1
IT,VASOSPASM,1
IT,VENTRICULAR FIBRILLATION,1
IT,VENTRICULAR HYPOKINESIA,1
IT,VIITH NERVE PARALYSIS,1
IT,VISUAL ACUITY REDUCED,1
IT,VITAMIN D DEFICIENCY,1
IT,WALKING DISABILITY,1
IT,WITHDRAWAL SYNDROME,1
JM,SUICIDAL IDEATION,1
JP,DIZZINESS,326
JP,SOMNOLENCE,287
JP,INTERSTITIAL LUNG DISEASE,259
JP,FALL,256
JP,NAUSEA,212
JP,PYREXIA,187
JP,PNEUMONIA,175
JP,DECREASED APPETITE,163
JP,LOSS OF CONSCIOUSNESS,163
JP,HEPATIC FUNCTION ABNORMAL,151
JP,ALTERED STATE OF CONSCIOUSNESS,148
JP,ANAEMIA,144
JP,MALAISE,143
JP,VOMITING,140
JP,PLATELET COUNT DECREASED,131
JP,DIARRHOEA,130
JP,RENAL IMPAIRMENT,124
JP,DELIRIUM,123
JP,MALIGNANT NEOPLASM PROGRESSION,118
JP,CONDITION AGGRAVATED,109
JP,CONSTIPATION,91
JP,PAIN,90
JP,CARDIAC FAILURE,89
JP,HYPOAESTHESIA,89
JP,DRUG INEFFECTIVE,85
JP,RASH,81
JP,ASPARTATE AMINOTRANSFERASE INCREASED,80
JP,GAIT DISTURBANCE,80
JP,WHITE BLOOD CELL COUNT DECREASED,78
JP,ALANINE AMINOTRANSFERASE INCREASED,77
JP,DYSPNOEA,75
JP,OEDEMA PERIPHERAL,75
JP,OEDEMA,74
JP,ASTHENIA,73
JP,LIVER DISORDER,72
JP,RHABDOMYOLYSIS,72
JP,DEPRESSED LEVEL OF CONSCIOUSNESS,71
JP,FEELING ABNORMAL,71
JP,DEHYDRATION,70
JP,BLOOD CREATININE INCREASED,68
JP,HEADACHE,68
JP,INSOMNIA,65
JP,ROAD TRAFFIC ACCIDENT,65
JP,MUSCULAR WEAKNESS,63
JP,NEUTROPHIL COUNT DECREASED,63
JP,FEBRILE NEUTROPENIA,62
JP,CEREBRAL INFARCTION,60
JP,DISSEMINATED INTRAVASCULAR COAGULATION,60
JP,HERPES ZOSTER,59
JP,WEIGHT INCREASED,59
JP,PNEUMONIA ASPIRATION,58
JP,DEATH,55
JP,DEMENTIA,55
JP,OSTEONECROSIS OF JAW,55
JP,DRUG ERUPTION,54
JP,HYPERKALAEMIA,53
JP,C-REACTIVE PROTEIN INCREASED,52
JP,ERYTHEMA MULTIFORME,52
JP,SEPSIS,52
JP,DRUG-INDUCED LIVER INJURY,51
JP,PAIN IN EXTREMITY,51
JP,PLEURAL EFFUSION,51
JP,ACUTE KIDNEY INJURY,49
JP,BACK PAIN,49
JP,OVERDOSE,49
JP,STOMATITIS,49
JP,BLOOD CREATINE PHOSPHOKINASE INCREASED,48
JP,HAEMOGLOBIN DECREASED,48
JP,URINARY TRACT INFECTION,48
JP,VISUAL ACUITY REDUCED,48
JP,SEIZURE,47
JP,NEUTROPENIA,46
JP,PRODUCT USE ISSUE,46
JP,BRADYCARDIA,45
JP,HYPERTENSION,45
JP,HYPOKALAEMIA,45
JP,COUGH,44
JP,PRURITUS,44
JP,BLOOD PRESSURE DECREASED,43
JP,HAEMORRHAGE SUBCUTANEOUS,43
JP,HYPOGLYCAEMIA,42
JP,ILEUS,42
JP,ARTHRALGIA,41
JP,VISION BLURRED,40
JP,DYSSTASIA,39
JP,NEUROPATHY PERIPHERAL,39
JP,RESPIRATORY FAILURE,39
JP,URINARY RETENTION,39
JP,BLOOD UREA INCREASED,38
JP,CONTUSION,37
JP,GASTRIC ULCER,37
JP,TREMOR,37
JP,FRACTURE,36
JP,HYPONATRAEMIA,36
JP,SUICIDE ATTEMPT,36
JP,GAMMA-GLUTAMYLTRANSFERASE INCREASED,35
JP,RENAL DISORDER,35
JP,DYSARTHRIA,34
JP,PALPITATIONS,34
JP,HALLUCINATION,33
JP,NASOPHARYNGITIS,33
JP,BLOOD POTASSIUM INCREASED,32
JP,CATARACT,32
JP,DIABETES MELLITUS,32
JP,DISEASE PROGRESSION,32
JP,ABASIA,31
JP,BLOOD ALKALINE PHOSPHATASE INCREASED,31
JP,HYPOCALCAEMIA,31
JP,MYOCLONUS,31
JP,THROMBOCYTOPENIA,31
JP,BLOOD LACTATE DEHYDROGENASE INCREASED,30
JP,GASTROINTESTINAL HAEMORRHAGE,30
JP,LYMPHOCYTE COUNT DECREASED,30
JP,MUSCULOSKELETAL STIFFNESS,30
JP,SEPTIC SHOCK,30
JP,WHITE BLOOD CELL COUNT INCREASED,30
JP,ARRHYTHMIA,29
JP,DYSPHAGIA,29
JP,HYPERGLYCAEMIA,29
JP,INTENTIONAL OVERDOSE,29
JP,URTICARIA,29
JP,CHEST PAIN,28
JP,LUNG NEOPLASM MALIGNANT,28
JP,MYOCARDIAL INFARCTION,28
JP,SPINAL COMPRESSION FRACTURE,28
JP,ABDOMINAL PAIN,27
JP,DIPLOPIA,27
JP,EPILEPSY,27
JP,HYPERHIDROSIS,27
JP,PANCYTOPENIA,27
JP,RESTLESSNESS,27
JP,COLON CANCER,26
JP,ERYTHEMA,26
JP,PLASMA CELL MYELOMA,26
JP,ATRIAL FIBRILLATION,25
JP,BONE MARROW FAILURE,25
JP,CONVULSION,25
JP,DYSKINESIA,25
JP,ELECTROCARDIOGRAM QT PROLONGED,25
JP,FEMUR FRACTURE,25
JP,HALLUCINATION_ VISUAL,25
JP,HEAD INJURY,25
JP,RECTAL CANCER,25
JP,DRUG EFFECT INCOMPLETE,24
JP,INFECTION,24
JP,INTENTIONAL PRODUCT MISUSE,24
JP,LUNG DISORDER,24
JP,PERITONITIS,24
JP,RENAL FAILURE ACUTE,24
JP,DEPRESSION,23
JP,PULMONARY OEDEMA,23
JP,RENAL FAILURE,23
JP,DEEP VEIN THROMBOSIS,22
JP,GLAUCOMA,22
JP,MELAENA,22
JP,WEIGHT DECREASED,22
JP,ANXIETY,21
JP,DRUG WITHDRAWAL SYNDROME,21
JP,FATIGUE,21
JP,GASTRIC CANCER,21
JP,HAEMATEMESIS,21
JP,INTESTINAL OBSTRUCTION,21
JP,JAUNDICE,21
JP,RESPIRATORY DEPRESSION,21
JP,ABDOMINAL DISCOMFORT,20
JP,BLOOD BILIRUBIN INCREASED,20
JP,BLOOD GLUCOSE INCREASED,20
JP,FACE OEDEMA,20
JP,HYPOXIA,20
JP,TACHYCARDIA,20
JP,TOXIC ENCEPHALOPATHY,20
JP,TOXICITY TO VARIOUS AGENTS,20
JP,BLOOD PRESSURE INCREASED,19
JP,CARDIAC FAILURE CONGESTIVE,19
JP,GENERALISED OEDEMA,19
JP,HAEMORRHAGE,19
JP,HYPOTENSION,19
JP,INTERNATIONAL NORMALISED RATIO INCREASED,19
JP,NEURALGIA,19
JP,PNEUMOTHORAX,19
JP,PULMONARY EMBOLISM,19
JP,RED BLOOD CELL COUNT DECREASED,19
JP,SPEECH DISORDER,19
JP,THIRST,19
JP,BREAST CANCER,18
JP,BRONCHITIS,18
JP,CEREBRAL HAEMORRHAGE,18
JP,DYSGEUSIA,18
JP,HEPATITIS FULMINANT,18
JP,LEUKOPENIA,18
JP,PNEUMONIA BACTERIAL,18
JP,RETINAL HAEMORRHAGE,18
JP,WITHDRAWAL SYNDROME,18
JP,ASTHMA,17
JP,BRAIN NATRIURETIC PEPTIDE INCREASED,17
JP,CARDIO-RESPIRATORY ARREST,17
JP,CERVIX CARCINOMA,17
JP,DEAFNESS,17
JP,EPISTAXIS,17
JP,GENERAL PHYSICAL HEALTH DETERIORATION,17
JP,MUSCULOSKELETAL PAIN,17
JP,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,17
JP,PANCREATIC CARCINOMA,17
JP,SEROTONIN SYNDROME,17
JP,SHOCK,17
JP,SUICIDAL IDEATION,17
JP,ABDOMINAL PAIN UPPER,16
JP,ALOPECIA,16
JP,ANGINA PECTORIS,16
JP,DISORIENTATION,16
JP,ENTEROCOLITIS,16
JP,EYELID OEDEMA,16
JP,HYPERURICAEMIA,16
JP,HYPOALBUMINAEMIA,16
JP,ILEUS PARALYTIC,16
JP,MEMORY IMPAIRMENT,16
JP,MOVEMENT DISORDER,16
JP,RIB FRACTURE,16
JP,SKIN ULCER,16
JP,ABDOMINAL DISTENSION,15
JP,ABNORMAL BEHAVIOUR,15
JP,ANAPHYLACTIC SHOCK,15
JP,ASCITES,15
JP,CELLULITIS,15
JP,CHILLS,15
JP,DYSURIA,15
JP,FAECES DISCOLOURED,15
JP,HAEMOPTYSIS,15
JP,HYPOTHYROIDISM,15
JP,INFLUENZA,15
JP,MYALGIA,15
JP,OROPHARYNGEAL PAIN,15
JP,PARAESTHESIA,15
JP,PARONYCHIA,15
JP,PNEUMOCYSTIS JIROVECII PNEUMONIA,15
JP,RHEUMATOID ARTHRITIS,15
JP,STEVENS-JOHNSON SYNDROME,15
JP,SYNCOPE,15
JP,TINNITUS,15
JP,TUBULOINTERSTITIAL NEPHRITIS,15
JP,UPPER RESPIRATORY TRACT INFLAMMATION,15
JP,BLOOD ALBUMIN DECREASED,14
JP,BLOOD POTASSIUM DECREASED,14
JP,CONJUNCTIVAL HAEMORRHAGE,14
JP,CREATININE RENAL CLEARANCE DECREASED,14
JP,GASTROENTERITIS,14
JP,HYPOPHAGIA,14
JP,INFLAMMATION,14
JP,INTERVERTEBRAL DISC PROTRUSION,14
JP,NEOPLASM PROGRESSION,14
JP,OSTEOMYELITIS,14
JP,SUBDURAL HAEMATOMA,14
JP,VISUAL FIELD DEFECT,14
JP,ACTIVITIES OF DAILY LIVING IMPAIRED,13
JP,ACUTE RESPIRATORY FAILURE,13
JP,ANAPHYLACTIC REACTION,13
JP,ASPIRATION,13
JP,BLOOD SODIUM DECREASED,13
JP,CANCER PAIN,13
JP,CARDIAC ARREST,13
JP,CHEST DISCOMFORT,13
JP,CHOLECYSTITIS,13
JP,COMA,13
JP,CONFUSIONAL STATE,13
JP,DYSPHONIA,13
JP,HEPATIC ENCEPHALOPATHY,13
JP,INJURY,13
JP,MUSCLE SPASMS,13
JP,NON-SMALL CELL LUNG CANCER,13
JP,PURPURA,13
JP,PYELONEPHRITIS,13
JP,RASH GENERALISED,13
JP,BALANCE DISORDER,12
JP,BLADDER CANCER,12
JP,BLOOD URIC ACID INCREASED,12
JP,COMPRESSION FRACTURE,12
JP,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,12
JP,DYSPNOEA EXERTIONAL,12
JP,EATING DISORDER,12
JP,ENCEPHALOPATHY,12
JP,FEMORAL NECK FRACTURE,12
JP,HAEMATOCHEZIA,12
JP,HAEMATOCRIT DECREASED,12
JP,HALLUCINATION_ AUDITORY,12
JP,HEPATIC FAILURE,12
JP,INTRAOCULAR PRESSURE INCREASED,12
JP,IRRITABILITY,12
JP,LIVER FUNCTION TEST ABNORMAL,12
JP,METASTASES TO BONE,12
JP,ORGANISING PNEUMONIA,12
JP,PRODUCT USE IN UNAPPROVED INDICATION,12
JP,PRODUCTIVE COUGH,12
JP,RESPIRATORY DISORDER,12
JP,SHOCK HAEMORRHAGIC,12
JP,URINARY INCONTINENCE,12
JP,BLOOD TRIGLYCERIDES INCREASED,11
JP,CARDIAC FAILURE ACUTE,11
JP,CHOLANGITIS,11
JP,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,11
JP,COLD SWEAT,11
JP,CYSTITIS,11
JP,DERMATITIS ACNEIFORM,11
JP,DISEASE RECURRENCE,11
JP,DRUG INTOLERANCE,11
JP,DRUG LEVEL INCREASED,11
JP,EOSINOPHIL COUNT INCREASED,11
JP,EYE PAIN,11
JP,GASTRIC ULCER HAEMORRHAGE,11
JP,HAEMATURIA,11
JP,HYPERCALCAEMIA,11
JP,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,11
JP,INTENTIONAL PRODUCT USE ISSUE,11
JP,LUNG INFECTION,11
JP,MENTAL IMPAIRMENT,11
JP,NEUROLEPTIC MALIGNANT SYNDROME,11
JP,ORAL CANDIDIASIS,11
JP,OXYGEN SATURATION DECREASED,11
JP,PARALYSIS,11
JP,RHINORRHOEA,11
JP,SPINAL COLUMN STENOSIS,11
JP,URINE OUTPUT DECREASED,11
JP,VISUAL IMPAIRMENT,11
JP,ACUTE MYOCARDIAL INFARCTION,10
JP,ACUTE RESPIRATORY DISTRESS SYNDROME,10
JP,ATYPICAL FEMUR FRACTURE,10
JP,BLOOD CALCIUM DECREASED,10
JP,BODY TEMPERATURE DECREASED,10
JP,CHRONIC KIDNEY DISEASE,10
JP,COLITIS,10
JP,DRUG PRESCRIBING ERROR,10
JP,DUODENAL ULCER,10
JP,ECZEMA,10
JP,FEEDING DISORDER,10
JP,GASTROOESOPHAGEAL REFLUX DISEASE,10
JP,GLYCOSYLATED HAEMOGLOBIN INCREASED,10
JP,HYPERLIPIDAEMIA,10
JP,HYPOTHERMIA,10
JP,INFUSION RELATED REACTION,10
JP,LYMPHANGIOSIS CARCINOMATOSA,10
JP,MALIGNANT PLEURAL EFFUSION,10
JP,MOBILITY DECREASED,10
JP,MUSCLE RIGIDITY,10
JP,OSTEONECROSIS,10
JP,PARKINSONISM,10
JP,PNEUMONITIS,10
JP,PROTEINURIA,10
JP,PULMONARY ALVEOLAR HAEMORRHAGE,10
JP,SWELLING FACE,10
JP,TRANSIENT ISCHAEMIC ATTACK,10
JP,TUMOUR LYSIS SYNDROME,10
JP,WRONG TECHNIQUE IN DRUG USAGE PROCESS,10
JP,ADRENAL INSUFFICIENCY,9
JP,AGRANULOCYTOSIS,9
JP,AMNESIA,9
JP,AMYLASE INCREASED,9
JP,ATRIOVENTRICULAR BLOCK COMPLETE,9
JP,COGNITIVE DISORDER,9
JP,COLITIS ISCHAEMIC,9
JP,DECUBITUS ULCER,9
JP,DYSPEPSIA,9
JP,EOSINOPHILIC PNEUMONIA,9
JP,GASTRITIS,9
JP,HEMIPLEGIA,9
JP,HYPERCAPNIA,9
JP,HYPOAESTHESIA ORAL,9
JP,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,9
JP,LUMBAR SPINAL STENOSIS,9
JP,METASTASES TO LIVER,9
JP,NEOPLASM MALIGNANT,9
JP,ORTHOSTATIC HYPOTENSION,9
JP,OSTEOPOROSIS,9
JP,PERIPHERAL SWELLING,9
JP,PHARYNGITIS,9
JP,PROSTATE CANCER,9
JP,RIGHT VENTRICULAR FAILURE,9
JP,VENTRICULAR EXTRASYSTOLES,9
JP,WHEEZING,9
JP,AKATHISIA,8
JP,ATRIOVENTRICULAR BLOCK SECOND DEGREE,8
JP,CARDIAC FAILURE CHRONIC,8
JP,CHROMATURIA,8
JP,CIRCULATORY COLLAPSE,8
JP,FEELING COLD,8
JP,GENERALISED ERYTHEMA,8
JP,GLOMERULAR FILTRATION RATE DECREASED,8
JP,HEPATIC STEATOSIS,8
JP,HEPATITIS,8
JP,HOSPITALISATION,8
JP,HUMERUS FRACTURE,8
JP,HYPERSENSITIVITY,8
JP,IMPAIRED HEALING,8
JP,NEPHROTIC SYNDROME,8
JP,NEUTROPHIL COUNT INCREASED,8
JP,POLLAKIURIA,8
JP,PROTEIN TOTAL DECREASED,8
JP,PULMONARY CONGESTION,8
JP,SINUSITIS,8
JP,SKIN EXFOLIATION,8
JP,THERAPEUTIC RESPONSE DECREASED,8
JP,THERAPEUTIC RESPONSE UNEXPECTED,8
JP,TOXIC EPIDERMAL NECROLYSIS,8
JP,VENTRICULAR TACHYCARDIA,8
JP,VIITH NERVE PARALYSIS,8
JP,AGITATION,7
JP,APHAGIA,7
JP,CARDIAC DISORDER,7
JP,CYTOMEGALOVIRUS VIRAEMIA,7
JP,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,7
JP,DRY SKIN,7
JP,DYSLALIA,7
JP,EMBOLIC STROKE,7
JP,EYE DISORDER,7
JP,GYNAECOMASTIA,7
JP,HAEMORRHAGIC DIATHESIS,7
JP,HEART RATE INCREASED,7
JP,HOT FLUSH,7
JP,HYDRONEPHROSIS,7
JP,HYPOACUSIS,7
JP,HYPOPITUITARISM,7
JP,INADEQUATE ANALGESIA,7
JP,INCONTINENCE,7
JP,IRON DEFICIENCY ANAEMIA,7
JP,LARGE INTESTINE PERFORATION,7
JP,LOSS OF CONTROL OF LEGS,7
JP,LYMPHADENOPATHY,7
JP,MALIGNANT NEOPLASM OF UNKNOWN PRIMARY SITE,7
JP,METASTASES TO CENTRAL NERVOUS SYSTEM,7
JP,METASTASES TO LUNG,7
JP,MULTIPLE SCLEROSIS RELAPSE,7
JP,MYELODYSPLASTIC SYNDROME,7
JP,NEUROGENIC BLADDER,7
JP,NIGHTMARE,7
JP,OBESITY,7
JP,OSTEOARTHRITIS,7
JP,PANCREATITIS ACUTE,7
JP,PARKINSON^S DISEASE,7
JP,PERIPHERAL COLDNESS,7
JP,PNEUMONIA INFLUENZAL,7
JP,POST HERPETIC NEURALGIA,7
JP,PRESCRIBED UNDERDOSE,7
JP,RESPIRATORY ARREST,7
JP,RESPIRATORY DISTRESS,7
JP,SKIN DISORDER,7
JP,TREATMENT NONCOMPLIANCE,7
JP,AGGRESSION,6
JP,ANGER,6
JP,ARTHRITIS,6
JP,AZOTAEMIA,6
JP,BEDRIDDEN,6
JP,BLISTER,6
JP,BLOOD CHLORIDE INCREASED,6
JP,COMPLETED SUICIDE,6
JP,CONCOMITANT DISEASE AGGRAVATED,6
JP,CONTRAINDICATION TO MEDICAL TREATMENT,6
JP,CYTOPENIA,6
JP,DIABETES MELLITUS INADEQUATE CONTROL,6
JP,EUPHORIC MOOD,6
JP,EYELID PTOSIS,6
JP,HEART RATE DECREASED,6
JP,HEPATIC ENZYME INCREASED,6
JP,HEPATOCELLULAR CARCINOMA,6
JP,HYPERSOMNIA,6
JP,INCORRECT DRUG ADMINISTRATION DURATION,6
JP,INTENTIONAL DRUG MISUSE,6
JP,INTERNAL HAEMORRHAGE,6
JP,LACTIC ACIDOSIS,6
JP,LOCAL SWELLING,6
JP,LUNG ADENOCARCINOMA,6
JP,MACULAR OEDEMA,6
JP,MENTAL DISORDER,6
JP,METASTASES TO LYMPH NODES,6
JP,MONOPLEGIA,6
JP,MULTIPLE ORGAN DYSFUNCTION SYNDROME,6
JP,NEUTROPHIL PERCENTAGE INCREASED,6
JP,NO ADVERSE EVENT,6
JP,OCULAR HYPERAEMIA,6
JP,PANCREATITIS,6
JP,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,6
JP,PHARYNGEAL OEDEMA,6
JP,PRESCRIBED OVERDOSE,6
JP,RASH MACULO-PAPULAR,6
JP,RENAL CANCER,6
JP,RHINITIS ALLERGIC,6
JP,SINUS NODE DYSFUNCTION,6
JP,SKIN EROSION,6
JP,SMALL INTESTINAL HAEMORRHAGE,6
JP,STAPHYLOCOCCAL SEPSIS,6
JP,SUBCUTANEOUS HAEMATOMA,6
JP,SUDDEN HEARING LOSS,6
JP,SUDDEN ONSET OF SLEEP,6
JP,THROMBOSIS,6
JP,THROMBOTIC MICROANGIOPATHY,6
JP,TOXIC SKIN ERUPTION,6
JP,UTERINE CANCER,6
JP,VIRAL UPPER RESPIRATORY TRACT INFECTION,6
JP,ABDOMINAL PAIN LOWER,5
JP,AGE-RELATED MACULAR DEGENERATION,5
JP,ANGINA UNSTABLE,5
JP,ANGIOEDEMA,5
JP,ASPHYXIA,5
JP,ATAXIA,5
JP,AUTOIMMUNE HAEMOLYTIC ANAEMIA,5
JP,BLOOD CREATINE PHOSPHOKINASE MB INCREASED,5
JP,BLOOD GLUCOSE DECREASED,5
JP,BLOOD PHOSPHORUS DECREASED,5
JP,BLOOD PRESSURE SYSTOLIC INCREASED,5
JP,BRAIN STEM HAEMORRHAGE,5
JP,BRONCHOPULMONARY ASPERGILLOSIS,5
JP,BURNING SENSATION,5
JP,CARDIAC VALVE DISEASE,5
JP,CHOLECYSTITIS ACUTE,5
JP,CHOLELITHIASIS,5
JP,CHOLINERGIC SYNDROME,5
JP,COORDINATION ABNORMAL,5
JP,CYTOMEGALOVIRUS ENTEROCOLITIS,5
JP,CYTOMEGALOVIRUS INFECTION,5
JP,CYTOMEGALOVIRUS TEST POSITIVE,5
JP,DIPLEGIA,5
JP,DISTURBANCE IN ATTENTION,5
JP,DIVERTICULITIS,5
JP,DIVERTICULUM INTESTINAL HAEMORRHAGIC,5
JP,DIZZINESS POSTURAL,5
JP,DYSTONIA,5
JP,ELECTROLYTE IMBALANCE,5
JP,FACIAL PAIN,5
JP,FAECAL INCONTINENCE,5
JP,FEELING HOT,5
JP,FIBRIN D DIMER INCREASED,5
JP,FLUID RETENTION,5
JP,FLUSHING,5
JP,FOREIGN BODY,5
JP,GAIT INABILITY,5
JP,GASTRIC PERFORATION,5
JP,GASTROINTESTINAL DISORDER,5
JP,GAZE PALSY,5
JP,GLUCOSE TOLERANCE IMPAIRED,5
JP,HAEMOGLOBIN INCREASED,5
JP,HAEMORRHOIDAL HAEMORRHAGE,5
JP,HEAD DISCOMFORT,5
JP,HEAT ILLNESS,5
JP,HEPATITIS ACUTE,5
JP,HISTIOCYTOSIS HAEMATOPHAGIC,5
JP,HYPERTHERMIA,5
JP,HYPOKINESIA,5
JP,HYPOPHOSPHATAEMIA,5
JP,IMMUNE THROMBOCYTOPENIC PURPURA,5
JP,INCORRECT DOSE ADMINISTERED,5
JP,INTENTIONAL UNDERDOSE,5
JP,LISTLESS,5
JP,MALNUTRITION,5
JP,MOTOR DYSFUNCTION,5
JP,MUCOUS MEMBRANE DISORDER,5
JP,MULTIPLE SCLEROSIS,5
JP,MYOCARDIAL ISCHAEMIA,5
JP,NECK PAIN,5
JP,NERVOUS SYSTEM DISORDER,5
JP,NYSTAGMUS,5
JP,OESOPHAGITIS,5
JP,OPTIC NERVE DISORDER,5
JP,ORAL PAIN,5
JP,PAIN IN JAW,5
JP,PALLOR,5
JP,PERICARDIAL EFFUSION,5
JP,PERIODONTITIS,5
JP,PERIPHERAL SENSORY NEUROPATHY,5
JP,PRE-EXISTING CONDITION IMPROVED,5
JP,PRERENAL FAILURE,5
JP,PROTEIN URINE PRESENT,5
JP,RECTOSIGMOID CANCER,5
JP,RENAL FAILURE CHRONIC,5
JP,RETINAL DETACHMENT,5
JP,SENSORY DISTURBANCE,5
JP,SLEEP APNOEA SYNDROME,5
JP,SLEEP DISORDER,5
JP,SOLILOQUY,5
JP,SPONDYLOLISTHESIS,5
JP,SUDDEN DEATH,5
JP,ULCER HAEMORRHAGE,5
JP,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,5
JP,ABNORMAL SENSATION IN EYE,4
JP,ABSCESS,4
JP,ACUTE HEPATIC FAILURE,4
JP,ADENOVIRUS INFECTION,4
JP,ANKYLOSING SPONDYLITIS,4
JP,APLASIA PURE RED CELL,4
JP,ARTERIAL THROMBOSIS,4
JP,ASTERIXIS,4
JP,BACTERAEMIA,4
JP,BENIGN PROSTATIC HYPERPLASIA,4
JP,BIPOLAR I DISORDER,4
JP,BLADDER TAMPONADE,4
JP,BLOOD CHLORIDE DECREASED,4
JP,BLOOD CHOLESTEROL INCREASED,4
JP,BLOOD CREATINE PHOSPHOKINASE DECREASED,4
JP,BLOOD URINE PRESENT,4
JP,BONE PAIN,4
JP,BRAIN OEDEMA,4
JP,CARDIOMEGALY,4
JP,CD4 LYMPHOCYTES DECREASED,4
JP,CHEILITIS,4
JP,CHEST X-RAY ABNORMAL,4
JP,CHOLESTASIS,4
JP,CHRONIC GASTRITIS,4
JP,CONJUNCTIVITIS,4
JP,CORONARY ARTERY STENOSIS,4
JP,CYSTITIS HAEMORRHAGIC,4
JP,DEPRESSED MOOD,4
JP,DEPRESSIVE SYMPTOM,4
JP,DISCOMFORT,4
JP,DRUG ABUSE,4
JP,DRUG ADMINISTRATION ERROR,4
JP,DRUG DOSE OMISSION,4
JP,DRY EYE,4
JP,EMOTIONAL DISORDER,4
JP,EXPOSED BONE IN JAW,4
JP,FIBROMYALGIA,4
JP,FOOT FRACTURE,4
JP,GASTRIC DISORDER,4
JP,GASTRIC FISTULA,4
JP,GASTRIC HAEMORRHAGE,4
JP,GASTRITIS EROSIVE,4
JP,GASTROINTESTINAL NECROSIS,4
JP,GASTROINTESTINAL PERFORATION,4
JP,GINGIVAL BLEEDING,4
JP,GLOSSITIS,4
JP,GOUT,4
JP,GRAFT VERSUS HOST DISEASE,4
JP,GUILLAIN-BARRE SYNDROME,4
JP,HAEMATOCRIT INCREASED,4
JP,HAEMORRHOIDS,4
JP,HELICOBACTER INFECTION,4
JP,HEPATOSPLENOMEGALY,4
JP,HERNIA,4
JP,HYPERBILIRUBINAEMIA,4
JP,HYPERKERATOSIS,4
JP,HYPOMAGNESAEMIA,4
JP,INJECTION SITE ERYTHEMA,4
JP,INTRACRANIAL PRESSURE INCREASED,4
JP,LACUNAR INFARCTION,4
JP,LANGUAGE DISORDER,4
JP,LARGE INTESTINAL HAEMORRHAGE,4
JP,LARGE INTESTINE POLYP,4
JP,LIPASE INCREASED,4
JP,LIVER FUNCTION TEST INCREASED,4
JP,LOGORRHOEA,4
JP,LOWER GASTROINTESTINAL HAEMORRHAGE,4
JP,MANIA,4
JP,METASTASES TO MENINGES,4
JP,MUSCLE SPASTICITY,4
JP,NEPHROPATHY,4
JP,OTITIS MEDIA,4
JP,OVARIAN CANCER,4
JP,PARALYSIS RECURRENT LARYNGEAL NERVE,4
JP,PHOTOPSIA,4
JP,PORIOMANIA,4
JP,POSTRENAL FAILURE,4
JP,PRURITUS GENERALISED,4
JP,PULMONARY FIBROSIS,4
JP,PUTAMEN HAEMORRHAGE,4
JP,QUADRIPLEGIA,4
JP,RADIATION PNEUMONITIS,4
JP,RASH ERYTHEMATOUS,4
JP,RENAL TUBULAR ACIDOSIS,4
JP,SALIVARY HYPERSECRETION,4
JP,SCHIZOPHRENIA,4
JP,SCIATICA,4
JP,SHOCK SYMPTOM,4
JP,SHUNT OCCLUSION,4
JP,SINUS BRADYCARDIA,4
JP,SINUS TACHYCARDIA,4
JP,SMALL INTESTINE ULCER,4
JP,SPINAL FRACTURE,4
JP,SUBARACHNOID HAEMORRHAGE,4
JP,SUPRAVENTRICULAR TACHYCARDIA,4
JP,SWOLLEN TONGUE,4
JP,TRI-IODOTHYRONINE FREE DECREASED,4
JP,TRIGEMINAL NEURALGIA,4
JP,UPPER RESPIRATORY TRACT INFECTION,4
JP,URINARY BLADDER HAEMORRHAGE,4
JP,UTERINE HAEMORRHAGE,4
JP,VENOUS THROMBOSIS LIMB,4
JP,VERTIGO,4
JP,WOUND,4
JP,ACCIDENT,3
JP,ACCOMMODATION DISORDER,3
JP,ACIDOSIS,3
JP,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,3
JP,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,3
JP,ACUTE PULMONARY OEDEMA,3
JP,ANAL FISTULA,3
JP,ANTIPHOSPHOLIPID SYNDROME,3
JP,ANURIA,3
JP,APTYALISM,3
JP,ATELECTASIS,3
JP,ATONIC SEIZURES,3
JP,ATRIOVENTRICULAR BLOCK,3
JP,AUTONOMIC NERVOUS SYSTEM IMBALANCE,3
JP,BILIARY CIRRHOSIS PRIMARY,3
JP,BILIARY TRACT DISORDER,3
JP,BILIARY TRACT INFECTION,3
JP,BLOOD CREATININE DECREASED,3
JP,BLOOD FIBRINOGEN INCREASED,3
JP,BLOOD MAGNESIUM INCREASED,3
JP,BLOOD PRESSURE DIASTOLIC INCREASED,3
JP,BLOOD THYROID STIMULATING HORMONE DECREASED,3
JP,BLOOD THYROID STIMULATING HORMONE INCREASED,3
JP,BLOOD UREA DECREASED,3
JP,BLOOD URIC ACID DECREASED,3
JP,BRAIN CONTUSION,3
JP,BRONCHIECTASIS,3
JP,BRONCHITIS CHRONIC,3
JP,CALCULUS URINARY,3
JP,CARCINOEMBRYONIC ANTIGEN INCREASED,3
JP,CARDIOVASCULAR DISORDER,3
JP,CEREBELLAR INFARCTION,3
JP,CEREBROVASCULAR STENOSIS,3
JP,CERVICAL SPINAL STENOSIS,3
JP,CLAVICLE FRACTURE,3
JP,COLON CANCER RECURRENT,3
JP,COLORECTAL CANCER,3
JP,COMA HEPATIC,3
JP,CONGESTIVE CARDIOMYOPATHY,3
JP,CORNEAL OPACITY,3
JP,DELUSION,3
JP,DEMENTIA ALZHEIMER^S TYPE,3
JP,DENTAL CARIES,3
JP,DEPERSONALISATION,3
JP,DERMATITIS BULLOUS,3
JP,DERMATITIS EXFOLIATIVE,3
JP,DEVICE RELATED INFECTION,3
JP,DIABETES INSIPIDUS,3
JP,DIABETIC NEUROPATHY,3
JP,DIALYSIS,3
JP,DISUSE SYNDROME,3
JP,DNA ANTIBODY POSITIVE,3
JP,DROPPED HEAD SYNDROME,3
JP,DRUG DEPENDENCE,3
JP,EAR HAEMORRHAGE,3
JP,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,3
JP,EOSINOPHILIC CYSTITIS,3
JP,EXTRAOCULAR MUSCLE PARESIS,3
JP,EYE HAEMORRHAGE,3
JP,FACE INJURY,3
JP,FACIAL PARALYSIS,3
JP,FEELING DRUNK,3
JP,GASTRIC ANTRAL VASCULAR ECTASIA,3
JP,GASTRODUODENAL ULCER,3
JP,HAEMODIALYSIS,3
JP,HAEMORRHAGE INTRACRANIAL,3
JP,HAEMOTHORAX,3
JP,HEPATIC CANCER,3
JP,HEPATOBILIARY DISEASE,3
JP,HYPERAESTHESIA,3
JP,HYPERALDOSTERONISM,3
JP,HYPERTRIGLYCERIDAEMIA,3
JP,HYPERVENTILATION,3
JP,HYPOGLYCAEMIC COMA,3
JP,IDIOPATHIC PULMONARY FIBROSIS,3
JP,ILIUM FRACTURE,3
JP,IMMOBILE,3
JP,INCREASED APPETITE,3
JP,INJECTION SITE REACTION,3
JP,IRON OVERLOAD,3
JP,JAUNDICE CHOLESTATIC,3
JP,KERATITIS,3
JP,LACERATION,3
JP,LACRIMATION INCREASED,3
JP,LARYNGEAL OEDEMA,3
JP,LEUKOENCEPHALOPATHY,3
JP,LIMB DISCOMFORT,3
JP,LYMPHOCYTE PERCENTAGE DECREASED,3
JP,LYMPHOCYTE STIMULATION TEST POSITIVE,3
JP,LYMPHOMA,3
JP,LYMPHOPENIA,3
JP,MACULAR DEGENERATION,3
JP,MALIGNANT NEOPLASM OF RENAL PELVIS,3
JP,MENINGITIS,3
JP,METASTASIS,3
JP,METASTATIC RENAL CELL CARCINOMA,3
JP,MULTI-ORGAN FAILURE,3
JP,MUSCLE ATROPHY,3
JP,MUSCLE HAEMORRHAGE,3
JP,MUSCLE TIGHTNESS,3
JP,MUSCULOSKELETAL DISORDER,3
JP,MYDRIASIS,3
JP,MYOCLONIC EPILEPSY,3
JP,MYOGLOBIN BLOOD INCREASED,3
JP,MYOPATHY,3
JP,NEPHROLITHIASIS,3
JP,NEUROLOGICAL SYMPTOM,3
JP,NOCTURIA,3
JP,OBSTRUCTIVE AIRWAYS DISORDER,3
JP,OESOPHAGEAL CARCINOMA,3
JP,OLIGURIA,3
JP,ORAL DISORDER,3
JP,ORAL HERPES,3
JP,PANIC DISORDER,3
JP,PARESIS,3
JP,PELVIC FRACTURE,3
JP,PEMPHIGOID,3
JP,PERFORMANCE STATUS DECREASED,3
JP,PERIARTHRITIS,3
JP,PETIT MAL EPILEPSY,3
JP,PHOTOPHOBIA,3
JP,PLATELET COUNT INCREASED,3
JP,PLEURAL MESOTHELIOMA MALIGNANT,3
JP,PNEUMATOSIS INTESTINALIS,3
JP,POLYMYALGIA RHEUMATICA,3
JP,POST PROCEDURAL HAEMORRHAGE,3
JP,PROCTITIS,3
JP,PROTHROMBIN TIME PROLONGED,3
JP,PSORIASIS,3
JP,PSYCHOMOTOR HYPERACTIVITY,3
JP,PULMONARY HYPERTENSION,3
JP,PULMONARY TUBERCULOSIS,3
JP,RADICULOPATHY,3
JP,RASH MACULAR,3
JP,RECTAL PERFORATION,3
JP,RENAL FUNCTION TEST ABNORMAL,3
JP,RENAL INFARCT,3
JP,RESTLESS LEGS SYNDROME,3
JP,RETINAL DEGENERATION,3
JP,RETINAL TEAR,3
JP,RETINAL VEIN OCCLUSION,3
JP,RHINITIS,3
JP,SEASONAL ALLERGY,3
JP,SEDATION,3
JP,SICK SINUS SYNDROME,3
JP,SINUS ARREST,3
JP,SKIN DISCOLOURATION,3
JP,SKIN INFECTION,3
JP,SPINAL OSTEOARTHRITIS,3
JP,SPUTUM INCREASED,3
JP,SPUTUM RETENTION,3
JP,STOMA SITE HAEMORRHAGE,3
JP,SWELLING,3
JP,THERAPY CESSATION,3
JP,THROMBOTIC CEREBRAL INFARCTION,3
JP,TINEA INFECTION,3
JP,TONSILLITIS,3
JP,TOOTHACHE,3
JP,TRANSAMINASES INCREASED,3
JP,TUBERCULOSIS,3
JP,UNDERDOSE,3
JP,UPPER GASTROINTESTINAL HAEMORRHAGE,3
JP,UPPER LIMB FRACTURE,3
JP,URETERIC CANCER RECURRENT,3
JP,UVEITIS,3
JP,VITREOUS HAEMORRHAGE,3
JP,WRIST FRACTURE,3
JP,XERODERMA,3
JP,ABDOMINAL ABSCESS,2
JP,ABDOMINAL TENDERNESS,2
JP,ABNORMAL FAECES,2
JP,ABSCESS LIMB,2
JP,ACARODERMATITIS,2
JP,ACCIDENT AT WORK,2
JP,ACCIDENTAL OVERDOSE,2
JP,ACNE,2
JP,ACUTE INTERSTITIAL PNEUMONITIS,2
JP,ADVERSE EVENT,2
JP,AFFECT LABILITY,2
JP,ALOPECIA AREATA,2
JP,AMAUROSIS,2
JP,AMOEBIC DYSENTERY,2
JP,AMYLOIDOSIS,2
JP,ANAESTHETIC COMPLICATION,2
JP,ANAL ULCER,2
JP,ANAPHYLACTOID REACTION,2
JP,ANASTOMOTIC ULCER,2
JP,ANGIOSARCOMA,2
JP,ANKLE FRACTURE,2
JP,ANORECTAL DISORDER,2
JP,ANTIPHOSPHOLIPID ANTIBODIES POSITIVE,2
JP,ANTITHROMBIN III DECREASED,2
JP,AORTIC DISSECTION,2
JP,APATHY,2
JP,APHASIA,2
JP,APHTHOUS STOMATITIS,2
JP,APLASTIC ANAEMIA,2
JP,APNOEA,2
JP,APPLICATION SITE PRURITUS,2
JP,ARTHROPATHY,2
JP,ASTHENOPIA,2
JP,ATRIOVENTRICULAR BLOCK FIRST DEGREE,2
JP,ATYPICAL MYCOBACTERIAL INFECTION,2
JP,AUTOIMMUNE HEPATITIS,2
JP,BACTERIAL INFECTION,2
JP,BALANOPOSTHITIS,2
JP,BILE DUCT OBSTRUCTION,2
JP,BILE DUCT STENOSIS,2
JP,BILIRUBIN CONJUGATED INCREASED,2
JP,BLINDNESS,2
JP,BLOOD ALBUMIN ABNORMAL,2
JP,BLOOD ALKALINE PHOSPHATASE ABNORMAL,2
JP,BLOOD CREATINE INCREASED,2
JP,BLOOD FIBRINOGEN DECREASED,2
JP,BLOOD FOLATE DECREASED,2
JP,BLOOD PH DECREASED,2
JP,BLOOD PRESSURE IMMEASURABLE,2
JP,BLOOD SODIUM INCREASED,2
JP,BLOOD UREA NITROGEN/CREATININE RATIO INCREASED,2
JP,BONE DISORDER,2
JP,BONE FISSURE,2
JP,BONE MARROW DISORDER,2
JP,BRAIN ABSCESS,2
JP,BRAIN NATRIURETIC PEPTIDE ABNORMAL,2
JP,BRAIN STEM INFARCTION,2
JP,BRONCHOPNEUMONIA,2
JP,BRUXISM,2
JP,CARDIAC AMYLOIDOSIS,2
JP,CARDIAC HYPERTROPHY,2
JP,CARDIOMYOPATHY,2
JP,CEREBROVASCULAR ACCIDENT,2
JP,CEREBROVASCULAR DISORDER,2
JP,CERVICAL DYSPLASIA,2
JP,CERVICAL MYELOPATHY,2
JP,CHEMOTHERAPY,2
JP,CHOKING,2
JP,CHOKING SENSATION,2
JP,CHOLANGIOCARCINOMA,2
JP,CLOSTRIDIUM DIFFICILE COLITIS,2
JP,CLOSTRIDIUM DIFFICILE INFECTION,2
JP,COAGULOPATHY,2
JP,COLITIS MICROSCOPIC,2
JP,COMMUNICATION DISORDER,2
JP,CONJUNCTIVITIS ALLERGIC,2
JP,CONTRAINDICATED PRODUCT ADMINISTERED,2
JP,CYANOSIS,2
JP,CYTOMEGALOVIRUS MUCOCUTANEOUS ULCER,2
JP,DEAFNESS NEUROSENSORY,2
JP,DECREASED ACTIVITY,2
JP,DEMYELINATION,2
JP,DERMATITIS,2
JP,DERMATITIS CONTACT,2
JP,DERMATOMYOSITIS,2
JP,DEVICE DISLOCATION,2
JP,DIABETIC GANGRENE,2
JP,DIABETIC NEPHROPATHY,2
JP,DIFFUSE LARGE B-CELL LYMPHOMA,2
JP,DROOLING,2
JP,DRUG EFFECT INCREASED,2
JP,DRUG HYPERSENSITIVITY,2
JP,DRUG LEVEL DECREASED,2
JP,DRUG RESISTANCE,2
JP,DRY MOUTH,2
JP,DUODENAL PERFORATION,2
JP,DUODENAL ULCER HAEMORRHAGE,2
JP,DUODENAL ULCER PERFORATION,2
JP,DYSAESTHESIA,2
JP,DYSCHEZIA,2
JP,DYSGRAPHIA,2
JP,DYSMENORRHOEA,2
JP,EAR PAIN,2
JP,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,2
JP,EMBOLISM VENOUS,2
JP,EMPHYSEMA,2
JP,EMPYEMA,2
JP,ENCEPHALITIS,2
JP,ENDOCARDITIS,2
JP,ENTERITIS INFECTIOUS,2
JP,ENTEROCOLITIS INFECTIOUS,2
JP,EOSINOPHILIC PUSTULAR FOLLICULITIS,2
JP,EPIDERMOLYSIS,2
JP,EPIGLOTTIC OEDEMA,2
JP,ERUCTATION,2
JP,ERYSIPELAS,2
JP,EXTRA DOSE ADMINISTERED,2
JP,EXTRASYSTOLES,2
JP,EXTREMITY NECROSIS,2
JP,EYE CONTUSION,2
JP,EYE INJURY,2
JP,EYE OEDEMA,2
JP,EYE SWELLING,2
JP,EYELID BLEEDING,2
JP,FACIAL BONES FRACTURE,2
JP,FACIAL SPASM,2
JP,FAECES PALE,2
JP,FANCONI SYNDROME ACQUIRED,2
JP,FEAR,2
JP,FEMALE GENITAL TRACT FISTULA,2
JP,FOLATE DEFICIENCY,2
JP,FOLLICULITIS,2
JP,FOOD POISONING,2
JP,FRACTURE DELAYED UNION,2
JP,FRACTURE PAIN,2
JP,FULL BLOOD COUNT DECREASED,2
JP,FULMINANT TYPE 1 DIABETES MELLITUS,2
JP,GANGRENE,2
JP,GASTRIC POLYPS,2
JP,GASTRIC ULCER PERFORATION,2
JP,GASTROINTESTINAL INFLAMMATION,2
JP,GASTROINTESTINAL OEDEMA,2
JP,GINGIVAL CANCER,2
JP,GINGIVAL SWELLING,2
JP,GINGIVITIS,2
JP,GLOSSODYNIA,2
JP,GRIP STRENGTH DECREASED,2
JO,DRUG ABUSE,19
JO,ACUTE KIDNEY INJURY,2
JO,CARDIAC ARREST,1
JO,HEPATIC ENZYME INCREASED,1
JO,INTENTIONAL OVERDOSE,1
JO,LOSS OF CONSCIOUSNESS,1
JO,PNEUMONITIS,1
JO,SEIZURE,1
KP,ATAXIA,1
KP,BLOOD GLUCOSE INCREASED,1
KP,DERMATITIS ALLERGIC,1
KP,HYPERAESTHESIA,1
KP,NEUROPATHY PERIPHERAL,1
KP,NEUROTOXICITY,1
KP,OTOTOXICITY,1
KR,PNEUMONIA,20
KR,PYREXIA,12
KR,NEUTROPENIA,10
KR,DIZZINESS,9
KR,NAUSEA,9
KR,DIARRHOEA,8
KR,ANAEMIA,7
KR,VESTIBULAR DISORDER,7
KR,ASTHENIA,6
KR,FEBRILE NEUTROPENIA,6
KR,HYPERAESTHESIA,6
KR,PLATELET COUNT DECREASED,6
KR,VOMITING,6
KR,DELIRIUM,5
KR,DRUG INEFFECTIVE,5
KR,DYSPNOEA,5
KR,HYPERHIDROSIS,5
KR,NERVOUS SYSTEM DISORDER,5
KR,NEUTROPHIL COUNT DECREASED,5
KR,SEROTONIN SYNDROME,5
KR,ABDOMINAL PAIN,4
KR,ATAXIA,4
KR,BALANCE DISORDER,4
KR,CONSTIPATION,4
KR,DYSPEPSIA,4
KR,FALL,4
KR,NYSTAGMUS,4
KR,PAIN,4
KR,PLEURAL EFFUSION,4
KR,PULMONARY EMBOLISM,4
KR,RHINORRHOEA,4
KR,SEPSIS,4
KR,CHEST DISCOMFORT,3
KR,CHILLS,3
KR,EYE MOVEMENT DISORDER,3
KR,HYPERTENSION,3
KR,HYPOALBUMINAEMIA,3
KR,INSOMNIA,3
KR,MALIGNANT NEOPLASM PROGRESSION,3
KR,PANCYTOPENIA,3
KR,PULMONARY OEDEMA,3
KR,PYELONEPHRITIS ACUTE,3
KR,RENAL IMPAIRMENT,3
KR,SOMNOLENCE,3
KR,TREMOR,3
KR,URINARY TRACT INFECTION,3
KR,ABDOMINAL PAIN UPPER,2
KR,ACUTE KIDNEY INJURY,2
KR,ARTHRITIS BACTERIAL,2
KR,ASPARTATE AMINOTRANSFERASE INCREASED,2
KR,CARDIAC ARREST,2
KR,CARDIAC FAILURE,2
KR,CEREBRAL INFARCTION,2
KR,CHEST PAIN,2
KR,CHOLANGIOCARCINOMA,2
KR,DEATH,2
KR,DECREASED APPETITE,2
KR,DEEP VEIN THROMBOSIS,2
KR,DIABETES MELLITUS,2
KR,DIABETIC KETOACIDOSIS,2
KR,FACIAL PARALYSIS,2
KR,FATIGUE,2
KR,FEMUR FRACTURE,2
KR,HAEMORRHOIDS,2
KR,HEADACHE,2
KR,HEPATIC FAILURE,2
KR,HYPERGLYCAEMIA,2
KR,HYPOAESTHESIA,2
KR,HYPOREFLEXIA,2
KR,ILEUS,2
KR,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,2
KR,INTERSTITIAL LUNG DISEASE,2
KR,IRRITABILITY,2
KR,LUNG NEOPLASM MALIGNANT,2
KR,NEUROPATHY PERIPHERAL,2
KR,ORAL CANDIDIASIS,2
KR,ORAL PAIN,2
KR,OSTEOARTHRITIS,2
KR,PAIN IN EXTREMITY,2
KR,PARESIS,2
KR,SEPTIC SHOCK,2
KR,SPINAL COMPRESSION FRACTURE,2
KR,STOMATITIS,2
KR,SURGERY,2
KR,TOXICITY TO VARIOUS AGENTS,2
KR,TYPE 2 DIABETES MELLITUS,2
KR,URINE OUTPUT DECREASED,2
KR,VESTIBULAR FUNCTION TEST ABNORMAL,2
KR,ABDOMINAL DISTENSION,1
KR,ABSCESS,1
KR,ACUTE RESPIRATORY DISTRESS SYNDROME,1
KR,ACUTE RESPIRATORY FAILURE,1
KR,ALANINE AMINOTRANSFERASE INCREASED,1
KR,AMYOTROPHY,1
KR,ANION GAP INCREASED,1
KR,ANXIETY,1
KR,ARTERIOVENOUS FISTULA SITE INFECTION,1
KR,ARTHRALGIA,1
KR,ARTHRITIS,1
KR,ASCITES,1
KR,ASPIRATION,1
KR,AUTOIMMUNE DISORDER,1
KR,BACK PAIN,1
KR,BACTERIAL INFECTION,1
KR,BENIGN PROSTATIC HYPERPLASIA,1
KR,BILIARY DILATATION,1
KR,BLOOD ALBUMIN DECREASED,1
KR,BLOOD ALKALINE PHOSPHATASE INCREASED,1
KR,BLOOD BICARBONATE DECREASED,1
KR,BLOOD BILIRUBIN INCREASED,1
KR,BLOOD CREATININE INCREASED,1
KR,BLOOD GLUCOSE ABNORMAL,1
KR,BLOOD GLUCOSE INCREASED,1
KR,BLOOD KETONE BODY DECREASED,1
KR,BLOOD KETONE BODY INCREASED,1
KR,BLOOD LACTIC ACID INCREASED,1
KR,BLOOD PH DECREASED,1
KR,BODY TEMPERATURE INCREASED,1
KR,BONE PAIN,1
KR,BRONCHIOLITIS,1
KR,BRONCHITIS,1
KR,CANCER PAIN,1
KR,CATARACT,1
KR,CELLULITIS,1
KR,CHEST INJURY,1
KR,CHOLANGITIS,1
KR,CHOLELITHIASIS,1
KR,COGNITIVE DISORDER,1
KR,COLD SWEAT,1
KR,COLITIS,1
KR,CONDITION AGGRAVATED,1
KR,CONVULSION,1
KR,CORONARY ARTERY DISEASE,1
KR,CORONARY ARTERY STENOSIS,1
KR,COUGH,1
KR,DETACHMENT OF RETINAL PIGMENT EPITHELIUM,1
KR,DIABETES MELLITUS INADEQUATE CONTROL,1
KR,DIABETIC NEUROPATHY,1
KR,DISEASE PROGRESSION,1
KR,DISEASE RECURRENCE,1
KR,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
KR,DUODENAL ULCER,1
KR,DYSURIA,1
KR,ELECTROCARDIOGRAM QT PROLONGED,1
KR,ENCEPHALOPATHY,1
KR,ENTEROBACTER BACTERAEMIA,1
KR,EYE PAIN,1
KR,FACIAL BONES FRACTURE,1
KR,FEELING HOT,1
KR,FLUID RETENTION,1
KR,FUNCTIONAL GASTROINTESTINAL DISORDER,1
KR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
KR,GASTRIC DISORDER,1
KR,GASTRIC STENOSIS,1
KR,GASTROENTERITIS,1
KR,GASTROINTESTINAL STROMAL TUMOUR,1
KR,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
KR,GUILLAIN-BARRE SYNDROME,1
KR,HAEMATOCHEZIA,1
KR,HAEMOLYTIC URAEMIC SYNDROME,1
KR,HAEMOPTYSIS,1
KR,HEPATIC CIRRHOSIS,1
KR,HEPATIC NEOPLASM,1
KR,HYPERBILIRUBINAEMIA,1
KR,HYPERCALCAEMIA,1
KR,HYPERCAPNIA,1
KR,HYPERSENSITIVITY,1
KR,HYPERTONIC BLADDER,1
KR,HYPOACUSIS,1
KR,HYPOGLYCAEMIA,1
KR,HYPOPHAGIA,1
KR,HYPOPHOSPHATAEMIA,1
KR,HYPOXIA,1
KR,INCREASED APPETITE,1
KR,INFLUENZA,1
KR,INFLUENZA LIKE ILLNESS,1
KR,INFUSION RELATED REACTION,1
KR,INJECTION SITE ABSCESS,1
KR,INSULIN C-PEPTIDE DECREASED,1
KR,IRIS DISORDER,1
KR,ISCHAEMIC STROKE,1
KR,LABYRINTHITIS,1
KR,LIVER FUNCTION TEST INCREASED,1
KR,LYMPHOCYTE COUNT DECREASED,1
KR,MICTURITION FREQUENCY DECREASED,1
KR,MULTIPLE SCLEROSIS,1
KR,MULTIPLE SCLEROSIS RELAPSE,1
KR,MUSCULAR WEAKNESS,1
KR,MUSCULOSKELETAL CHEST PAIN,1
KR,MYALGIA,1
KR,NEOPLASM PROGRESSION,1
KR,NERVE BLOCK,1
KR,NIGHT BLINDNESS,1
KR,NON-SMALL CELL LUNG CANCER,1
KR,OBSTRUCTIVE AIRWAYS DISORDER,1
KR,OEDEMA PERIPHERAL,1
KR,OPTIC ISCHAEMIC NEUROPATHY,1
KR,PARAESTHESIA,1
KR,PARKINSON^S DISEASE,1
KR,PERICARDIAL DISEASE,1
KR,PERINEAL ERYTHEMA,1
KR,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
KR,PERIPHERAL COLDNESS,1
KR,PERIPHERAL SENSORY NEUROPATHY,1
KR,PLASMA CELL MYELOMA,1
KR,PNEUMONIA ASPIRATION,1
KR,PNEUMONIA FUNGAL,1
KR,PNEUMOTHORAX,1
KR,PO2 INCREASED,1
KR,PORTAL HYPERTENSIVE GASTROPATHY,1
KR,POSTOPERATIVE ILEUS,1
KR,PRESCRIBED UNDERDOSE,1
KR,PRODUCT USE ISSUE,1
KR,PUBIS FRACTURE,1
KR,RENAL CELL CARCINOMA,1
KR,RENAL CYST,1
KR,RENAL PAIN,1
KR,RHEUMATOID ARTHRITIS,1
KR,ROAD TRAFFIC ACCIDENT,1
KR,SEIZURE,1
KR,SHOCK,1
KR,SMALL INTESTINAL HAEMORRHAGE,1
KR,SPEECH DISORDER,1
KR,SPINAL FRACTURE,1
KR,SPLENOMEGALY,1
KR,SUICIDAL IDEATION,1
KR,SWELLING FACE,1
KR,SYSTEMIC MYCOSIS,1
KR,TENDON RUPTURE,1
KR,THROMBOCYTOPENIA,1
KR,THROMBOTIC THROMBOCYTOPENIC PURPURA,1
KR,TOOTH EXTRACTION,1
KR,TOXIC ENCEPHALOPATHY,1
KR,TOXIC EPIDERMAL NECROLYSIS,1
KR,TRIGGER FINGER,1
KR,TUMOUR HAEMORRHAGE,1
KR,TUMOUR PAIN,1
KR,UPPER GASTROINTESTINAL HAEMORRHAGE,1
KR,UPPER RESPIRATORY TRACT INFECTION,1
KR,URINE FLOW DECREASED,1
KR,VASCULAR STENT STENOSIS,1
KR,VERTEBROBASILAR INSUFFICIENCY,1
KR,VERTIGO,1
KR,VIITH NERVE PARALYSIS,1
KR,VISUAL ACUITY REDUCED,1
KR,WEIGHT DECREASED,1
KR,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
KW,ABDOMINAL DISTENSION,1
KW,ARTERIOVENOUS FISTULA SITE HAEMORRHAGE,1
KW,ASCITES,1
KW,DEPRESSION,1
KW,DYSPNOEA,1
KW,HEPATIC ENZYME INCREASED,1
KW,HEPATIC FAILURE,1
KW,HEPATOPULMONARY SYNDROME,1
KW,RASH,1
KW,ROAD TRAFFIC ACCIDENT,1
KG,AGGRESSION,1
KG,ANXIETY,1
KG,CONFUSIONAL STATE,1
KG,EUPHORIC MOOD,1
KG,MYALGIA,1
KG,PSYCHOTIC BEHAVIOUR,1
LV,OSTEONECROSIS OF JAW,1
LB,TOE AMPUTATION,2
LB,AGITATION,1
LB,ANAEMIA,1
LB,ANXIETY,1
LB,APHASIA,1
LB,BALANCE DISORDER,1
LB,BIPOLAR DISORDER,1
LB,BREAST CANCER,1
LB,CARDIAC DISORDER,1
LB,DEATH,1
LB,DEPRESSED MOOD,1
LB,DISCOMFORT,1
LB,DISEASE PROGRESSION,1
LB,DISTURBANCE IN ATTENTION,1
LB,DRUG ABUSE,1
LB,DRUG DEPENDENCE,1
LB,FATIGUE,1
LB,FEELING OF RELAXATION,1
LB,HEADACHE,1
LB,HYPERHIDROSIS,1
LB,HYPONATRAEMIA,1
LB,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
LB,INTENTIONAL OVERDOSE,1
LB,MYCOSIS FUNGOIDES,1
LB,NEUROPATHY PERIPHERAL,1
LB,OVERDOSE,1
LB,PALPITATIONS,1
LB,PANCREATIC DISORDER,1
LB,PLASMA CELL LEUKAEMIA,1
LB,PLASMA CELL MYELOMA,1
LB,PLASMA CELL MYELOMA RECURRENT,1
LB,PLASMACYTOMA,1
LB,PULSE ABNORMAL,1
LB,READING DISORDER,1
LB,RENAL FAILURE,1
LB,SEIZURE,1
LB,SEPSIS,1
LB,SUICIDAL IDEATION,1
LB,THROMBOPHLEBITIS,1
LB,VERTIGO,1
LB,WITHDRAWAL SYNDROME,1
LY,CHEST PAIN,1
LY,PLEURAL EFFUSION,1
LT,DRUG INEFFECTIVE,1
LT,RASH PAPULAR,1
LU,RHABDOMYOLYSIS,3
LU,DEHYDRATION,2
LU,FALL,2
LU,ACUTE KIDNEY INJURY,1
LU,ATRIAL FIBRILLATION,1
LU,BRADYCARDIA,1
LU,CARDIAC DISORDER,1
LU,CIRRHOSIS ALCOHOLIC,1
LU,COUGH,1
LU,CYANOSIS,1
LU,DIARRHOEA,1
LU,DYSPNOEA,1
LU,FEMORAL NECK FRACTURE,1
LU,GASTRIC HAEMORRHAGE,1
LU,HAEMATOCHEZIA,1
LU,HYPERNATRAEMIA,1
LU,HYPOTHERMIA,1
LU,HYPOTHYROIDISM,1
LU,INTERSTITIAL LUNG DISEASE,1
LU,KETOACIDOSIS,1
LU,LACUNAR INFARCTION,1
LU,LARGE INTESTINAL HAEMORRHAGE,1
LU,MELAENA,1
LU,OCULAR ICTERUS,1
LU,OEDEMA,1
LU,PAIN IN EXTREMITY,1
LU,PNEUMONIA,1
LU,PYREXIA,1
LU,RENAL FAILURE,1
LU,SKIN DISCOLOURATION,1
LU,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
MY,DIZZINESS,4
MY,PALPITATIONS,2
MY,PYREXIA,2
MY,STEVENS-JOHNSON SYNDROME,2
MY,VOMITING,2
MY,ANAEMIA,1
MY,ARRHYTHMIA,1
MY,ASTHMA,1
MY,AUTONOMIC NEUROPATHY,1
MY,BURNING SENSATION,1
MY,COMA,1
MY,CONTUSION,1
MY,COUGH,1
MY,DEATH,1
MY,DIARRHOEA,1
MY,DISEASE RECURRENCE,1
MY,DRUG ABUSE,1
MY,DRUG DEPENDENCE,1
MY,DRUG HYPERSENSITIVITY,1
MY,DYSPEPSIA,1
MY,DYSPNOEA,1
MY,EYELID OEDEMA,1
MY,FALL,1
MY,FATIGUE,1
MY,HEADACHE,1
MY,HYPERSOMNIA,1
MY,HYPOAESTHESIA,1
MY,HYPOGLYCAEMIA,1
MY,LOSS OF CONSCIOUSNESS,1
MY,MALAISE,1
MY,NAUSEA,1
MY,ORBITAL OEDEMA,1
MY,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
MY,PARAESTHESIA,1
MY,PERIORBITAL OEDEMA,1
MY,PERIPHERAL SENSORY NEUROPATHY,1
MY,PHOTOPHOBIA,1
MY,PRODUCT USE ISSUE,1
MY,RASH,1
MY,SEIZURE,1
MY,STOMATITIS,1
MY,SYNCOPE,1
MY,THROMBOCYTOPENIA,1
MY,TINNITUS,1
MY,TOXIC EPIDERMAL NECROLYSIS,1
MY,TREMOR,1
MY,UPPER RESPIRATORY TRACT INFECTION,1
MT,ABDOMINAL DISTENSION,1
MT,ABDOMINAL PAIN UPPER,1
MT,HEPATOTOXICITY,1
MT,LIVER FUNCTION TEST ABNORMAL,1
MX,DEATH,28
MX,DIZZINESS,23
MX,PAIN IN EXTREMITY,19
MX,ARTHRALGIA,17
MX,DIABETES MELLITUS,17
MX,FALL,16
MX,PAIN,15
MX,FEELING ABNORMAL,14
MX,FATIGUE,13
MX,ABASIA,12
MX,ASTHENIA,12
MX,DRUG INEFFECTIVE,11
MX,HEADACHE,11
MX,HYPERTENSION,11
MX,MALAISE,11
MX,PRODUCT USE ISSUE,11
MX,BACK PAIN,10
MX,MUSCULOSKELETAL PAIN,10
MX,MYOCARDIAL INFARCTION,10
MX,NEOPLASM MALIGNANT,10
MX,SOMNOLENCE,10
MX,SPEECH DISORDER,10
MX,DYSPNOEA,9
MX,GAIT DISTURBANCE,9
MX,INSOMNIA,9
MX,NAUSEA,9
MX,PYREXIA,9
MX,ANXIETY,8
MX,BLOOD PRESSURE INCREASED,8
MX,GENERAL PHYSICAL HEALTH DETERIORATION,8
MX,INFARCTION,8
MX,INFLUENZA,8
MX,TREMOR,8
MX,WEIGHT DECREASED,8
MX,WRONG TECHNIQUE IN DRUG USAGE PROCESS,8
MX,BLOOD GLUCOSE INCREASED,7
MX,COUGH,7
MX,EMBOLISM,7
MX,HYPOAESTHESIA,7
MX,MEMORY IMPAIRMENT,7
MX,PNEUMONIA,7
MX,BALANCE DISORDER,6
MX,BONE PAIN,6
MX,CEREBROVASCULAR ACCIDENT,6
MX,DIARRHOEA,6
MX,INFLAMMATION,6
MX,MOBILITY DECREASED,6
MX,PARAESTHESIA,6
MX,ROAD TRAFFIC ACCIDENT,6
MX,SYNCOPE,6
MX,VOMITING,6
MX,WEIGHT INCREASED,6
MX,ALTERED STATE OF CONSCIOUSNESS,5
MX,CONSTIPATION,5
MX,DECREASED APPETITE,5
MX,DEPRESSED MOOD,5
MX,GASTRITIS,5
MX,INTERVERTEBRAL DISC PROTRUSION,5
MX,MUSCULOSKELETAL STIFFNESS,5
MX,NECK PAIN,5
MX,URINARY TRACT INFECTION,5
MX,VISUAL IMPAIRMENT,5
MX,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,5
MX,ASPHYXIA,4
MX,BLINDNESS,4
MX,BRONCHITIS,4
MX,BURNING SENSATION,4
MX,DEAFNESS,4
MX,DELIRIUM,4
MX,DEPRESSION,4
MX,DRUG PRESCRIBING ERROR,4
MX,HEPATIC FAILURE,4
MX,HIATUS HERNIA,4
MX,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,4
MX,MUSCLE SPASMS,4
MX,MUSCULAR WEAKNESS,4
MX,NERVOUSNESS,4
MX,PERIPHERAL SWELLING,4
MX,SPINAL PAIN,4
MX,THYROID DISORDER,4
MX,ABDOMINAL DISCOMFORT,3
MX,ABDOMINAL PAIN UPPER,3
MX,ANGINA UNSTABLE,3
MX,BEDRIDDEN,3
MX,BLOOD GLUCOSE DECREASED,3
MX,BONE CANCER,3
MX,CARDIAC DISORDER,3
MX,CARDIOVASCULAR DISORDER,3
MX,CHEST PAIN,3
MX,COORDINATION ABNORMAL,3
MX,DEHYDRATION,3
MX,DISEASE PROGRESSION,3
MX,DISTURBANCE IN ATTENTION,3
MX,DRUG DEPENDENCE,3
MX,DRUG HYPERSENSITIVITY,3
MX,DRY SKIN,3
MX,DYSPHONIA,3
MX,GAIT INABILITY,3
MX,HERPES ZOSTER,3
MX,HIP FRACTURE,3
MX,HYPOTENSION,3
MX,INJURY,3
MX,INTENTIONAL PRODUCT MISUSE,3
MX,LIGAMENT SPRAIN,3
MX,LOWER LIMB FRACTURE,3
MX,METASTASES TO BONE,3
MX,MOOD ALTERED,3
MX,MUSCLE RIGIDITY,3
MX,NEUROPATHY PERIPHERAL,3
MX,OSTEOARTHRITIS,3
MX,OSTEOPOROSIS,3
MX,PARKINSON^S DISEASE,3
MX,RASH,3
MX,RHINORRHOEA,3
MX,SPINAL DEFORMITY,3
MX,SPINAL DISORDER,3
MX,STATUS EPILEPTICUS,3
MX,STRESS,3
MX,TACHYCARDIA,3
MX,THROMBOSIS,3
MX,UPPER LIMB FRACTURE,3
MX,VISION BLURRED,3
MX,ABDOMINAL PAIN,2
MX,AGITATION,2
MX,ANAEMIA,2
MX,ANGER,2
MX,ARRHYTHMIA,2
MX,ARTHRITIS,2
MX,BACK INJURY,2
MX,BLOOD PRESSURE DECREASED,2
MX,BRAIN INJURY,2
MX,CATARACT,2
MX,CHILLS,2
MX,CHOLELITHIASIS,2
MX,COCCYDYNIA,2
MX,COLITIS,2
MX,CONCOMITANT DISEASE AGGRAVATED,2
MX,CONTUSION,2
MX,DIABETES MELLITUS INADEQUATE CONTROL,2
MX,DIABETIC NEUROPATHY,2
MX,DISORIENTATION,2
MX,DIVERTICULUM,2
MX,DRY MOUTH,2
MX,DRY THROAT,2
MX,DYSKINESIA,2
MX,EAR DISCOMFORT,2
MX,EYE DISORDER,2
MX,FACIAL PARALYSIS,2
MX,FEELING HOT,2
MX,FEELING OF DESPAIR,2
MX,FIBROMYALGIA,2
MX,FLANK PAIN,2
MX,FLATULENCE,2
MX,FLUID RETENTION,2
MX,FOOD INTOLERANCE,2
MX,GASTRIC DISORDER,2
MX,HAEMOGLOBIN DECREASED,2
MX,HAEMORRHOIDS,2
MX,HEPATIC LESION,2
MX,HYPERHIDROSIS,2
MX,HYPERSOMNIA,2
MX,HYPERTONIA,2
MX,HYPOACUSIS,2
MX,HYPOXIA,2
MX,ILL-DEFINED DISORDER,2
MX,INFECTION,2
MX,IRRITABILITY,2
MX,JOINT STIFFNESS,2
MX,JOINT SWELLING,2
MX,LIMB DISCOMFORT,2
MX,LIMB INJURY,2
MX,LIVER DISORDER,2
MX,LIVER INJURY,2
MX,METABOLIC ACIDOSIS,2
MX,MICTURITION URGENCY,2
MX,MONOPLEGIA,2
MX,MULTIPLE SCLEROSIS,2
MX,MYALGIA,2
MX,MYDRIASIS,2
MX,NASOPHARYNGITIS,2
MX,NERVE COMPRESSION,2
MX,NERVE INJURY,2
MX,NERVOUS SYSTEM DISORDER,2
MX,OROPHARYNGEAL DISCOMFORT,2
MX,PALPITATIONS,2
MX,PENILE PAIN,2
MX,POISONING,2
MX,PRODUCT USE IN UNAPPROVED INDICATION,2
MX,PROSTATIC DISORDER,2
MX,PRURITUS,2
MX,RASH MACULAR,2
MX,RENAL FAILURE,2
MX,RESPIRATORY DISTRESS,2
MX,RHEUMATOID ARTHRITIS,2
MX,SENILE DEMENTIA,2
MX,SEPTIC SHOCK,2
MX,SKIN DISCOLOURATION,2
MX,SKIN PAPILLOMA,2
MX,SPINAL COLUMN INJURY,2
MX,SPINAL FRACTURE,2
MX,STOMATITIS,2
MX,SWELLING,2
MX,SYSTEMIC LUPUS ERYTHEMATOSUS,2
MX,TENSION,2
MX,THERAPEUTIC RESPONSE UNEXPECTED,2
MX,THROMBOPHLEBITIS,2
MX,TINNITUS,2
MX,UNEVALUABLE EVENT,2
MX,VARICOSE ULCERATION,2
MX,WALKING DISABILITY,2
MX,WHITE BLOOD CELL COUNT DECREASED,2
MX,ABNORMAL DREAMS,1
MX,ACCIDENT,1
MX,ACUTE KIDNEY INJURY,1
MX,ACUTE MYOCARDIAL INFARCTION,1
MX,ACUTE PULMONARY OEDEMA,1
MX,AFFECT LABILITY,1
MX,AGGRESSION,1
MX,ALANINE AMINOTRANSFERASE INCREASED,1
MX,AMNESIA,1
MX,ANEURYSM,1
MX,ANKLE FRACTURE,1
MX,APATHY,1
MX,APHAGIA,1
MX,APHASIA,1
MX,APHTHOUS STOMATITIS,1
MX,APPENDICITIS,1
MX,APPLICATION SITE BRUISE,1
MX,APPLICATION SITE PRURITUS,1
MX,ASPARTATE AMINOTRANSFERASE INCREASED,1
MX,ASTHMA,1
MX,AXILLARY PAIN,1
MX,BED REST,1
MX,BILE DUCT STONE,1
MX,BLADDER DISORDER,1
MX,BLOOD CHOLESTEROL,1
MX,BLOOD CHOLESTEROL INCREASED,1
MX,BLOOD GLUCOSE FLUCTUATION,1
MX,BLOOD LACTATE DEHYDROGENASE INCREASED,1
MX,BLOOD POTASSIUM DECREASED,1
MX,BLOOD PRESSURE,1
MX,BLOOD PRESSURE ABNORMAL,1
MX,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
MX,BLOOD SODIUM DECREASED,1
MX,BLOOD TRIGLYCERIDES,1
MX,BLOOD TRIGLYCERIDES INCREASED,1
MX,BLOOD URIC ACID INCREASED,1
MX,BODY HEIGHT BELOW NORMAL,1
MX,BODY TEMPERATURE INCREASED,1
MX,BONE DECALCIFICATION,1
MX,BONE NEOPLASM,1
MX,BRAIN NEOPLASM,1
MX,BRAIN OEDEMA,1
MX,C-REACTIVE PROTEIN INCREASED,1
MX,CARDIAC ARREST,1
MX,CARDIAC FAILURE,1
MX,CARDIAC VALVE DISEASE,1
MX,CARDIO-RESPIRATORY ARREST,1
MX,CARDIOMEGALY,1
MX,CARDIOMYOPATHY,1
MX,CARDIOPULMONARY FAILURE,1
MX,CARTILAGE INJURY,1
MX,CEREBRAL HAEMORRHAGE,1
MX,CEREBROVASCULAR DISORDER,1
MX,CHONDROPATHY,1
MX,CLAVICLE FRACTURE,1
MX,COGNITIVE DISORDER,1
MX,COLD SWEAT,1
MX,COLON CANCER,1
MX,COLONIC ABSCESS,1
MX,COMPLEX PARTIAL SEIZURES,1
MX,CONCUSSION,1
MX,CONDITION AGGRAVATED,1
MX,CONFUSIONAL STATE,1
MX,CONJUNCTIVITIS,1
MX,CONVULSION,1
MX,CRYING,1
MX,CYSTITIS NONINFECTIVE,1
MX,DARK CIRCLES UNDER EYES,1
MX,DEEP VEIN THROMBOSIS,1
MX,DEMENTIA ALZHEIMER^S TYPE,1
MX,DEPRESSED LEVEL OF CONSCIOUSNESS,1
MX,DERMATITIS ALLERGIC,1
MX,DEVICE ISSUE,1
MX,DIABETIC NEPHROPATHY,1
MX,DIAPHRAGMATIC DISORDER,1
MX,DIPLOPIA,1
MX,DISEASE RECURRENCE,1
MX,DRUG ADMINISTRATION ERROR,1
MX,DRUG DOSE OMISSION,1
MX,DRUG WITHDRAWAL SYNDROME,1
MX,DRUG-INDUCED LIVER INJURY,1
MX,DYSBACTERIOSIS,1
MX,DYSGEUSIA,1
MX,DYSGRAPHIA,1
MX,DYSPEPSIA,1
MX,DYSPHAGIA,1
MX,DYSPHEMIA,1
MX,DYSURIA,1
MX,EAR INFECTION,1
MX,EFFUSION,1
MX,ENCEPHALOPATHY,1
MX,EPISTAXIS,1
MX,ERECTILE DYSFUNCTION,1
MX,EYE IRRITATION,1
MX,EYE MOVEMENT DISORDER,1
MX,EYE SWELLING,1
MX,EYELID OEDEMA,1
MX,FACIAL BONES FRACTURE,1
MX,FAECES DISCOLOURED,1
MX,FEAR,1
MX,FEEDING DISORDER,1
MX,FEELING DRUNK,1
MX,FEELING OF BODY TEMPERATURE CHANGE,1
MX,FEMORAL ARTERY OCCLUSION,1
MX,FLAVIVIRUS INFECTION,1
MX,FLUID INTAKE REDUCED,1
MX,FOOT FRACTURE,1
MX,FRACTURE,1
MX,FRONTOTEMPORAL DEMENTIA,1
MX,GASTRIC INFECTION,1
MX,GASTRIC ULCER,1
MX,GASTROINTESTINAL DISORDER,1
MX,GASTROINTESTINAL HAEMORRHAGE,1
MX,GASTROINTESTINAL PAIN,1
MX,GASTROINTESTINAL ULCER,1
MX,GASTROOESOPHAGEAL REFLUX DISEASE,1
MX,HAEMATEMESIS,1
MX,HAEMATOLOGICAL MALIGNANCY,1
MX,HAEMATOMA,1
MX,HAEMORRHAGE,1
MX,HALLUCINATION,1
MX,HEAD DISCOMFORT,1
MX,HEAD INJURY,1
MX,HEARING IMPAIRED,1
MX,HEPATIC PAIN,1
MX,HEPATIC STEATOSIS,1
MX,HEPATITIS,1
MX,HEPATOMEGALY,1
MX,HEPATOTOXICITY,1
MX,HERNIA,1
MX,HYPERTENSIVE HEART DISEASE,1
MX,HYPERTHYROIDISM,1
MX,HYPERTRIGLYCERIDAEMIA,1
MX,HYPOGLYCAEMIA,1
MX,HYPONATRAEMIA,1
MX,HYPOPHAGIA,1
MX,HYPOTHYROIDISM,1
MX,ILEUS PARALYTIC,1
MX,IMMUNOSUPPRESSION,1
MX,IMPAIRED DRIVING ABILITY,1
MX,IMPAIRED HEALING,1
MX,INCREASED VISCOSITY OF NASAL SECRETION,1
MX,INFLUENZA LIKE ILLNESS,1
MX,INTENTIONAL PRODUCT USE ISSUE,1
MX,INTERNAL HAEMORRHAGE,1
MX,INTERVERTEBRAL DISCITIS,1
MX,INTESTINAL ADENOCARCINOMA,1
MX,INTESTINAL DILATATION,1
MX,INTESTINAL OBSTRUCTION,1
MX,INTRAOCULAR PRESSURE INCREASED,1
MX,IRRITABLE BOWEL SYNDROME,1
MX,JOINT DISLOCATION,1
MX,JOINT INJURY,1
MX,KIDNEY INFECTION,1
MX,LACRIMAL DISORDER,1
MX,LACTOSE INTOLERANCE,1
MX,LARYNGEAL INJURY,1
MX,LEUKOCYTOSIS,1
MX,LIGAMENT RUPTURE,1
MX,LOSS OF CONSCIOUSNESS,1
MX,LUMBAR SPINAL STENOSIS,1
MX,LUNG DISORDER,1
MX,LUNG NEOPLASM MALIGNANT,1
MX,MALNUTRITION,1
MX,MASTECTOMY,1
MX,MELANOCYTIC NAEVUS,1
MX,MENINGITIS,1
MX,MENTAL IMPAIRMENT,1
MX,METASTASES TO LIVER,1
MX,METASTATIC NEOPLASM,1
MX,MICTURITION DISORDER,1
MX,MIDDLE INSOMNIA,1
MX,MOVEMENT DISORDER,1
MX,MULTI-ORGAN FAILURE,1
MX,MULTIPLE SCLEROSIS RELAPSE,1
MX,MUSCULOSKELETAL CHEST PAIN,1
MX,MUSCULOSKELETAL DISCOMFORT,1
MX,MUSCULOSKELETAL DISORDER,1
MX,MYOCARDIAL ISCHAEMIA,1
MX,NASAL DISCHARGE DISCOLOURATION,1
MX,NASAL DRYNESS,1
MX,NERVE DEGENERATION,1
MX,NEUROGENIC BLADDER,1
MX,NEUTROPENIA,1
MX,NEUTROPHIL COUNT DECREASED,1
MX,NEUTROPHIL COUNT INCREASED,1
MX,OBSESSIVE THOUGHTS,1
MX,OEDEMA,1
MX,OEDEMA PERIPHERAL,1
MX,OESOPHAGEAL DISORDER,1
MX,OESOPHAGITIS,1
MX,ONYCHOMYCOSIS,1
MX,OPTIC NERVE INJURY,1
MX,OPTIC NEURITIS,1
MX,OROPHARYNGEAL PAIN,1
MX,PALLOR,1
MX,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
MX,PANCREATIC CARCINOMA,1
MX,PARALYSIS,1
MX,PARAPLEGIA,1
MX,PARTIAL SEIZURES,1
MX,PELVIC FRACTURE,1
MX,PENILE HAEMORRHAGE,1
MX,PEPTIC ULCER,1
MX,PHARYNGITIS,1
MX,PLASMA CELL MYELOMA,1
MX,POLIOMYELITIS,1
MX,POLLAKIURIA,1
MX,POOR QUALITY SLEEP,1
MX,PRE-EXISTING CONDITION IMPROVED,1
MX,PRESCRIBED UNDERDOSE,1
MX,PROCEDURAL PAIN,1
MX,PRODUCTIVE COUGH,1
MX,PROSTATE CANCER,1
MX,PROSTATITIS,1
MX,PSORIASIS,1
MX,PULMONARY FIBROSIS,1
MX,QUADRIPLEGIA,1
MX,RADICULITIS,1
MX,RED MAN SYNDROME,1
MX,REFLUX GASTRITIS,1
MX,RELAPSING-REMITTING MULTIPLE SCLEROSIS,1
MX,RENAL IMPAIRMENT,1
MX,RENAL PAIN,1
MX,RESTLESSNESS,1
MX,RETINOPATHY,1
MX,SALIVARY HYPERSECRETION,1
MX,SARCOMA,1
MX,SCAN ABNORMAL,1
MX,SCAR PAIN,1
MX,SCIATICA,1
MX,SCLERITIS,1
MX,SCREAMING,1
MX,SEDATION,1
MX,SEIZURE,1
MX,SEPSIS,1
MX,SEROTONIN SYNDROME,1
MX,SHOCK,1
MX,SHOULDER OPERATION,1
MX,SKIN BURNING SENSATION,1
MX,SKIN CANCER,1
MX,SKIN DEPIGMENTATION,1
MX,SKIN DISORDER,1
MX,SKIN EXFOLIATION,1
MX,SKIN LESION,1
MX,SLOW SPEECH,1
MX,SNEEZING,1
MX,SPINAL COMPRESSION FRACTURE,1
MX,SPINAL CORD DISORDER,1
MX,SPINAL CORD INFECTION,1
MX,SPINAL OPERATION,1
MX,SUICIDAL IDEATION,1
MX,SURGERY,1
MX,TENDON DISORDER,1
MX,TENDON PAIN,1
MX,TESTICULAR PAIN,1
MX,THERAPEUTIC EMBOLISATION,1
MX,THERAPEUTIC PRODUCT INEFFECTIVE,1
MX,THYROID NEOPLASM,1
MX,TONGUE MOVEMENT DISTURBANCE,1
MX,TOOTH DISORDER,1
MX,TRAUMATIC HAEMATOMA,1
MX,TRIGEMINAL NERVE DISORDER,1
MX,TRIGGER FINGER,1
MX,TRISMUS,1
MX,TUBERCULOSIS LIVER,1
MX,TYPE 2 DIABETES MELLITUS,1
MX,TYPHOID FEVER,1
MX,ULCER,1
MX,UMBILICAL HERNIA,1
MX,URINARY BLADDER ABSCESS,1
MX,URINARY RETENTION,1
MX,URINE OUTPUT DECREASED,1
MX,UTERINE DISORDER,1
MX,VAGINAL MUCOSAL BLISTERING,1
MX,VARICOSE VEIN,1
MX,VENOUS THROMBOSIS,1
MX,VENTRICULAR EXTRASYSTOLES,1
MX,VERTIGO,1
MX,VISUAL ACUITY REDUCED,1
MX,WEIGHT FLUCTUATION,1
MX,X-RAY ABNORMAL,1
MX,XEROPHTHALMIA,1
MC,DYSPNOEA,1
MC,ELECTROCARDIOGRAM QT PROLONGED,1
MC,EPILEPSY,1
MC,FATIGUE,1
MC,NAUSEA,1
MC,RESPIRATORY ARREST,1
MC,VERTIGO,1
ME,SUFFOCATION FEELING,1
ME,TONGUE DISORDER,1
MA,ABDOMINAL PAIN UPPER,1
MA,COMA,1
MA,FAECAL INCONTINENCE,1
MA,LOSS OF CONSCIOUSNESS,1
MA,NAUSEA,1
MA,PETIT MAL EPILEPSY,1
MA,THROMBOCYTOPENIA,1
MA,URINARY INCONTINENCE,1
MA,VOMITING,1
NL,DEATH,15
NL,NAUSEA,15
NL,WEIGHT DECREASED,15
NL,PYREXIA,13
NL,PAIN,12
NL,DYSPNOEA,11
NL,HEADACHE,11
NL,PNEUMONIA,11
NL,DIARRHOEA,9
NL,FATIGUE,9
NL,MALAISE,9
NL,SYNCOPE,9
NL,ABDOMINAL PAIN,8
NL,DECREASED APPETITE,8
NL,GAIT DISTURBANCE,8
NL,MUSCLE SPASMS,8
NL,SOMNOLENCE,8
NL,VISION BLURRED,8
NL,CONFUSIONAL STATE,7
NL,FALL,7
NL,HYPOTENSION,7
NL,SUICIDAL IDEATION,7
NL,ASTIGMATISM,6
NL,BLINDNESS TRANSIENT,6
NL,BRADYCARDIA,6
NL,COLOUR BLINDNESS,6
NL,DIZZINESS,6
NL,EYE DISORDER,6
NL,EYE IRRITATION,6
NL,HALLUCINATION,6
NL,TREMOR,6
NL,VISUAL IMPAIRMENT,6
NL,VOMITING,6
NL,DRUG INEFFECTIVE,5
NL,HYPERHIDROSIS,5
NL,MALIGNANT NEOPLASM PROGRESSION,5
NL,METASTASIS,5
NL,MYALGIA,5
NL,PERIPHERAL SWELLING,5
NL,RENAL IMPAIRMENT,5
NL,TERMINAL STATE,5
NL,TOXICITY TO VARIOUS AGENTS,5
NL,URINARY TRACT INFECTION,5
NL,WEIGHT INCREASED,5
NL,ABDOMINAL DISTENSION,4
NL,AGGRESSION,4
NL,ANGIOEDEMA,4
NL,ANXIETY,4
NL,APHASIA,4
NL,ARRHYTHMIA,4
NL,ASTHENIA,4
NL,DEHYDRATION,4
NL,DELIRIUM,4
NL,DEPRESSED LEVEL OF CONSCIOUSNESS,4
NL,DISEASE PROGRESSION,4
NL,ERYTHEMA,4
NL,HAEMOGLOBIN DECREASED,4
NL,MEMORY IMPAIRMENT,4
NL,MYOCARDIAL INFARCTION,4
NL,OEDEMA PERIPHERAL,4
NL,PAIN IN EXTREMITY,4
NL,PRODUCT USE IN UNAPPROVED INDICATION,4
NL,PSYCHOTIC DISORDER,4
NL,SEPSIS,4
NL,THROMBOCYTOPENIA,4
NL,WOUND,4
NL,ABASIA,3
NL,ANAEMIA,3
NL,BACK PAIN,3
NL,BLOOD TEST ABNORMAL,3
NL,CHEST PAIN,3
NL,CHILLS,3
NL,CONDITION AGGRAVATED,3
NL,DEPRESSED MOOD,3
NL,DEPRESSION,3
NL,DIABETES MELLITUS INADEQUATE CONTROL,3
NL,DRUG ABUSE,3
NL,EPILEPSY,3
NL,FEELING ABNORMAL,3
NL,FOETAL GROWTH RESTRICTION,3
NL,GENERAL PHYSICAL HEALTH DETERIORATION,3
NL,HEPATITIS,3
NL,HYPOCALCAEMIA,3
NL,INSOMNIA,3
NL,MOBILITY DECREASED,3
NL,MULTIPLE SCLEROSIS RELAPSE,3
NL,MUSCULAR WEAKNESS,3
NL,OEDEMA,3
NL,PERIPHERAL COLDNESS,3
NL,PLASMA CELL MYELOMA,3
NL,PLEURAL EFFUSION,3
NL,PRODUCT USE ISSUE,3
NL,PROSTATE CANCER METASTATIC,3
NL,RENAL DISORDER,3
NL,RESTLESSNESS,3
NL,SKIN DISCOLOURATION,3
NL,SUICIDE ATTEMPT,3
NL,ABNORMAL BEHAVIOUR,2
NL,ACUTE MYOCARDIAL INFARCTION,2
NL,AGITATION,2
NL,AMNESIA,2
NL,ASPIRATION,2
NL,ATRIAL FIBRILLATION,2
NL,BACTERIAL INFECTION,2
NL,BALANCE DISORDER,2
NL,BONE PAIN,2
NL,BRONCHOPULMONARY ASPERGILLOSIS,2
NL,C-REACTIVE PROTEIN INCREASED,2
NL,CARDIAC FAILURE,2
NL,CATARACT,2
NL,CHEST DISCOMFORT,2
NL,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
NL,CONSTIPATION,2
NL,CONVULSION,2
NL,COUGH,2
NL,DEPENDENCE,2
NL,DISORIENTATION,2
NL,DISTURBANCE IN ATTENTION,2
NL,DIVERTICULITIS,2
NL,DRUG ADMINISTRATION ERROR,2
NL,DRUG DOSE TITRATION NOT PERFORMED,2
NL,DRUG EFFECT INCOMPLETE,2
NL,DRUG WITHDRAWAL SYNDROME,2
NL,DRY MOUTH,2
NL,DYSARTHRIA,2
NL,DYSKINESIA,2
NL,DYSPHAGIA,2
NL,ENDOMETRIOSIS,2
NL,EPISTAXIS,2
NL,ERYSIPELAS,2
NL,FEBRILE NEUTROPENIA,2
NL,FOETAL DEATH,2
NL,FOETAL EXPOSURE DURING PREGNANCY,2
NL,GASTROINTESTINAL DISORDER,2
NL,HAEMATOMA,2
NL,HAIR GROWTH ABNORMAL,2
NL,HEPATIC FUNCTION ABNORMAL,2
NL,HOSPITALISATION,2
NL,HYPERGLYCAEMIA,2
NL,HYPERTENSION,2
NL,HYPOMAGNESAEMIA,2
NL,HYPONATRAEMIA,2
NL,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
NL,INCONTINENCE,2
NL,INFLUENZA LIKE ILLNESS,2
NL,ISCHAEMIC STROKE,2
NL,LIMB DISCOMFORT,2
NL,LIPODYSTROPHY ACQUIRED,2
NL,LIVER DISORDER,2
NL,LUNG DISORDER,2
NL,LUNG NEOPLASM MALIGNANT,2
NL,MALNUTRITION,2
NL,MATERNAL EXPOSURE DURING PREGNANCY,2
NL,MENTAL IMPAIRMENT,2
NL,METASTASES TO BONE,2
NL,METASTASES TO LIVER,2
NL,METASTATIC RENAL CELL CARCINOMA,2
NL,MULTIPLE SCLEROSIS,2
NL,MUSCULOSKELETAL PAIN,2
NL,MYOCLONUS,2
NL,NEUROPATHY PERIPHERAL,2
NL,NEUTROPENIA,2
NL,NIGHTMARE,2
NL,OSTEOMYELITIS,2
NL,PARAESTHESIA,2
NL,PARESIS,2
NL,PELVIC PAIN,2
NL,PETIT MAL EPILEPSY,2
NL,POLYNEUROPATHY,2
NL,POTENTIATING DRUG INTERACTION,2
NL,PRURITUS,2
NL,PULMONARY EMBOLISM,2
NL,RECTAL HAEMORRHAGE,2
NL,RESTLESS LEGS SYNDROME,2
NL,RIB FRACTURE,2
NL,SEIZURE,2
NL,SINUS ARREST,2
NL,SINUS BRADYCARDIA,2
NL,SKIN WOUND,2
NL,SPEECH DISORDER,2
NL,SUDDEN ONSET OF SLEEP,2
NL,SWOLLEN TONGUE,2
NL,TACHYCARDIA,2
NL,TRANSIENT ISCHAEMIC ATTACK,2
NL,TRIGEMINAL NEURALGIA,2
NL,TUNNEL VISION,2
NL,UNRESPONSIVE TO STIMULI,2
NL,UROSEPSIS,2
NL,WHITE BLOOD CELL COUNT DECREASED,2
NL,ABDOMINAL PAIN LOWER,1
NL,ABDOMINAL PAIN UPPER,1
NL,ABNORMAL FAECES,1
NL,ACTIVITIES OF DAILY LIVING IMPAIRED,1
NL,ACUTE KIDNEY INJURY,1
NL,ADMINISTRATION RELATED REACTION,1
NL,ADRENAL NEOPLASM,1
NL,ADVERSE REACTION,1
NL,AFFECT LABILITY,1
NL,ALANINE AMINOTRANSFERASE INCREASED,1
NL,ALCOHOLISM,1
NL,ALOPECIA,1
NL,ANAPHYLACTIC REACTION,1
NL,ANGINA PECTORIS,1
NL,APNOEIC ATTACK,1
NL,ARTERIAL RUPTURE,1
NL,ARTERIOSCLEROSIS,1
NL,ARTERIOSCLEROSIS CORONARY ARTERY,1
NL,ARTHRITIS,1
NL,ARTHROPATHY,1
NL,ASCITES,1
NL,ASPARTATE AMINOTRANSFERASE INCREASED,1
NL,ASTHMA,1
NL,ATAXIA,1
NL,ATRIOVENTRICULAR BLOCK FIRST DEGREE,1
NL,ATRIOVENTRICULAR BLOCK SECOND DEGREE,1
NL,AXONAL NEUROPATHY,1
NL,BACK DISORDER,1
NL,BACTERAEMIA,1
NL,BILE DUCT CANCER,1
NL,BILIARY TRACT DISORDER,1
NL,BLADDER CANCER,1
NL,BLADDER TRANSITIONAL CELL CARCINOMA,1
NL,BLINDNESS,1
NL,BLINDNESS UNILATERAL,1
NL,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
NL,BLOOD GLUCOSE INCREASED,1
NL,BLOOD PRESSURE DECREASED,1
NL,BLOOD PRESSURE INCREASED,1
NL,BODY TEMPERATURE INCREASED,1
NL,BONE DISORDER,1
NL,BREAST CANCER METASTATIC,1
NL,BREAST RECONSTRUCTION,1
NL,CARDIAC ARREST,1
NL,CARDIAC VENTRICULAR DISORDER,1
NL,CENTRAL NERVOUS SYSTEM LESION,1
NL,CEREBELLAR ATAXIA,1
NL,CEREBRAL INFARCTION,1
NL,CEREBROVASCULAR ACCIDENT,1
NL,CHOKING,1
NL,CHOLELITHIASIS,1
NL,CHROMATOPSIA,1
NL,CIRCULATORY COLLAPSE,1
NL,COAGULATION TIME PROLONGED,1
NL,COLITIS,1
NL,COLON ADENOMA,1
NL,COLON CANCER,1
NL,COLORECTAL ADENOCARCINOMA,1
NL,COLOUR BLINDNESS ACQUIRED,1
NL,COMA,1
NL,COMPLETED SUICIDE,1
NL,COMPLICATIONS OF TRANSPLANTED KIDNEY,1
NL,CONTRAINDICATED DRUG ADMINISTERED,1
NL,CONTUSION,1
NL,CRYING,1
NL,CUTANEOUS SYMPTOM,1
NL,CYSTITIS,1
NL,CYSTITIS NONINFECTIVE,1
NL,DECUBITUS ULCER,1
NL,DEMENTIA,1
NL,DEMENTIA ALZHEIMER^S TYPE,1
NL,DEPERSONALISATION,1
NL,DEVICE RELATED INFECTION,1
NL,DIABETES MELLITUS,1
NL,DIALYSIS,1
NL,DIARRHOEA HAEMORRHAGIC,1
NL,DIPLOPIA,1
NL,DISCOMFORT,1
NL,DRUG EFFECT DECREASED,1
NL,DRUG EFFECT INCREASED,1
NL,DRUG LEVEL INCREASED,1
NL,DYSSTASIA,1
NL,DYSTONIA,1
NL,EMOTIONAL DISORDER,1
NL,EMOTIONAL DISTRESS,1
NL,ENCEPHALOPATHY,1
NL,ERECTION INCREASED,1
NL,ESSENTIAL HYPERTENSION,1
NL,EUPHORIC MOOD,1
NL,EXPOSURE DURING PREGNANCY,1
NL,EYELID OEDEMA,1
NL,FACE OEDEMA,1
NL,FEELING COLD,1
NL,FINGERPRINT LOSS,1
NL,FLANK PAIN,1
NL,FLATULENCE,1
NL,FLUSHING,1
NL,FOOT DEFORMITY,1
NL,FRACTURE PAIN,1
NL,FRACTURED SACRUM,1
NL,FUNCTIONAL GASTROINTESTINAL DISORDER,1
NL,FUNGAL INFECTION,1
NL,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
NL,GASTRIC DISORDER,1
NL,GASTRIC HAEMORRHAGE,1
NL,GASTRIC ULCER,1
NL,GASTRITIS,1
NL,GASTROENTERITIS,1
NL,GASTROINTESTINAL CARCINOMA,1
NL,GASTROINTESTINAL INFLAMMATION,1
NL,GASTROINTESTINAL NECROSIS,1
NL,GASTROINTESTINAL OBSTRUCTION,1
NL,GENERAL SYMPTOM,1
NL,GUILLAIN-BARRE SYNDROME,1
NL,HAEMATOCHEZIA,1
NL,HAEMATOCRIT DECREASED,1
NL,HAEMORRHAGE,1
NL,HAEMORRHAGE INTRACRANIAL,1
NL,HAEMORRHOIDS,1
NL,HAND-EYE COORDINATION IMPAIRED,1
NL,HEAD DISCOMFORT,1
NL,HEART RATE DECREASED,1
NL,HEMIPARESIS,1
NL,HEPATIC ENZYME INCREASED,1
NL,HEPATITIS TOXIC,1
NL,HIGH DENSITY LIPOPROTEIN INCREASED,1
NL,HIP FRACTURE,1
NL,HOT FLUSH,1
NL,HYPERCHOLESTEROLAEMIA,1
NL,HYPERKINESIA,1
NL,HYPERPARATHYROIDISM,1
NL,HYPERPHAGIA,1
NL,HYPERSEXUALITY,1
NL,HYPERTROPHIC CARDIOMYOPATHY,1
NL,HYPERVENTILATION,1
NL,HYPOAESTHESIA,1
NL,HYPOGLYCAEMIA NEONATAL,1
NL,HYPOKALAEMIA,1
NL,HYPOKINESIA,1
NL,HYPOVOLAEMIC SHOCK,1
NL,HYSTERECTOMY,1
NL,HYSTEROSALPINGO-OOPHORECTOMY,1
NL,ILEUS,1
NL,IMPAIRED SELF-CARE,1
NL,IMPLANTABLE DEFIBRILLATOR INSERTION,1
NL,INCORRECT DOSE ADMINISTERED,1
NL,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
NL,INFECTION,1
NL,INFLAMMATION,1
NL,INGROWING NAIL,1
NL,INGUINAL HERNIA REPAIR,1
NL,INJECTION SITE PAIN,1
NL,INJECTION SITE PRURITUS,1
NL,INJECTION SITE REACTION,1
NL,INJECTION SITE URTICARIA,1
NL,INTENTIONAL OVERDOSE,1
NL,INTERNAL HAEMORRHAGE,1
NL,INTERVERTEBRAL DISC OPERATION,1
NL,INTERVERTEBRAL DISC PROTRUSION,1
NL,INTESTINAL ISCHAEMIA,1
NL,JAW CYST,1
NL,KIDNEY INFECTION,1
NL,KIDNEY TRANSPLANT REJECTION,1
NL,LARGE INTESTINE PERFORATION,1
NL,LIP SWELLING,1
NL,LISTLESS,1
NL,LIVER FUNCTION TEST INCREASED,1
NL,LOCAL SWELLING,1
NL,LOCALISED INFECTION,1
NL,LOCALISED OEDEMA,1
NL,LOSS OF CONSCIOUSNESS,1
NL,LOSS OF CONTROL OF LEGS,1
NL,LOSS OF LIBIDO,1
NL,LOWER RESPIRATORY TRACT INFECTION FUNGAL,1
NL,LUMBAR VERTEBRAL FRACTURE,1
NL,LUNG CANCER METASTATIC,1
NL,LUPUS-LIKE SYNDROME,1
NL,MELAENA,1
NL,MENTAL DISORDER,1
NL,METASTASES TO CENTRAL NERVOUS SYSTEM,1
NL,METASTASES TO LUNG,1
NL,METASTASES TO PLEURA,1
NL,METASTASES TO SPINE,1
NL,METASTATIC BRONCHIAL CARCINOMA,1
NL,METASTATIC PAIN,1
NL,MOOD SWINGS,1
NL,MOTOR DYSFUNCTION,1
NL,MULTI-ORGAN FAILURE,1
NL,MULTIMORBIDITY,1
NL,MUSCLE CONTRACTIONS INVOLUNTARY,1
NL,MUSCLE SPASTICITY,1
NL,MUSCULOSKELETAL CHEST PAIN,1
NL,MYOCARDITIS,1
NL,MYOPATHY,1
NL,NECK PAIN,1
NL,NEOPLASM MALIGNANT,1
NL,NEOPLASM PROGRESSION,1
NL,NEPHROLITHIASIS,1
NL,NERVOUS SYSTEM DISORDER,1
NL,NEURALGIA,1
NL,NEUTROPENIC COLITIS,1
NL,NEUTROPHIL COUNT ABNORMAL,1
NL,NO ADVERSE EVENT,1
NL,OBSESSIVE THOUGHTS,1
NL,OEDEMA GENITAL,1
NL,OESOPHAGEAL CARCINOMA,1
NL,ON AND OFF PHENOMENON,1
NL,OOPHORECTOMY,1
NL,OSTEITIS,1
NL,OSTEOPOROSIS,1
NL,PAIN IN JAW,1
NL,PANCREATIC CARCINOMA,1
NL,PANCREATIC NEOPLASM,1
NL,PANCYTOPENIA,1
NL,PANIC ATTACK,1
NL,PANIC DISORDER,1
NL,PARALYSIS,1
NL,PARAPLEGIA,1
NL,PARATHYROID TUMOUR BENIGN,1
NL,PARKINSONISM,1
NL,PERICARDIAL EFFUSION,1
NL,PERIOSTITIS,1
NL,PERITONITIS,1
NL,PERSONALITY CHANGE,1
NL,PHARYNGEAL OEDEMA,1
NL,PHOTOPHOBIA,1
NL,PHRENIC NERVE PARALYSIS,1
NL,PLATELET COUNT DECREASED,1
NL,PLATELET DISORDER,1
NL,POISONING,1
NL,POOR QUALITY SLEEP,1
NL,POST LAMINECTOMY SYNDROME,1
NL,POST PROCEDURAL INFLAMMATION,1
NL,PRE-EXISTING CONDITION IMPROVED,1
NL,PRODUCT QUALITY ISSUE,1
NL,PRODUCT SUBSTITUTION ISSUE,1
NL,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
NL,PROSTATIC HAEMORRHAGE,1
NL,PROSTATIC SPECIFIC ANTIGEN DECREASED,1
NL,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
NL,PROTEIN TOTAL INCREASED,1
NL,PULMONARY INFARCTION,1
NL,PULMONARY NECROSIS,1
NL,PYELONEPHRITIS,1
NL,RADIUS FRACTURE,1
NL,RASH,1
NL,RASH ERYTHEMATOUS,1
NL,READING DISORDER,1
NL,RED BLOOD CELL COUNT DECREASED,1
NL,RENAL ABSCESS,1
NL,RENAL CANCER,1
NL,RENAL FAILURE,1
NL,RESPIRATORY DEPRESSION,1
NL,RESPIRATORY FAILURE,1
NL,RESPIRATORY RATE INCREASED,1
NL,RESPIRATORY TRACT INFECTION,1
NL,SENSORY DISTURBANCE,1
NL,SKIN DISORDER,1
NL,SKIN FISSURES,1
NL,SKIN HAEMORRHAGE,1
NL,SKIN INFECTION,1
NL,SLEEP ATTACKS,1
NL,SPINAL OSTEOARTHRITIS,1
NL,STRIDOR,1
NL,SUBSTANCE USE,1
NL,SUDDEN CARDIAC DEATH,1
NL,SUDDEN DEATH,1
NL,SUICIDAL BEHAVIOUR,1
NL,SUPRAVENTRICULAR TACHYCARDIA,1
NL,SWELLING FACE,1
NL,TENDON PAIN,1
NL,TENDONITIS,1
NL,THERAPEUTIC RESPONSE CHANGED,1
NL,THERAPEUTIC RESPONSE UNEXPECTED,1
NL,THROMBOSIS,1
NL,TONGUE DISORDER,1
NL,TONGUE OEDEMA,1
NL,TONGUE SPASM,1
NL,TOXIC SKIN ERUPTION,1
NL,UNDERDOSE,1
NL,UNEVALUABLE EVENT,1
NL,UPPER RESPIRATORY TRACT INFECTION,1
NL,URETEROLITHIASIS,1
NL,URETHRITIS,1
NL,URINARY INCONTINENCE,1
NL,URINARY RETENTION,1
NL,URTICARIA,1
NL,VAGINAL HAEMORRHAGE,1
NL,VENTRICULAR EXTRASYSTOLES,1
NL,VENTRICULAR FIBRILLATION,1
NL,VIRAL INFECTION,1
NL,VISUAL ACUITY REDUCED,1
NL,WALDENSTROM^S MACROGLOBULINAEMIA,1
NL,WHITE BLOOD CELL DISORDER,1
NL,WITHDRAWAL SYNDROME,1
NL,WOUND DEHISCENCE,1
NL,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
NZ,CHEST PAIN,1
NZ,DENTAL CARIES,1
NZ,DEPRESSED LEVEL OF CONSCIOUSNESS,1
NZ,DISTURBANCE IN ATTENTION,1
NZ,DRY MOUTH,1
NZ,EYE INJURY,1
NZ,HYPOGLYCAEMIA,1
NZ,INTENTIONAL PRODUCT MISUSE,1
NZ,INTENTIONAL UNDERDOSE,1
NZ,PRODUCT USE ISSUE,1
NZ,TOXICITY TO VARIOUS AGENTS,1
NZ,TREMOR,1
NZ,URETERIC CANCER,1
NZ,VISUAL IMPAIRMENT,1
NG,FOETAL DISTRESS SYNDROME,1
NG,MATERNAL EXPOSURE TIMING UNSPECIFIED,1
NO,TOXICITY TO VARIOUS AGENTS,34
NO,SOMNOLENCE,16
NO,RENAL IMPAIRMENT,15
NO,CONSTIPATION,14
NO,IMPAIRED GASTRIC EMPTYING,14
NO,DRUG ABUSE,13
NO,HEAD TITUBATION,13
NO,HYPERHIDROSIS,13
NO,DYSPEPSIA,11
NO,SLEEP APNOEA SYNDROME,11
NO,DEATH,10
NO,FALL,8
NO,DRUG WITHDRAWAL SYNDROME,7
NO,WITHDRAWAL SYNDROME,7
NO,NAUSEA,6
NO,WEIGHT INCREASED,6
NO,DRUG DEPENDENCE,5
NO,PNEUMONIA,5
NO,ABDOMINAL PAIN UPPER,4
NO,BACK PAIN,4
NO,DYSPNOEA,4
NO,FATIGUE,4
NO,MYALGIA,4
NO,NEUROPATHY PERIPHERAL,4
NO,OSTEONECROSIS OF JAW,4
NO,PAIN IN EXTREMITY,4
NO,PARAESTHESIA,4
NO,SLEEP DISORDER,4
NO,SUICIDAL IDEATION,4
NO,ANXIETY,3
NO,APATHY,3
NO,COLD SWEAT,3
NO,COMA,3
NO,DEPRESSED LEVEL OF CONSCIOUSNESS,3
NO,DERMATITIS ALLERGIC,3
NO,DIZZINESS,3
NO,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,3
NO,INJURY,3
NO,MUSCLE SPASMS,3
NO,OROPHARYNGEAL PAIN,3
NO,PRODUCT USE ISSUE,3
NO,WEIGHT DECREASED,3
NO,ABDOMINAL PAIN,2
NO,ABNORMAL BEHAVIOUR,2
NO,ACTIVITIES OF DAILY LIVING IMPAIRED,2
NO,ALANINE AMINOTRANSFERASE INCREASED,2
NO,ARTHRALGIA,2
NO,ASPARTATE AMINOTRANSFERASE INCREASED,2
NO,ASTHENIA,2
NO,BEDRIDDEN,2
NO,BLOOD ALKALINE PHOSPHATASE INCREASED,2
NO,BLOOD BILIRUBIN INCREASED,2
NO,BLOOD LACTATE DEHYDROGENASE INCREASED,2
NO,CEREBRAL HAEMATOMA,2
NO,CERVICAL VERTEBRAL FRACTURE,2
NO,CHRONIC MYELOMONOCYTIC LEUKAEMIA,2
NO,COGNITIVE DISORDER,2
NO,CONFUSIONAL STATE,2
NO,DECREASED APPETITE,2
NO,DEEP VEIN THROMBOSIS,2
NO,DEPRESSION,2
NO,DERMATITIS ACNEIFORM,2
NO,DIARRHOEA,2
NO,DRUG DISPENSED TO WRONG PATIENT,2
NO,DRUG INEFFECTIVE,2
NO,DRUG INTOLERANCE,2
NO,DRUG TOLERANCE,2
NO,DRUG-INDUCED LIVER INJURY,2
NO,DRY SKIN,2
NO,DYSPHAGIA,2
NO,EXTRADURAL HAEMATOMA,2
NO,FEELING ABNORMAL,2
NO,FEELING COLD,2
NO,FEELING DRUNK,2
NO,HALLUCINATION,2
NO,HEPATIC ENZYME INCREASED,2
NO,HOT FLUSH,2
NO,HYPOAESTHESIA,2
NO,IMPAIRED WORK ABILITY,2
NO,INSOMNIA,2
NO,IRIDOCYCLITIS,2
NO,JOINT SWELLING,2
NO,LOSS OF CONSCIOUSNESS,2
NO,MEMORY IMPAIRMENT,2
NO,NERVOUSNESS,2
NO,NEUTROPENIA,2
NO,ODYNOPHAGIA,2
NO,OSTEITIS,2
NO,OVERDOSE,2
NO,OXYGEN SATURATION DECREASED,2
NO,POST-TRAUMATIC STRESS DISORDER,2
NO,PRODUCT USE IN UNAPPROVED INDICATION,2
NO,PRURITUS,2
NO,RENAL FAILURE ACUTE,2
NO,RESPIRATORY ARREST,2
NO,RESPIRATORY FAILURE,2
NO,SUICIDE ATTEMPT,2
NO,TARDIVE DYSKINESIA,2
NO,URTICARIA,2
NO,UVEITIS,2
NO,VISION BLURRED,2
NO,ABNORMAL DREAMS,1
NO,ACCIDENTAL OVERDOSE,1
NO,ALOPECIA,1
NO,AMNESIA,1
NO,ANGER,1
NO,ANGINA PECTORIS,1
NO,APHASIA,1
NO,BIOPSY KIDNEY ABNORMAL,1
NO,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
NO,BLOOD CREATININE INCREASED,1
NO,BLOOD PRESSURE FLUCTUATION,1
NO,BONE GRAFT,1
NO,BONE LESION,1
NO,BONE NEOPLASM,1
NO,BRAIN OEDEMA,1
NO,BREAST CANCER METASTATIC,1
NO,CARBOHYDRATE DEFICIENT TRANSFERRIN INCREASED,1
NO,CARDIAC ARREST,1
NO,CARDIAC FIBRILLATION,1
NO,CATARACT,1
NO,CEREBRAL INFARCTION,1
NO,CHEST DISCOMFORT,1
NO,CHEST PAIN,1
NO,CHILLS,1
NO,CONGENITAL ANOMALY,1
NO,CONGENITAL CYSTIC KIDNEY DISEASE,1
NO,CONVULSION,1
NO,CORNEAL OEDEMA,1
NO,COUGH,1
NO,CRYSTAL URINE,1
NO,CYANOSIS,1
NO,DECREASED INTEREST,1
NO,DEHYDRATION,1
NO,DENTAL FISTULA,1
NO,DEPENDENCE,1
NO,DIABETIC KETOACIDOSIS,1
NO,DIALYSIS,1
NO,DIPLOPIA,1
NO,DISCOMFORT,1
NO,DISORIENTATION,1
NO,DISTURBANCE IN ATTENTION,1
NO,DRUG EFFECT INCOMPLETE,1
NO,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
NO,DYSURIA,1
NO,ECZEMA,1
NO,EPILEPSY,1
NO,EUPHORIC MOOD,1
NO,EXPOSED BONE IN JAW,1
NO,EYE IRRITATION,1
NO,FACE OEDEMA,1
NO,FEAR,1
NO,FIBRIN D DIMER INCREASED,1
NO,FLUID OVERLOAD,1
NO,FOETAL EXPOSURE DURING PREGNANCY,1
NO,FOETAL GROWTH RESTRICTION,1
NO,FOOT FRACTURE,1
NO,GAIT DISTURBANCE,1
NO,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
NO,GENERALISED OEDEMA,1
NO,GROWING PAINS,1
NO,HAEMORRHAGE INTRACRANIAL,1
NO,HAEMORRHOIDS,1
NO,HAEMORRHOIDS THROMBOSED,1
NO,HEART RATE ABNORMAL,1
NO,HEART RATE INCREASED,1
NO,HEMIPARESIS,1
NO,HEPATIC ENZYME ABNORMAL,1
NO,HEPATIC STEATOSIS,1
NO,HOSTILITY,1
NO,HYPERGLYCAEMIA,1
NO,HYPOGLYCAEMIA,1
NO,HYPONATRAEMIA,1
NO,HYPOXIA,1
NO,IMPAIRED DRIVING ABILITY,1
NO,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
NO,INCORRECT DOSE ADMINISTERED,1
NO,INDIFFERENCE,1
NO,INFLUENZA,1
NO,INFLUENZA LIKE ILLNESS,1
NO,INFUSION RELATED REACTION,1
NO,INHIBITORY DRUG INTERACTION,1
NO,INTENTIONAL OVERDOSE,1
NO,INTENTIONAL PRODUCT MISUSE,1
NO,INTENTIONAL PRODUCT USE ISSUE,1
NO,INTERSTITIAL LUNG DISEASE,1
NO,IRRITABILITY,1
NO,KLINEFELTER^S SYNDROME,1
NO,LIMB DISCOMFORT,1
NO,LIMB REDUCTION DEFECT,1
NO,LIP OEDEMA,1
NO,LISTLESS,1
NO,LOW BIRTH WEIGHT BABY,1
NO,LYMPHADENOPATHY,1
NO,LYMPHOCYTE COUNT DECREASED,1
NO,MALAISE,1
NO,MEDICATION ERROR,1
NO,MENTAL DISORDER,1
NO,MICROENCEPHALY,1
NO,MOOD ALTERED,1
NO,MOOD SWINGS,1
NO,MULTIPLE CONGENITAL ABNORMALITIES,1
NO,MUSCLE TIGHTNESS,1
NO,MUSCLE TWITCHING,1
NO,NEGATIVE THOUGHTS,1
NO,NERVOUS SYSTEM DISORDER,1
NO,NEUROLOGICAL SYMPTOM,1
NO,NEUROSURGERY,1
NO,OEDEMA PERIPHERAL,1
NO,OSTEOSYNTHESIS,1
NO,PAIN,1
NO,PALPITATIONS,1
NO,PANIC ATTACK,1
NO,PEMPHIGOID,1
NO,PHARYNGEAL OEDEMA,1
NO,PNEUMONIA ASPIRATION,1
NO,PSYCHOPATHIC PERSONALITY,1
NO,PYREXIA,1
NO,QUADRIPLEGIA,1
NO,RENAL FAILURE,1
NO,RHABDOMYOLYSIS,1
NO,SEBORRHOEA,1
NO,SEIZURE,1
NO,SPEECH DISORDER,1
NO,SPINA BIFIDA,1
NO,SPINAL DECOMPRESSION,1
NO,SUBCUTANEOUS ABSCESS,1
NO,SUBSTANCE ABUSE,1
NO,SUBSTANCE USE,1
NO,SUICIDAL BEHAVIOUR,1
NO,SWEATING FEVER,1
NO,TEMPERATURE DIFFERENCE OF EXTREMITIES,1
NO,TINNITUS,1
NO,TOOTH LOSS,1
NO,TREMOR,1
NO,TRISOMY 21,1
NO,TUBULOINTERSTITIAL NEPHRITIS,1
NO,TUNNEL VISION,1
NO,ULTRASOUND ANTENATAL SCREEN,1
NO,URINARY TRACT INFECTION,1
NO,URINE ALCOHOL TEST POSITIVE,1
NO,VERTEBRAL COLUMN MASS,1
NO,VISUAL ACUITY REDUCED,1
NO,VOMITING,1
OM,CHEST DISCOMFORT,1
OM,CHEST PAIN,1
OM,MYOCARDIAL INFARCTION,1
OM,MYOCARDIAL ISCHAEMIA,1
OM,PAIN IN EXTREMITY,1
PK,ACUTE HEPATIC FAILURE,1
PK,ARTHROPATHY,1
PK,CENTRAL NERVOUS SYSTEM DERMOID TUMOUR,1
PK,DRUG DOSE OMISSION,1
PK,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
PK,HEPATITIS B,1
PK,HYPOACUSIS,1
PK,MUSCLE ATROPHY,1
PK,TRANSIENT PSYCHOSIS,1
PK,WITHDRAWAL SYNDROME,1
PS,BLOOD GLUCOSE INCREASED,1
PS,DIABETES MELLITUS,1
PS,DIABETES MELLITUS INADEQUATE CONTROL,1
PA,HIP FRACTURE,2
PA,ARTHRALGIA,1
PA,FALL,1
PA,FEMUR FRACTURE,1
PA,RESPIRATORY DISORDER,1
PA,SPINAL FRACTURE,1
PY,AKATHISIA,1
PE,DEATH,47
PE,ABASIA,18
PE,DIABETES MELLITUS,18
PE,FALL,17
PE,PAIN,16
PE,DRUG INEFFECTIVE,13
PE,CEREBROVASCULAR ACCIDENT,11
PE,PAIN IN EXTREMITY,11
PE,DIZZINESS,10
PE,ACCIDENT,8
PE,LIMB DISCOMFORT,7
PE,MALAISE,7
PE,MYOCARDIAL INFARCTION,7
PE,CONDITION AGGRAVATED,6
PE,NEUROPATHY PERIPHERAL,6
PE,BEDRIDDEN,5
PE,CARDIAC DISORDER,5
PE,GENERAL PHYSICAL HEALTH DETERIORATION,5
PE,HIP FRACTURE,5
PE,PERIPHERAL SWELLING,5
PE,RENAL DISORDER,5
PE,SOMNOLENCE,5
PE,SPINAL DISORDER,5
PE,CATARACT,4
PE,CEREBRAL INFARCTION,4
PE,DEAFNESS,4
PE,FEELING ABNORMAL,4
PE,FEMUR FRACTURE,4
PE,FIBROMYALGIA,4
PE,GAIT DISTURBANCE,4
PE,HYPOACUSIS,4
PE,LUNG NEOPLASM MALIGNANT,4
PE,OSTEOARTHRITIS,4
PE,POISONING,4
PE,URINARY TRACT INFECTION,4
PE,ANXIETY,3
PE,ARTHROPATHY,3
PE,BACK PAIN,3
PE,DIABETIC FOOT,3
PE,DISEASE PROGRESSION,3
PE,DRUG EFFECT INCOMPLETE,3
PE,DYSSTASIA,3
PE,HYPOAESTHESIA,3
PE,INSOMNIA,3
PE,INTENTIONAL PRODUCT MISUSE,3
PE,MUSCULOSKELETAL DISORDER,3
PE,OVERDOSE,3
PE,PRODUCT USE ISSUE,3
PE,RASH,3
PE,ROAD TRAFFIC ACCIDENT,3
PE,SPINAL CORD HERNIATION,3
PE,ANAEMIA,2
PE,ANGINA UNSTABLE,2
PE,ANKLE FRACTURE,2
PE,BLOOD GLUCOSE INCREASED,2
PE,BLOOD PRESSURE ABNORMAL,2
PE,BURNING SENSATION,2
PE,CARDIO-RESPIRATORY ARREST,2
PE,CONTUSION,2
PE,CYST,2
PE,CYSTITIS,2
PE,DIABETIC COMA,2
PE,DISCOMFORT,2
PE,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,2
PE,DYSPNOEA,2
PE,FEELING OF DESPAIR,2
PE,GASTRIC CANCER,2
PE,GASTRIC DISORDER,2
PE,GASTRIC INFECTION,2
PE,GASTRITIS,2
PE,HAEMOGLOBIN DECREASED,2
PE,HEADACHE,2
PE,HEPATITIS,2
PE,HERPES VIRUS INFECTION,2
PE,INFECTION,2
PE,INFLAMMATION,2
PE,INFLUENZA,2
PE,INTENTIONAL PRODUCT USE ISSUE,2
PE,INTERVERTEBRAL DISC PROTRUSION,2
PE,INTESTINAL OBSTRUCTION,2
PE,KIDNEY INFECTION,2
PE,LABYRINTHITIS,2
PE,LIGAMENT SPRAIN,2
PE,LOWER LIMB FRACTURE,2
PE,MACULAR DEGENERATION,2
PE,MEMORY IMPAIRMENT,2
PE,MOBILITY DECREASED,2
PE,MULTIPLE SCLEROSIS,2
PE,MUSCLE SPASMS,2
PE,MUSCULOSKELETAL PAIN,2
PE,MYALGIA,2
PE,NAUSEA,2
PE,NEOPLASM MALIGNANT,2
PE,NERVOUS SYSTEM DISORDER,2
PE,PATELLA FRACTURE,2
PE,PERITONITIS,2
PE,PNEUMONIA,2
PE,PRURITUS,2
PE,PYREXIA,2
PE,SEPTIC SHOCK,2
PE,STRESS,2
PE,SUICIDAL IDEATION,2
PE,TREMOR,2
PE,ULCER HAEMORRHAGE,2
PE,UPPER LIMB FRACTURE,2
PE,VARICELLA,2
PE,VISUAL ACUITY REDUCED,2
PE,VOMITING,2
PE,WEIGHT DECREASED,2
PE,ABDOMINAL DISCOMFORT,1
PE,ACNE,1
PE,ACUTE STRESS DISORDER,1
PE,AMNESIA,1
PE,ANAPHYLACTIC SHOCK,1
PE,APHASIA,1
PE,ARACHNOID CYST,1
PE,ARTHRALGIA,1
PE,ASTHENIA,1
PE,ASTHMA,1
PE,BACTERIAL INFECTION,1
PE,BALANCE DISORDER,1
PE,BENIGN RENAL NEOPLASM,1
PE,BLADDER PROLAPSE,1
PE,BLINDNESS UNILATERAL,1
PE,BLOOD CHOLESTEROL INCREASED,1
PE,BLOOD CORTISOL DECREASED,1
PE,BLOOD PHOSPHORUS INCREASED,1
PE,BLOOD POTASSIUM INCREASED,1
PE,BLOOD PRESSURE DECREASED,1
PE,BONE DISORDER,1
PE,BONE PAIN,1
PE,BONE TUBERCULOSIS,1
PE,BRAIN NEOPLASM,1
PE,BREAST HYPERPLASIA,1
PE,BRONCHIAL DISORDER,1
PE,CARDIAC ARREST,1
PE,CARDIAC FAILURE,1
PE,CARDIAC FIBRILLATION,1
PE,CARDIAC PACEMAKER INSERTION,1
PE,CARDIOVASCULAR DISORDER,1
PE,CEREBROVASCULAR DISORDER,1
PE,CHEST INJURY,1
PE,CHOLELITHIASIS,1
PE,CLAVICLE FRACTURE,1
PE,COLITIS,1
PE,CONJUNCTIVITIS,1
PE,COUGH,1
PE,CROHN^S DISEASE,1
PE,CRYING,1
PE,CYANOSIS,1
PE,DECREASED APPETITE,1
PE,DEEP VEIN THROMBOSIS,1
PE,DENGUE FEVER,1
PE,DEPRESSED MOOD,1
PE,DEVICE RELATED INFECTION,1
PE,DIABETIC COMPLICATION,1
PE,DIABETIC METABOLIC DECOMPENSATION,1
PE,DIARRHOEA,1
PE,DISEASE RECURRENCE,1
PE,DRUG DOSE OMISSION,1
PE,DRUG INTOLERANCE,1
PE,DRUG PRESCRIBING ERROR,1
PE,DRY THROAT,1
PE,DYSPEPSIA,1
PE,EAR INFECTION,1
PE,EATING DISORDER,1
PE,EXPIRED PRODUCT ADMINISTERED,1
PE,EXPOSURE DURING PREGNANCY,1
PE,EXTREMITY NECROSIS,1
PE,EYE DISORDER,1
PE,EYE SWELLING,1
PE,FEAR,1
PE,FOOD ALLERGY,1
PE,FOOT FRACTURE,1
PE,FRACTURE,1
PE,GALLBLADDER PAIN,1
PE,GANGRENE,1
PE,GASTRIC CANCER STAGE IV,1
PE,GASTRIC ULCER,1
PE,GASTRIC ULCER HELICOBACTER,1
PE,GASTRITIS BACTERIAL,1
PE,GASTROINTESTINAL DISORDER,1
PE,HAEMORRHAGE,1
PE,HALLUCINATION,1
PE,HERNIA,1
PE,HYPERKALAEMIA,1
PE,HYPERSENSITIVITY,1
PE,HYPERSENSITIVITY VASCULITIS,1
PE,HYPERSOMNIA,1
PE,HYPERTENSION,1
PE,HYPOGLYCAEMIA,1
PE,HYPOGLYCAEMIA NEONATAL,1
PE,HYPOKINESIA,1
PE,INCREASED UPPER AIRWAY SECRETION,1
PE,INFARCTION,1
PE,INFECTION PARASITIC,1
PE,INTERNAL HAEMORRHAGE,1
PE,IRRITABILITY,1
PE,JAUNDICE NEONATAL,1
PE,JOINT DISLOCATION,1
PE,JOINT SWELLING,1
PE,LARYNGEAL CANCER,1
PE,LEG AMPUTATION,1
PE,LIMB INJURY,1
PE,LIVER DISORDER,1
PE,LOCAL SWELLING,1
PE,LOSS OF CONSCIOUSNESS,1
PE,MALIGNANT NEOPLASM PROGRESSION,1
PE,MATERNAL EXPOSURE TIMING UNSPECIFIED,1
PE,MENISCUS INJURY,1
PE,MENTAL DISORDER,1
PE,METASTASES TO CENTRAL NERVOUS SYSTEM,1
PE,METASTASIS,1
PE,MOVEMENT DISORDER,1
PE,MUSCLE SPASTICITY,1
PE,MUSCULAR WEAKNESS,1
PE,MUSCULOSKELETAL STIFFNESS,1
PE,NASAL DISORDER,1
PE,NASOPHARYNGITIS,1
PE,NEONATAL ASPIRATION,1
PE,NEOPLASM PROGRESSION,1
PE,NERVE INJURY,1
PE,OVARIAN DISORDER,1
PE,OVERWEIGHT,1
PE,PARAESTHESIA,1
PE,PARALYSIS,1
PE,PERIPHERAL NERVE INJURY,1
PE,PHARYNGITIS,1
PE,PHOTOSENSITIVITY REACTION,1
PE,PLASMA CELL MYELOMA,1
PE,PREMATURE BABY,1
PE,PRODUCT USE IN UNAPPROVED INDICATION,1
PE,RENAL FAILURE,1
PE,RESPIRATORY DEPRESSION,1
PE,RESPIRATORY FAILURE,1
PE,RESPIRATORY PARALYSIS,1
PE,RHEUMATIC DISORDER,1
PE,RHEUMATOID ARTHRITIS,1
PE,RIB FRACTURE,1
PE,SCRATCH,1
PE,SEIZURE,1
PE,SENSORY LOSS,1
PE,SKIN DISCOLOURATION,1
PE,SKIN ULCER,1
PE,SOFT TISSUE INJURY,1
PE,SOMNAMBULISM,1
PE,SPEECH DISORDER,1
PE,SPINAL CORD NEOPLASM,1
PE,SPINAL PAIN,1
PE,STOMATITIS,1
PE,SWELLING FACE,1
PE,SYNCOPE,1
PE,SYNOVIAL CYST,1
PE,SYSTEMIC LUPUS ERYTHEMATOSUS,1
PE,TENDON DISORDER,1
PE,TENDON RUPTURE,1
PE,THYROID DISORDER,1
PE,TOXICITY TO VARIOUS AGENTS,1
PE,TRAUMATIC HAEMATOMA,1
PE,UNDERWEIGHT,1
PE,URINARY INCONTINENCE,1
PE,VARICOSE VEIN,1
PE,VENTRICULAR ARRHYTHMIA,1
PE,VERTEBRAL COLUMN MASS,1
PE,VERTEBRAL LESION,1
PE,VISION BLURRED,1
PE,VISUAL IMPAIRMENT,1
PE,WALKING DISABILITY,1
PE,WHITE BLOOD CELL COUNT INCREASED,1
PE,WOUND,1
PE,WRIST FRACTURE,1
PE,YELLOW SKIN,1
PH,DIZZINESS,5
PH,CARDIAC ARREST,4
PH,DEATH,4
PH,VOMITING,4
PH,HYPERSENSITIVITY,2
PH,MYOCARDIAL INFARCTION,2
PH,RASH,2
PH,VISION BLURRED,2
PH,ACNE,1
PH,ADVERSE EVENT,1
PH,ASTHENIA,1
PH,ASTHMA,1
PH,BALANCE DISORDER,1
PH,BLOOD 25-HYDROXYCHOLECALCIFEROL DECREASED,1
PH,BONE PAIN,1
PH,C-REACTIVE PROTEIN ABNORMAL,1
PH,C-REACTIVE PROTEIN INCREASED,1
PH,CHAPPED LIPS,1
PH,CHOLECYSTITIS,1
PH,COLON CANCER STAGE IV,1
PH,CONSTIPATION,1
PH,CONVULSION,1
PH,COUGH,1
PH,DEHYDRATION,1
PH,DIABETIC COMPLICATION,1
PH,DIARRHOEA,1
PH,DIARRHOEA INFECTIOUS,1
PH,DRUG DISPENSING ERROR,1
PH,DRUG HYPERSENSITIVITY,1
PH,DRUG INEFFECTIVE,1
PH,DRUG RESISTANCE,1
PH,DRY SKIN,1
PH,DRY THROAT,1
PH,DYSARTHRIA,1
PH,DYSPHONIA,1
PH,DYSPNOEA,1
PH,ECZEMA,1
PH,EYE IRRITATION,1
PH,EYE PRURITUS,1
PH,FACIAL ASYMMETRY,1
PH,FIBROSIS,1
PH,GASTRITIS,1
PH,GASTROENTERITIS,1
PH,GASTROOESOPHAGEAL REFLUX DISEASE,1
PH,HAEMATOPOIETIC NEOPLASM,1
PH,HEADACHE,1
PH,HEART RATE INCREASED,1
PH,HEPATIC ENZYME INCREASED,1
PH,HEPATIC FAILURE,1
PH,HILAR LYMPHADENOPATHY,1
PH,HOSPITALISATION,1
PH,HYPERKALAEMIA,1
PH,HYPERSOMNIA,1
PH,HYPERTENSION,1
PH,IMMUNE SYSTEM DISORDER,1
PH,INCORRECT DOSE ADMINISTERED,1
PH,INFLAMMATION,1
PH,INTERMITTENT CLAUDICATION,1
PH,LACRIMATION INCREASED,1
PH,LACUNAR INFARCTION,1
PH,LARYNGEAL INFLAMMATION,1
PH,LIP SWELLING,1
PH,LIVER DISORDER,1
PH,LYMPHADENOPATHY MEDIASTINAL,1
PH,MASS,1
PH,MEAN CELL HAEMOGLOBIN DECREASED,1
PH,MEAN CELL VOLUME DECREASED,1
PH,MENTAL DISORDER,1
PH,MYALGIA,1
PH,NAUSEA,1
PH,NEOPLASM MALIGNANT,1
PH,OPTIC NERVE DISORDER,1
PH,OPTIC NERVE SHEATH HAEMORRHAGE,1
PH,PAIN,1
PH,PALPITATIONS,1
PH,PAPILLOEDEMA,1
PH,PERIORBITAL OEDEMA,1
PH,PHOTOPHOBIA,1
PH,PNEUMONIA,1
PH,PRODUCTIVE COUGH,1
PH,PRURITUS,1
PH,PRURITUS GENERALISED,1
PH,PSYCHIATRIC SYMPTOM,1
PH,RASH ERYTHEMATOUS,1
PH,RASH MACULAR,1
PH,RASH MACULO-PAPULAR,1
PH,RASH PRURITIC,1
PH,RED BLOOD CELL COUNT INCREASED,1
PH,RED BLOOD CELL SEDIMENTATION RATE ABNORMAL,1
PH,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
PH,RENAL TUBULAR DISORDER,1
PH,RETINAL HAEMORRHAGE,1
PH,SCAR,1
PH,SEPSIS,1
PH,SINUS HEADACHE,1
PH,SOMNOLENCE,1
PH,SPINAL DISORDER,1
PH,STOMATITIS,1
PH,STRESS,1
PH,SWELLING FACE,1
PH,ULCER,1
PH,UTERINE ATROPHY,1
PH,WEIGHT DECREASED,1
PH,WHEEZING,1
PL,CONSTIPATION,8
PL,VOMITING,8
PL,BALANCE DISORDER,6
PL,DISTURBANCE IN ATTENTION,5
PL,ASTHENIA,4
PL,DYSPNOEA,4
PL,FATIGUE,4
PL,NAUSEA,4
PL,PALPITATIONS,4
PL,CONDITION AGGRAVATED,3
PL,DRUG INEFFECTIVE,3
PL,FEAR,3
PL,HYPERHIDROSIS,3
PL,LOSS OF CONSCIOUSNESS,3
PL,PERIPHERAL SENSORY NEUROPATHY,3
PL,SEDATION COMPLICATION,3
PL,SOMNOLENCE,3
PL,AMNESIA,2
PL,BURNING SENSATION,2
PL,CARDIOVASCULAR INSUFFICIENCY,2
PL,CATARACT,2
PL,COUGH,2
PL,DIARRHOEA,2
PL,EYELID OEDEMA,2
PL,EYELID PTOSIS,2
PL,FACE OEDEMA,2
PL,GASTRIC DISORDER,2
PL,GENERAL PHYSICAL HEALTH DETERIORATION,2
PL,HYPOAESTHESIA,2
PL,PAIN IN EXTREMITY,2
PL,PLEURAL EFFUSION,2
PL,POLYNEUROPATHY,2
PL,PRODUCT USE ISSUE,2
PL,RENAL IMPAIRMENT,2
PL,TACHYCARDIA,2
PL,VISUAL ACUITY REDUCED,2
PL,ABDOMINAL DISCOMFORT,1
PL,ABDOMINAL PAIN,1
PL,ACTIVITIES OF DAILY LIVING IMPAIRED,1
PL,ACUTE CORONARY SYNDROME,1
PL,ADENOCARCINOMA OF COLON,1
PL,AGEUSIA,1
PL,ALANINE AMINOTRANSFERASE INCREASED,1
PL,ALLODYNIA,1
PL,ALTERED STATE OF CONSCIOUSNESS,1
PL,ANXIETY,1
PL,ARTHRALGIA,1
PL,ASPARTATE AMINOTRANSFERASE INCREASED,1
PL,BACK PAIN,1
PL,BLOOD ALKALINE PHOSPHATASE INCREASED,1
PL,BLOOD PRESSURE ABNORMAL,1
PL,BLOOD PRESSURE INCREASED,1
PL,BONE PAIN,1
PL,COLON CANCER,1
PL,COMPRESSION FRACTURE,1
PL,CONFUSIONAL STATE,1
PL,DISSOCIATIVE DISORDER,1
PL,DIVERTICULUM INTESTINAL,1
PL,DIZZINESS,1
PL,DRUG INTOLERANCE,1
PL,DRY EYE,1
PL,DRY MOUTH,1
PL,DYSAESTHESIA,1
PL,DYSARTHRIA,1
PL,DYSGRAPHIA,1
PL,DYSPHAGIA,1
PL,DYSPHONIA,1
PL,ERYTHEMA,1
PL,FEELING ABNORMAL,1
PL,FEELING DRUNK,1
PL,FLATULENCE,1
PL,FOOD AVERSION,1
PL,FORMICATION,1
PL,GAIT DISTURBANCE,1
PL,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
PL,GASTROINTESTINAL OBSTRUCTION,1
PL,GENERAL PHYSICAL CONDITION ABNORMAL,1
PL,GUILLAIN-BARRE SYNDROME,1
PL,HAEMATEMESIS,1
PL,HEADACHE,1
PL,HEPATIC ENZYME INCREASED,1
PL,HOSPITALISATION,1
PL,HYPERAESTHESIA,1
PL,HYPOTENSION,1
PL,IMPAIRED WORK ABILITY,1
PL,INITIAL INSOMNIA,1
PL,INTRACRANIAL ANEURYSM,1
PL,ISCHAEMIC STROKE,1
PL,LARYNGOSPASM,1
PL,MASKED FACIES,1
PL,MEDIAN NERVE INJURY,1
PL,MENTAL IMPAIRMENT,1
PL,METABOLIC ENCEPHALOPATHY,1
PL,METASTASES TO ABDOMINAL CAVITY,1
PL,MUCOSAL INFLAMMATION,1
PL,MUSCULOSKELETAL STIFFNESS,1
PL,NECK PAIN,1
PL,NEUROPATHY PERIPHERAL,1
PL,OEDEMA PERIPHERAL,1
PL,OESOPHAGEAL PAIN,1
PL,ORAL DISCOMFORT,1
PL,PAIN,1
PL,PAIN IN JAW,1
PL,PANIC ATTACK,1
PL,PARAESTHESIA,1
PL,PARESIS,1
PL,PHARYNGEAL DISORDER,1
PL,PNEUMONIA CYTOMEGALOVIRAL,1
PL,PRODUCT PHYSICAL ISSUE,1
PL,PRODUCTIVE COUGH,1
PL,PRURITUS GENERALISED,1
PL,PULMONARY EMBOLISM,1
PL,PYREXIA,1
PL,QUALITY OF LIFE DECREASED,1
PL,RASH,1
PL,READING DISORDER,1
PL,REFUSAL OF TREATMENT BY PATIENT,1
PL,SALIVARY GLAND NEOPLASM,1
PL,SEDATION,1
PL,SEIZURE,1
PL,SUFFOCATION FEELING,1
PL,SUICIDAL IDEATION,1
PL,SUICIDE ATTEMPT,1
PL,TENSION,1
PL,TONGUE OEDEMA,1
PL,TONGUE SPASM,1
PL,TRANSAMINASES INCREASED,1
PL,VERTIGO,1
PL,WEIGHT INCREASED,1
PT,DRUG INEFFECTIVE,9
PT,PYREXIA,9
PT,FATIGUE,7
PT,MUSCULAR WEAKNESS,7
PT,DEPRESSION,6
PT,HEADACHE,6
PT,PNEUMONIA,6
PT,ABNORMAL BEHAVIOUR,5
PT,ASTHENIA,5
PT,CONDITION AGGRAVATED,5
PT,CONFUSIONAL STATE,5
PT,DIARRHOEA,5
PT,DIZZINESS,5
PT,DYSPNOEA,5
PT,SOMNOLENCE,5
PT,TREMOR,5
PT,BALANCE DISORDER,4
PT,DIPLOPIA,4
PT,DRUG WITHDRAWAL SYNDROME,4
PT,FALL,4
PT,HYPERHIDROSIS,4
PT,HYPERTENSION,4
PT,HYPOMANIA,4
PT,MULTIPLE SCLEROSIS RELAPSE,4
PT,PRODUCT USE ISSUE,4
PT,RASH,4
PT,VOMITING,4
PT,ABDOMINAL PAIN,3
PT,ANAEMIA,3
PT,BLOOD PRESSURE INCREASED,3
PT,COUGH,3
PT,DEHYDRATION,3
PT,GAIT DISTURBANCE,3
PT,GENERAL PHYSICAL HEALTH DETERIORATION,3
PT,HALLUCINATION_ AUDITORY,3
PT,HALLUCINATION_ VISUAL,3
PT,MALAISE,3
PT,MUTISM,3
PT,PAIN IN EXTREMITY,3
PT,PRURITUS,3
PT,PSYCHOMOTOR HYPERACTIVITY,3
PT,RHABDOMYOLYSIS,3
PT,TOXICITY TO VARIOUS AGENTS,3
PT,TUMOUR HAEMORRHAGE,3
PT,URINARY RETENTION,3
PT,URINARY TRACT INFECTION,3
PT,VISION BLURRED,3
PT,ABASIA,2
PT,ACUTE CORONARY SYNDROME,2
PT,ACUTE KIDNEY INJURY,2
PT,AGGRESSION,2
PT,AGITATION,2
PT,AGRANULOCYTOSIS,2
PT,ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC,2
PT,ARRHYTHMIA,2
PT,ARTHRALGIA,2
PT,BACK PAIN,2
PT,BLADDER CANCER,2
PT,BREAST NEOPLASM,2
PT,CHEST DISCOMFORT,2
PT,COMA,2
PT,COORDINATION ABNORMAL,2
PT,DEATH,2
PT,DELIRIUM,2
PT,DISORIENTATION,2
PT,DISTRIBUTIVE SHOCK,2
PT,DRUG HYPERSENSITIVITY,2
PT,DYSARTHRIA,2
PT,DYSPEPSIA,2
PT,FACE OEDEMA,2
PT,FANCONI SYNDROME,2
PT,HAEMATURIA,2
PT,HALLUCINATION,2
PT,HERPES ZOSTER,2
PT,HYPOAESTHESIA,2
PT,HYPOGLYCAEMIA,2
PT,INSOMNIA,2
PT,INTENTIONAL PRODUCT USE ISSUE,2
PT,LACRIMATION INCREASED,2
PT,LYMPHOCYTE COUNT DECREASED,2
PT,LYMPHOPENIA,2
PT,MEMORY IMPAIRMENT,2
PT,MIGRAINE,2
PT,MUSCULOSKELETAL STIFFNESS,2
PT,MYALGIA,2
PT,NAUSEA,2
PT,NEUROLEPTIC MALIGNANT SYNDROME,2
PT,NEUTROPENIA,2
PT,PAIN,2
PT,PARAESTHESIA,2
PT,PHARYNGEAL OEDEMA,2
PT,PRODUCT QUALITY ISSUE,2
PT,PRURITUS GENERALISED,2
PT,RASH MACULO-PAPULAR,2
PT,RENAL FUNCTION TEST ABNORMAL,2
PT,RENAL IMPAIRMENT,2
PT,ROAD TRAFFIC ACCIDENT,2
PT,SENSORY DISTURBANCE,2
PT,SEPTIC SHOCK,2
PT,SKIN EXFOLIATION,2
PT,SLEEP DISORDER,2
PT,SPINAL FRACTURE,2
PT,STRESS,2
PT,SYNCOPE,2
PT,TOOTH LOSS,2
PT,WEIGHT DECREASED,2
PT,ABDOMINAL MASS,1
PT,ABORTION SPONTANEOUS,1
PT,ACUTE RESPIRATORY DISTRESS SYNDROME,1
PT,AFFECTIVE DISORDER,1
PT,ALANINE AMINOTRANSFERASE INCREASED,1
PT,AMNESIA,1
PT,ANAL FISTULA,1
PT,ANAL HAEMORRHAGE,1
PT,ANGULAR CHEILITIS,1
PT,ANKYLOSING SPONDYLITIS,1
PT,ARTHRITIS INFECTIVE,1
PT,ASPARTATE AMINOTRANSFERASE INCREASED,1
PT,B-CELL LYMPHOMA,1
PT,BASAL CELL CARCINOMA,1
PT,BLADDER NEOPLASM,1
PT,BLINDNESS,1
PT,BLINDNESS TRANSIENT,1
PT,BLOOD CHOLESTEROL INCREASED,1
PT,BLOOD CREATINE INCREASED,1
PT,BLOOD CREATININE INCREASED,1
PT,BLOOD TRIGLYCERIDES INCREASED,1
PT,BLOOD UREA INCREASED,1
PT,BONE FISSURE,1
PT,BREAST CYST,1
PT,BURNING SENSATION,1
PT,CACHEXIA,1
PT,CARDIAC FAILURE,1
PT,CARDIOTOXICITY,1
PT,CATATONIA,1
PT,CENTRAL NERVOUS SYSTEM LESION,1
PT,CEREBRAL MICROHAEMORRHAGE,1
PT,CHEST PAIN,1
PT,CHEST X-RAY ABNORMAL,1
PT,CHOLECYSTITIS,1
PT,COLITIS,1
PT,COLOUR BLINDNESS ACQUIRED,1
PT,CONCOMITANT DISEASE AGGRAVATED,1
PT,CYTOMEGALOVIRUS INFECTION,1
PT,DECREASED APPETITE,1
PT,DEEP VEIN THROMBOSIS,1
PT,DEPERSONALISATION/DEREALISATION DISORDER,1
PT,DEPRESSED LEVEL OF CONSCIOUSNESS,1
PT,DERMATITIS BULLOUS,1
PT,DIABETES MELLITUS,1
PT,DIABETIC NEPHROPATHY,1
PT,DIET REFUSAL,1
PT,DISEASE RECURRENCE,1
PT,DRUG ABUSE,1
PT,DRUG ADMINISTRATION ERROR,1
PT,DRY MOUTH,1
PT,DUODENAL ULCER PERFORATION,1
PT,DYSPHAGIA,1
PT,DYSPHONIA,1
PT,ECCHYMOSIS,1
PT,EJECTION FRACTION DECREASED,1
PT,ELECTROLYTE IMBALANCE,1
PT,ELEVATED MOOD,1
PT,EPISTAXIS,1
PT,EXPOSURE VIA PARTNER,1
PT,EYE SWELLING,1
PT,EYELID OEDEMA,1
PT,FACIAL PAIN,1
PT,FANCONI SYNDROME ACQUIRED,1
PT,FEBRILE NEUTROPENIA,1
PT,FEELING ABNORMAL,1
PT,FLUSHING,1
PT,FOLLICULITIS,1
PT,GALLBLADDER ABSCESS,1
PT,GALLBLADDER PERFORATION,1
PT,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
PT,GASTROOESOPHAGEAL REFLUX DISEASE,1
PT,GINGIVAL BLEEDING,1
PT,GINGIVAL OEDEMA,1
PT,GLYCOSURIA,1
PT,HAEMATOCHEZIA,1
PT,HAEMATOTOXICITY,1
PT,HAEMORRHAGE INTRACRANIAL,1
PT,HALLUCINATION_ TACTILE,1
PT,HAND DERMATITIS,1
PT,HEART RATE INCREASED,1
PT,HEPATIC ENZYME INCREASED,1
PT,HEPATITIS,1
PT,HIGH DENSITY LIPOPROTEIN INCREASED,1
PT,HISTIOCYTOSIS HAEMATOPHAGIC,1
PT,HYPERKALAEMIA,1
PT,HYPERSENSITIVITY,1
PT,HYPERTHERMIA,1
PT,HYPERTRIGLYCERIDAEMIA,1
PT,HYPOGONADISM,1
PT,HYPOKALAEMIA,1
PT,HYPONATRAEMIA,1
PT,HYPOPHOSPHATAEMIA,1
PT,HYPOTENSION,1
PT,HYPOVOLAEMIA,1
PT,HYPOXIA,1
PT,ILLUSION,1
PT,IMPAIRED DRIVING ABILITY,1
PT,IMPAIRED WORK ABILITY,1
PT,INCOHERENT,1
PT,INFLUENZA LIKE ILLNESS,1
PT,INGROWING NAIL,1
PT,INTERMITTENT CLAUDICATION,1
PT,INTERVERTEBRAL DISC PROTRUSION,1
PT,INTESTINAL ISCHAEMIA,1
PT,IRRITABILITY,1
PT,ISCHAEMIC STROKE,1
PT,LETHARGY,1
PT,LEUKOPENIA,1
PT,LIMB DISCOMFORT,1
PT,LIP OEDEMA,1
PT,LOCAL SWELLING,1
PT,LOGORRHOEA,1
PT,LOSS OF CONSCIOUSNESS,1
PT,MALIGNANT LYMPHOID NEOPLASM,1
PT,MALIGNANT NEOPLASM PROGRESSION,1
PT,MELAENA,1
PT,MENINGIOMA,1
PT,METASTASES TO CENTRAL NERVOUS SYSTEM,1
PT,MOUTH ULCERATION,1
PT,MOVEMENT DISORDER,1
PT,MULTIPLE SCLEROSIS,1
PT,MUSCLE RIGIDITY,1
PT,MUSCLE SPASMS,1
PT,MUSCULOSKELETAL PAIN,1
PT,MYCOBACTERIUM TEST POSITIVE,1
PT,MYOCARDIAL INFARCTION,1
PT,MYOCARDIAL ISCHAEMIA,1
PT,NASOPHARYNGITIS,1
PT,NECK PAIN,1
PT,NEOPLASM MALIGNANT,1
PT,NEPHRITIS ALLERGIC,1
PT,NEPHROPATHY TOXIC,1
PT,NEURALGIA,1
PT,ODYNOPHAGIA,1
PT,OEDEMA,1
PT,OEDEMA PERIPHERAL,1
PT,ORAL CANDIDIASIS,1
PT,ORAL MUCOSAL BLISTERING,1
PT,OROPHARYNGEAL DISCOMFORT,1
PT,OSTEOPOROSIS,1
PT,PERIPHERAL SWELLING,1
PT,PLATELET COUNT DECREASED,1
PT,PNEUMOCOCCAL SEPSIS,1
PT,PNEUMONIA PNEUMOCOCCAL,1
PT,PNEUMONITIS,1
PT,PRESCRIBED UNDERDOSE,1
PT,PRESYNCOPE,1
PT,PRODUCT USE IN UNAPPROVED INDICATION,1
PT,PROTEINURIA,1
PT,PURPURA,1
PT,RASH PRURITIC,1
PT,RASH PUSTULAR,1
PT,RED BLOOD CELL COUNT INCREASED,1
PT,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
PT,RENAL FAILURE,1
PT,RENAL TUBULAR DYSFUNCTION,1
PT,RENAL TUBULAR NECROSIS,1
PT,RESPIRATORY DEPRESSION,1
PT,RESTLESSNESS,1
PT,RETINOPATHY,1
PT,SENSORIMOTOR DISORDER,1
PT,SEPSIS,1
PT,SEROTONIN SYNDROME,1
PT,SINUS BRADYCARDIA,1
PT,SINUS TACHYCARDIA,1
PT,SKIN DISCOLOURATION,1
PT,SKIN TOXICITY,1
PT,SLOW SPEECH,1
PT,SNEEZING,1
PT,STAPHYLOCOCCAL INFECTION,1
PT,STAPHYLOCOCCAL SKIN INFECTION,1
PT,STOMATITIS,1
PT,SUICIDAL IDEATION,1
PT,SWELLING,1
PT,SYNOVIAL RUPTURE,1
PT,SYNOVITIS,1
PT,SYSTOLIC DYSFUNCTION,1
PT,TACHYARRHYTHMIA,1
PT,TEMPERATURE DIFFERENCE OF EXTREMITIES,1
PT,THROMBOCYTOPENIA,1
PT,TINNITUS,1
PT,TONGUE OEDEMA,1
PT,TOOTH FRACTURE,1
PT,TOXIC SKIN ERUPTION,1
PT,TRANSAMINASES INCREASED,1
PT,TUNNEL VISION,1
PT,ULCER,1
PT,URINE ODOUR ABNORMAL,1
PT,URINE OUTPUT DECREASED,1
PT,URTICARIA,1
PT,VERTIGO,1
PT,VISUAL ACUITY REDUCED,1
PT,WHEEZING,1
PT,WHITE BLOOD CELL COUNT INCREASED,1
PT,WHITE BLOOD CELLS URINE POSITIVE,1
PR,PAIN,22
PR,INJECTION SITE PAIN,19
PR,NASOPHARYNGITIS,18
PR,DIZZINESS,16
PR,DRUG INEFFECTIVE,16
PR,SOMNOLENCE,14
PR,PAIN IN EXTREMITY,13
PR,ARTHRALGIA,12
PR,HEADACHE,12
PR,FATIGUE,11
PR,GAIT DISTURBANCE,8
PR,VOMITING,8
PR,BACK PAIN,7
PR,DIARRHOEA,7
PR,INSOMNIA,7
PR,MALAISE,7
PR,BLOOD GLUCOSE INCREASED,6
PR,BURNING SENSATION,6
PR,DEPRESSION,6
PR,NAUSEA,6
PR,PRURITUS,6
PR,WEIGHT INCREASED,6
PR,ARTHRITIS,5
PR,INFLAMMATION,5
PR,PNEUMONIA,5
PR,ABDOMINAL PAIN,4
PR,ARTHROPATHY,4
PR,ASTHENIA,4
PR,BRONCHITIS,4
PR,DECREASED APPETITE,4
PR,FALL,4
PR,FIBROMYALGIA,4
PR,JOINT SWELLING,4
PR,MEMORY IMPAIRMENT,4
PR,ANXIETY,3
PR,ASTHMA,3
PR,BALANCE DISORDER,3
PR,BEDRIDDEN,3
PR,BONE PAIN,3
PR,DIABETES MELLITUS,3
PR,DISCOMFORT,3
PR,DRUG EFFECT INCOMPLETE,3
PR,DRUG HYPERSENSITIVITY,3
PR,DYSPHONIA,3
PR,FEELING ABNORMAL,3
PR,HYPERHIDROSIS,3
PR,HYPOAESTHESIA,3
PR,MOOD ALTERED,3
PR,MOVEMENT DISORDER,3
PR,NASAL CONGESTION,3
PR,NEOPLASM MALIGNANT,3
PR,PSORIASIS,3
PR,PYREXIA,3
PR,UNEVALUABLE EVENT,3
PR,ABSCESS,2
PR,AMNESIA,2
PR,ANKLE FRACTURE,2
PR,BLOOD PRESSURE INCREASED,2
PR,BRAIN NEOPLASM,2
PR,CEREBROVASCULAR ACCIDENT,2
PR,CHILLS,2
PR,CONDITION AGGRAVATED,2
PR,CONFUSIONAL STATE,2
PR,DEPRESSED MOOD,2
PR,DISORIENTATION,2
PR,DRUG DEPENDENCE,2
PR,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,2
PR,DYSPHAGIA,2
PR,ERYTHEMA,2
PR,HAEMATOMA,2
PR,HEPATIC ENZYME INCREASED,2
PR,HERPES ZOSTER,2
PR,HYPERSENSITIVITY,2
PR,HYPERTENSION,2
PR,INFLUENZA,2
PR,INJECTION SITE ERYTHEMA,2
PR,INJECTION SITE PRURITUS,2
PR,INJECTION SITE RASH,2
PR,INTERVERTEBRAL DISC PROTRUSION,2
PR,JOINT RANGE OF MOTION DECREASED,2
PR,MIGRAINE,2
PR,MUSCULAR WEAKNESS,2
PR,MUSCULOSKELETAL DISORDER,2
PR,MUSCULOSKELETAL PAIN,2
PR,NECK PAIN,2
PR,NERVE COMPRESSION,2
PR,PALPITATIONS,2
PR,PERIPHERAL SWELLING,2
PR,PHARYNGITIS,2
PR,PRODUCT USE ISSUE,2
PR,PRODUCTIVE COUGH,2
PR,RASH MACULAR,2
PR,SEIZURE,2
PR,SINUSITIS,2
PR,SUICIDAL IDEATION,2
PR,TREATMENT FAILURE,2
PR,URINARY TRACT INFECTION,2
PR,VIRAL INFECTION,2
PR,WEIGHT DECREASED,2
PR,ABDOMINAL DISCOMFORT,1
PR,ABNORMAL DREAMS,1
PR,ABSCESS LIMB,1
PR,ADVERSE DRUG REACTION,1
PR,AGITATION,1
PR,ALOPECIA,1
PR,ANGIOEDEMA,1
PR,ASPIRATION,1
PR,BACK DISORDER,1
PR,BACTERIAL INFECTION,1
PR,BLINDNESS,1
PR,BLISTER,1
PR,BLOOD GLUCOSE DECREASED,1
PR,BLOOD PRESSURE ABNORMAL,1
PR,BLOOD URIC ACID INCREASED,1
PR,BONE OPERATION,1
PR,BREAST CANCER METASTATIC,1
PR,BURSITIS,1
PR,CARDIAC DISORDER,1
PR,CATARACT,1
PR,CELLULITIS,1
PR,CERUMEN IMPACTION,1
PR,CERVICAL VERTEBRAL FRACTURE,1
PR,CONJUNCTIVITIS,1
PR,CONTUSION,1
PR,COUGH,1
PR,CROHN^S DISEASE,1
PR,DEATH,1
PR,DEHYDRATION,1
PR,DERMATITIS ALLERGIC,1
PR,DEVICE ALLERGY,1
PR,DEVICE MALFUNCTION,1
PR,DIABETIC NEUROPATHY,1
PR,DISCOLOURED VOMIT,1
PR,DISTURBANCE IN ATTENTION,1
PR,DRUG ADMINISTERED AT INAPPROPRIATE SITE,1
PR,DRUG RESISTANCE,1
PR,DRUG TOLERANCE,1
PR,DRY MOUTH,1
PR,DYSURIA,1
PR,EAR DISCOMFORT,1
PR,EMBOLISM,1
PR,EUPHORIC MOOD,1
PR,EYE PAIN,1
PR,FACE OEDEMA,1
PR,FAECAL VOMITING,1
PR,FAECES SOFT,1
PR,FEELING HOT,1
PR,FREQUENT BOWEL MOVEMENTS,1
PR,FUNGAL SKIN INFECTION,1
PR,GALLBLADDER NON-FUNCTIONING,1
PR,GASTRITIS,1
PR,GASTROINTESTINAL INFLAMMATION,1
PR,GENERALISED OEDEMA,1
PR,GOITRE,1
PR,HAEMATOCHEZIA,1
PR,HAEMOGLOBIN DECREASED,1
PR,HAEMORRHOIDS,1
PR,HALLUCINATION,1
PR,HEARING IMPAIRED,1
PR,HEART RATE INCREASED,1
PR,HEPATIC CANCER,1
PR,HEPATIC MASS,1
PR,HEPATOMEGALY,1
PR,HOSPITALISATION,1
PR,HUNGER,1
PR,HYPERCHOLESTEROLAEMIA,1
PR,HYPERSOMNIA,1
PR,HYPOPHAGIA,1
PR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
PR,INCOHERENT,1
PR,INFARCTION,1
PR,INFUSION SITE EXTRAVASATION,1
PR,INJECTION SITE DISCOLOURATION,1
PR,INJECTION SITE HAEMATOMA,1
PR,INJECTION SITE HAEMORRHAGE,1
PR,INJECTION SITE INDURATION,1
PR,INJECTION SITE INFLAMMATION,1
PR,INJECTION SITE SWELLING,1
PR,INJECTION SITE URTICARIA,1
PR,INJECTION SITE VESICLES,1
PR,INJECTION SITE WARMTH,1
PR,INTENTIONAL PRODUCT MISUSE,1
PR,INTENTIONAL PRODUCT USE ISSUE,1
PR,INTESTINAL OBSTRUCTION,1
PR,IRRITABILITY,1
PR,KNEE ARTHROPLASTY,1
PR,LARYNGITIS,1
PR,LIMB DISCOMFORT,1
PR,LIP NEOPLASM,1
PR,LOWER LIMB FRACTURE,1
PR,LUNG DISORDER,1
PR,LUNG NEOPLASM MALIGNANT,1
PR,MALIGNANT NEOPLASM OF THORAX,1
PR,MASS,1
PR,MELANOCYTIC NAEVUS,1
PR,MENISCUS INJURY,1
PR,METASTASES TO BONE,1
PR,MOBILITY DECREASED,1
PR,MULTIPLE SCLEROSIS,1
PR,MUSCULOSKELETAL STIFFNESS,1
PR,MYALGIA,1
PR,MYOCARDIAL INFARCTION,1
PR,NEOPLASM PROGRESSION,1
PR,NERVE BLOCK,1
PR,NEUROPATHIC MUSCULAR ATROPHY,1
PR,NEUROPATHY PERIPHERAL,1
PR,NODULE,1
PR,OEDEMA,1
PR,ORAL SURGERY,1
PR,OROPHARYNGEAL PAIN,1
PR,OSTEOARTHRITIS,1
PR,OSTEOPENIA,1
PR,PANCREATIC DISORDER,1
PR,PANCREATITIS,1
PR,PARAESTHESIA,1
PR,PATELLA FRACTURE,1
PR,PERIPHERAL VENOUS DISEASE,1
PR,PERSECUTORY DELUSION,1
PR,PHARYNGEAL CYST,1
PR,PHLEBITIS,1
PR,PLATELET COUNT DECREASED,1
PR,POOR QUALITY SLEEP,1
PR,POST HERPETIC NEURALGIA,1
PR,POST PROCEDURAL COMPLICATION,1
PR,PRE-EXISTING CONDITION IMPROVED,1
PR,PRODUCT USE IN UNAPPROVED INDICATION,1
PR,PRURITUS GENERALISED,1
PR,PULMONARY HYPERTENSION,1
PR,PULMONARY OEDEMA,1
PR,RASH,1
PR,RECTAL HAEMORRHAGE,1
PR,RED BLOOD CELL COUNT DECREASED,1
PR,RESPIRATORY ARREST,1
PR,RESPIRATORY TRACT CONGESTION,1
PR,RESTLESSNESS,1
PR,ROAD TRAFFIC ACCIDENT,1
PR,SCIATIC NERVE INJURY,1
PR,SCIATICA,1
PR,SKIN DISCOLOURATION,1
PR,SLEEP APNOEA SYNDROME,1
PR,SPINAL FRACTURE,1
PR,SPINAL OPERATION,1
PR,SPINAL PAIN,1
PR,SYSTEMIC LUPUS ERYTHEMATOSUS,1
PR,TENDONITIS,1
PR,THERAPEUTIC RESPONSE UNEXPECTED,1
PR,THYROID CANCER METASTATIC,1
PR,THYROID MASS,1
PR,TIBIA FRACTURE,1
PR,TINNITUS,1
PR,TRANSIENT ISCHAEMIC ATTACK,1
PR,TYMPANIC MEMBRANE PERFORATION,1
PR,ULCER,1
PR,URINARY RETENTION,1
PR,UTERINE HAEMORRHAGE,1
PR,UTERINE LEIOMYOMA,1
PR,VISION BLURRED,1
PR,VISUAL IMPAIRMENT,1
PR,VITAMIN D DEFICIENCY,1
PR,WHITE BLOOD CELL COUNT DECREASED,1
PR,WOUND,1
RO,DEATH,2
RO,ACUTE MYOCARDIAL INFARCTION,1
RO,ADVERSE EVENT,1
RO,ALANINE AMINOTRANSFERASE INCREASED,1
RO,CONGENITAL ANOMALY,1
RO,DIZZINESS,1
RO,DRUG ABUSE,1
RO,DRUG DEPENDENCE,1
RO,FOETAL EXPOSURE DURING PREGNANCY,1
RO,HOSPITALISATION,1
RO,HYPERURICAEMIA,1
RO,MALIGNANT NEOPLASM OF UNKNOWN PRIMARY SITE,1
RO,ORAL CANDIDIASIS,1
RO,TACHYCARDIA,1
RU,NAUSEA,17
RU,SUSPECTED COUNTERFEIT PRODUCT,16
RU,APALLIC SYNDROME,15
RU,ALTERED STATE OF CONSCIOUSNESS,14
RU,WITHDRAWAL SYNDROME,9
RU,DRUG ABUSE,8
RU,ANXIETY,7
RU,DRUG DEPENDENCE,7
RU,DEPRESSED MOOD,5
RU,HYPERHIDROSIS,5
RU,AGGRESSION,4
RU,INSOMNIA,4
RU,INTENTIONAL OVERDOSE,4
RU,CHILLS,3
RU,CONVULSION,3
RU,EUPHORIC MOOD,3
RU,AGITATION,2
RU,ASTHENIA,2
RU,CONFUSIONAL STATE,2
RU,DIARRHOEA,2
RU,DRUG INTOLERANCE,2
RU,FEELING ABNORMAL,2
RU,HEADACHE,2
RU,LIBIDO DECREASED,2
RU,PANIC ATTACK,2
RU,RESTLESSNESS,2
RU,SLEEP DISORDER,2
RU,ABDOMINAL PAIN,1
RU,ACTIVITIES OF DAILY LIVING IMPAIRED,1
RU,AMNESIA,1
RU,BLOOD PRESSURE DECREASED,1
RU,BURNS THIRD DEGREE,1
RU,CARDIAC DISORDER,1
RU,CONDITION AGGRAVATED,1
RU,COUGH,1
RU,DECREASED APPETITE,1
RU,DEPENDENCE,1
RU,DEPRESSION,1
RU,DISORIENTATION,1
RU,DIZZINESS,1
RU,DRUG INEFFECTIVE,1
RU,DRUG RESISTANCE,1
RU,EMBOLISM,1
RU,GALACTORRHOEA,1
RU,GENERAL PHYSICAL HEALTH DETERIORATION,1
RU,GENERALISED TONIC-CLONIC SEIZURE,1
RU,HAEMOGLOBIN DECREASED,1
RU,HAEMORRHAGIC VASCULITIS,1
RU,HEART RATE IRREGULAR,1
RU,HOSPITALISATION,1
RU,HYPOREFLEXIA,1
RU,IRRITABILITY,1
RU,LABILE BLOOD PRESSURE,1
RU,LYMPHOCYTE COUNT DECREASED,1
RU,MAJOR DEPRESSION,1
RU,MONOPLEGIA,1
RU,MOOD ALTERED,1
RU,MYOCARDIAL INFARCTION,1
RU,MYOCARDIAL ISCHAEMIA,1
RU,NEUROSIS,1
RU,NEUTROPHIL COUNT DECREASED,1
RU,PAIN,1
RU,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,1
RU,PRE-EXISTING CONDITION IMPROVED,1
RU,PRODUCT USE ISSUE,1
RU,RED BLOOD CELL COUNT DECREASED,1
RU,RHINITIS,1
RU,SALIVARY HYPERSECRETION,1
RU,SUICIDAL IDEATION,1
RU,THERAPEUTIC RESPONSE UNEXPECTED,1
RU,TONIC CONVULSION,1
RU,TREMOR,1
RU,TUBERCULOSIS,1
RU,URINARY INCONTINENCE,1
RU,WHITE BLOOD CELL COUNT DECREASED,1
SM,GUILLAIN-BARRE SYNDROME,1
SA,DRUG ABUSE,23
SA,AGGRESSION,6
SA,COGNITIVE DISORDER,6
SA,SOCIAL AVOIDANT BEHAVIOUR,5
SA,ABNORMAL BEHAVIOUR,4
SA,APATHY,2
SA,FALL,2
SA,HYPERSOMNIA,2
SA,PERSONALITY CHANGE,2
SA,ROAD TRAFFIC ACCIDENT,2
SA,SEDATION,2
SA,SOMNOLENCE,2
SA,ANKLE FRACTURE,1
SA,ANXIETY,1
SA,DIZZINESS,1
SA,DYSARTHRIA,1
SA,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
SA,INTENTIONAL OVERDOSE,1
SA,MANIA,1
SA,MENTAL IMPAIRMENT,1
SA,MYOCLONIC EPILEPSY,1
SA,PRIAPISM,1
RS,ARRHYTHMIA,1
RS,BLOOD PRESSURE FLUCTUATION,1
RS,CONFUSIONAL STATE,1
RS,DISTURBANCE IN ATTENTION,1
RS,DYSPNOEA,1
RS,FEMORAL NECK FRACTURE,1
RS,GENERALISED OEDEMA,1
RS,HEAD DISCOMFORT,1
RS,HEART RATE IRREGULAR,1
RS,HYPERSENSITIVITY,1
RS,HYPERTENSION,1
RS,INSOMNIA,1
RS,MEMORY IMPAIRMENT,1
RS,PAIN,1
RS,PAIN IN EXTREMITY,1
RS,PALPITATIONS,1
RS,PHARYNGEAL OEDEMA,1
RS,PNEUMONIA,1
RS,PYREXIA,1
RS,RESTLESSNESS,1
RS,STEVENS-JOHNSON SYNDROME,1
RS,SWOLLEN TONGUE,1
RS,TACHYCARDIA,1
RS,TENSION,1
RS,WEIGHT INCREASED,1
SG,ANKLE FRACTURE,2
SG,RASH,2
SG,ANXIETY,1
SG,ARTHRITIS INFECTIVE,1
SG,BACK PAIN,1
SG,BALANCE DISORDER,1
SG,BLOOD SODIUM DECREASED,1
SG,BURNING SENSATION,1
SG,DEPRESSION,1
SG,DIARRHOEA,1
SG,DRUG DOSE OMISSION,1
SG,DRUG INEFFECTIVE,1
SG,EYE SWELLING,1
SG,FALL,1
SG,FATIGUE,1
SG,FUNGAL INFECTION,1
SG,HUNGER,1
SG,HYPOAESTHESIA,1
SG,LOCAL SWELLING,1
SG,MOOD SWINGS,1
SG,NEUROLOGICAL SYMPTOM,1
SG,NOCTURIA,1
SG,OEDEMA PERIPHERAL,1
SG,PAIN,1
SG,PANIC ATTACK,1
SG,PARONYCHIA,1
SG,PRE-EXISTING CONDITION IMPROVED,1
SG,RENAL DISORDER,1
SG,SEPSIS,1
SG,SOMNOLENCE,1
SG,TENSION,1
SG,THERAPEUTIC RESPONSE UNEXPECTED,1
SG,UPPER LIMB FRACTURE,1
SG,WEIGHT INCREASED,1
SK,BACK PAIN,2
SK,DRUG-INDUCED LIVER INJURY,2
SK,PAIN,2
SK,ABDOMINAL PAIN UPPER,1
SK,ACUTE KIDNEY INJURY,1
SK,ANGINA UNSTABLE,1
SK,ARTHRALGIA,1
SK,BRACHIAL PLEXUS INJURY,1
SK,BRONCHITIS,1
SK,CARDIAC FAILURE,1
SK,CEREBRAL ISCHAEMIA,1
SK,CEREBROVASCULAR ACCIDENT,1
SK,CONSTIPATION,1
SK,DECREASED APPETITE,1
SK,DEHYDRATION,1
SK,DERMATITIS ACNEIFORM,1
SK,DIARRHOEA,1
SK,DIVERTICULITIS,1
SK,DYSPNOEA,1
SK,EXCORIATION,1
SK,GAIT DISTURBANCE,1
SK,HAEMOPTYSIS,1
SK,HEMIPARESIS,1
SK,HIP ARTHROPLASTY,1
SK,HYPERTENSION,1
SK,ILEUS,1
SK,IMPAIRED WORK ABILITY,1
SK,INSOMNIA,1
SK,LIVER DISORDER,1
SK,LUNG HYPERINFLATION,1
SK,MALAISE,1
SK,MEGACOLON,1
SK,MENTAL DISORDER,1
SK,MULTI-ORGAN FAILURE,1
SK,MUSCLE RIGIDITY,1
SK,OEDEMA,1
SK,PALLOR,1
SK,PARAPARESIS,1
SK,PHLEBITIS,1
SK,POLLAKIURIA,1
SK,RENAL COLIC,1
SK,RESTRICTIVE PULMONARY DISEASE,1
SK,SKIN DISCOLOURATION,1
SK,SUICIDAL IDEATION,1
SK,SYNCOPE,1
SK,TUBERCULIN TEST POSITIVE,1
SK,WEIGHT INCREASED,1
SI,HALLUCINATION,6
SI,PARANOIA,6
SI,BACK PAIN,5
SI,CONFUSIONAL STATE,5
SI,DEATH,5
SI,PULMONARY EMBOLISM,5
SI,RESTLESSNESS,5
SI,CHILLS,3
SI,MULTIPLE SCLEROSIS,3
SI,PALPITATIONS,3
SI,ANAEMIA,2
SI,ATRIAL FIBRILLATION,2
SI,COMA,2
SI,CYTOKINE RELEASE SYNDROME,2
SI,DIZZINESS,2
SI,FATIGUE,2
SI,INTENTIONAL OVERDOSE,2
SI,ISCHAEMIC STROKE,2
SI,MALAISE,2
SI,NAUSEA,2
SI,OEDEMA PERIPHERAL,2
SI,OSTEONECROSIS OF JAW,2
SI,OXYGEN SATURATION DECREASED,2
SI,PRODUCT USE IN UNAPPROVED INDICATION,2
SI,PYREXIA,2
SI,SUICIDE ATTEMPT,2
SI,ACUTE RESPIRATORY FAILURE,1
SI,AMNESIA,1
SI,ARRHYTHMIA,1
SI,ARTHRALGIA,1
SI,ATRIOVENTRICULAR BLOCK,1
SI,BLOOD PRESSURE INCREASED,1
SI,BODY TEMPERATURE INCREASED,1
SI,C-REACTIVE PROTEIN INCREASED,1
SI,CEREBRAL HAEMORRHAGE,1
SI,CEREBRAL ISCHAEMIA,1
SI,CHEST PAIN,1
SI,CHOLECYSTITIS ACUTE,1
SI,CONDITION AGGRAVATED,1
SI,CONSTIPATION,1
SI,DEHYDRATION,1
SI,DELIRIUM,1
SI,DEMENTIA,1
SI,DIABETES MELLITUS,1
SI,DILATATION ATRIAL,1
SI,DISORIENTATION,1
SI,DISSEMINATED INTRAVASCULAR COAGULATION,1
SI,DRUG EFFECT INCOMPLETE,1
SI,DYSPNOEA,1
SI,ELECTROCARDIOGRAM QT PROLONGED,1
SI,ENCEPHALOPATHY,1
SI,ESCHERICHIA SEPSIS,1
SI,FIBRIN D DIMER INCREASED,1
SI,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
SI,GASTROINTESTINAL HAEMORRHAGE,1
SI,HAEMORRHAGIC DIATHESIS,1
SI,HALLUCINATION_ VISUAL,1
SI,HEART RATE IRREGULAR,1
SI,HOSPITALISATION,1
SI,HYDROCEPHALUS,1
SI,HYPOCALCAEMIA,1
SI,HYPOTENSION,1
SI,INCONTINENCE,1
SI,INTERNATIONAL NORMALISED RATIO INCREASED,1
SI,LEFT VENTRICULAR HYPERTROPHY,1
SI,LEUKOENCEPHALOPATHY,1
SI,LEUKOPENIA,1
SI,LUNG ADENOCARCINOMA METASTATIC,1
SI,LYMPHOPENIA,1
SI,MALIGNANT NEOPLASM PROGRESSION,1
SI,METASTASES TO LIVER,1
SI,MITRAL VALVE INCOMPETENCE,1
SI,MOBILITY DECREASED,1
SI,MUSCULAR WEAKNESS,1
SI,NEUTROPENIA,1
SI,PAIN,1
SI,PAIN IN EXTREMITY,1
SI,PARAESTHESIA,1
SI,PERFORMANCE STATUS DECREASED,1
SI,PERICARDIAL HAEMORRHAGE,1
SI,PLEURAL EFFUSION,1
SI,PLEURAL THICKENING,1
SI,POLYNEUROPATHY,1
SI,PRODUCT USE ISSUE,1
SI,PULMONARY HYPERTENSION,1
SI,RASH,1
SI,RASH PRURITIC,1
SI,RENAL FAILURE,1
SI,RESPIRATORY RATE DECREASED,1
SI,RIB FRACTURE,1
SI,SKIN EXFOLIATION,1
SI,TACHYCARDIA,1
SI,THROMBOCYTOPENIA,1
SI,TINNITUS,1
SI,TREMOR,1
SI,TRICUSPID VALVE INCOMPETENCE,1
SI,ULCER,1
SI,URINARY TRACT INFECTION BACTERIAL,1
SI,VOMITING,1
ZA,DEATH,16
ZA,FALL,8
ZA,FATIGUE,8
ZA,NAUSEA,8
ZA,PAIN,8
ZA,CEREBROVASCULAR ACCIDENT,6
ZA,VOMITING,6
ZA,CARDIAC FAILURE,5
ZA,COMA,5
ZA,CONFUSIONAL STATE,5
ZA,MALAISE,5
ZA,PAIN IN EXTREMITY,5
ZA,PNEUMONIA,5
ZA,RASH,5
ZA,SOMNOLENCE,5
ZA,CHEST PAIN,4
ZA,DIZZINESS,4
ZA,DRY MOUTH,4
ZA,HYPOTENSION,4
ZA,BLOOD GLUCOSE INCREASED,3
ZA,COUGH,3
ZA,DRUG DOSE OMISSION,3
ZA,DRUG INEFFECTIVE,3
ZA,DYSPNOEA,3
ZA,FEELING ABNORMAL,3
ZA,GAIT DISTURBANCE,3
ZA,HEADACHE,3
ZA,HOT FLUSH,3
ZA,HYPOGLYCAEMIA,3
ZA,JOINT SWELLING,3
ZA,MUSCULAR WEAKNESS,3
ZA,MUSCULOSKELETAL PAIN,3
ZA,NEOPLASM MALIGNANT,3
ZA,OEDEMA PERIPHERAL,3
ZA,SPEECH DISORDER,3
ZA,VISION BLURRED,3
ZA,ACUTE MYOCARDIAL INFARCTION,2
ZA,APHASIA,2
ZA,ARTHRALGIA,2
ZA,ARTHRITIS,2
ZA,ARTHROPATHY,2
ZA,ASTHENIA,2
ZA,BACK PAIN,2
ZA,BLOOD PRESSURE FLUCTUATION,2
ZA,BRADYCARDIA,2
ZA,CARDIAC ARREST,2
ZA,CHEST DISCOMFORT,2
ZA,CHOLELITHIASIS,2
ZA,CONDITION AGGRAVATED,2
ZA,CONVULSION,2
ZA,CORONARY ARTERY DISEASE,2
ZA,DEPRESSION,2
ZA,DRUG DEPENDENCE,2
ZA,DYSURIA,2
ZA,HEPATIC FAILURE,2
ZA,HYPOAESTHESIA,2
ZA,INSOMNIA,2
ZA,LUNG DISORDER,2
ZA,MENTAL DISORDER,2
ZA,MENTAL IMPAIRMENT,2
ZA,MULTIPLE SCLEROSIS RELAPSE,2
ZA,MUSCLE SPASMS,2
ZA,MYOCARDIAL ISCHAEMIA,2
ZA,PANIC ATTACK,2
ZA,PARAESTHESIA,2
ZA,PERIPHERAL SWELLING,2
ZA,PETIT MAL EPILEPSY,2
ZA,PRODUCT QUALITY ISSUE,2
ZA,RIB FRACTURE,2
ZA,ROAD TRAFFIC ACCIDENT,2
ZA,SPINAL OPERATION,2
ZA,STEVENS-JOHNSON SYNDROME,2
ZA,WEIGHT INCREASED,2
ZA,ABDOMINAL DISCOMFORT,1
ZA,ABDOMINAL DISTENSION,1
ZA,ABDOMINAL PAIN,1
ZA,ABDOMINAL PAIN LOWER,1
ZA,ABDOMINAL PAIN UPPER,1
ZA,ABNORMAL DREAMS,1
ZA,ABORTION SPONTANEOUS,1
ZA,ACTIVITIES OF DAILY LIVING IMPAIRED,1
ZA,ACUTE PULMONARY OEDEMA,1
ZA,ACUTE RESPIRATORY FAILURE,1
ZA,AFFECTIVE DISORDER,1
ZA,ALOPECIA,1
ZA,AMPUTATION,1
ZA,ANGINA PECTORIS,1
ZA,ANGIOEDEMA,1
ZA,ANKLE FRACTURE,1
ZA,ANXIETY,1
ZA,AORTIC STENOSIS,1
ZA,APHONIA,1
ZA,ARACHNOID CYST,1
ZA,ASTHMA,1
ZA,ATAXIA,1
ZA,BACK DISORDER,1
ZA,BALANCE DISORDER,1
ZA,BEDRIDDEN,1
ZA,BLADDER DISORDER,1
ZA,BLOOD COUNT ABNORMAL,1
ZA,BRONCHITIS,1
ZA,BURNING SENSATION,1
ZA,CARDIAC DISORDER,1
ZA,CARDIAC FAILURE CONGESTIVE,1
ZA,CHILLS,1
ZA,CHOLECYSTECTOMY,1
ZA,CHRONIC SINUSITIS,1
ZA,COMPLETED SUICIDE,1
ZA,CONTUSION,1
ZA,CORTISOL INCREASED,1
ZA,CYSTITIS,1
ZA,DEMENTIA,1
ZA,DIABETES MELLITUS,1
ZA,DIABETIC FOOT,1
ZA,DIABETIC KETOACIDOSIS,1
ZA,DIARRHOEA,1
ZA,DIASTOLIC DYSFUNCTION,1
ZA,DISEASE PROGRESSION,1
ZA,DISORIENTATION,1
ZA,DISTURBANCE IN ATTENTION,1
ZA,DRUG ADMINISTERED AT INAPPROPRIATE SITE,1
ZA,DRUG EFFECT DELAYED,1
ZA,DRUG HYPERSENSITIVITY,1
ZA,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
ZA,DYSGEUSIA,1
ZA,DYSKINESIA,1
ZA,DYSPHEMIA,1
ZA,DYSPNOEA PAROXYSMAL NOCTURNAL,1
ZA,ELECTROCARDIOGRAM Q WAVES,1
ZA,ELECTROCARDIOGRAM T WAVE INVERSION,1
ZA,ENCEPHALITIS,1
ZA,ENURESIS,1
ZA,EPISTAXIS,1
ZA,ERYTHEMA,1
ZA,EXPOSURE VIA PARTNER,1
ZA,EYE DISORDER,1
ZA,EYE PAIN,1
ZA,FEELING HOT,1
ZA,FEMUR FRACTURE,1
ZA,FIBROMYALGIA,1
ZA,FLUID OVERLOAD,1
ZA,FLUID RETENTION,1
ZA,FOOD POISONING,1
ZA,GASTRIC ULCER PERFORATION,1
ZA,GASTROENTERITIS,1
ZA,GASTROINTESTINAL BACTERIAL INFECTION,1
ZA,GASTROOESOPHAGEAL REFLUX DISEASE,1
ZA,GENITAL HAEMORRHAGE,1
ZA,HAEMORRHAGE,1
ZA,HEART RATE DECREASED,1
ZA,HEART RATE INCREASED,1
ZA,HEART VALVE INCOMPETENCE,1
ZA,HIP FRACTURE,1
ZA,HOMICIDAL IDEATION,1
ZA,HOSPITALISATION,1
ZA,HYPERAESTHESIA,1
ZA,HYPERSENSITIVITY,1
ZA,HYPERSOMNIA,1
ZA,HYPERTENSION,1
ZA,HYPERVITAMINOSIS,1
ZA,HYPOKINESIA,1
ZA,HYPONATRAEMIA,1
ZA,IMPAIRED DRIVING ABILITY,1
ZA,INCONTINENCE,1
ZA,INCORRECT DOSE ADMINISTERED,1
ZA,INCORRECT DRUG ADMINISTRATION DURATION,1
ZA,INCREASED APPETITE,1
ZA,INFECTION,1
ZA,INFECTIVE MYOSITIS,1
ZA,INFLUENZA,1
ZA,INFLUENZA LIKE ILLNESS,1
ZA,INJECTION SITE ERYTHEMA,1
ZA,INJECTION SITE PAIN,1
ZA,INJECTION SITE RASH,1
ZA,INTERVERTEBRAL DISC PROTRUSION,1
ZA,INVESTIGATION ABNORMAL,1
ZA,IRRITABLE BOWEL SYNDROME,1
ZA,KIDNEY INFECTION,1
ZA,LARYNGITIS,1
ZA,LEFT VENTRICULAR FAILURE,1
ZA,LETHARGY,1
ZA,LIGAMENT DISORDER,1
ZA,LIMB INJURY,1
ZA,LISTLESS,1
ZA,LOSS OF CONSCIOUSNESS,1
ZA,LOWER RESPIRATORY TRACT INFECTION,1
ZA,MACULAR DEGENERATION,1
ZA,MALIGNANT NEOPLASM PROGRESSION,1
ZA,MEMORY IMPAIRMENT,1
ZA,MITRAL VALVE INCOMPETENCE,1
ZA,MONOPLEGIA,1
ZA,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
ZA,MULTIPLE SCLEROSIS,1
ZA,MUSCLE ATROPHY,1
ZA,MUSCLE HAEMORRHAGE,1
ZA,MUSCULOSKELETAL CHEST PAIN,1
ZA,MYALGIA,1
ZA,MYOCARDIAL INFARCTION,1
ZA,NASOPHARYNGITIS,1
ZA,NECK PAIN,1
ZA,NEOPLASM PROGRESSION,1
ZA,NEPHROLITHIASIS,1
ZA,NEURALGIA,1
ZA,NIGHT SWEATS,1
ZA,NON-CARDIAC CHEST PAIN,1
ZA,ODYNOPHAGIA,1
ZA,ORAL PAIN,1
ZA,OROMANDIBULAR DYSTONIA,1
ZA,ORTHOPNOEA,1
ZA,OSTEOARTHRITIS,1
ZA,OVERDOSE,1
ZA,PALPITATIONS,1
ZA,PANCREATITIS,1
ZA,PARALYSIS,1
ZA,PHOTOPHOBIA,1
ZA,PITUITARY-DEPENDENT CUSHING^S SYNDROME,1
ZA,PNEUMONIA ASPIRATION,1
ZA,PRE-EXISTING CONDITION IMPROVED,1
ZA,PRODUCT GEL FORMATION,1
ZA,PRURITUS,1
ZA,PSEUDOMONAS INFECTION,1
ZA,PSYCHOTIC DISORDER,1
ZA,PULMONARY EMBOLISM,1
ZA,PULMONARY FUNCTION TEST ABNORMAL,1
ZA,PULMONARY OEDEMA,1
ZA,PULMONARY THROMBOSIS,1
ZA,PYREXIA,1
ZA,RASH PRURITIC,1
ZA,RENAL FAILURE,1
ZA,RENAL IMPAIRMENT,1
ZA,RENAL STONE REMOVAL,1
ZA,RESPIRATORY ARREST,1
ZA,RESPIRATORY DISORDER,1
ZA,RESPIRATORY DISTRESS,1
ZA,RESTLESSNESS,1
ZA,SARCOIDOSIS,1
ZA,SEIZURE,1
ZA,SEPSIS,1
ZA,SJOGREN^S SYNDROME,1
ZA,SLEEP DISORDER,1
ZA,STOMATITIS,1
ZA,STREPTOCOCCAL INFECTION,1
ZA,SUDDEN DEATH,1
ZA,SWELLING,1
ZA,SWELLING FACE,1
ZA,SYNCOPE,1
ZA,TACHYCARDIA,1
ZA,TARDIVE DYSKINESIA,1
ZA,THERAPEUTIC RESPONSE UNEXPECTED,1
ZA,THERAPY CESSATION,1
ZA,THINKING ABNORMAL,1
ZA,TONGUE SPASM,1
ZA,TREMOR,1
ZA,UNRESPONSIVE TO STIMULI,1
ZA,URINARY RETENTION POSTOPERATIVE,1
ZA,URINARY TRACT INFECTION,1
ZA,VULVOVAGINAL CANDIDIASIS,1
ZA,WOUND HAEMATOMA,1
ZA,WOUND SECRETION,1
ES,SOMNOLENCE,24
ES,FATIGUE,23
ES,PYREXIA,22
ES,DIZZINESS,21
ES,DRUG INEFFECTIVE,21
ES,FALL,21
ES,DIARRHOEA,19
ES,OVERDOSE,19
ES,CONSTIPATION,18
ES,PAIN,18
ES,CONFUSIONAL STATE,17
ES,SUICIDE ATTEMPT,17
ES,MYOCLONUS,16
ES,RESPIRATORY FAILURE,16
ES,CONDITION AGGRAVATED,14
ES,DYSPNOEA,14
ES,ARTHRALGIA,13
ES,INSOMNIA,13
ES,PANCREATITIS ACUTE,13
ES,URINARY TRACT INFECTION,13
ES,DEPRESSED LEVEL OF CONSCIOUSNESS,12
ES,HYPOTENSION,12
ES,INTENTIONAL OVERDOSE,12
ES,NEUROTOXICITY,12
ES,PAIN IN EXTREMITY,12
ES,WEIGHT INCREASED,12
ES,ACUTE KIDNEY INJURY,11
ES,HEADACHE,11
ES,HYPONATRAEMIA,11
ES,MALAISE,11
ES,NAUSEA,11
ES,PSYCHOTIC DISORDER,11
ES,RENAL IMPAIRMENT,11
ES,TREMOR,11
ES,VOMITING,11
ES,ANXIETY,10
ES,DRUG ABUSE,10
ES,GAIT DISTURBANCE,10
ES,HYPERTENSION,10
ES,NEUTROPENIA,10
ES,PNEUMONIA,10
ES,ASTHENIA,9
ES,ATRIAL FIBRILLATION,9
ES,DISORIENTATION,9
ES,ERECTILE DYSFUNCTION,9
ES,FEBRILE NEUTROPENIA,9
ES,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,9
ES,PANCYTOPENIA,9
ES,PRURITUS,9
ES,RENAL FAILURE,9
ES,TOXICITY TO VARIOUS AGENTS,9
ES,CARDIO-RESPIRATORY ARREST,8
ES,DEATH,8
ES,PANCREATITIS,8
ES,PARAESTHESIA,8
ES,SYNCOPE,8
ES,THROMBOCYTOPENIA,8
ES,TINNITUS,8
ES,COMPLETED SUICIDE,7
ES,DECREASED APPETITE,7
ES,DEPRESSION,7
ES,INJECTION SITE ERYTHEMA,7
ES,METABOLIC ACIDOSIS,7
ES,MUSCULOSKELETAL STIFFNESS,7
ES,PRODUCT USE ISSUE,7
ES,ACUTE RESPIRATORY FAILURE,6
ES,AMNESIA,6
ES,ANAEMIA,6
ES,ANGINA PECTORIS,6
ES,APHASIA,6
ES,BACK PAIN,6
ES,BLINDNESS,6
ES,CARDIAC FAILURE,6
ES,CEREBROVASCULAR ACCIDENT,6
ES,CHEST PAIN,6
ES,DEPRESSED MOOD,6
ES,HYPERHIDROSIS,6
ES,INTENTIONAL PRODUCT MISUSE,6
ES,MYALGIA,6
ES,RESPIRATORY TRACT INFECTION,6
ES,SEROTONIN SYNDROME,6
ES,ABDOMINAL DISTENSION,5
ES,ACUTE PULMONARY OEDEMA,5
ES,ASPIRATION BRONCHIAL,5
ES,BRONCHITIS,5
ES,DRUG DEPENDENCE,5
ES,FEELING ABNORMAL,5
ES,HYPOAESTHESIA,5
ES,HYPOTHYROIDISM,5
ES,INTERVERTEBRAL DISC PROTRUSION,5
ES,MENTAL DISORDER,5
ES,OEDEMA,5
ES,PALPITATIONS,5
ES,PULMONARY EMBOLISM,5
ES,RHABDOMYOLYSIS,5
ES,SEIZURE,5
ES,UPPER GASTROINTESTINAL HAEMORRHAGE,5
ES,VISUAL IMPAIRMENT,5
ES,WITHDRAWAL SYNDROME,5
ES,ABASIA,4
ES,ABNORMAL BEHAVIOUR,4
ES,ARTHRITIS,4
ES,BALANCE DISORDER,4
ES,COLITIS ULCERATIVE,4
ES,COUGH,4
ES,DELIRIUM,4
ES,DYSKINESIA,4
ES,DYSPHAGIA,4
ES,ERYTHEMA,4
ES,GASTROINTESTINAL DISORDER,4
ES,HAEMOLYTIC ANAEMIA,4
ES,HAEMOLYTIC URAEMIC SYNDROME,4
ES,HEPATITIS ACUTE,4
ES,HIP FRACTURE,4
ES,HOT FLUSH,4
ES,INCORRECT DRUG ADMINISTRATION DURATION,4
ES,INFECTION,4
ES,INFLAMMATION,4
ES,INJECTION SITE PAIN,4
ES,INJECTION SITE PRURITUS,4
ES,INJECTION SITE REACTION,4
ES,MALIGNANT NEOPLASM PROGRESSION,4
ES,MEMORY IMPAIRMENT,4
ES,MULTIPLE SCLEROSIS RELAPSE,4
ES,MUSCULAR WEAKNESS,4
ES,PERSONALITY DISORDER,4
ES,PRESCRIBED OVERDOSE,4
ES,PSYCHOMOTOR HYPERACTIVITY,4
ES,RASH,4
ES,SCIATICA,4
ES,SEPTIC SHOCK,4
ES,STUPOR,4
ES,SUBDURAL HAEMATOMA,4
ES,TACHYCARDIA,4
ES,UNEVALUABLE EVENT,4
ES,UNRESPONSIVE TO STIMULI,4
ES,WEIGHT DECREASED,4
ES,ABDOMINAL DISCOMFORT,3
ES,ABDOMINAL PAIN UPPER,3
ES,ACUTE HEPATIC FAILURE,3
ES,ADVERSE EVENT,3
ES,ALTERED STATE OF CONSCIOUSNESS,3
ES,ANAEMIA MEGALOBLASTIC,3
ES,ASCITES,3
ES,ASPHYXIA,3
ES,BLOOD CHOLESTEROL INCREASED,3
ES,CARDIOGENIC SHOCK,3
ES,CHEST DISCOMFORT,3
ES,COAGULOPATHY,3
ES,COMA,3
ES,DEAFNESS BILATERAL,3
ES,DEAFNESS NEUROSENSORY,3
ES,DEHYDRATION,3
ES,DRUG PRESCRIBING ERROR,3
ES,DYSARTHRIA,3
ES,DYSPHONIA,3
ES,EPISTAXIS,3
ES,EYELID OEDEMA,3
ES,FEELING OF DESPAIR,3
ES,FEMUR FRACTURE,3
ES,GASTROENTERITIS,3
ES,GASTROINTESTINAL HAEMORRHAGE,3
ES,GENERAL PHYSICAL HEALTH DETERIORATION,3
ES,HAEMATURIA,3
ES,HAEMORRHOIDS,3
ES,HALLUCINATION_ VISUAL,3
ES,HEPATITIS,3
ES,HEPATOTOXICITY,3
ES,HYPERAESTHESIA,3
ES,HYPERGLYCAEMIA,3
ES,HYPERKALAEMIA,3
ES,HYPERSENSITIVITY,3
ES,HYPOGAMMAGLOBULINAEMIA,3
ES,HYPOKALAEMIA,3
ES,HYPOXIA,3
ES,MOBILITY DECREASED,3
ES,NERVOUSNESS,3
ES,NEUROPATHY PERIPHERAL,3
ES,OEDEMA PERIPHERAL,3
ES,OTOTOXICITY,3
ES,PALLOR,3
ES,PARKINSON^S DISEASE,3
ES,PLEURAL EFFUSION,3
ES,PNEUMONIA ASPIRATION,3
ES,POLYNEUROPATHY,3
ES,PROCEDURAL HYPOTENSION,3
ES,PRODUCT USE IN UNAPPROVED INDICATION,3
ES,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,3
ES,PULMONARY HAEMORRHAGE,3
ES,RESPIRATORY ACIDOSIS,3
ES,RESTLESSNESS,3
ES,SEPSIS,3
ES,SPEECH DISORDER,3
ES,STATUS EPILEPTICUS,3
ES,STOMATITIS,3
ES,SUDDEN HEARING LOSS,3
ES,SUICIDAL IDEATION,3
ES,THROMBOCYTOPENIC PURPURA,3
ES,TOXIC SKIN ERUPTION,3
ES,TRANSAMINASES INCREASED,3
ES,URINARY RETENTION,3
ES,VERTIGO,3
ES,VISION BLURRED,3
ES,ABDOMINAL PAIN,2
ES,ABORTION SPONTANEOUS,2
ES,ACCIDENTAL OVERDOSE,2
ES,ACNE,2
ES,AFFECTIVE DISORDER,2
ES,AGITATION,2
ES,ALANINE AMINOTRANSFERASE INCREASED,2
ES,ANAL FISSURE,2
ES,ANGIOEDEMA,2
ES,APATHY,2
ES,ATAXIA,2
ES,ATELECTASIS,2
ES,ATRIOVENTRICULAR BLOCK SECOND DEGREE,2
ES,ATROPHY,2
ES,ATYPICAL FEMUR FRACTURE,2
ES,BLEPHARITIS,2
ES,BLOOD PRESSURE DECREASED,2
ES,BONE MARROW FAILURE,2
ES,BRADYARRHYTHMIA,2
ES,BREAST PAIN,2
ES,BRONCHOSPASM,2
ES,BUNDLE BRANCH BLOCK LEFT,2
ES,CARDIAC DISORDER,2
ES,CATARACT,2
ES,CHILLS,2
ES,CHOLESTASIS,2
ES,COGNITIVE DISORDER,2
ES,CONJUNCTIVITIS,2
ES,CONTUSION,2
ES,CRYING,2
ES,CYTOMEGALOVIRUS INFECTION,2
ES,DEAFNESS,2
ES,DERMATITIS,2
ES,DERMATITIS BULLOUS,2
ES,DEVICE DISLOCATION,2
ES,DIABETES MELLITUS,2
ES,DIABETIC KETOACIDOSIS,2
ES,DIPLOPIA,2
ES,DISEASE PROGRESSION,2
ES,DIVERTICULUM,2
ES,DRUG HYPERSENSITIVITY,2
ES,DRY MOUTH,2
ES,DYSSTASIA,2
ES,EAR PAIN,2
ES,ECZEMA,2
ES,EJACULATION DELAYED,2
ES,ENURESIS,2
ES,EYE OEDEMA,2
ES,FACE OEDEMA,2
ES,FEELING HOT,2
ES,FLATULENCE,2
ES,FLUID RETENTION,2
ES,FRACTURE,2
ES,GASTRIC PERFORATION,2
ES,GASTRIC ULCER,2
ES,GASTROOESOPHAGEAL REFLUX DISEASE,2
ES,GLOSSITIS,2
ES,HAEMATOCHEZIA,2
ES,HAEMOGLOBIN DECREASED,2
ES,HEAD DISCOMFORT,2
ES,HEMIPARESIS,2
ES,HEPATIC FAILURE,2
ES,HEPATIC NEOPLASM,2
ES,HEPATOMEGALY,2
ES,HERNIA,2
ES,HIATUS HERNIA,2
ES,HYPOCALCAEMIA,2
ES,HYPOGLYCAEMIA,2
ES,HYPOKINESIA,2
ES,HYPOMAGNESAEMIA,2
ES,HYPOVENTILATION,2
ES,HYPOXIC-ISCHAEMIC ENCEPHALOPATHY,2
ES,ILEUS,2
ES,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
ES,INCOHERENT,2
ES,INJECTION SITE URTICARIA,2
ES,INTENTIONAL PRODUCT USE ISSUE,2
ES,INTERVERTEBRAL DISC DEGENERATION,2
ES,LETHARGY,2
ES,LEUKOCYTOSIS,2
ES,LIBIDO DECREASED,2
ES,LOCALISED OEDEMA,2
ES,LOSS OF CONSCIOUSNESS,2
ES,LYMPHOEDEMA,2
ES,MENTAL IMPAIRMENT,2
ES,METABOLIC ENCEPHALOPATHY,2
ES,MIDDLE INSOMNIA,2
ES,MITRAL VALVE DISEASE,2
ES,MOTOR DYSFUNCTION,2
ES,MOVEMENT DISORDER,2
ES,MUCOSAL INFLAMMATION,2
ES,MULTI-ORGAN FAILURE,2
ES,MUSCLE RIGIDITY,2
ES,MUSCLE SPASMS,2
ES,NASOPHARYNGITIS,2
ES,NECK PAIN,2
ES,NERVE COMPRESSION,2
ES,PARALYSIS,2
ES,PARANOIA,2
ES,PARKINSONISM,2
ES,PETECHIAE,2
ES,PLATELET COUNT DECREASED,2
ES,PNEUMOCYSTIS JIROVECII PNEUMONIA,2
ES,POISONING,2
ES,POST-TRAUMATIC NECK SYNDROME,2
ES,PULMONARY OEDEMA,2
ES,PURPURA,2
ES,RECTAL HAEMORRHAGE,2
ES,RETROGRADE EJACULATION,2
ES,SINUS TACHYCARDIA,2
ES,SKIN DISCOLOURATION,2
ES,SKIN DISORDER,2
ES,SKIN NECROSIS,2
ES,SLEEP DISORDER,2
ES,SNEEZING,2
ES,SPINAL DISORDER,2
ES,SPLENOMEGALY,2
ES,SQUAMOUS CELL CARCINOMA,2
ES,SUDDEN DEATH,2
ES,SWELLING FACE,2
ES,SWOLLEN TONGUE,2
ES,THEFT,2
ES,THROMBOTIC THROMBOCYTOPENIC PURPURA,2
ES,TONGUE DISORDER,2
ES,TRACHEOBRONCHITIS,2
ES,TUMOUR LYSIS SYNDROME,2
ES,UPPER LIMB FRACTURE,2
ES,URINARY INCONTINENCE,2
ES,URTICARIA,2
ES,VISUAL ACUITY REDUCED,2
ES,VISUAL FIELD DEFECT,2
ES,WOLFF-PARKINSON-WHITE SYNDROME,2
ES,ABDOMINAL TENDERNESS,1
ES,ABNORMAL WEIGHT GAIN,1
ES,ABORTION INDUCED,1
ES,ACUTE CORONARY SYNDROME,1
ES,ACUTE LYMPHOCYTIC LEUKAEMIA,1
ES,ACUTE MYELOID LEUKAEMIA,1
ES,ACUTE MYOCARDIAL INFARCTION,1
ES,ACUTE RESPIRATORY DISTRESS SYNDROME,1
ES,AGEUSIA,1
ES,AGGRESSION,1
ES,AGRANULOCYTOSIS,1
ES,AKATHISIA,1
ES,ALOPECIA,1
ES,AMPUTATION,1
ES,ANAEMIA POSTOPERATIVE,1
ES,ANAL ABSCESS,1
ES,ANAL SPHINCTER ATONY,1
ES,ANAPHYLACTIC SHOCK,1
ES,ANKLE FRACTURE,1
ES,ANURIA,1
ES,AORTIC ANEURYSM,1
ES,AORTIC ELONGATION,1
ES,APNOEA,1
ES,APTYALISM,1
ES,ARRHYTHMIA,1
ES,ATRIOVENTRICULAR BLOCK,1
ES,ATRIOVENTRICULAR BLOCK COMPLETE,1
ES,AUTOIMMUNE THYROIDITIS,1
ES,BACTERAEMIA,1
ES,BAND NEUTROPHIL COUNT INCREASED,1
ES,BICYTOPENIA,1
ES,BILIARY DILATATION,1
ES,BIPOLAR DISORDER,1
ES,BLADDER CATHETERISATION,1
ES,BLINDNESS TRANSIENT,1
ES,BLISTER,1
ES,BLOOD ALKALINE PHOSPHATASE INCREASED,1
ES,BLOOD PRESSURE INCREASED,1
ES,BLOOD TESTOSTERONE DECREASED,1
ES,BLOOD TRIGLYCERIDES INCREASED,1
ES,BONE PAIN,1
ES,BOWEN^S DISEASE,1
ES,BRADYPHRENIA,1
ES,BRADYPNOEA,1
ES,BRAIN CONTUSION,1
ES,BRAIN OEDEMA,1
ES,BREAST CANCER,1
ES,BREAST CANCER METASTATIC,1
ES,BREAST SWELLING,1
ES,BRONCHOPULMONARY ASPERGILLOSIS,1
ES,BURNING SENSATION,1
ES,BURNING SENSATION MUCOSAL,1
ES,BURNS THIRD DEGREE,1
ES,C-REACTIVE PROTEIN INCREASED,1
ES,CARDIAC AMYLOIDOSIS,1
ES,CARDIAC ARREST,1
ES,CARDIOMEGALY,1
ES,CARDIOPULMONARY FAILURE,1
ES,CAROTID ARTERY STENOSIS,1
ES,CARTILAGE INJURY,1
ES,CATARRH,1
ES,CELL DEATH,1
ES,CENTRAL NERVOUS SYSTEM LESION,1
ES,CEREBELLAR TUMOUR,1
ES,CEREBRAL INFARCTION,1
ES,CERVIX CARCINOMA,1
ES,CHEST INJURY,1
ES,CHOKING,1
ES,CHOKING SENSATION,1
ES,CHOLANGITIS,1
ES,CHRONIC KIDNEY DISEASE,1
ES,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
ES,CIRCULATORY COLLAPSE,1
ES,CLONIC CONVULSION,1
ES,CLOSTRIDIUM DIFFICILE INFECTION,1
ES,COLITIS,1
ES,COLONIC PSEUDO-OBSTRUCTION,1
ES,COMA SCALE ABNORMAL,1
ES,CONGENITAL ANOMALY IN OFFSPRING,1
ES,CONTRAINDICATION TO MEDICAL TREATMENT,1
ES,CORONARY ARTERY DISEASE,1
ES,CORONARY ARTERY STENOSIS,1
ES,CREPITATIONS,1
ES,CYANOSIS,1
ES,CYST,1
ES,CYSTIC LYMPHANGIOMA,1
ES,DECREASED IMMUNE RESPONSIVENESS,1
ES,DELIRIUM FEBRILE,1
ES,DEMENTIA,1
ES,DEPENDENCE,1
ES,DEPRESSIVE SYMPTOM,1
ES,DEVICE RELATED INFECTION,1
ES,DIABETES MELLITUS INADEQUATE CONTROL,1
ES,DIABETIC FOOT,1
ES,DIARRHOEA HAEMORRHAGIC,1
ES,DIASTOLIC DYSFUNCTION,1
ES,DILATATION INTRAHEPATIC DUCT ACQUIRED,1
ES,DISCOMFORT,1
ES,DISORGANISED SPEECH,1
ES,DISSOCIATION,1
ES,DISTURBANCE IN ATTENTION,1
ES,DIVERTICULITIS,1
ES,DRUG ADMINISTRATION ERROR,1
ES,DRUG DISPENSED TO WRONG PATIENT,1
ES,DRUG DOSE TITRATION NOT PERFORMED,1
ES,DRUG EFFECT DECREASED,1
ES,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
ES,DRUG INTOLERANCE,1
ES,DRUG TITRATION ERROR,1
ES,DRUG WITHDRAWAL SYNDROME,1
ES,DRY EYE,1
ES,DYSAESTHESIA,1
ES,DYSGEUSIA,1
ES,DYSPEPSIA,1
ES,DYSPNOEA AT REST,1
ES,EAR DISCOMFORT,1
ES,EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED,1
ES,ECCHYMOSIS,1
ES,EJACULATION DISORDER,1
ES,ELECTROCARDIOGRAM QT PROLONGED,1
ES,ENCEPHALITIS,1
ES,ENTERITIS,1
ES,EPILEPSY,1
ES,EPSTEIN-BARR VIRUS ANTIBODY POSITIVE,1
ES,ERYTHEMA MULTIFORME,1
ES,EUPHORIC MOOD,1
ES,EXPOSURE DURING PREGNANCY,1
ES,EXPOSURE VIA FATHER,1
ES,EXTRADURAL HAEMATOMA,1
ES,EYE PAIN,1
ES,EYELID FUNCTION DISORDER,1
ES,FACE INJURY,1
ES,FACIAL BONES FRACTURE,1
ES,FACIAL PARALYSIS,1
ES,FACIAL PARESIS,1
ES,FAECALOMA,1
ES,FEELING COLD,1
ES,FIBROMYALGIA,1
ES,FLUSHING,1
ES,FOETAL EXPOSURE DURING PREGNANCY,1
ES,FUNGAL INFECTION,1
ES,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
ES,GASTRIC POLYPS,1
ES,GASTRIC ULCER HAEMORRHAGE,1
ES,GASTRITIS,1
ES,GASTROINTESTINAL OEDEMA,1
ES,GASTROINTESTINAL PAIN,1
ES,GASTROINTESTINAL STROMAL TUMOUR,1
ES,GENITAL CANDIDIASIS,1
ES,GINGIVAL ABSCESS,1
ES,GINGIVAL BLEEDING,1
ES,GLAUCOMA,1
ES,GLOSSODYNIA,1
ES,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
ES,GRAND MAL CONVULSION,1
ES,GROIN PAIN,1
ES,GUILLAIN-BARRE SYNDROME,1
ES,H1N1 INFLUENZA,1
ES,HAEMATEMESIS,1
ES,HAEMATOCRIT DECREASED,1
ES,HAEMATOMA,1
ES,HAEMATOTOXICITY,1
ES,HAEMOPTYSIS,1
ES,HAEMORRHAGIC STROKE,1
ES,HAIR GROWTH ABNORMAL,1
ES,HALLUCINATION,1
ES,HALLUCINATION_ AUDITORY,1
ES,HALLUCINATIONS_ MIXED,1
ES,HEART RATE ABNORMAL,1
ES,HEMIPLEGIA,1
ES,HEPATIC ENZYME INCREASED,1
ES,HEPATIC FUNCTION ABNORMAL,1
ES,HEPATIC PAIN,1
ES,HEPATITIS C,1
ES,HEPATITIS C VIRUS TEST POSITIVE,1
ES,HEPATITIS CHOLESTATIC,1
ES,HEPATITIS TOXIC,1
ES,HEPATOCELLULAR CARCINOMA,1
ES,HERPES SIMPLEX,1
ES,HERPES VIRUS INFECTION,1
ES,HYDROCEPHALUS,1
ES,HYPERBILIRUBINAEMIA,1
ES,HYPERNATRAEMIA,1
ES,HYPERTHYROIDISM,1
ES,HYPERTONIA,1
ES,HYPERTONIC BLADDER,1
ES,HYPERTROPHIC CARDIOMYOPATHY,1
ES,HYPOACUSIS,1
ES,HYPOCOAGULABLE STATE,1
ES,HYPOPHOSPHATAEMIA,1
ES,HYPOTHERMIA,1
ES,HYPOTONIA,1
ES,HYPOVOLAEMIC SHOCK,1
ES,ILLUSION,1
ES,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,1
ES,INAPPROPRIATE AFFECT,1
ES,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
ES,INFECTED NEOPLASM,1
ES,INFLUENZA,1
ES,INJECTION SITE HAEMATOMA,1
ES,INJECTION SITE INFECTION,1
ES,INJECTION SITE MASS,1
ES,INJECTION SITE NECROSIS,1
ES,INJECTION SITE RASH,1
ES,INJECTION SITE SWELLING,1
ES,INJECTION SITE WARMTH,1
ES,INJURY,1
ES,INTERVERTEBRAL DISC CALCIFICATION,1
ES,INTESTINAL OBSTRUCTION,1
ES,IRON DEFICIENCY,1
ES,IRRITABILITY,1
ES,ISCHAEMIC CEREBRAL INFARCTION,1
ES,JOINT EFFUSION,1
ES,JOINT INJURY,1
ES,JOINT RANGE OF MOTION DECREASED,1
ES,JOINT SWELLING,1
ES,JUGULAR VEIN THROMBOSIS,1
ES,KLEBSIELLA TEST POSITIVE,1
ES,LACERATION,1
ES,LARYNGEAL OEDEMA,1
ES,LARYNGITIS,1
ES,LEUKAEMIA,1
ES,LIBIDO INCREASED,1
ES,LIGAMENT SPRAIN,1
ES,LIP OEDEMA,1
ES,LIP SWELLING,1
ES,LIVER DISORDER,1
ES,LOCAL SWELLING,1
ES,LOWER GASTROINTESTINAL HAEMORRHAGE,1
ES,LUNG ADENOCARCINOMA,1
ES,LYMPHOCYTE COUNT DECREASED,1
ES,LYMPHOCYTE COUNT INCREASED,1
ES,LYMPHOMA,1
ES,MACULOPATHY,1
ES,MATERNAL DRUGS AFFECTING FOETUS,1
ES,MATERNAL EXPOSURE DURING PREGNANCY,1
ES,MEDICATION ERROR,1
ES,MENINGIOMA,1
ES,MENORRHAGIA,1
ES,METASTASES TO LIVER,1
ES,METRORRHAGIA,1
ES,MICTURITION URGENCY,1
ES,MIGRAINE,1
ES,MIOSIS,1
ES,MIXED LIVER INJURY,1
ES,MOUTH ULCERATION,1
ES,MULTIPLE DRUG THERAPY,1
ES,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
ES,MUSCLE NECROSIS,1
ES,MUSCLE RUPTURE,1
ES,MUSCULOSKELETAL CHEST PAIN,1
ES,MUSCULOSKELETAL PAIN,1
ES,MYDRIASIS,1
ES,MYOCARDIAL INFARCTION,1
ES,MYOCARDITIS,1
ES,NAIL DISORDER,1
ES,NAIL PIGMENTATION,1
ES,NASAL CONGESTION,1
ES,NECROTISING FASCIITIS,1
ES,NEOPLASM PROGRESSION,1
ES,NERVOUS SYSTEM DISORDER,1
ES,NEURALGIA,1
ES,NEUROGENIC BLADDER,1
ES,NEUROPSYCHIATRIC SYNDROME,1
ES,NICOTINE DEPENDENCE,1
ES,NIGHTMARE,1
ES,NIPPLE ENLARGEMENT,1
ES,NO ADVERSE EVENT,1
ES,NODULE,1
ES,NYSTAGMUS,1
ES,OCULOGYRIC CRISIS,1
ES,ORAL DISCOMFORT,1
ES,ORAL HERPES,1
ES,OROMANDIBULAR DYSTONIA,1
ES,OROPHARYNGEAL CANDIDIASIS,1
ES,OSTEONECROSIS OF JAW,1
ES,PAINFUL RESPIRATION,1
ES,PALPABLE PURPURA,1
ES,PANCREATIC CARCINOMA,1
ES,PANIC ATTACK,1
ES,PANIC REACTION,1
ES,PARAESTHESIA ORAL,1
ES,PARANEOPLASTIC SYNDROME,1
ES,PARAPLEGIA,1
ES,PARAPSORIASIS,1
ES,PARKINSONIAN GAIT,1
ES,PAROTITIS,1
ES,PEMPHIGOID,1
ES,PERIORBITAL CELLULITIS,1
ES,PERIPHERAL SENSORY NEUROPATHY,1
ES,PERIPHERAL SWELLING,1
ES,PHARYNGEAL DISORDER,1
ES,PHARYNGITIS,1
ES,PHOTOPHOBIA,1
ES,PITUITARY TUMOUR BENIGN,1
ES,PLASMA CELL MYELOMA,1
ES,PNEUMONIA CYTOMEGALOVIRAL,1
ES,PNEUMONIA PNEUMOCOCCAL,1
ES,PNEUMOTHORAX,1
ES,PORTAL VEIN THROMBOSIS,1
ES,POST PROCEDURAL COMPLICATION,1
ES,POTENTIATING DRUG INTERACTION,1
ES,PRE-EXISTING CONDITION IMPROVED,1
ES,PREMATURE AGEING,1
ES,PRERENAL FAILURE,1
ES,PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION,1
ES,PRINZMETAL ANGINA,1
ES,PROCTALGIA,1
ES,PRODUCT QUALITY ISSUE,1
ES,PROSTATE CANCER,1
ES,PROSTHESIS IMPLANTATION,1
ES,PRURITUS GENERALISED,1
ES,PSEUDARTHROSIS,1
ES,PSEUDOMONAS INFECTION,1
ES,PSORIASIS,1
ES,PULMONARY MASS,1
ES,PYELONEPHRITIS,1
ES,RASH ERYTHEMATOUS,1
ES,RENAL CANCER METASTATIC,1
ES,RENAL FAILURE ACUTE,1
ES,RENAL NEOPLASM,1
ES,RENAL PAIN,1
ES,RESPIRATORY ALKALOSIS,1
ES,RESPIRATORY DEPRESSION,1
ES,RESPIRATORY DISTRESS,1
ES,RESPIRATORY MONILIASIS,1
ES,RESPIRATORY TRACT INFECTION BACTERIAL,1
ES,RHEUMATOID ARTHRITIS,1
ES,RHINITIS,1
ES,RHINORRHOEA,1
ES,RIB FRACTURE,1
ES,ROAD TRAFFIC ACCIDENT,1
ES,SCAB,1
ES,SECRETION DISCHARGE,1
ES,SEDATION,1
ES,SENSE OF OPPRESSION,1
ES,SENSORY LOSS,1
ES,SHOCK HAEMORRHAGIC,1
ES,SINOATRIAL BLOCK,1
ES,SINUS ARREST,1
ES,SINUS BRADYCARDIA,1
ES,SINUS NODE DYSFUNCTION,1
ES,SKIN HYPERPIGMENTATION,1
ES,SKIN INFECTION,1
ES,SKIN PLAQUE,1
ES,SKIN REACTION,1
ES,SKIN TOXICITY,1
ES,SKIN WRINKLING,1
ES,SLEEP TERROR,1
ES,SLUGGISHNESS,1
ES,SOMNAMBULISM,1
ES,SPINAL COLUMN STENOSIS,1
ES,SPINAL CORD COMPRESSION,1
ES,SPINAL PAIN,1
ES,SPONTANEOUS HAEMATOMA,1
ES,SPUTUM CULTURE POSITIVE,1
ES,SPUTUM DISCOLOURED,1
ES,STAPHYLOCOCCAL INFECTION,1
ES,STEVENS-JOHNSON SYNDROME,1
ES,STRABISMUS,1
ES,SUBARACHNOID HAEMORRHAGE,1
ES,SUBILEUS,1
ES,SUPERFICIAL SPREADING MELANOMA STAGE IV,1
ES,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,1
ES,SYSTOLIC HYPERTENSION,1
ES,TACHYPNOEA,1
ES,TELANGIECTASIA,1
ES,TENDON PAIN,1
ES,TENSION HEADACHE,1
ES,THERAPEUTIC RESPONSE UNEXPECTED,1
ES,THROMBOSIS MESENTERIC VESSEL,1
ES,THROMBOTIC STROKE,1
ES,TIBIA FRACTURE,1
ES,TONGUE COATED,1
ES,TONGUE DRY,1
ES,TONGUE ERUPTION,1
ES,TONGUE OEDEMA,1
ES,TONGUE ULCERATION,1
ES,TONIC CLONIC MOVEMENTS,1
ES,TOOTH DISCOLOURATION,1
ES,TOOTH DISORDER,1
ES,TOOTH INFECTION,1
ES,TOOTH LOSS,1
ES,TOXIC EPIDERMAL NECROLYSIS,1
ES,TRANSIENT ISCHAEMIC ATTACK,1
ES,TREATMENT FAILURE,1
ES,TREATMENT NONCOMPLIANCE,1
ES,TRICUSPID VALVE INCOMPETENCE,1
ES,TRIGEMINAL NEURALGIA,1
ES,TUMOUR PAIN,1
ES,TUNNEL VISION,1
ES,TYPE 1 LEPRA REACTION,1
ES,TYPE 2 DIABETES MELLITUS,1
ES,UNDERDOSE,1
ES,UROSEPSIS,1
ES,URTICARIA THERMAL,1
ES,USE OF ACCESSORY RESPIRATORY MUSCLES,1
ES,VARICOSE VEIN OPERATION,1
ES,VASCULAR PSEUDOANEURYSM,1
ES,VENTRICULAR HYPOPLASIA,1
ES,VERTEBRAL OSTEOPHYTE,1
ES,VIITH NERVE PARALYSIS,1
ES,VITAMIN D DEFICIENCY,1
ES,VITH NERVE PARALYSIS,1
ES,VITREOUS HAEMORRHAGE,1
ES,WHITE BLOOD CELL COUNT INCREASED,1
ES,WOUND,1
ES,WRONG DRUG ADMINISTERED,1
ES,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
SE,TOXICITY TO VARIOUS AGENTS,104
SE,FATIGUE,28
SE,ANXIETY,27
SE,OVERDOSE,26
SE,DRUG ABUSE,24
SE,DEPRESSED LEVEL OF CONSCIOUSNESS,23
SE,DIZZINESS,19
SE,INTENTIONAL SELF-INJURY,15
SE,MUSCLE SPASMS,14
SE,SUICIDE ATTEMPT,14
SE,CONFUSIONAL STATE,13
SE,BACK PAIN,12
SE,PAIN IN EXTREMITY,12
SE,SUICIDAL IDEATION,12
SE,DYSPNOEA,11
SE,HEADACHE,11
SE,HYPERHIDROSIS,11
SE,SOMNOLENCE,11
SE,TACHYCARDIA,11
SE,ARTHRALGIA,10
SE,DIPLOPIA,10
SE,DRUG DEPENDENCE,10
SE,HALLUCINATION,10
SE,MUSCULAR WEAKNESS,10
SE,PAIN,10
SE,TREMOR,10
SE,AMNESIA,9
SE,DRUG INEFFECTIVE,9
SE,NAUSEA,9
SE,NIGHTMARE,9
SE,WEIGHT INCREASED,9
SE,WITHDRAWAL SYNDROME,9
SE,DEPRESSION,8
SE,HYPOTENSION,8
SE,LOSS OF CONSCIOUSNESS,8
SE,POISONING,8
SE,ACCIDENTAL OVERDOSE,7
SE,AGITATION,7
SE,BALANCE DISORDER,7
SE,DIARRHOEA,7
SE,DYSARTHRIA,7
SE,FEELING ABNORMAL,7
SE,PANIC ATTACK,7
SE,PRODUCT USE ISSUE,7
SE,WEIGHT DECREASED,7
SE,ANALGESIC DRUG LEVEL INCREASED,6
SE,CARDIAC DISORDER,6
SE,COMPLETED SUICIDE,6
SE,DISTURBANCE IN ATTENTION,6
SE,DYSURIA,6
SE,EPILEPSY,6
SE,HEPATIC CONGESTION,6
SE,HYPERTENSION,6
SE,INTENTIONAL OVERDOSE,6
SE,LIBIDO DECREASED,6
SE,MALAISE,6
SE,MYALGIA,6
SE,PRURITUS,6
SE,PULMONARY CONGESTION,6
SE,RASH,6
SE,SEIZURE,6
SE,TINNITUS,6
SE,APHASIA,5
SE,CONVULSION,5
SE,DEREALISATION,5
SE,DRUG USE DISORDER,5
SE,EATING DISORDER,5
SE,FALL,5
SE,FEAR,5
SE,HALLUCINATION_ VISUAL,5
SE,HYPOAESTHESIA,5
SE,HYPOTONIA,5
SE,LETHARGY,5
SE,MEMORY IMPAIRMENT,5
SE,NEGATIVE THOUGHTS,5
SE,OXYGEN SATURATION DECREASED,5
SE,PANIC DISORDER,5
SE,RENAL DISORDER,5
SE,SLEEP DISORDER,5
SE,SOCIAL ANXIETY DISORDER,5
SE,SOMNAMBULISM,5
SE,SYNCOPE,5
SE,VISUAL IMPAIRMENT,5
SE,ABDOMINAL PAIN,4
SE,ACCIDENT,4
SE,ALOPECIA,4
SE,ALTERED STATE OF CONSCIOUSNESS,4
SE,ARRHYTHMIA,4
SE,BURNOUT SYNDROME,4
SE,COELIAC DISEASE,4
SE,COORDINATION ABNORMAL,4
SE,DISORIENTATION,4
SE,DRY MOUTH,4
SE,DYSKINESIA,4
SE,EMOTIONAL DISTRESS,4
SE,FORMICATION,4
SE,GAIT DISTURBANCE,4
SE,GASTRIC DISORDER,4
SE,HYPONATRAEMIA,4
SE,JOINT SWELLING,4
SE,MIOSIS,4
SE,MUSCLE RIGIDITY,4
SE,MUSCLE TIGHTNESS,4
SE,MUSCULOSKELETAL PAIN,4
SE,OEDEMA PERIPHERAL,4
SE,PALPITATIONS,4
SE,PARAESTHESIA,4
SE,PELVIC INFLAMMATORY DISEASE,4
SE,PRODUCT USE IN UNAPPROVED INDICATION,4
SE,PSYCHIATRIC SYMPTOM,4
SE,ABDOMINAL PAIN UPPER,3
SE,ABNORMAL DREAMS,3
SE,AGGRESSION,3
SE,ASPHYXIA,3
SE,BREAST CANCER METASTATIC,3
SE,CAMPTOCORMIA,3
SE,CONDITION AGGRAVATED,3
SE,CONSTIPATION,3
SE,COUGH,3
SE,DEPENDENCE,3
SE,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,3
SE,DRUG LEVEL INCREASED,3
SE,DRUG WITHDRAWAL SYNDROME,3
SE,DYSGEUSIA,3
SE,DYSGRAPHIA,3
SE,DYSPHAGIA,3
SE,FEELING DRUNK,3
SE,MOOD SWINGS,3
SE,MUSCLE CONTRACTIONS INVOLUNTARY,3
SE,OSTEONECROSIS OF JAW,3
SE,PERIPHERAL SWELLING,3
SE,PERSONALITY CHANGE,3
SE,PETIT MAL EPILEPSY,3
SE,PNEUMONIA,3
SE,PULMONARY EMBOLISM,3
SE,RENAL IMPAIRMENT,3
SE,SEPSIS,3
SE,SEROTONIN SYNDROME,3
SE,VOMITING,3
SE,ABDOMINAL DISTENSION,2
SE,ABNORMAL BEHAVIOUR,2
SE,AGRANULOCYTOSIS,2
SE,AKATHISIA,2
SE,APNOEA,2
SE,ASTHENIA,2
SE,AUTONOMIC NEUROPATHY,2
SE,BODY TEMPERATURE INCREASED,2
SE,BONE MARROW FAILURE,2
SE,BRAIN HYPOXIA,2
SE,BRAIN NEOPLASM MALIGNANT,2
SE,C-REACTIVE PROTEIN INCREASED,2
SE,CARDIAC ARREST,2
SE,CARDIAC FAILURE,2
SE,CHEST DISCOMFORT,2
SE,CIRCULATORY COLLAPSE,2
SE,CLUMSINESS,2
SE,DEATH,2
SE,DEHYDRATION,2
SE,DELUSION,2
SE,DEMENTIA,2
SE,DRUG TOLERANCE,2
SE,DYSSTASIA,2
SE,EUPHORIC MOOD,2
SE,FEELING COLD,2
SE,FUNGAL INFECTION,2
SE,GROIN PAIN,2
SE,HALLUCINATION_ AUDITORY,2
SE,HEARING IMPAIRED,2
SE,HEMIPLEGIA,2
SE,HYPERAESTHESIA,2
SE,HYPERTHERMIA,2
SE,INCORRECT DOSE ADMINISTERED,2
SE,INSOMNIA,2
SE,INTENTIONAL PRODUCT MISUSE,2
SE,MANIA,2
SE,MENTAL DISORDER,2
SE,MENTAL IMPAIRMENT,2
SE,MOTOR DYSFUNCTION,2
SE,MULTI-ORGAN FAILURE,2
SE,MUSCLE TWITCHING,2
SE,MUSCULOSKELETAL STIFFNESS,2
SE,MYOPATHY,2
SE,NEUROLOGICAL SYMPTOM,2
SE,OBSESSIVE-COMPULSIVE DISORDER,2
SE,OEDEMA,2
SE,OROPHARYNGEAL PAIN,2
SE,OSTEITIS,2
SE,PANCREATITIS ACUTE,2
SE,PANIC REACTION,2
SE,PARAESTHESIA ORAL,2
SE,PHOTOPSIA,2
SE,PNEUMONIA PNEUMOCOCCAL,2
SE,PSORIASIS,2
SE,PSYCHOTIC DISORDER,2
SE,PYREXIA,2
SE,READING DISORDER,2
SE,RENAL FAILURE,2
SE,RESPIRATORY ARREST,2
SE,RESPIRATORY DEPRESSION,2
SE,RESPIRATORY DISORDER,2
SE,RESTLESSNESS,2
SE,SCREAMING,2
SE,SELF INJURIOUS BEHAVIOUR,2
SE,SEXUAL DYSFUNCTION,2
SE,SKIN ULCER,2
SE,SPEECH DISORDER,2
SE,SPINAL DEFORMITY,2
SE,SUBSTANCE ABUSE,2
SE,SWELLING,2
SE,SWELLING FACE,2
SE,THROAT TIGHTNESS,2
SE,THROMBOCYTOPENIA,2
SE,TOOTH LOSS,2
SE,ULCER,2
SE,VASCULITIS,2
SE,VERTIGO,2
SE,VISION BLURRED,2
SE,VISUAL FIELD DEFECT,2
SE,ABDOMINAL DISCOMFORT,1
SE,ACCOMMODATION DISORDER,1
SE,ACNE,1
SE,ACUTE RESPIRATORY DISTRESS SYNDROME,1
SE,ADRENAL SUPPRESSION,1
SE,ALCOHOL INTERACTION,1
SE,ALCOHOL POISONING,1
SE,ALCOHOLISM,1
SE,AMENORRHOEA,1
SE,ANAEMIA MEGALOBLASTIC,1
SE,ANAPHYLACTIC REACTION,1
SE,ANGINA PECTORIS,1
SE,ANGIOEDEMA,1
SE,ANTISOCIAL BEHAVIOUR,1
SE,ANXIETY DISORDER,1
SE,ASTHENOPIA,1
SE,ASTHMA,1
SE,ATRIAL FIBRILLATION,1
SE,ATRIAL FLUTTER,1
SE,AUTONOMIC NERVOUS SYSTEM IMBALANCE,1
SE,BLADDER PAIN,1
SE,BLOOD CHOLESTEROL INCREASED,1
SE,BLOOD CREATININE INCREASED,1
SE,BLOOD IRON DECREASED,1
SE,BLOOD PRESSURE DECREASED,1
SE,BLOOD PRESSURE INCREASED,1
SE,BLOOD PROLACTIN INCREASED,1
SE,BLUNTED AFFECT,1
SE,BODY TEMPERATURE DECREASED,1
SE,BONE MARROW MYELOGRAM ABNORMAL,1
SE,BRADYCARDIA,1
SE,BRADYPHRENIA,1
SE,BREAST CANCER,1
SE,CARDIAC FIBRILLATION,1
SE,CENTRAL NERVOUS SYSTEM INFLAMMATION,1
SE,CEREBRAL INFARCTION,1
SE,CHYLOTHORAX,1
SE,COGNITIVE DISORDER,1
SE,CONGESTIVE CARDIOMYOPATHY,1
SE,CROHN^S DISEASE,1
SE,CUSHING^S SYNDROME,1
SE,CYANOSIS,1
SE,DAYDREAMING,1
SE,DEAFNESS,1
SE,DECREASED APPETITE,1
SE,DECREASED IMMUNE RESPONSIVENESS,1
SE,DEFAECATION URGENCY,1
SE,DELIRIUM,1
SE,DENTAL CARIES,1
SE,DEPERSONALISATION,1
SE,DEPRESSED MOOD,1
SE,DERMATITIS ACNEIFORM,1
SE,DIABETES MELLITUS,1
SE,DIABETES MELLITUS INADEQUATE CONTROL,1
SE,DIZZINESS POSTURAL,1
SE,DRUG ABUSER,1
SE,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
SE,DRUG EFFECT DECREASED,1
SE,DRUG EFFECT INCOMPLETE,1
SE,DRUG PRESCRIBING ERROR,1
SE,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
SE,DRUG TOLERANCE INCREASED,1
SE,DRUG WITHDRAWAL CONVULSIONS,1
SE,DRY EYE,1
SE,DYSCALCULIA,1
SE,DYSCHROMATOPSIA,1
SE,DYSPEPSIA,1
SE,ECZEMA,1
SE,ENTEROCOCCAL INFECTION,1
SE,EPISTAXIS,1
SE,ERECTILE DYSFUNCTION,1
SE,ERYSIPELAS,1
SE,ERYTHEMA,1
SE,EXPOSED BONE IN JAW,1
SE,EXPOSURE VIA INGESTION,1
SE,EXTRA DOSE ADMINISTERED,1
SE,EYE DISORDER,1
SE,EYE HAEMORRHAGE,1
SE,EYE MOVEMENT DISORDER,1
SE,EYE PRURITUS,1
SE,EYE SWELLING,1
SE,FEELING HOT,1
SE,FIBROMYALGIA,1
SE,FLATULENCE,1
SE,FLUSHING,1
SE,FOETAL EXPOSURE DURING PREGNANCY,1
SE,GALACTORRHOEA,1
SE,GASTRIC ATONY,1
SE,GASTRITIS EROSIVE,1
SE,GASTROINTESTINAL HAEMORRHAGE,1
SE,GASTROINTESTINAL NECROSIS,1
SE,GASTROINTESTINAL PAIN,1
SE,GENERAL PHYSICAL HEALTH DETERIORATION,1
SE,GENITAL NEOPLASM MALIGNANT FEMALE,1
SE,GINGIVAL PAIN,1
SE,GLOSSITIS,1
SE,GLOSSODYNIA,1
SE,GLUCOSE TOLERANCE IMPAIRED,1
SE,GOUT,1
SE,GRANULOCYTOPENIA,1
SE,GYNAECOMASTIA,1
SE,HAEMATOCHEZIA,1
SE,HAEMOGLOBIN DECREASED,1
SE,HAEMOPHILIA,1
SE,HALLUCINATION_ OLFACTORY,1
SE,HEAD DISCOMFORT,1
SE,HEAD INJURY,1
SE,HEART RATE ABNORMAL,1
SE,HEART RATE DECREASED,1
SE,HEART RATE INCREASED,1
SE,HEPATIC ENZYME INCREASED,1
SE,HICCUPS,1
SE,HOT FLUSH,1
SE,HUNGER,1
SE,HYPERACUSIS,1
SE,HYPERSENSITIVITY,1
SE,HYPERSENSITIVITY VASCULITIS,1
SE,HYPOAESTHESIA ORAL,1
SE,HYPOKALAEMIA,1
SE,HYPOMANIA,1
SE,HYPOTHERMIA,1
SE,IMMUNODEFICIENCY,1
SE,IMPAIRED WORK ABILITY,1
SE,IMPULSIVE BEHAVIOUR,1
SE,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
SE,INCOHERENT,1
SE,INCREASED APPETITE,1
SE,INFLUENZA LIKE ILLNESS,1
SE,INTENTIONAL DRUG MISUSE,1
SE,INTENTIONAL PRODUCT USE ISSUE,1
SE,JOINT STIFFNESS,1
SE,LEUKOPENIA,1
SE,LIMB INJURY,1
SE,LIP PRURITUS,1
SE,LIPOMA,1
SE,LOSS OF LIBIDO,1
SE,LUNG CANCER METASTATIC,1
SE,LYMPHOCYTE COUNT DECREASED,1
SE,MATERNAL EXPOSURE DURING PREGNANCY,1
SE,METASTASES TO LIVER,1
SE,MIGRAINE,1
SE,MUSCULOSKELETAL DISCOMFORT,1
SE,MUSCULOSKELETAL DISORDER,1
SE,MYCOBACTERIUM CHELONAE INFECTION,1
SE,MYCOTOXICOSIS,1
SE,MYDRIASIS,1
SE,MYOPIA,1
SE,NASAL CONGESTION,1
SE,NECK PAIN,1
SE,NEPHROLITHIASIS,1
SE,NERVOUS SYSTEM DISORDER,1
SE,NEUROLOGICAL DECOMPENSATION,1
SE,NEUTROPHIL COUNT DECREASED,1
SE,NOONAN SYNDROME,1
SE,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
SE,ODYNOPHAGIA,1
SE,ORAL PAIN,1
SE,ORGAN FAILURE,1
SE,ORTHOSTATIC HYPOTENSION,1
SE,OSCILLOPSIA,1
SE,OSTEOMYELITIS,1
SE,OSTEONECROSIS,1
SE,OVARIAN CANCER STAGE II,1
SE,OVERWEIGHT,1
SE,PAPILLOEDEMA,1
SE,PARANOIA,1
SE,PARANOID PERSONALITY DISORDER,1
SE,PERIODONTITIS,1
SE,PERIPHERAL CIRCULATORY FAILURE,1
SE,PERIPHERAL COLDNESS,1
SE,PERIPHERAL VASCULAR DISORDER,1
SE,PERSONALITY DISORDER,1
SE,PHARYNGEAL DISORDER,1
SE,PHARYNGEAL HAEMORRHAGE,1
SE,PHARYNGEAL OEDEMA,1
SE,PHOTOPHOBIA,1
SE,PITUITARY TUMOUR BENIGN,1
SE,PNEUMONIA ASPIRATION,1
SE,POISONING DELIBERATE,1
SE,POLYURIA,1
SE,POOR PERIPHERAL CIRCULATION,1
SE,POOR QUALITY SLEEP,1
SE,PRE-EXISTING CONDITION IMPROVED,1
SE,PRESCRIBED OVERDOSE,1
SE,PRESYNCOPE,1
SE,PRODUCT TAMPERING,1
SE,PROSTATE CANCER METASTATIC,1
SE,PRURITUS GENERALISED,1
SE,PSEUDOSEPSIS,1
SE,RASH ERYTHEMATOUS,1
SE,RECTAL HAEMORRHAGE,1
SE,RENAL FAILURE ACUTE,1
SE,RENAL INJURY,1
SE,RESPIRATORY DISORDER NEONATAL,1
SE,RESPIRATORY DISTRESS,1
SE,RETINAL DISORDER,1
SE,RETINAL HAEMORRHAGE,1
SE,RETINAL INJURY,1
SE,RHABDOMYOLYSIS,1
SE,RHINORRHOEA,1
SE,RIB FRACTURE,1
SE,ROAD TRAFFIC ACCIDENT,1
SE,ROSACEA,1
SE,SCHIZOPHRENIA,1
SE,SCIATICA,1
SE,SENSORY LOSS,1
SE,SINUS NODE DYSFUNCTION,1
SE,SKIN DISORDER,1
SE,SKIN INFECTION,1
SE,SKIN ULCER HAEMORRHAGE,1
SE,SKIN WOUND,1
SE,SKIN WRINKLING,1
SE,SNORING,1
SE,SPINAL DISORDER,1
SE,STOMA OBSTRUCTION,1
SE,STRESS,1
SE,STRESS CARDIOMYOPATHY,1
SE,STRESS FRACTURE,1
SE,SUDDEN DEATH,1
SE,SUICIDAL BEHAVIOUR,1
SE,SUPRAVENTRICULAR TACHYCARDIA,1
SE,SURGERY,1
SE,SWOLLEN TONGUE,1
SE,THERAPEUTIC RESPONSE UNEXPECTED,1
SE,THYROID FUNCTION TEST ABNORMAL,1
SE,TONGUE DISCOLOURATION,1
SE,TOOTH EROSION,1
SE,TOOTHACHE,1
SE,TOXIC EPIDERMAL NECROLYSIS,1
SE,UNRESPONSIVE TO STIMULI,1
SE,URINARY TRACT DISORDER,1
SE,URINE ODOUR ABNORMAL,1
SE,URINE OUTPUT DECREASED,1
SE,VISUAL ACUITY REDUCED,1
SE,WHEELCHAIR USER,1
SE,WOUND COMPLICATION,1
SE,WOUND INFECTION,1
SE,WOUND INFECTION STAPHYLOCOCCAL,1
SE,YAWNING,1
CH,CONFUSIONAL STATE,37
CH,FALL,36
CH,ABORTION SPONTANEOUS,30
CH,SOMNOLENCE,29
CH,MATERNAL EXPOSURE DURING PREGNANCY,26
CH,ACUTE KIDNEY INJURY,25
CH,FOETAL EXPOSURE DURING PREGNANCY,25
CH,EXPOSURE DURING PREGNANCY,23
CH,VOMITING,22
CH,PYREXIA,20
CH,ALTERED STATE OF CONSCIOUSNESS,19
CH,HYPOTENSION,19
CH,TREMOR,19
CH,AGITATION,18
CH,PNEUMONIA,18
CH,DIZZINESS,17
CH,CONDITION AGGRAVATED,16
CH,DIARRHOEA,16
CH,FATIGUE,16
CH,TOXICITY TO VARIOUS AGENTS,16
CH,HEPATOCELLULAR INJURY,15
CH,NAUSEA,15
CH,HAEMATURIA,14
CH,HYPOGLYCAEMIA,14
CH,MUSCULAR WEAKNESS,14
CH,DYSPNOEA,13
CH,ANAEMIA,12
CH,CARDIAC FAILURE,12
CH,DELIRIUM,12
CH,DYSPHAGIA,12
CH,HEADACHE,12
CH,PANCYTOPENIA,12
CH,RENAL IMPAIRMENT,12
CH,BRADYCARDIA,11
CH,OVERDOSE,11
CH,RASH,11
CH,RENAL FAILURE,11
CH,RESPIRATORY FAILURE,11
CH,ATAXIA,10
CH,GAIT DISTURBANCE,10
CH,GENERAL PHYSICAL HEALTH DETERIORATION,10
CH,MALAISE,10
CH,METABOLIC ACIDOSIS,10
CH,PNEUMONIA ASPIRATION,10
CH,SEPSIS,10
CH,THROMBOCYTOPENIA,10
CH,ALANINE AMINOTRANSFERASE INCREASED,9
CH,COMA,9
CH,DRUG ABUSE,9
CH,PRODUCT USE ISSUE,9
CH,SUBARACHNOID HAEMORRHAGE,9
CH,TACHYCARDIA,9
CH,TRAUMATIC HAEMATOMA,9
CH,AGGRESSION,8
CH,ASPARTATE AMINOTRANSFERASE INCREASED,8
CH,ASTHENIA,8
CH,DISTURBANCE IN ATTENTION,8
CH,DRUG LEVEL INCREASED,8
CH,HYPERSENSITIVITY,8
CH,INTENTIONAL OVERDOSE,8
CH,RESTLESSNESS,8
CH,SUICIDE ATTEMPT,8
CH,URINARY TRACT INFECTION,8
CH,VERTIGO,8
CH,VISUAL IMPAIRMENT,8
CH,WITHDRAWAL SYNDROME,8
CH,ABDOMINAL PAIN,7
CH,ABORTION INDUCED,7
CH,C-REACTIVE PROTEIN INCREASED,7
CH,CEREBROVASCULAR ACCIDENT,7
CH,CONGENITAL ANOMALY,7
CH,CRANIOCEREBRAL INJURY,7
CH,INSOMNIA,7
CH,MELAENA,7
CH,MYOCLONUS,7
CH,PAIN,7
CH,SUBDURAL HAEMATOMA,7
CH,AKATHISIA,6
CH,BALANCE DISORDER,6
CH,DEPRESSION,6
CH,DRUG INEFFECTIVE,6
CH,ELECTROCARDIOGRAM QT PROLONGED,6
CH,FOETAL GROWTH RESTRICTION,6
CH,HYPERKALAEMIA,6
CH,HYPOGLYCAEMIA NEONATAL,6
CH,INCORRECT DOSE ADMINISTERED,6
CH,LEUKOPENIA,6
CH,LIVER DISORDER,6
CH,NEUTROPENIA,6
CH,PRESCRIBED OVERDOSE,6
CH,PRURITUS,6
CH,RASH MACULO-PAPULAR,6
CH,RESPIRATORY DISTRESS,6
CH,WEIGHT INCREASED,6
CH,ABDOMINAL PAIN UPPER,5
CH,ACUTE HEPATIC FAILURE,5
CH,ANXIETY,5
CH,APHASIA,5
CH,ARTHRALGIA,5
CH,ATRIAL SEPTAL DEFECT,5
CH,BLOOD ALKALINE PHOSPHATASE INCREASED,5
CH,BLOOD PRESSURE DECREASED,5
CH,CATHETER SITE HAEMORRHAGE,5
CH,CHEST PAIN,5
CH,COGNITIVE DISORDER,5
CH,COMA SCALE ABNORMAL,5
CH,DEHYDRATION,5
CH,DEPRESSED LEVEL OF CONSCIOUSNESS,5
CH,DRUG ADMINISTRATION ERROR,5
CH,DYSARTHRIA,5
CH,EPILEPSY,5
CH,GAMMA-GLUTAMYLTRANSFERASE INCREASED,5
CH,GASTROINTESTINAL HAEMORRHAGE,5
CH,HALLUCINATION_ VISUAL,5
CH,HYPERHIDROSIS,5
CH,HYPERTENSION,5
CH,HYPOAESTHESIA,5
CH,HYPOXIA,5
CH,LIVER INJURY,5
CH,MULTIPLE ORGAN DYSFUNCTION SYNDROME,5
CH,MUSCLE HAEMORRHAGE,5
CH,NEONATAL RESPIRATORY DISTRESS SYNDROME,5
CH,PARAESTHESIA,5
CH,RENAL FAILURE CHRONIC,5
CH,RENAL TUBULAR NECROSIS,5
CH,SEIZURE,5
CH,SHOCK,5
CH,SPEECH DISORDER,5
CH,SYNCOPE,5
CH,UNDERDOSE,5
CH,URTICARIA,5
CH,ABNORMAL BEHAVIOUR,4
CH,ACCIDENTAL OVERDOSE,4
CH,ACUTE MYOCARDIAL INFARCTION,4
CH,AGRANULOCYTOSIS,4
CH,ANTIPSYCHOTIC DRUG LEVEL INCREASED,4
CH,CARDIAC ARREST,4
CH,CLOSTRIDIUM DIFFICILE COLITIS,4
CH,CONSTIPATION,4
CH,CYTOGENETIC ABNORMALITY,4
CH,DEATH,4
CH,DECREASED APPETITE,4
CH,DIABETES MELLITUS,4
CH,DISEASE PROGRESSION,4
CH,DRUG PRESCRIBING ERROR,4
CH,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,4
CH,DYSKINESIA,4
CH,ENCEPHALOPATHY,4
CH,ERYTHEMA,4
CH,FACE OEDEMA,4
CH,FEAR,4
CH,FEBRILE NEUTROPENIA,4
CH,HAEMATOMA,4
CH,HAEMORRHAGIC ANAEMIA,4
CH,HALLUCINATIONS_ MIXED,4
CH,HEAD INJURY,4
CH,HUMAN HERPESVIRUS 6 INFECTION,4
CH,HYPOKALAEMIA,4
CH,HYPOTONIA,4
CH,IMMUNOSUPPRESSION,4
CH,INFECTION,4
CH,IRRITABILITY,4
CH,JAUNDICE,4
CH,LACTIC ACIDOSIS,4
CH,LEUKOCYTOSIS,4
CH,MUSCLE CONTRACTIONS INVOLUNTARY,4
CH,MUSCLE RIGIDITY,4
CH,OEDEMA PERIPHERAL,4
CH,PAIN IN EXTREMITY,4
CH,PARKINSONISM,4
CH,RENAL FAILURE ACUTE,4
CH,SEPTIC SHOCK,4
CH,TINNITUS,4
CH,TRANSIENT ISCHAEMIC ATTACK,4
CH,UPPER GASTROINTESTINAL HAEMORRHAGE,4
CH,URINARY RETENTION,4
CH,ABASIA,3
CH,ABORTION,3
CH,ACUTE RESPIRATORY FAILURE,3
CH,ANTIDEPRESSANT DRUG LEVEL INCREASED,3
CH,ANURIA,3
CH,BACK PAIN,3
CH,BASAL GANGLIA HAEMATOMA,3
CH,BLOOD CREATINE PHOSPHOKINASE INCREASED,3
CH,BLOOD CREATININE INCREASED,3
CH,BURNING FEET SYNDROME,3
CH,CARDIAC TAMPONADE,3
CH,CENTRAL NERVOUS SYSTEM LESION,3
CH,CEREBRAL ATROPHY,3
CH,CEREBRAL VENTRICLE DILATATION,3
CH,CONTRAINDICATED PRODUCT ADMINISTERED,3
CH,COUGH,3
CH,DERMATITIS EXFOLIATIVE,3
CH,DISORIENTATION,3
CH,DISSEMINATED INTRAVASCULAR COAGULATION,3
CH,DRUG WITHDRAWAL SYNDROME,3
CH,DRUG WITHDRAWAL SYNDROME NEONATAL,3
CH,DRUG-INDUCED LIVER INJURY,3
CH,GENERALISED TONIC-CLONIC SEIZURE,3
CH,HAEMOGLOBIN DECREASED,3
CH,HAEMORRHAGE INTRACRANIAL,3
CH,HAEMORRHAGIC STROKE,3
CH,HALLUCINATION,3
CH,HEPATIC ENZYME INCREASED,3
CH,HEPATIC FAILURE,3
CH,HEPATITIS,3
CH,HYPERGLYCAEMIA,3
CH,HYPERPHOSPHATAEMIA,3
CH,HYPOGAMMAGLOBULINAEMIA,3
CH,HYPONATRAEMIA,3
CH,HYPOTHYROIDISM,3
CH,ILEUS,3
CH,ILEUS PARALYTIC,3
CH,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,3
CH,INTENTION TREMOR,3
CH,INTERNATIONAL NORMALISED RATIO INCREASED,3
CH,IRON DEFICIENCY ANAEMIA,3
CH,LOSS OF CONSCIOUSNESS,3
CH,LYMPHOPENIA,3
CH,MEMORY IMPAIRMENT,3
CH,MOTOR DYSFUNCTION,3
CH,MULTIPLE SCLEROSIS RELAPSE,3
CH,MYALGIA,3
CH,MYELODYSPLASTIC SYNDROME,3
CH,NEONATAL BEHAVIOURAL SYNDROME,3
CH,NORMAL NEWBORN,3
CH,OEDEMA,3
CH,OXYGEN SATURATION DECREASED,3
CH,PARALYSIS,3
CH,PERICARDIAL HAEMORRHAGE,3
CH,PERICARDITIS,3
CH,PERIPHERAL SWELLING,3
CH,PETECHIAE,3
CH,PNEUMONITIS,3
CH,PRESYNCOPE,3
CH,PSEUDOLYMPHOMA,3
CH,PSYCHOMOTOR HYPERACTIVITY,3
CH,REBOUND EFFECT,3
CH,RESPIRATORY DEPRESSION,3
CH,SEDATION,3
CH,SEROTONIN SYNDROME,3
CH,SINUS BRADYCARDIA,3
CH,SUICIDAL IDEATION,3
CH,VENTRICULAR SEPTAL DEFECT,3
CH,VENTRICULAR TACHYCARDIA,3
CH,VISION BLURRED,3
CH,WEIGHT DECREASED,3
CH,ABSCESS,2
CH,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,2
CH,ACUTE PRERENAL FAILURE,2
CH,ACUTE RESPIRATORY DISTRESS SYNDROME,2
CH,ANAL INCONTINENCE,2
CH,ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC,2
CH,APPLICATION SITE HAEMORRHAGE,2
CH,ATRIOVENTRICULAR BLOCK COMPLETE,2
CH,BLOOD FOLATE DECREASED,2
CH,BLOOD LACTATE DEHYDROGENASE INCREASED,2
CH,BONE DENSITY DECREASED,2
CH,CARDIAC FAILURE ACUTE,2
CH,CEREBELLAR HAEMORRHAGE,2
CH,CEREBELLAR SYNDROME,2
CH,CEREBRAL ISCHAEMIA,2
CH,CHEST DISCOMFORT,2
CH,CHILLS,2
CH,CHOLESTASIS,2
CH,CHRONIC KIDNEY DISEASE,2
CH,CIRCULATORY COLLAPSE,2
CH,COELIAC DISEASE,2
CH,COMMUNICATION DISORDER,2
CH,CREATININE RENAL CLEARANCE DECREASED,2
CH,DELUSION,2
CH,DELUSIONAL DISORDER_ PERSECUTORY TYPE,2
CH,DEVICE ISSUE,2
CH,DISEASE RECURRENCE,2
CH,DRUG DEPENDENCE,2
CH,DRUG EFFECT INCREASED,2
CH,DRUG ERUPTION,2
CH,DRUG LEVEL DECREASED,2
CH,DRY MOUTH,2
CH,DYSMORPHISM,2
CH,DYSPHONIA,2
CH,DYSSTASIA,2
CH,ECZEMA,2
CH,EMPHYSEMA,2
CH,EOSINOPHILIA,2
CH,EPISTAXIS,2
CH,EXTRASYSTOLES,2
CH,EYELID OEDEMA,2
CH,FEELING HOT,2
CH,FLUSHING,2
CH,FOETAL DEATH,2
CH,GASTROENTERITIS,2
CH,GENERALISED OEDEMA,2
CH,HAEMOLYTIC URAEMIC SYNDROME,2
CH,HAEMOPTYSIS,2
CH,HEPATITIS C,2
CH,HEPATOSPLENOMEGALY,2
CH,HERPES SIMPLEX,2
CH,HYPERBILIRUBINAEMIA NEONATAL,2
CH,HYPERCAPNIA,2
CH,HYPERREFLEXIA,2
CH,HYPERSENSITIVITY VASCULITIS,2
CH,HYPERSOMNIA,2
CH,HYPERTHYROIDISM,2
CH,HYPOACUSIS,2
CH,HYPOCHROMIC ANAEMIA,2
CH,INFECTION IN AN IMMUNOCOMPROMISED HOST,2
CH,INFLAMMATION,2
CH,INFLUENZA LIKE ILLNESS,2
CH,LARGE INTESTINE POLYP,2
CH,LARYNGEAL OEDEMA,2
CH,LIBIDO DECREASED,2
CH,LOCALISED OEDEMA,2
CH,LOWER GASTROINTESTINAL HAEMORRHAGE,2
CH,LUMBAR VERTEBRAL FRACTURE,2
CH,LUNG INFILTRATION,2
CH,LUPUS-LIKE SYNDROME,2
CH,LYMPHADENOPATHY,2
CH,LYMPHOCYTOSIS,2
CH,MALIGNANT NEOPLASM PROGRESSION,2
CH,MAMMARY DUCT ECTASIA,2
CH,MATERNAL DRUGS AFFECTING FOETUS,2
CH,MEDICATION ERROR,2
CH,MENINGOCOCCAL BACTERAEMIA,2
CH,MENTAL IMPAIRMENT,2
CH,MIXED LIVER INJURY,2
CH,MUCOSAL HAEMORRHAGE,2
CH,MULTI-ORGAN FAILURE,2
CH,MUSCLE SPASMS,2
CH,MUSCLE SPASTICITY,2
CH,MUSCLE TWITCHING,2
CH,MUSCULOSKELETAL CHEST PAIN,2
CH,MUSCULOSKELETAL PAIN,2
CH,MYOPATHY,2
CH,NASOPHARYNGITIS,2
CH,NECK PAIN,2
CH,NERVOUSNESS,2
CH,NEUTROPHIL COUNT DECREASED,2
CH,NEUTROPHILIA,2
CH,NOCTURIA,2
CH,NORMOCHROMIC NORMOCYTIC ANAEMIA,2
CH,OBESITY,2
CH,OSTEONECROSIS OF JAW,2
CH,OSTEOPOROSIS,2
CH,PALPITATIONS,2
CH,PANCREATITIS,2
CH,PANCREATITIS ACUTE,2
CH,PARAPARESIS,2
CH,PATHOLOGICAL FRACTURE,2
CH,PERIPROSTHETIC FRACTURE,2
CH,PERSONALITY CHANGE,2
CH,PHARYNGEAL OEDEMA,2
CH,PNEUMONIA BACTERIAL,2
CH,POTENTIATING DRUG INTERACTION,2
CH,PREMATURE BABY,2
CH,PROTHROMBIN TIME PROLONGED,2
CH,PRURITUS GENERALISED,2
CH,PSYCHOTIC DISORDER,2
CH,PULMONARY OEDEMA,2
CH,PURPURA FULMINANS,2
CH,RESPIRATORY ARREST,2
CH,RESPIRATORY DISORDER,2
CH,RETINOPATHY,2
CH,SALIVARY HYPERSECRETION,2
CH,SENSORY DISTURBANCE,2
CH,SINUS TACHYCARDIA,2
CH,SKIN LESION,2
CH,SKIN NECROSIS,2
CH,SLEEP APNOEA SYNDROME,2
CH,SPINAL FRACTURE,2
CH,SPINAL OSTEOARTHRITIS,2
CH,SPINAL PAIN,2
CH,SQUAMOUS CELL CARCINOMA OF SKIN,2
CH,STATUS EPILEPTICUS,2
CH,STOMATITIS,2
CH,STRESS CARDIOMYOPATHY,2
CH,STUPOR,2
CH,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,2
CH,TACHYPNOEA,2
CH,THINKING ABNORMAL,2
CH,THORACIC VERTEBRAL FRACTURE,2
CH,THROMBOCYTOSIS,2
CH,THYROIDITIS SUBACUTE,2
CH,TOOTH INJURY,2
CH,TRANSAMINASES INCREASED,2
CH,URINARY INCONTINENCE,2
CH,WHITE MATTER LESION,2
CH,ABDOMINAL DISCOMFORT,1
CH,ABDOMINAL DISTENSION,1
CH,ABNORMAL DREAMS,1
CH,ABORTION MISSED,1
CH,ACCIDENTAL EXPOSURE TO PRODUCT,1
CH,ACUTE PSYCHOSIS,1
CH,ACUTE PULMONARY OEDEMA,1
CH,ADVERSE EVENT,1
CH,AKINESIA,1
CH,ALCOHOL PROBLEM,1
CH,AMNESIA,1
CH,ANAEMIA OF PREGNANCY,1
CH,ANAPHYLACTOID REACTION,1
CH,ANEURYSM,1
CH,ANGINA PECTORIS,1
CH,ANGIODYSPLASIA,1
CH,ANGIOEDEMA,1
CH,ANGLE CLOSURE GLAUCOMA,1
CH,ANTEROGRADE AMNESIA,1
CH,ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC,1
CH,AORTA HYPOPLASIA,1
CH,AORTIC ANEURYSM,1
CH,AORTIC DISSECTION,1
CH,AORTIC INTRAMURAL HAEMATOMA,1
CH,APHTHOUS ULCER,1
CH,ARACHNODACTYLY,1
CH,ARACHNOID CYST,1
CH,ARTERIAL HAEMORRHAGE,1
CH,ATELECTASIS,1
CH,ATRIAL FLUTTER,1
CH,ATRIOVENTRICULAR BLOCK FIRST DEGREE,1
CH,AUTOIMMUNE HAEMOLYTIC ANAEMIA,1
CH,AUTOIMMUNE NEUROPATHY,1
CH,AUTONOMIC NERVOUS SYSTEM IMBALANCE,1
CH,AUTOSOMAL CHROMOSOME ANOMALY,1
CH,AVULSION FRACTURE,1
CH,AZOTAEMIA,1
CH,BACTERIAL INFECTION,1
CH,BASAL GANGLIA HAEMORRHAGE,1
CH,BEDRIDDEN,1
CH,BICYTOPENIA,1
CH,BLOOD CALCIUM DECREASED,1
CH,BLOOD GLUCOSE DECREASED,1
CH,BLOOD GLUCOSE FLUCTUATION,1
CH,BLOOD GLUCOSE INCREASED,1
CH,BLOOD IMMUNOGLOBULIN M INCREASED,1
CH,BLOOD PRESSURE INCREASED,1
CH,BLOOD PRESSURE SYSTOLIC INCREASED,1
CH,BLOOD URIC ACID INCREASED,1
CH,BONE MARROW FAILURE,1
CH,BONE MARROW INFILTRATION,1
CH,BRADYPHRENIA,1
CH,BRAIN COMPRESSION,1
CH,BREAST CANCER,1
CH,BREAST DISCHARGE,1
CH,BRONCHIAL OBSTRUCTION,1
CH,BRONCHOSPASM,1
CH,BUTTOCK INJURY,1
CH,CACHEXIA,1
CH,CALCINOSIS,1
CH,CANDIDA INFECTION,1
CH,CARDIAC ANEURYSM,1
CH,CARDIAC DISORDER,1
CH,CARDIAC VALVE DISEASE,1
CH,CARDIOGENIC SHOCK,1
CH,CARDIOMEGALY,1
CH,CARDIORENAL SYNDROME,1
CH,CARDIOVASCULAR INSUFFICIENCY,1
CH,CAROTID ARTERY ANEURYSM,1
CH,CEREBELLAR HYPOPLASIA,1
CH,CEREBELLAR ISCHAEMIA,1
CH,CEREBRAL MICROHAEMORRHAGE,1
CH,CEREBRAL VASOCONSTRICTION,1
CH,CEREBRAL VENTRICULAR RUPTURE,1
CH,CEREBROVASCULAR STENOSIS,1
CH,CHOKING,1
CH,CHOLECYSTITIS ACUTE,1
CH,CHOLESTATIC LIVER INJURY,1
CH,CHROMATURIA,1
CH,CHRONIC GASTRITIS,1
CH,CHRONIC HEPATITIS C,1
CH,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
CH,CLAVICLE FRACTURE,1
CH,CLEAR CELL RENAL CELL CARCINOMA,1
CH,CLINODACTYLY,1
CH,CLOSTRIDIUM COLITIS,1
CH,COARCTATION OF THE AORTA,1
CH,COLITIS ISCHAEMIC,1
CH,COMPLEX REGIONAL PAIN SYNDROME,1
CH,COMPUTERISED TOMOGRAM THORAX ABNORMAL,1
CH,CONCOMITANT DISEASE AGGRAVATED,1
CH,CONGENITAL ANOMALY IN OFFSPRING,1
CH,CONGENITAL CARDIOVASCULAR ANOMALY,1
CH,CONGENITAL MUSCULOSKELETAL ANOMALY,1
CH,CONGESTIVE CARDIOMYOPATHY,1
CH,CONJUNCTIVITIS,1
CH,CORONARY ARTERY DISEASE,1
CH,CORYNEBACTERIUM INFECTION,1
CH,CRANIECTOMY,1
CH,CREATININE RENAL CLEARANCE ABNORMAL,1
CH,CRYPTORCHISM,1
CH,CYSTITIS BACTERIAL,1
CH,CYTOPENIA,1
CH,DEAFNESS UNILATERAL,1
CH,DEMENTIA ALZHEIMER^S TYPE,1
CH,DEMYELINATION,1
CH,DEPENDENCE,1
CH,DEPERSONALISATION,1
CH,DERMATITIS,1
CH,DERMATITIS ALLERGIC,1
CH,DERMATITIS BULLOUS,1
CH,DEVICE CONNECTION ISSUE,1
CH,DEVICE DAMAGE,1
CH,DEVICE DISLOCATION,1
CH,DEXTROCARDIA,1
CH,DIARRHOEA HAEMORRHAGIC,1
CH,DIEULAFOY^S VASCULAR MALFORMATION,1
CH,DIFFUSE LARGE B-CELL LYMPHOMA,1
CH,DIPLEGIA,1
CH,DIPLOPIA,1
CH,DISABILITY,1
CH,DIVERTICULITIS,1
CH,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
CH,DRUG DISPENSING ERROR,1
CH,DRUG EFFECT INCOMPLETE,1
CH,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
CH,DRUG INTOLERANCE,1
CH,DRUG LEVEL ABOVE THERAPEUTIC,1
CH,DRY SKIN,1
CH,DUODENITIS,1
CH,DYSGEUSIA,1
CH,DYSLIPIDAEMIA,1
CH,DYSPNOEA EXERTIONAL,1
CH,EAR DISCOMFORT,1
CH,EAR PAIN,1
CH,ECZEMA INFECTED,1
CH,ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY,1
CH,ELECTROENCEPHALOGRAM ABNORMAL,1
CH,EMBOLISM,1
CH,ENTERITIS,1
CH,EOSINOPHILIC PNEUMONIA,1
CH,ERYTHROMELALGIA,1
CH,ESCHERICHIA BACTERAEMIA,1
CH,ESCHERICHIA INFECTION,1
CH,ESCHERICHIA URINARY TRACT INFECTION,1
CH,ESSENTIAL TREMOR,1
CH,EUPHORIC MOOD,1
CH,EUTHYROID SICK SYNDROME,1
CH,EXERCISE TOLERANCE DECREASED,1
CH,EXPIRED DRUG ADMINISTERED,1
CH,EXPOSURE DURING BREAST FEEDING,1
CH,EXTENSOR PLANTAR RESPONSE,1
CH,EXTRADURAL ABSCESS,1
CH,EXTRAPYRAMIDAL DISORDER,1
CH,EYE DISCHARGE,1
CH,EYE MOVEMENT DISORDER,1
CH,EYE SWELLING,1
CH,FACTITIOUS DISORDER,1
CH,FAECALOMA,1
CH,FEAR OF DISEASE,1
CH,FEELING ABNORMAL,1
CH,FEELING DRUNK,1
CH,FEMORAL NECK FRACTURE,1
CH,FEMUR FRACTURE,1
CH,FOETAL HEART RATE ABNORMAL,1
CH,FOETAL MONITORING ABNORMAL,1
CH,FRACTURED SACRUM,1
CH,FUNGAL SKIN INFECTION,1
CH,GASTRIC PERFORATION,1
CH,GASTRIC ULCER,1
CH,GASTRODUODENAL ULCER,1
CH,GASTROENTERITIS VIRAL,1
CH,GASTROINTESTINAL TRACT MUCOSAL PIGMENTATION,1
CH,GASTROOESOPHAGEAL REFLUX DISEASE,1
CH,GENOTYPE DRUG RESISTANCE TEST POSITIVE,1
CH,GESTATIONAL DIABETES,1
CH,GINGIVAL BLEEDING,1
CH,GOUTY ARTHRITIS,1
CH,GRANULOCYTOSIS,1
CH,GRIMACING,1
CH,GUILLAIN-BARRE SYNDROME,1
CH,GYNAECOMASTIA,1
CH,HAEMANGIOMA,1
CH,HAEMANGIOMA OF LIVER,1
CH,HAEMATOCHEZIA,1
CH,HAEMOCHROMATOSIS,1
CH,HAEMOLYTIC ANAEMIA,1
CH,HAEMORRHAGE,1
CH,HEARING IMPAIRED,1
CH,HEART DISEASE CONGENITAL,1
CH,HEMIANOPIA,1
CH,HEMIPARESIS,1
CH,HEPATIC ATROPHY,1
CH,HEPATIC ENZYME ABNORMAL,1
CH,HEPATIC NEOPLASM,1
CH,HEPATIC PAIN,1
CH,HEPATIC STEATOSIS,1
CH,HEPATITIS A,1
CH,HEPATITIS ACUTE,1
CH,HEPATITIS E,1
CH,HEPATOCELLULAR CARCINOMA,1
CH,HIP FRACTURE,1
CH,HISTONE ANTIBODY POSITIVE,1
CH,HUMERUS FRACTURE,1
CH,HYDRANENCEPHALY,1
CH,HYDROCEPHALUS,1
CH,HYDRONEPHROSIS,1
CH,HYPERAMMONAEMIA,1
CH,HYPERKERATOSIS,1
CH,HYPEROSMOLAR HYPERGLYCAEMIC STATE,1
CH,HYPERTENSIVE CRISIS,1
CH,HYPERTENSIVE HEART DISEASE,1
CH,HYPERTRANSAMINASAEMIA,1
CH,HYPOAESTHESIA ORAL,1
CH,HYPOALBUMINAEMIA,1
CH,HYPOCALCAEMIA,1
CH,HYPOPHOSPHATAEMIA,1
CH,HYPOREFLEXIA,1
CH,HYPORESPONSIVE TO STIMULI,1
CH,HYPOTONIA NEONATAL,1
CH,ILLUSION,1
CH,IMMUNOLOGY TEST ABNORMAL,1
CH,IMMUNOSUPPRESSANT DRUG LEVEL DECREASED,1
CH,IMPAIRED DRIVING ABILITY,1
CH,IMPAIRED HEALING,1
CH,IMPAIRED WORK ABILITY,1
CH,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
CH,INCOHERENT,1
CH,INCORRECT DRUG DOSAGE FORM ADMINISTERED,1
CH,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
CH,INFARCTION,1
CH,INFUSION RELATED REACTION,1
CH,INFUSION SITE DISCOLOURATION,1
CH,INFUSION SITE ERYTHEMA,1
CH,INFUSION SITE EXTRAVASATION,1
CH,INFUSION SITE INDURATION,1
CH,INJECTION SITE HAEMATOMA,1
CH,INJECTION SITE IRRITATION,1
CH,INTENTIONAL PRODUCT MISUSE,1
CH,INTERSPINOUS OSTEOARTHRITIS,1
CH,INTERSTITIAL LUNG DISEASE,1
CH,INTESTINAL OBSTRUCTION,1
CH,INTESTINAL PERFORATION,1
CH,INTRAVENTRICULAR HAEMORRHAGE,1
CH,ISCHAEMIC STROKE,1
CH,JOINT DISLOCATION,1
CH,LABORATORY TEST ABNORMAL,1
CH,LACERATION,1
CH,LACRIMATION INCREASED,1
CH,LANGUAGE DISORDER,1
CH,LATE METABOLIC ACIDOSIS OF NEWBORN,1
CH,LEFT-TO-RIGHT CARDIAC SHUNT,1
CH,LETHARGY,1
CH,LICHEN PLANUS,1
CH,LIGAMENT SPRAIN,1
CH,LIMB INJURY,1
CH,LIP DISORDER,1
CH,LIP OEDEMA,1
CH,LIP SWELLING,1
CH,LIPASE INCREASED,1
CH,LIPODYSTROPHY ACQUIRED,1
CH,LIPOMATOSIS,1
CH,LIVE BIRTH,1
CH,LIVEDO RETICULARIS,1
CH,LIVER FUNCTION TEST ABNORMAL,1
CH,LIVER FUNCTION TEST INCREASED,1
CH,LOCAL SWELLING,1
CH,LOCALISED INFECTION,1
CH,LONG QT SYNDROME,1
CH,LOSS OF PROPRIOCEPTION,1
CH,LUMBAR SPINAL STENOSIS,1
CH,LUNG ADENOCARCINOMA STAGE IV,1
CH,LUNG CANCER METASTATIC,1
CH,LUNG INFECTION,1
CH,LYMPHOCYTE COUNT DECREASED,1
CH,MENISCUS INJURY,1
CH,METABOLIC DISORDER,1
CH,METAMORPHOPSIA,1
CH,METASTASES TO ADRENALS,1
CH,METASTASES TO BONE,1
CH,METASTASES TO CENTRAL NERVOUS SYSTEM,1
CH,METASTASES TO LIVER,1
CH,METASTASES TO LUNG,1
CH,METASTASES TO SPINE,1
CH,MICTURITION FREQUENCY DECREASED,1
CH,MIDDLE INSOMNIA,1
CH,MIGRAINE WITHOUT AURA,1
CH,MITOCHONDRIAL ENCEPHALOMYOPATHY,1
CH,MOBILITY DECREASED,1
CH,MONARTHRITIS,1
CH,MONONEUROPATHY,1
CH,MONOPLEGIA,1
CH,MOUTH HAEMORRHAGE,1
CH,MUCOSAL INFLAMMATION,1
CH,MULTIPLE SCLEROSIS,1
CH,MUSCLE ABSCESS,1
CH,MUSCLE ATROPHY,1
CH,MUSCLE DISORDER,1
CH,MUSCULOSKELETAL STIFFNESS,1
CH,MYDRIASIS,1
CH,MYELOMALACIA,1
CH,MYELOPROLIFERATIVE DISORDER,1
CH,MYOCARDIAL ISCHAEMIA,1
CH,NASOPHARYNGEAL CANCER,1
CH,NECROTISING FASCIITIS,1
CH,NEOPLASM PROGRESSION,1
CH,NEPHROLITHIASIS,1
CH,NEURITIS,1
CH,NEUROPATHY PERIPHERAL,1
CH,NEUROTOXICITY,1
CH,NEUTROPENIC COLITIS,1
CH,NEUTROPHIL COUNT INCREASED,1
CH,NUCHAL RIGIDITY,1
CH,NYSTAGMUS,1
CH,OCCIPITAL NEURALGIA,1
CH,OESOPHAGEAL ULCER HAEMORRHAGE,1
CH,OPHTHALMIC HERPES ZOSTER,1
CH,OPTIC ISCHAEMIC NEUROPATHY,1
CH,OPTIC NEURITIS,1
CH,ORAL HERPES,1
CH,ORAL MUCOSAL ERUPTION,1
CH,ORAL MUCOSAL ERYTHEMA,1
CH,OSTEOCHONDROSIS,1
CH,OSTEOPENIA,1
CH,PANCREATIC ENZYMES INCREASED,1
CH,PANCREATITIS NECROTISING,1
CH,PANIC ATTACK,1
CH,PARKINSONIAN CRISIS,1
CH,PARKINSON^S DISEASE,1
CH,PAROTID GLAND ENLARGEMENT,1
CH,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,1
CH,PATENT DUCTUS ARTERIOSUS,1
CH,PCO2 DECREASED,1
CH,PERICARDIAL EFFUSION,1
CH,PERIPHERAL VASCULAR DISORDER,1
CH,PERITONITIS,1
CH,PERITONITIS BACTERIAL,1
CH,PHLEBITIS,1
CH,PHOTOSENSITIVITY REACTION,1
CH,PHYSICAL DISABILITY,1
CH,PIGMENTATION DISORDER,1
CH,PLASMA CELL MYELOMA,1
CH,PLATELET COUNT DECREASED,1
CH,PLATELET COUNT INCREASED,1
CH,PLEURAL EFFUSION,1
CH,PNEUMATOSIS INTESTINALIS,1
CH,PNEUMONIA FUNGAL,1
CH,PNEUMONIA PNEUMOCOCCAL,1
CH,PNEUMONIA VIRAL,1
CH,PNEUMOTHORAX,1
CH,POISONING,1
CH,PORTAL VENOUS GAS,1
CH,POST-TRAUMATIC STRESS DISORDER,1
CH,PRE-ECLAMPSIA,1
CH,PREMATURE SEPARATION OF PLACENTA,1
CH,PRESCRIBED UNDERDOSE,1
CH,PROCEDURAL PNEUMOTHORAX,1
CH,PRODUCT APPEARANCE CONFUSION,1
CH,PRODUCT NAME CONFUSION,1
CH,PRODUCTIVE COUGH,1
CH,PROSTATE CANCER METASTATIC,1
CH,PROTHROMBIN LEVEL INCREASED,1
CH,PSEUDARTHROSIS,1
CH,PSEUDOMONAS INFECTION,1
CH,PSORIASIS,1
CH,PULMONARY ARTERIAL HYPERTENSION,1
CH,PULMONARY EMBOLISM,1
CH,PULMONARY SEPSIS,1
CH,PULSELESS ELECTRICAL ACTIVITY,1
CH,PUNCTATE KERATITIS,1
CH,PUPILS UNEQUAL,1
CH,PURULENT DISCHARGE,1
CH,PYELONEPHRITIS,1
CH,RADICULAR PAIN,1
CH,RADICULITIS,1
CH,RASH MACULAR,1
CH,RASH PUSTULAR,1
CH,REACTIVE PERFORATING COLLAGENOSIS,1
CH,READING DISORDER,1
CH,RED MAN SYNDROME,1
CH,REFLEXES ABNORMAL,1
CH,RELAPSING-REMITTING MULTIPLE SCLEROSIS,1
CH,RENAL ATROPHY,1
CH,RENAL DISORDER,1
CH,RENAL FAILURE NEONATAL,1
CH,RESPIRATORY ACIDOSIS,1
CH,RESPIRATORY TRACT INFECTION,1
CH,RETINAL DETACHMENT,1
CH,RHABDOMYOLYSIS,1
CH,RIB DEFORMITY,1
CH,RIGHT VENTRICULAR FAILURE,1
CH,SCAR,1
CH,SCROTAL HAEMATOMA,1
CH,SECOND PRIMARY MALIGNANCY,1
CH,SELF INJURIOUS BEHAVIOUR,1
CH,SENSATION OF HEAVINESS,1
CH,SENSORIMOTOR DISORDER,1
CH,SHOULDER OPERATION,1
CH,SKIN INFECTION,1
CH,SLEEP DISORDER,1
CH,SOCIAL PROBLEM,1
CH,SOPOR,1
CH,SPINAL COLUMN INJURY,1
CH,SPINAL CORD ABSCESS,1
CH,SPINAL CORD ISCHAEMIA,1
CH,SPONDYLOLYSIS,1
CH,SPONTANEOUS HAEMATOMA,1
CH,SQUAMOUS CELL CARCINOMA,1
CH,STAPHYLOCOCCUS TEST POSITIVE,1
CH,STEVENS-JOHNSON SYNDROME,1
CH,STOMA SITE DISCHARGE,1
CH,STOMA SITE INFECTION,1
CH,STOMA SITE INFLAMMATION,1
CH,STREPTOCOCCAL INFECTION,1
CH,SUBACUTE HEPATIC FAILURE,1
CH,SUBCUTANEOUS EMPHYSEMA,1
CH,SUBILEUS,1
CH,SUBSTANCE DEPENDENCE,1
CH,SUDDEN DEATH,1
CH,SWELLING,1
CH,SWOLLEN TONGUE,1
CH,SYNOVIAL CYST,1
CH,SYSTEMIC LUPUS ERYTHEMATOSUS RASH,1
CH,TACHYARRHYTHMIA,1
CH,THERMAL BURN,1
CH,THROMBIN TIME PROLONGED,1
CH,THROMBOTIC MICROANGIOPATHY,1
CH,THYMUS ENLARGEMENT,1
CH,TOBACCO ABUSE,1
CH,TOE AMPUTATION,1
CH,TONIC CLONIC MOVEMENTS,1
CH,TONIC CONVULSION,1
CH,TORSADE DE POINTES,1
CH,TOXIC ENCEPHALOPATHY,1
CH,TOXIC EPIDERMAL NECROLYSIS,1
CH,TOXIC SKIN ERUPTION,1
CH,TRACHEOBRONCHITIS,1
CH,TRANSITIONAL CELL CARCINOMA,1
CH,TRIGEMINAL NEURALGIA,1
CH,TRISOMY 21,1
CH,TUNNEL VISION,1
CH,TYPE 2 DIABETES MELLITUS,1
CH,TYPE I HYPERSENSITIVITY,1
CH,TYPE III IMMUNE COMPLEX MEDIATED REACTION,1
CH,ULCER,1
CH,ULTRASOUND DOPPLER ABNORMAL,1
CH,UMBILICAL HERNIA,1
CH,UPPER MOTOR NEURONE LESION,1
CH,URETEROLITHIASIS,1
CH,URINARY TRACT INFECTION ENTEROCOCCAL,1
CH,UROSEPSIS,1
CH,VAGINAL EROSION,1
CH,VAGINAL HAEMORRHAGE,1
CH,VEIN DISORDER,1
CH,VENOUS THROMBOSIS,1
CH,VENTRICULAR DRAINAGE,1
CH,VENTRICULAR EXTRASYSTOLES,1
CH,VENTRICULAR HYPOKINESIA,1
CH,VESTIBULAR NEURONITIS,1
CH,VISUAL ACUITY REDUCED,1
CH,VOLVULUS,1
CH,VOMITING PROJECTILE,1
CH,WOUND INFECTION,1
CH,WOUND INFECTION PSEUDOMONAS,1
CH,XEROSIS,1
TW,ALTERED STATE OF CONSCIOUSNESS,3
TW,PNEUMONIA,3
TW,ABDOMINAL PAIN,2
TW,ARTHRALGIA,2
TW,CONSTIPATION,2
TW,DUPUYTREN^S CONTRACTURE,2
TW,DYSPNOEA,2
TW,FINGER DEFORMITY,2
TW,HAEMORRHAGE,2
TW,JOINT SWELLING,2
TW,MALAISE,2
TW,OSTEONECROSIS OF JAW,2
TW,PYREXIA,2
TW,THROMBOCYTOPENIA,2
TW,TOOTHACHE,2
TW,ACUTE RESPIRATORY FAILURE,1
TW,AGGRESSION,1
TW,AGITATION,1
TW,ALOPECIA,1
TW,BACK PAIN,1
TW,BALANCE DISORDER,1
TW,BANDAEMIA,1
TW,BLOOD CREATININE INCREASED,1
TW,BLOOD SODIUM DECREASED,1
TW,CARDIAC FAILURE,1
TW,CATHETER PLACEMENT,1
TW,CELLULITIS,1
TW,CEREBROVASCULAR ACCIDENT,1
TW,CONDITION AGGRAVATED,1
TW,CORNEAL EROSION,1
TW,DEATH,1
TW,DELIRIUM,1
TW,DIZZINESS,1
TW,DRUG INEFFECTIVE,1
TW,DRUG LEVEL INCREASED,1
TW,DRY MOUTH,1
TW,DRY SKIN,1
TW,DYSKINESIA,1
TW,EYELID INJURY,1
TW,FALL,1
TW,FEBRILE NEUTROPENIA,1
TW,GASTRIC HAEMORRHAGE,1
TW,GINGIVAL INFLAMMATION,1
TW,GLOMERULAR FILTRATION RATE DECREASED,1
TW,HAEMORRHAGIC STROKE,1
TW,HAEMORRHOIDAL HAEMORRHAGE,1
TW,HALLUCINATION,1
TW,HERPES OPHTHALMIC,1
TW,HYPOGLYCAEMIA,1
TW,HYPOTENSION,1
TW,HYPOVOLAEMIC SHOCK,1
TW,IMPAIRED HEALING,1
TW,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
TW,INTENTIONAL PRODUCT MISUSE,1
TW,INTENTIONAL PRODUCT USE ISSUE,1
TW,INTERMITTENT CLAUDICATION,1
TW,INTERSTITIAL LUNG DISEASE,1
TW,LETHARGY,1
TW,LOSS OF CONSCIOUSNESS,1
TW,MEMORY IMPAIRMENT,1
TW,MENOPAUSE,1
TW,METABOLIC ACIDOSIS,1
TW,MUSCLE ABSCESS,1
TW,MUSCULOSKELETAL STIFFNESS,1
TW,MYOCARDIAL ISCHAEMIA,1
TW,NEPHROLITHIASIS,1
TW,NEUTROPENIA,1
TW,OEDEMA,1
TW,OSTEOPOROSIS,1
TW,PHARYNGEAL OEDEMA,1
TW,PRODUCTIVE COUGH,1
TW,RASH PRURITIC,1
TW,RESPIRATORY FAILURE,1
TW,RHEUMATOID ARTHRITIS,1
TW,SEIZURE,1
TW,SEPTIC SHOCK,1
TW,SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION,1
TW,SOMNOLENCE,1
TW,SPINAL COLUMN INJURY,1
TW,STOMATITIS,1
TW,SUBCUTANEOUS ABSCESS,1
TW,TOXICITY TO VARIOUS AGENTS,1
TW,TREMOR,1
TW,TUBERCULIN TEST POSITIVE,1
TW,UPPER GASTROINTESTINAL HAEMORRHAGE,1
TW,URINARY TRACT INFECTION,1
TW,VAGINAL DISCHARGE,1
TW,VISION BLURRED,1
TH,ACUTE KIDNEY INJURY,1
TH,BRAIN DEATH,1
TH,CARDIAC ARREST,1
TH,DECREASED APPETITE,1
TH,DEPRESSION,1
TH,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
TH,EPISTAXIS,1
TH,HYPOGLYCAEMIA,1
TH,HYPONATRAEMIA,1
TH,MALIGNANT NEOPLASM PROGRESSION,1
TH,PLASMA CELL MYELOMA,1
TH,POOR PERIPHERAL CIRCULATION,1
TH,RETINAL VEIN OCCLUSION,1
TH,SECONDARY ADRENOCORTICAL INSUFFICIENCY,1
TH,SECONDARY HYPOGONADISM,1
TH,SHOCK,1
TH,STRESS,1
TH,SUICIDE ATTEMPT,1
TH,TOXIC EPIDERMAL NECROLYSIS,1
TH,URETERIC STENOSIS,1
TH,URINARY TRACT INFECTION PSEUDOMONAL,1
TH,VOMITING,1
TH,WEIGHT DECREASED,1
TT,ANAPHYLACTIC REACTION,1
TT,BLISTER,1
TT,GASTRITIS,1
TT,HEPATITIS,1
TT,PANCREATITIS,1
TT,PRE-EXISTING CONDITION IMPROVED,1
TT,THERAPEUTIC RESPONSE UNEXPECTED,1
TT,URTICARIA,1
TN,ABASIA,1
TN,BALANCE DISORDER,1
TN,COMA,1
TN,DELIRIUM,1
TN,DYSARTHRIA,1
TN,ENURESIS,1
TN,EXTRA DOSE ADMINISTERED,1
TN,GENERALISED OEDEMA,1
TN,HEMIPARESIS,1
TN,HYPONATRAEMIA,1
TN,ISCHAEMIC STROKE,1
TN,LANGUAGE DISORDER,1
TN,MOTOR DYSFUNCTION,1
TN,NERVOUS SYSTEM DISORDER,1
TN,PYREXIA,1
TR,DIZZINESS,9
TR,DRUG ABUSE,9
TR,SOMNOLENCE,8
TR,FATIGUE,7
TR,DRUG DEPENDENCE,6
TR,OVERDOSE,6
TR,PNEUMONIA,6
TR,FALL,5
TR,HEADACHE,5
TR,HYPERTENSION,5
TR,INTENTIONAL OVERDOSE,5
TR,AGGRESSION,4
TR,DRUG USE DISORDER,4
TR,DYSPNOEA,4
TR,EUPHORIC MOOD,4
TR,HYPERHIDROSIS,4
TR,HYPERSENSITIVITY VASCULITIS,4
TR,LOSS OF CONSCIOUSNESS,4
TR,NAUSEA,4
TR,PAIN,4
TR,SEIZURE,4
TR,SUICIDE ATTEMPT,4
TR,SYNCOPE,4
TR,TREMOR,4
TR,VISION BLURRED,4
TR,VOMITING,4
TR,WEIGHT INCREASED,4
TR,WITHDRAWAL SYNDROME,4
TR,ANXIETY,3
TR,BACK PAIN,3
TR,BLINDNESS,3
TR,BURNING SENSATION,3
TR,DRUG WITHDRAWAL SYNDROME,3
TR,DYSKINESIA,3
TR,HALLUCINATION,3
TR,HYPERAESTHESIA,3
TR,INSOMNIA,3
TR,PALPITATIONS,3
TR,STATUS EPILEPTICUS,3
TR,SUICIDAL IDEATION,3
TR,TOXICITY TO VARIOUS AGENTS,3
TR,ABDOMINAL DISTENSION,2
TR,ABDOMINAL PAIN,2
TR,ABDOMINAL PAIN UPPER,2
TR,AFFECTIVE DISORDER,2
TR,ALANINE AMINOTRANSFERASE INCREASED,2
TR,ARTHRALGIA,2
TR,ASPARTATE AMINOTRANSFERASE INCREASED,2
TR,ATRIOVENTRICULAR BLOCK COMPLETE,2
TR,BONE PAIN,2
TR,C-REACTIVE PROTEIN INCREASED,2
TR,CARDIAC DISORDER,2
TR,CHEST PAIN,2
TR,CLEFT PALATE,2
TR,DECREASED APPETITE,2
TR,DIABETES MELLITUS,2
TR,DIPLOPIA,2
TR,DRUG INEFFECTIVE,2
TR,DRUG TOLERANCE,2
TR,EAR DISORDER,2
TR,FEELING ABNORMAL,2
TR,GAIT DISTURBANCE,2
TR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
TR,GLAUCOMA,2
TR,MATERNAL EXPOSURE DURING PREGNANCY,2
TR,MENTAL DISABILITY,2
TR,MUSCLE CONTRACTIONS INVOLUNTARY,2
TR,MUSCLE SPASMS,2
TR,MUSCULAR WEAKNESS,2
TR,NEUROPATHY PERIPHERAL,2
TR,PLATELET COUNT DECREASED,2
TR,PREGNANCY,2
TR,PREGNANCY ON CONTRACEPTIVE,2
TR,PRODUCT USE ISSUE,2
TR,PRURITUS,2
TR,RENAL PAIN,2
TR,RESTLESSNESS,2
TR,SCOLIOSIS,2
TR,SUDDEN UNEXPLAINED DEATH IN EPILEPSY,2
TR,TREATMENT FAILURE,2
TR,URINARY TRACT INFECTION,2
TR,UTERINE POLYP,2
TR,ABASIA,1
TR,ABNORMAL DREAMS,1
TR,ABORTION,1
TR,ABORTION INDUCED,1
TR,ADRENAL MASS,1
TR,AGITATION,1
TR,AKATHISIA,1
TR,ANAEMIA,1
TR,ANAPHYLACTIC SHOCK,1
TR,ANHEDONIA,1
TR,APATHY,1
TR,ARACHNOID CYST,1
TR,ARRHYTHMIA,1
TR,ARTERIOSCLEROSIS,1
TR,ASTHENIA,1
TR,AZOTAEMIA,1
TR,BALANCE DISORDER,1
TR,BENIGN VAGINAL NEOPLASM,1
TR,BLOOD CHOLESTEROL INCREASED,1
TR,BLOOD GLUCOSE INCREASED,1
TR,BLOOD LACTATE DEHYDROGENASE INCREASED,1
TR,BLOOD PRESSURE INCREASED,1
TR,BLOOD PRESSURE SYSTOLIC INCREASED,1
TR,BREAST DISCHARGE,1
TR,BUNDLE BRANCH BLOCK RIGHT,1
TR,CARDIAC ARREST,1
TR,CARDIAC FAILURE CONGESTIVE,1
TR,CARDIAC FLUTTER,1
TR,CEREBRAL INFARCTION,1
TR,CERVIX CARCINOMA STAGE II,1
TR,CHOLECYSTITIS,1
TR,CHOLELITHIASIS,1
TR,CONDITION AGGRAVATED,1
TR,CONFUSIONAL STATE,1
TR,CONVULSION,1
TR,DEATH,1
TR,DEEP VEIN THROMBOSIS,1
TR,DELIRIUM,1
TR,DEMENTIA,1
TR,DEMENTIA ALZHEIMER^S TYPE,1
TR,DEPERSONALISATION/DEREALISATION DISORDER,1
TR,DEPRESSED LEVEL OF CONSCIOUSNESS,1
TR,DEPRESSED MOOD,1
TR,DEPRESSION,1
TR,DIARRHOEA,1
TR,DISEASE PROGRESSION,1
TR,DISEASE RECURRENCE,1
TR,DISTURBANCE IN ATTENTION,1
TR,DRUG HYPERSENSITIVITY,1
TR,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
TR,DRUG RESISTANCE,1
TR,DRY MOUTH,1
TR,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,1
TR,ENDOMETRIAL HYPERPLASIA,1
TR,ERECTILE DYSFUNCTION,1
TR,EYE MOVEMENT DISORDER,1
TR,EYE PAIN,1
TR,FAMILY STRESS,1
TR,FEBRILE NEUTROPENIA,1
TR,FEEDING DISORDER,1
TR,FEMORAL NECK FRACTURE,1
TR,FEMUR FRACTURE,1
TR,FIBRIN D DIMER INCREASED,1
TR,FLATULENCE,1
TR,FOETAL EXPOSURE DURING PREGNANCY,1
TR,GASTROINTESTINAL HAEMORRHAGE,1
TR,GENERALISED ANXIETY DISORDER,1
TR,GRANDIOSITY,1
TR,HAEMATURIA,1
TR,HAEMOGLOBIN DECREASED,1
TR,HAEMOLYTIC ANAEMIA,1
TR,HAEMORRHAGE SUBCUTANEOUS,1
TR,HALLUCINATION_ VISUAL,1
TR,HEART RATE IRREGULAR,1
TR,HEPATIC ENZYME INCREASED,1
TR,HERPES SIMPLEX,1
TR,HIP FRACTURE,1
TR,HODGKIN^S DISEASE,1
TR,HYPERSOMNIA,1
TR,HYPOKALAEMIA,1
TR,HYPOMANIA,1
TR,HYPONATRAEMIA,1
TR,HYPOTENSION,1
TR,ILLUSION,1
TR,IMPAIRED DRIVING ABILITY,1
TR,IMPAIRED WORK ABILITY,1
TR,INCORRECT DOSE ADMINISTERED,1
TR,INFLUENZA LIKE ILLNESS,1
TR,INJECTION SITE BRUISING,1
TR,INJECTION SITE ERYTHEMA,1
TR,INJECTION SITE MASS,1
TR,INJECTION SITE PAIN,1
TR,INTENTIONAL PRODUCT MISUSE,1
TR,INTERVERTEBRAL DISCITIS,1
TR,INTRAOCULAR PRESSURE FLUCTUATION,1
TR,INTRAOCULAR PRESSURE INCREASED,1
TR,IRRITABILITY,1
TR,LEUKOCYTURIA,1
TR,LEUKOPENIA,1
TR,LIMB IMMOBILISATION,1
TR,LONG QT SYNDROME,1
TR,MATERNAL EXPOSURE TIMING UNSPECIFIED,1
TR,MENINGIOMA,1
TR,MENTAL IMPAIRMENT,1
TR,MIGRAINE,1
TR,MOBILITY DECREASED,1
TR,MOOD ALTERED,1
TR,MOVEMENT DISORDER,1
TR,MULTIPLE SCLEROSIS RELAPSE,1
TR,MYALGIA,1
TR,MYDRIASIS,1
TR,MYOCARDIAL INFARCTION,1
TR,MYOCLONIC EPILEPSY,1
TR,MYOCLONUS,1
TR,NEOPLASM RECURRENCE,1
TR,NERVOUSNESS,1
TR,NEUTROPENIA,1
TR,OEDEMA PERIPHERAL,1
TR,OSTEOPOROSIS,1
TR,PANCREATITIS,1
TR,PARAESTHESIA,1
TR,PARTIAL SEIZURES,1
TR,PERIPHERAL SWELLING,1
TR,PLEURAL EFFUSION,1
TR,PNEUMOPERITONEUM,1
TR,PO2 DECREASED,1
TR,POSTMENOPAUSAL HAEMORRHAGE,1
TR,PRODUCT SUBSTITUTION,1
TR,PRODUCT SUBSTITUTION ISSUE,1
TR,PRODUCT USE IN UNAPPROVED INDICATION,1
TR,PROSTATITIS,1
TR,PRURITUS GENERALISED,1
TR,PYREXIA,1
TR,RADICULAR PAIN,1
TR,RASH PUSTULAR,1
TR,RED BLOOD CELL COUNT DECREASED,1
TR,RENAL TUBULAR ACIDOSIS,1
TR,RESPIRATORY ACIDOSIS,1
TR,RESPIRATORY ARREST,1
TR,RESPIRATORY DEPRESSION,1
TR,RESPIRATORY FAILURE,1
TR,RESTLESS LEGS SYNDROME,1
TR,RETINAL HAEMORRHAGE,1
TR,RETINAL INFARCTION,1
TR,RETINAL VASCULAR DISORDER,1
TR,SEDATION,1
TR,SERUM FERRITIN DECREASED,1
TR,SKIN DISCOLOURATION,1
TR,SKIN HAEMORRHAGE,1
TR,SKIN INFECTION,1
TR,SLEEP APNOEA SYNDROME,1
TR,SPEECH DISORDER,1
TR,STEM CELL TRANSPLANT,1
TR,SUBARACHNOID HAEMORRHAGE,1
TR,SUBSTANCE USE,1
TR,TACHYCARDIA,1
TR,THERAPEUTIC RESPONSE UNEXPECTED,1
TR,THERAPY PARTIAL RESPONDER,1
TR,THROMBOCYTOPENIA,1
TR,THROMBOPHLEBITIS SUPERFICIAL,1
TR,TRAUMATIC HAEMATOMA,1
TR,TRIGEMINAL NEURALGIA,1
TR,URINARY RETENTION,1
TR,URINE OUTPUT DECREASED,1
TR,UTERINE CANCER,1
TR,UTERINE CYST,1
TR,VENTRICULAR SEPTAL DEFECT,1
TR,VENTRICULAR TACHYCARDIA,1
TR,VERTIGO,1
TR,VISUAL ACUITY REDUCED,1
TR,VISUAL IMPAIRMENT,1
TR,WOUND,1
UG,SEROTONIN SYNDROME,1
UA,CONDITION AGGRAVATED,2
UA,PRODUCT USE ISSUE,2
UA,ABASIA,1
UA,ANAL INCONTINENCE,1
UA,CERVIX CARCINOMA,1
UA,DEATH,1
UA,DISEASE PROGRESSION,1
UA,DIZZINESS,1
UA,DRUG HYPERSENSITIVITY,1
UA,ENURESIS,1
UA,INTERVERTEBRAL DISC PROTRUSION,1
UA,ISCHAEMIC STROKE,1
UA,PRIAPISM,1
UA,PRURITUS,1
UA,SNEEZING,1
UA,SOMNOLENCE,1
UA,UNDERDOSE,1
UA,URINARY INCONTINENCE,1
AE,DEPRESSION,2
AE,CARDIAC ARREST,1
AE,CHEST PAIN,1
AE,DRUG DEPENDENCE,1
AE,DRUG WITHDRAWAL SYNDROME,1
AE,DYSPNOEA,1
AE,EYE PAIN,1
AE,FALL,1
AE,HYPERSOMNIA,1
AE,HYPOTENSION,1
AE,INTENTIONAL OVERDOSE,1
AE,LAZINESS,1
AE,OCULAR HYPERAEMIA,1
AE,PELVIC FRACTURE,1
AE,RASH MACULO-PAPULAR,1
AE,SPEECH DISORDER,1
AE,TACHYCARDIA,1
AE,VISUAL ACUITY REDUCED,1
GB,TOXICITY TO VARIOUS AGENTS,310
GB,MALAISE,210
GB,DRUG ABUSE,204
GB,DIZZINESS,197
GB,DIARRHOEA,191
GB,SOMNOLENCE,172
GB,DYSPNOEA,164
GB,CONFUSIONAL STATE,155
GB,FATIGUE,154
GB,HEADACHE,143
GB,PAIN,143
GB,NAUSEA,141
GB,DEATH,137
GB,SUICIDAL IDEATION,134
GB,OVERDOSE,128
GB,DEPRESSION,120
GB,VOMITING,120
GB,ANXIETY,119
GB,ARTHRALGIA,117
GB,HYPERHIDROSIS,115
GB,INSOMNIA,114
GB,LOSS OF CONSCIOUSNESS,114
GB,ACUTE KIDNEY INJURY,109
GB,TREMOR,108
GB,FEELING ABNORMAL,107
GB,LOWER RESPIRATORY TRACT INFECTION,102
GB,CONDITION AGGRAVATED,97
GB,AGITATION,96
GB,PNEUMONIA,95
GB,SEIZURE,94
GB,VISION BLURRED,94
GB,DYSARTHRIA,92
GB,MYALGIA,88
GB,FALL,87
GB,PAIN IN EXTREMITY,85
GB,WITHDRAWAL SYNDROME,85
GB,PARAESTHESIA,83
GB,CONTUSION,81
GB,PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION,79
GB,GAIT DISTURBANCE,78
GB,BACK PAIN,77
GB,BALANCE DISORDER,77
GB,COUGH,76
GB,SWELLING FACE,76
GB,CONSTIPATION,72
GB,PYREXIA,72
GB,ACCIDENTAL OVERDOSE,71
GB,AGGRESSION,71
GB,DISTURBANCE IN ATTENTION,71
GB,DECREASED APPETITE,70
GB,RASH,70
GB,ASTHENIA,69
GB,DRUG DEPENDENCE,68
GB,INTENTIONAL OVERDOSE,67
GB,ANGER,66
GB,DRUG WITHDRAWAL SYNDROME,66
GB,DEPRESSED LEVEL OF CONSCIOUSNESS,65
GB,MUSCLE SPASMS,65
GB,CIRCULATORY COLLAPSE,61
GB,DRUG INEFFECTIVE,61
GB,PERIPHERAL SWELLING,61
GB,PRURITUS,61
GB,AMNESIA,56
GB,INTENTIONAL PRODUCT MISUSE,56
GB,CHEST PAIN,55
GB,DYSPHAGIA,55
GB,PALPITATIONS,55
GB,ABDOMINAL PAIN,54
GB,LIVER FUNCTION TEST ABNORMAL,54
GB,SYNCOPE,53
GB,VISUAL IMPAIRMENT,53
GB,LETHARGY,52
GB,SLEEP DISORDER,52
GB,WHEEZING,51
GB,HYPONATRAEMIA,50
GB,CARDIAC ARREST,49
GB,HYPOTENSION,49
GB,SEPSIS,49
GB,ALOPECIA,48
GB,DYSKINESIA,48
GB,NEUROPATHY PERIPHERAL,48
GB,HYPERTENSION,47
GB,MEMORY IMPAIRMENT,47
GB,MUSCLE TWITCHING,47
GB,HALLUCINATION,46
GB,COGNITIVE DISORDER,45
GB,HYPOAESTHESIA,45
GB,MENTAL IMPAIRMENT,45
GB,MYOCARDIAL INFARCTION,45
GB,ABDOMINAL PAIN UPPER,44
GB,DEHYDRATION,44
GB,MUSCULAR WEAKNESS,44
GB,BRADYCARDIA,43
GB,INTENTIONAL SELF-INJURY,43
GB,TACHYCARDIA,42
GB,URINARY RETENTION,42
GB,COMPLETED SUICIDE,41
GB,DEPRESSED MOOD,41
GB,DRY MOUTH,41
GB,SPEECH DISORDER,40
GB,INFECTION,39
GB,UNRESPONSIVE TO STIMULI,39
GB,LIP SWELLING,38
GB,URINARY TRACT INFECTION,38
GB,WEIGHT INCREASED,38
GB,CONVULSION,36
GB,PULMONARY EMBOLISM,36
GB,PARANOIA,35
GB,EPILEPSY,34
GB,MUSCULOSKELETAL STIFFNESS,34
GB,RENAL FAILURE ACUTE,34
GB,COMA,33
GB,NEURALGIA,32
GB,BLISTER,31
GB,FEAR,31
GB,MOUTH ULCERATION,31
GB,NERVOUSNESS,31
GB,PNEUMONITIS,31
GB,PRODUCT USE IN UNAPPROVED INDICATION,31
GB,BURNING SENSATION,30
GB,NERVOUS SYSTEM DISORDER,30
GB,NIGHTMARE,30
GB,SPUTUM DISCOLOURED,30
GB,SUICIDE ATTEMPT,30
GB,ABNORMAL BEHAVIOUR,29
GB,CHEST DISCOMFORT,29
GB,DEEP VEIN THROMBOSIS,29
GB,HYPERSENSITIVITY,29
GB,SEDATION,29
GB,THINKING ABNORMAL,29
GB,TINNITUS,29
GB,ANAEMIA,28
GB,APHASIA,28
GB,EYE PAIN,28
GB,INFLUENZA LIKE ILLNESS,28
GB,MOOD ALTERED,28
GB,PALLOR,28
GB,IRRITABILITY,27
GB,RESPIRATORY DEPRESSION,27
GB,ABNORMAL WEIGHT GAIN,26
GB,DISSOCIATION,26
GB,SENSORY DISTURBANCE,26
GB,SEROTONIN SYNDROME,26
GB,SWOLLEN TONGUE,26
GB,ARRHYTHMIA,25
GB,ASTHMA,25
GB,CLUMSINESS,25
GB,COLD SWEAT,25
GB,DRY EYE,25
GB,HYPERKALAEMIA,25
GB,HYPERSOMNIA,25
GB,LOCAL SWELLING,25
GB,NEUTROPENIA,25
GB,RHABDOMYOLYSIS,25
GB,VERTIGO,25
GB,WEIGHT DECREASED,25
GB,ABDOMINAL DISCOMFORT,24
GB,CHILLS,24
GB,DELIRIUM,24
GB,HYPOGLYCAEMIA,24
GB,JOINT SWELLING,24
GB,MUSCLE RIGIDITY,24
GB,MUSCULOSKELETAL PAIN,24
GB,OXYGEN SATURATION DECREASED,24
GB,PRURITUS GENERALISED,24
GB,RESTLESS LEGS SYNDROME,24
GB,TENDONITIS,24
GB,ANAPHYLACTIC REACTION,23
GB,CHROMATURIA,23
GB,ERYTHEMA,23
GB,GENERAL PHYSICAL HEALTH DETERIORATION,23
GB,JOINT STIFFNESS,23
GB,MOOD SWINGS,23
GB,PARALYSIS,23
GB,THROMBOCYTOPENIA,23
GB,FEELING DRUNK,22
GB,FLUID RETENTION,22
GB,HAEMOGLOBIN DECREASED,22
GB,PANIC ATTACK,22
GB,PERSONALITY CHANGE,22
GB,PRODUCT USE ISSUE,22
GB,SKIN ULCER,22
GB,ABNORMAL DREAMS,21
GB,DYSPEPSIA,21
GB,DYSTONIA,21
GB,EUPHORIC MOOD,21
GB,FOETAL EXPOSURE DURING PREGNANCY,21
GB,PSYCHOTIC DISORDER,21
GB,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,20
GB,DISORIENTATION,20
GB,GENERALISED TONIC-CLONIC SEIZURE,20
GB,HEART RATE INCREASED,20
GB,MENTAL DISORDER,20
GB,SELF INJURIOUS BEHAVIOUR,20
GB,SKIN ABRASION,20
GB,COORDINATION ABNORMAL,19
GB,DROOLING,19
GB,DYSURIA,19
GB,GASTROOESOPHAGEAL REFLUX DISEASE,19
GB,KETOACIDOSIS,19
GB,SNORING,19
GB,SUICIDAL BEHAVIOUR,19
GB,TEARFULNESS,19
GB,URTICARIA,19
GB,ATRIAL FIBRILLATION,18
GB,AUTONOMIC NERVOUS SYSTEM IMBALANCE,18
GB,FEELING COLD,18
GB,FRUSTRATION,18
GB,HALLUCINATIONS_ MIXED,18
GB,MATERNAL EXPOSURE DURING PREGNANCY,18
GB,MOBILITY DECREASED,18
GB,MUSCLE SPASTICITY,18
GB,MYOCLONUS,18
GB,NIGHT SWEATS,18
GB,PSORIASIS,18
GB,RASH PRURITIC,18
GB,SUBSTANCE-INDUCED PSYCHOTIC DISORDER,18
GB,ABDOMINAL DISTENSION,17
GB,ACUTE RESPIRATORY DISTRESS SYNDROME,17
GB,ACUTE RESPIRATORY FAILURE,17
GB,CARDIAC DISORDER,17
GB,CARDIAC FAILURE,17
GB,CELLULITIS,17
GB,CEREBROVASCULAR ACCIDENT,17
GB,COMMUNICATION DISORDER,17
GB,CRYING,17
GB,DEREALISATION,17
GB,DYSPNOEA EXERTIONAL,17
GB,EMOTIONAL DISTRESS,17
GB,FOAMING AT MOUTH,17
GB,HEART RATE IRREGULAR,17
GB,HOT FLUSH,17
GB,MULTIPLE SCLEROSIS,17
GB,NEUROLEPTIC MALIGNANT SYNDROME,17
GB,PULMONARY OEDEMA,17
GB,RASH GENERALISED,17
GB,ARTHRITIS,16
GB,GASTRITIS,16
GB,JAUNDICE,16
GB,LIMB DISCOMFORT,16
GB,MOVEMENT DISORDER,16
GB,NERVE INJURY,16
GB,TENDON PAIN,16
GB,TOOTH ABSCESS,16
GB,ABORTION SPONTANEOUS,15
GB,BEDRIDDEN,15
GB,BLOOD CREATINE PHOSPHOKINASE INCREASED,15
GB,DISCOMFORT,15
GB,GASTROINTESTINAL DISORDER,15
GB,INHIBITORY DRUG INTERACTION,15
GB,MIGRAINE,15
GB,NEUTROPENIC SEPSIS,15
GB,PRODUCT QUALITY ISSUE,15
GB,RESPIRATORY ARREST,15
GB,SPINAL PAIN,15
GB,WHITE BLOOD CELL COUNT INCREASED,15
GB,ACUTE PSYCHOSIS,14
GB,BIPOLAR I DISORDER,14
GB,BLOOD ALKALINE PHOSPHATASE INCREASED,14
GB,DIABETES MELLITUS,14
GB,DIABETIC KETOACIDOSIS,14
GB,DRUG HYPERSENSITIVITY,14
GB,EXPOSURE DURING BREAST FEEDING,14
GB,EXPOSURE DURING PREGNANCY,14
GB,FEEDING DISORDER,14
GB,IMPAIRED WORK ABILITY,14
GB,INCONTINENCE,14
GB,METABOLIC ACIDOSIS,14
GB,OBSESSIVE-COMPULSIVE DISORDER,14
GB,OEDEMA,14
GB,ORAL PAIN,14
GB,POSTURE ABNORMAL,14
GB,RASH MACULAR,14
GB,RESTLESSNESS,14
GB,SALIVARY HYPERSECRETION,14
GB,TOOTH DISORDER,14
GB,ALANINE AMINOTRANSFERASE INCREASED,13
GB,CHOREA,13
GB,CYANOSIS,13
GB,DERMATITIS BULLOUS,13
GB,DIPLOPIA,13
GB,DISINHIBITION,13
GB,DRUG DOSE OMISSION,13
GB,DYSPHORIA,13
GB,ERECTILE DYSFUNCTION,13
GB,FAILURE TO ANASTOMOSE,13
GB,GAMMA-GLUTAMYLTRANSFERASE INCREASED,13
GB,HAEMORRHAGE,13
GB,HOSTILITY,13
GB,IRON DEFICIENCY,13
GB,MENTAL STATUS CHANGES,13
GB,MULTIPLE SCLEROSIS RELAPSE,13
GB,NEUTROPHIL COUNT INCREASED,13
GB,OCULOGYRIC CRISIS,13
GB,OPISTHOTONUS,13
GB,ORAL DISCOMFORT,13
GB,PHLEBITIS,13
GB,PHOTOSENSITIVITY REACTION,13
GB,PULMONARY INFARCTION,13
GB,RESPIRATORY RATE DECREASED,13
GB,RIGHT VENTRICULAR HYPERTROPHY,13
GB,SCHIZOPHRENIA,13
GB,SKIN TIGHTNESS,13
GB,SUBILEUS,13
GB,SUDDEN DEATH,13
GB,THERAPY NON-RESPONDER,13
GB,TONGUE DRY,13
GB,WRONG PATIENT RECEIVED MEDICATION,13
GB,AURA,12
GB,BLOOD PRESSURE FLUCTUATION,12
GB,BORDERLINE PERSONALITY DISORDER,12
GB,CATATONIA,12
GB,CHOLECYSTITIS,12
GB,COAGULOPATHY,12
GB,COATING IN MOUTH,12
GB,DERMATITIS CONTACT,12
GB,ESSENTIAL HYPERTENSION,12
GB,EXTENSOR PLANTAR RESPONSE,12
GB,FEBRILE NEUTROPENIA,12
GB,FORMICATION,12
GB,HAEMATEMESIS,12
GB,HEMIPLEGIA,12
GB,HYPERGLYCAEMIA,12
GB,HYPORESPONSIVE TO STIMULI,12
GB,HYPOXIA,12
GB,IMMUNE THROMBOCYTOPENIC PURPURA,12
GB,LUPUS-LIKE SYNDROME,12
GB,MUCOSAL DRYNESS,12
GB,NECK PAIN,12
GB,PHARYNGEAL OEDEMA,12
GB,PNEUMONIA ASPIRATION,12
GB,POLYURIA,12
GB,RECTAL HAEMORRHAGE,12
GB,SENSORY LOSS,12
GB,SPLENOMEGALY,12
GB,STUPOR,12
GB,TONGUE COATED,12
GB,TUNNEL VISION,12
GB,ALCOHOL ABUSE,11
GB,ATAXIA,11
GB,BLOOD CHOLESTEROL INCREASED,11
GB,BLOOD CREATININE INCREASED,11
GB,BRUXISM,11
GB,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,11
GB,DERMATITIS ALLERGIC,11
GB,DISEASE PROGRESSION,11
GB,DYSGRAPHIA,11
GB,FEELING OF BODY TEMPERATURE CHANGE,11
GB,HAEMATURIA,11
GB,HALLUCINATION_ AUDITORY,11
GB,HEAD DISCOMFORT,11
GB,HUNGER,11
GB,IMPAIRED SELF-CARE,11
GB,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,11
GB,LEFT VENTRICULAR HYPERTROPHY,11
GB,MANIA,11
GB,MELAENA,11
GB,MUSCLE STRAIN,11
GB,NASAL DRYNESS,11
GB,PERIODIC LIMB MOVEMENT DISORDER,11
GB,PERSONALITY DISORDER,11
GB,POLYDIPSIA,11
GB,PREMATURE BABY,11
GB,PRESCRIBED UNDERDOSE,11
GB,SINUS BRADYCARDIA,11
GB,SLOW SPEECH,11
GB,VISUAL ACUITY REDUCED,11
GB,WAIST CIRCUMFERENCE INCREASED,11
GB,ABASIA,10
GB,AGITATED DEPRESSION,10
GB,AKATHISIA,10
GB,AORTIC ARTERIOSCLEROSIS,10
GB,ATRIOVENTRICULAR BLOCK COMPLETE,10
GB,BLISTER INFECTED,10
GB,BLOODY DISCHARGE,10
GB,BODY TEMPERATURE INCREASED,10
GB,BONE PAIN,10
GB,BUNDLE BRANCH BLOCK LEFT,10
GB,CARDIAC FAILURE CONGESTIVE,10
GB,COLITIS,10
GB,DEPERSONALISATION,10
GB,DRUG DIVERSION,10
GB,DRUG PRESCRIBING ERROR,10
GB,DYSGEUSIA,10
GB,EPISTAXIS,10
GB,FEELING OF DESPAIR,10
GB,GALACTORRHOEA,10
GB,GASTROINTESTINAL HAEMORRHAGE,10
GB,GASTROINTESTINAL MOTILITY DISORDER,10
GB,HEPATIC STEATOSIS,10
GB,HIPPOCAMPAL SCLEROSIS,10
GB,HYPERTHERMIA,10
GB,INCORRECT DOSE ADMINISTERED,10
GB,INFLAMMATORY MARKER INCREASED,10
GB,INITIAL INSOMNIA,10
GB,INJECTION SITE ERYTHEMA,10
GB,INJURY,10
GB,INTERNATIONAL NORMALISED RATIO DECREASED,10
GB,LIGAMENT PAIN,10
GB,MEDICATION ERROR,10
GB,MUSCLE TIGHTNESS,10
GB,NEUROTOXICITY,10
GB,NON-24-HOUR SLEEP-WAKE DISORDER,10
GB,OESOPHAGITIS,10
GB,OSTEOPENIA,10
GB,PERIPHERAL COLDNESS,10
GB,POOR QUALITY DRUG ADMINISTERED,10
GB,PROCEDURAL HAEMORRHAGE,10
GB,PULSELESS ELECTRICAL ACTIVITY,10
GB,QUALITY OF LIFE DECREASED,10
GB,RASH PAPULAR,10
GB,RESPIRATORY FAILURE,10
GB,RHEUMATOID ARTHRITIS,10
GB,SINUS TACHYCARDIA,10
GB,SPINAL COMPRESSION FRACTURE,10
GB,SUBSTANCE USE,10
GB,TEMPORAL LOBE EPILEPSY,10
GB,THIRST,10
GB,UPPER GASTROINTESTINAL HAEMORRHAGE,10
GB,ATRIOVENTRICULAR BLOCK,9
GB,BLOOD GLUCOSE INCREASED,9
GB,BRAIN HYPOXIA,9
GB,COMA SCALE ABNORMAL,9
GB,CONTRAINDICATED DRUG ADMINISTERED,9
GB,CONTRAINDICATED PRODUCT ADMINISTERED,9
GB,CORONARY ARTERY STENOSIS,9
GB,DELUSION,9
GB,DRUG-INDUCED LIVER INJURY,9
GB,ELECTROCARDIOGRAM QT PROLONGED,9
GB,FINE MOTOR SKILL DYSFUNCTION,9
GB,GASTRIC ULCER,9
GB,GINGIVAL PAIN,9
GB,GRIP STRENGTH DECREASED,9
GB,HYPERPROLACTINAEMIA,9
GB,HYPERTONIC BLADDER,9
GB,LOW BIRTH WEIGHT BABY,9
GB,MENTAL STATUS CHANGES POSTOPERATIVE,9
GB,MIDDLE INSOMNIA,9
GB,NEOPLASM,9
GB,OEDEMA PERIPHERAL,9
GB,ONYCHOPHAGIA,9
GB,ORAL MUCOSAL BLISTERING,9
GB,PANIC DISORDER,9
GB,PARTIAL SEIZURES,9
GB,POTENTIATING DRUG INTERACTION,9
GB,PULSE ABNORMAL,9
GB,SKIN DISORDER,9
GB,TOOTH INFECTION,9
GB,ULCER,9
GB,UNEVALUABLE EVENT,9
GB,ACTIVITIES OF DAILY LIVING IMPAIRED,8
GB,APGAR SCORE LOW,8
GB,ARTHROPATHY,8
GB,BLOOD PRESSURE INCREASED,8
GB,CAMPYLOBACTER INFECTION,8
GB,CARPAL TUNNEL SYNDROME,8
GB,CONFUSION POSTOPERATIVE,8
GB,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,8
GB,DRUG USE DISORDER,8
GB,DYSPHEMIA,8
GB,EYE MOVEMENT DISORDER,8
GB,EYE SWELLING,8
GB,FACIAL PARESIS,8
GB,FRUSTRATION TOLERANCE DECREASED,8
GB,GASTROINTESTINAL PAIN,8
GB,HAEMORRHAGE INTRACRANIAL,8
GB,HEAD CIRCUMFERENCE ABNORMAL,8
GB,HYPERPYREXIA,8
GB,JAUNDICE NEONATAL,8
GB,LIP DISCOLOURATION,8
GB,MALIGNANT NEOPLASM PROGRESSION,8
GB,METABOLIC ALKALOSIS,8
GB,MIOSIS,8
GB,MYOCLONIC EPILEPSY,8
GB,MYOPATHY,8
GB,NEONATAL RESPIRATORY DISTRESS SYNDROME,8
GB,NEPHROLITHIASIS,8
GB,NERVE ROOT COMPRESSION,8
GB,OESOPHAGEAL ULCER,8
GB,OROPHARYNGEAL PAIN,8
GB,OSTEOMYELITIS,8
GB,OSTEONECROSIS OF JAW,8
GB,PANIC REACTION,8
GB,PLEURAL EFFUSION,8
GB,PRESYNCOPE,8
GB,PSYCHOMOTOR HYPERACTIVITY,8
GB,PYROGLUTAMATE INCREASED,8
GB,TENDON DISCOMFORT,8
GB,TRANSAMINASES INCREASED,8
GB,TUBULOINTERSTITIAL NEPHRITIS,8
GB,URINARY HESITATION,8
GB,VITREOUS FLOATERS,8
GB,WHITE BLOOD CELL COUNT DECREASED,8
GB,ALCOHOL INTERACTION,7
GB,ANTINUCLEAR ANTIBODY POSITIVE,7
GB,ARTERIOVENOUS MALFORMATION,7
GB,BRADYPHRENIA,7
GB,BRAIN INJURY,7
GB,BRAIN OEDEMA,7
GB,C-REACTIVE PROTEIN INCREASED,7
GB,CEREBELLAR HAEMORRHAGE,7
GB,DISORGANISED SPEECH,7
GB,EATING DISORDER,7
GB,EYE CONTUSION,7
GB,FLATULENCE,7
GB,GINGIVAL SWELLING,7
GB,GINGIVITIS,7
GB,HEAD INJURY,7
GB,HEPATITIS ACUTE,7
GB,ILEUS PARALYTIC,7
GB,INCOHERENT,7
GB,INCORRECT DRUG ADMINISTRATION DURATION,7
GB,INTRUSIVE THOUGHTS,7
GB,LARGE INTESTINE PERFORATION,7
GB,LIMB REDUCTION DEFECT,7
GB,MUSCLE INJURY,7
GB,NEOPLASM MALIGNANT,7
GB,OSTEOPOROSIS,7
GB,PAIN IN JAW,7
GB,PANCYTOPENIA,7
GB,POISONING DELIBERATE,7
GB,PRE-EXISTING CONDITION IMPROVED,7
GB,PRODUCT SUBSTITUTION ISSUE,7
GB,SCREAMING,7
GB,SPASMODIC DYSPHONIA,7
GB,STRESS,7
GB,TOXIC EPIDERMAL NECROLYSIS,7
GB,TRANSIENT ISCHAEMIC ATTACK,7
GB,VISUAL SNOW SYNDROME,7
GB,WRONG DRUG ADMINISTERED,7
GB,ABDOMINAL TENDERNESS,6
GB,ABNORMAL FAECES,6
GB,ABNORMAL LOSS OF WEIGHT,6
GB,ACUTE HEPATIC FAILURE,6
GB,ACUTE MYOCARDIAL INFARCTION,6
GB,ADVERSE DRUG REACTION,6
GB,ALCOHOLISM,6
GB,APPLICATION SITE ERYTHEMA,6
GB,ATRIOVENTRICULAR BLOCK FIRST DEGREE,6
GB,BLADDER DISCOMFORT,6
GB,BLEEDING TIME PROLONGED,6
GB,BLOOD ALCOHOL INCREASED,6
GB,BLOOD PRESSURE DECREASED,6
GB,BRAIN MIDLINE SHIFT,6
GB,CHANGE OF BOWEL HABIT,6
GB,COMPLEX REGIONAL PAIN SYNDROME,6
GB,CONGENITAL SCOLIOSIS,6
GB,DEAFNESS,6
GB,DEVELOPMENTAL HIP DYSPLASIA,6
GB,DRUG DISPENSING ERROR,6
GB,DRUG INTOLERANCE,6
GB,DRUG LEVEL INCREASED,6
GB,DRUG WITHDRAWAL HEADACHE,6
GB,DUODENAL ULCER HAEMORRHAGE,6
GB,DYSSTASIA,6
GB,EXTRAPYRAMIDAL DISORDER,6
GB,FAECES DISCOLOURED,6
GB,FLUID OVERLOAD,6
GB,FLUSHING,6
GB,GAMBLING DISORDER,6
GB,HYPOACUSIS,6
GB,HYPOPHAGIA,6
GB,HYPOTONIA,6
GB,IMPULSIVE BEHAVIOUR,6
GB,INCREASED APPETITE,6
GB,INFLAMMATION,6
GB,INJECTION SITE HAEMORRHAGE,6
GB,LACTIC ACIDOSIS,6
GB,LIBIDO DECREASED,6
GB,LIP ULCERATION,6
GB,LUNG INFECTION,6
GB,MIGRAINE WITH AURA,6
GB,MULTI-ORGAN FAILURE,6
GB,MUSCULOSKELETAL DISCOMFORT,6
GB,MYOSITIS,6
GB,NASOPHARYNGITIS,6
GB,NEUTROPHIL COUNT DECREASED,6
GB,OBSESSIVE THOUGHTS,6
GB,ORAL MUCOSAL EXFOLIATION,6
GB,ORGASM ABNORMAL,6
GB,PARKINSON^S DISEASE,6
GB,PELVIC PAIN,6
GB,PHOTOPHOBIA,6
GB,PREMATURE LABOUR,6
GB,PULSE ABSENT,6
GB,RASH ERYTHEMATOUS,6
GB,RENAL FAILURE,6
GB,RHINORRHOEA,6
GB,SINGLE FUNCTIONAL KIDNEY,6
GB,SKIN ODOUR ABNORMAL,6
GB,SKIN REACTION,6
GB,SKULL FRACTURE,6
GB,SPINAL FRACTURE,6
GB,SUBDURAL HAEMATOMA,6
GB,SUPERFICIAL SPREADING MELANOMA STAGE UNSPECIFIED,6
GB,TERMINAL STATE,6
GB,THERAPEUTIC RESPONSE CHANGED,6
GB,THERAPY CESSATION,6
GB,THROAT IRRITATION,6
GB,THROMBOTIC THROMBOCYTOPENIC PURPURA,6
GB,TONGUE ULCERATION,6
GB,URINE FLOW DECREASED,6
GB,WOUND HAEMORRHAGE,6
GB,ADDISON^S DISEASE,5
GB,AFFECT LABILITY,5
GB,ANGINA PECTORIS,5
GB,APATHY,5
GB,APPLICATION SITE PRURITUS,5
GB,ASPIRATION,5
GB,BASAL CELL CARCINOMA,5
GB,BONE DISORDER,5
GB,BREAST CANCER,5
GB,CARDIAC FAILURE ACUTE,5
GB,CARDIOGENIC SHOCK,5
GB,CEREBRAL HAEMORRHAGE,5
GB,CEREBRAL INFARCTION,5
GB,CONTRAINDICATED DRUG PRESCRIBED,5
GB,CONVERSION DISORDER,5
GB,DENTAL CARIES,5
GB,DIABETES MELLITUS INADEQUATE CONTROL,5
GB,DRUG ERUPTION,5
GB,FACIAL PARALYSIS,5
GB,FOETAL MALFORMATION,5
GB,GASTROENTERITIS,5
GB,HAEMORRHAGE IN PREGNANCY,5
GB,HAIR COLOUR CHANGES,5
GB,HEART RATE DECREASED,5
GB,HEPATIC HAEMORRHAGE,5
GB,HIATUS HERNIA,5
GB,HYPOMANIA,5
GB,INGUINAL MASS,5
GB,INJECTION SITE BRUISING,5
GB,INTERCEPTED MEDICATION ERROR,5
GB,INTESTINAL OBSTRUCTION,5
GB,MUSCLE ATROPHY,5
GB,MYOCARDIAL ISCHAEMIA,5
GB,OESOPHAGEAL ATRESIA,5
GB,OSTEONECROSIS,5
GB,PARKINSONISM,5
GB,PAROSMIA,5
GB,PELVIC DEFORMITY,5
GB,PERONEAL NERVE PALSY,5
GB,PHARYNGITIS,5
GB,POOR QUALITY SLEEP,5
GB,PROCTALGIA,5
GB,PRODUCT SUPPLY ISSUE,5
GB,PROSTATE CANCER,5
GB,PSYCHOLOGICAL TRAUMA,5
GB,PUPIL FIXED,5
GB,QUADRIPLEGIA,5
GB,SECRETION DISCHARGE,5
GB,SKIN EXFOLIATION,5
GB,SNEEZING,5
GB,SPINAL CORD COMPRESSION,5
GB,SPINAL CORD HAEMORRHAGE,5
GB,STAB WOUND,5
GB,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,5
GB,TARDIVE DYSKINESIA,5
GB,THROAT TIGHTNESS,5
GB,TOOTH DISCOLOURATION,5
GB,TREATMENT FAILURE,5
GB,UPPER LIMB FRACTURE,5
GB,URINARY INCONTINENCE,5
GB,VENTRICULAR HYPERTROPHY,5
GB,VIOLENCE-RELATED SYMPTOM,5
GB,VIRAL INFECTION,5
GB,ABDOMINAL SEPSIS,4
GB,ACUTE CORONARY SYNDROME,4
GB,ADRENOCORTICAL INSUFFICIENCY ACUTE,4
GB,ANAL INFECTION,4
GB,ANDROGEN DEFICIENCY,4
GB,APPENDICITIS PERFORATED,4
GB,APPLICATION SITE INFLAMMATION,4
GB,APPLICATION SITE RASH,4
GB,ASPARTATE AMINOTRANSFERASE INCREASED,4
GB,BACTERIAL INFECTION,4
GB,BENIGN INTRACRANIAL HYPERTENSION,4
GB,BLINDNESS,4
GB,BLOOD BILIRUBIN INCREASED,4
GB,BLOOD PRESSURE ABNORMAL,4
GB,BLOOD URINE PRESENT,4
GB,BRAIN DEATH,4
GB,BURSITIS,4
GB,CHOLANGIOCARCINOMA,4
GB,CIRCADIAN RHYTHM SLEEP DISORDER,4
GB,CORTISOL DECREASED,4
GB,DEPRESSIVE SYMPTOM,4
GB,DERMATITIS,4
GB,DERMATITIS ACNEIFORM,4
GB,DIABETIC FOOT,4
GB,DISEASE RECURRENCE,4
GB,DIVERTICULUM INTESTINAL HAEMORRHAGIC,4
GB,DRUG MONITORING PROCEDURE NOT PERFORMED,4
GB,DRUG WITHDRAWAL SYNDROME NEONATAL,4
GB,EAR PAIN,4
GB,ELECTROCARDIOGRAM T WAVE INVERSION,4
GB,ENDOCRINE TOXICITY,4
GB,ESCHERICHIA URINARY TRACT INFECTION,4
GB,EYE DISORDER,4
GB,EYE PRURITUS,4
GB,FEELING JITTERY,4
GB,FLUID INTAKE REDUCED,4
GB,FORCEPS DELIVERY,4
GB,GENITAL ULCERATION,4
GB,HAEMORRHAGIC DIATHESIS,4
GB,HEMIPARESIS,4
GB,HEPATIC ENZYME INCREASED,4
GB,HEPATIC FUNCTION ABNORMAL,4
GB,HYPERAESTHESIA,4
GB,HYPOCALCAEMIA,4
GB,HYPOKALAEMIA,4
GB,HYPOTHERMIA,4
GB,HYPOVENTILATION,4
GB,IMMOBILE,4
GB,INFLUENZA,4
GB,INJECTION SITE PAIN,4
GB,INTERNATIONAL NORMALISED RATIO INCREASED,4
GB,LACUNAR INFARCTION,4
GB,LEUKOCYTOSIS,4
GB,LYMPHOCYTE COUNT DECREASED,4
GB,MACULOPATHY,4
GB,MASS,4
GB,METASTASES TO LIVER,4
GB,MOUTH SWELLING,4
GB,NEGATIVE THOUGHTS,4
GB,OESOPHAGEAL CARCINOMA,4
GB,ORAL CANDIDIASIS,4
GB,ORTHOSTATIC HYPOTENSION,4
GB,OSTEOARTHRITIS,4
GB,PHOTOPSIA,4
GB,POLYARTHRITIS,4
GB,POVERTY OF SPEECH,4
GB,PRESCRIBED OVERDOSE,4
GB,PYELONEPHRITIS ACUTE,4
GB,QUADRIPARESIS,4
GB,RAPID EYE MOVEMENTS SLEEP ABNORMAL,4
GB,RED BLOOD CELL COUNT DECREASED,4
GB,RENAL IMPAIRMENT,4
GB,RENAL PAIN,4
GB,RESPIRATORY DISORDER,4
GB,RESPIRATORY TRACT INFECTION,4
GB,SELF-INJURIOUS IDEATION,4
GB,SKIN DISCOLOURATION,4
GB,SKIN SWELLING,4
GB,SLEEP PARALYSIS,4
GB,SMALL INTESTINAL OBSTRUCTION,4
GB,TACHYPHRENIA,4
GB,TENDON RUPTURE,4
GB,TOXIC SKIN ERUPTION,4
GB,TRAUMATIC LIVER INJURY,4
GB,VENOUS PRESSURE JUGULAR INCREASED,4
GB,VIRAL RASH,4
GB,WHEELCHAIR USER,4
GB,ACCIDENT,3
GB,ACNE,3
GB,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,3
GB,AGORAPHOBIA,3
GB,ALTERED STATE OF CONSCIOUSNESS,3
GB,ANGIOEDEMA,3
GB,ANKLE FRACTURE,3
GB,ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC,3
GB,APHONIA,3
GB,APPLICATION SITE SCAR,3
GB,ATYPICAL FRACTURE,3
GB,BALLISMUS,3
GB,BIPOLAR DISORDER,3
GB,BLEPHAROSPASM,3
GB,BLOOD ALBUMIN DECREASED,3
GB,BLOOD CREATINE PHOSPHOKINASE ABNORMAL,3
GB,BLOOD POTASSIUM DECREASED,3
GB,BLOOD PROLACTIN INCREASED,3
GB,BONE MARROW FAILURE,3
GB,BRAIN COMPRESSION,3
GB,BRAIN STEM HAEMORRHAGE,3
GB,BREAST PAIN,3
GB,BREAST TENDERNESS,3
GB,CARDIOMYOPATHY,3
GB,CEREBROVASCULAR DISORDER,3
GB,CHOLELITHIASIS,3
GB,CLONUS,3
GB,CROHN^S DISEASE,3
GB,DEAFNESS BILATERAL,3
GB,DEMENTIA,3
GB,DROPPED HEAD SYNDROME,3
GB,DRUG EFFECT INCOMPLETE,3
GB,DRUG WITHDRAWAL CONVULSIONS,3
GB,DYSAESTHESIA,3
GB,ECZEMA,3
GB,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,3
GB,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,3
GB,EMBOLISM,3
GB,EMOTIONAL DISORDER,3
GB,ENCEPHALITIS,3
GB,EOSINOPHIL COUNT DECREASED,3
GB,ERYTHRODERMIC PSORIASIS,3
GB,EYELID OEDEMA,3
GB,FATTY LIVER ALCOHOLIC,3
GB,FEELING HOT,3
GB,FIBROMYALGIA,3
GB,FLAT AFFECT,3
GB,GASTRIC HAEMORRHAGE,3
GB,GENERAL PHYSICAL CONDITION ABNORMAL,3
GB,GENERALISED OEDEMA,3
GB,GLOMERULAR FILTRATION RATE DECREASED,3
GB,GRAND MAL CONVULSION,3
GB,HAEMATOMA,3
GB,HALLUCINATION_ VISUAL,3
GB,HEAD BANGING,3
GB,HEARING IMPAIRED,3
GB,HEPATITIS E,3
GB,HOSPITALISATION,3
GB,HYPERLIPIDAEMIA,3
GB,HYPOMAGNESAEMIA,3
GB,HYPONATRAEMIC SEIZURE,3
GB,HYPOPNOEA,3
GB,HYPOVITAMINOSIS,3
GB,IMPAIRED DRIVING ABILITY,3
GB,INAPPROPRIATE AFFECT,3
GB,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,3
GB,INCORRECT ROUTE OF DRUG ADMINISTRATION,3
GB,INJECTION SITE SWELLING,3
GB,INTENTIONAL DRUG MISUSE,3
GB,INTESTINAL DIAPHRAGM DISEASE,3
GB,JAUNDICE CHOLESTATIC,3
GB,LACRIMATION INCREASED,3
GB,LOSS OF PROPRIOCEPTION,3
GB,LUNG CONSOLIDATION,3
GB,LYMPHOPENIA,3
GB,MEDICATION MONITORING ERROR,3
GB,MENSTRUAL DISORDER,3
GB,MORBID THOUGHTS,3
GB,MUCOSAL INFLAMMATION,3
GB,MUMPS,3
GB,NERVE COMPRESSION,3
GB,OESOPHAGITIS HAEMORRHAGIC,3
GB,ORAL HERPES,3
GB,OSCILLOPSIA,3
GB,OVARIAN CANCER,3
GB,OXYGEN CONSUMPTION DECREASED,3
GB,PAIN OF SKIN,3
GB,PLASMA CELL MYELOMA,3
GB,PLATELET COUNT INCREASED,3
GB,POISONING,3
GB,POLLAKIURIA,3
GB,POOR VENOUS ACCESS,3
GB,POSTOPERATIVE WOUND INFECTION,3
GB,POVERTY OF THOUGHT CONTENT,3
GB,PREGNANCY,3
GB,PSORIATIC ARTHROPATHY,3
GB,PULMONARY MASS,3
GB,PURPURA,3
GB,RASH MACULO-PAPULAR,3
GB,RIB FRACTURE,3
GB,ROAD TRAFFIC ACCIDENT,3
GB,ROMBERG TEST POSITIVE,3
GB,SENSATION OF FOREIGN BODY,3
GB,SKIN ATROPHY,3
GB,SKIN BURNING SENSATION,3
GB,SKIN IRRITATION,3
GB,SKIN LESION,3
GB,SKIN SENSITISATION,3
GB,SKIN WOUND,3
GB,SLEEP APNOEA SYNDROME,3
GB,SLEEP TERROR,3
GB,SOCIAL AVOIDANT BEHAVIOUR,3
GB,STAPHYLOCOCCAL INFECTION,3
GB,STEVENS-JOHNSON SYNDROME,3
GB,STRESS CARDIOMYOPATHY,3
GB,SURGERY,3
GB,SWELLING,3
GB,TACHYPNOEA,3
GB,TEMPERATURE INTOLERANCE,3
GB,THERAPEUTIC RESPONSE UNEXPECTED,3
GB,THROAT CANCER,3
GB,TOE AMPUTATION,3
GB,TOOTHACHE,3
GB,TOXIC ENCEPHALOPATHY,3
GB,TYPE 2 DIABETES MELLITUS,3
GB,URINARY TRACT DISORDER,3
GB,URINE OUTPUT DECREASED,3
GB,VAGINAL HAEMORRHAGE,3
GB,VENTRICULAR TACHYCARDIA,3
GB,VISUAL BRIGHTNESS,3
GB,WRIST FRACTURE,3
GB,ABDOMINAL PAIN LOWER,2
GB,ADRENAL INSUFFICIENCY,2
GB,AGE-RELATED MACULAR DEGENERATION,2
GB,ALVEOLITIS ALLERGIC,2
GB,AMENORRHOEA,2
GB,ANTIPSYCHOTIC DRUG LEVEL INCREASED,2
GB,APNOEA,2
GB,APPLICATION SITE VESICLES,2
GB,ARACHNOIDITIS,2
GB,ARTERIOSCLEROSIS CORONARY ARTERY,2
GB,ATRIAL FLUTTER,2
GB,ATRIAL TACHYCARDIA,2
GB,ATYPICAL FEMUR FRACTURE,2
GB,BILIARY SEPSIS,2
GB,BINOCULAR EYE MOVEMENT DISORDER,2
GB,BLADDER ADENOCARCINOMA STAGE UNSPECIFIED,2
GB,BLADDER CANCER,2
GB,BLEPHARITIS,2
GB,BLOOD CHOLESTEROL ABNORMAL,2
GB,BLOOD GLUCOSE DECREASED,2
GB,BLOOD POTASSIUM INCREASED,2
GB,BLOOD PRESSURE SYSTOLIC INCREASED,2
GB,BRAIN NATRIURETIC PEPTIDE INCREASED,2
GB,BREAST SWELLING,2
GB,BRONCHITIS,2
GB,BROW PTOSIS,2
GB,CANDIDA INFECTION,2
GB,CARDIAC TAMPONADE,2
GB,CARDIOMEGALY,2
GB,CATARACT,2
GB,CHEILITIS,2
GB,CHOROIDAL NEOVASCULARISATION,2
GB,CLOSTRIDIAL INFECTION,2
GB,CLOSTRIDIUM DIFFICILE INFECTION,2
GB,COLITIS ULCERATIVE,2
GB,CONSCIOUSNESS FLUCTUATING,2
GB,COUNTERFEIT PRODUCT ADMINISTERED,2
GB,CREPITATIONS,2
GB,CUTANEOUS VASCULITIS,2
GB,DECUBITUS ULCER,2
GB,DEMYELINATION,2
GB,DEPENDENCE,2
GB,DEPRESSION SUICIDAL,2
GB,DEVICE OCCLUSION,2
GB,DEVICE RELATED INFECTION,2
GB,DEVICE RELATED SEPSIS,2
GB,DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL,2
GB,DIZZINESS POSTURAL,2
GB,DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT,2
GB,DRUG LEVEL ABOVE THERAPEUTIC,2
GB,DRUG TITRATION ERROR,2
GB,DRUG TOLERANCE,2
GB,DRY SKIN,2
GB,DYSPHONIA,2
GB,ELECTROCARDIOGRAM ABNORMAL,2
GB,ELECTROCARDIOGRAM QT INTERVAL ABNORMAL,2
GB,ELECTROLYTE IMBALANCE,2
GB,ENTHESOPATHY,2
GB,EOSINOPHILIC PNEUMONIA ACUTE,2
GB,ESCHERICHIA INFECTION,2
GB,EXCORIATION,2
GB,EXPIRED PRODUCT ADMINISTERED,2
GB,EXTREMITY NECROSIS,2
GB,EYE HAEMORRHAGE,2
GB,EYELID THICKENING,2
GB,FACE INJURY,2
GB,FACIAL PAIN,2
GB,FACIAL SPASM,2
GB,FAECAL INCONTINENCE,2
GB,FISTULA,2
GB,FOOD CRAVING,2
GB,FREQUENT BOWEL MOVEMENTS,2
GB,FURUNCLE,2
GB,GASTROINTESTINAL HYPOMOTILITY,2
GB,GINGIVAL RECESSION,2
GB,GLOSSODYNIA,2
GB,GOUT,2
GB,HAEMATOCHEZIA,2
GB,HAEMATOCRIT DECREASED,2
GB,HAEMOLYSIS,2
GB,HAEMOPTYSIS,2
GB,HEPATITIS C,2
GB,HEPATOBILIARY DISEASE,2
GB,HEPATOCELLULAR CARCINOMA,2
GB,HEPATOTOXICITY,2
GB,HIP ARTHROPLASTY,2
GB,HYPERACUSIS,2
GB,HYPERCALCAEMIA,2
GB,HYPERLACTACIDAEMIA,2
GB,HYPERSENSITIVITY VASCULITIS,2
GB,HYPERTONIA,2
GB,HYPERTRIGLYCERIDAEMIA,2
GB,HYPERVIGILANCE,2
GB,HYPOKINESIA,2
GB,HYPONATRAEMIC ENCEPHALOPATHY,2
GB,IDIOPATHIC PULMONARY FIBROSIS,2
GB,IIIRD NERVE PARALYSIS,2
GB,IMPAIRED HEALING,2
GB,IMPATIENCE,2
GB,INDIFFERENCE,2
GB,INJECTION SITE DISCOMFORT,2
GB,INJECTION SITE MASS,2
GB,INTENTIONAL PRODUCT USE ISSUE,2
GB,INTERSTITIAL LUNG DISEASE,2
GB,INVASIVE DUCTAL BREAST CARCINOMA,2
GB,IRRITABLE BOWEL SYNDROME,2
GB,ISCHAEMIC STROKE,2
GB,JAW DISORDER,2
GB,LEFT VENTRICULAR FAILURE,2
GB,LEUKOPENIA,2
GB,LIMB INJURY,2
GB,LIVER DISORDER,2
GB,LOSS OF CONTROL OF LEGS,2
GB,LOSS OF LIBIDO,2
US,PAIN,9758
US,DRUG INEFFECTIVE,8899
US,MALAISE,3996
US,PAIN IN EXTREMITY,3848
US,WEIGHT INCREASED,3631
US,DIZZINESS,3458
US,FEELING ABNORMAL,3252
US,FATIGUE,2964
US,INSOMNIA,2949
US,NAUSEA,2914
US,SOMNOLENCE,2667
US,HEADACHE,2606
US,CONDITION AGGRAVATED,2602
US,DRUG HYPERSENSITIVITY,2569
US,FALL,2481
US,GAIT DISTURBANCE,2355
US,DEPRESSION,1850
US,PERIPHERAL SWELLING,1768
US,DIARRHOEA,1745
US,DRUG EFFECT INCOMPLETE,1738
US,ARTHRALGIA,1713
US,DYSPNOEA,1710
US,VISION BLURRED,1662
US,ANXIETY,1661
US,HYPOAESTHESIA,1645
US,BACK PAIN,1597
US,PARAESTHESIA,1537
US,MEMORY IMPAIRMENT,1443
US,VOMITING,1427
US,ASTHENIA,1395
US,PRODUCT USE ISSUE,1346
US,WEIGHT DECREASED,1343
US,BURNING SENSATION,1341
US,DRUG WITHDRAWAL SYNDROME,1325
US,INTENTIONAL PRODUCT MISUSE,1296
US,DRUG DOSE OMISSION,1277
US,NEUROPATHY PERIPHERAL,1229
US,MUSCLE SPASMS,1174
US,PNEUMONIA,1163
US,TREMOR,1112
US,WITHDRAWAL SYNDROME,1108
US,RASH,1089
US,THERAPEUTIC RESPONSE UNEXPECTED,1066
US,FIBROMYALGIA,1051
US,PRURITUS,986
US,NASOPHARYNGITIS,969
US,INTENTIONAL PRODUCT USE ISSUE,960
US,BALANCE DISORDER,899
US,SUICIDAL IDEATION,869
US,CONFUSIONAL STATE,862
US,SWELLING,849
US,JOINT SWELLING,837
US,CONSTIPATION,835
US,HYPERHIDROSIS,826
US,MYALGIA,826
US,DRUG INTOLERANCE,824
US,NEURALGIA,801
US,DRY MOUTH,796
US,COUGH,782
US,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,774
US,HYPERTENSION,772
US,DEATH,766
US,CEREBROVASCULAR ACCIDENT,759
US,ACTIVITIES OF DAILY LIVING IMPAIRED,738
US,PRE-EXISTING CONDITION IMPROVED,724
US,OEDEMA PERIPHERAL,704
US,ABDOMINAL PAIN UPPER,699
US,HYPERSENSITIVITY,696
US,VISUAL IMPAIRMENT,690
US,AMNESIA,688
US,ABDOMINAL DISCOMFORT,687
US,MUSCULAR WEAKNESS,666
US,PYREXIA,662
US,DECREASED APPETITE,656
US,ARTHROPATHY,647
US,CHEST PAIN,638
US,DIABETES MELLITUS,624
US,URINARY TRACT INFECTION,611
US,ARTHRITIS,607
US,MIGRAINE,592
US,DISTURBANCE IN ATTENTION,578
US,SEIZURE,576
US,INFLUENZA,575
US,LOSS OF CONSCIOUSNESS,558
US,OVERDOSE,557
US,NECK PAIN,548
US,BLOOD GLUCOSE INCREASED,544
US,IRRITABILITY,536
US,LOCAL SWELLING,536
US,MYOCARDIAL INFARCTION,527
US,MUSCULOSKELETAL PAIN,518
US,LIMB DISCOMFORT,517
US,ABDOMINAL PAIN,503
US,ROAD TRAFFIC ACCIDENT,503
US,BACK DISORDER,501
US,MUSCULOSKELETAL STIFFNESS,487
US,ABASIA,483
US,ALOPECIA,470
US,BLOOD PRESSURE INCREASED,464
US,SPEECH DISORDER,461
US,BRONCHITIS,460
US,DEHYDRATION,453
US,SINUSITIS,452
US,CONTUSION,451
US,NERVOUSNESS,445
US,PRODUCT USE IN UNAPPROVED INDICATION,442
US,URTICARIA,442
US,STRESS,437
US,CHILLS,435
US,DYSPHAGIA,427
US,AGITATION,413
US,INJECTION SITE PAIN,410
US,HERPES ZOSTER,409
US,SLEEP DISORDER,408
US,CARDIAC DISORDER,402
US,IMPAIRED WORK ABILITY,401
US,ERYTHEMA,399
US,ANAEMIA,397
US,OEDEMA,395
US,PRODUCT QUALITY ISSUE,392
US,INTERVERTEBRAL DISC PROTRUSION,388
US,HYPOTENSION,387
US,CRYING,383
US,DYSSTASIA,382
US,OROPHARYNGEAL PAIN,380
US,COMPLETED SUICIDE,378
US,DRUG DEPENDENCE,376
US,MOBILITY DECREASED,372
US,ABDOMINAL DISTENSION,367
US,HALLUCINATION,366
US,INFLUENZA LIKE ILLNESS,365
US,PRESCRIBED OVERDOSE,364
US,OSTEOARTHRITIS,361
US,NERVE INJURY,359
US,FLUID RETENTION,353
US,IMPAIRED DRIVING ABILITY,353
US,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,349
US,RHEUMATOID ARTHRITIS,347
US,GASTROOESOPHAGEAL REFLUX DISEASE,344
US,SWELLING FACE,343
US,DRUG EFFECT DECREASED,339
US,MULTIPLE SCLEROSIS RELAPSE,336
US,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,334
US,INCORRECT DOSE ADMINISTERED,334
US,DISCOMFORT,331
US,THINKING ABNORMAL,329
US,DISEASE PROGRESSION,325
US,BLISTER,321
US,RENAL FAILURE,320
US,HOT FLUSH,317
US,CATARACT,316
US,INFECTION,316
US,HYPOACUSIS,312
US,INTENTIONAL DRUG MISUSE,308
US,BLOOD CHOLESTEROL INCREASED,307
US,DEPRESSED MOOD,306
US,THROMBOSIS,306
US,MOVEMENT DISORDER,297
US,ANGER,293
US,PALPITATIONS,293
US,CARDIAC FAILURE CONGESTIVE,292
US,DYSPHONIA,288
US,DYSPEPSIA,287
US,HEART RATE INCREASED,287
US,ASTHMA,285
US,NEOPLASM MALIGNANT,285
US,CONVULSION,284
US,DYSKINESIA,284
US,COGNITIVE DISORDER,283
US,PANIC ATTACK,281
US,TOXICITY TO VARIOUS AGENTS,281
US,FEELING HOT,280
US,EUPHORIC MOOD,279
US,BEDRIDDEN,273
US,GASTROINTESTINAL HAEMORRHAGE,270
US,HYPERSOMNIA,266
US,OSTEOPOROSIS,262
US,LETHARGY,260
US,UNEVALUABLE EVENT,260
US,FEELING DRUNK,259
US,VERTIGO,259
US,EMOTIONAL DISORDER,258
US,SYNCOPE,258
US,BODY HEIGHT DECREASED,256
US,DIABETIC NEUROPATHY,252
US,EYE DISORDER,249
US,MULTIPLE SCLEROSIS,249
US,SEPSIS,249
US,ABNORMAL BEHAVIOUR,248
US,FLUSHING,247
US,BONE PAIN,241
US,VISUAL ACUITY REDUCED,241
US,RESTLESS LEGS SYNDROME,240
US,SLEEP APNOEA SYNDROME,237
US,FOOT FRACTURE,236
US,INTERVERTEBRAL DISC DEGENERATION,236
US,INCREASED APPETITE,234
US,INJURY,234
US,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,231
US,LIMB INJURY,228
US,CHEST DISCOMFORT,226
US,MENTAL IMPAIRMENT,225
US,NIGHTMARE,224
US,DYSARTHRIA,221
US,NERVOUS SYSTEM DISORDER,220
US,PULMONARY EMBOLISM,220
US,SEDATION,219
US,RENAL DISORDER,215
US,ACUTE KIDNEY INJURY,214
US,GASTROINTESTINAL DISORDER,214
US,BLINDNESS,213
US,RESTLESSNESS,213
US,DYSURIA,212
US,HEAD INJURY,212
US,GASTRIC DISORDER,211
US,MENTAL DISORDER,211
US,CELLULITIS,210
US,DRY EYE,210
US,SWOLLEN TONGUE,209
US,UPPER RESPIRATORY TRACT INFECTION,209
US,MUSCLE TWITCHING,208
US,NASAL CONGESTION,208
US,DISORIENTATION,207
US,MUSCULOSKELETAL DISORDER,207
US,HAEMORRHAGE,203
US,TINNITUS,203
US,DIPLOPIA,202
US,JOINT INJURY,202
US,POOR QUALITY SLEEP,202
US,ATRIAL FIBRILLATION,201
US,MOOD ALTERED,200
US,NIGHT SWEATS,200
US,DRUG DISPENSING ERROR,199
US,SPINAL DISORDER,197
US,ANKLE FRACTURE,196
US,FEELING COLD,191
US,UPPER LIMB FRACTURE,191
US,MUSCULOSKELETAL DISCOMFORT,190
US,PSORIASIS,189
US,RHINORRHOEA,189
US,LOWER LIMB FRACTURE,188
US,URINARY INCONTINENCE,187
US,ABNORMAL DREAMS,186
US,INJECTION SITE ERYTHEMA,186
US,STAPHYLOCOCCAL INFECTION,183
US,AGGRESSION,182
US,DEEP VEIN THROMBOSIS,180
US,BONE DISORDER,179
US,GENERAL PHYSICAL HEALTH DETERIORATION,178
US,MENTAL STATUS CHANGES,176
US,NEPHROLITHIASIS,176
US,PLATELET COUNT DECREASED,176
US,WHITE BLOOD CELL COUNT DECREASED,176
US,DRY SKIN,175
US,SCIATICA,175
US,RIB FRACTURE,172
US,CYSTITIS,170
US,DYSGEUSIA,170
US,SKIN DISCOLOURATION,170
US,EATING DISORDER,169
US,POLLAKIURIA,169
US,HIP FRACTURE,168
US,LOCALISED INFECTION,167
US,HYPOKINESIA,166
US,LIP SWELLING,166
US,BLOOD POTASSIUM DECREASED,164
US,INJECTION SITE BRUISING,164
US,TOOTH DISORDER,164
US,EPISTAXIS,161
US,DRUG PRESCRIBING ERROR,160
US,WHEEZING,159
US,CARDIAC ARREST,155
US,EYE PAIN,155
US,RESPIRATORY FAILURE,155
US,EXPIRED PRODUCT ADMINISTERED,154
US,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,154
US,HEPATIC ENZYME INCREASED,153
US,MIDDLE INSOMNIA,153
US,SPINAL OSTEOARTHRITIS,153
US,ADVERSE EVENT,152
US,BACK INJURY,152
US,BLOOD GLUCOSE DECREASED,152
US,SYSTEMIC LUPUS ERYTHEMATOSUS,152
US,BLOOD PRESSURE DECREASED,151
US,HAEMOGLOBIN DECREASED,151
US,CARPAL TUNNEL SYNDROME,150
US,WRONG TECHNIQUE IN DRUG USAGE PROCESS,148
US,SPINAL COLUMN STENOSIS,147
US,STOMATITIS,147
US,COLD SWEAT,145
US,ADVERSE DRUG REACTION,144
US,SUICIDE ATTEMPT,143
US,SKIN DISORDER,142
US,LUNG DISORDER,140
US,PLASMA CELL MYELOMA,140
US,EMOTIONAL DISTRESS,139
US,FLATULENCE,139
US,MOOD SWINGS,137
US,APHASIA,135
US,ROTATOR CUFF SYNDROME,135
US,PHARYNGEAL OEDEMA,134
US,TYPE 2 DIABETES MELLITUS,134
US,DRUG ABUSE,132
US,TRANSIENT ISCHAEMIC ATTACK,130
US,URINARY RETENTION,130
US,GASTROENTERITIS VIRAL,129
US,NERVE COMPRESSION,128
US,SKIN ULCER,127
US,COORDINATION ABNORMAL,125
US,MUSCLE TIGHTNESS,125
US,SPINAL FRACTURE,125
US,RENAL IMPAIRMENT,124
US,FEAR,122
US,IRRITABLE BOWEL SYNDROME,122
US,BREAST CANCER,121
US,NO ADVERSE EVENT,121
US,SURGERY,121
US,FEELING JITTERY,120
US,IMPAIRED HEALING,119
US,HOSPITALISATION,118
US,HYPOTHYROIDISM,118
US,INJECTION SITE PRURITUS,118
US,PANCREATITIS,118
US,DRUG ADMINISTRATION ERROR,116
US,RECTAL HAEMORRHAGE,115
US,THERAPY CESSATION,115
US,DRUG TOLERANCE,114
US,INFLAMMATION,114
US,INTERVERTEBRAL DISC DISORDER,113
US,JOINT STIFFNESS,113
US,ORAL PAIN,113
US,THROAT IRRITATION,113
US,FEELING OF BODY TEMPERATURE CHANGE,112
US,VITAMIN D DEFICIENCY,112
US,FEEDING DISORDER,111
US,OBESITY,111
US,OSTEOMYELITIS,111
US,HERNIA,110
US,WOUND,110
US,EAR PAIN,109
US,HUNGER,109
US,PRODUCT ADHESION ISSUE,109
US,PRURITUS GENERALISED,109
US,UNDERDOSE,109
US,INTENTIONAL OVERDOSE,108
US,SENSORY LOSS,108
US,ACCIDENT,107
US,GLYCOSYLATED HAEMOGLOBIN INCREASED,107
US,HEARING IMPAIRED,107
US,LARYNGITIS,107
US,PERIPHERAL COLDNESS,107
US,THERAPEUTIC RESPONSE DECREASED,107
US,COMA,106
US,OXYGEN SATURATION DECREASED,106
US,VIRAL INFECTION,106
US,EAR INFECTION,105
US,PRODUCTIVE COUGH,105
US,SKIN EXFOLIATION,105
US,TACHYCARDIA,105
US,THROMBOCYTOPENIA,105
US,WRIST FRACTURE,105
US,EYE SWELLING,104
US,INJECTION SITE HAEMORRHAGE,104
US,SKIN LESION,104
US,THERAPEUTIC RESPONSE CHANGED,104
US,CARDIO-RESPIRATORY ARREST,103
US,SINUS DISORDER,103
US,SPINAL PAIN,103
US,CROHN^S DISEASE,102
US,FORMICATION,102
US,PLEURAL EFFUSION,102
US,GAIT INABILITY,101
US,LIGAMENT SPRAIN,101
US,FOOT DEFORMITY,100
US,APPARENT DEATH,99
US,DEMENTIA,99
US,EXOSTOSIS,99
US,DISEASE RECURRENCE,98
US,DYSGRAPHIA,98
US,FACIAL PAIN,98
US,RASH PRURITIC,98
US,GOUT,97
US,ANAPHYLACTIC REACTION,96
US,CHRONIC KIDNEY DISEASE,96
US,HYPERLIPIDAEMIA,96
US,INJECTION SITE REACTION,96
US,WHITE BLOOD CELL COUNT INCREASED,96
US,BLOOD CREATININE INCREASED,95
US,DEAFNESS,95
US,ERECTILE DYSFUNCTION,95
US,FUNGAL INFECTION,95
US,MUSCULOSKELETAL CHEST PAIN,95
US,SKIN BURNING SENSATION,95
US,TOOTHACHE,95
US,CHOLELITHIASIS,94
US,HEAD DISCOMFORT,94
US,JOINT RANGE OF MOTION DECREASED,94
US,KIDNEY INFECTION,94
US,OSTEOPENIA,94
US,VITAMIN D DECREASED,94
US,LUNG NEOPLASM MALIGNANT,93
US,SCAR,93
US,APHONIA,92
US,PAIN IN JAW,92
US,TENDERNESS,92
US,UNRESPONSIVE TO STIMULI,92
US,HIATUS HERNIA,91
US,LYMPHADENOPATHY,91
US,BLADDER DISORDER,90
US,FEMUR FRACTURE,90
US,GALLBLADDER DISORDER,90
US,DYSPNOEA EXERTIONAL,89
US,RESPIRATORY ARREST,89
US,BIPOLAR DISORDER,88
US,CORONARY ARTERY DISEASE,88
US,PULMONARY OEDEMA,88
US,DIVERTICULITIS,87
US,SENSORY DISTURBANCE,87
US,TOOTH LOSS,87
US,HYPOKALAEMIA,86
US,NEUTROPENIA,86
US,HAEMATOCHEZIA,85
US,LACERATION,85
US,MULTIPLE FRACTURES,85
US,CARDIAC FAILURE,84
US,RASH GENERALISED,84
US,WEIGHT FLUCTUATION,84
US,BURSITIS,82
US,CONCUSSION,82
US,GASTRITIS,81
US,GLAUCOMA,81
US,HYPOXIA,81
US,LACRIMATION INCREASED,81
US,PSORIATIC ARTHROPATHY,81
US,SCOLIOSIS,81
US,LIVER DISORDER,80
US,MUSCLE DISORDER,80
US,RETCHING,80
US,ULCER,80
US,ACNE,79
US,DEVICE MALFUNCTION,79
US,EYE IRRITATION,79
US,MENISCUS INJURY,79
US,TREATMENT NONCOMPLIANCE,79
US,BLOOD TRIGLYCERIDES INCREASED,78
US,HYPERAESTHESIA,78
US,MALIGNANT NEOPLASM PROGRESSION,78
US,OCULAR HYPERAEMIA,78
US,PERSONALITY CHANGE,78
US,THYROID DISORDER,78
US,BLOOD GLUCOSE ABNORMAL,77
US,DENTAL CARIES,77
US,IMPAIRED GASTRIC EMPTYING,77
US,INTESTINAL OBSTRUCTION,77
US,RHABDOMYOLYSIS,77
US,ANGINA PECTORIS,76
US,ARRHYTHMIA,76
US,DEVICE ISSUE,75
US,DRUG EFFECT DELAYED,75
US,MUSCLE SPASTICITY,75
US,PARALYSIS,75
US,PARKINSON^S DISEASE,75
US,POOR QUALITY DRUG ADMINISTERED,75
US,PRODUCT PHYSICAL ISSUE,75
US,TOOTH FRACTURE,75
US,BLOOD PRESSURE ABNORMAL,74
US,BRAIN INJURY,74
US,DISABILITY,74
US,CORONARY ARTERY OCCLUSION,73
US,DYSPHEMIA,73
US,HEART RATE DECREASED,73
US,HEPATIC STEATOSIS,73
US,HAEMORRHOIDS,72
US,PHOTOPHOBIA,72
US,SNEEZING,72
US,ANGIOEDEMA,71
US,PERONEAL NERVE PALSY,71
US,SOMNAMBULISM,71
US,APHAGIA,70
US,CLOSTRIDIUM DIFFICILE INFECTION,70
US,COLITIS,70
US,DECREASED INTEREST,70
US,HEART RATE IRREGULAR,70
US,MEDICATION ERROR,70
US,INTENTIONAL UNDERDOSE,69
US,RENAL FAILURE ACUTE,69
US,BLOOD SODIUM DECREASED,68
US,GASTRIC ULCER,68
US,HYPOAESTHESIA ORAL,68
US,RESPIRATORY DISORDER,68
US,THROAT TIGHTNESS,68
US,DELIRIUM,67
US,ILL-DEFINED DISORDER,67
US,MOTOR DYSFUNCTION,67
US,OSTEONECROSIS OF JAW,67
US,RASH MACULAR,67
US,VAGINAL HAEMORRHAGE,67
US,WALKING AID USER,67
US,HAND FRACTURE,66
US,KNEE ARTHROPLASTY,66
US,PSYCHOMOTOR HYPERACTIVITY,66
US,TENDONITIS,66
US,ATAXIA,65
US,BRADYCARDIA,65
US,FRUSTRATION,65
US,PANCYTOPENIA,65
US,POST PROCEDURAL COMPLICATION,65
US,RASH ERYTHEMATOUS,65
US,CYST,64
US,GLOSSODYNIA,64
US,PRESYNCOPE,64
US,SJOGREN^S SYNDROME,64
US,HAEMATOMA,63
US,SLUGGISHNESS,63
US,TRIGEMINAL NEURALGIA,63
US,HYPOGLYCAEMIA,62
US,CENTRAL NERVOUS SYSTEM LESION,61
US,MAJOR DEPRESSION,61
US,BLOOD POTASSIUM INCREASED,60
US,COMPLEX REGIONAL PAIN SYNDROME,60
US,DEPRESSED LEVEL OF CONSCIOUSNESS,60
US,GRIP STRENGTH DECREASED,60
US,HAEMORRHAGIC ANAEMIA,60
US,HEMIPARESIS,60
US,LIVER FUNCTION TEST ABNORMAL,60
US,MANIA,60
US,PARANOIA,60
US,PRESCRIBED UNDERDOSE,60
US,BREAKTHROUGH PAIN,59
US,CHOKING,59
US,HAEMATURIA,59
US,INJECTION SITE SWELLING,59
US,JOINT DISLOCATION,59
US,RESPIRATORY TRACT CONGESTION,59
US,SEXUAL DYSFUNCTION,59
US,GLUCOSE TOLERANCE IMPAIRED,58
US,HALLUCINATION_ AUDITORY,58
US,INCORRECT DRUG ADMINISTRATION DURATION,58
US,INJECTION SITE MASS,58
US,MICTURITION URGENCY,58
US,CHROMATURIA,57
US,FULL BLOOD COUNT DECREASED,57
US,GENERALISED TONIC-CLONIC SEIZURE,57
US,LABORATORY TEST ABNORMAL,57
US,MALABSORPTION,57
US,PULMONARY THROMBOSIS,57
US,TEMPERATURE INTOLERANCE,57
US,THIRST,57
US,HYPOPHAGIA,56
US,IMMUNE SYSTEM DISORDER,56
US,LOGORRHOEA,56
US,LUNG INFECTION,56
US,MACULAR DEGENERATION,56
US,MUSCLE ATROPHY,56
US,PULMONARY HYPERTENSION,56
US,WOUND INFECTION,56
US,HAEMOPTYSIS,55
US,PAIN OF SKIN,55
US,PULMONARY MASS,55
US,BLINDNESS UNILATERAL,54
US,BLOOD IRON DECREASED,54
US,DIABETIC KETOACIDOSIS,54
US,LEUKOPENIA,54
US,LUMBAR SPINAL STENOSIS,54
US,MASS,54
US,MOUTH SWELLING,54
US,PANIC REACTION,54
US,PARAESTHESIA ORAL,54
US,RED BLOOD CELL COUNT DECREASED,54
US,SEPTIC SHOCK,54
US,BLOOD URINE PRESENT,53
US,BRAIN NEOPLASM,53
US,EYE PRURITUS,53
US,POST-TRAUMATIC STRESS DISORDER,53
US,SCRATCH,53
US,SINUS CONGESTION,53
US,ARTERIAL OCCLUSIVE DISEASE,52
US,EMPHYSEMA,52
US,RESPIRATORY TRACT INFECTION,52
US,HALLUCINATION_ VISUAL,51
US,HYPONATRAEMIA,51
US,ORTHOSTATIC HYPOTENSION,51
US,QUALITY OF LIFE DECREASED,51
US,SEASONAL ALLERGY,51
US,ATELECTASIS,50
US,CANDIDA INFECTION,50
US,DERMATITIS,50
US,ENERGY INCREASED,50
US,INCONTINENCE,50
US,INTERNAL HAEMORRHAGE,50
US,LIBIDO DECREASED,50
US,LOWER RESPIRATORY TRACT INFECTION,50
US,LYMPHOEDEMA,50
US,MOUTH ULCERATION,50
US,PROCEDURAL PAIN,50
US,SPINAL OPERATION,50
US,APPLICATION SITE PRURITUS,49
US,BACTERIAL INFECTION,49
US,BLOOD COUNT ABNORMAL,49
US,BRADYPHRENIA,49
US,DIABETES MELLITUS INADEQUATE CONTROL,49
US,NECK INJURY,49
US,NOCTURIA,49
US,ALANINE AMINOTRANSFERASE INCREASED,48
US,ASPARTATE AMINOTRANSFERASE INCREASED,48
US,DECUBITUS ULCER,48
US,DRUG SCREEN FALSE POSITIVE,48
US,EAR DISCOMFORT,48
US,PULMONARY FIBROSIS,48
US,SKIN CANCER,48
US,TOOTH INFECTION,48
US,APPLICATION SITE ERYTHEMA,47
US,HAEMATEMESIS,47
US,HEPATIC CIRRHOSIS,47
US,HYPERGLYCAEMIA,47
US,ORAL MUCOSAL BLISTERING,47
US,PALLOR,47
US,PNEUMONIA ASPIRATION,47
US,ACUTE RESPIRATORY FAILURE,46
US,APPETITE DISORDER,46
US,BLOOD PRESSURE FLUCTUATION,46
US,BLOOD TESTOSTERONE DECREASED,46
US,EPILEPSY,46
US,ESSENTIAL HYPERTENSION,46
US,HEPATIC FAILURE,46
US,INCORRECT ROUTE OF DRUG ADMINISTRATION,46
US,PERIPHERAL VASCULAR DISORDER,46
US,SINUS HEADACHE,46
US,TONGUE DISORDER,46
US,UPPER GASTROINTESTINAL HAEMORRHAGE,46
US,WHEELCHAIR USER,46
US,BLOOD TEST ABNORMAL,45
US,BREAST CANCER FEMALE,45
US,DIVERTICULUM,45
US,DRUG SCREEN POSITIVE,45
US,ERUCTATION,45
US,INCOHERENT,45
US,PRODUCT SUBSTITUTION ISSUE,45
US,RESPIRATORY DISTRESS,45
US,ACCIDENTAL OVERDOSE,44
US,AFFECT LABILITY,44
US,METASTASES TO BONE,44
US,NODULE,44
US,ORAL DISCOMFORT,44
US,TOOTH ABSCESS,44
US,VIRAL UPPER RESPIRATORY TRACT INFECTION,44
US,APATHY,43
US,EXTRA DOSE ADMINISTERED,43
US,FRACTURE,43
US,PELVIC PAIN,43
US,PHOTOSENSITIVITY REACTION,43
US,UPPER-AIRWAY COUGH SYNDROME,43
US,BASAL CELL CARCINOMA,42
US,BLOOD MAGNESIUM DECREASED,42
US,CARDIOMEGALY,42
US,CARDIOVASCULAR DISORDER,42
US,EYE HAEMORRHAGE,42
US,HOMICIDAL IDEATION,42
US,LYMPHOCYTE COUNT DECREASED,42
US,MUSCLE STRAIN,42
US,MYOCLONUS,42
US,NEOPLASM,42
US,NO THERAPEUTIC RESPONSE,42
US,ORAL HERPES,42
US,PROSTATE CANCER,42
US,SCREAMING,42
US,SEROTONIN SYNDROME,42
US,SPINAL CORD INJURY,42
US,AGEUSIA,41
US,BLOOD CHOLESTEROL ABNORMAL,41
US,BODY MASS INDEX INCREASED,41
US,CEREBRAL HAEMORRHAGE,41
US,COAGULOPATHY,41
US,DYSPHORIA,41
US,FAECES DISCOLOURED,41
US,INCREASED TENDENCY TO BRUISE,41
US,OSTEONECROSIS,41
US,POOR PERIPHERAL CIRCULATION,41
US,POST HERPETIC NEURALGIA,41
US,TIBIA FRACTURE,41
US,ASPIRATION,40
US,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,40
US,ECZEMA,40
US,FACIAL BONES FRACTURE,40
US,FOOD CRAVING,40
US,GINGIVAL PAIN,40
US,GINGIVAL SWELLING,40
US,INADEQUATE ANALGESIA,40
US,INITIAL INSOMNIA,40
US,IRON DEFICIENCY ANAEMIA,40
US,PELVIC FRACTURE,40
US,PERICARDIAL EFFUSION,40
US,RADICULOPATHY,40
US,RENAL CYST,40
US,SPINAL COMPRESSION FRACTURE,40
US,TUBULOINTERSTITIAL NEPHRITIS,40
US,BREAST PAIN,39
US,COMPRESSION FRACTURE,39
US,DEPENDENCE,39
US,HANGOVER,39
US,HYPERCHOLESTEROLAEMIA,39
US,INCORRECT PRODUCT STORAGE,39
US,MYOSITIS,39
US,OVERWEIGHT,39
US,PSYCHOTIC DISORDER,39
US,SPINAL CORD DISORDER,39
US,SUICIDAL BEHAVIOUR,39
US,TREATMENT FAILURE,39
US,BLOOD CREATINE PHOSPHOKINASE INCREASED,38
US,DECREASED ACTIVITY,38
US,EXPIRED DRUG ADMINISTERED,38
US,FLUID OVERLOAD,38
US,GROIN PAIN,38
US,INFUSION RELATED REACTION,38
US,INTRACRANIAL ANEURYSM,38
US,ORAL DISORDER,38
US,PNEUMOTHORAX,38
US,BLOOD ALKALINE PHOSPHATASE INCREASED,37
US,GASTROINTESTINAL PAIN,37
US,GINGIVAL BLEEDING,37
US,MALIGNANT MELANOMA,37
US,RASH PAPULAR,37
US,SHOCK,37
US,UTERINE DISORDER,37
US,ABSCESS,36
US,ADRENAL INSUFFICIENCY,36
US,BODY TEMPERATURE INCREASED,36
US,CLUMSINESS,36
US,DRUG-INDUCED LIVER INJURY,36
US,INJECTION SITE RASH,36
US,INTERNATIONAL NORMALISED RATIO INCREASED,36
US,LIGAMENT RUPTURE,36
US,MITRAL VALVE INCOMPETENCE,36
US,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,36
US,PHARYNGITIS STREPTOCOCCAL,36
US,STEVENS-JOHNSON SYNDROME,36
US,ACUTE MYOCARDIAL INFARCTION,35
US,APPLICATION SITE PAIN,35
US,CERVICAL SPINAL STENOSIS,35
US,DRY THROAT,35
US,INTERSTITIAL LUNG DISEASE,35
US,JOINT EFFUSION,35
US,LARGE INTESTINE POLYP,35
US,MEDICATION RESIDUE PRESENT,35
US,SKIN IRRITATION,35
US,TENDON RUPTURE,35
US,ARTHROPOD BITE,34
US,BRUXISM,34
US,CEREBRAL DISORDER,34
US,COLON CANCER,34
US,DRUG ADMINISTERED AT INAPPROPRIATE SITE,34
US,FACE INJURY,34
US,FREQUENT BOWEL MOVEMENTS,34
US,INJECTION SITE URTICARIA,34
US,LEUKAEMIA,34
US,METABOLIC ACIDOSIS,34
US,NAIL DISORDER,34
US,THERMAL BURN,34
US,ABDOMINAL PAIN LOWER,33
US,BLOOD GLUCOSE FLUCTUATION,33
US,DERMATITIS CONTACT,33
US,DRUG USE DISORDER,33
US,ENDOMETRIOSIS,33
US,FRUSTRATION TOLERANCE DECREASED,33
US,HAIR GROWTH ABNORMAL,33
US,SCAB,33
US,SKIN FISSURES,33
US,AFFECTIVE DISORDER,32
US,ANAL INCONTINENCE,32
US,HYPERKALAEMIA,32
US,LUNG INFILTRATION,32
US,PULMONARY CONGESTION,32
US,RENAL FAILURE CHRONIC,32
US,SKIN ABRASION,32
US,SKIN WARM,32
US,SNORING,32
US,VITAMIN B12 DEFICIENCY,32
US,AORTIC ANEURYSM,31
US,ARTHRITIS INFECTIVE,31
US,BLOOD DISORDER,31
US,DELUSION,31
US,DEMENTIA ALZHEIMER^S TYPE,31
US,DEVICE RELATED INFECTION,31
US,FLANK PAIN,31
US,HEPATITIS C,31
US,MUSCLE RUPTURE,31
US,PARTIAL SEIZURES,31
US,PNEUMONITIS,31
US,POST PROCEDURAL INFECTION,31
US,TOOTH EXTRACTION,31
US,UROSEPSIS,31
US,VERTEBRAL FORAMINAL STENOSIS,31
US,ANEURYSM,30
US,ANHEDONIA,30
US,ARTERIOSCLEROSIS,30
US,BONE DENSITY DECREASED,30
US,EAR DISORDER,30
US,EYELID PTOSIS,30
US,FACE OEDEMA,30
US,GANGRENE,30
US,GOITRE,30
US,HAIR TEXTURE ABNORMAL,30
US,LOWER GASTROINTESTINAL HAEMORRHAGE,30
US,LYMPHOMA,30
US,ONYCHOMYCOSIS,30
US,ORAL CANDIDIASIS,30
US,OSTEOSCLEROSIS,30
US,PRODUCT LABEL ISSUE,30
US,REACTION TO DRUG EXCIPIENTS,30
US,RHINITIS ALLERGIC,30
US,SKIN HAEMORRHAGE,30
US,SKIN INFECTION,30
US,TENDON DISORDER,30
US,VISUAL FIELD DEFECT,30
US,VITREOUS FLOATERS,30
US,ASCITES,29
US,BLOOD CALCIUM DECREASED,29
US,CERVICAL VERTEBRAL FRACTURE,29
US,DYSTONIA,29
US,ENCEPHALOPATHY,29
US,END STAGE RENAL DISEASE,29
US,EXPOSED BONE IN JAW,29
US,FEBRILE NEUTROPENIA,29
US,FIBULA FRACTURE,29
US,HYPOMAGNESAEMIA,29
US,IMMUNODEFICIENCY,29
US,MULTIPLE ALLERGIES,29
US,PANCREATIC CARCINOMA,29
US,PATHOLOGICAL FRACTURE,29
US,PRODUCT TASTE ABNORMAL,29
US,SPLENOMEGALY,29
US,SPONDYLOLISTHESIS,29
US,TEMPOROMANDIBULAR JOINT SYNDROME,29
US,URINARY HESITATION,29
US,AUTOIMMUNE DISORDER,28
US,BLOOD UREA INCREASED,28
US,BONE LOSS,28
US,CARDIAC MURMUR,28
US,CLAVICLE FRACTURE,28
US,ENURESIS,28
US,EYELID OEDEMA,28
US,FURUNCLE,28
US,GLOMERULAR FILTRATION RATE DECREASED,28
US,HEART RATE ABNORMAL,28
US,INJECTION SITE WARMTH,28
US,LOSS OF CONTROL OF LEGS,28
US,LUMBAR RADICULOPATHY,28
US,METASTASES TO LIVER,28
US,NARCOLEPSY,28
US,NEOPLASM PROGRESSION,28
US,OESOPHAGITIS,28
US,POLYP,28
US,RAYNAUD^S PHENOMENON,28
US,SECRETION DISCHARGE,28
US,SPINAL CORD COMPRESSION,28
US,SPINAL FUSION SURGERY,28
US,TRICUSPID VALVE INCOMPETENCE,28
US,TRIGGER FINGER,28
US,ANGIOPATHY,27
US,ARTERIOSCLEROSIS CORONARY ARTERY,27
US,CARDIOMYOPATHY,27
US,CYSTITIS INTERSTITIAL,27
US,DEFORMITY,27
US,DISSOCIATION,27
US,EXPOSURE DURING PREGNANCY,27
US,FAECAL INCONTINENCE,27
US,HIP ARTHROPLASTY,27
US,HYPERCALCAEMIA,27
US,JAW DISORDER,27
US,KNEE OPERATION,27
US,LEUKOCYTOSIS,27
US,MELAENA,27
US,OPTIC NEURITIS,27
US,PHOTOPSIA,27
US,READING DISORDER,27
US,SINUS TACHYCARDIA,27
US,TYPE 1 DIABETES MELLITUS,27
US,ATTENTION DEFICIT/HYPERACTIVITY DISORDER,26
US,CHONDROPATHY,26
US,CIRCULATORY COLLAPSE,26
US,COELIAC DISEASE,26
US,COLITIS ULCERATIVE,26
US,DEVICE DISLOCATION,26
US,DEVICE FAILURE,26
US,ECCHYMOSIS,26
US,EYE DISCHARGE,26
US,FACIAL PARALYSIS,26
US,GASTRIC HAEMORRHAGE,26
US,HEPATOMEGALY,26
US,HYPERPHAGIA,26
US,LYME DISEASE,26
US,METASTASES TO LUNG,26
US,OEDEMA MOUTH,26
US,ONYCHOCLASIS,26
US,OSTEOLYSIS,26
US,PERIPHERAL NERVE INJURY,26
US,PHARYNGEAL DISORDER,26
US,REGURGITATION,26
US,SPINAL COLUMN INJURY,26
US,UTERINE LEIOMYOMA,26
US,ANORGASMIA,25
US,ANXIETY DISORDER,25
US,BREAST MASS,25
US,CHOLECYSTECTOMY,25
US,CLOSTRIDIUM DIFFICILE COLITIS,25
US,DIABETIC COMA,25
US,ELECTROCARDIOGRAM ABNORMAL,25
US,GENERALISED OEDEMA,25
US,INTENTIONAL SELF-INJURY,25
US,INTRAOCULAR PRESSURE INCREASED,25
US,NASAL DISCOMFORT,25
US,RENAL PAIN,25
US,RESPIRATORY DEPRESSION,25
US,SINUS BRADYCARDIA,25
US,SPONDYLITIS,25
US,SQUAMOUS CELL CARCINOMA,25
US,SYNOVIAL CYST,25
US,ULCER HAEMORRHAGE,25
US,VEIN DISORDER,25
US,VIITH NERVE PARALYSIS,25
US,WEIGHT LOSS POOR,25
US,ACCIDENT AT WORK,24
US,BONE LESION,24
US,CALCIUM DEFICIENCY,24
US,DRUG EFFECT INCREASED,24
US,EYE INFECTION,24
US,EYE MOVEMENT DISORDER,24
US,FEELING OF DESPAIR,24
US,FOREIGN BODY,24
US,HAEMATOCRIT DECREASED,24
US,INJECTION SITE DISCOLOURATION,24
US,OESOPHAGEAL DISORDER,24
US,PHYSICAL DISABILITY,24
US,SOCIAL AVOIDANT BEHAVIOUR,24
US,ACCIDENTAL EXPOSURE TO PRODUCT,23
US,ANAPHYLACTIC SHOCK,23
US,AORTIC ARTERIOSCLEROSIS,23
US,BENIGN PROSTATIC HYPERPLASIA,23
US,CARTILAGE INJURY,23
US,DIABETIC FOOT,23
US,DIZZINESS POSTURAL,23
US,DROOLING,23
US,DYSAESTHESIA,23
US,FACET JOINT SYNDROME,23
US,GASTROENTERITIS,23
US,GINGIVAL DISORDER,23
US,GINGIVITIS,23
US,HYPERKERATOSIS,23
US,HYPERTONIC BLADDER,23
US,LIVER FUNCTION TEST INCREASED,23
US,MYOFASCIAL PAIN SYNDROME,23
US,NECK SURGERY,23
US,OVARIAN CYST,23
US,PETECHIAE,23
US,PHARYNGITIS,23
US,STRESS FRACTURE,23
US,THYROID FUNCTION TEST ABNORMAL,23
US,UMBILICAL HERNIA,23
US,ANKYLOSING SPONDYLITIS,22
US,BLADDER CANCER,22
US,BOWEL MOVEMENT IRREGULARITY,22
US,BRAIN OEDEMA,22
US,CARDIAC VALVE DISEASE,22
US,CAROTID ARTERY OCCLUSION,22
US,CHOLECYSTITIS,22
US,COMMUNICATION DISORDER,22
US,CRANIOCEREBRAL INJURY,22
US,EYE CONTUSION,22
US,HAEMORRHAGIC STROKE,22
US,HAIR COLOUR CHANGES,22
US,HYSTERECTOMY,22
US,KYPHOSIS,22
US,LUMBAR VERTEBRAL FRACTURE,22
US,ODYNOPHAGIA,22
US,PLEURISY,22
US,POSTOPERATIVE WOUND INFECTION,22
US,PRODUCT PACKAGING ISSUE,22
US,PROTEINURIA,22
US,RHINITIS,22
US,SKIN ATROPHY,22
US,SUBDURAL HAEMATOMA,22
US,SYNOVITIS,22
US,TENDON INJURY,22
US,URINE ODOUR ABNORMAL,22
US,VITAMIN B12 DECREASED,22
US,ADVERSE REACTION,21
US,APNOEA,21
US,BLADDER PROLAPSE,21
US,BLOOD BILIRUBIN INCREASED,21
US,BONE CANCER,21
US,BONE CYST,21
US,BRONCHOSPASM,21
US,HAEMORRHAGIC DIATHESIS,21
US,HYPERTHYROIDISM,21
US,HYPERVENTILATION,21
US,INGROWING NAIL,21
US,JOINT CREPITATION,21
US,JOINT INSTABILITY,21
UM,CEREBROVASCULAR ACCIDENT,1
UM,DEPRESSION,1
UM,DISORIENTATION,1
UM,DIZZINESS,1
UM,HYPOACUSIS,1
UM,LIMB DISCOMFORT,1
UM,WEIGHT INCREASED,1
UY,ANOSMIA,2
UY,CHRONIC SINUSITIS,2
UY,HEADACHE,2
UY,MUSCLE SPASMS,2
UY,RHINORRHOEA,2
UY,SPINAL PAIN,2
UY,ALOPECIA,1
UY,CARDIAC ARREST,1
UY,CEREBROVASCULAR ACCIDENT,1
UY,COMMUNICATION DISORDER,1
UY,MALAISE,1
UY,MOBILITY DECREASED,1
UY,PULMONARY OEDEMA,1
UY,SEIZURE,1
UY,SKIN MASS,1
UY,VENTRICULAR FIBRILLATION,1
VE,DEATH,32
VE,RESPIRATORY ARREST,10
VE,CEREBROVASCULAR ACCIDENT,6
VE,MYOCARDIAL INFARCTION,6
VE,SOMNOLENCE,6
VE,FALL,5
VE,NEOPLASM MALIGNANT,5
VE,TUBERCULIN TEST POSITIVE,5
VE,CARDIAC ARREST,4
VE,DIZZINESS,4
VE,HEADACHE,4
VE,PYREXIA,4
VE,HYPERTENSION,3
VE,PAIN,3
VE,TACHYCARDIA,3
VE,TREMOR,3
VE,ARTHRALGIA,2
VE,BACK DISORDER,2
VE,BACK PAIN,2
VE,BONE PAIN,2
VE,BRONCHITIS,2
VE,CAESAREAN SECTION,2
VE,COLON CANCER,2
VE,CONVULSION,2
VE,DISCOMFORT,2
VE,DRUG INEFFECTIVE,2
VE,GAIT DISTURBANCE,2
VE,GROIN PAIN,2
VE,HAEMOGLOBIN DECREASED,2
VE,HERNIA,2
VE,INFARCTION,2
VE,INFLAMMATION,2
VE,INGUINAL HERNIA,2
VE,INTERVERTEBRAL DISC PROTRUSION,2
VE,LIMB DISCOMFORT,2
VE,METASTASES TO LIVER,2
VE,OSTEOPOROSIS,2
VE,PAIN IN EXTREMITY,2
VE,RENAL FAILURE,2
VE,RHEUMATOID ARTHRITIS,2
VE,SPEECH DISORDER,2
VE,SYNCOPE,2
VE,TENDONITIS,2
VE,WRIST FRACTURE,2
VE,ABDOMINAL DISCOMFORT,1
VE,ACCIDENT,1
VE,ACTIVITIES OF DAILY LIVING IMPAIRED,1
VE,ANKLE FRACTURE,1
VE,ANORECTAL DISORDER,1
VE,APPENDICITIS,1
VE,ARRHYTHMIA,1
VE,ASPHYXIA,1
VE,ASTHENIA,1
VE,BEDRIDDEN,1
VE,BLOOD CHOLESTEROL INCREASED,1
VE,BLOOD IRON DECREASED,1
VE,BLOOD PRESSURE DECREASED,1
VE,BLOOD PRESSURE INCREASED,1
VE,BLOOD URINE,1
VE,BONE CANCER,1
VE,BONE DISORDER,1
VE,BRAIN NEOPLASM,1
VE,BRAIN OEDEMA,1
VE,BREAST CANCER,1
VE,BREAST CANCER FEMALE,1
VE,BREAST DISORDER,1
VE,BURSITIS,1
VE,CARDIAC FAILURE,1
VE,CARDIAC OPERATION,1
VE,CARDIO-RESPIRATORY ARREST,1
VE,CARTILAGE INJURY,1
VE,CEREBRAL INFARCTION,1
VE,CERVIX DISORDER,1
VE,CHEST DISCOMFORT,1
VE,CHILLS,1
VE,COLORECTAL CANCER,1
VE,CONCOMITANT DISEASE AGGRAVATED,1
VE,CONDITION AGGRAVATED,1
VE,CONTUSION,1
VE,DEHYDRATION,1
VE,DEPRESSION,1
VE,DIABETES MELLITUS,1
VE,DIABETIC COMPLICATION,1
VE,DIET REFUSAL,1
VE,DROOLING,1
VE,DRY SKIN,1
VE,DYSPNOEA,1
VE,DYSURIA,1
VE,ERYTHEMA,1
VE,EXPIRED PRODUCT ADMINISTERED,1
VE,FAECAL VOMITING,1
VE,FEELING ABNORMAL,1
VE,FEELING COLD,1
VE,FEMUR FRACTURE,1
VE,FLAVIVIRUS INFECTION,1
VE,FLUID RETENTION,1
VE,FOOT FRACTURE,1
VE,FRACTURE,1
VE,GAIT INABILITY,1
VE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
VE,GASTRIC CANCER,1
VE,GASTRIC DISORDER,1
VE,GASTRIC ULCER HELICOBACTER,1
VE,GASTROINTESTINAL INFECTION,1
VE,GLAUCOMA,1
VE,HAEMATOCHEZIA,1
VE,HEPATOCELLULAR INJURY,1
VE,HEPATOMEGALY,1
VE,HIP DEFORMITY,1
VE,HYPERSENSITIVITY,1
VE,HYPOAESTHESIA,1
VE,HYPOKINESIA,1
VE,HYSTEROTOMY,1
VE,IMPAIRED DRIVING ABILITY,1
VE,INCOHERENT,1
VE,INFECTION,1
VE,INFLUENZA,1
VE,INTENTIONAL PRODUCT MISUSE,1
VE,INTENTIONAL UNDERDOSE,1
VE,INTERVERTEBRAL DISC DISPLACEMENT,1
VE,INTESTINAL INFARCTION,1
VE,INTESTINAL OBSTRUCTION,1
VE,LARGE INTESTINE BENIGN NEOPLASM,1
VE,LOCAL SWELLING,1
VE,LUNG CANCER METASTATIC,1
VE,LUNG DISORDER,1
VE,MALAISE,1
VE,MONOPLEGIA,1
VE,MUCOSAL INFLAMMATION,1
VE,MUSCULOSKELETAL DISORDER,1
VE,MYALGIA,1
VE,MYCOSIS FUNGOIDES,1
VE,MYELODYSPLASTIC SYNDROME,1
VE,MYOCARDIAL ISCHAEMIA,1
VE,MYOFASCIAL PAIN SYNDROME,1
VE,NAUSEA,1
VE,NERVE COMPRESSION,1
VE,NEURALGIA,1
VE,NEUROLOGICAL EXAMINATION ABNORMAL,1
VE,NIGHTMARE,1
VE,NON-HODGKIN^S LYMPHOMA,1
VE,OEDEMA PERIPHERAL,1
VE,ORAL DISCOMFORT,1
VE,ORAL DISORDER,1
VE,OSTEOARTHRITIS,1
VE,OVERDOSE,1
VE,PANIC REACTION,1
VE,PATIENT-DEVICE INCOMPATIBILITY,1
VE,PERFORATED ULCER,1
VE,PERIPHERAL VASCULAR DISORDER,1
VE,PLATELET COUNT DECREASED,1
VE,PNEUMONIA,1
VE,POISONING,1
VE,PRESYNCOPE,1
VE,PRURITUS GENERALISED,1
VE,READING DISORDER,1
VE,RECTAL HAEMORRHAGE,1
VE,RESPIRATORY FAILURE,1
VE,RHABDOMYOSARCOMA,1
VE,ROTATOR CUFF SYNDROME,1
VE,SARCOMA,1
VE,SCAR,1
VE,SCIATIC NERVE INJURY,1
VE,SEIZURE,1
VE,SICKLE CELL ANAEMIA WITH CRISIS,1
VE,SKIN LESION,1
VE,SKIN ULCER,1
VE,SPINAL DEFORMITY,1
VE,SPINAL PAIN,1
VE,SPONDYLITIS,1
VE,SUICIDE ATTEMPT,1
VE,ULTRASOUND SCAN ABNORMAL,1
VE,UNEVALUABLE EVENT,1
VE,UPPER LIMB FRACTURE,1
VE,URETERIC OBSTRUCTION,1
VE,UTERINE CANCER,1
VE,UTERINE HAEMORRHAGE,1
VE,VARICOSE VEIN,1
VE,VISUAL ACUITY REDUCED,1
VE,VOMITING,1
VE,WALKING DISABILITY,1
VE,WEIGHT INCREASED,1
VN,ACUTE KIDNEY INJURY,1
VN,ANAEMIA,1
VN,ARTHRALGIA,1
VN,CEREBRAL VENTRICLE DILATATION,1
VN,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
VN,FEMUR FRACTURE,1
VN,INTERNAL FIXATION OF FRACTURE,1
VN,LIMB OPERATION,1
VN,PAIN,1
VN,WALKING AID USER,1
VI,DRUG EFFECT INCOMPLETE,2
VI,ANXIETY,1
VI,ASTHENIA,1
VI,CONDITION AGGRAVATED,1
VI,HEADACHE,1
VI,INTENTIONAL PRODUCT MISUSE,1
VI,OEDEMA PERIPHERAL,1
VI,PAIN,1
VI,PALPITATIONS,1
VI,PERIPHERAL SWELLING,1
